
@article{ WOS:000244483200015,
Author = {Batty, G. David and Deary, Ian J. and Macintyre, Sally},
Title = {Childhood IQ in relation to risk factors for premature mortality in
   middle-aged persons: the Aberdeen Children of the 1950s study},
Journal = {JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH},
Year = {2007},
Volume = {61},
Number = {3},
Pages = {241-247},
Month = {MAR},
Abstract = {Objective: A series of studies have shown an association between high
   childhood IQ scores and reduced rates of total mortality in adulthood.
   Several mechanisms have been advanced to explain these relationships,
   including mediation via established risk factors. This study examines
   the association between childhood IQ and a range of established
   physiological and behavioural risk factors for premature mortality in
   adulthood.
   Design, setting and participants: In 1962, 12 150 children took part in
   a school-based survey when their IQ scores were extracted from
   educational records. When re-surveyed forty years later (n = 7183;
   63.7\% response), they self-reported information on risk factors for
   premature mortality (smoking, heavy alcohol consumption, obesity,
   height, hypertension and diabetes).
   Main results: In sex-adjusted analyses based on an analytical sample of
   5340 (2687 women), higher childhood IQ scores were associated with a
   decreased prevalence of ever having smoked regularly in adulthood (ORper
   (SD) (increase) (in) (IQ) (95\% CI): 0.77 (0.73 to 0.81)), heavy alcohol
   consumption (0.89 (0.84 to 0.94)), obesity (0.78 (0.72 to 0.83)) and
   overweight (0.86 (0.81 to 0.91)). Higher IQ scores were similarly
   related to a reduced prevalence of short stature and higher rates of
   smoking cessation in smokers; effects that were stronger in women (p
   value for interaction: <= 0.04). Adjusting for indicators of early and,
   particularly, later-life socioeconomic circumstances led to heavy
   attenuation of these gradients with statistical significance at
   conventional levels lost in most analyses.
   Conclusions: The IQ-risk factor gradients reported may offer some
   insights into the apparent link between high pre-adult IQ and reduced
   mortality rates.},
Publisher = {BMJ PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Batty, GD (Corresponding Author), Univ Glasgow, MRC Social \& Publ Hlth Sci Unit, 4 Lilybank Gardens, Glasgow G12 8RZ, Lanark, Scotland.
   Univ Glasgow, MRC Social \& Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland.
   Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland.},
DOI = {10.1136/jech.2006.048215},
ISSN = {0143-005X},
EISSN = {1470-2738},
Keywords-Plus = {CORONARY-HEART-DISEASE; MENTAL SURVEY 1932; INTELLIGENCE-TEST
   PERFORMANCE; EARLY-LIFE INTELLIGENCE; BODY-MASS INDEX; FOLLOW-UP;
   SOCIOECONOMIC POSITION; EDUCATIONAL-ATTAINMENT; CANCER-MORTALITY;
   BLOOD-PRESSURE},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {david-b@msoc.mrc.gla.ac.uk},
ResearcherID-Numbers = {Deary, Ian J/C-6297-2009
   Batty, GD/Y-4401-2018
   Macintyre, Sally/P-6246-2014},
ORCID-Numbers = {Deary, Ian J/0000-0002-1733-263X
   Batty, GD/0000-0003-1822-5753
   },
Funding-Acknowledgement = {Medical Research CouncilUK Research \& Innovation (UKRI)Medical Research
   Council UK (MRC)European Commission {[}MC\_U130059821] Funding Source:
   Medline; MRCUK Research \& Innovation (UKRI)Medical Research Council UK
   (MRC) {[}MC\_U130059821] Funding Source: UKRI},
Cited-References = {Batty GD, 2006, HEART, V92, P886, DOI 10.1136/hrt.2005.072637.
   Batty GD, 2006, J EPIDEMIOL COMMUN H, V60, P872, DOI 10.1136/jech.2005.045039.
   Batty GD, 2003, BRIT J CANCER, V89, P1243, DOI 10.1038/sj.bjc.6601255.
   Batty GD, 2004, CANCER CAUSE CONTROL, V15, P873, DOI 10.1007/s10552-004-1050-z.
   Batty GD, 2005, INT J OBESITY, V29, P1267, DOI 10.1038/sj.ijo.0803020.
   Batty GD, 2005, PAEDIATR PERINAT EP, V19, P452, DOI 10.1111/j.1365-3016.2005.00671.x.
   Batty GD, 2005, J EPIDEMIOL COMMUN H, V59, P898, DOI 10.1136/jech.2004.030932.
   Batty GD, 2005, J EPIDEMIOL COMMUN H, V59, P809.
   Batty GD, 2005, LANCET, V365, P1765, DOI 10.1016/S0140-6736(05)66573-7.
   Batty GD, 2004, BMJ-BRIT MED J, V329, P585, DOI 10.1136/bmj.329.7466.585.
   Batty GD, 2004, PAEDIATR PERINAT EP, V18, P221, DOI 10.1111/j.1365-3016.2004.00552.x.
   Birch HG, 1970, MENTAL SUBNORMALITY.
   Chandola T, 2006, INT J OBESITY, V30, P1422, DOI 10.1038/sj.ijo.0803279.
   COX DR, 1972, J R STAT SOC B, V34, P187.
   Deary IJ, 2007, INTELLIGENCE, V35, P13, DOI 10.1016/j.intell.2006.02.001.
   Deary IJ, 2006, INT J EPIDEMIOL, V35, P670, DOI 10.1093/ije/dyl053.
   Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130.
   Deary IJ, 2000, INTELLIGENCE, V28, P49, DOI 10.1016/S0160-2896(99)00031-8.
   DEARY IJ, IN PRESS J EPIDEMIOL.
   FULLER JH, 1979, J CHRON DIS, V32, P721, DOI 10.1016/0021-9681(79)90051-1.
   {*}GEN REG OFF, 1951, CLASS OCC 1950.
   Halkjoer J, 2003, OBES RES, V11, P1238, DOI 10.1038/oby.2003.170.
   Hart CL, 2004, SOC SCI MED, V59, P2131, DOI 10.1016/j.socscimed.2004.03.016.
   Hart CL, 2003, PSYCHOSOM MED, V65, P877, DOI 10.1097/01.PSY.0000088584.82822.86.
   Hart CL, 2003, J EPIDEMIOL COMMUN H, V57, P385, DOI 10.1136/jech.57.5.385.
   HAWKES D, ROYAL STAT SOC C STA.
   Hemmingsson T, 2006, INT J EPIDEMIOL, V35, P665, DOI 10.1093/ije/dyi321.
   ILLSLEY R, 1981, PROSPECTIVE LONGITUD, P66.
   Kauhanen J, 1997, EPIDEMIOLOGY, V8, P310, DOI 10.1097/00001648-199705000-00014.
   Kauhanen J, 1997, BMJ-BRIT MED J, V315, P846, DOI 10.1136/bmj.315.7112.846.
   Kubicka L, 2001, ADDICTION, V96, P1615, DOI 10.1046/j.1360-0443.2001.961116158.x.
   Kuh D, 2004, INT J EPIDEMIOL, V33, P408, DOI 10.1093/ije/dyh043.
   Langenberg C, 2005, AM J PUBLIC HEALTH, V95, P628, DOI 10.2105/2004.046219.
   Lawlor DA, 2006, INT J OBESITY, V30, P1758, DOI 10.1038/sj.ijo.0803330.
   Lawlor DA, 2005, AM J PUBLIC HEALTH, V95, P1245, DOI 10.2105/AJPH.2004.041129.
   Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8.
   LI X, 1995, INT J OBESITY, V19, P355.
   LINDGARDE F, 1987, J EPIDEMIOL COMMUN H, V41, P220, DOI 10.1136/jech.41.3.220.
   Martin LT, 2004, J EPIDEMIOL COMMUN H, V58, P674, DOI 10.1136/jech.2003.016444.
   Mortensen LH, 2005, ADDICTION, V100, P1445, DOI 10.1111/j.1360-0443.2005.01229.x.
   MORTON SMB, 2001, J EPIDEMIOL COMMUNIT, V55, pA24.
   Neisser U, 1996, AM PSYCHOL, V51, P77, DOI 10.1037/0003-066X.51.2.77.
   Nishiwaki Yuji, 2005, BMC Med Res Methodol, V5, P16, DOI 10.1186/1471-2288-5-16.
   Osler M, 2004, INT J EPIDEMIOL, V33, P414, DOI 10.1093/ije/dyh095.
   Osler M, 2003, J EPIDEMIOL COMMUN H, V57, P681, DOI 10.1136/jech.57.9.681.
   Parsons TJ, 2005, EUR J CLIN NUTR, V59, P49, DOI 10.1038/sj.ejcn.1602032.
   Scottish Council for Research in Education, 1933, INT SCOTT SCH CHILDR.
   SNOWDON DA, 1999, PARADOXES LONGEVITY, P103, DOI DOI 10.1007/978-3-642-60100-2\_9.
   SONNEHOLM S, 1989, J EPIDEMIOL COMMUN H, V43, P369, DOI 10.1136/jech.43.4.369.
   SORENSEN TIA, 1983, LANCET, V1, P1105.
   SORENSEN TIA, 1985, J BIOSOC SCI, V17, P379.
   Starr JM, 2004, J HYPERTENS, V22, P893, DOI 10.1097/00004872-200405000-00009.
   Taylor MD, 2003, J EPIDEMIOL COMMUN H, V57, P464, DOI 10.1136/jech.57.6.464.
   TEASDALE TW, 1992, HUM BIOL, V64, P99.
   van Lenthe FJ, 2001, J EPIDEMIOL COMMUN H, V55, P681, DOI 10.1136/jech.55.9.681.
   Wadsworth MEJ, 2003, SOC SCI MED, V57, P2193, DOI 10.1016/S0277-9536(03)00083-2.
   Whalley LJ, 2001, BRIT MED J, V322, P819, DOI 10.1136/bmj.322.7290.819.
   World Health Organization, 1995.
   Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487.},
Number-of-Cited-References = {59},
Times-Cited = {100},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {13},
Journal-ISO = {J. Epidemiol. Community Health},
Doc-Delivery-Number = {140DG},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000244483200015},
OA = {Green Published},
DA = {2022-03-29},
}

@article{ WOS:000592723900049,
Author = {Frieden, Thomas R. and Cobb, Laura K. and Leidig, Robynn C. and Mehta,
   Sumi and Kass, Daniel},
Title = {Reducing Premature Mortality from Cardiovascular and Other
   Non-Communicable Diseases by One Third: Achieving Sustainable
   Development Goal Indicator 3.4.1},
Journal = {GLOBAL HEART},
Year = {2020},
Volume = {15},
Number = {1},
Abstract = {Non-communicable diseases (NCDs) are the world's leading causes of death
   and disability, with cardiovascular disease (CVD) accounting for half of
   NCD deaths. An ambitious global target established by the United Nations
   Sustainable Development Goals - indicator 3.4.1 - aims to reduce the
   risk of premature death among people aged 30-69 years from CVD, cancer,
   diabetes, and chronic lung disease by one third by 2030. This article
   reviews the science and practice informing what is required to achieve
   this target, identifying seven interventions that can accelerate
   progress: 1) tobacco control; 2) treatment to reduce cardiovascular
   risk; 3) reduction of dietary sodium; 4) reduction of household air
   pollution; 5) elimination of artificial trans fat; 6) reduction of
   alcohol use; and 7) prevention, detection, and treatment of cancers.
   Achieving the target is possible - there has already been progress in
   some areas, particularly related to CVD reduction - but only if there is
   faster, more concerted action.},
Publisher = {UBIQUITY PRESS LTD},
Address = {Unit 3.22, East London Works, 65-75 Whitechapel Road, LONDON, E1 1DU,
   ENGLAND},
Type = {Review},
Language = {English},
Affiliation = {Frieden, TR (Corresponding Author), Resolve To Save Lives, New York, NY 10005 USA.
   Frieden, Thomas R.; Cobb, Laura K.; Leidig, Robynn C., Resolve To Save Lives, New York, NY 10005 USA.
   Mehta, Sumi; Kass, Daniel, Vital Strategies, New York, NY USA.},
DOI = {10.5334/gh.531},
Article-Number = {50},
ISSN = {2211-8160},
EISSN = {2211-8179},
Keywords = {noncommunicable disease prevention; cardiovascular disease prevention;
   public health interventions; public health policy; global health;
   tobacco control},
Keywords-Plus = {SYSTEMATIC ANALYSIS; AIR-POLLUTION; HYPERTENSION; PREVENTION; POLYPILL;
   DEATHS; UPDATE; TRENDS},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems},
Author-Email = {tfrieden@rtsl.org},
Cited-References = {Afshin A, 2019, LANCET, V393, P1958, DOI 10.1016/S0140-6736(19)30041-8.
   Angell SY, 2015, LANCET, V385, P825, DOI 10.1016/S0140-6736(14)62256-X.
   {[}Anonymous], 2018, 2016 DIS BURD MORT E.
   {[}Anonymous], 2014, HLTH CONSMOK 50 YE.
   {[}Anonymous], 2019, WORLD POP PROSP 2019.
   {[}Anonymous], 2019, 90 90 90 AMB TREATM.
   {[}Anonymous], 2012, POL DECL HIGH LEV M.
   {[}Anonymous], 2018, SURV RAT COL CANC.
   {[}Anonymous], 2017, BEST BUYS OTH REC IN.
   {[}Anonymous], 2013, HOUS EN COOK PROJ DE.
   {[}Anonymous], 2015, INDICATORS MONITORIN.
   {[}Anonymous], 2018, SAFER PREV RED ALC R.
   {[}Anonymous], 2020, GLOBAL AIDS UPDATE 2.
   {[}Anonymous], 2007, PREV CARD DIS GUID A.
   {[}Anonymous], 2012, GLOB DAT IMPL NUTR A.
   {[}Anonymous], 2016, 3 HIGH LEV M GEN ASS.
   {[}Anonymous], 2019, STAT GLOB AIR.
   Bennett JE, 2018, LANCET, V392, P1072, DOI 10.1016/S0140-6736(18)31992-5.
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1.
   Bruni L, 2016, LANCET GLOB HEALTH, V4, pE453, DOI 10.1016/S2214-109X(16)30099-7.
   Campbell NRC, 2019, J CLIN HYPERTENS, V21, P700, DOI 10.1111/jch.13551.
   Cappuccio FP, 2019, NUTR METAB CARDIOVAS, V29, P107, DOI 10.1016/j.numecd.2018.11.010.
   Centers for Disease Control and Prevention, 1999, MMWR-MORBID MORTAL W, V48, P241, DOI DOI 10.1001/JAMA.281.16.1481.
   Corvalan C, 2019, OBES REV, V20, P367, DOI 10.1111/obr.12802.
   Council on Foreign Relations, 2014, EMERGING GLOBAL HLTH.
   Data from: Tobacco Free Institute (TFI), 2018, DAT TOB FREE I TFI G.
   Department of Economic and Social Affairs, 2012, POP FACTS POP AG NON.
   Dusing R, 2017, J HUM HYPERTENS, V31, P501, DOI 10.1038/jhh.2017.5.
   Farley TA, 2010, AM J PREV MED, V38, P600, DOI 10.1016/j.amepre.2010.02.016.
   Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8.
   Frieden TR, 2019, J CLIN HYPERTENS, V21, P1442, DOI 10.1111/jch.13655.
   Frieden TR, 2018, LANCET, V391, P709, DOI 10.1016/S0140-6736(17)32443-1.
   Furman J, 2016, P WINN TAX WARS GLOB.
   He FJ, 2018, INT J EPIDEMIOL, V47, P1784, DOI 10.1093/ije/dyy114.
   Jemal I, 2019, CANC ATLAS, P29.
   Kishore SP, 2018, LANCET, V392, P819, DOI 10.1016/S0140-6736(18)31814-2.
   Kochanek Kenneth D, 2019, Natl Vital Stat Rep, V68, P1.
   Kontis V, 2014, LANCET, V384, P427, DOI 10.1016/S0140-6736(14)60616-4.
   Kontis V, 2019, CIRCULATION, V140, P715, DOI 10.1161/CIRCULATIONAHA.118.038160.
   Lloyd-Jones DM, 2019, J AM COLL CARDIOL, V73, P3153, DOI 10.1016/j.jacc.2018.11.005.
   Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912.
   Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127.
   Munoz D, 2019, NEW ENGL J MED, V381, P1114, DOI 10.1056/NEJMoa1815359.
   Norheim OF, 2015, LANCET, V385, P239, DOI 10.1016/S0140-6736(14)61591-9.
   Padwal RS, 2016, CAN J CARDIOL, V32, P687, DOI 10.1016/j.cjca.2015.07.734.
   Powles J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003733.
   Rajagopalan S, 2018, J AM COLL CARDIOL, V72, P2054, DOI 10.1016/j.jacc.2018.07.099.
   Roshandel G, 2019, LANCET, V394, P672, DOI 10.1016/S0140-6736(19)31791-X.
   Salam A, 2019, J HYPERTENS, V37, P1567, DOI 10.1097/HJH.0000000000002089.
   Selak V, 2019, HEART, V105, P42, DOI 10.1136/heartjnl-2018-313108.
   Sustainable Development Goals, 2015, GOAL 3 ENS HLTH LIV.
   Tripathi A, 2019, UJJWALA 2 0 ACCESS S.
   W. World Health Organization, 2019, CANCER.
   Wang Q, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002891.
   Webster R, 2018, JAMA-J AM MED ASSOC, V320, P566, DOI 10.1001/jama.2018.10359.
   WHO, 2019, WHO REP GLOB TOB EP.
   WHO, 2016, SHAKE SALT HAB TECHN.
   WHO, 2016, HEARTS TECHN PACK CA.
   WHO, 2019, COUNTD 2023 WHO REP COUNTD 2023 WHO REP.
   WHO, 2019, IMM COV KEY FACTS.
   World Health Orgainzation, 2014, WHO GUID IND AIR QUA.
   World Health Organization, 2018, REPLACE T FAT ACT PA.
   World Health Organization, 2019, WORLD HLTH STAT 2019, V2019.
   World Health Organization, 2008, MPOWER POL PACK REV.
   World Health Organization, 2019, GLOBAL STATUS REPORT.
   World Health Organization. (WHO), 2013, GLOB ACT PLAN PREV C.},
Number-of-Cited-References = {66},
Times-Cited = {4},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Glob. Heart},
Doc-Delivery-Number = {OW2LA},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000592723900049},
OA = {gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000332769700015,
Author = {Fazel, Seena and Wolf, Achim and Pillas, Demetris and Lichtenstein, Paul
   and Langstrom, Niklas},
Title = {Suicide, Fatal Injuries, and Other Causes of Premature Mortality in
   Patients With Traumatic Brain Injury A 41-Year Swedish Population Study},
Journal = {JAMA PSYCHIATRY},
Year = {2014},
Volume = {71},
Number = {3},
Pages = {326-333},
Month = {MAR},
Abstract = {IMPORTANCE Longer-term mortality in individuals who have survived a
   traumatic brain injury (TBI) is not known.
   OBJECTIVES To examine the relationship between TBI and premature
   mortality, particularly by external causes, and determine the role of
   psychiatric comorbidity.
   DESIGN, SETTING, AND PATIENTS We studied all persons born in 1954 or
   later in Sweden who received inpatient and outpatient International
   Classification of Diseases-based diagnoses of TBI from 1969 to 2009 (n =
   218 300). We compared mortality rates 6 months or more after TBI to
   general population controls matched on age and sex (n = 2 163 190) and
   to unaffected siblings of patients with TBI (n = 150 513). Furthermore,
   we specifically examined external causes of death (suicide, injury, or
   assault). We conducted sensitivity analyses to investigate whether
   mortality rates differed by sex, age at death, severity (including
   concussion), and different follow-up times after diagnosis.
   MAIN OUTCOMES AND MEASURES Adjusted odds ratios (AORs) of premature
   death by external causes in patients with TBI compared with general
   population controls.
   RESULTS Among those who survived 6 months after TBI, we found a 3-fold
   increased odds of mortality (AOR, 3.2; 95\% CI, 3.0-3.4) compared with
   general population controls and an adjusted increased odds of mortality
   of 2.6 (95\% CI, 2.3-2.8) compared with unaffected siblings. Risks of
   mortality from external causes were elevated, including for suicide
   (AOR, 3.3; 95\% CI, 2.9-3.7), injuries (AOR, 4.3; 95\% CI, 3.8-4.8), and
   assault (AOR, 3.9; 95\% CI, 2.7-5.7). Among those with TBI, absolute
   rates of death were high in those with any psychiatric or substance
   abuse comorbidity (3.8\% died prematurely) and those with solely
   substance abuse (6.2\%) compared with those without comorbidity (0.5\%).
   CONCLUSIONS AND RELEVANCE Traumatic brain injury is associated with
   substantially elevated risks of premature mortality, particularly for
   suicide, injuries, and assaults, even after adjustment for
   sociodemographic and familial factors. Current clinical guidelines may
   need revision to reduce mortality risks beyond the first few months
   after injury and address high rates of psychiatric comorbidity and
   substance abuse.},
Publisher = {AMER MEDICAL ASSOC},
Address = {330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA},
Type = {Article},
Language = {English},
Affiliation = {Fazel, S (Corresponding Author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.
   Fazel, Seena; Wolf, Achim, Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.
   Pillas, Demetris, UCL, Dept Epidemiol \& Publ Hlth, London, England.
   Lichtenstein, Paul; Langstrom, Niklas, Karolinska Inst, Dept Med Epidemiol \& Biostat, Stockholm, Sweden.},
DOI = {10.1001/jamapsychiatry.2013.3935},
ISSN = {2168-622X},
EISSN = {2168-6238},
Keywords-Plus = {UNITED-STATES; HEAD-INJURY; RISK; SCHIZOPHRENIA; DIAGNOSES; DISCHARGE;
   REGISTER; HEALTH; DISORDERS; VALIDITY},
Research-Areas = {Psychiatry},
Web-of-Science-Categories  = {Psychiatry},
Author-Email = {seena.fazel@psych.ox.ac.uk},
ResearcherID-Numbers = {Langstrom, Niklas/C-5615-2009
   Fazel, Seena/B-5307-2008
   },
ORCID-Numbers = {Langstrom, Niklas/0000-0002-2686-6799
   Fazel, Seena/0000-0002-5383-5365
   lichtenstein, paul/0000-0003-3037-5287},
Funding-Acknowledgement = {Wellcome TrustWellcome TrustEuropean Commission {[}095806]; Swedish
   Prison and Probation Service; Swedish Research CouncilSwedish Research
   CouncilEuropean Commission},
Funding-Text = {This study was funded by grant 095806 from the Wellcome Trust (Dr Fazel
   and Mr Wolf), the Swedish Prison and Probation Service (Dr Langstrom),
   and the Swedish Research Council (Drs Lichtenstein and Langstrom).},
Cited-References = {ACHTE KA, 1971, ACTA PSYCHIAT SCAND, P1.
   Ameratunga S, 2006, LANCET, V367, P1533, DOI 10.1016/S0140-6736(06)68654-6.
   Bartlett J, 1998, BRIT J NEUROSURG, V12, P349, DOI 10.1080/02688699844871.
   Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599.
   Brown AW, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318280d3e6.
   Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093.
   Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531.
   Coronado V. G., 2011, SURVEILLANCE FOR TRA.
   Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011.
   Dalman C, 2002, SOC PSYCH PSYCH EPID, V37, P527, DOI 10.1007/s00127-002-0582-3.
   Ekholm B, 2005, NORD J PSYCHIAT, V59, P457, DOI 10.1080/08039480500360906.
   Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53.
   Fazel S, 2013, LANCET, V382, P1646, DOI 10.1016/S0140-6736(13)60899-5.
   Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150.
   Fazel S, 2009, JAMA-J AM MED ASSOC, V301, P2016, DOI 10.1001/jama.2009.675.
   Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119.
   Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250.
   Gedeborg R, 2008, EPIDEMIOLOGY, V19, P860, DOI 10.1097/EDE.0b013e318181319e.
   Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972.
   Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17.
   Horton R, 2013, LANCET, V381, P509, DOI 10.1016/S0140-6736(13)60100-2.
   Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341.
   Hyder AA, 2007, NEUROREHABILITATION, V22, P341.
   JIANG GX, 1995, ACTA NEUROL SCAND, V91, P109.
   Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3.
   Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742.
   Klein-Geltink JE, 2007, J CLIN EPIDEMIOL, V60, P766, DOI 10.1016/j.jclinepi.2006.11.008.
   LINDBLAD U, 1993, SCAND J SOC MED, V21, P3, DOI 10.1177/140349489302100102.
   Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450.
   Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9.
   Mathers C, 2008, THE GLOBAL BURDEN OF.
   McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232.
   National Board of Health and Welfare, CAUSE OF DEATH REGIS.
   National Institute for Health and Clinical Excellence, 2004, SELF HARM THE SHORT.
   Neeleman J, 1997, PSYCHOL MED, V27, P467, DOI 10.1017/S0033291796004631.
   Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95.
   Redelmeier DA, 2003, LANCET, V361, P2177, DOI 10.1016/S0140-6736(03)13770-1.
   Ruff RL, 2012, JAMA-J AM MED ASSOC, V308, P2032, DOI 10.1001/jama.2012.14008.
   Runeson B, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3222.
   SACKS JJ, 1991, JAMA-J AM MED ASSOC, V266, P3016, DOI 10.1001/jama.266.21.3016.
   Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008.
   Sellgren C, 2011, ACTA PSYCHIAT SCAND, V124, P447, DOI 10.1111/j.1600-0447.2011.01747.x.
   Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009.
   SOSIN DM, 1990, JAMA-J AM MED ASSOC, V264, P2395, DOI 10.1001/jama.264.18.2395.
   Statistics Sweden, 2005, FLERGENERATIONSREGIS.
   Swedish National Board of Health and Welfare, PATIENTREGISTRET.
   Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436.
   Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151.
   Volavka J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001148.
   Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac.},
Number-of-Cited-References = {50},
Times-Cited = {95},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {16},
Journal-ISO = {JAMA Psychiatry},
Doc-Delivery-Number = {AC8FU},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000332769700015},
OA = {Green Accepted, Bronze},
DA = {2022-03-29},
}

@article{ WOS:000482101600033,
Author = {Awuor, Luckrezia and Melles, Stephanie},
Title = {The influence of environmental and health indicators on premature
   mortality: An empirical analysis of the City of Toronto's 140
   neighborhoods},
Journal = {HEALTH \& PLACE},
Year = {2019},
Volume = {58},
Month = {JUL},
Abstract = {The objective of this paper was to assess the link between premature
   mortality and a combination of neighbourhood contextual (environmental
   and health) and compositional (socioeconomic and demographic)
   characteristics. We statistically and spatially examined six
   environmental variables (ultrafine particles, carcinogenic and
   non-carcinogenic pollutants, pollution released to air, tree cover, and
   walkability index), six health service indicators (number health
   providers, breast, colorectal and cervical cancer screening uptake
   rates, student nutrition program uptake rates, and healthy food index),
   and eight socioeconomic indicators (total income, Gini coefficient, two
   age categories-below and above 40 years, proportion of females to males,
   visible minorities, Indigenous peoples, education, less than grade 9)
   among 140 neighbourhoods of the City of Toronto in Ontario (Canada). We
   applied principal component analysis to identify patterns and to reduce
   the number of explanatory variables into combined component axes that
   represent unique variation in these confounded and overlapping factors.
   We then applied regression analysis to model the relationship between
   the indices of enviro-health and socioeconomics and their potential
   relationship with premature mortality. Residual spatial analysis was
   used to investigate any remaining spatial structure (such as
   neighbourhoods with higher residual premature mortality rates).
   Neighbourhood Equity Index was correlated with our enviro-health and
   socioeconomic indices. Premature mortality within neighbourhoods was
   predicted by poor cancer screenings, pollution, lack of tree canopy,
   increased uptake of student nutrition programs and high walkability
   index. A negative association between premature mortality and pollution
   was associated low walkability index and presence of visible minorities
   within neighbourhoods. There was some unexplained residual spatial
   variation in our model of premature mortality-especially along the
   shores of Lake Ontario and in neighbourhoods with major highways or road
   corridors: premature mortality in Toronto neighbourhoods was higher than
   expected along highway-corridor neighbourhoods and shorelines. Our
   analysis revealed a significant relationship between neighbourhood
   contextual features-both environmental and health-and premature
   mortality, suggesting that these contextual components of neighbourhoods
   can predict rates of urban premature mortality in Toronto.},
Publisher = {ELSEVIER SCI LTD},
Address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Awuor, L (Corresponding Author), Ryerson Univ, Sch Occupat \& Publ Hlth, Environm Appl Sci \& Management Yeates Sch Grad St, 350 Victoria St, Toronto, ON M5B 2K3, Canada.
   Melles, S (Corresponding Author), Ryerson Univ, Dept Chem \& Biol, Environm Appl Sci \& Management Yeates Sch Grad St, 350 Victoria St, Toronto, ON M5B 2K3, Canada.
   Awuor, Luckrezia, Ryerson Univ, Sch Occupat \& Publ Hlth, Environm Appl Sci \& Management Yeates Sch Grad St, 350 Victoria St, Toronto, ON M5B 2K3, Canada.
   Melles, Stephanie, Ryerson Univ, Dept Chem \& Biol, Environm Appl Sci \& Management Yeates Sch Grad St, 350 Victoria St, Toronto, ON M5B 2K3, Canada.},
DOI = {10.1016/j.healthplace.2019.102155},
Article-Number = {102155},
ISSN = {1353-8292},
EISSN = {1873-2054},
Keywords = {Premature mortality; Contextual factors; Neighbourhood; Cancer
   screening; Walkability; Tree cover; Green space; Healthy food
   environment; Pollution; Public health; Neighbourhood equity; Built
   environment},
Keywords-Plus = {URBAN GREEN SPACE; PHYSICAL-ACTIVITY; CERVICAL-CANCER; BREAST-CANCER;
   AIR-POLLUTION; UNITED-STATES; DEPRIVATION; INEQUALITIES; IMPACT; ONTARIO},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {lawuor@ryerson.ca
   stephanie.melles@ryerson.ca},
ResearcherID-Numbers = {Melles, Stephanie/AAH-1507-2020},
ORCID-Numbers = {Melles, Stephanie/0000-0002-2983-8136},
Cited-References = {Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101.
   Akinyemiju T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012753.
   Anderson RT, 2014, HEALTH SERV RES, V49, P546, DOI 10.1111/1475-6773.12108.
   {[}Anonymous], 2013, ENV REPORTING DISCLO.
   {[}Anonymous], 2018, NEIGHBOURHOOD PROFIL.
   {[}Anonymous], 2018, NEIGHBOURHOOD IMPROV.
   {[}Anonymous], 2017, BACKGROUNDER 2016 CE.
   {[}Anonymous], 2014, TSNS 2020 NEIGHBOURH, P4.
   Canadian Cancer Statistics Advisory Committee, 2018, CANADIAN CANC STAT.
   Chan W, 2014, DIABETIC MED, V31, P806, DOI 10.1111/dme.12422.
   CIHI-Canadian Institute for Health Information, 2005, DEV HLTH COMM IND CO.
   CIHI-Canadian Institute for Health Information, 2012, HLTH IND 2012.
   City of Toronto, 2015, TORONTO STRONG NEIGH.
   Clark A. E., 2016, 23 ANN C EUR EC ASS, V7, P519.
   Coldman A, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju261.
   Coulton C, 2012, CITYSCAPE, V14, P231.
   de Souza RJ, 2018, CITIES HLTH, V2, P163, DOI DOI 10.1080/23748834.2018.1548071.
   Doubeni CA, 2012, AM J PUBLIC HEALTH, V102, P680, DOI 10.2105/AJPH.2011.300158.
   Droomers M, 2016, J EPIDEMIOL COMMUN H, V70, P147, DOI 10.1136/jech-2014-205210.
   Ellen IG, 2001, J URBAN AFF, V23, P391, DOI 10.1111/0735-2166.00096.
   Engler-Stringer R, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-522.
   EVANS M, 2006, INFORM EC ACTIVITIES.
   Finch BK, 2010, HEALTH PLACE, V16, P1058, DOI 10.1016/j.healthplace.2010.05.009.
   Frank LD, 2005, INT REGIONAL SCI REV, V28, P193, DOI 10.1177/0160017604273853.
   Galster G, 2001, URBAN STUD, V38, P2111, DOI 10.1080/00420980120087072.
   Gower S., 2014, PATH TO HEALTHIER AI, DOI {[}10.13140/2.1.4817.5363, DOI 10.13140/2.1.4817.5363].
   Gurjar B.R., 2010, AIR POLLUTION HLTH E, VFirst.
   Israel BA, 2006, J URBAN HEALTH, V83, P523, DOI 10.1007/s11524-006-9053-6.
   JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574.
   James P, 2015, ENVIRON RES, V142, P703, DOI 10.1016/j.envres.2015.09.005.
   Jemal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002181.
   Jolliffe I.T, 2002, ENCY STAT BEHAV SCI, DOI DOI 10.2307/1270093.
   Kamphuis CBM, 2006, BRIT J NUTR, V96, P620, DOI 10.1079/BJN20061896.
   Kardan O, 2015, SCI REP-UK, V5, DOI 10.1038/srep11610.
   KATZ SJ, 1994, JAMA-J AM MED ASSOC, V272, P530, DOI 10.1001/jama.272.7.530.
   Kawachi, 2003, NEIGHBORHOODS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195138382.001.0001.
   Kawachi I., 2003, NEIGHBOURHOODS HLTH, P45, DOI DOI 10.1093/ACPROF:OSO/9780195138382.003.0003.
   Lachowycz K, 2011, OBES REV, V12, pe183, DOI 10.1111/j.1467-789X.2010.00827.x.
   Lee ACK, 2011, J PUBLIC HEALTH-UK, V33, P212, DOI 10.1093/pubmed/fdq068.
   Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371.
   Lian M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043000.
   Lin SJ, 2008, J R SOC PROMO HEALTH, V128, P327, DOI 10.1177/1466424007092802.
   Lupton R., 2003, CASE73.
   Maas J, 2009, J EPIDEMIOL COMMUN H, V63, P967, DOI 10.1136/jech.2008.079038.
   Marshall JD, 2009, ENVIRON HEALTH PERSP, V117, P1752, DOI 10.1289/ehp.0900595.
   Nowak David J., 2006, Urban Forestry \& Urban Greening, V5, P93, DOI {[}10.1016/j.ufug.2006.04.002, 10.1016/j.ufug.2006.01.007].
   O'Campo P, 2015, HEALTH PLACE, V31, P65, DOI 10.1016/j.healthplace.2014.11.001.
   Ollevier M., 2007, ENV JUSTICE TORONTO.
   Ontario Medical Association, 2005, ILLN COSTS AIR POLL, V11.
   Ontario Trillium Foundation, 2019, CAN IND WELLB.
   Ontario Trillium Foundation, 2014, AR ONT REALL DOING.
   Park MJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-257.
   Parrish RG, 2010, PREV CHRONIC DIS, V7.
   Pearce J, 2007, INT J EPIDEMIOL, V36, P348, DOI 10.1093/ije/dyl267.
   Pearce JR, 2011, SOC SCI MED, V73, P410, DOI 10.1016/j.socscimed.2011.05.039.
   Pearce JR, 2010, T I BRIT GEOGR, V35, P522, DOI 10.1111/j.1475-5661.2010.00399.x.
   Pruss-Ustun A, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-9.
   Raudenbush S., 2003, NEIGHBORHOODS HLTH, DOI {[}10.1093/acprof:oso/9780195138382.001.0001, DOI 10.1093/ACPROF:OSO/9780195138382.001.0001].
   Richardson EA, 2013, PUBLIC HEALTH, V127, P318, DOI 10.1016/j.puhe.2013.01.004.
   Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303.
   Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x.
   Sabaliauskas K, 2015, ATMOS ENVIRON, V110, P84, DOI 10.1016/j.atmosenv.2015.02.018.
   Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401.
   Sampson R.J., 2003, NEIGHBORHOODS HLTH, P132, DOI DOI 10.1093/ACPROF:OSO/9780195138382.003.0006.
   Sampson RJ, 2003, PERSPECT BIOL MED, V46, pS53, DOI 10.1353/pbm.2003.0073.
   Schwartz J, 1996, J AIR WASTE MANAGE, V46, P927, DOI 10.1080/10473289.1996.10467528.
   Shortt NK, 2012, HEALTH PLACE, V18, P1132, DOI 10.1016/j.healthplace.2012.04.008.
   Stafford M, 2003, INT J EPIDEMIOL, V32, P357, DOI 10.1093/ije/dyg084.
   Swan J, 2003, CANCER, V97, P1528, DOI 10.1002/cncr.11208.
   Teelucksingh C., 2002, ETHNOLOGIES, V24, P119.
   Toronto Public Health, 2013, TRACK RED CHEM TOR C.
   Toronto Public Health, 2015, UN CIT 2015 INC HLTH.
   Toronto Public Health, 2008, UN CIT INC HLTH IN T.
   Toronto Public Health, 2012, WALK CIT NEIGHB DES.
   Towne SD, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-18.
   Tunstall H, 2004, INT J EPIDEMIOL, V34, P231, DOI DOI 10.1093/IJE/DYH3871.
   United Way of Greater Toronto and Canadian Council on Social Development, 2004, POV POST COD GEOGR N.
   Villeneuve PJ, 2012, ENVIRON RES, V115, P51, DOI 10.1016/j.envres.2012.03.003.
   Weinhold B, 2011, ENVIRON HEALTH PERSP, V119, pA162, DOI 10.1289/ehp.119-a162.
   Wilson M, 1997, BRIT MED J, V314, P1271, DOI 10.1136/bmj.314.7089.1271.
   Wolfson M, 1999, BRIT MED J, V319, P953, DOI 10.1136/bmj.319.7215.953.
   World Health Organization, 1946, CONST WHO.
   World Health Organization, 2015, REF MAN SERV AV READ, DOI {[}10.1021/la951504r, DOI 10.1021/LA951504R].
   Zimmerman E., 2018, NAM PERSPECT, V4, DOI {[}DOI 10.31478/201406A, 10.31478/201406a].
   Zupancic T., 2015, IMPACT GREEN SPACE H.},
Number-of-Cited-References = {85},
Times-Cited = {6},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {17},
Journal-ISO = {Health Place},
Doc-Delivery-Number = {IS4CT},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000482101600033},
DA = {2022-03-29},
}

@article{ WOS:000522388500042,
Author = {Sohrabi, Soheil and Zietsman, Joe and Khreis, Haneen},
Title = {Burden of Disease Assessment of Ambient Air Pollution and Premature
   Mortality in Urban Areas: The Role of Socioeconomic Status and
   Transportation},
Journal = {INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH},
Year = {2020},
Volume = {17},
Number = {4},
Month = {FEB},
Abstract = {With recent rapid urbanization, sustainable development is required to
   prevent health risks associated with adverse environmental exposures
   from the unsustainable development of cities. Ambient air pollution is
   the greatest environmental risk factor for human health and is
   responsible for considerable levels of mortality worldwide. Burden of
   disease assessment (BoD) of air pollution in and across cities, and how
   these estimates vary according to socioeconomic status and exposure to
   road traffic, can help city planners and health practitioners to
   mitigate adverse exposures and promote public health. In this study, we
   quantified the health impacts of air pollution exposure (PM2.5 and NO2)
   at the census tract level in Houston, Texas, employing a standard BoD
   assessment framework to estimate the premature deaths (adults 30 to 78
   years old) attributable to PM2.5 and NO2. We found that 631 (95\% CI:
   366-809) premature deaths were attributable to PM2.5 in Houston, and 159
   (95\% CI: 0-609) were attributable to NO2, in 2010. Complying with the
   World Health Organization air quality guidelines (annual mean: 10 mu
   g/m(3) for PM2.5) and the US National Ambient Air Quality standard
   (annual mean: 12 mu g/m(3) for PM2.5) could save 82 (95\% CI: 42-95) and
   8 (95\% CI: 6-10) lives in Houston, respectively. PM2.5 was responsible
   for 7.3\% of all-cause premature deaths in Houston, in 2010, which is
   higher than the death rate associated with diabetes mellites,
   Alzheimer's disease, or motor vehicle crashes in the US. Households with
   lower income had a higher risk of adverse exposure and attributable
   premature deaths. We also showed a positive relationship between health
   impacts attributable to air pollution and road traffic passing through
   census tracts, which was more prominent for NO2.},
Publisher = {MDPI},
Address = {ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND},
Type = {Article},
Language = {English},
Affiliation = {Khreis, H (Corresponding Author), Texas A\&M Transportat Inst TTI, CARTEEH, College Stn, TX 77843 USA.
   Khreis, H (Corresponding Author), Barcelona Inst Global Hlth ISGlobal, Ctr Res Environm Epidemiol CREAL, Barcelona 08003, Spain.
   Sohrabi, Soheil, Texas A\&M Univ, Zachry Dept Civil Engn, College Stn, TX 77840 USA.
   Sohrabi, Soheil; Zietsman, Joe; Khreis, Haneen, Texas A\&M Transportat Inst TTI, CARTEEH, College Stn, TX 77843 USA.
   Khreis, Haneen, Barcelona Inst Global Hlth ISGlobal, Ctr Res Environm Epidemiol CREAL, Barcelona 08003, Spain.},
DOI = {10.3390/ijerph17041166},
Article-Number = {1166},
EISSN = {1660-4601},
Keywords = {burden of disease; air pollution; premature deaths; attributable deaths;
   road traffic; socioeconomic inequities; United States},
Keywords-Plus = {PLANNING RELATED EXPOSURES; HEALTH IMPACT ASSESSMENT; LAND-USE
   REGRESSION; SUSTAINABLE DEVELOPMENT; INCOME INEQUALITY; NO2; CO},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {sohrabi.s@tamu.edu
   zietsman@tamu.edu
   h-khreis@tti.tamu.edu},
ResearcherID-Numbers = {Sohrabi, Soheil/AAD-2114-2020},
Funding-Acknowledgement = {Texas A\&M Transportation Institute's (TTI) Center for Advancing
   Research in Transportation Emissions, Energy, and Health (CARTEEH), a
   U.S. Department of Transportation's University Transportation Center
   {[}69A3551747128]},
Funding-Text = {This research was made possible by funding from the Texas A\&M
   Transportation Institute's (TTI) Center for Advancing Research in
   Transportation Emissions, Energy, and Health (CARTEEH), a U.S.
   Department of Transportation's University Transportation Center with the
   grant number (69A3551747128).},
Cited-References = {Alotaibi R, 2019, ENVIRON INT, V127, P858, DOI 10.1016/j.envint.2019.03.041.
   Anderson RT, 1997, EPIDEMIOLOGY, V8, P42, DOI 10.1097/00001648-199701000-00007.
   {[}Anonymous], 2013, FED REG, V78, P78.
   Bechle MJ, 2015, ENVIRON SCI TECHNOL, V49, P12297, DOI 10.1021/acs.est.5b02882.
   Beelen R, 2009, SCI TOTAL ENVIRON, V407, P1852, DOI 10.1016/j.scitotenv.2008.11.048.
   Beelen R, 2014, LANCET, V383, P785, DOI 10.1016/S0140-6736(13)62158-3.
   Bhalla K., 2014, TRANSP HLTH GLOB BUR.
   Bhanarkar AD, 2005, ATMOS ENVIRON, V39, P7745, DOI 10.1016/j.atmosenv.2005.07.070.
   Bronnum-Hansen H, 2018, ENVIRON INT, V121, P973, DOI 10.1016/j.envint.2018.09.050.
   Cesaroni G, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7412.
   Cesaroni G, 2013, ENVIRON HEALTH PERSP, V121, P324, DOI 10.1289/ehp.1205862.
   Christina H.F., 2020, TRAFFIC RELATED AIR.
   Clark LP, 2017, ENVIRON HEALTH PERSP, V125, DOI {[}10.1289/EHP959, 10.1289/ehp959].
   Colvile RN, 2004, SCI TOTAL ENVIRON, V334, P481, DOI 10.1016/j.scitotenv.2004.04.052.
   DOUGHTY J H, 1951, Can J Public Health, V42, P134.
   Environmental Protection Agency, 1971, FED REGISTER.
   Garling T, 2007, J SOC ISSUES, V63, P139, DOI 10.1111/j.1540-4560.2007.00500.x.
   Goodkind AL, 2019, P NATL ACAD SCI USA, V116, P8775, DOI 10.1073/pnas.1816102116.
   Hao JM, 2001, J ENVIRON SCI HEAL A, V36, P215, DOI 10.1081/ESE-100102619.
   Health Effects Institute, 2010, TRAFF REL AIR POLL C TRAFF REL AIR POLL C.
   Holnicki P, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111359.
   Hystad P, 2011, ENVIRON HEALTH PERSP, V119, P1123, DOI 10.1289/ehp.1002976.
   Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012.
   Kates RW, 2005, ENVIRONMENT, V47, P8.
   Kheirbek I, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0172-6.
   Khreis H, 2018, ENVIRON INT, V114, P365, DOI 10.1016/j.envint.2018.03.008.
   Khreis H, 2016, J TRANSP HEALTH, V3, P249, DOI 10.1016/j.jth.2016.07.002.
   Kim S.-Y., PARSIMONIOUS APPROAC.
   Kurt OK, 2016, CURR OPIN PULM MED, V22, P138, DOI 10.1097/MCP.0000000000000248.
   Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371.
   Mueller N, 2018, ENVIRON INT, V121, P931, DOI 10.1016/j.envint.2018.10.017.
   Mueller N, 2017, ENVIRON INT, V107, P243, DOI 10.1016/j.envint.2017.07.020.
   Mueller N, 2017, ENVIRON HEALTH PERSP, V125, P89, DOI 10.1289/EHP220.
   Murphy SL., 2013, DEATHS FINAL DATA 20.
   New York City New York Population, 2019, WORLD POPULATION REV.
   Pickett KE, 2015, SOC SCI MED, V128, P316, DOI 10.1016/j.socscimed.2014.12.031.
   Raaschou-Nielsen O, 2013, LANCET ONCOL, V14, P813, DOI 10.1016/S1470-2045(13)70279-1.
   Sa T. H. de, 2017, Environment International, V108, P22.
   Savage M, 2019, J IMMUNOTHER CANCER, V7.
   Sundvor I., 2012, 201214 ETCACM.
   Tainio M, 2016, PREV MED, V87, P233, DOI 10.1016/j.ypmed.2016.02.002.
   Tainio M, 2015, J TRANSP HEALTH, V2, P423, DOI 10.1016/j.jth.2015.06.005.
   U.S. Department of Transportation Federal Highway Administartion, 2016, TRANSP AIR QUAL SEL.
   United Nations, 2014, WORLD URB PROSP 2014.
   Vienneau D, 2013, ENVIRON SCI TECHNOL, V47, P13555, DOI 10.1021/es403089q.
   Wang L, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121196.
   Wheeler S., 2014, SUSTAINABLE URBAN DE.
   WHO, 2013, REV EVIDENCE HLTH AS.
   WHO, 2014, WHO EXP M METH TOOLS.
   WHO, 2006, AIR QUAL GUID UPD 20.
   Wilkinson RG, 2008, AM J PUBLIC HEALTH, V98, P699, DOI 10.2105/AJPH.2007.109637.
   World Health Organization, 2018, FACT SHEET AMB OUTD.
   World Health Organization (WHO), 2016, WHO GLOB URB AMB AIR.
   Zhang C, 2017, ENVIRON POLLUT, V229, P790, DOI 10.1016/j.envpol.2017.06.022.},
Number-of-Cited-References = {54},
Times-Cited = {10},
Usage-Count-Last-180-days = {4},
Usage-Count-Since-2013 = {11},
Journal-ISO = {Int. J. Environ. Res. Public Health},
Doc-Delivery-Number = {KY2GF},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000522388500042},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000243181900007,
Author = {Chen, Jarvis T. and Rehkopf, David H. and Waterman, Pamela D. and
   Subramanian, S. V. and Coull, Brent A. and Cohen, Bruce and Ostrem, Mary
   and Krieger, Nancy},
Title = {Mapping and measuring social disparities in premature mortality: The
   impact of census tract poverty within and across Boston neighborhoods,
   1999-2001},
Journal = {JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE},
Year = {2006},
Volume = {83},
Number = {6},
Pages = {1063-1084},
Month = {NOV},
Abstract = {The identification and documentation of health disparities are important
   functions of public health surveillance. These disparities, typically
   falling along lines defined by gender, race/ethnicity, and social class,
   are often made visible in urban settings as geographic disparities in
   health between neighborhoods. Recognizing that Premature mortality is a
   powerful indicator of disparities in both health status and access to
   health care that can readily be monitored using routinely available
   public health surveillance data, we undertook a systematic analysis of
   spatial variation in premature mortality in Boston (1999-2001) across
   neighborhoods and sub-neigbborboods in relation to census tract (CT)
   poverty. Using a multilevel model based framework, we estimated that the
   incidence of premature mortality was 1.39 times higher (95\% credible
   interval 1.09-1.78) among persons living in the most economically
   deprived CTs (>= 20\% below poverty) compared to those in the least
   impoverished tracts (<5\% below poverty). We present maps of model-based
   standardized mortality ratios that show substantial within-neighborhood
   variation in premature mortality and a sizeable decrease in spatial
   variation after adjustment for CT poverty. Additionally, we present maps
   of model-based direct standardized rates that can more readily be
   compared to externally published rates and targets, as well as maps of
   the population attributable fraction that show that in some of Boston's
   poorest neighborhoods, the proportion of excess deaths associated with
   CT poverty reaches 25-30\%. We recommend that these methods be
   incorporated into routine analyses of public health surveillance data to
   highlight continuing social disparities in premature mortality.},
Publisher = {SPRINGER},
Address = {ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES},
Type = {Article},
Language = {English},
Affiliation = {Chen, JT (Corresponding Author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev \& Hlth, 677 Huntington Ave, Boston, MA 02115 USA.
   Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev \& Hlth, Boston, MA 02115 USA.
   Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.
   Massachusetts Dept Publ Hlth, Boston, MA USA.
   Boston Publ Hlth Commiss, Boston, MA USA.},
DOI = {10.1007/s11524-006-9089-7},
ISSN = {1099-3460},
EISSN = {1468-2869},
Keywords = {age standardization; area-based socioeconomic measures; geocoding;
   mapping; multilevel models; poverty; premature mortality},
Keywords-Plus = {MULTILEVEL ANALYSIS; HEART-DISEASE; HEALTH; INEQUALITIES; AREA;
   POPULATIONS; CONTEXT; CANCER; CHOICE},
Research-Areas = {Public, Environmental \& Occupational Health; General \& Internal
   Medicine},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health; Medicine, General \&
   Internal},
Author-Email = {jarvis@hsph.harvard.edu},
Funding-Acknowledgement = {EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH \&HUMAN
   DEVELOPMENTUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health \& Human Development (NICHD) {[}R01HD036865,
   R25HD047185] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND
   BLOOD INSTITUTEUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung
   \& Blood Institute (NHLBI) {[}K25HL081275] Funding Source: NIH RePORTER;
   NHLBI NIH HHSUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung
   \& Blood Institute (NHLBI) {[}K25 HL081275] Funding Source: Medline;
   NICHD NIH HHSUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health \& Human Development (NICHD)
   {[}R01 HD36865-01, R25 HD047185, R25 HD047185-01] Funding Source:
   Medline; NIDA NIH HHSUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   on Drug Abuse (NIDA) {[}R01 DA036865] Funding Source: Medline},
Cited-References = {Anderson R N, 1998, Natl Vital Stat Rep, V47, P1.
   Beattie A, 1988, HLTH DEPRIVATION INE.
   {*}BOST PUBL HLTH CO, 2005, DISP PROJ DAT REP.
   Boston Public Health Commission, 2005, HLTH BOST 2005.
   BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284.
   Brewer C, 2006, COLORBREWER.
   {*}BUR HLTH STAT, 2004, MASS DEATHS 2002.
   {*}BUR HLTH STAT RES, 2003, MASS DEATHS 2001 PRE.
   Carstairs V, 1991, DEPRIVATION HLTH SCO.
   CASPER ML, 2000, WOMEN HEART DIS ATLA.
   Clayton D., 1992, GEOGRAPHICAL ENV EPI, P205.
   Cooper RS, 2001, PUBLIC HEALTH REP, V116, P464, DOI 10.1016/S0033-3549(04)50074-2.
   {*}DEP HOUS URB DEV, QUAL CENS TRACTS DIF.
   Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171.
   DiezRoux AV, 1997, AM J EPIDEMIOL, V146, P48, DOI 10.1093/oxfordjournals.aje.a009191.
   Elliott P, 2000, SPATIAL EPIDEMIOLOGY.
   EYLES J, 1993, CAN J PUBLIC HEALTH, V84, P112.
   FASTRUP J, 1996, PUBLIC HLTH STAT IND.
   Franzini L, 2003, SOC SCI MED, V57, P1847, DOI 10.1016/S0277-9536(03)00018-2.
   Galea S, 2005, ANNU REV PUBL HEALTH, V26, P341, DOI 10.1146/annurev.publhealth.26.021304.144708.
   GELMAN A, 2005, BAYESIAN ANAL, V0001, P00001.
   Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221.
   GREENLAND S, 1989, INT J EPIDEMIOL, V18, P269, DOI 10.1093/ije/18.1.269.
   GREENLAND S, 1988, AM J EPIDEMIOL, V128, P1185, DOI 10.1093/oxfordjournals.aje.a115073.
   Health Resources and Services Administration, HLTH PROF SHORT AR.
   Janssen I, 2006, AM J CLIN NUTR, V83, P139.
   Jarup L, 2002, INT J CANCER, V97, P695, DOI 10.1002/ijc.10113.
   Krieger N, 2003, AM J PUBLIC HEALTH, V93, P1655, DOI 10.2105/AJPH.93.10.1655.
   Krieger N, 1992, J Public Health Policy, V13, P412.
   Krieger N, 2005, AM J PUBLIC HEALTH, V95, P312, DOI 10.2105/AJPH.2003.032482.
   Krieger N, 2001, AM J PUBLIC HEALTH, V91, P1114, DOI 10.2105/AJPH.91.7.1114.
   Krieger N, 2002, AM J EPIDEMIOL, V156, P471, DOI 10.1093/aje/kwf068.
   Krieger N, GEOCODING MONITORING.
   Mansfield CJ, 1999, AM J PUBLIC HEALTH, V89, P893, DOI 10.2105/AJPH.89.6.893.
   {*}NAT CTR HLTH STAT, 2005, HLTH US 2004 CHARTB.
   {*}NIH, NIH STRAT PLAN RED U.
   Northridge ME, 2003, J URBAN HEALTH, V80, P556, DOI 10.1093/jurban/jtg064.
   Openshaw S., 1984, MODIFABLE AREAL UNIT.
   Pickle L.W., 1996, ATLAS US MORTALITY.
   PICKLE LW, 1995, STAT MED, V14, P615, DOI 10.1002/sim.4780140519.
   REHKOPF DH, IN PRESS AM J PUBLIC.
   Ronzio CR, 2004, J EPIDEMIOL COMMUN H, V58, P175, DOI 10.1136/jech.2003.008672.
   Shaw M, 1999, WIDENING GAP HLTH IN.
   Sorlie PD, 1996, EPIDEMIOLOGY, V7, P437, DOI 10.1097/00001648-199607000-00017.
   Spiegelhalter D.J., 2003, BUGS BAYESIAN INFERE.
   Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353.
   Stafford M, 2004, J EPIDEMIOL COMMUN H, V58, P772, DOI 10.1136/jech.2003.015941.
   Sturm RA, 2002, MELANOMA RES, V12, P405, DOI 10.1097/00008390-200209000-00001.
   Subramanian SV, 2005, AM J PUBLIC HEALTH, V95, P260, DOI 10.2105/AJPH.2003.034132.
   SUBRAMANIAN SV, IN PRESS AM J EPIDEM.
   SUBRAMANIAN SV, 2000, NEIGHBORHOODS HLTH, P65.
   Tonne C, 2005, CIRCULATION, V111, P3063, DOI 10.1161/CIRCULATIONAHA.104.496174.
   U S Census Bureau, POV AR.
   {*}US BUR CENS, CENS 3000 SUMM FIL 3.
   {*}US BUR CENS, 1991, CENS POP HOUS 1990 S, pA5.
   US Department of Health and Human Services, 2000, HLTH PEOPL 2010.
   VILLERME LR, MORTALITE DANS DIVER.
   Waller L.A., 2004, APPL SPATIAL STAT PU.
   {[}No title captured].},
Number-of-Cited-References = {59},
Times-Cited = {73},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {20},
Journal-ISO = {J. Urban Health},
Doc-Delivery-Number = {121UG},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000243181900007},
OA = {Green Published},
DA = {2022-03-29},
}

@article{ WOS:000427949700004,
Author = {Pearce, Alison and Sharp, Linda and Hanly, Paul and Barchuk, Anton and
   Bray, Freddie and Cancela, Marianna de Camargo and Gupta, Prakash and
   Meheus, Filip and Qiao, You-Lin and Sitas, Freddy and Wang, Shao-Ming
   and Soerjomataram, Isabelle},
Title = {Productivity losses due to premature mortality from cancer in Brazil,
   Russia, India, China, and South Africa (BRICS): A population-based
   comparison},
Journal = {CANCER EPIDEMIOLOGY},
Year = {2018},
Volume = {53},
Pages = {27-34},
Month = {APR},
Abstract = {Background: Over two-thirds of the world's cancer deaths occur in
   economically developing countries; however, the societal costs of cancer
   have rarely been assessed in these settings. Our aim was to estimate the
   value of productivity lost in 2012 due to cancer-related premature
   mortality in the major developing economies of Brazil, the Russian
   Federation, India, China and South Africa (BRICS).
   Methods: We applied an incidence-based method using the human capital
   approach. We used annual adult cancer deaths from GLOBOCAN2012 to
   estimate the years of productive life lost between cancer death and
   pensionable age in each country, valued using national and international
   data for wages, and workforce statistics. Sensitivity analyses examined
   various methodological assumptions.
   Results: The total cost of lost productivity due to premature cancer
   mortality in the BRICS countries in 2012 was \$46.3 billion,
   representing 0.33\% of their combined gross domestic product. The
   largest total productivity loss was in China (\$28 billion), while South
   Africa had the highest cost per cancer death (\$101,000). Total
   productivity losses were greatest for lung cancer in Brazil, the Russian
   Federation and South Africa; liver cancer in China; and lip and oral
   cavity cancers in India.
   Conclusion: Locally-tailored strategies are required to reduce the
   economic burden of cancer in developing economies. Focussing on tobacco
   control, vaccination programs and cancer screening, combined with access
   to adequate treatment, could yield significant gains for both public
   health and economic performance of the BRICS countries.},
Publisher = {ELSEVIER SCI LTD},
Address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Pearce, A (Corresponding Author), Natl Canc Registry Ireland, Bldg 6800,Cork Airport Business Pk,Kinsale Rd, Cork, Ireland.
   Pearce, A (Corresponding Author), Univ Technol Sydney, Bldg 5D,1-59 Quay St, Sydney, NSW 2007, Australia.
   Pearce, Alison, Natl Canc Registry Ireland, Bldg 6800,Cork Airport Business Pk,Kinsale Rd, Cork, Ireland.
   Sharp, Linda, Newcastle Univ, Baddiley Clark Bldg,Richardson Rd, Newcastle Upon Tyne NE2 4AX, Tyne \& Wear, England.
   Hanly, Paul, Natl Coll Ireland, Mayor St IFSC, Dublin 1, Ireland.
   Barchuk, Anton, Petrov Res Inst Oncol, 68 Leningradskaya St, St Petersburg 197758, Russia.
   Barchuk, Anton, Univ Tampere, Kalevantie 4, Tampere 33100, Finland.
   Bray, Freddie; Meheus, Filip; Soerjomataram, Isabelle, Int Agcy Res Canc, 150 Cours Albert Thomas, F-69008 Lyon, France.
   Cancela, Marianna de Camargo, Brazilian Natl Canc Inst, Rua Marques de Pombal 125,7o Andar Ctr, Rio De Janeiro, Brazil.
   Gupta, Prakash, Healis Sekhsaria Inst Publ Hlth, MIDC, 501 Technocity,Plot X-4-5A, Mahape 400701, Navi Mumbai, India.
   Qiao, You-Lin; Wang, Shao-Ming, Chinese Acad Med Sci, 9 Dongdan 3rd Alley, Beijing 100006, Peoples R China.
   Qiao, You-Lin; Wang, Shao-Ming, Peking Union Med Coll, 9 Dongdan 3rd Alley, Beijing 100006, Peoples R China.
   Sitas, Freddy, Canc Council Australia, Level 14-447 Pitt St, Sydney, NSW 2000, Australia.
   Pearce, Alison, Univ Technol Sydney, Bldg 5D,1-59 Quay St, Sydney, NSW 2007, Australia.},
DOI = {10.1016/j.canep.2017.12.013},
ISSN = {1877-7821},
EISSN = {1877-783X},
Keywords = {Neoplasms; Work; Economics; Cost of illness; Mortality; Premature;
   Developing countries; Health services research; Health services needs
   and demand},
Keywords-Plus = {ATTRIBUTABLE CAUSES; UNITED-STATES; BURDEN; COSTS; TOBACCO},
Research-Areas = {Oncology; Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Oncology; Public, Environmental \& Occupational Health},
Author-Email = {alison.pearce@chere.uts.edu.au},
ResearcherID-Numbers = {de Camargo Cancela, Marianna/F-7309-2017
   Barchuk, Anton/U-2826-2017
   Qiao, You-Lin/B-4139-2012
   Pearce, Alison/AAC-3702-2019
   De Camargo Cancela, Marianna/D-4053-2015
   },
ORCID-Numbers = {Barchuk, Anton/0000-0002-4629-3326
   Qiao, You-Lin/0000-0001-6380-0871
   Pearce, Alison/0000-0002-5690-9542
   Sitas, Freddy/0000-0001-9679-1481
   Wang, ShaoMing/0000-0003-0420-2833
   Hanly, Paul/0000-0002-5348-4825
   De Camargo Cancela, Marianna/0000-0002-8169-8054
   Bray, Freddie/0000-0002-3248-7787},
Funding-Acknowledgement = {Health Research Board (HRB) Interdisciplinary Capacity Enhancement (ICE)
   Award {[}ICE/2012/9]; COST Action IS1211 CANWONEuropean Cooperation in
   Science and Technology (COST)},
Funding-Text = {This work was supported by a Health Research Board (HRB)
   Interdisciplinary Capacity Enhancement (ICE) Award, which funded a
   post-doctoral fellowship for Alison Pearce (grant number ICE/2012/9).
   COST Action IS1211 CANWON funded a Short Term Scientific Mission for
   Alison Pearce to IARC, to establish this project (no grant number).
   These sources of funding and support had no involvement in the study
   design, data collection, analysis or interpretation, or the writing of
   the report.},
Cited-References = {Silva GAE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148761.
   Bekhouche Y., 2014, GLOBAL GENDER GAP RE.
   Boffetta P, 2008, LANCET ONCOL, V9, P667, DOI 10.1016/S1470-2045(08)70173-6.
   Bradley CJ, 2008, JNCI-J NATL CANCER I, V100, P1763, DOI 10.1093/jnci/djn384.
   COALE A, 1989, POPUL INDEX, V55, P613, DOI 10.2307/3644567.
   Colombara DV, 2013, VACCINE, V31, P4057, DOI 10.1016/j.vaccine.2013.06.031.
   Ekwueme DU, 2011, J AM ACAD DERMATOL, V65, pS133, DOI 10.1016/j.jaad.2011.04.036.
   Esposito M., 2017, WORLD EC FORUM.
   Fan JH, 2013, ASIAN PAC J CANCER P, V14, P7251, DOI 10.7314/APJCP.2013.14.12.7251.
   Global Burden of Disease Collaborative Network, 2017, GLOB BURD DIS STUD 2.
   Hanly P, 2014, EXPERT REV PHARM OUT, V14, P355, DOI 10.1586/14737167.2014.909287.
   Instituto Brasileiro De Geografia E Estatistica, 2014, BRICS JOINT STAT REP.
   International Agency for Research on Cancer, 2015, GLOBOCAN.
   International labour organization. informal economy Internationl Labour Organization, 2016, INF EC.
   Jagger C., 2014, HLTH EXPECTANCY CALC, Vfourth.
   Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1.
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI {[}10.3322/caac.20107, 10.3322/caac.20115].
   Karami-Matin Behzad, 2016, Asian Pac J Cancer Prev, V17, P2131.
   Key Indicators of the Labour Market (KILM), 2013, KEY IND LAB MARK KIL.
   Khorasani Soheila, 2015, Asian Pac J Cancer Prev, V16, P1845.
   Kishor S, 2009, GENDER EQUALITY WOME.
   KOOPMANSCHAP MA, 1995, J HEALTH ECON, V14, P171, DOI 10.1016/0167-6296(94)00044-5.
   Levy D, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001336.
   Luengo-Fernandez R, 2013, LANCET ONCOL, V14, P1165, DOI 10.1016/S1470-2045(13)70442-X.
   OECD, 2015, OECD DAT.
   OECD, 2013, PENS GLANC 2013.
   OECD, STAT EC OUTL NO 95 M.
   Office for national statistics, 2014, UK WAG 4 DEC 2014.
   Singh S. P., 2013, BRICS NEW WORLD ORDE.
   Sitas F, 2004, TOB CONTROL, V13, P396, DOI 10.1136/tc.2004.007682.
   Sloan FA, 2007, I MED US COMMITTEE C.
   The World Bank, 2015, RUR POP.
   Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263.
   Tingstedt B, 2011, WORLD J SURG, V35, P2298, DOI {[}10.1007/s00268-011-1208-2, 10.1007/s00268-010-0866-9].
   United Nations Department of Economic and Social Affairs United Nations Conference on Trade and Development United Nations, 2016, UN REG COMM AFR EUR.
   Wang JB, 2012, ANN ONCOL, V23, P2983, DOI 10.1093/annonc/mds139.
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1.
   World Health Organisation, 2016, TOB US ATL.
   Zaridze D, 2014, LANCET, V383, P1465, DOI 10.1016/S0140-6736(13)62247-3.
   Zhang W., 1982, SOC SCI MED, V2011, P185.},
Number-of-Cited-References = {40},
Times-Cited = {36},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {26},
Journal-ISO = {Cancer Epidemiol.},
Doc-Delivery-Number = {FZ9RQ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000427949700004},
DA = {2022-03-29},
}

@article{ WOS:000441240200010,
Author = {Shankar, R. and Henley, W. and Boland, C. and Laugharne, R. and McLean,
   B. N. and Newman, C. and Hanna, J. and Ashby, S. and Walker, M. C. and
   Sander, J. W.},
Title = {Decreasing the risk of sudden unexpected death in epilepsy: structured
   communication of risk factors for premature mortality in people with
   epilepsy},
Journal = {EUROPEAN JOURNAL OF NEUROLOGY},
Year = {2018},
Volume = {25},
Number = {9},
Pages = {1121-1127},
Month = {SEP},
Abstract = {Background and purpose: Good practice guidelines highlight the
   importance of making people with epilepsy aware of the risk of premature
   mortality in epilepsy particularly due to sudden unexpected death in
   epilepsy (SUDEP). The SUDEP and Seizure Safety Checklist ('Checklist')
   is a structured risk communication tool used in UK clinics. It is not
   known if sharing structured information on risk factors allows
   individuals to reduce SUDEP and premature mortality risks. The aim of
   this study was to ascertain if the introduction of the Checklist in
   epilepsy clinics led to individual risk reduction. Methods: The
   Checklist was administered to 130 consecutive people with epilepsy
   attending a specialized epilepsy neurology clinic and 129 attending an
   epilepsy intellectual disability (ID) clinic within a 4-month period. At
   baseline, no attendees at the neurology clinic had received formal risk
   advice, whereas all those attending the ID clinic had received formal
   risk advice on multiple occasions for 6 years. The Checklist was
   readministered 1 year later to each group and scores were compared with
   baseline and between groups. Results: Of 12 risk factors considered,
   there was an overall reduction in mean risk score for the general (P =
   0.0049) but not for the ID (P = 0.322) population. Subanalysis of the
   25\% of people at most risk in both populations showed that both sets
   had a significant reduction in risk scores (P < 0.001). Conclusion:
   Structured discussion results in behavioural change that reduces
   individual risk factors. This impact seems to be higher in those who are
   at current higher risk. It is important that clinicians share risk
   information with individuals as a matter of public health and health
   promotion.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Shankar, R (Corresponding Author), Chy Govenek, Threemilestone Ind Estate, Truro TR4 9LD, Cornwall, England.
   Shankar, R.; Boland, C.; Laugharne, R., Cornwall Partnership NHS Fdn Trust, Truro, England.
   Shankar, R.; Henley, W.; Laugharne, R., Royal Cornwall Hosp, Exeter Med Sch, Knowledge Spa, Truro, England.
   McLean, B. N., Royal Cornwall Hosp, Truro, England.
   Newman, C., Plymouth Univ, Peninsula Sch Med, Plymouth, Devon, England.
   Newman, C., Plymouth Univ, Peninsula Sch Dent, Plymouth, Devon, England.
   Hanna, J.; Ashby, S., SUDEP Act, Wantage, England.
   Walker, M. C.; Sander, J. W., UCL, Inst Neurol, Univ Coll London Hosp, NIHR,Biomed Res Ctr, London, England.
   Sander, J. W., Chalfont Ctr Epilepsy, Gerrards Cross, Bucks, England.
   Sander, J. W., SEIN, Heemstede, Netherlands.},
DOI = {10.1111/ene.13651},
ISSN = {1351-5101},
EISSN = {1468-1331},
Keywords = {classification; risk assessment; risk stratification; safety check list},
Keywords-Plus = {SAFETY CHECKLIST; SUDEP},
Research-Areas = {Neurosciences \& Neurology},
Web-of-Science-Categories  = {Clinical Neurology; Neurosciences},
Author-Email = {rohit.shankar@nhs.net},
ResearcherID-Numbers = {Shankar, Rohit/I-9028-2019
   Walker, Matthew C/C-1577-2008
   Sander, Ley/C-1576-2008
   },
ORCID-Numbers = {Shankar, Rohit/0000-0002-1183-6933
   Walker, Matthew C/0000-0002-0812-0352
   Sander, Ley/0000-0001-6041-9661
   Newman, Craig/0000-0002-0525-8217
   Mclean, Brendan/0000-0003-1419-8540
   Ashby, Samantha/0000-0002-0812-6041
   Laugharne, Richard/0000-0001-9916-343X},
Funding-Acknowledgement = {Department of Health's National Institute for Health Research (NIHR)
   Biomedical Research CentresNational Institute for Health Research
   (NIHR); Dr Marvin Weil Epilepsy Research Fund; NIHR Collaboration for
   Leadership in Applied Health Research and Care for the South West
   Peninsula},
Funding-Text = {M.C.W. and J.W.S. are based at the UCLH/UCL Comprehensive Bio-Medical
   Research Centre, which received a proportion of funding from the
   Department of Health's National Institute for Health Research (NIHR)
   Biomedical Research Centres funding scheme. The current position of
   J.W.S. is endowed by the UK Epilepsy Society and he receives research
   support from the Dr Marvin Weil Epilepsy Research Fund. W.H. was funded
   by the NIHR Collaboration for Leadership in Applied Health Research and
   Care for the South West Peninsula. The views expressed in this
   publication are those of the authors and not necessarily those of the
   National Health Service, NIHR or Department of Health.},
Cited-References = {Fischhoff B, 2011, COMMUNICATING RISKS.
   Harden C, 2017, NEUROLOGY, V88, P1674, DOI 10.1212/WNL.0000000000003685.
   Harden J, 2015, CHRONIC ILLN, V11, P230, DOI 10.1177/1742395314557705.
   National Clinical Guideline Centre, 2012, CLIN GUIDELINE 137 N.
   Office for National Statistics, 2013, DEATH REGISTRATIONS.
   Shankar R, 2017, EPILEPTIC DISORD, V19, P1, DOI 10.1684/epd.2017.0891.
   Shankar R, 2016, J NEUROL, V263, P1840, DOI 10.1007/s00415-016-8203-3.
   Shankar R, 2015, BRIT J GEN PRACT, V65, P448, DOI 10.3399/bjgp15X686413.
   Shankar R, 2014, SEIZURE-EUR J EPILEP, V23, P382, DOI 10.1016/j.seizure.2014.02.005.
   Shankar R, 2013, SEIZURE-EUR J EPILEP, V22, P812, DOI 10.1016/j.seizure.2013.07.014.
   Strzelczyk A, 2016, EPILEPSIA, V57, P612, DOI 10.1111/epi.13337.
   Waddell B, 2013, SEIZURE-EUR J EPILEP, V22, P74, DOI 10.1016/j.seizure.2012.09.017.},
Number-of-Cited-References = {12},
Times-Cited = {19},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Eur. J. Neurol.},
Doc-Delivery-Number = {GP9MD},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000441240200010},
OA = {Green Published},
DA = {2022-03-29},
}

@article{ WOS:000253132900005,
Author = {Bourgkard, Eve and Wild, Pascal and Massin, Nicole and Meyer,
   Jean-Pierre and Sierra, Carmen Otero and Fontana, Jean-Marc and
   Benamghar, Lahoucine and Mur, Jean-Marie and Ravaud, Jean-Francois and
   Guillemin, Francis and Chau, Nearkasen and Lorhandicap Grp},
Title = {Association of physical job demands, smoking and alcohol abuse with
   subsequent premature mortality: A 9-year follow-up population-based
   study},
Journal = {JOURNAL OF OCCUPATIONAL HEALTH},
Year = {2008},
Volume = {50},
Number = {1},
Pages = {31-40},
Month = {JAN},
Abstract = {This study assessed the relationships of physical job demands (PJD),
   smoking, and alcohol abuse, with premature mortality before age 70
   (PM-70) among the working or inactive population. The sample included
   4,268 subjects aged 15 or more randomly selected in northeastern France.
   They completed a mailed questionnaire (birth date, sex, weight, height,
   job, PJD, smoking habit, alcohol abuse (Deta questionnaire)) in 1996 and
   were followed for mortality until 2004 (9 yr). PJD score was defined by
   the cumulative number of the following high job demands at work: hammer,
   vibrating platform, pneumatic tools, other vibrating hand tools,
   screwdriver, handling objects, awkward posture, tasks at heights,
   machine tools, pace, working on a production line, standing about and
   walking. The data were analyzed using the Poisson regression model.
   Those with PM-70 were 126 (3.81 per 1,000 person-years). The leading
   causes of death were cancers (46.4\% in men, 57.1\% in women),
   cardiovascular diseases (20.2\% and 11.9\%), suicide (9.5\% and 7.1 \%),
   respiratory diseases (6.0\% and 4.8\%), and digestive diseases (2.4\%
   and 4.8\%). PJD >= 3, smoker, and alcohol abuse had adjusted risk ratios
   of 1.71 (95\% Cl 1.02-2.88), 1.76 (1.08-2.88), and 2.07 (1.31-3.26)
   respectively for all-cause mortality. Manual workers had a risk ratio of
   1.84 (1.00-3.37) compared to the higher socio-economic classes. The men
   had a twofold higher mortality rate than the women; this difference
   became non-significant when controlling for job, PJD, smoker and alcohol
   abuse. For cancer mortality the factors PJD 3, smoker, and alcohol abuse
   had adjusted risk ratios of 2.00 (1.00-3.99), 2.34 (1.19-4.63), and 2.22
   (1.17-4.20), respectively. Health promotion efforts should be directed
   at structural measures of task redesign and they should also concern
   lifestyle.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Chau, N (Corresponding Author), INSERM, U669, 8 Rue Breuil, F-54180 Heillecourt, France.
   Chau, Nearkasen; Lorhandicap Grp, INSERM, U669, F-54180 Heillecourt, France.
   Bourgkard, Eve; Wild, Pascal; Massin, Nicole; Fontana, Jean-Marc; Mur, Jean-Marie; Chau, Nearkasen, INRS, WHO Collaborat Ctr, Dept Epidemiol Entreprises, Paris, France.
   Meyer, Jean-Pierre, INRS, Dept Homme Travail, Paris, France.
   Sierra, Carmen Otero; Benamghar, Lahoucine; Mur, Jean-Marie, INSERM, U420, WHO Collaborat Ctr, F-75654 Paris 13, France.
   Ravaud, Jean-Francois, INSERM, U750, CERMES, IFR IFRH 25, F-75654 Paris 13, France.
   Guillemin, Francis, Univ Nancy 1, Fac Med, F-54013 Nancy, France.
   Chau, Nearkasen, Univ Paris 11, U669, Paris, France.
   Chau, Nearkasen, Univ Paris 05, Paris, France.},
DOI = {10.1539/joh.50.31},
ISSN = {1341-9145},
EISSN = {1348-9585},
Keywords = {job category; physical job demands; premature mortality; cancer;
   smoking; alcohol; gender},
Keywords-Plus = {OCCUPATIONAL INJURIES; INDIVIDUAL CHARACTERISTICS; WORKERS; RISK;
   ENVIRONMENT; PREVALENCE; MORBIDITY; EMPLOYEES; TOBACCO; PEOPLE},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {Nearkasen.Chau@wanadoo.fr},
ResearcherID-Numbers = {Wild, Pascal/A-9585-2012
   RAVAUD, Jean-François/F-7190-2013
   Wild, Pascal/O-9791-2019},
ORCID-Numbers = {Wild, Pascal/0000-0003-3165-3808
   RAVAUD, Jean-François/0000-0003-3959-4195
   Wild, Pascal/0000-0003-3165-3808},
Cited-References = {Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P55.
   Barbini N, 2003, G Ital Med Lav Ergon, V25, P168.
   Bhattacherjee A, 2003, J OCCUP HEALTH, V45, P382, DOI 10.1539/joh.45.382.
   Bhattacherjee A, 2007, IND HEALTH, V45, P352, DOI 10.2486/indhealth.45.352.
   Bjarnason T, 2004, ESPAD REPORT 2003.
   {*}BRIT DEP HLTH, SER BRIT DEP HLTH, V4386.
   Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423.
   Challier B, 2000, EUR J EPIDEMIOL, V16, P33, DOI 10.1023/A:1007644331197.
   Chau N, 2005, REV EPIDEMIOL SANTE, V53, P614, DOI 10.1016/S0398-7620(05)84741-8.
   Chau N, 2004, AM J IND MED, V45, P84, DOI 10.1002/ajim.10319.
   CHAU N, 2005, ADV MINING TECHNOLOG, P543.
   CHAU N, 2007, IN PRESS INT ARCH OC.
   Chau N, 2007, INT ARCH OCC ENV HEA, V80, P517, DOI 10.1007/s00420-006-0158-8.
   Chen ZM, 1997, JAMA-J AM MED ASSOC, V278, P1500, DOI 10.1001/jama.278.18.1500.
   CHERIECHALLINE L, 2003, BEH, V30, P146.
   {*}CNAMTS, 2002, STAT FIN TECHN ACC T.
   Cohidon C, 2005, Sante Publique, V17, P325.
   DAHLGREN G, 2006, STUDIES SOC EC DETER.
   DIDERICHSEN F, 1997, ANAL PROPORTION TOTA.
   Etter JF, 1997, J CLIN EPIDEMIOL, V50, P1123, DOI 10.1016/S0895-4356(97)00166-2.
   FALISSARD B, 1998, COMPRENDRE UTILISER.
   Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861.
   Galea S, 2004, EPIDEMIOL REV, V26, P36, DOI 10.1093/epirev/mxh007.
   Galobardes B, 2004, EPIDEMIOL REV, V26, P7, DOI 10.1093/epirev/mxh008.
   Gauchard GC, 2006, NEUROEPIDEMIOLOGY, V26, P108, DOI 10.1159/000090445.
   Gauchard GC, 2003, OCCUP ENVIRON MED, V60, P330, DOI 10.1136/oem.60.5.330.
   Ghosh AK, 2004, J OCCUP HEALTH, V46, P470, DOI 10.1539/joh.46.470.
   Guilbert P, 2001, BAROMETRE SANTE 2000, V2.
   Haustein KO, 2006, EUR J CARDIOV PREV R, V13, P312, DOI 10.1097/00149831-200606000-00004.
   {*}HAUT COM SANT PUB, 1994, SANT FRANC 1994 8.
   Hingson R, 2005, ANNU REV PUBL HEALTH, V26, P259, DOI 10.1146/annurev.publhealth.26.021304.144652.
   {*}INSEE, 1993, REC POP 1990.
   {*}INSEE, FRANC FAITS CHIFFR M.
   {*}INSEE, 2001, PROJ POP HOR, V2050.
   KANT IJ, 2003, OCCUP ENV MED S1, V60, P132.
   Kristal-Boneh E, 2000, J OCCUP ENVIRON MED, V42, P127, DOI 10.1097/00043764-200002000-00005.
   Kubo T, 2006, AM J EPIDEMIOL, V164, P549, DOI 10.1093/aje/kwj232.
   Lapeyre-Mestre M, 2004, THERAPIE, V59, P615, DOI 10.2515/therapie:2004107.
   Lefevre H, 2004, REV EPIDEMIOL SANTE, V52, P317, DOI 10.1016/S0398-7620(04)99061-X.
   Lewis RJ, 2002, J OCCUP ENVIRON MED, V44, P39.
   Lochner K, 2001, AM J PUBLIC HEALTH, V91, P385, DOI 10.2105/AJPH.91.3.385.
   {*}LORH GROUP, 2000, HANDICAP REV SCI HUM, V88, P1.
   {*}LORH GROUP, 2004, OCCUP ENVIRON MED, V61, pE46.
   Lynch JW, 1997, SOC SCI MED, V44, P809, DOI 10.1016/S0277-9536(96)00191-8.
   Mackenbach JP, 1997, LANCET, V349, P1655, DOI 10.1016/S0140-6736(96)07226-1.
   MARCHAND JL, 2003, BEH, V30, P150.
   MEJER L, 2004, DIFFERENTIAL MORTALI.
   Melchior M, 2006, OCCUP ENVIRON MED, V63, P754, DOI 10.1136/oem.2005.025122.
   Mesle F, 2004, REV EPIDEMIOL SANTE, V52, P333, DOI 10.1016/S0398-7620(04)99063-3.
   {*}NAT BOARD HLTH SO, 2005, SWED PUBL HLTH REP 2.
   PEQUIGNOT F, 2003, BEH, V30, P139.
   Peto R., 2004, MORTALITY SMOKING DE.
   Puddey IB, 2006, CLIN EXP PHARMACOL P, V33, P847, DOI 10.1111/j.1440-1681.2006.04452.x.
   Rehm J, 2001, AM J EPIDEMIOL, V153, P64, DOI 10.1093/aje/153.1.64.
   Sun J, 2002, OCCUP ENVIRON MED, V59, P512, DOI 10.1136/oem.59.8.512.
   Teschke K, 2002, OCCUP ENVIRON MED, V59, P575, DOI 10.1136/oem.59.9.575.
   TIANWU H, 1995, ACTA OTO-LARYNGOL, P127.
   Vahtera J, 2002, AM J EPIDEMIOL, V156, P969, DOI 10.1093/aje/kwf138.
   {*}WHO, 2000, WHO OB TECHN REP SER, V894.
   Zhang RB, 2000, AM J HYPERTENS, V13, P1308, DOI 10.1016/S0895-7061(00)01254-1.},
Number-of-Cited-References = {60},
Times-Cited = {15},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {7},
Journal-ISO = {J. Occup. Health},
Doc-Delivery-Number = {262EX},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000253132900005},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000500820600005,
Author = {Aghazadeh-Attari, Javad and EntezarMahdi, Rasool and Ahmadzadeh, Jamal
   and Mobaraki, Kazhal and Mansorian, Behnam and Karimi, Hasan and
   Mirghaffarzadeh, Shamsi and Hajimohammadian, Mahnaz and Mohebbi, Iraj},
Title = {The Burden of Premature Mortality Related to Suicide in West Azerbaijan
   From 2014 to 2016 A Death Registry System-Based Study},
Journal = {CRISIS-THE JOURNAL OF CRISIS INTERVENTION AND SUICIDE PREVENTION},
Year = {2019},
Volume = {40},
Number = {6},
Pages = {407-412},
Month = {NOV},
Abstract = {Background: Examining the premature death rate represents the first step
   in estimating the overall burden of disease. reflecting a full picture
   of how different causes affect population health and providing a way of
   monitoring and evaluating population health. Aims: This study was
   conducted to assess the burden of premature mortality from suicides in
   West Azerbaijan Province, northwest of Iran from 2014 to 2016. Method:
   To calculate years of potential life lost (YPLL), we categorized all
   methods of suicide, then we subtracted actual age at death by suicide
   from the relevant age-based life table produced by the World Health
   Organization in 2015, after which we added the results for each type of
   suicide in a particular year. Results: We analyzed 638 suicides.
   Overall, during the 3-year study period for both sexes. the greatest
   sources of premature death among all methods of suicide were: hanging,
   strangulation, and suffocation (X70); smoke, fire, and flames (X76); and
   poisoning by narcotics and psychodysleptics (X62). Limitations:
   Limitations of the study include a lack of accurate, systematic
   recording and reporting of all cases of suicide, which might lead to
   measurement bias. Conclusion: This study identified and highlighted the
   most common methods of suicide in West Azerbaijan.},
Publisher = {HOGREFE \& HUBER PUBLISHERS},
Address = {MERKELSTR 3, D-37085 GOTTINGEN, GERMANY},
Type = {Article},
Language = {English},
Affiliation = {Mohebbi, I (Corresponding Author), Urmia Univ Med Sci, Social Determinants Hlth Res Ctr, Occupat Med Ctr, Resalat St, Orumiyeh, Iran.
   Aghazadeh-Attari, Javad, Urmia Univ Med Sci, Dept Neurosurg, Social Determinants Hlth Res Ctr, Orumiyeh, Iran.
   EntezarMahdi, Rasool; Ahmadzadeh, Jamal; Mobaraki, Kazhal; Mansorian, Behnam; Karimi, Hasan; Mirghaffarzadeh, Shamsi; Hajimohammadian, Mahnaz; Mohebbi, Iraj, Urmia Univ Med Sci, Social Determinants Hlth Res Ctr, Orumiyeh, Iran.},
DOI = {10.1027/0227-5910/a000581},
ISSN = {0227-5910},
EISSN = {2151-2396},
Keywords = {suicide; premature mortality; life expectancy; burden of suicide; years
   of potential (YPLL)},
Keywords-Plus = {SELF-IMMOLATION; EPIDEMIOLOGY; SMOKING; IMPACT; GENDER},
Research-Areas = {Psychiatry; Psychology},
Web-of-Science-Categories  = {Psychiatry; Psychology, Multidisciplinary},
Author-Email = {irajmohebbi@umsu.ac.ir},
ResearcherID-Numbers = {Mohebbi, Iraj/G-1494-2017
   },
ORCID-Numbers = {Mohebbi, Iraj/0000-0001-9158-5742},
Funding-Acknowledgement = {Urmia University of Medical Sciences {[}2100]},
Funding-Text = {This study was supported by grant no. 2100 and funding from the Urmia
   University of Medical Sciences. The funders had no role in the design
   and conduct of the study; collection, management, analysis, and
   interpretation of the data; preparation, review, or approval of the
   manuscript; and decision to submit the manuscript for publication.},
Cited-References = {Aghazadeh J, 2017, SEX REPROD HEALTHC, V14, P7, DOI 10.1016/j.srhc.2017.08.003.
   Ahmadi A, 2008, J BURN CARE RES, V29, P451, DOI 10.1097/BCR.0b013e31817112f1.
   Bonita R., 2006, BASIC EPIDEMIOLOGY, P32.
   Dastgiri S, 2005, EUR J GEN MED, V2, P14, DOI 10.29333/ejgm/82260.
   Fernandes F. E. C. V., 2017, INT ARCH MED, V10, DOI {[}10.3823/2423, DOI 10.3823/2423].
   Gordis L., 2008, EPIDEMIOLOGY.
   Gutierrez-Abejon E, 2015, MED CLIN-BARCELONA, V145, P520, DOI 10.1016/j.medcli.2015.03.013.
   Kanchan T, 2009, J FORENSIC SCI, V54, P938, DOI 10.1111/j.1556-4029.2009.01054.x.
   Kunde L, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040352.
   Liutkute V, 2017, EUR J PUBLIC HEALTH, V27, P736, DOI 10.1093/eurpub/ckx035.
   Michel K, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14030243.
   Paiman MA, 2017, ASIAN J PSYCHIATR, V26, P29, DOI 10.1016/j.ajp.2017.01.004.
   Park CHK, 2017, COMPR PSYCHIAT, V75, P27, DOI 10.1016/j.comppsych.2017.02.012.
   Pham TM, 2009, EUR J PUBLIC HEALTH, V19, P189, DOI 10.1093/eurpub/ckp020.
   Poorolajal Jalal, 2012, Epidemiol Health, V34, pe2012005, DOI 10.4178/epih/e2012005.
   Pritchard C, 2005, INT J GERIATR PSYCH, V20, P17, DOI 10.1002/gps.1213.
   Rezaeian M., 2012, HLTH SYSTEM RES, V8, P1190.
   Rezaeian M, 2013, BURNS, V39, P184, DOI 10.1016/j.burns.2012.05.022.
   van der Feltz-Cornelis CM, 2011, CRISIS, V32, P319, DOI 10.1027/0227-5910/a000109.
   Wasserman Danuta, 2005, World Psychiatry, V4, P114.
   World Health Organization, 2015, SUIC DAT.
   World Health Organization, 2014, PREVENTING SUICIDE G.
   World Health Organization, 2015, STATISTICS.
   World Health Organization, 2010, INT STAT CLASS DIS R.
   World Health Organization {[}WHO], 2018, SUICIDE.},
Number-of-Cited-References = {25},
Times-Cited = {2},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Crisis},
Doc-Delivery-Number = {JT2IX},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000500820600005},
DA = {2022-03-29},
}

@article{ WOS:000667480400010,
Author = {Ghani, Ali Raza and Mughal, Mohsin Sheraz and Kumar, Sundeep and Aslam,
   Sara and Alam, Mahboob and Usman, Mohammed Haris and Mikhalkova, Deanna},
Title = {The contemporary trends and geographic variation in premature mortality
   due to heart failure from 1999 to 2018 in the United States},
Journal = {IJC HEART \& VASCULATURE},
Year = {2021},
Volume = {34},
Month = {JUN},
Abstract = {Objectives: We aimed to examine the contemporary trends and regional
   variations in premature mortality due to heart failure across the U.S.
   from 1999 to 2018.
   Background: For most U.S. census regions, it is unknown whether
   premature mortality (deaths among persons under age 65) due to heart
   failure is increasing -or decreasing.
   Methods: In this descriptive study, the death certificate data were
   retrieved from the Centers for Disease Control and Prevention
   Wide-Ranging Online Data for Epidemiologic Research (WONDER) database
   and examined from 1999 to 2018 for the underlying cause of death.
   Age-adjusted mortality rates (AAMR) per 100,000 persons and annual
   percent change (APC) in rates stratified by census region were
   calculated using Joinpoint trend analysis software.
   Results: There were 118,116 premature deaths due to heart failure from
   1999 to 2018 across the U.S. Of these 52.40\% of deaths were reported in
   the South, 20.30\% in the Midwest, 15.10\% in the West, and 12.20\% in
   the Northeast. The AAMRs were the highest in the South region (range:
   3.1-4.9) and the lowest in the Northeast region (range: 1.5-1.9). There
   was an overall decline in mortality across all regions from 1999 till
   2011-2012. However, mortality has an upward trajectory throughout all
   the census regions after 2012.
   Conclusions: This study on nationwide data showed that overall premature
   mortality due to heart failure declined from 1999 to 2011-2012 followed
   by an upward trajectory from 2012 to 2018; the explanation for this
   merits further discovery. (C) 2021 The Authors. Published by Elsevier
   B.V.},
Publisher = {ELSEVIER IRELAND LTD},
Address = {ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND},
Type = {Article},
Language = {English},
Affiliation = {Mughal, MS (Corresponding Author), RWJ Barabas Healthcare Syst, Monmouth Med Ctr, Dept Med, Long Branch, NJ 07740 USA.
   Ghani, Ali Raza; Kumar, Sundeep; Mikhalkova, Deanna, St Louis Univ Hosp, Div Cardiol, Dept Med, St Louis, MO 63110 USA.
   Mughal, Mohsin Sheraz, RWJ Barabas Healthcare Syst, Monmouth Med Ctr, Dept Med, Long Branch, NJ 07740 USA.
   Alam, Mahboob, Baylor Coll Med, Sect Cardiol, Dept Med, One Baylor Plaza,MS BCM620, Houston, TX 77030 USA.
   Usman, Mohammed Haris, Newark Beth Israel Med Ctr, Dept Med, Sect Cardiol, Newark, NJ USA.
   Aslam, Sara, Univ Med \& Dent Coll, Faisalabad, Pakistan.},
DOI = {10.1016/j.ijcha.2021.100812},
EarlyAccessDate = {JUN 2021},
Article-Number = {100812},
EISSN = {2352-9067},
Keywords = {Heart failure; Premature mortality; Census regions; Disparities},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems},
ORCID-Numbers = {Kumar, Sundeep/0000-0003-3976-2603},
Cited-References = {{[}Anonymous], 2014, GLOBAL STATUS REPORT.
   Benjamin E.J., CIRCULATION, V139.
   Casper M, 2016, CIRCULATION, V133, P1171, DOI 10.1161/CIRCULATIONAHA.115.018663.
   Chen YX, 2019, JAMA CARDIOL, V4, P1230, DOI 10.1001/jamacardio.2019.3891.
   Curtin Sally C, 2019, Natl Vital Stat Rep, V68, P1.
   Liu LJ, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00132.
   Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757.
   Wu AH, 2007, HEART, V93, P403, DOI 10.1136/hrt.2005.085761.},
Number-of-Cited-References = {8},
Times-Cited = {1},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {IJC Heart Vasc.},
Doc-Delivery-Number = {TA8FM},
Web-of-Science-Index = {Emerging Sources Citation Index (ESCI)},
Unique-ID = {WOS:000667480400010},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000685649300005,
Author = {Alari, Anna and Schwarz, Lara and Zabrocki, Leo and Le Nir, Geraldine
   and Chaix, Basile and Benmarhnia, Tarik},
Title = {The effects of an air quality alert program on premature mortality: A
   difference-in-differences evaluation in the region of Paris},
Journal = {ENVIRONMENT INTERNATIONAL},
Year = {2021},
Volume = {156},
Month = {NOV},
Abstract = {Background: Daily exposure to air pollution has been shown to increase
   cardiovascular and respiratory mortality. While increases in short-term
   exposure to air pollutants at any daily concentrations has been shown to
   be associated to adverse health outcomes, days with extreme levels, also
   known as air pollution peaks based on specific thresholds, have been
   used to implement air quality alerts in various cities across the globe.
   Objectives: We aimed at evaluating the potential effects of the Air
   Quality Alerts (AQA) system on different causes of premature mortality
   in Paris, France. Methods: Air quality alerts (AQA) based on particulate
   matter (PM10) levels and related interventions were implemented in the
   region of Paris in 2008 and were revised to be more stringent in 2011.
   In this study, we applied a difference-in-differences (DID) approach
   coupled with propensity-score matching (PSM) to daily mortality data for
   the period 2000 to 2015 to evaluate the effects of the Paris AQA program
   on different causes of premature mortality for the entire population and
   for adults > 75 years old. Results: Overall, results did not show
   evidence of a reduction in mortality of the PM10 AQA program when first
   implemented in 2008 with initial thresholds (80 mu g/m(3)); DID
   estimates were slightly above 1 for cardiovascular and respiratory
   mortality. However, when evaluating the drastic reduction in revised
   thresholds in 2011 (50 mu g/ m(3)) to trigger interventions, we
   identified a reduction in cardiovascular (DID = 0.84, 95\% CI: 0.755 to
   0.930) mortality, but no change in respiratory mortality was detected
   (DID = 0.97, 95\% CI: 0.796, 1.191). Discussion: Our study suggests that
   AQA may not have health benefits for the population when thresholds are
   set at high daily PM10 levels. Given that such policies are implemented
   in many other metropolitan areas across the globe, evaluating the
   effectiveness of AQA is important to provide public authorities and
   researchers a rationale for defining specific thresholds and extending
   the scope of these policies to lower air pollution levels.},
Publisher = {PERGAMON-ELSEVIER SCIENCE LTD},
Address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Alari, A (Corresponding Author), Sorbonne Univ, Fac Med St Antoine, Inst Pierre Louis Epidemiol \& Sante Publ IPLESP, INSERM,Nemesis Team, 27 Rue Chaligny, F-75012 Paris, France.
   Alari, Anna; Chaix, Basile, Sorbonne Univ, Fac Med St Antoine, Inst Pierre Louis Epidemiol \& Sante Publ IPLESP, INSERM,Nemesis Team, 27 Rue Chaligny, F-75012 Paris, France.
   Schwarz, Lara; Benmarhnia, Tarik, Univ Calif San Diego, Dept Family Med \& Publ Hlth, 8622 Kennel Way, San Diego, CA 92103 USA.
   Schwarz, Lara; Benmarhnia, Tarik, Univ Calif San Diego, Scripps Inst Oceanog, 8622 Kennel Way, San Diego, CA 92103 USA.
   Zabrocki, Leo, Paris Sch Econ, 48 Blvd Jourdan, F-75014 Paris, France.
   Le Nir, Geraldine, Airparif, Air Qual Monitoring Assoc, 7 Rue Crillon, F-75004 Paris, France.},
DOI = {10.1016/j.envint.2021.106583},
EarlyAccessDate = {MAY 2021},
Article-Number = {106583},
ISSN = {0160-4120},
EISSN = {1873-6750},
Keywords = {Air pollution; Air Quality Alert System; Premature mortality;
   Quasi-experimental methods; Policy evaluation},
Keywords-Plus = {CONCENTRATION-RESPONSE RELATION; TIME-SERIES; SHORT-TERM;
   RESPIRATORY-DISEASES; NATURAL-HISTORY; POLLUTION; HEALTH; TRENDS;
   IMPACT; CHINA},
Research-Areas = {Environmental Sciences \& Ecology},
Web-of-Science-Categories  = {Environmental Sciences},
Author-Email = {anna.alari@iplesp.upmc.fr},
ResearcherID-Numbers = {Chaix, Basile/B-8625-2014
   },
ORCID-Numbers = {Schwarz, Lara/0000-0003-2567-0986},
Funding-Acknowledgement = {ADEME (Primequal) {[}1862C0011]},
Funding-Text = {This research was supported by ADEME (Primequal, \#1862C0011) .},
Cited-References = {Abadie A, 2018, ANNU REV ECON, V10, P465, DOI 10.1146/annurev-economics-080217-053402.
   Apte JS, 2015, ENVIRON SCI TECHNOL, V49, P8057, DOI 10.1021/acs.est.5b01236.
   Chen H, 2018, LANCET PLANET HEALTH, V2, pE19, DOI 10.1016/S2542-5196(17)30185-7.
   Daniels MJ, 2000, AM J EPIDEMIOL, V152, P397, DOI 10.1093/aje/152.5.397.
   Dominici F, 2002, J AM STAT ASSOC, V97, P100, DOI 10.1198/016214502753479266.
   Franchini M, 2009, SEMIN THROMB HEMOST, V35, P665, DOI 10.1055/s-0029-1242720.
   Guan WJ, 2016, LANCET, V388, P1939, DOI 10.1016/S0140-6736(16)31597-5.
   Joint FAO/WHO Expert Committee on Food Additives, 2006, World Health Organ Tech Rep Ser, V930, P1.
   Kodukula S., 2018, GREENPEACE, P1.
   Lin C.Z., 2011, AGR APPL EC ASS AAEA, DOI {[}10.22004/ag.econ.103381, DOI 10.22004/AG.ECON.103381].
   Liu C, 2019, NEW ENGL J MED, V381, P705, DOI 10.1056/NEJMoa1817364.
   Lu F, 2015, SCI TOTAL ENVIRON, V536, P123, DOI 10.1016/j.scitotenv.2015.07.048.
   Mason TG, 2020, ENVIRON INT, V135, DOI 10.1016/j.envint.2019.105344.
   Mason TG, 2019, ATMOS ENVIRON, V211, P151, DOI 10.1016/j.atmosenv.2019.05.013.
   Mullins J, 2015, AM J AGR ECON, V97, P1107, DOI 10.1093/ajae/aau081.
   Neidell M, 2010, J EPIDEMIOL COMMUN H, V64, P921, DOI 10.1136/jech.2008.081489.
   Noonan DS, 2014, POLICY STUD J, V42, P122, DOI 10.1111/psj.12045.
   Papadogeorgou G, 2019, CURR ENV HLTH REP, V6, P105, DOI 10.1007/s40572-019-00235-7.
   Pope CA, 2007, INHAL TOXICOL, V19, P33, DOI 10.1080/08958370701492961.
   Samoli E, 2001, ENVIRON HEALTH PERSP, V109, P349, DOI 10.2307/3454893.
   Schwartz J, 2001, ENVIRON HEALTH PERSP, V109, P1001, DOI 10.2307/3454953.
   Schwartz J, 2002, ENVIRON HEALTH PERSP, V110, P1025, DOI 10.1289/ehp.021101025.
   Schwartz J, 2000, EPIDEMIOLOGY, V11, P666, DOI 10.1097/00001648-200011000-00009.
   Semenza JC, 2008, ENVIRON RES, V107, P401, DOI 10.1016/j.envres.2008.03.005.
   Sese L, 2018, CHEST, V154, P726, DOI 10.1016/j.chest.2018.05.043.
   Sese L, 2018, THORAX, V73, P145, DOI 10.1136/thoraxjnl-2017-209967.
   Stuart EA, 2014, HEALTH SERV OUTCOME, V14, P166, DOI 10.1007/s10742-014-0123-z.
   Tribby CP, 2013, TRANSPORT POLICY, V30, P173, DOI 10.1016/j.tranpol.2013.09.012.
   World Health Organization, 2013, TECHNICAL REPORT, DOI {[}10.1007/BF00379640, DOI 10.1007/BF00379640].
   Yan ML, 2019, ENVIRON HEALTH PERSP, V127, DOI 10.1289/EHP4464.
   Zhang C, 2017, ENVIRON POLLUT, V229, P790, DOI 10.1016/j.envpol.2017.06.022.},
Number-of-Cited-References = {31},
Times-Cited = {2},
Usage-Count-Last-180-days = {4},
Usage-Count-Since-2013 = {9},
Journal-ISO = {Environ. Int.},
Doc-Delivery-Number = {UB1ZL},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000685649300005},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000336528000039,
Author = {Oliver, Jose M. and Gallego, Pastora and Gonzalez, Ana E. and
   Sanchez-Recalde, Angel and Bret, Monserrat and Aroca, Angel},
Title = {Pulmonary hypertension in young adults with repaired coarctation of the
   aorta: An unrecognised factor associated with premature mortality and
   heart failure},
Journal = {INTERNATIONAL JOURNAL OF CARDIOLOGY},
Year = {2014},
Volume = {174},
Number = {2},
Pages = {324-329},
Month = {JUN 15},
Abstract = {Background: Adults with repaired coarctation of the aorta (CoA) are at
   risk for premature cardiovascular death or heart failure (HF). We sought
   to evaluate risk factors for death or HF in young adults with repaired
   CoA in childhood.
   Methods: The medical records of a cohort of 159 adults diagnosed with
   CoA repaired at amean age of 4.1 +/- 5.7 years were retrospectively
   reviewed to identify predictors of a combined endpoint of all cause
   death or hospitalisation for HF by using Cox proportional hazard models.
   Results: Over a follow-up of 26 +/- 8 years (median 27 years) after
   repair, 5 patients died and 7 developed HF requiring hospitalisation.
   Pulmonary artery systolic pressure >40 mmHg (PH) was the main predictor
   of death or admission for HF (HR 32; 95\% CI 4.0-250; p=0.001). Neither
   systemic hypertension, recoarctation, aortic aneurysm, intracardiac
   lesions nor treatment with beta-blockers or ACEi/ARBs were statistically
   related to death or HF. Restrictive left ventricular physiology (RLVP)
   was the main predictor of PH by logistic regression analysis (OR 31;
   95\% CI 10-92; p < 0.001). Patients with severe PH (pulmonary artery
   systolic pressure >60 mmHg) showed RLVP (9/10), severe elevation of
   end-diastolic LV pressure at cardiac catheterization (8/8) and
   subendocardial late gadolinium enhancement on MRI (5/5). Pathological
   examination of an explanted heart demonstrated extensive left
   ventricular subendocardial fibrosis.
   Conclusions: Pulmonary hypertension related to restrictive left
   ventricular physiology was the strongest predictor of death or HF in
   young adults with CoA repaired in childhood. Persistent subendocardial
   fibrosis might be the structural substrate in some patients. (C) 2014
   Elsevier Ireland Ltd. All rights reserved.},
Publisher = {ELSEVIER IRELAND LTD},
Address = {ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND},
Type = {Article},
Language = {English},
Affiliation = {Oliver, JM (Corresponding Author), Hosp Univ La Paz, Unidad Cardiopatias Congenitas Adulto, Paseo Castellana 261, Madrid 28046, Spain.
   Oliver, Jose M.; Gallego, Pastora; Gonzalez, Ana E.; Sanchez-Recalde, Angel; Bret, Monserrat; Aroca, Angel, Hosp Univ La Paz, Adult Congenital Heart Dis Unit, Madrid 28046, Spain.
   Oliver, Jose M.; Gonzalez, Ana E.; Sanchez-Recalde, Angel, Hosp Univ La Paz, Div Cardiol, Madrid 28046, Spain.
   Gallego, Pastora, Virgen Macarena Univ Hosp Seville, Div Cardiol, Seville, Spain.
   Bret, Monserrat, Hosp Univ La Paz, Div Radiol, Madrid 28046, Spain.
   Aroca, Angel, Hosp Univ La Paz, Madrid 28046, Spain.},
DOI = {10.1016/j.ijcard.2014.04.060},
ISSN = {0167-5273},
EISSN = {1874-1754},
Keywords = {Adult congenital heart disease; Coarctation of the aorta; Pulmonary
   hypertension; Diastolic dysfunction; Subendocardial fibrosis},
Keywords-Plus = {TERM FOLLOW-UP; RISK; DYSFUNCTION; STIFFNESS; STENOSIS; DISEASE; DEATH},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems},
Author-Email = {joliver@salud.madrid.org},
ORCID-Numbers = {Oliver, Jose Maria/0000-0002-7774-9963},
Cited-References = {Burch M, 2004, HEART, V90, P918, DOI 10.1136/hrt.2003.024760.
   COHEN M, 1989, CIRCULATION, V80, P840, DOI 10.1161/01.CIR.80.4.840.
   Connolly HM, 2003, MAYO CLIN PROC, V78, P1491, DOI 10.4065/78.12.1491.
   Cook SC, 2009, INT J CARDIOL, V133, P95, DOI 10.1016/j.ijcard.2007.12.015.
   de Divitiis M, 2001, CIRCULATION, V104, pI165.
   Gallego P, 2012, AM J CARDIOL, V110, P109, DOI 10.1016/j.amjcard.2012.02.057.
   Guazzi M, 2011, CIRCULATION, V124, P164, DOI 10.1161/CIRCULATIONAHA.110.983866.
   Han RK, 2007, J AM COLL CARDIOL, V50, P2406, DOI 10.1016/j.jacc.2007.07.082.
   Kannell WB, 1999, ARCH INTERN MED, V159, P1197, DOI 10.1001/archinte.159.11.1197.
   KROGMANN ON, 1993, J AM COLL CARDIOL, V21, P1454, DOI 10.1016/0735-1097(93)90323-S.
   Lam YY, 2010, INT J CARDIOL, V145, P78, DOI 10.1016/j.ijcard.2009.05.016.
   Lofland GK, 2001, J THORAC CARDIOV SUR, V121, P10, DOI 10.1067/mtc.2001.111207.
   McElhinney DB, 2010, AM J CARDIOL, V106, P1792, DOI 10.1016/j.amjcard.2010.08.022.
   McElhinney DB, 2009, CIRCULATION, V120, P1482, DOI 10.1161/CIRCULATIONAHA.109.848994.
   Mutlak D, 2012, AM J MED SCI, V343, P397, DOI 10.1097/MAJ.0b013e3182309431.
   Oechslin EN, 2000, AM J CARDIOL, V86, P1111, DOI 10.1016/S0002-9149(00)01169-3.
   Oliver JM, 2004, J AM COLL CARDIOL, V44, P1641, DOI 10.1016/j.jacc.2004.07.037.
   Ou P, 2008, AM HEART J, V155, P187, DOI 10.1016/j.ahj.2007.09.008.
   Oudiz RJ, 2007, CLIN CHEST MED, V28, P233, DOI 10.1016/j.ccm.2006.12.001.
   Perloff JK, 2010, AM J CARDIOL, V106, P1038, DOI 10.1016/j.amjcard.2010.04.046.
   PRESBITERO P, 1987, BRIT HEART J, V57, P462.
   Robinson JD, 2010, AM J CARDIOL, V106, P426, DOI 10.1016/j.amjcard.2010.03.045.
   Roifman I, 2012, CIRCULATION, V126, P16, DOI 10.1161/CIRCULATIONAHA.111.088294.
   SEHESTED J, 1982, CIRCULATION, V65, P1060, DOI 10.1161/01.CIR.65.6.1060.
   Senzaki H, 2008, CIRCULATION, V118, pS191, DOI 10.1161/CIRCULATIONAHA.107.757096.
   Silka MJ, 1998, J AM COLL CARDIOL, V32, P245, DOI 10.1016/S0735-1097(98)00187-9.
   Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI {[}10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029].
   Toro-Salazar OH, 2002, AM J CARDIOL, V89, P541, DOI 10.1016/S0002-9149(01)02293-7.
   Verheugt CL, 2010, EUR HEART J, V31, P1220, DOI 10.1093/eurheartj/ehq032.
   Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052.
   Vogt M, 2005, CIRCULATION, V111, P3269, DOI 10.1161/CIRCULATIONAHA.104.529792.
   Xu JP, 1997, AM HEART J, V134, P93, DOI 10.1016/S0002-8703(97)70111-X.},
Number-of-Cited-References = {32},
Times-Cited = {8},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {5},
Journal-ISO = {Int. J. Cardiol.},
Doc-Delivery-Number = {AI0HT},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000336528000039},
DA = {2022-03-29},
}

@article{ WOS:000302730100008,
Author = {Tomkins, Susannah and Collier, Tim and Oralov, Alexey and Saburova,
   Lyudmila and McKee, Martin and Shkolnikov, Vladimir and Kiryanov,
   Nikolay and Leon, David A.},
Title = {Hazardous Alcohol Consumption Is a Major Factor in Male Premature
   Mortality in a Typical Russian City: Prospective Cohort Study 2003-2009},
Journal = {PLOS ONE},
Year = {2012},
Volume = {7},
Number = {2},
Month = {FEB 8},
Abstract = {Introduction: Russia has experienced massive fluctuations in mortality
   at working ages over the past three decades. Routine data analyses
   suggest that these are largely driven by fluctuations in heavy alcohol
   drinking. However, individual-level evidence supporting alcohol having a
   major role in Russian mortality comes from only two case-control
   studies, which could be subject to serious biases due to their design.
   Methods and Findings: A prospective study of mortality (2003-9) of 2000
   men aged 25-54 years at recruitment was conducted in the city of
   Izhevsk, Russia. This cohort was free from key limitations inherent in
   the design of the two earlier case-control studies. Cox proportional
   hazards regression was used to estimate hazard ratios of all-cause
   mortality by alcohol drinking type as reported by a proxy informant.
   Hazardous drinkers were defined as those who either drank non-beverage
   alcohols or were reported to regularly have hangovers or other
   behaviours related to heavy drinking episodes. Over the follow-up period
   113 men died. Compared to non-hazardous drinkers and abstainers, men who
   drank hazardously had appreciably higher mortality (HR = 3.4, 95\% CI
   2.2, 5.1) adjusted for age, smoking and education. The population
   attributable risk percent (PAR\%) for hazardous drinking was 26\% (95\%
   CI 14,37). However, larger effects were seen in the first two years of
   follow-up, with a HR of 4.6 (2.5, 8.2) and a corresponding PAR\% of 37\%
   (17, 51).
   Interpretation: This prospective cohort study strengthens the evidence
   that hazardous alcohol consumption has been a major determinant of
   mortality among working age men in a typical Russian city. As such the
   similar findings of the previous case-control studies cannot be
   explained as artefacts of limitations of their design. As Russia
   struggles to raise life expectancy, which even in 2009 was only 62 years
   among men, control of hazardous drinking must remain a top public health
   priority.},
Publisher = {PUBLIC LIBRARY SCIENCE},
Address = {1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA},
Type = {Article},
Language = {English},
Affiliation = {Tomkins, S (Corresponding Author), London Sch Hyg \& Trop Med, London WC1, England.
   Tomkins, Susannah; Collier, Tim; McKee, Martin; Leon, David A., London Sch Hyg \& Trop Med, London WC1, England.
   Oralov, Alexey, Izhevsk State Tech Univ, Izhevsk, Russia.
   Saburova, Lyudmila, Social Technol Inst, Izhevsk, Russia.
   Shkolnikov, Vladimir, Max Planck Inst Demog Res, Rostock, Germany.
   Shkolnikov, Vladimir, New Econ Sch, Moscow, Russia.
   Kiryanov, Nikolay, Izhevsk Med Acad, Izhevsk, Russia.},
DOI = {10.1371/journal.pone.0030274},
Article-Number = {e30274},
ISSN = {1932-6203},
Keywords-Plus = {CRISIS},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {david.leon@lshtm.ac.uk},
ResearcherID-Numbers = {Saburova, Lyudmila A./K-2275-2018
   Mckee, Martin/E-6673-2018
   McKee, Marc D/E-2187-2011
   Shkolnikov, Vladimir/D-2986-2017
   Leon, David A/G-2195-2010},
ORCID-Numbers = {Saburova, Lyudmila A./0000-0002-7243-652X
   Mckee, Martin/0000-0002-0121-9683
   McKee, Marc D/0000-0001-8349-965X
   Shkolnikov, Vladimir/0000-0003-2259-5423
   Leon, David A/0000-0001-9747-1762},
Funding-Acknowledgement = {Wellcome TrustWellcome TrustEuropean Commission {[}067232, 078557]},
Funding-Text = {The study was funded by the Wellcome Trust, grant numbers 067232 and
   078557. http://www.wellcome.ac.uk. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.},
Cited-References = {Deev A, 1998, ANN EPIDEMIOL, V8, P147, DOI 10.1016/S1047-2797(98)00004-0.
   Fillmore KM, 2007, ANN EPIDEMIOL, V17, pS16, DOI 10.1016/j.annepidem.2007.01.005.
   Gil A, 2009, ALCOHOL CLIN EXP RES, V33, P79, DOI 10.1111/j.1530-0277.2008.00813.x.
   GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206.
   Khaltourina DA, 2008, EVAL HEALTH PROF, V31, P272, DOI 10.1177/0163278708320160.
   Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6.
   Leon DA, 2011, INT J EPIDEMIOL, V40, P271, DOI 10.1093/ije/dyr061.
   Leon DA, 2010, INT J EPIDEMIOL, V39, P1279, DOI 10.1093/ije/dyq102.
   Leon DA, 2009, ADDICTION, V104, P1630, DOI 10.1111/j.1360-0443.2009.02655.x.
   McKee M, 2005, ALCOHOL CLIN EXP RES, V29, P1884, DOI 10.1097/01.alc.0000183012.93303.90.
   Tomkins S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-343.
   Torvik FA, 2011, SOC PSYCHIAT PSYCHIA.
   Treisman D, 2010, ECON TRANSIT, V18, P281, DOI 10.1111/j.1468-0351.2009.00382.x.
   Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5.},
Number-of-Cited-References = {14},
Times-Cited = {48},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {8},
Journal-ISO = {PLoS One},
Doc-Delivery-Number = {924ZP},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000302730100008},
OA = {Green Accepted, Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000445765600044,
Author = {Sandor, Janos and Palinkas, Anita and Vincze, Ferenc and Kovacs, Nora
   and Sipos, Valeria and Korosi, Laszlo and Falusi, Zsofia and Pal, Laszlo
   and Furjes, Gergely and Papp, Magor and Adany, Roza},
Title = {Healthcare Utilization and All-Cause Premature Mortality in Hungarian
   Segregated Roma Settlements: Evaluation of Specific Indicators in a
   Cross-Sectional Study},
Journal = {INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH},
Year = {2018},
Volume = {15},
Number = {9},
Month = {SEP},
Abstract = {Roma is the largest ethnic minority of Europe with deprived health
   status, which is poorly explored due to legal constrains of ethnicity
   assessment. We aimed to elaborate health indicators for adults living in
   segregated Roma settlements (SRS), representing the most vulnerable Roma
   subpopulation. SRSs were mapped in a study area populated by 54,682
   adults. Records of all adults living in the study area were processed in
   the National Institute of Health Insurance Fund Management. Aggregated,
   age-sex standardized SRS-specific and non-SRS-specific indicators on
   healthcare utilization and all-cause premature death along with the
   ratio of them (RR) were computed with 95\% confidence intervals. The
   rate of GP appointments was significantly higher among SRS inhabitants
   (RR = 1.152, 95\% CI: 1.136-1.167). The proportion of subjects
   hospitalized (RR = 1.286, 95\% CI: 1.177-1.405) and the reimbursement
   for inpatient care (RR = 1.060, 95\% CI: 1.057-1.064) were elevated for
   SRS. All-cause premature mortality was significantly higher in SRSs (RR
   = 1.711, 1.085-2.696). Our study demonstrated that it is possible to
   compute the SRS-specific version of routine healthcare indicators
   without violating the protection of personal data by converting a
   sensitive ethical issue into a non-sensitive small-area geographical
   analysis; there is an SRS-specific healthcare utilization pattern, which
   is associated with elevated costs and increased risk of all-cause
   premature death.},
Publisher = {MDPI},
Address = {ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND},
Type = {Article},
Language = {English},
Affiliation = {Sandor, J (Corresponding Author), Univ Debrecen, Fac Publ Hlth, Dept Prevent Med, Kassai St 26-B, H-4028 Debrecen, Hungary.
   Sandor, Janos; Palinkas, Anita; Vincze, Ferenc; Kovacs, Nora; Sipos, Valeria; Adany, Roza, Univ Debrecen, Fac Publ Hlth, Dept Prevent Med, Kassai St 26-B, H-4028 Debrecen, Hungary.
   Korosi, Laszlo; Falusi, Zsofia; Pal, Laszlo, Natl Hlth Insurance Fund, Dept Financing, Vaci Rd 73-A, H-1139 Budapest, Hungary.
   Furjes, Gergely; Papp, Magor, Natl Inst Hlth Dev, Dioszegi St 64, H-1113 Budapest, Hungary.
   Adany, Roza, Univ Debrecen, Fac Publ Hlth, Dept Prevent Med, MTA DE Publ Hlth Res Grp, Kassai St 26-B, H-4028 Debrecen, Hungary.
   Adany, Roza, Univ Debrecen, Fac Publ Hlth, Dept Prevent Med, WHO Collaborating Ctr Vulnerabil \& Hlth, Kassai St 26-B, H-4028 Debrecen, Hungary.},
DOI = {10.3390/ijerph15091835},
Article-Number = {1835},
EISSN = {1660-4601},
Keywords = {Roma minority; legal constraints; healthcare utilization; health status;
   geographical inequality},
Keywords-Plus = {VULNERABLE POPULATIONS; SOCIOECONOMIC-STATUS; SERVICES; EQUITY; ACCESS},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {sandor.janos@sph.unideb.hu
   palinkas.anita@sph.unideb.hu
   vincze.ferenc@sph.unideb.hu
   kovacs.nora@sph.unideb.hu
   sipos.valeria@sph.unideb.hu
   korosi.l@neak.gov.hu
   falusi.zs@neak.gov.hu
   pal.l@neak.gov.hu
   furjes.gergely@sph.unideb.hu
   papp.magor@nefi.hu
   adany.roza@sph.unideb.hu},
ResearcherID-Numbers = {Pálinkás, Anita/AAZ-1017-2020
   },
ORCID-Numbers = {Vincze, Ferenc/0000-0003-3595-7737},
Funding-Acknowledgement = {Swiss Government via the Swiss Contribution Programme {[}SH/8/1];
   Government of Hungary; Hungarian Academy of SciencesHungarian Academy of
   Sciences {[}MTA 11003, 2006TKI227]; IGEN-HUNGARIAN project
   {[}TAMOP-4.2.2.AA-11/1/KONV-2012-0031]; European UnionEuropean
   Commission; European Social FundEuropean Social Fund (ESF); European
   Regional Development FundEuropean Commission; 
   {[}GINOP-2.3.2-15-2016-00005]},
Funding-Text = {The reported study was carried out in the framework of the ``Public
   Health Focused Model Programme for Organizing Primary Care Services
   Backed by a Virtual Care Service Centre{''} (SH/8/1). The Model
   Programme is funded by the Swiss Government via the Swiss Contribution
   Programme (SH/8/1) in agreement with the Government of Hungary.
   Additional source of funding was from the grant of Hungarian Academy of
   Sciences (MTA 11003, 2006TKI227), from IGEN-HUNGARIAN
   (TAMOP-4.2.2.AA-11/1/KONV-2012-0031) project, which was co-financed by
   the European Union and the European Social Fund, and from
   GINOP-2.3.2-15-2016-00005 project, which was co-financed by the European
   Union and the European Regional Development Fund.},
Cited-References = {adany R., 2013, OPERATIONS MANUAL GP.
   Adany R, 2014, EUR J PUBLIC HEALTH, V24, P702, DOI 10.1093/eurpub/cku143.
   Adany Roza, 2013, Eur J Public Health, V23, P529, DOI 10.1093/eurpub/ckt095.
   Badrick E, 2014, PRIM HEALTH CARE RES, V15, P80, DOI 10.1017/S1463423612000606.
   Boruzs K, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00066.
   Carrasco-Garrido P, 2011, EUR J PUBLIC HEALTH, V21, P793, DOI 10.1093/eurpub/ckq153.
   Colombini M, 2012, GLOB PUBLIC HEALTH, V7, P522, DOI 10.1080/17441692.2011.641990.
   Tran DT, 2016, PRIM CARE DIABETES, V10, P66, DOI 10.1016/j.pcd.2015.07.001.
   Ekuklu G, 2003, YONSEI MED J, V44, P414, DOI 10.3349/ymj.2003.44.3.414.
   European Commission, 2012, EUR COMM COMM ASS HU.
   European Commission, 2014, HLTH STAT ROM POP DA.
   European Commission, 2011, EUR COMM COMM COMM E.
   Government of Hungary, 2015, NAT SOC INCL STRAT G.
   Hajioff S, 2000, J EPIDEMIOL COMMUN H, V54, P864, DOI 10.1136/jech.54.11.864.
   Hull S, 2014, BRIT J GEN PRACT, V64, P653, DOI 10.3399/bjgp14X683053.
   Hull SA, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X572544.
   Jackson C, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4178-y.
   Jakab Z, 2017, EUR J CANCER PREV, V26, pS183, DOI 10.1097/CEJ.0000000000000386.
   Jakab Z, 2013, EUR J PUBLIC HEALTH, V23, P528, DOI 10.1093/eurpub/ckt091.
   Kosa I, 2013, INT J CARDIOL, V168, P5012, DOI 10.1016/j.ijcard.2013.07.148.
   Kosa K, 2007, EPIDEMIOLOGY, V18, P290, DOI 10.1097/01.ede.0000258919.15281.4f.
   Kosa K, 2011, EUR J PUBLIC HEALTH, V21, P463, DOI 10.1093/eurpub/ckp097.
   Kosa Z, 2007, AM J PUBLIC HEALTH, V97, P853, DOI 10.2105/AJPH.2005.072173.
   Kosa Z, 2015, EUR J PUBLIC HEALTH, V25, P299, DOI 10.1093/eurpub/cku157.
   Levesque JF, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-18.
   Lin SS, 2000, EPIDEMIOL REV, V22, P187, DOI 10.1093/oxfordjournals.epirev.a018032.
   Marmot M., 2013, HLTH INEQUALITIES EU.
   Nagy C, 2012, EUR J PUBLIC HEALTH, V22, P620, DOI 10.1093/eurpub/ckr143.
   Richard L, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0351-7.
   Ringold D., 2005, ROMA EXPANDING EUROP.
   Sandor J, 2017, INT J PUBLIC HEALTH, V62, P803, DOI 10.1007/s00038-017-0954-9.
   Sandor J, 2017, FAM PRACT, V34, P83, DOI 10.1093/fampra/cmw102.
   Sandor J, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00200.
   Sebestyen A, 2011, EUR J TRAUMA EMERG S, V37, P503, DOI 10.1007/s00068-010-0072-3.
   Smylie Janet, 2015, Stat J IAOS, V31, P67.
   Sudzinova A, 2013, INT J PUBLIC HEALTH, V58, P409, DOI 10.1007/s00038-013-0462-5.
   Sudzinova A, 2015, EUR J PUBLIC HEALTH, V25, P765, DOI 10.1093/eurpub/ckv057.},
Number-of-Cited-References = {37},
Times-Cited = {5},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Int. J. Environ. Res. Public Health},
Doc-Delivery-Number = {GV0PX},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000445765600044},
OA = {Green Published, Green Submitted, gold},
DA = {2022-03-29},
}

@article{ WOS:000294436000001,
Author = {Nyhlen, Anna and Fridell, Mats and Backstrom, Martin and Hesse, Morten
   and Krantz, Peter},
Title = {Substance abuse and psychiatric co-morbidity as predictors of premature
   mortality in Swedish drug abusers a prospective longitudinal study
   1970-2006},
Journal = {BMC PSYCHIATRY},
Year = {2011},
Volume = {11},
Month = {JUL 30},
Abstract = {Background: Few longitudinal cohort studies have focused on the impact
   of substances abused and psychiatric disorders on premature mortality.
   The aim of the present study was to identify predictors of increased
   risk of drug related death and non drug related death in substance
   abusers of opiates, stimulants, cannabis, sedatives/hypnotics,
   hallucinogens and alcohol over several decades.
   Methods: Follow-up study of a consecutive cohort of 561 substance
   abusers, admitted to a detoxification unit January 1970 to February 1978
   in southern Sweden, and followed up in 2006. Demographic and clinical
   data, substance diagnoses and three groups of psychiatric diagnoses were
   identified at first admission. Causes of death were coded according to
   ICD-10 and classified as drug related deaths or non drug related deaths.
   To identify the incidence of some probable risk factors of drug related
   premature death, the data were subjected to a competing risks Cox
   regression analysis.
   Results: Of 561 patients in the cohort, 11 individuals had either
   emigrated or could not be located, and 204/561 patients (36.4\%) were
   deceased by 2006. The cumulative risk of drug related death increased
   more in the first 15 years and leveled out later on when non drug
   related causes of death had a similar incidence. In the final model,
   male gender, regular use of opiates or barbiturates at first admission,
   and neurosis were associated with an increased risk of drug related
   premature death, while cannabis use and psychosis were associated with a
   decreased risk. Neurosis, mainly depression and/or anxiety disorders,
   predicted drug related premature death while chronic psychosis and
   personality disorders did not. Chronic alcohol addiction was associated
   with increased risk of non drug related death.
   Conclusions: The cohort of drug abusers had an increased risk of
   premature death to the age of 69. Drug related premature death was
   predicted by male gender, the use of opiates or barbiturates and
   depression and anxiety disorders at first admission. The predicted
   cumulative incidence of drug related death was significantly higher in
   opiate and barbiturate abusers over the observed period of 37 years,
   while stimulant abuse did not have any impact. Alcohol contributed to
   non drug related death.},
Publisher = {BMC},
Address = {CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Fridell, M (Corresponding Author), Lund Univ, Dept Psychol, SE-35195 Vaxjo, Sweden.
   Fridell, Mats, Lund Univ, Dept Psychol, SE-35195 Vaxjo, Sweden.
   Fridell, Mats, Vaxjo Univ, Sch Educ Psychol \& Sport Sci, SE-35195 Vaxjo, Sweden.
   Nyhlen, Anna, Univ Lund Hosp, Dept Psychiat, SE-22185 Lund, Sweden.
   Backstrom, Martin, Lund Univ, Dept Psychol, SE-22100 Lund, Sweden.
   Hesse, Morten, Univ Aarhus, Ctr Alcohol \& Drug Res, DK-2300 Copenhagen S, Denmark.
   Krantz, Peter, Univ Lund Hosp, Dept Forens Med, S-22185 Lund, Sweden.},
DOI = {10.1186/1471-244X-11-122},
Article-Number = {122},
EISSN = {1471-244X},
Keywords = {drug related death; risk factor; gender; competing risks Cox regression;
   cohort study; Predictors},
Keywords-Plus = {FOLLOW-UP; COHORT; USERS; AMPHETAMINE; ADDICTS; OPIATE; DEATH; OVERDOSE;
   IMPACT; LUNDBY},
Research-Areas = {Psychiatry},
Web-of-Science-Categories  = {Psychiatry},
Author-Email = {mats.fridell@psychology.lu.se},
ResearcherID-Numbers = {Hesse, Morten/AAX-6198-2020},
ORCID-Numbers = {Hesse, Morten/0000-0002-6849-6554},
Funding-Acknowledgement = {Commission for Social Research, {[}SFR 92-0244:1b]; Mobilization Against
   Drugs {[}MOB-DNR 238/2006:39]; Swedish Prison and Probation Service
   {[}Dnr. 52-2007-28104]},
Funding-Text = {This research was supported by the Commission for Social Research,
   Stockholm (Grant \# SFR 92-0244:1b), The Mobilization Against Drugs,
   Stockholm (Grant \# MOB-DNR 238/2006:39), and the Swedish Prison and
   Probation Service (Grant \# Dnr. 52-2007-28104).},
Cited-References = {ANDREASSON S, 1990, SCAND J SOC MED, V18, P9.
   BALDACCHINO A, 2006, EUROPEAN COLLABORATI, V4, P307.
   Bargagli AM, 2006, EUR J PUBLIC HEALTH, V16, P198, DOI 10.1093/eurpub/cki168.
   BARR HL, 1984, J STUD ALCOHOL, V45, P440, DOI 10.15288/jsa.1984.45.440.
   Bartu A, 2004, ADDICTION, V99, P53, DOI 10.1111/j.1360-0443.2004.00602.x.
   Bejerot N, 1975, Acta Psychiatr Scand Suppl, V256, P3.
   BERGLUND GW, 1991, J SUBST ABUSE TREAT, V8, P161, DOI 10.1016/0740-5472(91)90008-X.
   Bogren M, 2009, NORD J PSYCHIAT, V63, P336, DOI 10.1080/08039480903009118.
   Brugal MT, 2005, ADDICTION, V100, P981, DOI 10.1111/j.1360-0443.2005.01089.x.
   Chen CC, 2001, ADDICTION, V96, P729, DOI 10.1046/j.1360-0443.2001.9657298.x.
   Copeland L, 2004, ARCH INTERN MED, V164, P1214, DOI 10.1001/archinte.164.11.1214.
   Darke S, 1996, ADDICTION, V91, P1765, DOI 10.1111/j.1360-0443.1996.tb03800.x.
   Degenhardt Louisa, 2005, J Clin Forensic Med, V12, P187, DOI 10.1016/j.jcfm.2004.11.003.
   Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437.
   {*}EMCDDA, 2010, ANN REP STAT DRUGS P, P87.
   Fridell M, 2006, ADDICT BEHAV, V31, P559, DOI 10.1016/j.addbeh.2005.05.036.
   Fridell M, 2008, ADDICT BEHAV, V33, P799, DOI 10.1016/j.addbeh.2008.01.001.
   FRISCHER M, 1993, J EPIDEMIOL COMMUN H, V47, P59, DOI 10.1136/jech.47.1.59.
   FRYKHOLM B, 1980, DRUG ALCOHOL DEPEN, V5, P123, DOI 10.1016/0376-8716(80)90188-X.
   Ghodse H, 1998, INT J EPIDEMIOL, V27, P473, DOI 10.1093/ije/27.3.473.
   Gossop M, 2002, ADDICTION, V97, P39, DOI 10.1046/j.1360-0443.2002.00079.x.
   Hser YI, 2001, ARCH GEN PSYCHIAT, V58, P503, DOI 10.1001/archpsyc.58.5.503.
   Hulse GK, 1999, ADDICTION, V94, P221, DOI 10.1046/j.1360-0443.1999.9422216.x.
   Nettelbladt P, 2005, ACTA PSYCHIAT SCAND, V111, P444, DOI 10.1111/j.1600-0447.2005.00518.x.
   Nilsson M, 2006, EUROPEAN COLLABORATI, V4, P351.
   Nyhlen A, 2011, J FORENSIC LEG MED, V18, P66, DOI 10.1016/j.jflm.2011.01.003.
   OPPENHEIMER E, 1994, ADDICTION, V89, P1299, DOI 10.1111/j.1360-0443.1994.tb03309.x.
   Oyefeso A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-148.
   Pintilie M, 2007, STAT MED, V26, P1360, DOI 10.1002/sim.2655.
   Ravndal E, 1999, EUR ADDICT RES, V5, P63, DOI 10.1159/000018967.
   Rehm J, 2005, DRUG ALCOHOL DEPEN, V79, P137, DOI 10.1016/j.drugalcdep.2005.01.005.
   Risser D, 2001, DRUG ALCOHOL DEPEN, V64, P251, DOI 10.1016/S0376-8716(01)00131-4.
   Schifano F, 2010, NEUROPSYCHOBIOLOGY, V61, P122, DOI 10.1159/000279302.
   Sidney S, 1997, AM J PUBLIC HEALTH, V87, P585, DOI 10.2105/AJPH.87.4.585.
   Skurtveit S, 2002, DRUG ALCOHOL DEPEN, V68, P143, DOI 10.1016/S0376-8716(02)00185-0.
   Sorensen HJ, 2005, ACTA PSYCHIAT SCAND, V111, P244, DOI 10.1111/j.1600-0447.2004.00445.x.
   SZASZ T, 1974, CEREMONIAL CHEM, P3.
   TUNVING K, 1988, ACTA PSYCHIAT SCAND, V77, P551, DOI 10.1111/j.1600-0447.1988.tb05168.x.
   {*}UNO, 1980, UNO HEAV DRUG US SPE.
   Wahren CA, 1997, INT J EPIDEMIOL, V26, P1219, DOI 10.1093/ije/26.6.1219.
   White JM, 1999, ADDICTION, V94, P961, DOI 10.1046/j.1360-0443.1999.9479612.x.
   World Health Organization, 1993, WHO ICD 10 CLASS MEN.},
Number-of-Cited-References = {42},
Times-Cited = {39},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {11},
Journal-ISO = {BMC Psychiatry},
Doc-Delivery-Number = {814GJ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000294436000001},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000323329300003,
Author = {Reynolds, Rebecca M. and Allan, Keith M. and Raja, Edwin A. and
   Bhattacharya, Sohinee and McNeill, Geraldine and Hannaford, Philip C.
   and Sarwar, Nadeem and Lee, Amanda J. and Bhattacharya, Siladitya and
   Norman, Jane E.},
Title = {Maternal obesity during pregnancy and premature mortality from
   cardiovascular event in adult offspring: follow-up of 1 323 275 person
   years},
Journal = {BMJ-BRITISH MEDICAL JOURNAL},
Year = {2013},
Volume = {347},
Month = {AUG 13},
Abstract = {Objectives To determine whether maternal obesity during pregnancy is
   associated with increased mortality from cardiovascular events in adult
   offspring.
   Design Record linkage cohort analysis.
   Setting Birth records from the Aberdeen Maternity and Neonatal databank
   linked to the General Register of Deaths, Scotland, and the Scottish
   Morbidity Record systems.
   Population 37 709 people with birth records from 1950 to present day.
   Main outcome measures Death and hospital admissions for cardiovascular
   events up to 1 January 2012 in offspring aged 34-61. Maternal body mass
   index (BMI) was calculated from height and weight measured at the first
   antenatal visit. The effect of maternal obesity on outcomes in offspring
   was tested with time to event analysis with Cox proportional hazard
   regression to compare outcomes in offspring of mothers in underweight,
   overweight, or obese categories of BMI compared with offspring of women
   with normal BMI.
   Results All cause mortality was increased in offspring of obese mothers
   (BMI >30) compared with mothers with normal BMI after adjustment for
   maternal age at delivery, socioeconomic status, sex of offspring,
   current age, birth weight, gestation at delivery, and gestation at
   measurement of BMI (hazard ratio 1.35, 95\% confidence interval 1.17 to
   1.55). In adjusted models, offspring of obese mothers also had an
   increased risk of hospital admission for a cardiovascular event (1.29,
   1.06 to 1.57) compared with offspring of mothers with normal BMI. The
   offspring of overweight mothers also had a higher risk of adverse
   outcomes.
   Conclusions Maternal obesity is associated with an increased risk of
   premature death in adult offspring. As one in five women in the United
   Kingdom is obese at antenatal booking, strategies to optimise weight
   before pregnancy are urgently required.},
Publisher = {BMJ PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Reynolds, RM (Corresponding Author), Univ Edinburgh, Queens Med Res Inst, Endocrinol Unit, BHF Univ Ctr Cardiovasc Sci, Edinburgh EH14 6TJ, Midlothian, Scotland.
   Reynolds, Rebecca M., Univ Edinburgh, Queens Med Res Inst, Endocrinol Unit, BHF Univ Ctr Cardiovasc Sci, Edinburgh EH14 6TJ, Midlothian, Scotland.
   Allan, Keith M.; Raja, Edwin A.; Bhattacharya, Sohinee; McNeill, Geraldine; Hannaford, Philip C.; Sarwar, Nadeem; Lee, Amanda J.; Bhattacharya, Siladitya, Univ Aberdeen, Inst Appl Hlth Sci, Aberdeen AB25 2ZD, Scotland.
   Norman, Jane E., Univ Edinburgh, Queens Med Res Inst, Med Res Council Ctr Reprod Hlth, Tommys Ctr Fetal \& Maternal Hlth, Edinburgh EH14 6TJ, Midlothian, Scotland.},
DOI = {10.1136/bmj.f4539},
Article-Number = {f4539},
ISSN = {1756-1833},
Keywords-Plus = {CORONARY-HEART-DISEASE; BODY-MASS INDEX; WEIGHT-GAIN;
   INSULIN-RESISTANCE; RISK-FACTORS; ADIPOSITY; BIRTH; COHORT; MEN;
   ASSOCIATIONS},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {R.Reynolds@ed.ac.uk},
ResearcherID-Numbers = {Reynolds, Rebecca M/C-3044-2008
   },
ORCID-Numbers = {Reynolds, Rebecca M/0000-0001-6226-8270
   Norman, Jane/0000-0001-6031-6953
   Bhattacharya, Siladitya/0000-0002-4588-356X
   Bhattacharya, Sohinee/0000-0002-2358-5860
   McNeill, Geraldine/0000-0003-0373-650X},
Funding-Acknowledgement = {chief scientist office, Scotland; Chest, Heart and Stroke, Scotland;
   Tommy's and the British Heart Foundation; Medical Research CouncilUK
   Research \& Innovation (UKRI)Medical Research Council UK (MRC)European
   Commission {[}G1002033] Funding Source: researchfish; Chief Scientist
   Office {[}CZB/4/582, CZG/2/478] Funding Source: researchfish; The Sir
   Jules Thorn Charitable Trust {[}09/01PhD] Funding Source: researchfish;
   MRCUK Research \& Innovation (UKRI)Medical Research Council UK (MRC)
   {[}G1002033] Funding Source: UKRI},
Funding-Text = {This work was supported by grants from the chief scientist office,
   Scotland, and Chest, Heart and Stroke, Scotland. We also acknowledge
   support from Tommy's and the British Heart Foundation. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.},
Cited-References = {Aagaard-Tillery KM, 2008, J MOL ENDOCRINOL, V41, P91, DOI 10.1677/JME-08-0025.
   BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171.
   Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x.
   Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077.
   Cooper R, 2010, AM J CLIN NUTR, V92, P946, DOI 10.3945/ajcn.2010.29477.
   Drake AJ, 2010, REPRODUCTION, V140, P387, DOI 10.1530/REP-10-0077.
   Dupout WD, 2008, STAT MODELLING BIOME.
   Fattah C, 2009, EUR J OBSTET GYN R B, V144, P32, DOI 10.1016/j.ejogrb.2009.01.015.
   Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39.
   Forsen T, 1997, BRIT MED J, V315, P837, DOI 10.1136/bmj.315.7112.837.
   Fraser A, 2010, CIRCULATION, V121, P2557, DOI 10.1161/CIRCULATIONAHA.109.906081.
   Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979.
   Heslehurst N, 2010, INT J OBESITY, V34, P420, DOI 10.1038/ijo.2009.250.
   Hochner H, 2012, CIRCULATION, V125, P1381, DOI 10.1161/CIRCULATIONAHA.111.070060.
   Huang Y, 2010, AM J PHYSIOL-ENDOC M, V299, pE968, DOI 10.1152/ajpendo.00434.2010.
   Kajantie E, 2005, INT J EPIDEMIOL, V34, P655, DOI 10.1093/ije/dyi048.
   LASKARZEWSKI P, 1980, AM J CLIN NUTR, V33, P2350, DOI 10.1093/ajcn/33.11.2350.
   Lawlor DA, 2011, AM J CLIN NUTR, V94, P142, DOI 10.3945/ajcn.110.009324.
   Li M, 2011, EXP DIABETES RES, DOI {[}10.4061/2011/179819, 10.1155/2011/592408].
   Ramsay JE, 2002, J CLIN ENDOCR METAB, V87, P4231, DOI 10.1210/jc.2002-020311.
   Reynolds RM, 2010, J CLIN ENDOCR METAB, V95, P5365, DOI 10.1210/jc.2010-0697.
   Reynolds RM, 2001, J CLIN ENDOCR METAB, V86, P245, DOI 10.1210/jc.86.1.245.
   Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477.
   Samuelsson AM, 2010, HYPERTENSION, V55, P76, DOI 10.1161/HYPERTENSIONAHA.109.139402.
   Simonen RL, 2002, MED SCI SPORT EXER, V34, P1137, DOI 10.1097/00005768-200207000-00014.
   Stommel M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-421.
   Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854.},
Number-of-Cited-References = {27},
Times-Cited = {303},
Usage-Count-Last-180-days = {3},
Usage-Count-Since-2013 = {38},
Journal-ISO = {BMJ-British Medical Journal},
Doc-Delivery-Number = {203XY},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000323329300003},
OA = {hybrid, Green Published, Green Accepted},
DA = {2022-03-29},
}

@article{ WOS:000471922200032,
Author = {Aminde, Leopold Ndemnge and Cobiac, Linda J. and Veerman, J. Lennert},
Title = {Potential impact of a modest reduction in salt intake on blood pressure,
   cardiovascular disease burden and premature mortality: a modelling study},
Journal = {OPEN HEART},
Year = {2019},
Volume = {6},
Number = {1},
Month = {JAN},
Abstract = {Objective To assess the potential impact of reduction in salt intake on
   the burden of cardiovascular disease (CVD) and premature mortality in
   Cameroon.
   Methods Using a multicohort proportional multistate life table model
   with Markov process, we modelled the impact of WHO's recommended 30\%
   relative reduction in population-wide sodium intake on the CVD burden
   for Cameroonian adults alive in 2016. Deterministic and probabilistic
   sensitivity analyses were conducted and used to quantify uncertainty.
   Results Over the lifetime, incidence is predicted to decrease by 5.2\%
   (95\% uncertainty interval (UI) 4.6 to 5.7) for ischaemic heart disease
   (IHD), 6.6\% (95\% UI 5.9 to 7.4) for haemorrhagic strokes, 4.8\% (95\%
   UI 4.2 to 5.4) for ischaemic strokes and 12.9\% (95\% UI 12.4 to 13.5)
   for hypertensive heart disease (HHD). Mortality over the lifetime is
   projected to reduce by 5.1\% (95\% UI 4.5 to 5.6) for IHD, by 6.9\%
   (95\% UI 6.1 to 7.7) for haemorrhagic stroke, by 4.5\% (95\% UI 4.0 to
   5.1) for ischaemic stroke and by 13.3\% (95\% UI 12.9 to 13.7) for HHD.
   About 776 400 (95\% UI 712 600 to 841 200) health-adjusted life years
   could be gained, and life expectancy might increase by 0.23 years and
   0.20 years for men and women, respectively. A projected 16.8\% change
   (reduction) between 2016 and 2030 in probability of premature mortality
   due to CVD would occur if population salt reduction recommended by WHO
   is attained.
   Conclusion Achieving the 30\% reduction in sodium intake recommended by
   WHO could considerably decrease the burden of CVD. Targeting blood
   pressure via decreasing population salt intake could translate in
   significant reductions in premature CVD mortality in Cameroon by 2030.},
Publisher = {BMJ PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Aminde, LN (Corresponding Author), Univ Queensland, Sch Publ Hlth, Fac Med, Brisbane, Qld, Australia.
   Aminde, LN (Corresponding Author), CRENC, Noncommunicable Dis Unit, Douala, Cameroon.
   Aminde, Leopold Ndemnge; Veerman, J. Lennert, Univ Queensland, Sch Publ Hlth, Fac Med, Brisbane, Qld, Australia.
   Aminde, Leopold Ndemnge, CRENC, Noncommunicable Dis Unit, Douala, Cameroon.
   Cobiac, Linda J., Univ Oxford, Nuffieid Dept Populat Hlth, Oxford, England.
   Veerman, J. Lennert, Griffith Univ, Sch Med, Gold Coast, Qld, Australia.},
DOI = {10.1136/openhrt-2018-000943},
Article-Number = {UNSP e000943},
ISSN = {2053-3624},
Keywords-Plus = {SUB-SAHARAN AFRICA; RISK-FACTORS; COST-EFFECTIVENESS; HYPERTENSION;
   SODIUM},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems},
Author-Email = {l.aminde@uq.net.au},
ORCID-Numbers = {AMINDE, Leopold/0000-0003-2787-7518},
Funding-Acknowledgement = {Australian Government Research Training Program (RTP) Scholarship Award},
Funding-Text = {Leopold N. Aminde is supported by the Australian Government Research
   Training Program (RTP) Scholarship Award.},
Cited-References = {Adeloye D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104300.
   Aminde LN, 2018, COST EFFECT RESOUR A, V16, DOI 10.1186/s12962-018-0108-9.
   ARREY WT, 2016, INT J HYPERTENS, V2016, P1, DOI DOI 10.1186/1742-4682-10-17.
   Ataklte F, 2015, HYPERTENSION, V65, P291, DOI 10.1161/HYPERTENSIONAHA.114.04394.
   Barendregt J J, 1998, Math Popul Stud, V7, P29.
   Barendregt Jan J, 2003, Popul Health Metr, V1, P4, DOI 10.1186/1478-7954-1-4.
   Barendregt JJ, 2010, J EPIDEMIOL COMMUN H, V64, P209, DOI 10.1136/jech.2009.090274.
   Barendregt JJ, EPIGEAR INT.
   Basu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044037.
   Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355.
   Cobiac LJ, 2010, HEART, V96, P1920, DOI 10.1136/hrt.2010.199240.
   Cogswell ME, 2016, NEW ENGL J MED, V375, P580, DOI 10.1056/NEJMsb1607161.
   Eckel RH, 2014, J AM COLL CARDIOL, V63, P2960, DOI 10.1016/j.jacc.2013.11.003.
   Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8.
   Gimou MM, 2013, FOOD ADDIT CONTAM A, V30, P1556, DOI 10.1080/19440049.2013.813649.
   Global Nutrition and Policy Consortium, 2014, GLOB DIET DAT MEAS D.
   He FJ, 2018, NAT REV CARDIOL, V15, P371, DOI 10.1038/s41569-018-0004-1.
   He FJ, 2013, COCHRANE DATABASE SY, V1.
   Hendriksen MAH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186760.
   Hendriksen MAH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118873.
   Karppanen H, 2006, PROG CARDIOVASC DIS, V49, P59, DOI 10.1016/j.pcad.2006.07.001.
   Kingue S, 2015, J CLIN HYPERTENS, V17, P819, DOI 10.1111/jch.12604.
   Kontis V, 2015, LANCET GLOB HEALTH, V3, pE746, DOI 10.1016/S2214-109X(15)00179-5.
   Lekoubou A, 2015, J NEUROL SCI, V350, P24, DOI 10.1016/j.jns.2015.02.002.
   Li YC, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0894-5.
   Mente A, 2016, LANCET, V388, P465, DOI 10.1016/S0140-6736(16)30467-6.
   NICE (The National Institute for Health and Care Excellence), 2010, CARD DIS PREV.
   Nkoke Clovis, 2017, BMC Res Notes, V10, P684, DOI 10.1186/s13104-017-3034-6.
   Roth GA, 2014, AMERICAN.
   Roth GA, 2015, CIRCULATION, V132, P1270, DOI 10.1161/CIRCULATIONAHA.115.016021.
   Watkins DA, 2016, HEALTH POLICY PLANN, V31, P75, DOI 10.1093/heapol/czv023.
   WHO, 2015, GLOB ACT PLAN ANT RE.
   Wilson N, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0161-1.
   World Health Organization, 2016, SHAK SALT HAB SHAK T.
   World Health Organization, 2017, NONC DIS PROGR MON 2.},
Number-of-Cited-References = {35},
Times-Cited = {7},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {5},
Journal-ISO = {Open Heart},
Doc-Delivery-Number = {ID8GR},
Web-of-Science-Index = {Emerging Sources Citation Index (ESCI)},
Unique-ID = {WOS:000471922200032},
OA = {gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000313010000005,
Author = {Lichtenberg, Frank R.},
Title = {The impact of new (orphan) drug approvals on premature mortality from
   rare diseases in the United States and France, 1999-2007},
Journal = {EUROPEAN JOURNAL OF HEALTH ECONOMICS},
Year = {2013},
Volume = {14},
Number = {1},
Pages = {41-56},
Month = {FEB},
Abstract = {This paper investigates the impact of the introduction of new orphan
   drugs on premature mortality from rare diseases using longitudinal,
   disease-level data obtained from a number of major databases. The
   analysis is performed using data from two countries: the United States
   (during the period 1999-2006) and France (during the period 2000-2007).
   For both countries, we estimate models using two alternative definitions
   of premature mortality, several alternative criteria for inclusion in
   the set of rare diseases, and several values of the potential lag
   between new drug approvals and premature mortality reduction. Both the
   United States and French estimates indicate that, overall, premature
   mortality from rare diseases is unrelated to the cumulative number of
   drugs approved 0-2 years earlier but is significantly inversely related
   to the cumulative number of drugs approved 3-4 years earlier. This delay
   is not surprising, since most patients probably do not have access to a
   drug until several years after it has been launched. Although the
   estimates for the two countries are qualitatively similar, the estimated
   magnitudes of the US coefficients are about four times as large as the
   magnitudes of the French coefficients. This may be partly due to greater
   errors in measuring dates of drug introduction in France. Also, access
   to new drugs may be more restricted in France than it is in the United
   States. Our estimates indicate that, in the United States, potential
   years of life lost to rare diseases before age 65 (PYLL65) declined at
   an average annual rate of 3.3\% and that, in the absence of lagged new
   drug approvals, PYLL65 would have increased at a rate of 0.9\%. Since
   the US population aged 0-64 was increasing at the rate of 1.0\% per
   year, this means that PYLL65 per person under 65 would have remained
   approximately constant. The reduction in the US growth rate of PYLL65
   attributable to lagged new drug approvals was 4.2\%. In France, PYLL65
   declined at an average annual rate of 1.8\%. The estimates imply that,
   in the absence of lagged new drug approvals, it would have declined at a
   rate of 0.6\%. The reduction in the French growth rate of PYLL65
   attributable to lagged new drug approvals was 1.1\%. Earlier access to
   orphan drugs could result in earlier reductions in premature mortality
   from rare diseases.},
Publisher = {SPRINGER},
Address = {ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES},
Type = {Article},
Language = {English},
Affiliation = {Lichtenberg, FR (Corresponding Author), Columbia Univ, Grad Sch Business, New York, NY 10027 USA.
   Lichtenberg, Frank R., Columbia Univ, Grad Sch Business, New York, NY 10027 USA.
   Lichtenberg, Frank R., Natl Bur Econ Res, Cambridge, MA 02138 USA.},
DOI = {10.1007/s10198-011-0349-4},
ISSN = {1618-7598},
EISSN = {1618-7601},
Keywords = {Orphan drugs; Orphan diseases; Rare diseases; Mortality; Innovation},
Research-Areas = {Business \& Economics; Health Care Sciences \& Services},
Web-of-Science-Categories  = {Economics; Health Policy \& Services},
Author-Email = {frank.lichtenberg@columbia.edu},
Cited-References = {{[}Anonymous], 2010, ORPH REP SER.
   Centers for Disease Control, COMPR MORT DAT.
   Centers for Disease Control, MULT CAUS OF DEATH P.
   Cranston JW, 1998, DRUG INF J, V32, P1049, DOI 10.1177/009286159803200425.
   Food and Drug Administration, LIST ORPH DES APPR.
   Food and Drug Administration, DRUGS FDA DAT.
   Lichtenberg F.R., 2009, MICH TELECOMM TECH L, P335.
   Lichtenberg FR, 2005, STUD INCOME, V65, P237.
   Lichtenberg FR, 2009, ECON INNOV NEW TECH, V18, P407, DOI 10.1080/10438590802547142.
   Lichtenberg FR, 2009, HEALTH ECON, V18, P519, DOI 10.1002/hec.1382.
   Liu MB, 2010, CLIN TRIALS MANUAL D.
   National Cancer Institute, CANC PREV DAT.
   ROMER PM, 1990, J POLIT ECON, V98, pS71, DOI 10.1086/261725.},
Number-of-Cited-References = {13},
Times-Cited = {16},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {19},
Journal-ISO = {Eur. J. Health Econ.},
Doc-Delivery-Number = {063OS},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000313010000005},
DA = {2022-03-29},
}

@article{ WOS:000343702900016,
Author = {Fazel, Seena and Wolf, Achim and Palm, Camilla and Lichtenstein, Paul},
Title = {Violent crime, suicide, and premature mortality in patients with
   schizophrenia and related disorders: a 38-year total population study in
   Sweden},
Journal = {LANCET PSYCHIATRY},
Year = {2014},
Volume = {1},
Number = {1},
Pages = {44-54},
Month = {JUN},
Abstract = {Background People with schizophrenia and related disorders are at an
   increased risk of adverse outcomes, including conviction of a violent
   offence, suicide, and premature mortality. However, the rates of, and
   risk factors for, these outcomes need clarification as a basis for
   population-based and targeted interventions. We aimed to determine rates
   and risk factors for these outcomes, and investigate to what extent they
   are shared across outcomes and are specific to schizophrenia and related
   disorders.
   Methods We undertook a total population cohort study in Sweden of 24 297
   patients with schizophrenia and related disorders between January, 1972
   and December, 2009. Patients were matched by age and sex to people from
   the general population (n=485 940) and also to unaffected sibling
   controls (n=26 357). First, we investigated rates of conviction of a
   violent offence, suicide, and premature mortality, with follow-up until
   conviction of a violent offence, emigration, death, or end of follow-up
   (Dec 31, 2009), whichever occurred first. Second, we analysed
   associations between these adverse outcomes and sociodemographic,
   individual, familial, and distal risk factors, for men and women
   separately, with Cox proportional hazards models. Finally, we assessed
   time trends in adverse outcomes between 1972 and 2009, for which we
   compared patients with unaffected siblings, and analysed associations
   with changes in the number of nights spent in inpatient beds in
   psychiatric facilities nationwide.
   Findings Within 5 years of their initial diagnosis, 13.9\% of men and
   4.7\% of women with schizophrenia and related disorders had a major
   adverse outcome (10.7\% of men and 2.7\% of women were convicted of a
   violent offence, and 3.3\% of men and 2.0\% of women died prematurely of
   any cause). During the study, the adjusted odds ratio of any adverse
   outcomes for patients compared with general population controls was 7.5
   (95\% CI 7.2-7.9) in men and 11.1 (10.2-12.1) in women. Three risk
   factors that were present before diagnosis were predictive of any
   adverse outcome: drug use disorders, criminality, and self-harm, which
   were also risk factors for these outcomes in unaffected siblings and in
   the general population. Over the period 1973-2009, the odds of these
   outcomes increased in patients with schizophrenia and related disorders
   compared with unaffected siblings.
   Interpretation Schizophrenia and related disorders are associated with
   substantially increased rates of violent crime, suicide, and premature
   mortality. Risk factors for these three outcomes included both those
   specific to individuals with schizophrenia and related disorders, and
   those shared with the general population. Therefore, a combination of
   population-based and targeted strategies might be necessary to reduce
   the substantial rates of adverse outcomes in patients with schizophrenia
   and related disorders. Copyright (C) Fazel et al.},
Publisher = {ELSEVIER SCI LTD},
Address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Fazel, S (Corresponding Author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.
   Fazel, Seena; Wolf, Achim, Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.
   Palm, Camilla; Lichtenstein, Paul, Karolinska Inst, Dept Med Epidemiol \& Biostat, Stockholm, Sweden.},
DOI = {10.1016/S2215-0366(14)70223-8},
ISSN = {2215-0374},
Keywords-Plus = {RISK; PSYCHOSIS; IQ; COMPLICATIONS; ASSOCIATIONS; PREVALENCE; REGISTER;
   VALIDITY; RATES; TWIN},
Research-Areas = {Psychiatry},
Web-of-Science-Categories  = {Psychiatry},
Author-Email = {seena.fazel@psych.ox.ac.uk},
ResearcherID-Numbers = {Fazel, Seena/B-5307-2008
   },
ORCID-Numbers = {Fazel, Seena/0000-0002-5383-5365
   lichtenstein, paul/0000-0003-3037-5287},
Funding-Acknowledgement = {Wellcome TrustWellcome TrustEuropean Commission {[}095806]; Swedish
   Research CouncilSwedish Research CouncilEuropean Commission},
Funding-Text = {This study was funded by the Wellcome Trust (095806) and the Swedish
   Research Council.},
Cited-References = {Agerbo E, 2007, ARCH GEN PSYCHIAT, V64, P1377, DOI 10.1001/archpsyc.64.12.1377.
   Becker HK, 1976, JUSTICE MODERN SWEDE.
   Breslow N, 1980, P248.
   Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080.
   Cavanagh JTO, 2003, PSYCHOL MED, V33, P395, DOI 10.1017/S0033291702006943.
   COID B, 1993, BRIT J PSYCHIAT, V162, P87, DOI 10.1192/bjp.162.1.87.
   Dalman C, 2002, SOC PSYCH PSYCH EPID, V37, P527, DOI 10.1007/s00127-002-0582-3.
   David AS, 1997, PSYCHOL MED, V27, P1311, DOI 10.1017/S0033291797005680.
   Dolmen L, 2001, CRIMINALITY DIFFEREN.
   Douglas KS, 2009, PSYCHOL BULL, V135, P679, DOI 10.1037/a0016311.
   Ekholm B, 2005, NORD J PSYCHIAT, V59, P457, DOI 10.1080/08039480500360906.
   Ellis L, 2009, HDB CRIME CORRELATES.
   Eurostat, DEATH DUE SUIC SEX S.
   Fazel S, 2006, AM J PSYCHIAT, V163, P1397, DOI 10.1176/appi.ajp.163.8.1397.
   Fazel S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4692.
   Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150.
   Fazel S, 2011, SCHIZOPHRENIA BULL, V37, P800, DOI 10.1093/schbul/sbp135.
   Fazel S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000120.
   Fazel S, 2009, JAMA-J AM MED ASSOC, V301, P2016, DOI 10.1001/jama.2009.675.
   Fuller Torrey E., 2013, AM PSYCHOSIS FEDERAL.
   Gunnell D, 2005, BMJ-BRIT MED J, V330, P167, DOI 10.1136/bmj.38310.473565.8F.
   Hawton K, 2005, BRIT J PSYCHIAT, V187, P9, DOI 10.1192/bjp.187.1.9.
   Hoang U, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5422.
   Hor K, 2010, J PSYCHOPHARMACOL, V24, P81, DOI 10.1177/1359786810385490.
   Horton R, 2013, LANCET, V381, P509, DOI 10.1016/S0140-6736(13)60100-2.
   Hultman CM, 1999, BRIT MED J, V318, P421, DOI 10.1136/bmj.318.7181.421.
   KENDLER KS, 1986, ARCH GEN PSYCHIAT, V43, P643.
   Kirkbride JB, 2011, SCHIZOPHRENIA BULL, V37, P262, DOI 10.1093/schbul/sbq120.
   Klein-Geltink JE, 2007, J CLIN EPIDEMIOL, V60, P766, DOI 10.1016/j.jclinepi.2006.11.008.
   Kooyman I, 2007, BRIT J PSYCHIAT, V191, pS29, DOI 10.1192/bjp.191.50.s29.
   Large MM, 2009, PSYCHOL PSYCHOTHER-T, V82, P113.
   Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450.
   Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x.
   Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1.
   McGorry PD, 2002, ARCH GEN PSYCHIAT, V59, P921, DOI 10.1001/archpsyc.59.10.921.
   Neeleman J, 1997, PSYCHOL MED, V27, P467, DOI 10.1017/S0033291796004631.
   Nordentoft M, 2004, BRIT MED J, V329, P261, DOI 10.1136/bmj.38133.622488.63.
   Osby U, 2000, SCHIZOPHR RES, V45, P21, DOI 10.1016/S0920-9964(99)00191-7.
   Priebe S, 2005, BMJ-BRIT MED J, V330, P123, DOI 10.1136/bmj.38296.611215.AE.
   RAINE A, 1994, ARCH GEN PSYCHIAT, V51, P984.
   Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141.
   Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123.
   Sellgren C, 2011, ACTA PSYCHIAT SCAND, V124, P447, DOI 10.1111/j.1600-0447.2011.01747.x.
   Singh JP, 2011, SCHIZOPHRENIA BULL, V37, P899, DOI 10.1093/schbul/sbr093.
   Statistics Sweden, 2005, MULTIGENERATION REG.
   Swedish National Board of Health and Welfare, 2010, CAUS DEATH REG.
   Wallace C, 2004, AM J PSYCHIAT, V161, P716, DOI 10.1176/appi.ajp.161.4.716.
   Webb RT, 2011, SCHIZOPHR RES, V130, P143, DOI 10.1016/j.schres.2011.04.031.
   Wennerstad KM, 2010, SOC SCI MED, V70, P575, DOI 10.1016/j.socscimed.2009.10.050.
   Wildgust HJ, 2010, J PSYCHOPHARMACOL, V24, P37, DOI 10.1177/1359786810384639.
   Witt K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055942.
   Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018.
   Wolf A, 2014, SOC SCI MED, V104, P220, DOI 10.1016/j.socscimed.2013.12.006.},
Number-of-Cited-References = {53},
Times-Cited = {127},
Usage-Count-Last-180-days = {4},
Usage-Count-Since-2013 = {22},
Journal-ISO = {Lancet Psychiatry},
Doc-Delivery-Number = {AR6ON},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000343702900016},
OA = {Green Submitted, hybrid, Green Accepted, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000248772000013,
Author = {Arndt, Volker and Rothenbacher, Dietrich and Zschenderlein, Bernd and
   Schuberth, Stephan and Brenner, Hermann},
Title = {Body mass index and premature mortality in physically heavily working
   men - a ten-year follow-up of 20,000 construction workers},
Journal = {JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE},
Year = {2007},
Volume = {49},
Number = {8},
Pages = {913-921},
Month = {AUG},
Abstract = {Objective: Although obesity is clearly associated with diabetes and
   cardiovascular disease, health consequences of being mildly or
   moderately overweight are less clear in physically heavily working men.
   Methods: The association between body mass index (BMI) and mortality was
   assessed over a 10-year period in a cohort of 19,513 mate construction
   workers, who underwent routine occupational health examination during
   1986 to 1992. Results: Among never smokers normal and overweight men
   experienced similar mortality. Among smokers, we observed a strong
   U-shaped association between BMI and all-cause mortality, which was
   lowest for BMI levels between 25 and 35 kg/m(2) after control for
   potential covariates. Conclusions: BMI levels commonly considered to
   reflect overweight may not necessarily be associated with increased
   mortality in physically heavily working men.},
Publisher = {LIPPINCOTT WILLIAMS \& WILKINS},
Address = {TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA},
Type = {Article},
Language = {English},
Affiliation = {Arndt, V (Corresponding Author), German Canc Res Ctr, Div Clin Epidemiol \& Aging Res, C070,Bergheimer Str 20, D-69115 Heidelberg, Germany.
   German Canc Res Ctr, Div Clin Epidemiol \& Aging Res, D-69115 Heidelberg, Germany.
   Occupat Hlth Serv, Workmens Compensat Board Construct Workers, Boblingen, Germany.},
DOI = {10.1097/JOM.0b013e31814544fe},
ISSN = {1076-2752},
EISSN = {1536-5948},
Keywords-Plus = {ALL-CAUSE MORTALITY; LOW-BACK-PAIN; PROSPECTIVE COHORT; RISK-FACTORS;
   FRACTIONAL POLYNOMIALS; DISABILITY PENSION; OBESITY; WEIGHT; OVERWEIGHT;
   OSTEOARTHRITIS},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {v.arndt@dkfz.de},
ResearcherID-Numbers = {Arndt, Volker/AAI-7282-2020
   Arndt, Volker/B-4999-2014
   /AAM-5330-2020
   Brenner, Hermann/B-4627-2017
   },
ORCID-Numbers = {Arndt, Volker/0000-0001-9320-8684
   Arndt, Volker/0000-0001-9320-8684
   Brenner, Hermann/0000-0002-6129-1572
   Rothenbacher, Dietrich/0000-0002-3563-2791},
Cited-References = {Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643.
   {[}Anonymous], 2000, WHO TECHN REP SER.
   Arndt V, 2004, OCCUP ENVIRON MED, V61, P419, DOI 10.1136/oem.2003.008680.
   Arnold AM, 2003, AM J EPIDEMIOL, V157, P74, DOI 10.1093/aje/kwf156.
   ARRIGHI HM, 1994, EPIDEMIOLOGY, V5, P189, DOI 10.1097/00001648-199403000-00009.
   Bigaard J, 2004, OBES RES, V12, P1042, DOI 10.1038/oby.2004.131.
   Bigaard J, 2004, INT J OBESITY, V28, P741, DOI 10.1038/sj.ijo.0802635.
   Brenner H, 1997, J CLIN EPIDEMIOL, V50, P1099, DOI 10.1016/S0895-4356(97)00123-6.
   Burton WN, 1998, J OCCUP ENVIRON MED, V40, P786, DOI 10.1097/00043764-199809000-00007.
   Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501.
   Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423.
   Chen ZM, 2006, INT J EPIDEMIOL, V35, P141, DOI 10.1093/ije/dyi215.
   Coggon D, 1998, AM J EPIDEMIOL, V147, P523.
   Cooper C, 1998, AM J EPIDEMIOL, V147, P516.
   COX DR, 1972, J R STAT SOC B, V34, P187.
   Dorn JM, 1997, AM J EPIDEMIOL, V146, P919, DOI 10.1093/oxfordjournals.aje.a009218.
   Felson DT, 1997, ARTHRITIS RHEUM, V40, P728, DOI 10.1002/art.1780400420.
   Finkelstein E, 2005, AM J HEALTH PROMOT, V20, P45, DOI 10.4278/0890-1171-20.1.45.
   Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861.
   Freedman DM, 2006, AM J PREV MED, V31, P355, DOI 10.1016/j.amepre.2006.07.022.
   Freedman DM, 2006, INT J OBESITY, V30, P822, DOI 10.1038/sj.ijo.0803193.
   Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733.
   GELBER RP, 2007, INT J OBES LOND.
   Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776.
   Hagen KB, 2002, SPINE, V27, P1790, DOI 10.1097/00007632-200208150-00019.
   Han TS, 1997, INT J OBESITY, V21, P600, DOI 10.1038/sj.ijo.0800448.
   Henley SJ, 2002, EPIDEMIOLOGY, V13, P268, DOI 10.1097/00001648-200205000-00006.
   Hu G, 2005, INT J OBESITY, V29, P894, DOI 10.1038/sj.ijo.0802870.
   Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017.
   Karnehed N, 2007, SCAND J PUBLIC HEALT, V35, P48, DOI 10.1080/14034940600858524.
   Lawlor DA, 2006, OBESITY, V14, P2294, DOI 10.1038/oby.2006.269.
   Leboeuf-Yde C, 1999, SPINE, V24, P779, DOI 10.1097/00007632-199904150-00009.
   LEE IM, 1993, JAMA-J AM MED ASSOC, V270, P2823, DOI 10.1001/jama.270.23.2823.
   Lievense AM, 2002, RHEUMATOLOGY, V41, P1155, DOI 10.1093/rheumatology/41.10.1155.
   LINDSTED K, 1991, INT J OBESITY, V15, P397.
   Manek NJ, 2003, ARTHRITIS RHEUM-US, V48, P1024, DOI 10.1002/art.10884.
   MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101.
   Mansson NO, 1996, INT J EPIDEMIOL, V25, P80, DOI 10.1093/ije/25.1.80.
   Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012.
   Meyer HE, 2002, MED SCI SPORT EXER, V34, P1065, DOI 10.1097/00005768-200207000-00002.
   Narbro K, 1996, INT J OBESITY, V20, P895.
   National Institute of Health, 1998, CLIN GUID ID EV TREA, P56.
   Ostbye T, 2007, ARCH INTERN MED, V167, P766, DOI 10.1001/archinte.167.8.766.
   PUSKA P, 2003, OBESITY OVERWEIGHT.
   RISSANEN A, 1990, BRIT MED J, V301, P835, DOI 10.1136/bmj.301.6756.835.
   Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9.
   Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964.
   Sauerbrei W, 2006, COMPUT STAT DATA AN, V50, P3464, DOI 10.1016/j.csda.2005.07.015.
   Sempos CT, 1998, ANN EPIDEMIOL, V8, P289, DOI 10.1016/S1047-2797(97)00233-0.
   Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101.
   Troiano RP, 1996, INT J OBESITY, V20, P63.
   Tsai SP, 2006, J OCCUP ENVIRON MED, V48, P22, DOI 10.1097/01.jom.0000184866.49000.e5.
   Tunceli K, 2006, OBESITY, V14, P1637, DOI 10.1038/oby.2006.188.
   Vainio H, 2002, IARC HDB CANC PREV, V6.
   Villareal DT, 2005, AM J CLIN NUTR, V82, P923, DOI 10.1093/ajcn/82.5.923.
   Visscher TLS, 2004, ARCH INTERN MED, V164, P1413, DOI 10.1001/archinte.164.13.1413.
   Wang FF, 2003, AM J HEALTH PROMOT, V17, P183, DOI 10.4278/0890-1171-17.3.183.
   Willett WC, 2005, JAMA-J AM MED ASSOC, V294, P551, DOI 10.1001/jama.294.5.551-b.},
Number-of-Cited-References = {58},
Times-Cited = {14},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {J. Occup. Environ. Med.},
Doc-Delivery-Number = {200OF},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000248772000013},
DA = {2022-03-29},
}

@article{ WOS:000081069400005,
Author = {Goeree, R and O'Brien, BJ and Blackhouse, G and Agro, K and Goering, P},
Title = {The valuation of productivity costs due to premature mortality: A
   comparison of the human-capital and friction-cost methods for
   schizophrenia},
Journal = {CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE},
Year = {1999},
Volume = {44},
Number = {5},
Pages = {455-463},
Month = {JUN},
Abstract = {Objective: To compare productivity-cost estimates for
   schizophrenia-related premature mortality in Canada in 1996 using the
   human-capital (HC) approach and friction-cost (FC) method.
   Methods: The number of deaths directly attributed to schizophrenia was
   combined with the estimated number of deaths attributable to
   schizophrenia from suicide. These premature deaths were valued using 2
   methods. 1) the traditional HC approach, based on ``potential{''} lost
   output to normal age of retirement, and 2) the FC method based on
   finding a replacement worker.
   Results: In 1996 there were 342 male and female preretirement deaths
   attributed to schizophrenia, directly or indirectly by suicide, in
   Canada. Most deaths were in males (78\%) and by suicide (97\%). The
   productivity cost of these deaths was estimated to be \$105 million
   using the HC approach but only \$1.53 million using the FC method.
   Conclusions: Productivity-cost estimates from the HC approach are
   substantially higher than those obtained from the FC method (69 times
   higher). In circumstances of unemployment, the NC approach is an
   overestimate of future productivity losses for premature mortality.},
Publisher = {CANADIAN PSYCHIATRIC ASSOC},
Address = {260-441 MACLAREN ST, OTTAWA, ONTARIO K2H 2P3, CANADA},
Type = {Review},
Language = {English},
Affiliation = {Goering, P (Corresponding Author), St Josephs Hosp, Ctr Evaluat Med, 50 Charlton Ave E,H-304, Hamilton, ON L8N 4A6, Canada.
   St Josephs Hosp, Ctr Evaluat Med, Hamilton, ON L8N 4A6, Canada.
   McMaster Univ, Dept Clin Epidemiol \& Biostat, Hamilton, ON L8S 4L8, Canada.
   Ctr Addict \& Mental Hlth, Clarke Div, Hlth Syst Res Unit, Toronto, ON, Canada.},
DOI = {10.1177/070674379904400505},
ISSN = {0706-7437},
Keywords = {schizophrenia; productivity cost; indirect cost; human-capital approach;
   friction-cost method},
Keywords-Plus = {DISEASE},
Research-Areas = {Psychiatry},
Web-of-Science-Categories  = {Psychiatry},
Cited-References = {BLAND RC, 1988, ACTA PSYCHIAT SCAND, V77, P338.
   Canadian Coordinating Office for Health Technology Assessment, 1994, GUID EC EV PHARM CAN, V1st.
   {*}COMM DEP HUM STAT, 1995, GUID PHARM IND PREP.
   Drummond, 2015, METHODS EC EVALUATIO.
   Farr W, 1876, CONTRIBUTION 39 ANN.
   Fein R., 1958, EC MENTAL ILLNESS.
   Gold MR., 1996, COST EFFECTIVENESS H.
   Goodwin F. K., 1990, MANIC DEPRESSIVE ILL.
   HART AC, 1998, ANTHONYS ILLUSTRATED.
   KLARMAN HE, 1965, MEASURING BENEFITS G, P364.
   KOOPMANSCHAP MA, 1994, HEALTH ECON, V3, P385, DOI 10.1002/hec.4730030606.
   KOOPMANSCHAP MA, 1992, SOC SCI MED, V34, P1005, DOI 10.1016/0277-9536(92)90131-9.
   KOOPMANSCHAP MA, 1995, J HEALTH ECON, V14, P171, DOI 10.1016/0167-6296(94)00044-5.
   Koopmanschap MA, 1996, PHARMACOECONOMICS, V10, P460, DOI 10.2165/00019053-199610050-00003.
   MUSHKIN SJ, 1959, PUBLIC HEALTH REP, V74, P795, DOI 10.2307/4590578.
   {*}ONT MIN HLTH, 1994, ONT GUID EC AN PHARM.
   Petty W., 1699, POLITICAL ARITHMETIC.
   Rice D.P., 1966, HLTH EC SERIES, V6.
   RICE DP, 1967, AM J PUBLIC HEALTH N, V57, P424, DOI 10.2105/AJPH.57.3.424.
   RICE DP, 1996, EC BURDEN SCHIZOPHRE.
   {*}STAT CAN, 1994, CAUS DEATH.
   {*}STAT CAN, 1995, EARN MEN WOM 1995.
   {*}STAT CAN, 1996, LAB FORC.
   {*}STAT CAN, 1995, ANN DEM STAT 1995.
   vanBeeck EF, 1997, J TRAUMA, V42, P1116, DOI 10.1097/00005373-199706000-00023.
   Weisbrod B, 1961, EC PUBLIC HLTH.},
Number-of-Cited-References = {26},
Times-Cited = {57},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {Can. J. Psychiat.-Rev. Can. Psychiat.},
Doc-Delivery-Number = {209VH},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000081069400005},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000565924500018,
Author = {Syahidi, M. H. and Savvina, V, N. and Timofeev, L. F. and Bessonova, O.
   G.},
Title = {MORTALITY AND LOST YEARS OF LIFE (YLL) DUE TO BREAST, CERVICAL, AND
   OVARIAN CANCER IN THE REPUBLIC SAKHA (YAKUTIA) IN 2006-2016},
Journal = {YAKUT MEDICAL JOURNAL},
Year = {2020},
Number = {2},
Pages = {57-59},
Abstract = {Introduction: Breast, cervical, and ovary cancer are the most common
   caused-of death cancer in women population in the world, so does in
   Russia. This study aims to depict breast, cervical, and ovary cancer
   mortality and years of life lost (YLL) trends in the Republic of Sakha
   (Yakutia) in the period 2006-2016.
   Methods: Data were obtained through the database of the Republic of
   Sakha (Yakutia) federal state statistics service (Rosstat) which
   included with ICD-10 code for cause of death.
   Results: There were 11.1\% deaths caused by breast cancer, 6.9\% by
   cervical cancer, and 4.6\% caused by ovary cancer from all death caused
   by cancer in women population in the research period. YLL from those
   cancers respectively were 9032, 7796, and 4545 life years. Average years
   of life lost (AYLL) of those cancers were 13.4; 20.1; and 16.2 life
   years.
   Conclusion: Mortality, YLL, and AYLL due to breast and ovary cancer
   decreased when those variables increased in cervical cancer. Based on
   YLL, cervical cancer is now leading to a greater number of deaths among
   younger generations of women in the Republic of Sakha (Yakutia). Breast
   cancer remains the dominant cause of cancer death.},
Publisher = {RUSSIAN ACAD SCIENCES SIBERIAN BRANCH},
Address = {S P C  U I G G M  S B  R A S, 3 AKADEMIKA KOPTYGA PROSPEKT, 630090
   NOVOSIBIRSK, RUSSIA},
Type = {Article},
Language = {English},
Affiliation = {Syahidi, MH (Corresponding Author), Gen Hyg \& Bioeth, Publ Hlth \& Hlth Care, Oyunsky St 27, Yakutsk 677016, Russia.
   Syahidi, M. H.; Bessonova, O. G., Gen Hyg \& Bioeth, Publ Hlth \& Hlth Care, Oyunsky St 27, Yakutsk 677016, Russia.
   Savvina, N., V, Med Inst SVFU MK Ammosov, Dept Publ Hlth \& Hlth Care, Gen Hyg \& Bioeth, Yakutsk, Russia.
   Timofeev, L. F., Med Inst SVFU MK Ammosov, Chair Publ Hlth \& Hlth Care, Gen Hyg \& Bioeth, Oyunsky St 27, Yakutsk 677016, Russia.},
DOI = {10.25789/YMJ.2020.70.17},
ISSN = {1813-1905},
EISSN = {2312-1017},
Keywords = {breast cancer; cervical cancer; ovary cancer; cancer in women; YLL;
   AYLL; mortality from malignant neoplasms; Republic of Sakha (Yakutia)},
Research-Areas = {Research \& Experimental Medicine},
Web-of-Science-Categories  = {Medicine, Research \& Experimental},
Author-Email = {syahidi.habibi@gmail.com
   nadvsavvina@mail.ru
   tlfnauka@mail.ru},
ResearcherID-Numbers = {Savvina, Nadezhda/AAD-9857-2020
   },
ORCID-Numbers = {Savvina, Nadezda/0000-0003-2441-6193
   Bessonova, Oksana/0000-0001-8209-1660},
Cited-References = {Afanasieva LN, 2019, YAKUT MED J, P6, DOI 10.25789/YMJ.2019.68.01.
   Barchuk A, 2018, CANCER EPIDEMIOL, V55, P73, DOI 10.1016/j.canep.2018.05.008.
   Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492.
   Broutet N., 2016, COMPR CERV CANC CONT, P137.
   Brustugun OT, 2014, BRIT J CANCER, V111, P1014, DOI 10.1038/bjc.2014.364.
   CDC, USCS DAT VIS CDC.
   Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2.
   Egorova AG, 2019, YAKUT MED J, V2, P86.
   Kaprin AD, 2017, MALIGNANT NEOPLASMS, V2018, P131.
   Khorasani Soheila, 2015, Asian Pac J Cancer Prev, V16, P1845.
   WHO, 2014, METR DIS ADJ LIF YEA.
   World Health Organization, 2014, WHO GLOB CANC COUNTR.},
Number-of-Cited-References = {12},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Yakut Med. J.},
Doc-Delivery-Number = {NJ3CC},
Web-of-Science-Index = {Emerging Sources Citation Index (ESCI)},
Unique-ID = {WOS:000565924500018},
DA = {2022-03-29},
}

@article{ WOS:000325111300003,
Author = {Punger, Elizabeth M. and West, J. Jason},
Title = {The effect of grid resolution on estimates of the burden of ozone and
   fine particulate matter on premature mortality in the USA},
Journal = {AIR QUALITY ATMOSPHERE AND HEALTH},
Year = {2013},
Volume = {6},
Number = {3},
Pages = {563-573},
Month = {SEP},
Abstract = {Assessments of human health impacts associated with outdoor air
   pollution often use air quality models to represent exposure, but
   involve uncertainties due to coarse model resolution. Here, we quantify
   how estimates of mortality in the USA attributable to ozone (O-3) and
   fine particulate matter (PM2.5) at coarse resolution differ from those
   at finer resolution. Using the finest modeled concentrations (12 km), we
   estimate that 66,000 (95 \% CI, 39,300-84,500) all-cause and 21,400
   (5,600-34,200) respiratory deaths per year are attributable to PM2.5 and
   O-3 concentrations above low-concentration thresholds, respectively.
   Using model results at 36 km resolution gives mortality burdens that are
   11 \% higher for PM2.5 and 12 \% higher for O-3 than the 12-km
   estimates, suggesting a modest positive bias. We also scale modeled
   concentrations at 12 km to coarser resolutions by simple averaging and
   repeat the mortality assessment at multiple resolutions from 24 to 408
   km, including the resolutions of global models; in doing so, we account
   for the effect of resolution on population exposure. Coarse grid
   resolutions produce mortality estimates that are substantially biased
   low for PM2.5 (30-40 \% lower than the 12-km estimate at > 250 km
   resolution), but less than 6 \% higher for O-3 at any resolution.
   Mortality estimates for primary PM2.5 species show greater bias at
   coarse resolution than secondary species. These results suggest that
   coarse resolution global models (> 100 km) are likely biased low for
   PM2.5 health effects. For ozone, biases due to coarse resolution may be
   much smaller, and the effect on modeled chemistry likely dominates.},
Publisher = {SPRINGER},
Address = {VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS},
Type = {Article},
Language = {English},
Affiliation = {West, JJ (Corresponding Author), Univ N Carolina, Dept Environm Sci \& Engn, CB 7431, Chapel Hill, NC 27599 USA.
   Punger, Elizabeth M.; West, J. Jason, Univ N Carolina, Dept Environm Sci \& Engn, Chapel Hill, NC 27599 USA.},
DOI = {10.1007/s11869-013-0197-8},
ISSN = {1873-9318},
EISSN = {1873-9326},
Keywords = {Air pollution; Exposure assessment; Grid resolution; Human health;
   Ozone; PM2.5},
Keywords-Plus = {AIR-QUALITY; HEALTH-BENEFITS; POLLUTION; EXPOSURE; EMISSIONS},
Research-Areas = {Environmental Sciences \& Ecology},
Web-of-Science-Categories  = {Environmental Sciences},
Author-Email = {jjwest@email.unc.edu},
ResearcherID-Numbers = {West, Jason/J-2322-2015},
ORCID-Numbers = {West, Jason/0000-0001-5652-4987},
Funding-Acknowledgement = {National Institute of Environmental Health SciencesUnited States
   Department of Health \& Human ServicesNational Institutes of Health
   (NIH) - USANIH National Institute of Environmental Health Sciences
   (NIEHS) {[}P30ES010126]; Environmental Protection Agency, Office of Air
   Quality Planning and Standards; NATIONAL INSTITUTE OF ENVIRONMENTAL
   HEALTH SCIENCESUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Environmental Health Sciences (NIEHS) {[}P30ES010126, R21ES022600]
   Funding Source: NIH RePORTER},
Funding-Text = {This work was supported by a grant from the National Institute of
   Environmental Health Sciences (P30ES010126) and by the Environmental
   Protection Agency, Office of Air Quality Planning and Standards. We
   thank Neal Fann, Charles Fulcher, Pat Dolwick, Sarav Arunachalam,
   Meridith Fry, Matt Woody, Susan Anenberg, Marc Serre, and Will Vizuete
   for their assistance with this project.},
Cited-References = {Anenberg SC, 2010, ENVIRON HEALTH PERSP, V118, P1189, DOI 10.1289/ehp.0901220.
   Arunachalam S, 2006, ATMOS ENVIRON, V40, P5010, DOI 10.1016/j.atmosenv.2006.01.024.
   Associates Incorporated, 2010, ENVIRONMENTAL BENEFI.
   Bell ML, 2006, ENVIRON HEALTH PERSP, V114, P532, DOI 10.1289/ehp.8816.
   Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372.
   Binkowski FS, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD001409.
   Blanchard CL, 2000, J AIR WASTE MANAGE, V50, P2073, DOI 10.1080/10473289.2000.10464239.
   Broeckaert F, 1999, LANCET, V353, P900, DOI 10.1016/S0140-6736(99)00540-1.
   Centers for Disease Control and Prevention, 2009, CDC WONDER.
   Cohen A. J., 2004, COMP QUANTIFICATION, V2, P1353.
   Corbett JJ, 2007, ENVIRON SCI TECHNOL, V41, P8512, DOI 10.1021/es071686z.
   Environmental Protection Agency, 2010, EPA 452 R 10 005.
   Fann N, 2012, RISK ANAL, V32, P81, DOI 10.1111/j.1539-6924.2011.01630.x.
   Fann N, 2011, RISK ANAL, V31, P908, DOI 10.1111/j.1539-6924.2011.01629.x.
   Greco SL, 2007, ATMOS ENVIRON, V41, P1011, DOI 10.1016/j.atmosenv.2006.09.025.
   Hubbell BJ, 2005, ENVIRON HEALTH PERSP, V113, P73, DOI 10.1289/ehp.7186.
   Hubbell BJ, 2009, AIR QUAL ATMOS HLTH, V2, P99, DOI 10.1007/s11869-009-0037-z.
   Ito K, 2005, EPIDEMIOLOGY, V16, P446, DOI 10.1097/01.ede.0000165821.90114.7f.
   JANG JCC, 1995, ATMOS ENVIRON, V29, P3085.
   Jerrett M, 2005, EPIDEMIOLOGY, V16, P727, DOI 10.1097/01.ede.0000181630.15826.7d.
   Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894.
   Krewski D, 2009, HEALTH EFFECTS INSTI.
   Laden F, 2006, AM J RESP CRIT CARE, V173, P667, DOI 10.1164/rccm.200503-443OC.
   Liang JY, 2000, ATMOS ENVIRON, V34, P2975, DOI 10.1016/S1352-2310(99)00520-8.
   Ostro B, 2004, WHO ENVIRONMENTAL BU, V5.
   Ostro B, 2007, ENVIRON HEALTH PERSP, V115, P13, DOI 10.1289/ehp.9281.
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132.
   Seinfeld J.H., 2006, ATMOSPHERIC CHEMISTR.
   Tang YH, 2002, ATMOS ENVIRON, V36, P1691, DOI 10.1016/S1352-2310(02)00093-6.
   Thompson TM, 2012, ATMOS CHEM PHYS, V12, P9753, DOI 10.5194/acp-12-9753-2012.
   US Environmental Protection Agency, 2010, EPA 454 R 10 00.
   US Environmental Protection Agency, 2007, EPA 454 B 07 002.
   West JJ, 2006, P NATL ACAD SCI USA, V103, P3988, DOI 10.1073/pnas.0600201103.
   Wild O, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006605.
   Woods and Poole Economics Inc, 2001, POPULATION BY SINGLE.},
Number-of-Cited-References = {35},
Times-Cited = {89},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {37},
Journal-ISO = {Air Qual. Atmos. Health},
Doc-Delivery-Number = {227KJ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000325111300003},
OA = {Green Accepted, Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000593119600017,
Author = {de Freminville, Jean-Baptiste and Vernier, Louis-Marie and Roumy, Jerome
   and Patat, Frederic and Gatault, Philippe and Sautenet, Benedicte and
   Bailly, Elodie and Chevallier, Eloi and Barbet, Christelle and Longuet,
   Helene and Merieau, Elodie and Baron, Christophe and Buchler, Matthias
   and Halimi, Jean-Michel},
Title = {The association between renal resistive index and premature mortality
   after kidney transplantation is modified by pre-transplant diabetes
   status: a cohort study},
Journal = {NEPHROLOGY DIALYSIS TRANSPLANTATION},
Year = {2020},
Volume = {35},
Number = {9},
Pages = {1577-1584},
Month = {SEP},
Abstract = {Background. Renal resistive index (RI) predicts mortality in renal
   transplant recipients, but we do not know whether this is true in
   diabetic patients. The objective of this study was to analyse the
   long-term predictive value of RI for death with a functioning graft
   (DWFG) in renal transplant recipients with or without pre-transplant
   diabetes.
   Methods. We conducted a retrospective study in 1800 renal transplant
   recipients between 1985 and 2017 who were followed for up to 30 years
   (total observation period: 14 202 patient years). Donor and recipient
   characteristics at time of transplantation and at 3 months were
   reviewed. The long-term predictive value of RI for DWFG and the age-RI
   and arterial pressure-RI relationships were assessed.
   Results. A total of 284/1800 (15.7\%) patients had diabetes mellitus
   before transplantation. RI was <0.75 in 1327/1800 patients (73.7\%).
   High RI was associated with a higher risk of DWFG in non-diabetic
   patients {[}hazard ratio (HR) = 3.39, 95\% confidence interval
   2.50-4.61; P < 0.001], but not in patients with pre-transplant diabetes
   (HR = 1.25, 0.70-2.19; P = 039), even after multiple adjustments. There
   was no interaction between diabetes and age. In contrast, there was an
   interaction between RI and pulse pressure.
   Conclusion. Our study indicates that RI is not a predictor of DWFG in
   diabetic renal transplant recipients, in contrast to non-diabetic
   recipients. These findings could be due to a different age-RI or pulse
   pressure-RI relationship.},
Publisher = {OXFORD UNIV PRESS},
Address = {GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {de Freminville, JB (Corresponding Author), CHU Tours, Hop Bretonneau, Nephrol Immunol Clin, Tours, France.
   de Freminville, Jean-Baptiste; Gatault, Philippe; Sautenet, Benedicte; Bailly, Elodie; Chevallier, Eloi; Barbet, Christelle; Longuet, Helene; Merieau, Elodie; Baron, Christophe; Buchler, Matthias; Halimi, Jean-Michel, CHU Tours, Hop Bretonneau, Nephrol Immunol Clin, Tours, France.
   Vernier, Louis-Marie, Hop Caremeau, Nephrol Dialyse, Nimes, France.
   Roumy, Jerome; Patat, Frederic, CHU Tours, Hop Bretonneau, Imagerie Med, Tours, Indre \& Loire, France.
   Roumy, Jerome; Patat, Frederic, CHU Tours, CIC IT 1415, Tours, France.
   Gatault, Philippe; Baron, Christophe; Buchler, Matthias; Halimi, Jean-Michel, Univ Tours, EA4245, Tours, France.},
DOI = {10.1093/ndt/gfz067},
ISSN = {0931-0509},
EISSN = {1460-2385},
Keywords = {diabetes mellitus; kidney transplantation; renal resistive index;
   ultrasonography; vascular resistance},
Keywords-Plus = {RESISTANCE INDEX; STIFFNESS; DAMAGE},
Research-Areas = {Transplantation; Urology \& Nephrology},
Web-of-Science-Categories  = {Transplantation; Urology \& Nephrology},
Author-Email = {jean.de-freminville@polytechni-que.org},
ResearcherID-Numbers = {de Freminville, Jean-Baptiste/AAC-2787-2020
   Bailly, Elodie/AAF-7022-2020
   },
ORCID-Numbers = {de Freminville, Jean-Baptiste/0000-0003-3829-9506
   Bailly, Elodie/0000-0001-6740-3961
   Sautenet, Benedicte/0000-0001-8430-4543},
Cited-References = {Ba S, 2009, TRANSPL P, V41, P645, DOI 10.1016/j.transproceed.2008.12.006.
   Bige N, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-139.
   Boeri D, 1998, DIABETOLOGIA, V41, P121, DOI 10.1007/s001250050877.
   Bruno RM, 2014, CARDIOVASC ULTRASOUN, V12, DOI 10.1186/1476-7120-12-9.
   Bude RO, 1999, RADIOLOGY, V212, P732, DOI 10.1148/radiology.212.3.r99se13732.
   Delahousse M, 2008, J AM SOC NEPHROL, V19, P798, DOI 10.1681/ASN.2007060634.
   Di Nicolo P, 2017, CLIN EXP NEPHROL, V21, P359, DOI 10.1007/s10157-016-1323-3.
   Halimi JM, 1999, J UROLOGY, V161, P28, DOI 10.1016/S0022-5347(01)62051-2.
   Halimi JM, 2005, AM J TRANSPLANT, V5, P2281, DOI 10.1111/j.1600-6143.2005.01020.x.
   Heine GH, 2007, NEPHROL DIAL TRANSPL, V22, P163, DOI 10.1093/ndt/gfl484.
   Howard RJ, 2002, TRANSPLANTATION, V73, P1923, DOI 10.1097/00007890-200206270-00013.
   Hsu JY, 2017, CLIN J AM SOC NEPHRO, V12, P1181, DOI 10.2215/CJN.10301016.
   Kimura N, 2015, CLIN EXP NEPHROL, V19, P1114, DOI 10.1007/s10157-015-1116-0.
   Latouche A, 2005, BIOMETRICAL J, V47, P807, DOI 10.1002/bimj.200410152.
   Lerolle N, 2012, CRIT CARE, V16, DOI 10.1186/cc11831.
   LONDON NJ, 1993, BRIT J RADIOL, V66, P510, DOI 10.1259/0007-1285-66-786-510.
   Mancini M, 2005, RADIOL MED, V109, P385.
   Murphy ME, 2000, J ULTRAS MED, V19, P303, DOI 10.7863/ultra.19.5.303.
   Mutinelli-Szymanski P, 2012, TRANSPL INT, V25, P464, DOI 10.1111/j.1432-2277.2012.01445.x.
   Naesens M, 2013, NEW ENGL J MED, V369, P1797, DOI 10.1056/NEJMoa1301064.
   O'Neill WC, 2014, HYPERTENSION, V64, P915, DOI 10.1161/HYPERTENSIONAHA.114.04183.
   Ohta Y, 2005, J HYPERTENS, V23, P1905, DOI 10.1097/01.hjh.0000181323.44162.01.
   Pourcelot L, 1975, Rev Prat, V25, P4671.
   Radermacher J, 2001, NEW ENGL J MED, V344, P410, DOI 10.1056/NEJM200102083440603.
   Radermacher J, 2003, NEW ENGL J MED, V349, P115, DOI 10.1056/NEJMoa022602.
   Rodrigo E, 2010, NEPHRON CLIN PRACT, V114, pC178, DOI 10.1159/000262300.
   Schwenger V, 2006, AM J TRANSPLANT, V6, P2721, DOI 10.1111/j.1600-6143.2006.01524.x.
   Seiler S, 2012, NEPHROL DIAL TRANSPL, V27, P3315, DOI 10.1093/ndt/gfr805.
   Sugiura T, 2009, NEPHROL DIAL TRANSPL, V24, P2780, DOI 10.1093/ndt/gfp121.
   Tedesco MA, 2007, J HUM HYPERTENS, V21, P291, DOI 10.1038/sj.jhh.1002145.
   Tublin ME, 2003, AM J ROENTGENOL, V180, P885, DOI 10.2214/ajr.180.4.1800885.
   Wang YK, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1409-7.},
Number-of-Cited-References = {32},
Times-Cited = {2},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Nephrol. Dial. Transplant.},
Doc-Delivery-Number = {OW8HC},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000593119600017},
DA = {2022-03-29},
}

@article{ WOS:000457511900028,
Author = {Ji, Wenjing and Zhou, Bin and Zhao, Bin},
Title = {Potential reductions in premature mortality attributable to PM2.5 by
   reducing indoor pollution: A model analysis for Beijing-Tianjin-Hebei of
   China},
Journal = {ENVIRONMENTAL POLLUTION},
Year = {2019},
Volume = {245},
Pages = {260-271},
Month = {FEB},
Abstract = {Background: China has one of the highest PM2.5 (particulate matter with
   an aerodynamic diameter smaller than 2.5 mu m) pollution levels in the
   world. It might still be long before air quality reaches the National
   Class II standard of 35 mu g/m(3).
   Objective: We aim to estimate the potential reduction in premature
   mortality by reducing indoor PM2.5 levels in the Beijing-Tianjin-Hebei
   (BTH) region and compare it with reducing outdoor levels. Methods: We
   combined PM2.5 transport model and the Global Burden of Disease (2016)
   methodology to estimate potential reductions in premature mortality
   attributable to PM2.5 by reducing indoor PM2.5 to National Class I
   standard of 15 mu g/m(3), and compared with reducing outdoor PM2.5 to
   Government 2020 Interim target of 64 mu g/m(3) or National Class II
   standard of 35 mu g/m(3).
   Results: A total of 74,000 (95\% confidence interval (CI):
   43,000-111,000) premature deaths were attributable to PM2.5 exposure in
   2013. Thirty percent, or 22,000 (95\% CI: 17,000-32,000) deaths, would
   have been averted if indoor PM2.5 had reached the National Class I
   standard. The benefit is greater than that from reaching the Government
   2020 Interim target for outdoor PM2.5 {[}22\%, or 16,000 (95\% CI:
   12,000-23,000), deaths], although still smaller than that from reaching
   the National Class II standard {[}42\%, or 31,000 (95\% CI:
   24,000-45,000), deaths].
   Conclusions: Reaching the National Class I level of indoor PM2.5 at
   current outdoor pollution levels could bring considerable health
   benefits, which are comparable to those from reaching the Government
   2020 Interim target for outdoor PM2.5. Main findings: The avertable
   premature deaths gained from cleaning indoor PM2.5 to National Class I
   standard level would be greater than reducing outdoor PM2.5 to
   Government 2020 Interim target. (C) 2018 Elsevier Ltd. All rights
   reserved.},
Publisher = {ELSEVIER SCI LTD},
Address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Zhao, B (Corresponding Author), Tsinghua Univ, Sch Architecture, Dept Bldg Sci, Beijing 100084, Peoples R China.
   Ji, Wenjing; Zhao, Bin, Tsinghua Univ, Sch Architecture, Dept Bldg Sci, Beijing 100084, Peoples R China.
   Zhou, Bin, Imperial Coll London, Sch Publ Hlth, Dept Epidemiol \& Biostat, London, England.
   Zhou, Bin, Imperial Coll London, MRC PHE Ctr Environm \& Hlth, London, England.
   Zhao, Bin, Tsinghua Univ, Beijing Key Lab Indoor Air Qual Evaluat \& Control, Beijing 100084, Peoples R China.},
DOI = {10.1016/j.envpol.2018.10.082},
ISSN = {0269-7491},
EISSN = {1873-6424},
Keywords = {PM2.5; Human exposure; Premature mortality; Indoor cleaning; Outdoor
   cleaning},
Keywords-Plus = {FINE PARTICULATE MATTER; AIR-POLLUTION; GLOBAL BURDEN; INFILTRATION
   FACTOR; HEALTH-BENEFITS; EXPOSURE; DISEASE; PARTICLES; RISK; FILTRATION},
Research-Areas = {Environmental Sciences \& Ecology},
Web-of-Science-Categories  = {Environmental Sciences},
Author-Email = {binzhao@tsinghua.edu.en},
ResearcherID-Numbers = {Zhao, Bin/B-5158-2012
   },
ORCID-Numbers = {Zhao, Bin/0000-0003-1325-6091
   Zhou, Bin/0000-0002-1741-8628},
Funding-Acknowledgement = {National Key Research and Development Program of China
   {[}2017YFC0702700]; Innovative Research Groups of the National Natural
   Science Foundation of ChinaNational Natural Science Foundation of China
   (NSFC) {[}51521005]},
Funding-Text = {This study was funded by the National Key Research and Development
   Program of China (Grant No. 2017YFC0702700) and funding from the
   Innovative Research Groups of the National Natural Science Foundation of
   China (No. 51521005).},
Cited-References = {Allen RW, 2012, ENVIRON HEALTH PERSP, V120, P824, DOI 10.1289/ehp.1104447.
   Anenberg SC, 2014, AIR QUAL ATMOS HLTH, V7, P369, DOI 10.1007/s11869-014-0248-9.
   Anenberg SC, 2010, ENVIRON HEALTH PERSP, V118, P1189, DOI 10.1289/ehp.0901220.
   Beko G, 2008, BUILD ENVIRON, V43, P1647, DOI 10.1016/j.buildenv.2007.10.006.
   Brauer M, 2012, ENVIRON SCI TECHNOL, V46, P652, DOI 10.1021/es2025752.
   Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049.
   Butz AM, 2011, ARCH PEDIAT ADOL MED, V165, P741, DOI 10.1001/archpediatrics.2011.111.
   Chen C, 2011, ATMOS ENVIRON, V45, P275, DOI 10.1016/j.atmosenv.2010.09.048.
   Chen RJ, 2015, J AM COLL CARDIOL, V65, P2279, DOI 10.1016/j.jacc.2015.03.553.
   Chen Z, 2013, LANCET, V382, P1959, DOI 10.1016/S0140-6736(13)62064-4.
   Davis DL, 2002, ENVIRON HEALTH PERSP, V110, pA734, DOI 10.1289/ehp.110-a734.
   Du X., 2014, TIANJIN STAT YB.
   Fisk WJ, 2017, INDOOR AIR, V27, P909, DOI 10.1111/ina.12371.
   Fisk WJ, 2013, INDOOR AIR, V23, P357, DOI 10.1111/ina.12036.
   Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8.
   Gao JL, 2016, SCI TOTAL ENVIRON, V543, P307, DOI 10.1016/j.scitotenv.2015.11.037.
   Guo YM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7139.
   Huang C, 2017, CIRCULATION, V136, P1575, DOI {[}10.1161/CIRCULATIONAHA.116.026487, 10.1161/circulationaha.116.026487].
   Ji WJ, 2015, BUILD ENVIRON, V90, P196, DOI 10.1016/j.buildenv.2015.04.006.
   Ji WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124238.
   Kulmala M, 2015, NATURE, V526, P497, DOI 10.1038/526497a.
   Li HC, 2017, CIRCULATION, V136, P618, DOI {[}10.1161/circulationaha.116.026796, 10.1161/CIRCULATIONAHA.116.026796].
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8.
   Lin HL, 2016, ENVIRON INT, V96, P91, DOI 10.1016/j.envint.2016.09.007.
   Long Y., 2014, POPULATION EXPOSURE.
   MacIntosh DL, 2010, J EXPO SCI ENV EPID, V20, P213, DOI 10.1038/jes.2009.16.
   Meng QY, 2007, ENVIRON SCI TECHNOL, V41, P7315, DOI 10.1021/es070037k.
   Ministry of Environment Protection of People's Republic of China, 2014, 2013 REP STAT ENV CH.
   Ministry of Environment Protection of People's Republic of China, 2013, EXP FACT HDB CHIN PO.
   Ministry of Environment Protection of People's Republic of China, 2015, 2014 REP STAT ENV CH.
   Murray Christopher JL, 2003, Popul Health Metr, V1, P1, DOI 10.1186/1478-7954-1-1.
   National development and reform commission, 2015, COORD DEV BEIJ TIANJ.
   National health and family planning committee, 2013, CHIN STAT YB HLTH FA.
   Pan XC, 2007, SCI TOTAL ENVIRON, V374, P242, DOI 10.1016/j.scitotenv.2007.01.005.
   Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888.
   Samet JM, 2016, AM J PUBLIC HEALTH, V106, P1352, DOI 10.2105/AJPH.2016.303292.
   Samet JM, 2011, NEW ENGL J MED, V365, P198, DOI 10.1056/NEJMp1103332.
   Shi SS, 2017, ENVIRON POLLUT, V220, P337, DOI 10.1016/j.envpol.2016.09.069.
   Sulser C, 2009, INT ARCH ALLERGY IMM, V148, P23, DOI 10.1159/000151502.
   United States Environmental Protection Agency, 2018, RES AIR CLEAN TECH S.
   van Donkelaar A, 2010, ENVIRON HEALTH PERSP, V118, P847, DOI 10.1289/ehp.0901623.
   Voorhees AS, 2014, SCI TOTAL ENVIRON, V485, P396, DOI 10.1016/j.scitotenv.2014.03.113.
   World Health Organization (WHO), 2016, WHO GLOB URB AMB AIR.
   Wu SW, 2014, ENVIRON SCI TECHNOL, V48, P3438, DOI 10.1021/es404778w.
   Xia Q., 2014, BEIJ STAT YB.
   Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1.
   Yin P, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j667.
   Yin Z, 2010, TABULATION 2010 POPU.
   Zhang J., 2010, TABULATION 2010 POPU.
   Zhao D, 2015, INT J ENV RES PUB HE, V12, P8448, DOI 10.3390/ijerph120708448.
   Zhou B, 2012, ATMOS ENVIRON, V62, P472, DOI 10.1016/j.atmosenv.2012.08.059.},
Number-of-Cited-References = {51},
Times-Cited = {10},
Usage-Count-Last-180-days = {5},
Usage-Count-Since-2013 = {35},
Journal-ISO = {Environ. Pollut.},
Doc-Delivery-Number = {HJ9IK},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000457511900028},
OA = {Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000535945000035,
Author = {Buajitti, Emmalin and Frank, John and Watson, Tristan and Kornas, Kathy
   and Rosella, Laura C.},
Title = {Changing relative and absolute socioeconomic health inequalities in
   Ontario, Canada: A population-based cohort study of adult premature
   mortality, 1992 to 2017},
Journal = {PLOS ONE},
Year = {2020},
Volume = {15},
Number = {4},
Month = {APR 2},
Abstract = {Background
   This study aimed to characterize trends in absolute and relative
   socioeconomic inequalities in adult premature mortality between 1992 and
   2017, in the context of declining population-wide mortality rates. We
   conducted a population-based cohort study of all adult premature deaths
   in Ontario, Canada using provincial vital statistics data linked to
   census-based, area-level deprivation indices for socioeconomic status.
   Methods
   The cohort included all individuals eligible for Ontario's single-payer
   health insurance system at any time between January 1, 1992 and December
   31, 2017 with a recorded Ontario place of residence and valid
   socioeconomic status information (N = 820,370). Deaths between ages 18
   and 74 were used to calculate adult premature mortality rates per 1000,
   stratified by provincial quintile of material deprivation. Relative
   inequalities were measured using Relative Index of Inequality (RII)
   measures. Absolute inequalities were estimated using Slope Index of
   Inequality (SII) measures. All outcome measures were calculated as
   sex-specific, annual measures for each year from 1992 to 2017.
   Results
   Premature mortality rates declined in all socioeconomic groups between
   1992 and 2017. Relative inequalities in premature mortality increased
   over the same period. Absolute inequalities were mostly stable between
   1992 and 2007, but increased dramatically between 2008 and 2017, with
   larger increases to absolute inequalities seen in females than in males.
   Conclusions
   As in other developed countries, long-term downward trends in all-cause
   premature mortality in Ontario, Canada have shifted to a plateau pattern
   in recent years, especially in lower-socioeconomic status
   subpopulations. Determinants of this may differ by setting. Regular
   monitoring of mortality by socioeconomic status is the only way that
   this phenomenon can be detected sensitively and early, for public health
   attention and possible corrective action.},
Publisher = {PUBLIC LIBRARY SCIENCE},
Address = {1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA},
Type = {Article},
Language = {English},
Affiliation = {Rosella, LC (Corresponding Author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   Rosella, LC (Corresponding Author), ICES, Toronto, ON, Canada.
   Buajitti, Emmalin; Kornas, Kathy; Rosella, Laura C., Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   Buajitti, Emmalin; Watson, Tristan; Rosella, Laura C., ICES, Toronto, ON, Canada.
   Frank, John, Univ Edinburgh, Coll Med \& Vet Med, Usher Inst Populat Hlth Sci \& Informat, Edinburgh, Midlothian, Scotland.},
DOI = {10.1371/journal.pone.0230684},
Article-Number = {e0230684},
ISSN = {1932-6203},
Keywords-Plus = {AVOIDABLE MORTALITY; INCOME; GRADIENTS; OUTCOMES; DISEASE; ACCESS; INDEX},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {laura.rosella@utoronto.ca},
ORCID-Numbers = {Watson, Tristan/0000-0001-8257-4216},
Funding-Acknowledgement = {Canadian Institutes for Health ResearchCanadian Institutes of Health
   Research (CIHR) {[}FRN-142498]; Canada Research Chair in Population
   Health Analytics {[}CRC-950-23072]},
Funding-Text = {This study was funded by the Canadian Institutes for Health Research
   (www.cihr-irsc.gc.ca) Operating Grant (FRN-142498) held by LCR. CLR is
   supported by a Canada Research Chair in Population Health Analytics
   (CRC-950-23072). The funders did not play any role in the study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.},
Cited-References = {{[}Anonymous], 2012, HLTH IND 2012.
   Blakely T, 2017, EPIDEMIOLOGY, V28, P594, DOI {[}10.1097/EDE.0000000000000671, 10.1097/ede.0000000000000671].
   Bor J, 2017, LANCET, V389, P1475, DOI 10.1016/S0140-6736(17)30571-8.
   Buajitti E, 2018, ONTARIO ATLAS ADULT.
   Buajitti E, 2020, SSM-POPUL HLTH, V10, DOI 10.1016/j.ssmph.2020.100553.
   Canada Statistics, POST CODEOM CONV FIL.
   Case A, 2017, BROOKINGS PAP ECO AC, P397.
   Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112.
   Chiu M, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0375-3.
   Dorling D, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3697.
   Fisher E., 2006, AUSTR NZ ATLAS AVOID.
   Frank JW, 2018, NEW FORMS DATA UNDER, V8.
   Fransham M, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1946.
   Giles-Corti B, 2002, PREV MED, V35, P601, DOI 10.1006/pmed.2002.1115.
   Green M, 2017, HEALTH PLACE, V44, P77, DOI 10.1016/j.healthplace.2017.02.002.
   Hajizadeh M, 2016, HEALTH POLICY, V120, P1040, DOI 10.1016/j.healthpol.2016.07.019.
   Health Quality Ontario, 2015, QUAL MATT REAL EXC C.
   Hemeon J., 2016, HIST DATA LINKAGE QU.
   Hiscock R, 2012, ANN NY ACAD SCI, V1248, P107, DOI 10.1111/j.1749-6632.2011.06202.x.
   Hosseinpoor AR, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0229-9.
   Hosseinpoor AR, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0307-y.
   Juhn YJ, 2011, J URBAN HEALTH, V88, P933, DOI 10.1007/s11524-011-9572-7.
   KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973.
   Kaufman JS, 2017, AM J LAW MED, V43, P193, DOI 10.1177/0098858817723659.
   Khan AM, 2017, J EPIDEMIOL COMMUN H, V71, P625, DOI 10.1136/jech-2016-208525.
   King NB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5774.
   Krieger N, 2008, PLOS MED, V5, P227, DOI 10.1371/journal.pmed.0050046.
   Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519.
   Mackenbach JP, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1732.
   Mackenbach JP, 2015, J EPIDEMIOL COMMUN H, V69, P207, DOI 10.1136/jech-2014-204319.
   Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1.
   MARMOT M, 2019, BMJ-BRIT MED J, V365, DOI DOI 10.1136/BMJ.L2278.
   Matheson F., 2012, ONTARIO MARGINALIZAT.
   Matheson FI., 2017, 2011 ONTARIO MARGINA.
   Matheson FI, 2012, CAN J PUBLIC HEALTH, V103, pS12, DOI 10.1007/BF03403823.
   Moreno-Betancur M, 2015, EPIDEMIOLOGY, V26, P518, DOI 10.1097/EDE.0000000000000311.
   National Center for Health Statistics, 2018, HLTH US 2017 SPEC FE.
   Newacheck PW, 1996, PEDIATRICS, V97, P26.
   Pathirana TI, 2018, AUST NZ J PUBL HEAL, V42, P186, DOI 10.1111/1753-6405.12762.
   Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111.
   Scottish Government, 2017, LONG TERM MON HLTH I.
   Shumany R., 2018, MORTALITY OVERVIEW 2.
   Southern DA, 2005, MED CARE, V43, P1116, DOI 10.1097/01.mlr.0000182517.57235.6d.
   Statistics Canada, 2018, CANSIM TABL 051 0005.
   Thomas B, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3639.
   Tjepkema Michael, 2011, Health Rep, V22, P25.
   Tobias M, 2001, AUST NZ J PUBL HEAL, V25, P12, DOI 10.1111/j.1467-842X.2001.tb00543.x.
   United Nations, 2015, SUSTAINABLE DEV GOAL.
   Vandenbroucke JP, 2007, PLOS MED, V4, P1628, DOI {[}10.1371/journal.pmed.0040297, 10.7326/0003-4819-147-8-200710160-00010-w1].},
Number-of-Cited-References = {49},
Times-Cited = {3},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {1},
Journal-ISO = {PLoS One},
Doc-Delivery-Number = {LR8KJ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000535945000035},
OA = {gold, Green Published, Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000277500400012,
Author = {Juhasz, Attila and Nagy, Csilla and Paldy, Anna and Beale, Linda},
Title = {Development of a Deprivation Index and its relation to premature
   mortality due to diseases of the circulatory system in Hungary,
   1998-2004},
Journal = {SOCIAL SCIENCE \& MEDICINE},
Year = {2010},
Volume = {70},
Number = {9},
Pages = {1342-1349},
Month = {MAY},
Abstract = {An association between health and socio-economic status is well known.
   Based on international and national studies, the aims of this study were
   to develop a multi-dimensional index at the municipality level, to
   provide information about socio-economic deprivation in Hungary and to
   investigate the association between socio-economic status and the
   spatial distribution of premature mortality due to diseases of the
   circulatory system. Seven municipality level socio-economic indicators
   were used from the National Information System of Spatial Development
   (income, low qualification, unemployment, one-parent families, large
   families, density of housing and car ownership). After normalisation and
   standardisation, indicator weights were evaluated using factor analysis.
   A risk analysis study was conducted using the Rapid Inquiry Facility
   software to evaluate the association between deprivation and the spatial
   distribution of premature mortality due to diseases of the circulatory
   system for the years 1998-2004. Areas of significantly high deprivation
   were identified in the northeastern, eastern and southwestern parts of
   Hungary. A statistically significant association was found between
   premature cardiovascular mortality and deprivation status in both
   genders. The Deprivation Index is the first composite index at the
   municipality level in Hungary and includes key factors that affect
   socio-economic status. The identified association highlighted the fact
   that inequalities in socio-economic status may reflect the spatial
   distribution of health status in a population. The results can be used
   to inform prevention strategies and help plan local health promotion
   programs aimed at reducing health inequalities. (C) 2010 Elsevier Ltd.
   All rights reserved.},
Publisher = {PERGAMON-ELSEVIER SCIENCE LTD},
Address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Juhasz, A (Corresponding Author), Natl Publ Hlth \& Med Officer Serv, Reg Inst Cent Hungary, Dept Hlth Promot, 174 Vaci Ave, H-1138 Budapest, Hungary.
   Juhasz, Attila; Nagy, Csilla, Natl Publ Hlth \& Med Officer Serv, Reg Inst Cent Hungary, Dept Hlth Promot, H-1138 Budapest, Hungary.
   Paldy, Anna, Natl Inst Environm Hlth, Budapest, Hungary.
   Beale, Linda, Univ London Imperial Coll Sci Technol \& Med, MRC Ctr Environm \& Hlth, Small Area Hlth Stat Unit, London SW7 2AZ, England.},
DOI = {10.1016/j.socscimed.2010.01.024},
ISSN = {0277-9536},
Keywords = {Socioeconomic status (SES); Hungary; Deprivation; Health inequalities;
   Cardiovascular disease; Mortality; Risk analysis; Ecological study},
Keywords-Plus = {INCOME INEQUALITY; SMALL-AREA; HEALTH; ENGLAND; WALES},
Research-Areas = {Public, Environmental \& Occupational Health; Biomedical Social Sciences},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health; Social Sciences,
   Biomedical},
Author-Email = {juhasz.attila@fovaros.antsz.hu},
ORCID-Numbers = {Juhasz, Attila/0000-0002-7839-6098},
Cited-References = {Adda J, 2003, J ECONOMETRICS, V112, P57, DOI 10.1016/S0304-4076(02)00146-X.
   Beale L, 2008, ENVIRON HEALTH PERSP, V116, P1105, DOI 10.1289/ehp.10816.
   Benach J, 2001, J EPIDEMIOL COMMUN H, V55, P239, DOI 10.1136/jech.55.4.239.
   BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466.
   Bland M., 2000, INTRO MED STAT, V3rd.
   BOKOR A, 1987, POVERTY TODAY HUNGAR.
   BOKOR A, 1985, DEPRIVATION POVERTY, V6.
   Breslow NE, 1987, STAT METHODS MED RES, VII.
   CARSTAIRS V, 1989, BRIT MED J, V299, P886, DOI 10.1136/bmj.299.6704.886.
   {*}COMM EUR COMM, 2005, HLTH CONS PROT STRAT.
   Council of the European Union, 2001, REP IND FIELD POV SO.
   Dibben C, 2004, ENGLISH INDICES DEPR.
   {*}ESRI INC, 2005, ARCVIEW COMP PROGR V.
   {*}EUR COMM, 2003, EUR REG STAT REF GUI.
   {*}EUR PARL, 2008, 20072191 INI EUR PAR.
   Forrest R, 1993, PEOPLE PLACES 1991 C.
   Hablicsek Laszlo, 1999, DEMOGRAPHIC CHARACTE.
   Havard S, 2008, SOC SCI MED, V67, P2007, DOI 10.1016/j.socscimed.2008.09.031.
   HAVAS G, 1999, GYPSIES HUNGARY, P163.
   Horvath Gy, 2004, MAGYAR TUDOMANY, V9, P962.
   {*}HUNG CENTR STAT O, 2007, STAT MIRR, V47.
   {*}IMP COLL, 2007, WINBUGS COMP PROGR V.
   {*}J BEL NAT CTR EP, 2005, NAT HLTH INT SURV 20.
   JARMAN B, 1983, BRIT MED J, V286, P1705, DOI 10.1136/bmj.286.6379.1705.
   Jordan H, 2004, J EPIDEMIOL COMMUN H, V58, P250, DOI 10.1136/jech.2003.013011.
   KAPITANY B, 2004, TRAC SOC CONT TURN P.
   Kawachi I, 1999, SOC SCI MED, V48, P719, DOI 10.1016/S0277-9536(98)00400-6.
   KONDOR Y, 1971, ECONOMETRICA, V39, P1041, DOI 10.2307/1909676.
   Kopp MS, 2007, ANN NY ACAD SCI, V1113, P325, DOI 10.1196/annals.1391.006.
   Kosa Z, 2007, AM J PUBLIC HEALTH, V97, P853, DOI 10.2105/AJPH.2005.072173.
   LAVECCHIA C, 1993, EUROPEAN J EPIDEMIOL, V14, P1.
   Law MR, 1998, J EPIDEMIOL COMMUN H, V52, P344, DOI 10.1136/jech.52.6.344.
   Levi F, 2002, HEART, V88, P119, DOI 10.1136/heart.88.2.119.
   LLOYD CEF, 1995, BRIT MED J, V310, P165.
   Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200.
   MACKENBACH JP, 1997, J EPIDEMIOLOGY COMMU, V48, P140.
   MARKOWE HL, 1985, BRIT MED J, V9, P291.
   MARMOT MG, 1978, J EPIDEMIOL COMMUN H, V32, P244, DOI 10.1136/jech.32.4.244.
   MILLER SM, 1961, SOC PROBL, V1, P86.
   MORGENSTERN H, 1998, MODERN EPIDEMIOLOGY, P459.
   MORRIS R, 1991, J PUBLIC HEALTH MED, V13, P318.
   MORRISON DF, 2005, MULTIVARIANT STAT ME.
   {*}OFF DEP PRIM MIN, 1998, IND LOC DEPR.
   SPEDER Z, 2002, DEMOGRAPHIC PROCESSE, P91.
   SPIEGELHALTER D, 2003, WINBUGS MANUAL.
   Titmuss R. M., 1962, INCOME DISTRIBUTION.
   TOTH A, 2001, NATL ETHNIC MINORITI.
   TOTH IGY, 2001, SOCIAL STATUS HUNGAR.
   TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341.
   {*}UN, 1990, HUM EV REP UN DEV PR.
   {*}WHO REG OFF EUR, 2008, EUR MORT DAT.
   WILKINSON RG, 1992, BRIT MED J, V304, P165, DOI 10.1136/bmj.304.6820.165.},
Number-of-Cited-References = {52},
Times-Cited = {32},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {5},
Journal-ISO = {Soc. Sci. Med.},
Doc-Delivery-Number = {593YX},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000277500400012},
DA = {2022-03-29},
}

@article{ WOS:000518823000006,
Author = {Klont, Frank and Kieneker, Lyanne M. and Gomes-Neto, Antonio W. and
   Stam, Suzanne P. and ten Hacken, Nick H. T. and Kema, Ido P. and van
   Beek, Andre P. and van den Berg, Else and Horvatovich, Peter and
   Bischoff, Rainer and Bakker, Stephan J. L.},
Title = {Female Specific Association of Low Insulin-Like Growth Factor 1 (IGF1)
   Levels with Increased Risk of Premature Mortality in Renal Transplant
   Recipients},
Journal = {JOURNAL OF CLINICAL MEDICINE},
Year = {2020},
Volume = {9},
Number = {2},
Month = {FEB},
Abstract = {Associations between insulin-like growth factor 1 (IGF1) and mortality
   have been reported to be female specific in mice and in human
   nonagenarians. Intervention in the growth hormone (GH)-IGF1 axis may
   particularly benefit patients with high risk of losing muscle mass,
   including renal transplant recipients (RTR). We investigated whether a
   potential association of circulating IGF1 with all-cause mortality in
   stable RTR could be female specific and mediated by variation in muscle
   mass. To this end, plasma IGF1 levels were measured in 277 female and
   343 male RTR by mass spectrometry, and their association with mortality
   was assessed by Cox regression. During a median follow-up time of 5.4
   years, 56 female and 77 male RTR died. In females, IGF1 was inversely
   associated with risk (hazard ratio (HR) per 1-unit increment in
   log2-transformed (doubling of) IGF1 levels, 95\% confidence interval
   (CI)) of mortality (0.40, 0.24-0.65; p < 0.001), independent of age and
   the estimated Glomerular filtration rate (eGFR). In equivalent analyses,
   no significant association was observed for males (0.85, 0.56-1.29; p =
   0.44), for which it should be noted that in males, age was negatively
   and strongly associated with IGF1 levels. The association for females
   remained materially unchanged upon adjustment for potential confounders
   and was furthermore found to be mediated for 39\% by 24 h urinary
   creatinine excretion. In conclusion, low IGF1 levels associate with an
   increased risk of all-cause mortality in female RTR, which may link to
   conditions of low muscle mass that are known to be associated with poor
   outcomes in transplantation patients. For males, the strongly negative
   association of age with IGF1 levels may explain why low IGF1 levels were
   not found to be associated with an increased risk of all-cause
   mortality.},
Publisher = {MDPI},
Address = {ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND},
Type = {Article},
Language = {English},
Affiliation = {Klont, F (Corresponding Author), Univ Groningen, Groningen Res Inst Pharm, Dept Analyt Biochem, NL-9713 AV Groningen, Netherlands.
   Klont, Frank; Horvatovich, Peter; Bischoff, Rainer, Univ Groningen, Groningen Res Inst Pharm, Dept Analyt Biochem, NL-9713 AV Groningen, Netherlands.
   Kieneker, Lyanne M.; Gomes-Neto, Antonio W.; Stam, Suzanne P.; van den Berg, Else; Bakker, Stephan J. L., Univ Groningen, Dept Internal Med, Div Nephrol, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands.
   ten Hacken, Nick H. T., Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, NL-9700 RB Groningen, Netherlands.
   Kema, Ido P., Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, NL-9700 RB Groningen, Netherlands.
   van Beek, Andre P., Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, NL-9700 RB Groningen, Netherlands.},
DOI = {10.3390/jcm9020293},
Article-Number = {293},
EISSN = {2077-0383},
Keywords = {insulin-like growth factor 1; growth hormone; muscle mass; patient
   survival; physical activity; renal transplant recipients},
Keywords-Plus = {ANOREXIA-CACHEXIA SYNDROME; GHRELIN RECEPTOR AGONIST; URINE CREATININE
   EXCRETION; BINDING PROTEIN-3 IGFBP-3; REFERENCE VALUES; SERUM
   CONCENTRATIONS; PHYSICAL-ACTIVITY; MUSCLE MASS; CALCINEURIN; RATIO},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {klont.frank@gmail.com
   l.m.kieneker@umcg.nl
   a.w.gomes.neto@umcg.nl
   s.p.stam@umcg.nl
   n.h.t.ten.hacken@umcg.nl
   i.p.kema@umcg.nl
   a.p.van.beek@umcg.nl
   elsevandenberg@hotmail.com
   P.L.Horvatovich@rug.nl
   r.p.h.bischoff@rug.nl
   s.j.l.bakker@umcg.nl},
ResearcherID-Numbers = {Bischoff, Rainer/H-5404-2011
   van Beek, Andre/O-3753-2014
   },
ORCID-Numbers = {Bischoff, Rainer/0000-0001-9849-0121
   Klont, Frank/0000-0003-3503-1694
   van Beek, Andre/0000-0002-0335-8177
   HORVATOVICH, PETER/0000-0003-2218-1140},
Funding-Acknowledgement = {Netherlands Organisation for Scientific Research NWO domain Applied and
   Engineering Sciences {[}P12-04, 13541]; Top Institute Food and Nutrition
   {[}A-1003]},
Funding-Text = {This research was funded by the Netherlands Organisation for Scientific
   Research NWO domain Applied and Engineering Sciences (Perspectief
   program P12-04, project 13541) and the Top Institute Food and Nutrition
   (program A-1003).},
Cited-References = {Alberti C, 2011, CLIN CHEM, V57, P1424, DOI 10.1373/clinchem.2011.169466.
   Bellizzi V, 2014, KIDNEY BLOOD PRESS R, V39, P212, DOI 10.1159/000355799.
   Bidlingmaier M, 2009, HORM RES, V71, P30, DOI 10.1159/000178034.
   Bokov AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026891.
   Bonert V, 2018, PITUITARY, V21, P65, DOI 10.1007/s11102-017-0849-z.
   Borner T, 2016, AM J PHYSIOL-REG I, V311, pR89, DOI 10.1152/ajpregu.00044.2016.
   Burkitt W, 2010, PROTEIN SCI, V19, P826, DOI 10.1002/pro.362.
   Campbell GA, 2018, NEPHROL DIAL TRANSPL, V33, P523, DOI 10.1093/ndt/gfw474.
   Chanson P, 2016, J CLIN ENDOCR METAB, V101, P3450, DOI 10.1210/jc.2016-1257.
   Chew J, 2019, J NUTR HEALTH AGING, V23, P979, DOI 10.1007/s12603-019-1255-1.
   Chu MP, 2017, J CACHEXIA SARCOPENI, V8, P298, DOI 10.1002/jcsm.12161.
   Clemmons DR, 2009, TRENDS ENDOCRIN MET, V20, P349, DOI 10.1016/j.tem.2009.04.002.
   Di Micco L, 2013, CLIN J AM SOC NEPHRO, V8, P1877, DOI 10.2215/CJN.01350213.
   Dunn SE, 1999, J BIOL CHEM, V274, P21908, DOI 10.1074/jbc.274.31.21908.
   Esposito A, 2015, CANCER TREAT REV, V41, P793, DOI 10.1016/j.ctrv.2015.09.002.
   FDA, 2001, GUID IND BIOAN METH.
   FLORINI JR, 1991, ANNU REV PHYSIOL, V53, P201, DOI 10.1146/annurev.ph.53.030191.001221.
   Friedrich N, 2008, GROWTH HORM IGF RES, V18, P228, DOI 10.1016/j.ghir.2007.09.005.
   HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207.
   Heijboer AC, 2012, CLIN CHEM, V58, P543, DOI 10.1373/clinchem.2011.176545.
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298.
   Hudson MB, 2013, INT J BIOCHEM CELL B, V45, P2173, DOI 10.1016/j.biocel.2013.06.029.
   Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248.
   Kalantari K, 2013, CLIN J AM SOC NEPHRO, V8, P1847, DOI 10.2215/CJN.09770913.
   Ketha H, 2015, METHODS, V81, P93, DOI 10.1016/j.ymeth.2015.04.029.
   Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4.
   Klont F, 2017, ANAL CHEM, V89, P6189, DOI 10.1021/acs.analchem.7b01125.
   Kong APS, 2007, CLIN BIOCHEM, V40, P1093, DOI 10.1016/j.clinbiochem.2007.06.004.
   Laron Z, 2001, J CLIN PATHOL-MOL PA, V54, P311.
   Makizako H, 2017, J CACHEXIA SARCOPENI, V8, P607, DOI 10.1002/jcsm.12197.
   Mao K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04805-5.
   Michel RN, 2004, P NUTR SOC, V63, P341, DOI 10.1079/PNS2004362.
   Milman S, 2016, CELL METAB, V23, P980, DOI 10.1016/j.cmet.2016.05.014.
   Milman S, 2014, AGING CELL, V13, P769, DOI 10.1111/acel.12213.
   Minovic I, 2017, AM J CLIN NUTR, V106, P1366, DOI 10.3945/ajcn.117.164012.
   Molnar MZ, 2011, NEPHROL DIAL TRANSPL, V26, P2000, DOI 10.1093/ndt/gfq690.
   Molnar MZ, 2011, AM J KIDNEY DIS, V58, P101, DOI 10.1053/j.ajkd.2010.11.027.
   Oterdoom LH, 2008, TRANSPLANTATION, V86, P391, DOI 10.1097/TP.0b013e3181788aea.
   Oterdoom LH, 2009, ATHEROSCLEROSIS, V207, P534, DOI 10.1016/j.atherosclerosis.2009.05.010.
   Oterdoom LH, 2009, TRANSPLANTATION, V87, P1562, DOI 10.1097/TP.0b013e3181a4bb80.
   Pietra C, 2014, J CACHEXIA SARCOPENI, V5, P329, DOI 10.1007/s13539-014-0159-5.
   Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553.
   Rosas SE, 2012, AM J NEPHROL, V35, P17, DOI 10.1159/000334732.
   Said MY, 2015, CLIN TRANSPLANT, V29, P447, DOI 10.1111/ctr.12536.
   Sowers MR, 2008, J CLIN ENDOCR METAB, V93, P3958, DOI 10.1210/jc.2008-0482.
   Stam SP, 2019, J CACHEXIA SARCOPENI, V10, P621, DOI 10.1002/jcsm.12399.
   Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105.
   Tazearslan C, 2011, AGING CELL, V10, P551, DOI 10.1111/j.1474-9726.2011.00697.x.
   Teppala S, 2010, CLIN EXP NEPHROL, V14, P440, DOI 10.1007/s10157-010-0307-y.
   Tubben A, 2019, J CLIN MED, V8, DOI 10.3390/jcm8122104.
   Tyrovolas S, 2016, J CACHEXIA SARCOPENI, V7, P312, DOI 10.1002/jcsm.12076.
   van den Berg E, 2014, J AM SOC NEPHROL, V25, P1303, DOI 10.1681/ASN.2013050497.
   Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8.
   Wennberg AMV, 2018, EXP GERONTOL, V106, P67, DOI 10.1016/j.exger.2018.02.015.
   Xu J, 2014, AGING CELL, V13, P19, DOI 10.1111/acel.12145.
   Yakar S, 2016, GROWTH HORM IGF RES, V28, P26, DOI 10.1016/j.ghir.2015.09.004.
   Zelle DM, 2011, CLIN J AM SOC NEPHRO, V6, P898, DOI 10.2215/CJN.03340410.},
Number-of-Cited-References = {57},
Times-Cited = {3},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {J. Clin. Med.},
Doc-Delivery-Number = {KT2DG},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000518823000006},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000396345200026,
Author = {Shiels, Meredith S. and Chernyavskiy, Pavel and Anderson, William F. and
   Best, Ana F. and Haozous, Emily A. and Hartge, Patricia and Rosenberg,
   Philip S. and Thomas, David and Freedman, Neal D. and de Gonzalez, Amy
   Berrington},
Title = {Trends in premature mortality in the USA by sex, race, and ethnicity
   from 1999 to 2014: an analysis of death certificate data},
Journal = {LANCET},
Year = {2017},
Volume = {389},
Number = {10073},
Pages = {1043-1054},
Month = {MAR 11},
Abstract = {Background Reduction of premature mortality is a UN Sustainable
   Development Goal. Unlike other high-income countries, age-adjusted
   mortality in the USA plateaued in 2010 and increased slightly in 2015,
   possibly because of rising premature mortality. We aimed to analyse
   trends in mortality in the USA between 1999 and 2014 in people aged
   25-64 years by age group, sex, and race and ethnicity, and to identify
   specific causes of death underlying the temporal trends.
   Methods For this analysis, we used cause-of-death and demographic data
   from death certificates from the US National Center for Health
   Statistics, and population estimates from the US Census Bureau. We
   estimated annual percentage changes in mortality using age-period-cohort
   models. Age-standardised excess deaths were estimated for 2000 to 2014
   as observed deaths minus expected deaths (estimated from 1999 mortality
   rates).
   Findings Between 1999 and 2014, premature mortality increased in white
   individuals and in American Indians and Alaska Natives. Increases were
   highest in women and those aged 25-30 years. Among 30-year-olds, annual
   mortality increases were 2.3\% (95\% CI 2.1-2.4) for white women, 0.6\%
   (0.5-0.7) for white men, and 4.3\% (3.5-5.0) and 1.9\% (1.3-2.5),
   respectively, for American Indian and Alaska Native women and men. These
   increases were mainly attributable to accidental deaths (primarily drug
   poisonings), chronic liver disease and cirrhosis, and suicide. Among
   individuals aged 25-49 years, an estimated 111 000 excess premature
   deaths occurred in white individuals and 6600 in American Indians and
   Alaska Natives during 2000-14. By contrast, premature mortality
   decreased substantially across all age groups in Hispanic individuals
   (up to 3.2\% per year), black individuals (up to 3.9\% per year), and
   Asians and Pacific Islanders (up to 2.6\% per year), mainly because of
   declines in HIV, cancer, and heart disease deaths, resulting in an
   estimated 112 000 fewer deaths in Hispanic individuals, 311 000 fewer
   deaths in black individuals, and 34 000 fewer deaths in Asians and
   Pacific Islanders aged 25-64 years. During 2011-14, American Indians and
   Alaska Natives had the highest premature mortality, followed by black
   individuals.
   Interpretation Important public health successes, including HIV
   treatment and smoking cessation, have contributed to declining premature
   mortality in Hispanic individuals, black individuals, and Asians and
   Pacific Islanders. However, this progress has largely been negated in
   young and middle-aged (25-49 years) white individuals, and American
   Indians and Alaska Natives, primarily because of potentially avoidable
   causes such as drug poisonings, suicide, and chronic liver disease and
   cirrhosis. The magnitude of annual mortality increases in the USA is
   extremely unusual in high-income countries, and a rapid public health
   response is needed to avert further premature deaths.},
Publisher = {ELSEVIER SCIENCE INC},
Address = {360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA},
Type = {Article},
Language = {English},
Affiliation = {Shiels, MS (Corresponding Author), NCI, Div Canc Epidemiol \& Genet, 9609 Med Ctr Dr, Bethesda, MD 20892 USA.
   Shiels, Meredith S.; Chernyavskiy, Pavel; Anderson, William F.; Best, Ana F.; Hartge, Patricia; Rosenberg, Philip S.; Freedman, Neal D.; de Gonzalez, Amy Berrington, NCI, Div Canc Epidemiol \& Genet, Rockville, MD USA.
   Haozous, Emily A., Univ New Mexico, Coll Nursing, Albuquerque, NM 87131 USA.
   Thomas, David, NIDA, Div Epidemiol Serv \& Prevent Res, Bethesda, MD 20892 USA.},
DOI = {10.1016/S0140-6736(17)30187-3},
ISSN = {0140-6736},
EISSN = {1474-547X},
Keywords-Plus = {UNITED-STATES; AMERICAN-INDIANS; CIGARETTE-SMOKING; ALASKA NATIVES;
   RISK-FACTORS; HEALTH; RATES; INDIVIDUALS; PATTERNS; SERVICES},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {shielsms@mail.nih.gov},
ResearcherID-Numbers = {de gonzalez, amy berrington/L-7017-2017
   Freedman, Neal David/AAA-5929-2022
   Freedman, Neal D/B-9741-2015
   Haozous, Emily/AAX-1119-2021
   },
ORCID-Numbers = {de gonzalez, amy berrington/0000-0002-7332-8387
   Freedman, Neal David/0000-0003-0074-1098
   Freedman, Neal D/0000-0003-0074-1098
   Haozous, Emily/0000-0003-1363-1453
   Best, Ana/0000-0002-4467-1725
   Rosenberg, Philip/0000-0001-6349-9126},
Funding-Acknowledgement = {US National Cancer InstituteUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI); NATIONAL CANCER INSTITUTEUnited States Department of
   Health \& Human ServicesNational Institutes of Health (NIH) - USANIH
   National Cancer Institute (NCI) {[}ZIACP010150] Funding Source: NIH
   RePORTER},
Funding-Text = {US National Cancer Institute Intramural Research Program.},
Cited-References = {Ahmad F., 2016, Q PROVISIONAL ESTIMA.
   {[}Anonymous], 2015, DEATHS MORT RAT SEL.
   {[}Anonymous], 2015, ASS SECR PLANN EV IS.
   {[}Anonymous], 2014, OP PAINK PRESCR.
   Arias E., 2016, VALIDITY RACE HISPAN.
   Arias Elizabeth, 2008, Vital Health Stat 2, P1.
   Berterame S, 2016, LANCET, V387, P1644, DOI 10.1016/S0140-6736(16)00161-6.
   Buchanich JM, 2016, PREV MED, V89, P317, DOI 10.1016/j.ypmed.2016.04.007.
   Byers T, 2016, CA-CANCER J CLIN, V66, P359, DOI 10.3322/caac.21348.
   Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112.
   Centers for Disease Control and Prevention National Center for Health Statistics, DEATH RAT 282 SEL CA.
   Centers for Disease Control (CDC), 1992, MMWR Morb Mortal Wkly Rep, V41, P354.
   Chen Li Hui, 2014, NCHS Data Brief, P1.
   Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226.
   Cobb N, 2014, AM J PUBLIC HEALTH, V104, pS481, DOI 10.2105/AJPH.2014.301879.
   Department of Health and Human Services Indian Health Service, 2011, INP MENT HLTH ASS.
   Dominguez K, 2015, MMWR-MORBID MORTAL W, V64, P469.
   Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI 10.15585/mmwr.rr6501e1.
   Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935.
   Han B, 2015, JAMA-J AM MED ASSOC, V314, P1468, DOI 10.1001/jama.2015.11859.
   Hastings KG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124341.
   HOLFORD TR, 1991, ANNU REV PUBL HEALTH, V12, P425, DOI 10.1146/annurev.pu.12.050191.002233.
   Institute for Health Metrics and Evaluation. Institute for Health Metrics and Evaluation, 2015, GBD COMPARE.
   Jacobs EJ, 2015, ANN EPIDEMIOL, V25, P179, DOI 10.1016/j.annepidem.2014.11.008.
   Jacobs-Wingo JL, 2016, AM J PUBLIC HEALTH, V106, P906, DOI 10.2105/AJPH.2015.303033.
   Jamal A, 2015, MMWR-MORBID MORTAL W, V64, P1233, DOI 10.15585/mmwr.mm6444a2.
   Jim MA, 2014, AM J PUBLIC HEALTH, V104, pS295, DOI 10.2105/AJPH.2014.301933.
   Jones CM, 2015, MMWR-MORBID MORTAL W, V64, P719.
   Kochanek Kenneth D, 2015, NCHS Data Brief, P1.
   Kochanek Kenneth D, 2016, Natl Vital Stat Rep, V65, P1.
   Kunitz SJ, 2008, AM J PUBLIC HEALTH, V98, P404, DOI 10.2105/AJPH.2007.114538.
   Ma JM, 2015, JAMA-J AM MED ASSOC, V314, P1731, DOI 10.1001/jama.2015.12319.
   Men T, 2003, BRIT MED J, V327, P964, DOI 10.1136/bmj.327.7421.964.
   Murthy VH, 2017, JAMA-J AM MED ASSOC, V317, P133, DOI 10.1001/jama.2016.18215.
   Norheim OF, 2015, LANCET, V385, P239, DOI 10.1016/S0140-6736(14)61591-9.
   Noymer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015812.
   Office for National Statistics, 2015, DEATH REG SUMM TABL.
   Office for National Statistics, 2016, DEATHS REL DRUG POIS.
   Parks SE, 2014, MMWR SURVEILL SUMM, V63, P1.
   Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283.
   Rosenberg PS, 2014, CANCER EPIDEM BIOMAR, V23, P2296, DOI 10.1158/1055-9965.EPI-14-0300.
   Ross RE, 2015, J HEALTH CARE POOR U, V26, P1081, DOI 10.1353/hpu.2015.0129.
   Rudd RA, 2014, MORB MORTAL WKLY REP.
   Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3.
   U. S. Department of Health and Human Services, 2014, 2014 SURG GEN REP HL.
   Urban Indian Health Institute, 2012, ADDR DEPR AM IND AL.},
Number-of-Cited-References = {46},
Times-Cited = {131},
Usage-Count-Last-180-days = {3},
Usage-Count-Since-2013 = {69},
Journal-ISO = {Lancet},
Doc-Delivery-Number = {EN9UN},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000396345200026},
OA = {Green Accepted},
DA = {2022-03-29},
}

@article{ WOS:000704336800010,
Author = {Lurie, Ido and Shoval, Gal and Hoshen, Moshe and Balicer, Ran and
   Weiser, Mark and Weizman, Abraham and Krivoy, Amir},
Title = {The association of medical resource utilization with physical morbidity
   and premature mortality among patients with schizophrenia: An historical
   prospective population cohort study},
Journal = {SCHIZOPHRENIA RESEARCH},
Year = {2021},
Volume = {237},
Pages = {62-68},
Month = {NOV},
Abstract = {Background: Schizophrenia patients have shorter life expectancy often
   owing to preventable physical illnesses and sub-optimal utilization of
   medical services. However, the association between service-utilization
   and mortality has not been explored. Aim: To assess whether medical
   service-utilization moderates the association between physical morbidity
   and premature mortality in a nation-wide cohort. Methods: A population
   representative database of the largest health provider in Israel was
   analyzed. All electronic health records of patients with schizophrenia
   diagnosis (ICD code F.20) (n = 24,679) were followed-up between 2012 and
   2015, and compared to the general population (n = 2,232,804), in terms
   of metabolic and cardiovascular morbidity, all-cause mortality, primary
   medical and specialist health service-utilization and general
   hospitalizations. Results: Schizophrenia was associated with increased
   mortality risk (adjusted hazard ratio (aHR) = 3.52, 95\%CI 3.35-3.72).
   Most deaths were related to physical illnesses. Metabolic syndrome
   components, except chronic hypertension, were more prevalent among
   patients. They were referred more frequently to primary and less to
   secondary services (aHR = 1.05, 95\%CI 1.04-1.06, aHR = 0.95, 95\%CI
   0.94-0.97, respectively), with higher hospitalization rates (0.23 +/-
   0.90 vs 0.10 +/- 0.50 per year), and longer mean duration of
   hospitalization (2.02 +/- 10.24 vs 0.68 +/- 5.51 days, P < 0.001). More
   contacts with primary care physicians or specialists positively
   moderated the association between mortality and metabolic disturbances
   in patients with schizophrenia; more contacts were associated with
   better outcomes. Conclusions: An association between premature mortality
   and metabolic syndrome was found among schizophrenia patients while
   utilization of primary/secondary medical services moderated the lethal
   effects of metabolic dysregulation. Increased integrative primary care
   and a national monitoring system are warranted to reduce mortality rate
   in this population.},
Publisher = {ELSEVIER},
Address = {RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS},
Type = {Article},
Language = {English},
Affiliation = {Lurie, I (Corresponding Author), Shalvata Mental Hlth Ctr, POB 94, Hod Hasharon, Israel.
   Lurie, Ido, Shalvata Mental Hlth Ctr, POB 94, Hod Hasharon, Israel.
   Lurie, Ido; Shoval, Gal; Weiser, Mark; Weizman, Abraham; Krivoy, Amir, Tel Aviv Univ, Sackler Sch Med, Dept Psychiat, Tel Aviv, Israel.
   Shoval, Gal; Weizman, Abraham; Krivoy, Amir, Geha Mental Hlth Ctr, Petah Tiqwa, Israel.
   Shoval, Gal, Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.
   Hoshen, Moshe; Balicer, Ran, Clalit Hlth Serv, Clalit Res Inst, Tel Aviv, Israel.
   Balicer, Ran, Ben Gurion Univ Negev, Fac Hlth Sci, Publ Hlth Dept, Beer Sheva, Israel.
   Weiser, Mark, Sheba Med Ctr, Psychiat Div, Ramat Gan, Israel.
   Krivoy, Amir, Kings Coll London, Inst Psychiat Psychol \& Neurosci, Dept Psychosis Studies, London, England.
   Hoshen, Moshe, Jerusalem Coll Technol, Dept Bioinformat, Jerusalem, Israel.},
DOI = {10.1016/j.schres.2021.08.019},
EarlyAccessDate = {SEP 2021},
ISSN = {0920-9964},
EISSN = {1573-2509},
Keywords = {Health services; Mortality; Physical morbidity; Schizophrenia},
Keywords-Plus = {HEALTH-CARE UTILIZATION; CARDIOVASCULAR RISK-FACTORS; SERIOUS
   MENTAL-ILLNESS; METABOLIC SYNDROME; PSYCHOTIC DISORDERS; LIFE
   EXPECTANCY; HEART-DISEASE; PEOPLE; PREVALENCE; COMMUNITY},
Research-Areas = {Psychiatry},
Web-of-Science-Categories  = {Psychiatry},
Author-Email = {ido.lurie@gmail.com},
Funding-Acknowledgement = {Israel National Institute for Health Policy Research Grant
   {[}R/192/2014]},
Funding-Text = {Funding of the was provided by Israel National Institute for Health
   Policy Research Grant R/192/2014. The Israeli National Institute for
   Health Policy Research had no further role in study design; in the
   collection, analysis and interpretation of data; in the writing of the
   report; and in the decision to submit the paper for publication.},
Cited-References = {Berren MR, 1999, PSYCHIAT SERV, V50, P559, DOI 10.1176/ps.50.4.559.
   Bresee LC, 2010, SCHIZOPHR RES, V117, P75, DOI 10.1016/j.schres.2009.12.016.
   Carr VJ, 2003, PSYCHIAT SERV, V54, P226, DOI 10.1176/appi.ps.54.2.226.
   Correll CU, 2017, WORLD PSYCHIATRY, V16, P163, DOI 10.1002/wps.20420.
   Crawford MJ, 2014, BRIT J PSYCHIAT, V205, P473, DOI 10.1192/bjp.bp.113.142521.
   De Hert M, 2006, Clin Pract Epidemiol Ment Health, V2, P14.
   De Hert M, 2009, LANCET, V374, P1591, DOI 10.1016/S0140-6736(09)61942-5.
   De Hert M, 2011, WORLD PSYCHIATRY, V10, P138.
   De Hert M, 2011, WORLD PSYCHIATRY, V10, P52, DOI 10.1002/j.2051-5545.2011.tb00014.x.
   Dickerson FB, 2003, MED CARE, V41, P560.
   Dieset I, 2016, SCHIZOPHRENIA BULL, V42, P1316, DOI 10.1093/schbul/sbw028.
   Falissard B, 2011, INT CLIN PSYCHOPHARM, V26, P291, DOI 10.1097/YIC.0b013e32834a5bf6.
   Fleischman A, 2012, PUBLIC HEALTH REV, V34, DOI 10.1007/BF03391679.
   Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032.
   Gardner-Sood P, 2015, PSYCHOL MED, V45, P2619, DOI 10.1017/S0033291715000562.
   Gur S, 2018, PSYCHIAT RES, V260, P177, DOI 10.1016/j.psychres.2017.11.042.
   Hackman AL, 2006, PSYCHIAT SERV, V57, P563, DOI 10.1176/appi.ps.57.4.563.
   Heald A, 2010, EUR PSYCHIAT, V25, pS41, DOI 10.1016/S0924-9338(10)71706-5.
   Hippisley-Cox J, 2007, HEART, V93, P1256, DOI 10.1136/hrt.2006.110171.
   Hjorthoj C, 2017, LANCET PSYCHIAT, V4, P295, DOI 10.1016/S2215-0366(17)30078-0.
   Krivoy A, 2016, J CLIN PSYCHIAT, V77, pE566, DOI 10.4088/JCP.14m09531.
   Laursen TM, 2011, SCHIZOPHR RES, V131, P101, DOI 10.1016/j.schres.2011.06.008.
   Laursen TM, 2009, ARCH GEN PSYCHIAT, V66, P713, DOI 10.1001/archgenpsychiatry.2009.61.
   Lawrence D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2539.
   Liao CH, 2011, SCHIZOPHR RES, V126, P110, DOI 10.1016/j.schres.2010.12.007.
   McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001.
   Millar H, 2008, EUR NEUROPSYCHOPHARM, V18, pS121, DOI 10.1016/j.euroneuro.2008.02.002.
   Mitchell AJ, 2013, SCHIZOPHRENIA BULL, V39, P306, DOI 10.1093/schbul/sbr148.
   Mitchell AJ, 2011, BRIT J PSYCHIAT, V198, P434, DOI 10.1192/bjp.bp.109.076950.
   Moore S, 2015, ACTA PSYCHIAT SCAND, V132, P109, DOI 10.1111/acps.12431.
   Morden NE, 2012, GEN HOSP PSYCHIAT, V34, P368, DOI 10.1016/j.genhosppsych.2012.02.009.
   Nasrallah HA, 2006, SCHIZOPHR RES, V86, P15, DOI 10.1016/j.schres.2006.06.026.
   Nielsen RE, 2013, SCHIZOPHR RES, V146, P22, DOI 10.1016/j.schres.2013.02.025.
   Norgaard HCB, 2019, SCAND J PRIM HEALTH, V37, P358, DOI 10.1080/02813432.2019.1639927.
   Oakley P, 2018, J PSYCHIATR RES, V102, P245, DOI 10.1016/j.jpsychires.2018.04.019.
   Olfson M, 2015, JAMA PSYCHIAT, V72, P1172, DOI 10.1001/jamapsychiatry.2015.1737.
   Oud MJT, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-92.
   Rennert G, 2001, ISR MED ASSOC J, V3, P404.
   Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123.
   Salsberry PJ, 2005, PSYCHIAT SERV, V56, P458, DOI 10.1176/appi.ps.56.4.458.
   Swildens W, 2016, ADM POLICY MENT HLTH, V43, P650, DOI 10.1007/s10488-015-0679-0.
   Toender A, 2020, SCHIZOPHR RES, V218, P99, DOI 10.1016/j.schres.2020.01.024.
   Vancampfort D, 2015, WORLD PSYCHIATRY, V14, P339, DOI 10.1002/wps.20252.
   Xiong GL, 2008, PSYCHIAT SERV, V59, P929, DOI 10.1176/ps.2008.59.8.929.
   Young JK, 2000, JAMA-J AM MED ASSOC, V283, P3198, DOI 10.1001/jama.283.24.3198.},
Number-of-Cited-References = {45},
Times-Cited = {0},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Schizophr. Res.},
Doc-Delivery-Number = {WC5ZS},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000704336800010},
DA = {2022-03-29},
}

@article{ WOS:000609492200010,
Author = {Truong-Minh Pham and Shen-Tu, Grace and Khanh Hoa Nguyen and Lu, Shuang
   and Dover, Douglas C. and Duggan, Peter and Shack, Lorraine and Cheung,
   Winson Y.},
Title = {Premature Mortality Due to Hodgkin Lymphoma, Non-Hodgkin Lymphoma,
   Multiple Myeloma, and Leukemia in Canada: A Nationwide Analysis From
   1980 to 2015},
Journal = {AMERICAN JOURNAL OF EPIDEMIOLOGY},
Year = {2021},
Volume = {190},
Number = {1},
Pages = {59-75},
Month = {JAN},
Abstract = {Recently, we introduced a novel measure of ``average life span
   shortened{''} (ALSS) to improve comparability of premature mortality
   over time. In this study, we applied this novel measure to examine
   trends in premature mortality caused by hematological cancers in Canada
   from 1980 to 2015. Mortality data for Hodgkin lymphoma, non-Hodgkin
   lymphoma, multiple myeloma, and leukemia were obtained from the World
   Health Organization mortality database. Years of life lost was
   calculated according to Canadian life tables. ALSS was defined as the
   ratio between years of life lost and expected life span. Over the study
   period, age-standardized rates of mortality decreased for all types of
   hematological cancers. Our new ALSS measure showed favorable trends in
   premature mortality for all types of hematological cancers among both
   sexes. For instance, men with non-Hodgkin lymphoma lost an average of
   23.7\% of their life span in 1980 versus 16.1\% in 2015, while women
   with non-Hodgkin lymphoma lost an average of 21.7\% of their life span
   in 1980 versus 15.5\% in 2015. Results from this study showed that
   patients with hematological cancers experienced prolonged survival over
   a 35-year period although the magnitude of these life span gains varied
   by types of hematological cancers.},
Publisher = {OXFORD UNIV PRESS INC},
Address = {JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA},
Type = {Article},
Language = {English},
Affiliation = {Pham, TM (Corresponding Author), Alberta Hlth Serv, Canc Care Alberta, Surveillance \& Reporting, Suite 1400,Sun Life Bldg,10123-99 St, Edmonton, AB T5J 3H1, Canada.
   Truong-Minh Pham; Lu, Shuang; Shack, Lorraine, Alberta Hlth Serv, Canc Care Alberta, Surveillance \& Reporting, Canc Res \& Analyt, Edmonton, AB, Canada.
   Truong-Minh Pham; Lu, Shuang; Shack, Lorraine, Alberta Hlth Serv, Canc Care Alberta, Surveillance \& Reporting, Canc Res \& Analyt, Calgary, AB, Canada.
   Shen-Tu, Grace, Alberta Hlth Serv, Canc Care Alberta, Albertas Tomorrow Project, Canc Res \& Analyt, Calgary, AB, Canada.
   Khanh Hoa Nguyen, Univ Alberta, Fac Med \& Dent, Dept Pharmacol, Edmonton, AB, Canada.
   Dover, Douglas C., Univ Alberta, Fac Med \& Dent, Dept Med, Canadian VIGOUR Ctr, Edmonton, AB, Canada.
   Duggan, Peter, Univ Calgary, Cumming Sch Med, Dept Med, Calgary, AB, Canada.
   Shack, Lorraine; Cheung, Winson Y., Univ Calgary, Cumming Sch Med, Dept Oncol, Calgary, AB, Canada.},
DOI = {10.1093/aje/kwaa160},
ISSN = {0002-9262},
EISSN = {1476-6256},
Keywords = {average life span shortened; average years of life lost; hematological
   cancers; premature mortality; years of life lost},
Keywords-Plus = {GLOBAL BURDEN; SURVIVAL; DISEASE; CANCER},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {truongminh.pham@ahs.ca},
Cited-References = {Armitage JO, 2017, LANCET, V390, P298, DOI 10.1016/S0140-6736(16)32407-2.
   Atchison KM, 2020, LARYNGOSCOPE, V130, P911, DOI 10.1002/lary.28024.
   Bessell EM, 2012, BRIT J CANCER, V107, P531, DOI 10.1038/bjc.2012.228.
   Burnet NG, 2005, BRIT J CANCER, V92, P241, DOI 10.1038/sj.bjc.6602321.
   Canadian Cancer Society, 2017, CAN CANC STAT 2017 CANADIAN CANC STAT.
   Christopher CJL, 1996, GLOBAL BURDEN DIS CO.
   DeVita VT, 2008, CANCER RES, V68, P8643, DOI 10.1158/0008-5472.CAN-07-6611.
   Feigin VL, 2016, LANCET NEUROL, V15, P913, DOI 10.1016/S1474-4422(16)30073-4.
   Global Burden of Disease Study 2013 Collaborators, 2015, LANCET, V386, P743, DOI {[}10.1016/S0140-6736(15)60692-4, DOI 10.1016/S0140-6736(15)60692-4].
   Grigoropoulos NF, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1660.
   HARRIS NL, 1994, BLOOD, V84, P1361.
   Harris NL, 2017, WHO CLASSIFICATION T, V2.
   Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2.
   Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4.
   Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442.
   Segi M., 1960, CANC MORTALITY SELEC.
   Shah A, 2013, BRIT J HAEMATOL, V162, P509, DOI 10.1111/bjh.12425.
   Statistics Canada, LIF TABL CAN PROV TE.
   Pham TM, 2019, ANN EPIDEMIOL, V37, P81, DOI 10.1016/j.annepidem.2019.07.011.
   Pham TM, 2019, J EPIDEMIOL, V29, P464, DOI 10.2188/jea.JE20180140.
   Pham TM, 2018, NEUROEPIDEMIOLOGY, V50, P195, DOI 10.1159/000488145.
   Pham TM, 2018, EUR J PUBLIC HEALTH, V28, P348, DOI 10.1093/eurpub/ckx195.
   World Health Organization, WHO STAT INF SYST WH.
   Yung L, 2003, LANCET, V361, P943, DOI 10.1016/S0140-6736(03)12777-8.},
Number-of-Cited-References = {24},
Times-Cited = {2},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Am. J. Epidemiol.},
Doc-Delivery-Number = {PU7PC},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000609492200010},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000505200400013,
Author = {Fitzmaurice, Christina and Abate, Degu and Abbasi, Naghmeh and
   Abbastabar, Hedayat and Abd-Allah, Foad and Abdel-Rahman, Omar and
   Abdelalim, Ahmed and Abdoli, Amir and Abdollahpour, Ibrahim and Abdulle,
   Abdishakur S. M. and Abebe, Nebiyu Dereje and Abraha, Haftom Niguse and
   Abu-Raddad, Laith Jamal and Abualhasan, Ahmed and Adedeji, Isaac
   Akinkunmi and Advani, Shailesh M. and Afarideh, Mohsen and Afshari,
   Mandi and Aghaali, Mohammad and Agius, Dominic and Agrawal, Sutapa and
   Ahmadi, Ayat and Ahmadian, Elham and Ahmadpour, Ehsan and Ahmed, Muktar
   Beshir and Akbari, Mohammad Esmaeil and Akinyemiju, Tomi and Al-Aly,
   Ziyad and AlAbdulKader, Assim M. and Alandab, Fares and Alam, Tahiya and
   Alamene, Genet Melak and Alemnew, Birhan Tamene T. and Alene, Kefyalew
   Addis and Alinia, Cyrus and Alipour, Vahid and Aljunid, Syed Mohamed and
   Bakeshei, Fatemeh Allah and Abdulrahman, Majid and Almadi, Hamad and
   Almasi-Hashiani, Amir and Alsharif, Ubai and Alsowaidi, Shirina and
   Alvis-Guzman, Nelson and Amini, Erfan and Amini, Saeed and Amoako, Yaw
   Ampem and Anbari, Zohreh and Anber, Nahla Hamed and Andrei, Catalina
   Liliana and Anjomshoa, Mina and Ansari, Fereshteh and Ansariadi,
   Ansariadi and Appiah, Seth Christopher Yaw and Arab-Zozani, Morteza and
   Arabloo, Jalal and Arefi, Zohreh and Aremu, Olatunde and Areri, Habtamu
   Abera and Al Artaman and Asayesh, Hamid and Asfaw, Ephrem Tsegay and
   Ashagre, Alebachew Fasil and Ataeinia, Bahar and Atalay, Hagos Tasew and
   Ataro, Zerihun and Atique, Suleman and Ausloos, Marcel and Avila-Burgos,
   Leticia and Avokpaho, Euripide F. G. A. and Awasthi, Ashish and Awoke,
   Nefsu and Quintanilla, Beatriz Paulina Ayala and Ayanore, Martin Amogre
   and Ayele, Henok Tadesse and Babaee, Ebrahim and Bacha, Umar and Badawi,
   Alaa and Bagherzadeh, Mojtaba and Bagli, Eleni and Balakrishnan,
   Senthilkuimar and Balouchi, Abbas and Barnighausen, Till Winfried and
   Battista, Robert J. and Behzadifar, Masoud and Behzadifar, Meysam and
   Bekele, Bayu Begashaw and Belay, Yared Belete and Belayneh, Yaschilal
   Muche and Berfield, Kathleen Kim Sachiko and Berhane, Adugnaw and
   Bernabe, Eduardo and Beuran, Mircea and Bhakta, Nickhill and
   Bhattacharyya, Krittika and Biadgo, Belete and Bijani, Ali and Bin
   Sayeed, Muhammad Shandaat and Birungi, Charles and Bisignano, Catherine
   and Bitew, Helen and Bjerge, Tone and Bleyer, Archie and Bogale,
   Kassawmar Angaw and Bojia, Hunduma Amensisa and Borzi, Antonio M. and
   Bosetti, Cristina and Bou-Orm, Ibrahim R. and Brenner, Hermann and
   Brewer, Jerry D. and Briko, Andrey Nikolaevich and Briko, Nikolay
   Ivanovich and Bustamante-Teixeira, Maria Teresa and Butt, Zahid A. and
   Carreras, Giulia and Carrero, Juan J. and Carvalho, Felix and Castro,
   Clara and Castro, Franz and Catala-Lopez, Ferran and Cerin, Ester and
   Chaiah, Yazan and Chanie, Wagaye Fentahun and Chattu, Vijay Kumar and
   Chaturvedi, Pankaj and Chauhan, Neelima Singh and Chehrazi, Mohammad and
   Chiang, Peggy Pei -Chia and Chichiabellu, Tesfaye Yitna and
   Chido-Amajuoyi, Onyema Greg and Chimed-Ochir, Odgerel and Choi,
   Jee-Young J. and Christopher, Devasahayam J. and Chu, Dinh-Toi and
   Constantin, Maria -Magdalena and Costa, Vera M. and Crocetti, Emanuele
   and Crowe, Christopher Stephen and Curado, Maria Paula and Dahlawi, Saad
   M. A. and Damiani, Giovanni and Darwish, Amira Hamed and Daryani, Ahmad
   and das Neves, Jose and Demeke, Feleke Mekonnen and Demis, Asmamaw
   Bizuneh and Demissie, Birhanu Wondimeneh and Demoz, Gebre Teldemariam
   and Denova-Gutierrez, Edgar and Derakhshani, Afshin and Deribe, Kalkidan
   Solomon and Desai, Rupak and Desalegn, Beruk Berhanu and Desta, Melaku
   and Dey, Subhojit and Dharmaratne, Samath Dhamminda and Dhimal, Meghnath
   and Diaz, Daniel and Dinberu, Mesfin Tadese Tadese and Djalalinia,
   Shirin and Doku, David Teye and Drake, Thomas M. and Dubey, Manisha and
   Dubljanin, Eleonora and Duken, Eyasu Ejeta and Ebrahimi, Hedyeh and
   Effiong, Andem and Eftekhari, Aziz and El Sayed, Man and Zaki, Maysaa El
   Sayed and EI-Jaafary, Shaimaa I. and El-Khatib, Ziad and Elemineh,
   Demelash Abewa and Elkout, Hajer and Ellenbogen, Richard G. and
   Elsharkawy, Aisha and Emamian, Mohammad Hassan and Endalew, Daniel Adane
   and Endries, Aman Yesuf and Eshrati, Babak and Fadhil, Ibtihal and
   Fallah, Vahid and Faramarzi, Mahbobeh and Farhangi, Mandieh Abbasalizad
   and Farioli, Andrea and Farzadfar, Farshad and Fentahun, Netsanet and
   Fernandes, Eduarda and Feyissa, Garumma Tolu and Filip, Irina and
   Fischer, Florian and Fisher, James L. and Force, Lisa M. and Foroutan,
   Masoud and Freitas, Marisa and Fukumoto, Takeshi and Futran, Neal D. and
   Gallus, Silvano and Gankpe, Fortune Gbetoho and Gayesa, Reta Tsegaye and
   Gebrehiwot, Tsegaye Tewelde and Gebremeskel, Gebreamlak Gebremedhn and
   Gedefaw, Getnet Azeze and Gelaw, Belayneh K. and Geta, Birhanu and
   Getachew, Sefonias and Gezae, Kebede Ernbaye and Ghafourifard, Mansour
   and Ghajar, Alireza and Ghashghaee, Ahmad and Gholamian, Asadollah and
   Gill, Paramjit Singh and Ginindza, Themba T. G. and Girmay, Alem and
   Gizaw, Muluken and Gomez, Ricardo Santiago and Gopalani, Sameer Vali and
   Gorini, Giuseppe and Goulart, Barbara Niegia Garcia and Grada, Ayman and
   Guerra, Maximiliano Ribeiro and Guimaraes, Andre Luiz Sena and Gupta,
   Prakash C. and Gupta, Rahul and Hadkhale, Kishor and Haj-Mirzaian, Arvin
   and Haj-Mirzaian, Arya and Hamadeh, Randall R. and Hamidi, Samer and
   Hanfore, Lolemo Kelbiso and Haro, Josep Maria and Hasankhani, Milad and
   Hasanzadeh, Amir and Hassen, Hamid Yimam and Hay, Roderick J. and Hay,
   Simon I. and Henok, Andualem and Henry, Nathaniel J. and Herteliu,
   Claudiu and Hidru, Hagos D. and Hoang, Chi Linh and Hole, Michael K. and
   Hoogar, Praveen and Horita, Nobuyuki and Hosgood, H. Dean and Hosseini,
   Mostafa and Hosseinzadeh, Mehdi and Hostiuc, Mihaela and Hostiuc, Sorin
   and Househ, Mowafa and Hussen, Mohammedaman Mama and Ileanu, Bogdan and
   Ilic, Milena D. and Innos, Kaire and Irvani, Seyed Sina Naghibi and
   Lseh, Kufre Robert and Islam, Sheikh Mohammed Shariful and Islami,
   Farhad and Balalami, Nader Jafari and Jafarinia, Morteza and Jahangiry,
   Leila and Jahani, Mohammad Ali and Jahanmehr, Nader and Jakovljevic,
   Mihajlo and James, Spencer L. and Javanbakht, Mehdi and Jayaraman, Sudha
   and Jee, Sun Ha and Jenabi, Ensiyeh and Jha, Ravi Prakash and Jonas,
   Jost B. and Jonnagaddala, Jitendra and Joo, Tamas and Jungari, Suresh
   Banayya and Jurisson, Mikk and Kabir, Ali and Kamangar, Farin and Karch,
   Andre and Karimi, Narges and Karimian, Ansar and Kasaeian, Amir and
   Kasahun, Gebremicheal Gebreslassie and Kassa, Delete and Kassa, Tesfaye
   Dessale and Kassaw, Mesfin Wudu and Kaul, Anil and Keiyoro, Peter Njenga
   and Kelbore, Abraham Getachew and Kerbo, Amene Abebe and Khader, Yousef
   Sale' and Khalilarjmandi, Maryam and Khan, Ejaz Ahmad and Khan, Gulfaraz
   and Hang, Young -Ho and Khatab, Haled and Hater, Amir and Khayamzadeh,
   Maryam and Khazaee-Pool, Maryam and Khazaei, Salman and Khoja, Abdullah
   T. and Khosravi, Mohammad Hossein and Khubchandani, Jagdish and
   Kianipour, Neda and Kim, Daniel and Kim, Yun Jin and Kisa, Adnan and
   Kisa, Sezer and Kissimova-Skarbek, Katarzyna and Komaki, Hamidreza and
   Koyanagi, Ai and Krohn, Kristopher J. and Dicer, Burcu Kucuk and Kugbey,
   Nuworza and Kumar, Vivek and Kuupiel, Desmond and La Vecchia, Carlo and
   Lad, Deepesh P. and Lake, Eyasu Alem and Lakew, Ayenew Molla and Lal,
   Dharmesh Kumar and Lami, Fads Hasan and Lan, Qing and Lasrado, Savita
   and Lauriola, Paolo and Lazarus, Jeffrey V. and Leigh, James and
   Leshargie, Cheru Tesema and Liao, Yu and Limenih, Miteku Andualem and
   Listl, Stefan and Lopez, Alan D. and Lopukhov, Platon D. and Lunevicius,
   Raimundas and Madadin, Mohammed and Magdeldin, Sameh and El Razek,
   Hassan Magdy Abd and Majeed, Azeem and Maleki, Afshin and Malekzadeh,
   Reza and Manafi, Ali and Manafi, Navid and Manamo, Wondimu Ayele and
   Mansourian, Morteza and Mansournia, Mohammad Ali and Mantovani, Lorenzo
   Giovanni and Maroufizadeh, Saman and Martini, Santi S. Martini and
   Mashamba-Thompson, Tivani Phosa and Massenburg, Benjamin Ballard and
   Maswabi, Motswadi Titus and Mathur, Manu Raj and McAlinden, Colm and
   Mckee, Martin and Meheretu, Hailemariam Abiy Alemu and Mehrotra, Ravi
   and Mehta, Varshil and Meier, Toni and Melaku, Yohannes A. and Meles,
   Gebrekiros Gebremichael and Meles, Hagazi Gebre and Melese, Addisu and
   Melku, Mulugeta and Memiah, Peter T. N. and Mendoza, Walter and Menezes,
   Ritesh G. and Merat, Shahin and Meretoja, Tuomo J. and Mestrovic,
   Tomislav and Miazgowski, Bartosz and Miazgowski, Tomasz and Mihretie,
   Kebadnew Mulatu M. and Miller, Ted R. and Mills, Edward J. and Mir,
   Seyed Mostafa and Mirzaei, Hamed and Mirzaei, Hamid Reza and Mishra,
   Rashmi and Moazen, Babak and Mohammad, Dara K. and Mohammad, Karzan
   Abdulmuhsin and Mohammad, Yousef and Darwesh, Aso Mohammad and
   Mohammadbeigi, Abolfazl and Mohammadi, Hiwa and Mohammadi, Moslem and
   Mohammadian, Mandi and Mohammadian-Hafshejani, Abdollah and
   Mohammadoo-Khorasani, Milad and Mohammadpourhodki, Reza and Mohammed,
   Ammas Siraj and Mohammed, Jemal Abdu and Mohammed, Shafiu and Mohebi,
   Farnam and Mokdad, Ali H. and Monasta, Lorenzo and Moodley, Yoshan and
   Moosazadeh, Mahmood and Moossavi, Maryam and Moradi, Ghobad and
   Moradi-Joo, Mohammad and Moradi-Lakeh, Maziar and Moradpour, Farhad and
   Morawska, Lidia and Morgado-Da-Costa, Joana and Morisaki, Naho and
   Morrison, Shane Douglas and Mosapour, Abbas and Mousavi, Seyyed Meysam
   and Muche, Achenef Asmamaw and Muhammed, Oumer Sada S. and Musa, Jonah
   and Nabhan, Ashraf R. and Naderi, Mehdi and Nagarajan, Ahamarshan
   Jayaraman and Nagel, Gabriele and Nahvijou, Azin and Naik, Gurudatta and
   Najafi, Farid and Naldi, Luigi and Nam, Hae Sung and Nasiri, Naser and
   Nazari, Javad and Negoi, Lonut and Neupane, Subas and Newcomb, Polly A.
   and Nggada, Haruna Asura and Ngunjiri, Josephine W. and Cuong Tat Nguyen
   and Nikniaz, Leila and Ningrum, Dina Nur Anggraini and Nirayo, Yirga
   Legesse and Nixon, Molly R. and Nnaji, Chukwudi A. and Nojomi, Marzieh
   and Nosratnejad, Shirin and Shiadeh, Malihe Nourollahpour and Obsa,
   Mohammed Suleiman and Ofori-Asenso, Richard and Ogbo, Felix Akpojene and
   Oh, In-Hwan and Olagunju, Andrew T. and Olagunju, Tinuke O. and
   Oluwasanu, Mojisola Morenike and Omonisi, Abidemi E. and Onwujekwe,
   Obinna E. and Oommen, Anu Mary and Oren, Eyal and Ortega-Altamirano,
   Doris D. V. and Ota, Erika and Otstavnov, Stanislav S. and Owolabi,
   Mayowa Ojo and Mahesh, P. A. and Padubidri, Jagadish Rao and Pakhale,
   Smita and Pakpour, Amir H. and Pana, Adrian and Park, Eun-Kee and
   Parsian, Hadi and Pashaei, Tahereh and Patel, Shanti and Patil, Snehal
   T. and Pennini, Alyssa and Pereira, David M. and Piccinelli, Cristiano
   and Pillay, Julian David and Pirestani, Majid and Pishgar, Farhad and
   Postma, Maarten J. and Pourjafar, Hadi and Pourmalek, Farshad and
   Pourshams, Akram and Prakash, Swayam and Prasad, Narayan and Qorbani,
   Mostafa and Rabiee, Mohammad and Rabiee, Navid and Radfar, Amir and
   Rafiei, Alireza and Rahim, Fakher and Rahimi, Mandi and Rahman, Muhammad
   Aziz and Rajati, Fatemeh and Rana, Saleem M. and Raoofi, Samira and
   Rath, Goura Kishor and Rawaf, David Laith and Rawaf, Salman and Reiner,
   Robert C. and Renzaho, Andre M. N. and Rezaei, Nima and Rezapour, Aziz
   and Ribeiro, Ana Isabel and Ribeiro, Daniela and Ronfani, Luca and Roro,
   Elias Merdassa and Roshandel, Gholamreza and Rostami, Ali and Saad, Ragy
   Safwat and Sabbagh, Parisa and Sabour, Siamak and Saddik, Basema and
   Safiri, Saeid and Sahebkar, Amirhossein and Salahshoor, Mohammad Reza
   and Salehi, Farkhonde and Salem, Hosni and Salem, Marwa Rashad and
   Salimzadeh, Hamideh and Salomon, Joshua A. and Samy, Abdallah M. and
   Sanabria, Juan and Milicevic, Milena M. Santric and Sartorius, Benn and
   Sarveazad, Arash and Sathian, Brijesh and Satpathy, Maheswar and Savic,
   Miloje and Sawhney, Monika and Sayyah, Mehdi and Schneider, Lone J. C.
   and Schottker, Ben and Sekerija, Mario and Sepanlou, Sadaf G. and
   Sepehrimanesh, Masood and Seyedmousavi, Seyedmojtaba and Shaahmadi,
   Faramarz and Shabaninejad, Hosein and Shahbaz, Mohammad and Shaikh,
   Masood Ali and Shamshirian, Amir and Shamsizadeh, Morteza and Sharafi,
   Heidar and Sharafi, Zeinab and Sharif, Mehdi and Sharifi, Ali and
   Sharifi, Hamid and Sharma, Rajesh and Sheikh, Aziz and Shirkoohi, Reza
   and Shukla, Sharvari Rahul and Siabani, Soraya and Silva, Diego Augusto
   Santos and Silveira, Dayane Gabriele Alves and Singh, Ambrish and Singh,
   Jasvinder A. and Sisay, Solomon and Sitas, Freddy and Sobngwi, Eugene
   and Soofi, Moslem and Soriano, Joan B. and Stathopoulou, Vasiliki and
   Sufiyan, Mu'awiyyah Babale and Tabares-Seisdedos, Rafael and Tabuchi,
   Takahiro and Takahashi, Ken and Tamtaji, Omid Reza and Tarawneh,
   Mohammed Rasoul and Tassew, Segen Gebremeskel and Taymoori, Parvaneh and
   Tehrani-Banihashemi, Arash and Temsah, Mohamad-Hani and Temsah, Omar and
   Tesfay, Etsay and Tesfay, Fisaha Haile and Teshale, Manaye Yihune and
   Tessema, Gizachew Assefa and Thapa, Subash and Tlaye, Kenean Getaneh and
   Topor-Madry, Roman and Tovani-Palone, Marcos Roberto and Traini, Eugenio
   and Bach Xuan Tran and Khanh Bao Tran and Tsadik, Afewerki Gebremeskel
   and Ullah, Irfan and Uthman, Olalekan A. and Vacante, Marco and Vaezi,
   Maryam and Perez, Patricia Varona and Veisani, Yousef and Vidale, Simone
   and Violante, Francesco S. and Vlassov, Vasily and Vollset, Stein Emil
   and Vos, Theo and Vosoughi, Kia and Giang Thu Vu and Vujcic, Isidora S.
   and Wabinga, Henry and Wachamo, Tesfahun Mulatu and Wagnew, Fasil
   Shiferaw and Waheed, Yasir and Weldegebreal, Fitsum and Weldesamuel,
   Girmay Teklay and Wijeratne, Tissa and Wondafrash, Dawit Zewdu and
   Wonde, Tewodros Eshete and Wondmieneh, Adam Belay and Workie,
   Hailemariam Mekonnen and Yadav, Rajaram and Yadegar, Abbas and
   Yadollahpour, Ali and Yaseri, Mehdi and Yazdi-Feyzabadi, Vahid and
   Yeshaneh, Alex and Yimam, Mohammed Ahmed and Yimer, Ebrahim M. and
   Yisma, Engida and Yonemoto, Naohiro and Younis, Mustafa Z. and Yousefi,
   Bahman and Yousefifard, Mahmoud and Yu, Chuanhua and Zabeh, Erfan and
   Zadnik, Vesna and Moghadam, Telma Zahirian and Zaidi, Zoubida and
   Zamani, Mohammad and Zandian, Hamed and Zangeneh, Alireza and Zaki,
   Leila and Zendehdel, Kazem and Zenebe, Zerihun Menlkalew and Zewale,
   Taye Abuhay and Ziapour, Arash and Zodpey, Sanjay and Murray,
   Christopher J. L. and Global Burden Dis Canc Collaborati},
Title = {Global, Regional, and National Cancer Incidence, Mortality, Years of
   Life Lost, Years Lived With Disability, and Disability-Adjusted
   Life-Years for 29 Cancer Groups, 1990 to 2017 A Systematic Analysis for
   the Global Burden of Disease Study},
Journal = {JAMA ONCOLOGY},
Year = {2019},
Volume = {5},
Number = {12},
Pages = {1749-1768},
Month = {DEC},
Abstract = {Importance Cancer and other noncommunicable diseases (NCDs) are now
   widely recognized as a threat to global development. The latest United
   Nations high-level meeting on NCDs reaffirmed this observation and also
   highlighted the slow progress in meeting the 2011 Political Declaration
   on the Prevention and Control of Noncommunicable Diseases and the third
   Sustainable Development Goal. Lack of situational analyses, priority
   setting, and budgeting have been identified as major obstacles in
   achieving these goals. All of these have in common that they require
   information on the local cancer epidemiology. The Global Burden of
   Disease (GBD) study is uniquely poised to provide these crucial data.
   Objective To describe cancer burden for 29 cancer groups in 195
   countries from 1990 through 2017 to provide data needed for cancer
   control planning. Evidence Review We used the GBD study estimation
   methods to describe cancer incidence, mortality, years lived with
   disability, years of life lost, and disability-adjusted life-years
   (DALYs). Results are presented at the national level as well as by
   Socio-demographic Index (SDI), a composite indicator of income,
   educational attainment, and total fertility rate. We also analyzed the
   influence of the epidemiological vs the demographic transition on cancer
   incidence. Findings In 2017, there were 24.5 million incident cancer
   cases worldwide (16.8 million without nonmelanoma skin cancer {[}NMSC])
   and 9.6 million cancer deaths. The majority of cancer DALYs came from
   years of life lost (97\%), and only 3\% came from years lived with
   disability. The odds of developing cancer were the lowest in the low SDI
   quintile (1 in 7) and the highest in the high SDI quintile (1 in 2) for
   both sexes. In 2017, the most common incident cancers in men were NMSC
   (4.3 million incident cases); tracheal, bronchus, and lung (TBL) cancer
   (1.5 million incident cases); and prostate cancer (1.3 million incident
   cases). The most common causes of cancer deaths and DALYs for men were
   TBL cancer (1.3 million deaths and 28.4 million DALYs), liver cancer
   (572000 deaths and 15.2 million DALYs), and stomach cancer (542000
   deaths and 12.2 million DALYs). For women in 2017, the most common
   incident cancers were NMSC (3.3 million incident cases), breast cancer
   (1.9 million incident cases), and colorectal cancer (819000 incident
   cases). The leading causes of cancer deaths and DALYs for women were
   breast cancer (601000 deaths and 17.4 million DALYs), TBL cancer (596000
   deaths and 12.6 million DALYs), and colorectal cancer (414000 deaths and
   8.3 million DALYs). Conclusions and Relevance The national
   epidemiological profiles of cancer burden in the GBD study show large
   heterogeneities, which are a reflection of different exposures to risk
   factors, economic settings, lifestyles, and access to care and
   screening. The GBD study can be used by policy makers and other
   stakeholders to develop and improve national and local cancer control in
   order to achieve the global targets and improve equity in cancer care.
   Question What is the cancer burden over time at the global and national
   levels, measured in incidence, mortality, years lived with disability,
   years of life lost, and disability-adjusted life-years (DALYs), and how
   does it compare with other diseases? Findings Results of this systematic
   analysis show that in 2017 there were 24.5 million incident cases (16.8
   million without nonmelanoma skin cancer), 9.6 million deaths, and 233.5
   million DALYs due to cancer; between 2007 and 2017, incident cases
   increased by 33\%, with the lowest increase in the most developed
   countries, and between 1990 and 2017 neoplasms increased among the top
   causes of DALYs from the sixth to the second place. Fifty-one percent of
   cancer cases occurred in countries of high Socio-demographic Index, but
   only 30\% of cancer deaths and 24\% of cancer DALYs. Meaning To ensure
   sustainable global development, increased efforts are needed in cancer
   prevention and in ensuring universal access to cancer care.
   This systematic analysis describes cancer burden for 29 cancer groups
   across 195 countries from 1990 through 2017 to provide data needed for
   cancer control planning.},
Publisher = {AMER MEDICAL ASSOC},
Address = {330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA},
Type = {Article},
Language = {English},
Affiliation = {Fitzmaurice, C (Corresponding Author), Univ Washington, Inst Hlth Metr \& Evaluat, Seattle, WA 98195 USA.
   Fitzmaurice, C (Corresponding Author), Univ Washington, Div Hematol, Seattle, WA 98195 USA.
   Fitzmaurice, Christina; Alam, Tahiya; Bisignano, Catherine; Dharmaratne, Samath Dhamminda; Force, Lisa M.; Hay, Simon I.; Henry, Nathaniel J.; James, Spencer L.; Krohn, Kristopher J.; Lopez, Alan D.; Mokdad, Ali H.; Nixon, Molly R.; Pennini, Alyssa; Reiner, Robert C.; Vos, Theo; Vosoughi, Kia; Murray, Christopher J. L., Univ Washington, Inst Hlth Metr \& Evaluat, Seattle, WA 98195 USA.
   Fitzmaurice, Christina, Univ Washington, Div Hematol, Seattle, WA 98195 USA.
   Abate, Degu, Haramaya Univ, Harar, Ethiopia.
   Abbasi, Naghmeh; Khalilarjmandi, Maryam; Mir, Seyed Mostafa; Mosapour, Abbas; Parsian, Hadi, Babol Univ Med Sci, Dept Clin Biochem, Babol Sar, Iran.
   Abbastabar, Hedayat, Univ Tehran Med Sci, Iranian Ctr Neurol Res, Tehran, Iran.
   Abd-Allah, Foad; Abdelalim, Ahmed; Abualhasan, Ahmed, Cairo Univ, Dept Neurol, Cairo, Egypt.
   Abdel-Rahman, Omar, Univ Calgary, Dept Oncol, Calgary, AB, Canada.
   Abdel-Rahman, Omar, Ain Shams Univ, Dept Oncol, Cairo, Egypt.
   Abdoli, Amir, Jahrom Univ Med Sci, Dept Parasitol \& Mycol, Jahrom, Iran.
   Abdoli, Amir, Jahrom Univ Med Sci, Res Ctr Noncommunicable Dis, Jahrom, Iran.
   Abdollahpour, Ibrahim; Almasi-Hashiani, Amir, Aral Univ Med Sci, Dept Epidemiol, Arak, Iran.
   Abdollahpour, Ibrahim, Multiple Sclerosis Res Ctr, Tehran, Iran.
   Abdulle, Abdishakur S. M., New York Univ Abu Dhabi, Publ Hlth Res Ctr, Abu Dhabi, U Arab Emirates.
   Abebe, Nebiyu Dereje; Berhane, Adugnaw; Gizaw, Muluken; Manamo, Wondimu Ayele; Roro, Elias Merdassa, Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia.
   Abebe, Nebiyu Dereje, Wachemo Univ, Dept Publ Hlth, Hossana, Ethiopia.
   Abraha, Haftom Niguse; Kassa, Tesfaye Dessale; Nirayo, Yirga Legesse, Mekelle Univ, Clin Pharm Unit, Mekelle, Ethiopia.
   Abu-Raddad, Laith Jamal, Weill Cornell Med Coll Qatar, Dept Healthcare Policy \& Res, Doha, Qatar.
   Advani, Shailesh M., NIH, Social Behav Res Branch, Bldg 10, Bethesda, MD 20892 USA.
   Advani, Shailesh M., Georgetown Univ, Canc Prevent \& Control Program, Washington, DC USA.
   Afarideh, Mohsen; Ghajar, Alireza; Rahim, Fakher, Univ Tehran Med Sci, Endocrinol \& Metab Res Inst, Tehran, Iran.
   Afshari, Mandi, Zabol Univ Med Sci, Zabol, Iran.
   Aghaali, Mohammad; Mohammadbeigi, Abolfazl, Qom Univ Med Sci, Dept Epidemiol \& Biostat, Qom, Iran.
   Agius, Dominic, Directorate Hlth Informat \& Res, Dept Hlth, Pieta, Malta.
   Agrawal, Sutapa; Awasthi, Ashish; Lal, Dharmesh Kumar; Mathur, Manu Raj; Zodpey, Sanjay, Publ Hlth Fdn India, Gurugram, India.
   Agrawal, Sutapa, Vital Strategies, Gurugram, India.
   Ahmadi, Ayat, Univ Tehran Med Sci, Knowledge Utilizat Res Ctr, Tehran, Iran.
   Ahmadian, Elham; Eftekhari, Aziz, Tabriz Univ Med Sci, Dept Pharmacol \& Toxicol, Tabriz, Iran.
   Ahmadpour, Ehsan, Tabriz Univ Med Sci, Dept Parasitol \& Mycol, Tabriz, Iran.
   Ahmed, Muktar Beshir; Gebrehiwot, Tsegaye Tewelde, Jimma Univ, Dept Epidemiol, Jimma, Ethiopia.
   Akbari, Mohammad Esmaeil; Khayamzadeh, Maryam, Shahid Beheshti Univ Med Sci, Canc Res Ctr, Tehran, Iran.
   Akinyemiju, Tomi, Duke Univ, Dept Populat Hlth Sci, Durham, NC USA.
   Akinyemiju, Tomi, Duke Univ, Duke Global Hlth Inst, Durham, NC USA.
   Al-Aly, Ziyad, Washington Univ, John T Milliken Dept Internal Med, St Louis, MO 63110 USA.
   Al-Aly, Ziyad, VA St Louis Hlth Care Syst, Clin Epidemiol Ctr, Dept Vet Affairs, St Louis, MO USA.
   AlAbdulKader, Assim M., Imam Abdulrahman Bin Faisal Univ, Dept Family \& Community Med, Dammam, Saudi Arabia.
   AlAbdulKader, Assim M., Case Western Reserve Univ, Dept Family Med \& Community Hlth, Cleveland, OH 44106 USA.
   Mayo Clin, Fdn Med Educ \& Res, Evidence Based Practice Res Ctr, Rochester, MN USA.
   Alamene, Genet Melak, Madda Walabu Univ, Sch Hlth Sci, Bale Goba, Ethiopia.
   Alemnew, Birhan Tamene T., Woldia Univ, Dept Hlth Sci, Woldia, Ethiopia.
   Alemnew, Birhan Tamene T., Addis Ababa Univ, Dept Microbiol Immunol \& Parasitol, Addis Ababa, Ethiopia.
   Alene, Kefyalew Addis; Bekele, Bayu Begashaw; Limenih, Miteku Andualem; Melaku, Yohannes A.; Melku, Mulugeta; Muche, Achenef Asmamaw; Tessema, Gizachew Assefa, Univ Gondar, Inst Publ Hlth, Gondar, Ethiopia.
   Alene, Kefyalew Addis, Australian Natl Univ, Res Sch Populat Hlth, Canberra, ACT, Australia.
   Alinia, Cyrus, Urmia Univ Med Sci, Dept Hlth Care Management \& Econ, Orumiyeh, Iran.
   Alipour, Vahid; Arabloo, Jalal; Behzadifar, Masoud, Iran Univ Med Sci, Hlth Management \& Econ Res Ctr, Tehran, Iran.
   Alipour, Vahid, Iran Univ Med Sci, Dept Hlth Econ, Tehran, Iran.
   Aljunid, Syed Mohamed, Kuwait Univ, Dept Hlth Policy \& Management, Safat, Kuwait.
   Aljunid, Syed Mohamed, Natl Univ Malaysia, Int Ctr Casemix \& Clin Coding, Bandar Tun Razak, Malaysia.
   Bakeshei, Fatemeh Allah, Behbahan Fac Med Sci, Dept Social Med, Behbahan, Iran.
   Almadi, Hamad, King Saud Univ, Dept Med, Riyadh, Saudi Arabia.
   Almadi, Hamad, McGill Univ, Dept Gastroenterol \& Hepatol, Montreal, PQ, Canada.
   Alsharif, Ubai, Knappschaftskrankenhaus Bochum, Univ Hosp, Dept Oral \& Maxillofacial Surg, Bochum, Germany.
   Alsowaidi, Shirina, United Arab Emirates Univ, Coll Med \& Hlth Sci, Al Ain, U Arab Emirates.
   Alvis-Guzman, Nelson, Univ Cartagena, Hlth Econ Res Grp, Cartagena, Colombia.
   Alvis-Guzman, Nelson, Univ Costa, Res Grp Hosp Management \& Hlth Policies, Barranquilla, Colombia.
   Amini, Erfan, Univ Tehran Med Sci, Dept Urol, Tehran, Iran.
   Amini, Saeed; Anbari, Zohreh, Arak Univ Med Sci, Dept Hlth Serv Management, Arak, Iran.
   Amoako, Yaw Ampem, Komfo Anokye Teaching Hosp, Dept Internal Med, Kumasi, Ghana.
   Anber, Nahla Hamed, Mansoura Univ, Mansoura, Egypt.
   Andrei, Catalina Liliana, Carol Davila Univ Med \& Pharm, Bucharest, Romania.
   Anjomshoa, Mina, Rafsanjan Univ Med Sci, Social Determinants Hlth Res Ctr, Rafsanjan, Iran.
   Ansari, Fereshteh, Tabriz Univ Med Sci, Hlth Management \& Safety Promot Res Inst, Res Ctr Evidence Based Med, Tabriz, Iran.
   Ansariadi, Ansariadi, Hasanuddin Univ, Sch Publ Hlth, Makassar, Indonesia.
   Appiah, Seth Christopher Yaw, Kwame Nkrumah Univ Sci \& Technol, Dept Sociol \& Social Work, Kumasi, Ghana.
   Appiah, Seth Christopher Yaw, Ludwig Maximilians Univ Munchen, Ctr Int Hlth, Munich, Germany.
   Arab-Zozani, Morteza, Tabriz Univ Med Sci, Dept Healthcare Management, Tabriz, Iran.
   Arefi, Zohreh, Univ Tehran Med Sci, Dept Hlth Educ \& Hlth Promot, Tehran, Iran.
   Aremu, Olatunde, Birmingham City Univ, Sch Hlth Sci, Birmingham, W Midlands, England.
   Areri, Habtamu Abera, Addis Ababa Univ, Sch Nursing \& Midwifery, Addis Ababa, Ethiopia.
   Al Artaman, Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada.
   Asayesh, Hamid, Qom Univ Med Sci, Qom, Iran.
   Asfaw, Ephrem Tsegay, Mekelle Univ, Inst Biomed Sci, Mekelle, Ethiopia.
   Ashagre, Alebachew Fasil; Biadgo, Belete, Univ Gondar, Dept Clin Chem, Gondar, Ethiopia.
   Mashhad Univ Med Sci, Educ Dev Ctr, Mashhad, Razavi Khorasan, Iran.
   Ataeinia, Bahar; Ebrahimi, Hedyeh; Farzadfar, Farshad; Irvani, Seyed Sina Naghibi; Mohebi, Farnam; Pishgar, Farhad, Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Tehran, Iran.
   Atalay, Hagos Tasew; Gebremeskel, Gebreamlak Gebremedhn; Weldesamuel, Girmay Teklay, Aksum Univ, Coll Nursing, Aksum, Ethiopia.
   Ataro, Zerihun; Weldegebreal, Fitsum, Haramaya Univ, Dept Med Lab Sci, Harar, Ethiopia.
   Avila-Burgos, Leticia; Ortega-Altamirano, Doris D. V., Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico.
   Awoke, Nefsu; Chichiabellu, Tesfaye Yitna; Demissie, Birhanu Wondimeneh; Hanfore, Lolemo Kelbiso; Lakew, Ayenew Molla, Wolaita Sodo Univ, Dept Nursing, Sodo, Ethiopia.
   Ayanore, Martin Amogre; Kugbey, Nuworza, Univ Hlth \& Allied Sci, Dept Family \& Community Hlth, Sch Publ Hlth, Ho, Ghana.
   Babaee, Ebrahim; Moradi-Lakeh, Maziar; Nojomi, Marzieh; Tehrani-Banihashemi, Arash, Iran Univ Med Sci, Prevent Med \& Publ Hlth Res Ctr, Tehran, Iran.
   Bacha, Umar, Univ Management \& Technol, Sch Hlth Sci, Lahore, Pakistan.
   Bagherzadeh, Mojtaba; Rabiee, Mohammad, Sharif Univ Technol, Dept Chem, Tehran, Iran.
   Bagli, Eleni, Univ Hosp Ioannina, Dept Ophthalmol, Ioannina, Greece.
   Balouchi, Abbas, Iran Univ Med Sci, Sch Nursing \& Allied Med, Tehran, Iran.
   Barnighausen, Till Winfried, Heidelberg Univ, Fac Med \& Univ Hosp, Heidelberg Inst Global Hlth, Heidelberg, Germany.
   Behzadifar, Meysam, Lorestan Univ Med Sci, Khorramabad, Iran.
   Bekele, Bayu Begashaw; Hassen, Hamid Yimam, Mizan Tepi Univ, Dept Publ Hlth, Teppi, Ethiopia.
   Belayneh, Yaschilal Muche; Geta, Birhanu, Wollo Univ, Dept Pharm, Dessie, Ethiopia.
   Berfield, Kathleen Kim Sachiko, Univ Washington, Div Cardiothorac Surg, Seattle, WA 98195 USA.
   Bernabe, Eduardo, Kings Coll London, Inst Dent, London, England.
   Beuran, Mircea; Negoi, Lonut, Carol Davila Univ Med \& Pharm, Emergency Hosp Bucharest, Bucharest, Romania.
   Bhakta, Nickhill, St Jude Childrens Res Hosp, Dept Global Pediat Med, 332 N Lauderdale St, Memphis, TN 38105 USA.
   Bhattacharyya, Krittika, Natl Inst Biomed Genom, Dept Biostat \& Bioinformat, Kalyani, W Bengal, India.
   Birungi, Charles, UCL, UCL Ctr Global Hlth Econ, London, England.
   Bleyer, Archie, Oregon Hlth \& Sci Univ, Dept Radiat Med, Portland, OR 97201 USA.
   Bleyer, Archie, Univ Texas Houston, Dept Pediat, Houston, TX USA.
   Brenner, Hermann; Schottker, Ben, German Canc Res Ctr, Div Clin Epidemiol \& Aging Res, Heidelberg, Germany.
   Brewer, Jerry D., Mayo Clin, Dept Dermatol, Rochester, MN USA.
   Bustamante-Teixeira, Maria Teresa, Univ Fed Juiz de Fora, Dept Publ Hlth, Juiz De Fora, Brazil.
   Carreras, Giulia, Inst Canc Res Prevent \& Clin Network, Florence, Italy.
   Carreras, Giulia, Karolinska Inst, Dept Med Epidemiol \& Biostat, Stockholm, Sweden.
   Castro, Franz, Gorgas Mem Inst Hlth Studies, Dept Res \& Hlth Technol Assessment, Panama City, Panama.
   Catala-Lopez, Ferran, Carlos III Hlth Inst, Natl Sch Publ Hlth, Madrid, Spain.
   Cerin, Ester, Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Melbourne, Vic, Australia.
   Cerin, Ester, Univ Hong Kong, Sch Publ Hlth, Hong Kong, Peoples R China.
   Chauhan, Neelima Singh, Peoples Coll Med Sci \& Res Ctr, Dept Obstet \& Gynecol, Bhopal, India.
   Chehrazi, Mohammad, Royan Inst, Epidemiol Res Ctr, Tehran, Iran.
   Chimed-Ochir, Odgerel, Univ Occupat \& Environm Hlth, Inst Ind Ecol Sci, Kitakyushu, Fukuoka, Japan.
   Choi, Jee-Young J., Seoul Natl Univ Hosp, Dept Biochem \& Biomed Sci, Seoul, South Korea.
   Constantin, Maria -Magdalena, Carol Davila Univ Med \& Pharm, Dept Dermatol, Clin Dermatol 2, Bucharest, Romania.
   Darwish, Amira Hamed, Tanta Univ, Fac Med, Dept Pediat, Tanta, Egypt.
   das Neves, Jose, Univ Porto, Inst Biomed Engn INEB, Porto, Portugal.
   Demeke, Feleke Mekonnen, Bahir Dar Univ, Coll Med \& Hlth Sci, Dept Med Lab Sci, Bahir Dar, Ethiopia.
   Demis, Asmamaw Bizuneh; Kassaw, Mesfin Wudu; Tlaye, Kenean Getaneh, Woldia Univ, Dept Nursing, Woldia, Ethiopia.
   Denova-Gutierrez, Edgar, Natl Inst Publ Hlth, Ctr Nutr \& Hlth Res, Cuernavaca, Morelos, Mexico.
   Deribe, Kalkidan Solomon; Getachew, Sefonias, Addis Ababa Univ, Dept Prevent Med, Addis Ababa, Ethiopia.
   Desta, Melaku; Diaz, Daniel, Autonomous Univ Sinaloa, Fac Vet Med \& Zootech, Culiacan Rosales, Mexico.
   Dhimal, Meghnath, Nepal Hlth Res Council, Hlth Res Sect, Kathmandu, Nepal.
   Diaz, Daniel, Univ Nacl Autonoma Mexico, Ctr Complex Sci, Mexico City, DF, Mexico.
   Dubey, Manisha, United Nations World Food Programme, New Delhi, India.
   Dubljanin, Eleonora; Vujcic, Isidora S., Univ Belgrade, Fac Med, Belgrade, Serbia.
   Ebrahimi, Hedyeh, Univ Tehran Med Sci, Liver \& Pancreaticobiliary Dis Res Ctr, Tehran, Iran.
   Effiong, Andem, Univ Newcastle, Dept Clin Epidemiol \& Biostat, Newcastle, NSW, Australia.
   Elkout, Hajer, Tripoli Univ, Dept Community Med, Tripoli, Libya.
   Ellenbogen, Richard G., Seattle Childrens Hosp, Dept Surg, Seattle, WA USA.
   Emamian, Mohammad Hassan, Shahroud Univ Med Sci, Ophthalm Epidemiol Res Ctr, Shahroud, Iran.
   Eshrati, Babak, Minist Hlth \& Med Educ, Ctr Communicable Dis Control, Tehran, Iran.
   Faramarzi, Mahbobeh, Babol Univ Med Sci, Babol Sar, Iran.
   Farioli, Andrea; Violante, Francesco S., Univ Bologna, Dept Med \& Surg Sci, Bologna, Italy.
   Fentahun, Netsanet, Bahir Dar Univ, Dept Publ Hlth Nutr, Bahir Dar, Ethiopia.
   Filip, Irina, Kaiser Permanente, Dept Psychiat, Fontana, CA USA.
   Fisher, James L., Ohio State Univ, James Canc Hosp, Columbus, OH 43210 USA.
   Freitas, Marisa, Univ Porto, Fac Pharm, Dept Chem Sci, Porto, Portugal.
   Fukumoto, Takeshi, Inst Canc Res, Gene Express \& Regulat Program, Philadelphia, PA USA.
   Fukumoto, Takeshi, Kobe Univ, Dept Dermatol, Kobe, Hyogo, Japan.
   Gallus, Silvano, Mario Negri Inst Pharmacol Res, Dept Environm Hlth Sci, Milan, Italy.
   Gayesa, Reta Tsegaye, Wollega Univ, Dept Nursing, Nekemte, Ethiopia.
   Gedefaw, Getnet Azeze, Bahir Dar Univ, Bahir Dar, Ethiopia.
   Gezae, Kebede Ernbaye, Mekelle Univ, Dept Biostat, Mekelle, Ethiopia.
   Ghajar, Alireza, Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.
   Gholamian, Asadollah, Islamic Azad Univ, Dept Med, Rasht, Iran.
   Ginindza, Themba T. G.; Kuupiel, Desmond; Mashamba-Thompson, Tivani Phosa; Moodley, Yoshan, Univ KwaZulu Natal, Dept Publ Hlth Med, Durban, South Africa.
   Gomez, Ricardo Santiago, Univ Fed Minas Gerais, Dept Surg, Belo Horizonte, MG, Brazil.
   Gorini, Giuseppe, Canc Prevent \& Res Inst, Occupat \& Environm Epidemiol Sect, Florence, Italy.
   Gupta, Prakash C., Healis Sekhsaria Inst Publ Hlth, Dept Epidemiol, Mumbai, Maharashtra, India.
   Haj-Mirzaian, Arvin; Haj-Mirzaian, Arya, Univ Tehran Med Sci, Dept Pharmacol, Tehran, Iran.
   Hamadeh, Randall R., Arabian Gulf Univ, Dept Family \& Community Med, Manama, Bahrain.
   Hamidi, Samer, Hamdan Bin Mohammed Smart Univ, Sch Hlth \& Environm Studies, Dubai, U Arab Emirates.
   Hasanzadeh, Amir, Maragheh Univ Med Sci, Dept Microbiol, Maragheh, Iran.
   Hay, Roderick J., Int Fdn Dermatol, London, England.
   Henok, Andualem, Mizan Tepi Univ, Teppi, Ethiopia.
   Hoang, Chi Linh; Giang Thu Vu, Nguyen Tat Thanh Univ, Ctr Excellence Behav Med, Ho Chi Minh City, Vietnam.
   Hosgood, H. Dean, Albert Einstein Coll Med, Dept Epidemiol \& Populat Hlth, Bronx, NY 10467 USA.
   Hostiuc, Mihaela, Carol Davila Univ Med \& Pharm, Dept Gen Surg, Bucharest, Romania.
   Househ, Mowafa, Hamad Bin Khalifa Univ, Coll Sci \& Engn, Div Informat \& Comp Technol, Doha, Qatar.
   Qatar Fdn, Doha, Qatar.
   Ilic, Milena D., Univ Kragujevac, Dept Epidemiol, Fac Med Sci, Kragujevac, Serbia.
   Usmanu Danfodiyo Univ, Teaching Hosp, Dept Surg, Sokoto, Nigeria.
   Islami, Farhad, Amer Canc Soc, Surveillance \& Hlth Serv Res, Atlanta, GA 30329 USA.
   Jahangiry, Leila, Tabriz Univ Med Sci, Hlth Educ \& Hlth Promot Dept, Tabriz, Iran.
   Jahani, Mohammad Ali, Babol Univ Med Sci, Fac Med, Babol Sar, Iran.
   Jahanmehr, Nader, Shahid Beheshti Univ Med Sci, Sch Publ Hlth, Tehran, Iran.
   Jayaraman, Sudha, Virginia Commonwealth Univ, Dept Surg, Richmond, VA 23284 USA.
   Kissimova-Skarbek, Katarzyna, Jagiellonian Univ, Med Coll, Dept Hlth Econ \& Social Secur, Krakow, Poland.
   Jenabi, Ensiyeh, Hamadan Univ Med Sci, Fac Nursing \& Midwifery, Hamadan, Iran.
   Jonnagaddala, Jitendra, NSW Hlth, Sydney, NSW, Australia.
   Joo, Tamas, Semmelweis Univ, Hlth Serv Management Training Ctr, Budapest, Hungary.
   Jungari, Suresh Banayya, Savitribai Phule Pune Univ, Sch Hlth Sci, Pune, Maharashtra, India.
   Jurisson, Mikk, Univ Tartu, Inst Family Med \& Publ Hlth, Tartu, Estonia.
   Nosratnejad, Shirin, Tabriz Univ Med Sci, Dept Hlth Econ, Tabriz, Iran.
   Shiadeh, Malihe Nourollahpour, Mazandaran Univ Med Sci, Sari, Iran.
   Olagunju, Andrew T., Univ Lagos, Dept Psychiat, Lagos, Nigeria.
   Omonisi, Abidemi E., Ekiti State Univ, Dept Anat Pathol, Ado Ekiti, Nigeria.
   Onwujekwe, Obinna E., Univ Nigeria, Dept Pharmacol \& Therapeut, Nsukka, Nigeria.
   Otstavnov, Stanislav S., Moscow Inst Phys \& Technol, Analyt Ctr, Dolgoprudnyi, Russia.
   Jagadguru Sri Shivarathreeswara Univ, Dept TB \& Resp Med, Mysore, Karnataka, India.
   Pakpour, Amir H., Qazvin Univ Med Sci, Dept Publ Hlth, Qazvin, Iran.
   Pashaei, Tahereh, Kurdistan Univ Med Sci, Res Inst Hlth Dev, Environm Hlth Res Ctr, Sanandaj, Iran.
   Pillay, Julian David, Durban Univ Technol, Basic Med Sci Dept, Durban, South Africa.
   Pirestani, Majid, Tarbiat Modares Univ, Fac Med Sci, Dept Parasitol \& Entomol, Tehran, Iran.
   Pishgar, Farhad, Univ Tehran Med Sci, Urooncol Res Ctr, Tehran, Iran.
   Postma, Maarten J., Univ Groningen, Fac Econ \& Business, Groningen, Netherlands.
   Rafiei, Alireza, Mazandaran Univ Med Sci, Dept Immunol, Sari, Iran.
   Rahman, Muhammad Aziz, La Trobe Univ, Austin Hlth Clin Sch Nursing, Heidelberg, Vic, Australia.
   Rajati, Fatemeh, Kermanshah Univ Med Sci, Dept Hlth Educ \& Promot, Kermanshah, Iran.
   Rana, Saleem M., Contech Sch Publ Hlth, Dept Publ Hlth, Lahore, Pakistan.
   Rezaei, Nima, Universal Sci Educ \& Res Network, Network Immun Infect Malignancy \& Autoimmun, Tehran, Iran.
   Ribeiro, Daniela, Univ Porto, Fac Pharm, Dept Appl Chem, Porto, Portugal.
   Rostami, Ali; Sabbagh, Parisa, Babol Univ Med Sci, Infect Dis \& Trop Med Res Ctr, Babol Sar, Iran.
   Sahebkar, Amirhossein, Mashhad Univ Med Sci, Biotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran.
   Salem, Hosni, Cairo Univ, Dept Urol, Cairo, Egypt.
   Salomon, Joshua A., Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA.
   Salomon, Joshua A., Stanford Univ, Ctr Primary Care \& Outcomes Res, Stanford, CA 94305 USA.
   Milicevic, Milena M. Santric, Univ Belgrade, Sch Publ Hlth \& Hlth Management, Belgrade, Serbia.
   Sarveazad, Arash, Iran Univ Med Sci, Colorectal Res Ctr, Tehran, Iran.
   Sathian, Brijesh, Hamad Med Corp, Dept Surg, Doha, Qatar.
   Satpathy, Maheswar, Utkal Univ, UGC Ctr Adv Study Psychol, Bhubaneswar, India.
   Savic, Miloje, GSK Biol, Wavre, Belgium.
   Sawhney, Monika, Univ N Carolina, Dept Publ Hlth Sci, Charlotte, NC USA.
   Sekerija, Mario, Univ Zagreb, Dept Med Stat Epidemiol \& Med Informat, Zagreb, Croatia.
   Seyedmousavi, Seyedmojtaba, Mazandaran Univ Med Sci, Invas Fungi Res Ctr, Sari, Iran.
   Shamshirian, Amir, Mazandaran Univ Med Sci, Dept Med Lab Sci, Sari, Iran.
   Sharifi, Ali, Islamic Azad Univ, Dept Basic Sci, Sari, Iran.
   Sharma, Rajesh, Delhi Technol Univ, Univ Sch Management \& Entrepreneurship, New Delhi, India.
   Sheikh, Aziz, Univ Edinburgh, Usher Inst Populat Hlth Sci \& Informat, Edinburgh, Midlothian, Scotland.
   Shirkoohi, Reza, Univ Tehran Med Sci, Canc Biol Res Ctr, Tehran, Iran.
   Shukla, Sharvari Rahul, Symbiosis Int Univ, Symbiosis Inst Hlth Sci, Pune, Maharashtra, India.
   Silva, Diego Augusto Santos, Univ Fed Santa Catarina, Sch Hlth Sci, Florianopolis, SC, Brazil.
   Singh, Ambrish, Eli Lilly \& Co, Global Patient Outcome \& Real World Evidence, Indianapolis, IN 46285 USA.
   Sitas, Freddy, Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia.
   Tarawneh, Mohammed Rasoul, Jordan Univ Sci \& Technol, Ramtha, Jordan.
   Temsah, Mohamad-Hani, King Saud Univ, Dept Pediat, Riyadh, Saudi Arabia.
   Teshale, Manaye Yihune, Arba Minch Univ, Dept Publ Hlth, Arba Minch, Ethiopia.
   Tessema, Gizachew Assefa, Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia.
   Thapa, Subash, Univ Southern Denmark, Dept Publ Hlth, Odense, Denmark.
   Topor-Madry, Roman, Jagiellonian Univ, Med Coll, Fac Hlth Sci, Krakow, Poland.
   Yadegar, Abbas, Shahid Beheshti Univ Med Sci, Foodborne \& Waterborne Dis Res Ctr, Tehran, Iran.
   Yadollahpour, Ali, Ahvaz Jundishapur Univ Med Sci, Dept Med Phys, Ahvaz, Iran.
   Yazdi-Feyzabadi, Vahid, Kerman Univ Med Sci, Dept Hlth Management Policy \& Econ, Kerman, Iran.
   Yazdi-Feyzabadi, Vahid, Kerman Univ Med Sci, Hlth Serv Management Res Ctr, Kerman, Iran.
   Kissimova-Skarbek, Katarzyna, Jagiellonian Univ Med Coll, Dept Hlth Econ \& Social Secur, Krakow, Poland.},
DOI = {10.1001/jamaoncol.2019.2996},
ISSN = {2374-2437},
EISSN = {2374-2445},
Keywords-Plus = {SEX-SPECIFIC MORTALITY; 195 COUNTRIES; TERRITORIES},
Research-Areas = {Oncology},
Web-of-Science-Categories  = {Oncology},
Author-Email = {cfll@uw.edu},
ResearcherID-Numbers = {Gedefaw, Getnet/AAM-3344-2020
   Kefale, Belayneh/AAK-7367-2020
   Nourollahpour Shiadeh, Malihe/AAY-8656-2021
   Ullah, Irfan/L-5150-2017
   Singh, Ambrish/W-2163-2017
   Alahdab, Fares/N-6680-2013
   Ortega-Altamirano, Doris V./ABA-8549-2020
   shirkoohi, reza/AAD-8261-2020
   Silva, Diego Augusto Santos/AAB-9249-2020
   Otstavnov, Stanislav S/T-9893-2018
   Lad, Deepesh/AAD-4095-2019
   Bärnighausen, Till/Y-2388-2019
   Mohammed, Shafiu/AAR-7889-2020
   Sekerija, Mario/W-8550-2019
   Carvalho, Félix/D-4914-2013
   Waheed, Yasir/AAC-3896-2019
   Derakhshani, Afshin/P-9085-2019
   Aghaali, Mohammad/M-2225-2015
   Monasta, Lorenzo/B-1388-2012
   Kuupiel, Desmond/V-8883-2019
   Muhammed, Oumer sada/AFK-7728-2022
   Ahmadi, Ayat/G-4602-2011
   Ziapour, Arash/AAJ-9043-2020
   Nagel, Gabriele/C-3635-2012
   Awasthi, Ashish/Y-5915-2019
   Bacha, Umar/M-2055-2015
   Yazdi-Feyzabadi, Vahid/H-9647-2017
   KIM, YUN JIN/AAE-8281-2019
   Topor-Madry, Roman/ABF-5449-2020
   Alsharif, Ubai/AAK-2088-2021
   Constantin, Maria Magdalena/B-8234-2018
   Abu-Raddad, Laith J/AAY-1441-2020
   Khan, Gulfaraz/AAC-2859-2022
   Catalá-López, Ferrán/N-6018-2018
   Takahashi, Ken/AAX-7705-2020
   Alene, Dr Kefyalew Addis/V-8240-2018
   Chehrazi, Mohammad/AAF-5640-2021
   Avila-Burgos, Leticia/AAR-1815-2021
   Alemu, Hailemariam Abiy/AAI-9315-2020
   Mihretie, Kebadnew Mulatu/AAB-6838-2021
   Dahlawi, Saad/P-4054-2016
   Pourmalek, Farshad/A-8188-2010
   Moradi-Lakeh, Maziar/ABC-9793-2021
   Alipour, Vahid/K-5099-2019
   Foroutan, Masoud/AAD-6837-2020
   Mantovani, Lorenzo Giovanni/AAC-4263-2021
   AlAbdulKader, Assim/AAM-5788-2020
   Shukla, Sharvari/AAK-3469-2020
   Diaz, Daniel/P-1916-2018
   Freitas, Marisa/AAY-7427-2020
   Atique, Suleman/ABA-4998-2020
   Force, Lisa M./AAP-7874-2021
   Oluwasanu, Mojisola/AAH-8946-2021
   Renzaho, Andre M.N./AAH-7679-2021
   Ahmadpour, Ehsan/K-2514-2017
   Institute, Symbiosis Statistical/AAA-3483-2019
   Brenner, Hermann/ABE-6383-2020
   Awoke, Nefsu/AFV-2432-2022
   Lopez, Alan/AAA-2734-2022
   Naldi, Luigi/K-6343-2016
   Rahimi/J-6064-2019
   Atalay, Hagos Tasew/O-2286-2016
   Sathian, Brijesh/G-7576-2014
   Ayele, Henok Tadesse/AAA-5856-2019
   Irvani, Seyed Sina Naghibi/O-2413-2018
   Gorini, Giuseppe/O-9560-2017
   vidale, simone/AAJ-4466-2020
   Siraj, Ammas/ABF-4925-2020
   Joó, Tamás/AAC-3026-2021
   Haj-Mirzaian, Arvin/W-6013-2019
   Hasankhani, M/AAA-2573-2019
   Jungari, Suresh/AAG-9393-2019
   Niguse, Haftom/AAF-8975-2020
   Singh, Jasvinder/R-6172-2019
   moosazadeh, mahmood/F-3730-2017
   Mousavi, Seyyed Meysam/P-7797-2015
   Haro, Josep Maria/D-1423-2011
   Roshandel, Gholamreza/AAJ-9562-2021
   Lauriola, Paolo/AAF-1998-2020
   kumar, vivek/I-4643-2019
   Al-Aly, Ziyad/S-4439-2016
   Hasanzadeh, Amir/AAI-8266-2020
   Yeshaneh, Alex/AAD-1562-2021
   Prakash, Swayam/ABB-6036-2020
   Mirzaei, Hamed/X-2374-2018
   Chu, Dinh Toi/I-7414-2019
   GININDZA, THEMBA G/N-5762-2013
   Bernabe, Eduardo/R-3441-2017
   Costa, Vera Marisa/D-6284-2013
   Rajati, Fatemeh/S-1041-2017
   babaee, Ebrahim/O-4416-2019
   Mohammadpourhodki, Reza/P-5260-2018
   Khoja, Abdullah/AAD-8780-2020
   Massenburg, Benjamin B./AAB-9349-2019
   mansourian, morteza/H-7536-2018
   Schöttker, Ben/F-8183-2014
   Hoogar, Praveen/C-4050-2017
   Kugbey, Nuworza/H-9264-2019
   Padubidri, Jagadish Rao/Q-2523-2017
   Meles, Gebrekiros Gebremichael/AAX-8170-2020
   Dereje, Nebiyu/AAF-7817-2019
   Kisa, Adnan/AAA-6824-2021
   Nahvijou, Azin/AAL-4117-2020
   Chattu, Vijay Kumar/C-2778-2014
   Shamsizadeh, Morteza/C-6000-2014
   yadollahpour, Ali/K-9098-2015
   Ribeiro, Ana Isabel/AAH-8373-2019
   Bizuneh, Asmamaw Demis/ABA-1868-2021
   Bekele, Bayu Begashaw/R-9348-2017
   Endries, Aman Yesuf/AAN-6871-2021
   Samy, Abdallah/B-4375-2010
   Guimarães, André Luiz Sena/D-8122-2011
   Cerin, Ester/L-1271-2015
   Koyanagi, Ai/D-3833-2018
   Borzì, Antonio Maria/X-8685-2018
   sharafi, zeinab/Q-1147-2019
   Tessema, Gizachew/J-9235-2018
   Bhakta, Nickhill/N-8142-2018
   Jafarinia, Morteza/W-7706-2019
   Khader, Yousef/AAE-9620-2019
   Moradi, Ghobad/R-1267-2016
   Zaki, Maysaa El Sayed/C-1522-2013
   Hay, Simon I/F-8967-2015
   Jenabi, Ensiyeh/S-6919-2017
   Kasaeian, Amir/C-8290-2017
   Abdelalim, Ahmed/A-6051-2015
   Darwish, Amira Hamed/Z-4625-2019
   Hassen, Hamid Y./K-6445-2019
   Dhimal, Meghnath/AAD-7261-2021
   Alemnew, Birhan/AAF-4865-2020
   Weldegebreal, Fitsum/AAU-4318-2021
   Demoz, Gebre Teklemariam/K-6986-2019
   Khubchandani, Jagdish/D-1831-2014
   Ahmed, Muktar/AAY-6783-2020
   Herteliu, Claudiu/K-4643-2014
   Appiah, Seth Christopher Yaw/J-8050-2019
   Temsah, Mohamad-Hani/AAJ-9703-2020
   Freitas, Marisa/D-4969-2013
   Gebremeskel, GEBREAMLAK/ABB-8484-2020
   Rahman, Muhammad Aziz/B-3380-2009
   Ausloos, Marcel/AAC-8812-2020
   Mokdad, Ali H./AAD-1232-2022
   Nikniaz, Leila/M-5747-2017
   Fadhil, Ibtihal/AAF-4123-2021
   Alemu, Belete Kassa/AAI-4829-2020
   Lopukhov, Platon D./S-8582-2017
   Berhanu, Beruk/AAN-3957-2020
   Daryani, Ahmad/E-2186-2017
   Nazari, Javad/ABE-6348-2021
   Hadkhale, Kishor/AAE-8390-2020
   Obsa, Mohammed/AAD-9390-2022
   Arabloo, Jalal/K-1829-2019
   Jakovljevic, Mihajlo B/B-3002-2014
   Pakpour, Amir H./C-6160-2014
   Mohebi, Farnam/AGB-7159-2022
   Lazarus, Jeffrey V./R-6248-2018
   Almasi-Hashiani, Amir/P-3356-2018
   Butt, Zahid Ahmad/W-4292-2017
   Chehrazi, Mohammad/AAF-5545-2021
   Fisher, James L./N-3935-2019
   Meles, Hagazi Gebre/AAM-5772-2020
   Radfar, Amir/I-8057-2019
   Tlaye, Kenean/Y-1960-2019
   El-Jaafary, Shaimaa/ABI-5451-2020
   Zangeneh, Alireza/AAF-2374-2021
   Pereira, David M./M-9286-2013
   Bin Sayeed, Muhammad Shahdaat Shahdaat/M-7055-2014
   Anber, Nahla/AAM-9830-2021
   Dubljanin, Eleonora/AAW-6278-2020
   Zamani, Mohammad/A-7733-2016
   Kasahun, Gebremicheal Gebreslassie/AAI-9900-2020
   Almadi, Majid A/K-7819-2017
   Jha, Ravi Prakash/ABC-6588-2020
   Ahmadian, Elham/P-8048-2017
   Nnaji, Chukwudi A/C-4019-2018
   Palone, Marcos Roberto Tovani/J-6491-2014
   Lopez, Alan D/F-1487-2010
   Bijani, Ali/B-1718-2017
   Pashaei, Tahereh/Q-1873-2016
   Brenner, Hermann/B-4627-2017
   Hostiuc, Sorin/I-2017-2019
   Gallus, Silvano/AAB-4127-2019
   Meier, Toni/AAB-1704-2021
   Listl, Stefan/S-7600-2017
   Violante, Francesco S/A-6934-2009
   Merat, Shahin/A-5478-2009
   Aljunid, Syed/J-6009-2014
   Mirzaei, Hamid Reza/I-4673-2019
   Jürisson, Mikk/M-1360-2017
   T., Olagunju Andrew/B-4746-2017
   Feyissa, Garumma/AAP-9097-2020
   Ningrum, Dina Nur Anggraini/ABA-1698-2020
   Balakrishnan, Senthilkumar/J-6908-2014
   Desai, Rupak/K-9846-2019
   Onwujekwe, Obinna/O-6232-2014
   Salimzadeh, Hamideh/AAL-6666-2020
   Mehrotra, Ravi/E-3285-2010
   Ebrahimi, Hedyeh/AAR-2899-2021
   Bagherzadeh, Mojtaba/ABC-2351-2020
   Rabiee, Navid/K-4407-2019
   Yisma, Engida/ABA-4170-2020
   Neupane, Subas/X-7446-2019
   Melese, Addisu/S-3175-2017
   Menezes, Ritesh G/A-7480-2015
   FRACP, Tissa Wijeratne MD PhD/I-2086-2019
   Jahangiry, Leila/F-9880-2017
   Manafi, Navid/AAM-7393-2020
   Kelbore, Abraham Getachew/ABG-6835-2021
   KISA, ADNAN/Q-2081-2019
   Badawi, Alaa/ABC-1300-2021
   Naderi, Mehdi/R-4325-2017
   Alvis-Guzman, Nelson/D-4913-2013
   Oh, In Hwan/AAI-9070-2020
   Sahebkar, Amirhossein/B-5124-2018
   Gomez, Ricardo Santiago/G-1976-2012
   Getachew, Sefonias/AAN-2237-2020
   Bhattacharyya, Krittika/AAA-8258-2021
   Veisani, Yousef/I-7684-2017
   Henry, Nathaniel/ABD-4631-2020
   Abbastabar, Hedayat/AAC-2595-2019
   Briko, Andrey/AAB-9340-2021
   Mohammed, Shafiu/P-2016-2014
   Zaki, Maysaa El Sayed/H-3049-2019
   Salomon, Joshua/D-3898-2009
   Kucuk Bicer, Burcu/G-4922-2017
   Fernandes, Eduarda/D-4943-2013
   Mosapour, Abbas/Q-5418-2016
   Madadin, Mohammed/F-5174-2015
   Karch, Andre/D-6973-2017
   Morawska, Lidia/B-4140-2011
   Yaseri, Mehdi/I-1645-2018
   Tran, Khanh Bao/V-4371-2018
   Shamshirian, Amir/K-4975-2017
   Soofi, Moslem/E-7665-2019
   Zandian, Hamed/J-9351-2017
   Abbastabar, Hedayat/D-8779-2017
   Miazgowski, Tomasz/H-9448-2014
   Grada, Ayman/N-3691-2013
   Soriano, Joan B/O-1215-2017
   teklay, girmay/O-9966-2018
   El-Khatib, Ziad/B-5161-2017
   Khosravi, Mohammad Hossein/G-3767-2015
   Pirestani, Majid/C-5414-2017
   Nabhan, Ashraf/A-1718-2008
   Lunevicius, Raimundas/B-2528-2018},
ORCID-Numbers = {Gedefaw, Getnet/0000-0003-4906-2555
   Nourollahpour Shiadeh, Malihe/0000-0002-2303-3054
   Singh, Ambrish/0000-0002-4618-7507
   Alahdab, Fares/0000-0001-5481-696X
   Silva, Diego Augusto Santos/0000-0002-0489-7906
   Otstavnov, Stanislav S/0000-0003-2043-495X
   Lad, Deepesh/0000-0003-3754-7774
   Mohammed, Shafiu/0000-0001-5715-966X
   Sekerija, Mario/0000-0001-7508-1501
   Carvalho, Félix/0000-0003-3858-3494
   Waheed, Yasir/0000-0002-5789-4215
   Derakhshani, Afshin/0000-0002-3243-233X
   Aghaali, Mohammad/0000-0003-3417-1580
   Monasta, Lorenzo/0000-0001-7774-548X
   Kuupiel, Desmond/0000-0001-7780-1955
   Ahmadi, Ayat/0000-0002-8018-9784
   Ziapour, Arash/0000-0001-8687-7484
   Nagel, Gabriele/0000-0001-6185-8535
   Awasthi, Ashish/0000-0002-9308-9782
   Bacha, Umar/0000-0002-4156-1125
   Yazdi-Feyzabadi, Vahid/0000-0002-8009-470X
   KIM, YUN JIN/0000-0001-8853-6587
   Alsharif, Ubai/0000-0002-4024-3950
   Constantin, Maria Magdalena/0000-0001-9914-3236
   Abu-Raddad, Laith J/0000-0003-0790-0506
   Khan, Gulfaraz/0000-0001-6836-1783
   Catalá-López, Ferrán/0000-0002-3833-9312
   Takahashi, Ken/0000-0002-7310-2257
   Alene, Dr Kefyalew Addis/0000-0002-1904-4682
   Alemu, Hailemariam Abiy/0000-0002-2985-0805
   Dahlawi, Saad/0000-0001-6178-9306
   Pourmalek, Farshad/0000-0002-2134-0771
   Moradi-Lakeh, Maziar/0000-0001-7381-5305
   Alipour, Vahid/0000-0003-1010-9571
   Foroutan, Masoud/0000-0002-8661-7217
   AlAbdulKader, Assim/0000-0002-9842-894X
   Shukla, Sharvari/0000-0002-7029-5532
   Diaz, Daniel/0000-0003-2302-1982
   Freitas, Marisa/0000-0001-9114-9967
   Atique, Suleman/0000-0002-5149-0703
   Force, Lisa M./0000-0003-3014-9204
   Ahmadpour, Ehsan/0000-0003-1202-6147
   Brenner, Hermann/0000-0002-6129-1572
   Awoke, Nefsu/0000-0002-1037-5004
   Naldi, Luigi/0000-0002-3160-2835
   Rahimi/0000-0002-3589-6463
   Atalay, Hagos Tasew/0000-0002-0886-815X
   Sathian, Brijesh/0000-0003-0851-4762
   Ayele, Henok Tadesse/0000-0002-6117-0578
   Irvani, Seyed Sina Naghibi/0000-0002-4566-7402
   Gorini, Giuseppe/0000-0002-1413-5948
   Joó, Tamás/0000-0002-3551-6125
   Haj-Mirzaian, Arvin/0000-0001-8977-6865
   Jungari, Suresh/0000-0003-4223-2603
   Singh, Jasvinder/0000-0003-3485-0006
   moosazadeh, mahmood/0000-0002-5452-514X
   Mousavi, Seyyed Meysam/0000-0002-6795-7224
   Haro, Josep Maria/0000-0002-3984-277X
   Roshandel, Gholamreza/0000-0002-5494-0722
   Lauriola, Paolo/0000-0003-4768-6612
   kumar, vivek/0000-0003-4379-5651
   Al-Aly, Ziyad/0000-0002-2600-0434
   Hasanzadeh, Amir/0000-0003-2893-4369
   Yeshaneh, Alex/0000-0001-5876-7325
   Mirzaei, Hamed/0000-0002-9399-8281
   Chu, Dinh Toi/0000-0002-4596-2022
   Bernabe, Eduardo/0000-0002-1858-3713
   Costa, Vera Marisa/0000-0002-0471-2756
   Rajati, Fatemeh/0000-0001-6426-664X
   Mohammadpourhodki, Reza/0000-0001-5677-0133
   Khoja, Abdullah/0000-0003-1844-3742
   Massenburg, Benjamin B./0000-0002-8570-5178
   Schöttker, Ben/0000-0002-1217-4521
   Hoogar, Praveen/0000-0003-2170-5643
   Kugbey, Nuworza/0000-0002-0413-0350
   Padubidri, Jagadish Rao/0000-0002-8671-7664
   Meles, Gebrekiros Gebremichael/0000-0001-6563-0001
   Kisa, Adnan/0000-0001-7825-3436
   Nahvijou, Azin/0000-0003-1973-7638
   Chattu, Vijay Kumar/0000-0001-9840-8335
   Shamsizadeh, Morteza/0000-0002-8153-5482
   yadollahpour, Ali/0000-0002-1216-2109
   Ribeiro, Ana Isabel/0000-0001-8880-6962
   Bekele, Bayu Begashaw/0000-0001-8590-4874
   Samy, Abdallah/0000-0003-3978-1134
   Guimarães, André Luiz Sena/0000-0002-3162-3206
   Cerin, Ester/0000-0002-7599-165X
   Koyanagi, Ai/0000-0002-9565-5004
   Borzì, Antonio Maria/0000-0001-6984-308X
   Tessema, Gizachew/0000-0002-4784-8151
   Bhakta, Nickhill/0000-0001-5282-7833
   Jafarinia, Morteza/0000-0002-3272-448X
   Khader, Yousef/0000-0002-7830-6857
   Moradi, Ghobad/0000-0003-2612-6528
   Zaki, Maysaa El Sayed/0000-0001-5431-0248
   Hay, Simon I/0000-0002-0611-7272
   Jenabi, Ensiyeh/0000-0002-4536-0814
   Kasaeian, Amir/0000-0003-2018-9368
   Abdelalim, Ahmed/0000-0001-6445-5539
   Darwish, Amira Hamed/0000-0003-1269-9712
   Hassen, Hamid Y./0000-0001-6485-4193
   Dhimal, Meghnath/0000-0001-7176-7821
   Weldegebreal, Fitsum/0000-0002-7867-1483
   Demoz, Gebre Teklemariam/0000-0002-2534-821X
   Khubchandani, Jagdish/0000-0002-9058-4278
   Ahmed, Muktar/0000-0002-9524-7027
   Herteliu, Claudiu/0000-0001-8860-9547
   Appiah, Seth Christopher Yaw/0000-0002-9844-1036
   Freitas, Marisa/0000-0001-9114-9967
   Rahman, Muhammad Aziz/0000-0003-1665-7966
   Ausloos, Marcel/0000-0001-9973-0019
   Mokdad, Ali H./0000-0002-4994-3339
   Nikniaz, Leila/0000-0003-2951-936X
   Lopukhov, Platon D./0000-0002-0872-2214
   Daryani, Ahmad/0000-0001-8571-5803
   Arabloo, Jalal/0000-0003-1223-4528
   Jakovljevic, Mihajlo B/0000-0002-9160-6846
   Pakpour, Amir H./0000-0002-8798-5345
   Lazarus, Jeffrey V./0000-0001-9618-2299
   Almasi-Hashiani, Amir/0000-0003-4434-561X
   Butt, Zahid Ahmad/0000-0002-2486-4781
   Chehrazi, Mohammad/0000-0003-1770-4170
   Fisher, James L./0000-0003-3211-2691
   Meles, Hagazi Gebre/0000-0001-5773-4011
   Radfar, Amir/0000-0001-6177-3048
   Tlaye, Kenean/0000-0001-8464-4345
   El-Jaafary, Shaimaa/0000-0003-0229-4420
   Zangeneh, Alireza/0000-0001-9692-9655
   Pereira, David M./0000-0003-0384-7592
   Bin Sayeed, Muhammad Shahdaat Shahdaat/0000-0003-0027-9614
   Anber, Nahla/0000-0001-5684-9298
   Zamani, Mohammad/0000-0003-1916-3873
   Kasahun, Gebremicheal Gebreslassie/0000-0002-8981-1832
   Almadi, Majid A/0000-0001-9917-2758
   Jha, Ravi Prakash/0000-0001-5230-1436
   Ahmadian, Elham/0000-0002-7230-0489
   Palone, Marcos Roberto Tovani/0000-0003-1149-2437
   Lopez, Alan D/0000-0001-5818-6512
   Bijani, Ali/0000-0003-2233-8726
   Brenner, Hermann/0000-0002-6129-1572
   Hostiuc, Sorin/0000-0003-4130-9402
   Gallus, Silvano/0000-0002-8967-0400
   Meier, Toni/0000-0001-6056-0665
   Listl, Stefan/0000-0002-8176-3397
   Violante, Francesco S/0000-0003-4084-2782
   Aljunid, Syed/0000-0002-0380-1335
   Mirzaei, Hamid Reza/0000-0002-3303-2565
   Jürisson, Mikk/0000-0002-4487-7045
   T., Olagunju Andrew/0000-0003-1736-9886
   Feyissa, Garumma/0000-0001-6179-0024
   Balakrishnan, Senthilkumar/0000-0003-4117-9695
   Desai, Rupak/0000-0002-5315-6426
   Onwujekwe, Obinna/0000-0002-1214-4285
   Salimzadeh, Hamideh/0000-0002-0102-1722
   Mehrotra, Ravi/0000-0001-9453-1408
   Rabiee, Navid/0000-0002-6945-8541
   Yisma, Engida/0000-0003-0703-1515
   Neupane, Subas/0000-0002-5868-0980
   Melese, Addisu/0000-0002-2362-5500
   Menezes, Ritesh G/0000-0002-2135-4161
   FRACP, Tissa Wijeratne MD PhD/0000-0002-1701-7111
   Jahangiry, Leila/0000-0002-0491-5764
   Manafi, Navid/0000-0002-4610-402X
   Naderi, Mehdi/0000-0002-5608-6582
   Alvis-Guzman, Nelson/0000-0001-9458-864X
   Oh, In Hwan/0000-0002-5450-9887
   Gomez, Ricardo Santiago/0000-0001-8770-8009
   Getachew, Sefonias/0000-0001-9506-1196
   Bhattacharyya, Krittika/0000-0002-9914-7031
   Henry, Nathaniel/0000-0001-8150-4988
   Briko, Andrey/0000-0002-7284-5649
   Mohammed, Shafiu/0000-0001-5715-966X
   Zaki, Maysaa El Sayed/0000-0001-5431-0248
   Kim, Daniel/0000-0001-8907-6420
   AVOKPAHO, Euripide/0000-0003-2321-0505
   Sufiyan, Muawiyyah Babale/0000-0003-3630-6995
   Salomon, Joshua/0000-0003-3929-5515
   Kucuk Bicer, Burcu/0000-0002-5615-264X
   LASRADO, SAVITA/0000-0001-9261-9238
   Hamidi, Samer/0000-0002-6766-3728
   Dereje, Nebiyu/0000-0002-3943-4434
   Hamadeh, Randah/0000-0002-4205-1354
   Fernandes, Eduarda/0000-0001-6424-0976
   Shahbaz, Mohammad/0000-0002-6953-6183
   Tsegaye, Reta/0000-0003-4721-3647
   Mosapour, Abbas/0000-0003-2599-5449
   Shabaninejad, Hosein/0000-0001-9512-1398
   Innos, Kaire/0000-0003-0120-2213
   Ginindza, Themba G/0000-0002-0993-8308
   Ilic, Milena/0000-0003-3229-4990
   Moodley, Yoshan/0000-0002-4119-1734
   Madadin, Mohammed/0000-0002-8594-5868
   Karch, Andre/0000-0003-3014-8543
   Desalegn, Beruk Berhanu/0000-0001-7161-8260
   Morawska, Lidia/0000-0002-0594-9683
   Househ, Mowafa/0000-0002-3648-6271
   Mulatu, kebadnew/0000-0002-1057-1267
   Pourshams, Akram/0000-0002-7950-3983
   Temsah, Mohamad-Hani/0000-0002-4389-9322
   Deribe, Kebede/0000-0002-8526-6996
   Ayala Quintanilla, Beatriz Paulina/0000-0002-2630-4569
   Kassaw, Mesfin Wudu/0000-0002-6327-7723
   Pakhale, Smita/0000-0002-4051-962X
   Angaw, Kassawmar/0000-0002-1945-8981
   Yaseri, Mehdi/0000-0002-4066-873X
   Ayele, Wondimu/0000-0001-5899-347X
   Effiong, Andem/0000-0003-2899-9656
   Nam, Hae-Sung/0000-0003-0911-4576
   Tabares-Seisdedos, Rafael/0000-0002-1089-2204
   Yadegar, Abbas/0000-0002-2135-7581
   Elemineh, Demelash/0000-0001-8821-0691
   Sharifi, Hamid/0000-0002-9008-7618
   siabani, soraya/0000-0003-2856-0205
   Komaki, Hamidreza/0000-0003-1830-9500
   Tran, Khanh Bao/0000-0002-8730-3340
   Olagunju, Tinuke/0000-0003-4019-8755
   Berhane, Adugnaw/0000-0003-2160-958X
   Meretoja, Tuomo/0000-0002-2691-0710
   Ribeiro, Daniela/0000-0001-9733-7934
   Shamshirian, Amir/0000-0002-2735-0209
   Moazen, Babak/0000-0002-2552-0438
   Soofi, Moslem/0000-0003-4922-8412
   Zandian, Hamed/0000-0002-1284-5823
   Muche, Achenef/0000-0001-7971-3537
   Bou-Orm, Ibrahim/0000-0003-3563-4014
   BOGDAN-VASILE, ILEANU/0000-0002-9229-3431
   Tabuchi, Takahiro/0000-0002-1050-3125
   Abbastabar, Hedayat/0000-0002-5713-4806
   nazari, javad/0000-0002-8277-6819
   Elkout, Hajer/0000-0003-3191-3868
   Oommen, Anu Mary/0000-0003-2932-7827
   Miller, Ted/0000-0002-0958-2639
   Miazgowski, Tomasz/0000-0002-4819-9376
   Hadkhale, Kishor/0000-0002-8173-9469
   Obsa, Mohammed/0000-0002-6579-1136
   Grada, Ayman/0000-0002-5321-0584
   Soriano, Joan B/0000-0001-9740-2994
   Ayanore, Martin/0000-0002-4095-3047
   Farzadfar, Farshad/0000-0001-8288-4046
   Prakash, Swayam/0000-0003-3986-890X
   teklay, girmay/0000-0002-3392-6585
   Tesfay (PhD), Fisaha Haile/0000-0003-0399-1711
   Gebremeskel, Afewerki/0000-0001-5818-3434
   Abdoli, Amir/0000-0003-4326-4586
   Mashamba-Thompson, Tivani/0000-0002-4193-2416
   Emamian, Mohammad Hassan/0000-0002-1994-1105
   El-Khatib, Ziad/0000-0003-0756-7280
   Ansariadi, Ansariadi/0000-0002-9692-6136
   Mohammad, Dara K./0000-0001-9201-0991
   Carreras, Giulia/0000-0002-1427-637X
   Khosravi, Mohammad Hossein/0000-0003-0426-5092
   Dubljanin, Eleonora/0000-0002-6484-3192
   RENZAHO, ANDRE/0000-0002-6844-0833
   Bjorge, Tone/0000-0002-9096-5257
   Mohebi, Farnam/0000-0002-6181-2008
   Yisma, Engida/0000-0002-7289-9946
   Workie, Hailemariam/0000-0001-5268-8124
   Moradi-Joo, Mohammad/0000-0002-9190-3429
   Aremu, Olatunde/0000-0002-5832-2403
   Nnaji, Chukwudi/0000-0002-4132-1922
   Chaturvedi, Pankaj/0000-0002-3520-1342
   Majeed, Azeem/0000-0002-2357-9858
   Moradpour, Farhad/0000-0002-4449-1978
   Pirestani, Majid/0000-0003-0046-4772
   Nabhan, Ashraf/0000-0003-4572-2210
   Postma, Maarten/0000-0002-6306-3653
   Bitew, Helen/0000-0001-7383-4960
   /0000-0002-4565-5364
   Lunevicius, Raimundas/0000-0003-3295-0142},
Funding-Acknowledgement = {Bill AMP; Melinda Gates FoundationCGIAR},
Funding-Text = {The Institute for Health Metrics and Evaluation received funding from
   the Bill \& Melinda Gates Foundation.},
Cited-References = {Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492.
   Dicker D, 2018, LANCET, V392, P1684, DOI 10.1016/s0140-6736(18)31891-9.
   Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210.
   Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688.
   Fitzmaurice C, 2018, JAMA ONCOL, V4, P1553, DOI 10.1001/jamaoncol.2018.2706.
   Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735.
   Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1.
   James SL, 2018, LANCET, V392, P1789, DOI 10.1016/s0140-6736(18)32279-7.
   Jan S, 2018, LANCET, V391, P2047, DOI 10.1016/S0140-6736(18)30323-4.
   JENSEN OM, 1990, EUR J CANCER, V26, P1167.
   Kyu HH, 2018, LANCET, V392, P1859, DOI {[}10.1016/S0140-6736(18)32335-3, 10.1016/s0140-6736(18)32335-3].
   Niessen LW, 2018, LANCET, V391, P2036, DOI {[}10.1016/s0140-6736(18)30482-3, 10.1016/S0140-6736(18)30482-3].
   Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7.
   Siegel RL, 2019, CA-CANCER J CLIN, V69, P7, DOI 10.3322/caac.21551.
   Truven Health Analytics, US MARKETSCAN COMM C.
   United Nations, 2016, SUST DEV GOALS KNOWL.
   United Nations, 2011 HIGH LEV M PREV.
   United Nations General Assembly, 2018, 3 HIGH LEV M GEN ASS.
   World Health Organization (WHO), 2018, WHO DIR GEN CALLS AL.
   World Health Organization. (WHO), 2013, GLOB ACT PLAN PREV C.},
Number-of-Cited-References = {20},
Times-Cited = {688},
Usage-Count-Last-180-days = {46},
Usage-Count-Since-2013 = {188},
Journal-ISO = {JAMA Oncol.},
Doc-Delivery-Number = {JZ6GV},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000505200400013},
OA = {hybrid, Green Submitted, Green Accepted, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000355413900032,
Author = {Matheson, Flora I. and Creatore, Maria Isabella and Gozdyra, Piotr and
   Park, Alison L. and Ray, Joel G.},
Title = {A population-based study of premature mortality in relation to
   neighbourhood density of alcohol sales and cheque cashing outlets in
   Toronto, Canada},
Journal = {BMJ OPEN},
Year = {2014},
Volume = {4},
Number = {12},
Abstract = {Objective: Alcohol overuse and poverty, each associated with premature
   death, often exist within disadvantaged neighbourhoods. Cheque cashing
   places (CCPs) may be opportunistically placed in disadvantaged
   neighbourhoods, where customers abound. We explored whether
   neighbourhood density of CCPs and alcohol outlets are each related to
   premature mortality among adults.
   Design: Retrospective population-based study.
   Setting: 140 neighbourhoods in Toronto, Ontario, 2005-2009.
   Participants: Adults aged 20-59 years.
   Measures: Our primary outcome was premature all-cause mortality among
   adults aged 20-59 years. Across neighbourhoods we explored neighbourhood
   density, in km(2), of CCPs and alcohol outlets, and the relation of each
   to premature mortality. Poisson regression provided adjusted relative
   risks (aRRs) and 95\% CIs, adjusting for material deprivation quintile
   (Q), crime Q and number of banks.
   Results: Intentional self-harm, accidental poisoning and liver disease
   were among the top five causes of premature death among males aged 20-59
   years. The overall premature mortality rate was 96.3/10 000 males and
   55.9/10 000 females. Comparing the highest versus lowest CCP density Q,
   the aRR for death was 1.25 (95\% CI 1.15 to 1.36) among males and 1.11
   (95\% CI 0.99 to 1.24) among females. The corresponding aRR comparing
   the highest Q versus lowest Q alcohol outlet density in relation to
   premature mortality was 1.36 (95\% CI 1.25 to 1.48) for males and 1.11
   (95\% CI 1.00 to 1.24) for females. The pattern of the relation between
   either CCPs or alcohol outlet density and premature mortality was
   typically J shaped.
   Conclusions: There is a J-shaped relation between CCP or alcohol outlet
   density and premature mortality, even on controlling for conventional
   measures of poverty. Formal banking and alcohol reduction strategies
   might be added to health promotion policies aimed at reducing premature
   mortality in highly affected neighbourhoods.},
Publisher = {BMJ PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Matheson, FI (Corresponding Author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   Matheson, Flora I., Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   Matheson, Flora I.; Creatore, Maria Isabella; Gozdyra, Piotr; Park, Alison L., St Michaels Hosp, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada.
   Ray, Joel G., Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada.
   Ray, Joel G., Univ Toronto, St Michaels Hosp, Dept Obstet \& Gynaecol, Toronto, ON, Canada.},
DOI = {10.1136/bmjopen-2014-006032},
Article-Number = {e006032},
ISSN = {2044-6055},
Keywords-Plus = {SOCIOECONOMIC CONTEXT; UNITED-STATES; HEALTH; CONSUMPTION; IMPACT;
   DRINKING; ASSAULT; GENDER; INCOME; CRIME},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {mathesonf@smh.ca},
Cited-References = {{[}Anonymous], 2009, LEADING CAUSES DEATH.
   ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x.
   ANTONOVSKY A, 1967, MILBANK FUND Q, V45, P31, DOI 10.2307/3348839.
   Backlund E, 1996, ANN EPIDEMIOL, V6, P12, DOI 10.1016/1047-2797(95)00090-9.
   Brand DA, 2007, PLOS MED, V4, P752, DOI 10.1371/journal.pmed.0040151.
   BUCKLAND J, 2012, HARD CHOICES FINANCI.
   Buu A, 2007, ALCOHOL CLIN EXP RES, V31, P1545, DOI 10.1111/j.1530-0277.2007.00449.x.
   CAMH, 2004, RET ALC MON REG PRES.
   Campbell CA, 2009, AM J PREV MED, V37, P556, DOI 10.1016/j.amepre.2009.09.028.
   Chen EY, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-2.
   Courtenay WH, 2000, J AM COLL HEALTH, V48, P243, DOI 10.1080/07448480009596265.
   Courtenay WH, 1998, J AM COLL HEALTH, V46, P279, DOI 10.1080/07448489809596004.
   Cubbin C, 2000, J EPIDEMIOL COMMUN H, V54, P517, DOI 10.1136/jech.54.7.517.
   Cullen MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032930.
   Doubeni CA, 2012, AM J PUBLIC HEALTH, V102, P680, DOI 10.2105/AJPH.2011.300158.
   Ely M, 2001, METHODS ESTIMATION I.
   Eskin SB, 1995, CHECK CASHING MODEL.
   Fiscella K, 1997, BRIT MED J, V314, P1724, DOI 10.1136/bmj.314.7096.1724.
   Fox JEAN ANN, 2006, CASHED OUT CONSUMERS.
   Genberg BL, 2011, ADDICTION, V106, P1966, DOI 10.1111/j.1360-0443.2011.03501.x.
   Grittner U, 2011, INT J METH PSYCH RES, V20, P50, DOI 10.1002/mpr.330.
   Hemstrom O, 2001, ADDICTION, V96, pS93, DOI 10.1080/09652140020021206.
   Katcher BS, 2010, BMC PUBLIC HEALTH, V10, P1.
   Kubrin CE, 2011, CRIMINOL PUBLIC POL, V10, P437, DOI 10.1111/j.1745-9133.2011.00719.x.
   Kuh D, 2002, BRIT MED J, V325, P1076, DOI 10.1136/bmj.325.7372.1076.
   Latkin CA, 2003, J HEALTH SOC BEHAV, V44, P34, DOI 10.2307/1519814.
   Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6.
   Leon DA, 2009, ADDICTION, V104, P1630, DOI 10.1111/j.1360-0443.2009.02655.x.
   LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958.
   Livingston M, 2008, ADDICTION, V103, P619, DOI 10.1111/j.1360-0443.2008.02136.x.
   Logan A., 2009, WHO BORROWS PAYDAY L.
   {[}MADD MADD], 2014, PROV LIQ BOARDS M BE, P1.
   Maniecka-Bryla I, 2013, KARDIOL POL, V71, P1065, DOI 10.5603/KP.2013.0262.
   Matheson FI, 2006, SOC SCI MED, V63, P2604, DOI 10.1016/j.socscimed.2006.07.001.
   Matheson FI, 2012, CAN J PUBLIC HEALTH, V103, pS12, DOI 10.1007/BF03403823.
   McCartney D, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000737.
   McCoy TP, 2009, J STUD ALCOHOL DRUGS, V70, P606, DOI 10.15288/jsad.2009.70.606.
   OUELLET BL, 1979, AM J EPIDEMIOL, V109, P451, DOI 10.1093/oxfordjournals.aje.a112703.
   Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111.
   Popova S, 2009, ALCOHOL ALCOHOLISM, V44, P500, DOI 10.1093/alcalc/agp054.
   Ray JG, 2013, SOCIAL MIND, V3, P278.
   Ray JG, 2008, PLOS MED, V5, P725, DOI 10.1371/journal.pmed.0050104.
   Rehm J, 2006, ADDICTION, V101, P373, DOI 10.1111/j.1360-0443.2005.01338.x.
   Rehm J, 2007, INT J EPIDEMIOL, V36, P458, DOI 10.1093/ije/dyl294.
   Rossow I, 2012, ADDICTION, V107, P530, DOI 10.1111/j.1360-0443.2011.03643.x.
   Sampson RJ, 1997, CRIME JUSTICE, V21, P311, DOI 10.1086/449253.
   Serido J, 2004, J HEALTH SOC BEHAV, V45, P17, DOI 10.1177/002214650404500102.
   Shakeshaft A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001617.
   SKOG OJ, 1983, BRIT J ADDICT, V78, P157.
   Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P153.
   Smith MM, 2009, ALTERNATIVE FINANCIA.
   Stafford M, 2008, SOC SCI MED, V67, P891, DOI 10.1016/j.socscimed.2008.05.028.
   Stevenson RJ, 1999, ADDICTION, V94, P397, DOI 10.1046/j.1360-0443.1999.9433979.x.
   Stockwell T, 2011, ADDICTION, V106, P768, DOI 10.1111/j.1360-0443.2010.03331.x.
   Struijk EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074294.
   Wheaton B., 1999, HDB STUDY MENTAL HLT, P176.
   Winkleby MA, 2003, J EPIDEMIOL COMMUN H, V57, P444, DOI 10.1136/jech.57.6.444.
   Zalcman RF, 2007, CONTEMP DRUG PROBL, V34, P589.},
Number-of-Cited-References = {58},
Times-Cited = {10},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {6},
Journal-ISO = {BMJ Open},
Doc-Delivery-Number = {CJ3WC},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000355413900032},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000255921900007,
Author = {Le Cai and Chongsuvivatwong, Virasakdi and Geater, Alan},
Title = {Changing pattern of premature mortality burden over 6 years of rapid
   growth of the economy in suburban south-west China: 1998-2003},
Journal = {PUBLIC HEALTH},
Year = {2008},
Volume = {122},
Number = {5},
Pages = {478-486},
Month = {MAY},
Abstract = {Background: This study was conducted in Kunming, the capital of Yunnan,
   a poor province in south-west China experiencing rapid economic growth.
   The study examined the short-term trend in premature mortality burden
   from common causes of death in a suburban region between 1998 and 2003.
   Methods: Years of Life lost (YLL) per 1000 population and mortality rate
   per 100,000 population were calculated from medical death certificates,
   and broken down by cause of death, sex and year without age weighting
   but with a discounting rate of 3\%.
   Results: Non-communicable diseases contributed over 80\% of all causes
   of YLL, with a slightly increasing trend. The combined rate for
   communicable, maternal, prenatal and nutritional deficiencies declined
   from 4.7 to 2.4 per 1000 population. Remarkably, declining trends in YLL
   were also seen for chronic obstructive pulmonary disease, drug use and
   road traffic accidents, whereas increasing trends were seen for
   ischaemic heart disease (IHD) and liver cancer (mates). The YLL rate for
   stroke, self-inflicted injuries, Lung cancer and stomach cancer
   fluctuated over time.
   Conclusions: The region should focus on further control of IHD and liver
   cancer. (C) 2008 The Royal Institute of Public Health. Published by
   Elsevier Ltd. All rights reserved.},
Publisher = {W B SAUNDERS CO LTD},
Address = {32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Cai, L (Corresponding Author), Kunming Med Coll, Fac Publ Hlth, Dept Hlth Informat \& Econ, Kunming 650031, Peoples R China.
   Le Cai, Kunming Med Coll, Fac Publ Hlth, Dept Hlth Informat \& Econ, Kunming 650031, Peoples R China.
   Chongsuvivatwong, Virasakdi; Geater, Alan, Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai 90112, Songkhla, Thailand.},
DOI = {10.1016/j.puhe.2007.08.017},
ISSN = {0033-3506},
EISSN = {1476-5616},
Keywords = {years of life lost; premature mortality burden; temporal trend; China},
Keywords-Plus = {OBSTRUCTIVE PULMONARY-DISEASE; ISCHEMIC-HEART-DISEASE; STROKE MORTALITY;
   HONG-KONG; TRENDS; RATES; SMOKING; DECLINE; GENDER},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {caile002@hotmail.com},
ORCID-Numbers = {Geater, Alan/0000-0003-1219-9814},
Cited-References = {{[}Anonymous], 2004, CHIN STAT YB.
   Bae JM, 2002, J KOREAN MED SCI, V17, P611, DOI 10.3346/jkms.2002.17.5.611.
   COALE A, 1989, POPUL INDEX, V55, P613, DOI 10.2307/3644567.
   Cooper RS, 2006, AM J PUBLIC HEALTH, V96, P94, DOI 10.2105/AJPH.2004.051417.
   Desai MA, 2004, WHO ENV BURDEN DIS S, V4.
   Drumond João Augusto Guimarães, 2006, Cad. Saúde Pública, V22, P2131, DOI 10.1590/S0102-311X2006001000019.
   Ekman R, 2005, INJURY PREV, V11, P29, DOI 10.1136/ip.2003.005074.
   Ezzati M, 2004, TOB CONTROL, V13, P388, DOI 10.1136/tc.2003.005215.
   GOLD J, 1994, MED J AUSTRALIA, V161, P652, DOI 10.5694/j.1326-5377.1994.tb126910.x.
   Hazen A, 2006, J NATL MED ASSOC, V98, P73.
   Howard G, 2001, STROKE, V32, P2213, DOI 10.1161/hs1001.096047.
   HU J, 2006, CHRONIC DIS CAN, V27, P89.
   Hyder AA, 2000, AM J PUBLIC HEALTH, V90, P1235, DOI 10.2105/AJPH.90.8.1235.
   Liu D, 2002, J MATER SCI TECHNOL, V18, P7.
   Liu LJ, 2001, STROKE, V32, P1745, DOI 10.1161/01.STR.32.8.1745.
   Maeda H, 1998, Gan To Kagaku Ryoho, V25, P1474.
   Mariotti S, 2003, EUR J EPIDEMIOL, V18, P513, DOI 10.1023/A:1024635401206.
   Markides KS, 2005, J GERONTOL B-PSYCHOL, V60, P68, DOI 10.1093/geronb/60.Special\_Issue\_2.S68.
   Michaud CM, 2001, JAMA-J AM MED ASSOC, V285, P535, DOI 10.1001/jama.285.5.535.
   Murray CJ, 1996, GLOBAL BURDEN DIS IN, V1.
   MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429.
   Ngoan Le Tran, 2002, Asian Pac J Cancer Prev, V3, P47.
   Nielsen Lasse Christian, 2004, Int J Circumpolar Health, V63 Suppl 2, P86.
   Okayama A, 2001, AM J EPIDEMIOL, V153, P1191, DOI 10.1093/aje/153.12.1191.
   Pride NB, 2002, CURR OPIN PULM MED, V8, P95, DOI 10.1097/00063198-200203000-00003.
   Redondo Calderon J, 2000, Gac Sanit, V14, P7.
   Rossetti CA, 2004, PESQUI VET BRASIL, V24, P6, DOI 10.1590/S0100-736X2004000100003.
   Sarti C, 2000, STROKE, V31, P1588, DOI 10.1161/01.STR.31.7.1588.
   Sintuvanich Apichart, 1997, Journal of the Medical Association of Thailand, V80, P631.
   Tobias Martin, 2006, N Z Med J, V119, pU1932.
   Varkey AB, 2004, CURR OPIN PULM MED, V10, P98, DOI 10.1097/00063198-200403000-00003.
   Venketasubramanian N, 1998, INT J EPIDEMIOL, V27, P15, DOI 10.1093/ije/27.1.15.
   Wang Zhengguo, 2003, Traffic Inj Prev, V4, P9, DOI 10.1080/15389580309860.
   Wei M, 1996, ANN EPIDEMIOL, V6, P307, DOI 10.1016/S1047-2797(96)00026-9.
   WU XG, 2003, CHIN J CHRON DIS PRE, V4, P15.
   Wu Y., 2001, CHIN J CARDIOL, V29, P74.
   Xia Y, 2000, CHIN J HLTH STAT, V17, P211.
   Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247.
   YANG GH, 2000, ZHONGHUA LIU XING BI, V25, P193.
   Yang GH, 2005, ZHONGHUA LIU XING BI, V26, P934.
   Yoshimi I, 2003, JPN J CLIN ONCOL, V33, P254.
   YU TS, 1995, J EPIDEMIOL COMMUN H, V49, P16, DOI 10.1136/jech.49.1.16.
   Yu TSI, 2000, NEUROEPIDEMIOLOGY, V19, P265, DOI 10.1159/000026264.
   {*}YUNN PROV STAT BU, 1999, YUNN STAT YB 1998.
   {*}YUNN PROV STAT BU, 2005, YUNN STAT YB 2004.
   ZARIDZE D, 1986, IARC SCI PUBLICATION, V74.
   Zuckerman JN, 2006, CURR OPIN INFECT DIS, V19, P456, DOI 10.1097/01.qco.0000244051.23511.09.},
Number-of-Cited-References = {47},
Times-Cited = {5},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {8},
Journal-ISO = {Public Health},
Doc-Delivery-Number = {301UT},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000255921900007},
OA = {Green Published},
DA = {2022-03-29},
}

@article{ WOS:000520867700044,
Author = {Roy, Brita and Kiefe, Catarina I. and Jacobs, David R. and Goff, David
   C. and Lloyd-Jones, Donald and Shikany, James M. and Reis, Jared P. and
   Gordon-Larsen, Penny and Lewis, Cora E.},
Title = {Education, Race/Ethnicity, and Causes of Premature Mortality Among
   Middle-Aged Adults in 4 US Urban Communities: Results From CARDIA,
   1985-2017},
Journal = {AMERICAN JOURNAL OF PUBLIC HEALTH},
Year = {2020},
Volume = {110},
Number = {4},
Pages = {530-536},
Month = {APR},
Abstract = {Objectives. To assess causes of premature death and whether
   race/ethnicity or education is more strongly and independently
   associated with premature mortality in a diverse sample of middle-aged
   adults in the United States.
   Methods. The Coronary Artery Risk Development in Young Adults study
   (CARDIA) is a longitudinal cohort study of 5114 participants recruited
   in 1985 to 1986 and followed for up to 29 years, with rigorous
   ascertainment of all deaths; recruitment was balanced regarding sex,
   Black and White race/ethnicity, education level (high school or less vs.
   greater than high school), and age group (18-24 and 25-30 years). This
   analysis included all 349 deaths that had been fully reviewed through
   month 348. Our primary outcome was years of potential life lost (YPLL).
   Results. The age-adjusted mortality rate per 1000 persons was 45.17
   among Black men, 25.20 among White men, 17.63 among Black women, and
   10.10 among White women. Homicide and AIDS were associated with the most
   YPLL, but cancer and cardiovascular disease were the most common causes
   of death. In multivariable models, each level of education achieved was
   associated with 1.37 fewer YPLL (P =.007); race/ethnicity was not
   independently associated with YPLL.
   Conclusions. Lower education level was an independent predictor of
   greater YPLL.},
Publisher = {AMER PUBLIC HEALTH ASSOC INC},
Address = {800 I STREET, NW, WASHINGTON, DC 20001-3710 USA},
Type = {Article},
Language = {English},
Affiliation = {Roy, B (Corresponding Author), Yale Sch Med, Gen Internal Med Sect, 367 Cedar St,ESH A,Suite 406A, New Haven, CT 06510 USA.
   Roy, Brita, Yale Sch Med, Dept Internal Med, New Haven, CT USA.
   Kiefe, Catarina I., Univ Massachusetts, Sch Med, Dept Populat \& Quantitat Hlth Sci, Worcester, MA USA.
   Jacobs, David R., Univ Minnesota, Sch Publ Hlth, Div Epidemiol \& Community Hlth, Minneapolis, MN USA.
   Goff, David C., Univ Colorado, Colorado Sch Publ Hlth, Aurora, CO USA.
   Goff, David C., NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA.
   Lloyd-Jones, Donald, Northwestern Univ, Feinberg Sch Med, Evanston, IL USA.
   Shikany, James M., Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA.
   Reis, Jared P., NHLBI, Bldg 10, Bethesda, MD 20892 USA.
   Gordon-Larsen, Penny, Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA.
   Lewis, Cora E., Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA.},
DOI = {10.2105/AJPH.2019.305506},
ISSN = {0090-0036},
EISSN = {1541-0048},
Keywords-Plus = {LIFE EXPECTANCY; UNITED-STATES; RACIAL DISPARITIES; HEALTH; RACE;
   TRENDS; NEIGHBORHOODS; GAP},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {brita.roy@yale.edu},
ResearcherID-Numbers = {Lewis, Cora Elizabeth/ABE-6435-2020
   },
ORCID-Numbers = {Lewis, Cora Elizabeth/0000-0002-2301-5796
   Lloyd-Jones, Donald/0000-0003-0847-6110
   Jacobs, David/0000-0002-7232-0543},
Funding-Acknowledgement = {National Heart, Lung, and Blood InstituteUnited States Department of
   Health \& Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung \& Blood Institute (NHLBI); University of Alabama at
   Birmingham {[}HHSN268201800005I, HHSN268201800007I]; Northwestern
   University {[}HHSN268201800003I]; University of MinnesotaUniversity of
   Minnesota System {[}HHSN268201800006I]; Kaiser Foundation Research
   Institute {[}HHSN268201800004I]},
Funding-Text = {The Coronary Artery Risk Development in Young Adults Study (CARDIA) is
   conducted and supported by the National Heart, Lung, and Blood Institute
   in collaboration with the University of Alabama at Birmingham
   (HHSN268201800005I and HHSN268201800007I), Northwestern University
   (HHSN268201800003I), University of Minnesota (HHSN268201800006I), and
   Kaiser Foundation Research Institute (HHSN268201800004I).; We appreciate
   the assistance of Chen Dai and Liang Shan in performing the analyses
   supporting the results presented in this article. This article has been
   reviewed by CARDIA for scientific content.},
Cited-References = {Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60.
   {[}Anonymous], {[}No title captured].
   Braveman P, 2014, PUBLIC HEALTH REP, V129, P19, DOI 10.1177/00333549141291S206.
   CARD D, 1992, Q J ECON, V107, P151, DOI 10.2307/2118326.
   Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112.
   Chetty R, 2016, AM ECON REV, V106, P855, DOI 10.1257/aer.20150572.
   Chetty Raj, 2018, OPPORTUNITY ATLAS MA.
   Crimmins EM, 2001, SOC SCI MED, V52, P1629, DOI 10.1016/S0277-9536(00)00273-2.
   Currie J, 2016, SCIENCE, V352, P708, DOI 10.1126/science.aaf1437.
   Dwyer-Lindgren L, 2017, JAMA INTERN MED, V177, P1003, DOI 10.1001/jamainternmed.2017.0918.
   FELDMAN JJ, 1989, AM J EPIDEMIOL, V129, P919, DOI 10.1093/oxfordjournals.aje.a115225.
   FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88.
   Harper S, 2007, JAMA-J AM MED ASSOC, V297, P1224, DOI 10.1001/jama.297.11.1224.
   Iribarren C, 2005, SOC SCI MED, V60, P471, DOI 10.1016/j.socscimed.2004.06.007.
   Jemal A, 2008, AM J PREV MED, V34, P1, DOI 10.1016/j.amepre.2007.09.017.
   Kawachi I, 2005, HEALTH AFFAIR, V24, P343, DOI 10.1377/hlthaff.24.2.343.
   Kochanek Kenneth D, 2017, NCHS Data Brief, P1.
   Koh HK, 2010, NEW ENGL J MED, V362, P1653, DOI 10.1056/NEJMp1001601.
   Kuzawa CW, 2009, AM J HUM BIOL, V21, P2, DOI 10.1002/ajhb.20822.
   Meara ER, 2008, HEALTH AFFAIR, V27, P350, DOI 10.1377/hlthaff.27.2.350.
   Morfeld P, 2004, Epidemiol Perspect Innov, V1, P5, DOI 10.1186/1742-5573-1-5.
   Mujahid MS, 2011, AM J HYPERTENS, V24, P187, DOI 10.1038/ajh.2010.200.
   Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260.
   Olshansky SJ, 2012, HEALTH AFFAIR, V31, P1803, DOI 10.1377/hlthaff.2011.0746.
   People H, 2000, HLTH PEOPL 2010, V1.
   Riley C, 2017, J URBAN HEALTH, V94, P619, DOI 10.1007/s11524-016-0121-2.
   Robert Wood Johnson Foundation, 2015, CIT MAPS SHORT DIST.
   Sampson RJ, 2003, PERSPECT BIOL MED, V46, pS53, DOI 10.1353/pbm.2003.0073.
   Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918.
   Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0.
   Williams DR, 1999, ANN NY ACAD SCI, V896, P173, DOI 10.1111/j.1749-6632.1999.tb08114.x.
   Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979.
   Xu J, 2015, NCHS DATA BRIEF, V2016, P1, DOI DOI 10.1056/NEJM184002260220306.},
Number-of-Cited-References = {35},
Times-Cited = {7},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {6},
Journal-ISO = {Am. J. Public Health},
Doc-Delivery-Number = {KW0MK},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000520867700044},
OA = {Green Published},
DA = {2022-03-29},
}

@article{ WOS:000399324800012,
Author = {Renard, Francoise and Gadeyne, Sylvie and Devleesschauwer, Brecht and
   Tafforeau, Jean and Deboosere, Patrick},
Title = {Trends in educational inequalities in premature mortality in Belgium
   between the 1990s and the 2000s: the contribution of specific causes of
   deaths},
Journal = {JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH},
Year = {2017},
Volume = {71},
Number = {4},
Pages = {371-380},
Month = {APR},
Abstract = {Background Reducing socioeconomic inequalities in mortality, a key
   public health objective may be supported by a careful monitoring and
   assessment of the contributions of specific causes of death to the
   global inequality.
   Methods The 1991 and 2001 Belgian censuses were linked with
   cause-of-death data, each yielding a study population of over 5 million
   individuals aged 25-64, followed up for 5 years. Age-standardised
   mortality rates (ASMR) were computed by educational level (EL) and
   cause. Inequalities were measured through rate differences (RDs), rate
   ratios (RRs) and population attributable fractions (PAFs). We analysed
   changes in educational inequalities between the 1990s and the 2000s, and
   decomposed the PAF into the main causes of death.
   Results All-cause and avoidable ASMR decreased in all ELs and both
   sexes. Lung cancer, ischaemic heart disease (IHD), chronic obstructive
   pulmonary disease (COPD) and suicide in men, and IHD, stroke, lung
   cancer and COPD in women had the highest impact on population mortality.
   RDs decreased in men but increased in women. RRs and PAFs increased in
   both sexes, albeit more in women. In men, the impact of lung cancer and
   COPD inequalities on population mortality decreased while that of
   suicide and IHD increased. In women, the impact of all causes except IHD
   increased.
   Conclusion Absolute inequalities decreased in men while increasing in
   women; relative inequalities increased in both sexes. The PAFs
   decomposition revealed that targeting mortality inequalities from lung
   cancer, IHD, COPD in both sexes, suicide in men and stroke in women
   would have the largest impact at population level.},
Publisher = {BMJ PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Renard, F (Corresponding Author), Sci Inst Publ Hlth WIV ISP, Dept Publ Hlth \& Surveillance, 14 Rue J Wytsman, B-1050 Brussels, Belgium.
   Renard, Francoise; Devleesschauwer, Brecht; Tafforeau, Jean, Sci Inst Publ Hlth WIV ISP, Dept Publ Hlth \& Surveillance, 14 Rue J Wytsman, B-1050 Brussels, Belgium.
   Gadeyne, Sylvie; Deboosere, Patrick, Free Univ Brussels, Sect Social Res, Interface Demog, Brussels, Belgium.},
DOI = {10.1136/jech-2016-208370},
ISSN = {0143-005X},
EISSN = {1470-2738},
Keywords-Plus = {BREAST-CANCER MORTALITY; SOCIOECONOMIC INEQUALITIES; SOCIAL
   INEQUALITIES; NEW-ZEALAND; HEALTH; NORWAY; WOMEN; EQUITY; MEN},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {francoise.renard@wiv-isp.be},
ResearcherID-Numbers = {Deboosere, Patrick/C-1113-2014
   Devleesschauwer, Brecht/G-9895-2018
   Gadeyne, Sylvie/C-2837-2016},
ORCID-Numbers = {Devleesschauwer, Brecht/0000-0002-2867-6892
   Gadeyne, Sylvie/0000-0002-6890-1855},
Cited-References = {Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219.
   Bostrom G, 2003, SCAND J PUBLIC HEALT, V31, P211, DOI 10.1080/14034940210164911.
   Braveman PA, 2003, J HEALTH POPUL NUTR, V21, P181.
   Dahlgren G, 2000, POLICIES STRATEGIES.
   Deboosere P, 1999, 19997 VRIJ U BRUSS V.
   Deboosere P, 2009, EUR J POPUL, V25, P175, DOI 10.1007/s10680-008-9167-5.
   EUROSTAT, 2016, AM PREV DEATHS STAT.
   Executive Agency for Health and Consumer, 2007, 2 PROGR COMM ACT FIE.
   Fawcett J, 2005, EUR J EPIDEMIOL, V20, P683, DOI 10.1007/s10654-005-7923-y.
   Fawcett J, 2007, J EPIDEMIOL COMMUN H, V61, P59, DOI 10.1136/jech.2005.044016.
   Gisle L, 2015, ENQUETE SANTE 2013 R.
   Harper S, 2005, NIH PUBLICATION.
   Harper S, 2010, MILBANK Q, V88, P4, DOI 10.1111/j.1468-0009.2010.00587.x.
   HOLLAND WW, 1994, J PUBLIC HEALTH MED, V16, P321.
   HUMBLET PC, 1987, SOC SCI MED, V25, P485, DOI 10.1016/0277-9536(87)90172-9.
   Jemal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002181.
   Layte R, 2016, EUR J PUBLIC HEALTH, V26, P451, DOI 10.1093/eurpub/ckw038.
   Mackenbach JP, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1732.
   Mackenbach JP, 2015, J EPIDEMIOL COMMUN H, V69, P207, DOI 10.1136/jech-2014-204319.
   Mackenbach JP, 2003, LANCET, V362, P1409, DOI 10.1016/S0140-6736(03)14639-9.
   Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209.
   Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1.
   Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6.
   Martikainen P, 2000, AM J PUBLIC HEALTH, V90, P277, DOI 10.2105/AJPH.90.2.277.
   Menvielle G, 2006, BRIT J CANCER, V94, P152, DOI 10.1038/sj.bjc.6602907.
   Office for National Statistics UK, 2012, DEF AV MORT FIN AV C.
   Renard F, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-34.
   Robert C. P., 2004, MONTE CARLO STAT MET.
   Speybroeck N, 2012, INT J PUBLIC HEALTH, V57, P855, DOI 10.1007/s00038-012-0386-5.
   Strand BH, 2007, EUR J CANCER, V43, P1200, DOI 10.1016/j.ejca.2007.01.021.
   Strand BH, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1208.
   Strand BH, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c654.
   Tarkiainen L, 2012, J EPIDEMIOL COMMUN H, V66, P573, DOI 10.1136/jech.2010.123182.
   Unesco, 1997, INT STAND CLASS ED I.
   WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U.
   WATERHOUSE J. A. H., 1976, CANC INCIDENCE 5 CON.
   {*}WHO, 1977, INT CLASS DIS INJ CA.
   WHO Regional Office for Europe, 1999, HLTH 21 HLTH ALL POL.
   World Health Organization, 1994, INT STAT CLASS DIS R.},
Number-of-Cited-References = {39},
Times-Cited = {11},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {13},
Journal-ISO = {J. Epidemiol. Community Health},
Doc-Delivery-Number = {ES1ZF},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000399324800012},
DA = {2022-03-29},
}

@article{ WOS:000489022700008,
Author = {Carrillo-Larco, Rodrigo M. and Albitres-Flores, Leonardo and Barengo,
   Noel C. and Bernabe-Ortiz, Antonio},
Title = {The association between serum lipids and risk of premature mortality in
   Latin America: a systematic review of population-based prospective
   cohort studies},
Journal = {PEERJ},
Year = {2019},
Volume = {7},
Month = {OCT 4},
Abstract = {Objective. To synthetize the scientific evidence on the association
   between serum lipids and premature mortality in Latin America (LA).
   Methods. Five data bases were searched from inception without language
   restrictions: Embase, Medline, Global Health, Scopus and LILACS.
   Population-based studies following random sampling methods were
   identified. The exposure variable was lipid biomarkers (e.g., total,
   LDL- or HDL- cholesterol). The outcome was all-cause and cause-specific
   mortality. The risk of bias was assessed following the Newcastle-Ottawa
   criteria. Results were summarized qualitatively.
   Results. The initial search resulted in 264 abstracts, five (N = 27,903)
   were included for the synthesis. Three papers reported on the same study
   from Puerto Rico (baseline in 1965), one was from Brazil (1996) and one
   from Peru (2007). All reports analysed different exposure variables and
   used different risk estimates (relative risks, hazard ratios or odds
   ratios). None of the reviewed reports showed strong association between
   individual lipid biomarkers and all-cause or cardiovascular mortality.
   Conclusion. The available evidence is outdated, inconsistently reported
   on several lipid biomarker definitions and used different methods to
   study the long-term mortality risk. These findings strongly support the
   need to better ascertain the mortality risk associated with lipid
   biomarkers in LA.},
Publisher = {PEERJ INC},
Address = {341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND},
Type = {Review},
Language = {English},
Affiliation = {Carrillo-Larco, RM (Corresponding Author), Imperial Coll London, Sch Publ Hlth, Dept Epidemiol \& Biostat, London, England.
   Carrillo-Larco, RM (Corresponding Author), Univ Peruana Cayetano Heredia, CRON Ctr Excellence Chron Dis, Lima, Peru.
   Carrillo-Larco, RM (Corresponding Author), Univ Catolica Angeles Chimbote ULADECH Catolica, Ctr Estudios Poblac, Chimbote, Peru.
   Carrillo-Larco, Rodrigo M., Imperial Coll London, Sch Publ Hlth, Dept Epidemiol \& Biostat, London, England.
   Carrillo-Larco, Rodrigo M.; Albitres-Flores, Leonardo; Bernabe-Ortiz, Antonio, Univ Peruana Cayetano Heredia, CRON Ctr Excellence Chron Dis, Lima, Peru.
   Carrillo-Larco, Rodrigo M., Univ Catolica Angeles Chimbote ULADECH Catolica, Ctr Estudios Poblac, Chimbote, Peru.
   Albitres-Flores, Leonardo, Univ Nacl Trujillo, Fac Med, Trujillo, Peru.
   Albitres-Flores, Leonardo, Univ Nacl Trujillo SOCEMUNT, Sociedad Cient Estudiantes Med, Trujillo, Peru.
   Barengo, Noel C., Florida Int Univ, Dept Med \& Populat Hlth Sci Res, Herbert Werthe Coll Med, Miami, FL 33199 USA.
   Barengo, Noel C., Univ Helsinki, Fac Med, Dept Publ Hlth, Helsinki, Finland.
   Barengo, Noel C., RSU, Fac Med, Riga, Latvia.
   Bernabe-Ortiz, Antonio, Univ Cient Sur, Lima, Peru.},
DOI = {10.7717/peerj.7856},
Article-Number = {e7856},
ISSN = {2167-8359},
Keywords = {Dyslipidaemias; Cholesterol; Survival; Latin America},
Keywords-Plus = {CORONARY-HEART-DISEASE; PUERTO-RICO; CARDIOVASCULAR-DISEASE;
   CHOLESTEROL; HEALTH; APOLIPOPROTEINS; URBAN},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {r.carrillo-larco@imperial.ac.uk},
ResearcherID-Numbers = {Albitres-Flores, Leonardo/O-6805-2018
   },
ORCID-Numbers = {Albitres-Flores, Leonardo/0000-0002-0077-3615
   Bernabe-Ortiz, Antonio/0000-0002-6834-1376},
Funding-Acknowledgement = {Wellcome Trust-Imperial College Centre for Global Health Research
   {[}100693/Z/12/Z]; Imperial College London Wellcome Trust Institutional
   Strategic Support Fund {[}Global Health Clinical Research Training
   Fellowship] {[}294834/Z/16/Z ISSF ICL]; Wellcome Trust International
   Training Fellowship {[}214185/Z/18/Z]},
Funding-Text = {This work was supported by the Strategic Award, Wellcome Trust-Imperial
   College Centre for Global Health Research (100693/Z/12/Z), Imperial
   College London Wellcome Trust Institutional Strategic Support Fund
   {[}Global Health Clinical Research Training Fellowship] (294834/Z/16/Z
   ISSF ICL), and Rodrigo M Carrillo-Larco is supported by a Wellcome Trust
   International Training Fellowship (214185/Z/18/Z). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.},
Cited-References = {Aguilar-Salinas CA, 2010, SALUD PUBLICA MEXICO, V52, pS44, DOI 10.1590/s0036-36342010000700008.
   {[}Anonymous], 2013, Rev. Mex. Cardiol, V24, P103.
   Atun R, 2015, LANCET, V385, P1230, DOI 10.1016/S0140-6736(14)61646-9.
   Authors/Task Force Members:, 2016, Atherosclerosis, V253, P281, DOI 10.1016/j.atherosclerosis.2016.08.018.
   Caja Costarricense de Seguridad Social, 2004, GUIAS DET DIAGN TRAT.
   Collins R, 2016, LANCET, V388, P2532, DOI 10.1016/S0140-6736(16)31357-5.
   Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3.
   Cotlear D, 2015, LANCET, V385, P1248, DOI 10.1016/S0140-6736(14)61647-0.
   Crespo CJ, 2002, ANN EPIDEMIOL, V12, P543, DOI 10.1016/S1047-2797(01)00296-4.
   CRUZVIDAL M, 1983, DIABETES CARE, V6, P556, DOI 10.2337/diacare.6.6.556.
   D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579.
   Danaei G, 2014, LANCET DIABETES ENDO, V2, P634, DOI 10.1016/S2213-8587(14)70102-0.
   Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619.
   Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3.
   Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7.
   Forouhi NG, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2139.
   Freire W.B, 2014, ENCUESTA NACL SALUD.
   Fulcher J, 2019, LANCET, V393, P407, DOI 10.1016/S0140-6736(18)31942-1.
   GARCIAPALMIERI MR, 1981, AM J EPIDEMIOL, V114, P29, DOI 10.1093/oxfordjournals.aje.a113171.
   GARCIAPALMIERI MR, 1988, J CLIN EPIDEMIOL, V41, P285, DOI 10.1016/0895-4356(88)90133-3.
   Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98.
   Grundy SM, 2019, J AM COLL CARDIOL, V73, P3168, DOI 10.1016/j.jacc.2018.11.002.
   Guthold R, 2018, LANCET GLOB HEALTH, V6, pE1077, DOI {[}10.1016/S2214-109X(18)30357-7, 10.1016/s2214-109x(18)30357-7].
   Lazo-Porras M, 2016, ATHEROSCLEROSIS, V246, P36, DOI 10.1016/j.atherosclerosis.2015.12.039.
   Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4.
   Liang YJ, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0685-z.
   Liberati A, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000100.
   Marafon Luiz Pedro, 2003, Cad. Saúde Pública, V19, P799, DOI 10.1590/S0102-311X2003000300012.
   McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4.
   NICE, 2014, LIP MOD CARD RISK AS.
   Ouzzani M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0384-4.
   Passi A., 2018, ARS MED REV CIENCIAS, V43, P30, DOI {[}10.11565/arsmed.v43i1.1354, DOI 10.11565/ARSMED.V43I1.1354].
   Ponte-Negretti Carlos Ignacio, 2017, Rev. Mex. Cardiol, V28, P57.
   Ravnskov U, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010401.
   Schwingshackl L, 2018, J LIPID RES, V59, P1771, DOI 10.1194/jlr.P085522.
   Sistema General de Seguridad Social en Salud Colombia, 2014, GUIA PRACT CLIN PREV.
   Sociedad Uruguaya de Aterosclerosis, 1998, 2 C UR DISL.
   SORLIE PD, 1990, INT J EPIDEMIOL, V19, P59, DOI 10.1093/ije/19.1.59.
   Stanaway JD, 2018, LANCET, V392, P1923, DOI 10.1016/s0140-6736(18)32225-6.
   Tugwell P, 2019, NEWCASTLE OTTAWA SCA.
   Werle MH, 2011, EUR J CARDIOV PREV R, V18, P369, DOI 10.1177/1741826710389405.
   Yi SW, 2018, ATHEROSCLEROSIS, V270, P211, DOI 10.1016/j.atherosclerosis.2017.12.003.
   Yusuf S, 2016, NEW ENGL J MED, V374, P2021, DOI 10.1056/NEJMoa1600176.},
Number-of-Cited-References = {43},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {PeerJ},
Doc-Delivery-Number = {JC1FA},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000489022700008},
OA = {Green Submitted, gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000301870000020,
Author = {Doubeni, Chyke A. and Schootman, Mario and Major, Jacqueline M. and
   Stone, Rosalie A. Torres and Laiyemo, Adeyinka O. and Park, Yikyung and
   Lian, Min and Messer, Lynne and Graubard, Barry I. and Sinha, Rashmi and
   Hollenbeck, Albert R. and Schatzkin, Arthur},
Title = {Health Status, Neighborhood Socioeconomic Context, and Premature
   Mortality in the United States: The National Institutes of Health-AARP
   Diet and Health Study},
Journal = {AMERICAN JOURNAL OF PUBLIC HEALTH},
Year = {2012},
Volume = {102},
Number = {4},
Pages = {680-688},
Month = {APR},
Abstract = {Objectives. We examined whether the risk of premature mortality
   associated with living in socioeconomically deprived neighborhoods
   varies according to the health status of individuals.
   Methods. Community-dwelling adults (n=566402; age=50-71 years) in 6 US
   states and 2 metropolitan areas participated in the ongoing prospective
   National Institutes of Health-AARP Diet and Health Study, which began in
   1995. We used baseline data for 565679 participants on health behaviors,
   self-rated health status, and medical history, collected by mailed
   questionnaires. Participants were linked to 2000 census data for an
   index of census tract socioeconomic deprivation. The main outcome was
   all-cause mortality ascertained through 2006.
   Results. In adjusted survival analyses of persons in good-to-excellent
   health at baseline, risk of mortality increased with increasing levels
   of census tract socioeconomic deprivation. Neighborhood socioeconomic
   mortality disparities among persons in fair-to-poor health were not
   statistically significant after adjustment for demographic
   characteristics, educational achievement, lifestyle, and medical
   conditions.
   Conclusions. Neighborhood socioeconomic inequalities lead to large
   disparities in risk of premature mortality among healthy US adults but
   not among those in poor health. (Am J Public Health. 2012;102:680-688.
   doi:10.2105/AJPH.2011.300158)},
Publisher = {AMER PUBLIC HEALTH ASSOC INC},
Address = {800 I STREET, NW, WASHINGTON, DC 20001-3710 USA},
Type = {Article},
Language = {English},
Affiliation = {Doubeni, CA (Corresponding Author), Univ Massachusetts, Dept Family Med \& Community Hlth, Sch Med, 55 Lake Ave N, Worcester, MA 01655 USA.
   Doubeni, Chyke A., Univ Massachusetts, Dept Family Med \& Community Hlth, Sch Med, Worcester, MA 01655 USA.
   Stone, Rosalie A. Torres, Univ Massachusetts, Dept Psychiat, Sch Med, Worcester, MA 01655 USA.
   Schootman, Mario; Lian, Min, Washington Univ, Sch Med, Dept Med, Div Hlth Behav Res, St Louis, MO 63110 USA.
   Major, Jacqueline M.; Park, Yikyung; Graubard, Barry I.; Sinha, Rashmi; Schatzkin, Arthur, NCI, Div Canc Epidemiol \& Genet, Bethesda, MD 20892 USA.
   Laiyemo, Adeyinka O., Howard Univ, Dept Med, Washington, DC 20059 USA.
   Messer, Lynne, Duke Univ, Ctr Hlth Policy, Durham, NC USA.
   Hollenbeck, Albert R., AARP, Washington, DC USA.},
DOI = {10.2105/AJPH.2011.300158},
ISSN = {0090-0036},
Keywords-Plus = {SELF-RATED HEALTH; ACUTE MYOCARDIAL-INFARCTION; RETIRED-PERSONS DIET;
   SOCIAL INEQUALITIES; LIFE EXPECTANCY; AMERICAN-ASSOCIATION; FOLLOW-UP;
   US; POPULATION; COHORT},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {chyke.doubeni@umassmed.edu},
ResearcherID-Numbers = {Doubeni, Chyke A/W-6749-2019
   Sinha, Rashmi/G-7446-2015
   Hollenbeck, Albert/AAG-9461-2020
   Schootman, Mario/AAF-3941-2019
   },
ORCID-Numbers = {Doubeni, Chyke A/0000-0001-7495-0285
   Sinha, Rashmi/0000-0002-2466-7462
   Schootman, Mario/0000-0003-1162-8824
   Park, Yikyung/0000-0002-6281-489X
   Torres Stone, Rosalie/0000-0002-1939-2046},
Funding-Acknowledgement = {NIHUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USA; National Cancer InstituteUnited States
   Department of Health \& Human ServicesNational Institutes of Health
   (NIH) - USANIH National Cancer Institute (NCI) {[}5K01CA127118-04,
   1R01CA151736-01, 5R01CA137750-02]; NATIONAL CANCER INSTITUTEUnited
   States Department of Health \& Human ServicesNational Institutes of
   Health (NIH) - USANIH National Cancer Institute (NCI) {[}R01CA137750,
   U01CA151736, K01CA127118, R01CA151736, ZIACP010196] Funding Source: NIH
   RePORTER},
Funding-Text = {This research was supported in part by the Intramural Research Program
   of the NIH and the National Cancer Institute. C. A. Doubeni was
   supported by grants from the National Cancer Institute (5K01CA127118-04
   and 1R01CA151736-01). M. Schootman and H. Lian were supported in part by
   a grant from the National Cancer Institute (5R01CA137750-02).},
Cited-References = {ANTONOVSKY A, 1967, MILBANK FUND Q, V45, P31, DOI 10.2307/3348839.
   ARBER S, 1987, BRIT MED J, V294, P1069, DOI 10.1136/bmj.294.6579.1069.
   Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879.
   Breeze E, 2001, AM J PUBLIC HEALTH, V91, P277, DOI 10.2105/AJPH.91.2.277.
   Burstrom B, 2001, J EPIDEMIOL COMMUN H, V55, P836, DOI 10.1136/jech.55.11.836.
   CARSTAIRS V, 1989, COMMUNITY MED, V11, P364.
   Chowdhury Pranesh, 2010, Morbidity and Mortality Weekly Report, V59, P1.
   Commission on Social Determinants of Health World Health Organization, 2008, CLOS GAP GEN HLTH EQ.
   Diez-Roux AV, 1999, J EPIDEMIOL COMMUN H, V53, P55, DOI 10.1136/jech.53.1.55.
   Do DP, 2008, AM J EPIDEMIOL, V168, P611, DOI 10.1093/aje/kwn182.
   Eibner Christine, 2004, J Ment Health Policy Econ, V7, P167.
   Ellen IG, 2001, J URBAN AFF, V23, P391, DOI 10.1111/0735-2166.00096.
   FELDMAN JJ, 1989, AM J EPIDEMIOL, V129, P919, DOI 10.1093/oxfordjournals.aje.a115225.
   Fiscella K, 2004, ACAD MED, V79, P1139, DOI 10.1097/00001888-200412000-00004.
   He W, 2003, INTERNAL MIGRATION O.
   Hemingway H, 1997, AM J PUBLIC HEALTH, V87, P1484, DOI 10.2105/AJPH.87.9.1484.
   Iribarren C, 2005, ARCH INTERN MED, V165, P2105, DOI 10.1001/archinte.165.18.2105.
   Kondo N, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4471.
   Krieger N, 2003, J EPIDEMIOL COMMUN H, V57, P186, DOI 10.1136/jech.57.3.186.
   Krieger N, 2007, EPIDEMIOLOGY, V18, P658, DOI 10.1097/EDE.0b013e318156bfcd.
   Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703.
   Messer LC, 2006, J URBAN HEALTH, V83, P1041, DOI 10.1007/s11524-006-9094-x.
   Mitrou PN, 2007, ARCH INTERN MED, V167, P2461, DOI 10.1001/archinte.167.22.2461.
   PAPPAS G, 1993, NEW ENGL J MED, V329, P103, DOI 10.1056/NEJM199307083290207.
   Phelan JC, 2004, J HEALTH SOC BEHAV, V45, P265, DOI 10.1177/002214650404500303.
   Pilote L, 2007, MED CARE, V45, P638, DOI 10.1097/MLR.0b013e3180536779.
   Power C, 1996, BRIT MED J, V313, P449.
   Regidor E, 2010, ANN EPIDEMIOL, V20, P395, DOI 10.1016/j.annepidem.2010.01.007.
   Rosvall M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-79.
   Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119.
   Singh GK, 2003, AM J PUBLIC HEALTH, V93, P1137, DOI 10.2105/AJPH.93.7.1137.
   Singh GK, 2006, INT J EPIDEMIOL, V35, P969, DOI 10.1093/ije/dyl083.
   Singh-Manoux A, 2007, INT J EPIDEMIOL, V36, P1222, DOI 10.1093/ije/dym170.
   SMITH GD, 1990, BMJ-BRIT MED J, V301, P373, DOI 10.1136/bmj.301.6748.373.
   Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297.
   Sundquist J, 1997, J EPIDEMIOL COMMUN H, V51, P35, DOI 10.1136/jech.51.1.35.
   Thompson FE, 2008, PUBLIC HEALTH NUTR, V11, P183, DOI 10.1017/S1368980007000419.
   Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039.
   Waitzman NJ, 1998, AM J PUBLIC HEALTH, V88, P973, DOI 10.2105/AJPH.88.6.973.
   WILKINSON RG, 1992, AM J PUBLIC HEALTH, V82, P1082, DOI 10.2105/AJPH.82.8.1082.
   WILKINSON RG, 1992, BRIT MED J, V304, P165, DOI 10.1136/bmj.304.6820.165.
   Winkleby MA, 2003, J EPIDEMIOL COMMUN H, V57, P444, DOI 10.1136/jech.57.6.444.
   Wolinsky FD, 2008, J AGING HEALTH, V20, P143, DOI 10.1177/0898264307310449.
   Xu J, 2009, NATL VITAL STAT REPO, V58.
   Yen IH, 1999, AM J EPIDEMIOL, V149, P898.},
Number-of-Cited-References = {45},
Times-Cited = {50},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {14},
Journal-ISO = {Am. J. Public Health},
Doc-Delivery-Number = {913IF},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000301870000020},
OA = {Green Published, Green Accepted},
DA = {2022-03-29},
}

@article{ WOS:000399425800017,
Author = {Fitzmaurice, Christina and Allen, Christine and Barber, Ryan M. and
   Barregard, Lars and Bhutta, Zulfiqar A. and Brenner, Hermann and Dicker,
   Daniel J. and Chimed-Orchir, Odgerel and Dandona, Rakhi and Dandona,
   Lalit and Fleming, Tom and Forouzanfar, Mohammad H. and Hancock, Jamie
   and Hay, Roderick J. and Hunter-Merrill, Rachel and Huynh, Chantal and
   Hosgood, H. Dean and Johnson, Catherine O. and Jonas, Jost B. and
   Khubchandani, Jagdish and Kumar, G. Anil and Kutz, Michael and Lan, Qing
   and Larson, Heidi J. and Liang, Xiaofeng and Lim, Stephen S. and Lopez,
   Alan D. and MacIntyre, Michael F. and Marczak, Laurie and Marquez, Neal
   and Mokdad, Ali H. and Pinho, Christine and Pourmalek, Farshad and
   Salomon, Joshua A. and Sanabria, Juan Ramon and Sandar, Logan and
   Sartorius, Benn and Schwartz, Stephen M. and Shackelford, Katya A. and
   Shibuya, Kenji and Stanaway, Jeff and Steiner, Caitlyn and Sun, Jiandong
   and Takahashi, Ken and Vollset, Stein Emil and Vos, Theo and Wagner,
   Joseph A. and Wang, Haidong and Westerman, Ronny and Zeeb, Hajo and
   Zoeckler, Leo and Abd-Allah, Foad and Ahmed, Muktar Beshir and Alabed,
   Samer and Alam, Noore K. and Aldhahri, Saleh Fahed and Alem, Girma and
   Alemayohu, Mulubirhan Assefa and Ali, Raghib and Al-Raddadi, Rajaa and
   Amare, Azmeraw and Amoako, Yaw and Artaman, Al and Asayesh, Hamid and
   Atnafu, Niguse and Awasthi, Ashish and Saleem, Huda Ba and Barac,
   Aleksandra and Bedi, Neeraj and Bensenor, Isabela and Berhane, Adugnaw
   and Bemabe, Eduardo and Betsu, Balem and Binagwaho, Agnes and Boneya,
   Dube and Campos-Nonato, Ismael and Castaneda-Orjuela, Carlos and
   Catala-Lopez, Ferran and Chiang, Peggy and Chibueze, Chioma and
   Chitheer, Abdulaal and Choi, Jee-Young and Cowie, Benjamin and Damtew,
   Solomon and das Neves, Jose and Dey, Suhojit and Dharmaratne, Samath and
   Dhillon, Preet and Ding, Eric and Driscoll, Tim and Ekwueme, Donatus and
   Endries, Aman Yesuf and Farvid, Maryam and Farzadfar, Farshad and
   Fernandes, Joao and Fischer, Florian and Ghiwot, Tsegaye Tewelde and
   Gebru, Alemseged and Gopalani, Sameer and Hailu, Alemayehu and Horino,
   Masako and Horita, Nobuyuki and Husseini, Abdullatif and Huybrechts,
   Inge and Inoue, Manami and Islami, Farhad and Jakovljevic, Mihajlo and
   James, Spencer and Javanbakht, Mehdi and Jee, Sun Ha and Kasaeian, Amir
   and Kedir, Muktar Sano and Khader, Yousef S. and Khang, Young-Ho and
   Kim, Daniel and Leigh, James and Linn, Shai and Lunevicius, Raimundas
   and Abd El Razek, Hassan Magdy and Malekzadeh, Reza and Malta, Deborah
   Carvalho and Marcenes, Wagner and Markos, Desalegn and Melaku, Yohannes
   A. and Meles, Kidanu G. and Mendoza, Walter and Mengiste, Desalegn
   Tadese and Meretoja, Tuomo J. and Miller, Ted R. and Mohammad, Karzan
   Abdulmuhsin and Mohammadi, Alireza and Mohammed, Shafiu and
   Moradi-Lakeh, Maziar and Nagel, Gabriele and Nand, Devina and Quyen Le
   Nguyen and Nolte, Sandra and Ogbo, Felix A. and Oladimeji, Kelechi E.
   and Oren, Eyal and Pa, Mahesh and Park, Eun-Kee and Pereira, David M.
   and Plass, Dietrich and Qorbani, Mostafa and Radfar, Amir and Rafay,
   Anwar and Rahman, Mahfuzar and Rana, Saleem M. and Soreide, Kjetil and
   Satpathy, Maheswar and Sawhney, Monika and Sepanlou, Sadaf G. and
   Shaikh, Masood Ali and She, Jun and Shiue, Ivy and Shore, Hirbo Roba and
   Shrime, Mark G. and So, Samuel and Soneji, Samir and Stathopoulou,
   Vasiliki and Stroumpoulis, Konstantinos and Sufiyan, Muawiyyah Babale
   and Sykes, Bryan L. and Tabares-Seisdedos, Rafael and Tadese, Fentaw and
   Tedla, Bemnet Amare and Tessema, Gizachew Assefa and Thakur, J. S. and
   Tran, Bach Xuan and Ukwaja, Kingsley Nnanna and Uzochukwu, Benjamin S.
   Chudi and Vlassov, Vasiliy Victorovich and Weiderpass, Elisabete and
   Terefe, Mamo Wubshet and Yebyo, Henock Gebremedhin and Yimam, Hassen
   Hamid and Yonemoto, Naohiro and Younis, Mustafa Z. and Yu, Chuanhua and
   Zaidi, Zoubida and Zaki, Maysaa El Sayed and Zenebe, Zerihun Menlkalew
   and Murray, Christopher J. L. and Naghavi, Mohsen and Global Bourden
   Disease Cancer Coll},
Title = {Global, Regional, and National Cancer Incidence, Mortality, Years of
   Life Lost, Years Lived With Disability, and Disability-Adjusted
   Life-years for 32 Cancer Groups, 1990 to 2015 A Systematic Analysis for
   the Global Burden of Disease Study},
Journal = {JAMA ONCOLOGY},
Year = {2017},
Volume = {3},
Number = {4},
Pages = {524-548},
Month = {APR 1},
Abstract = {IMPORTANCE Cancer is the second leading cause of death worldwide.
   Current estimates on the burden of cancer are needed for cancer control
   planning.
   OBJECTIVE To estimate mortality, incidence, years lived with disability
   (YLDs), years of life lost (YLLs), and disability-adjusted life-years
   (DALYs) for 32 cancers in 195 countries and territories from 1990 to
   2015.
   EVIDENCE REVIEW Cancer mortality was estimated using vital registration
   system data, cancer registry incidence data (transformed to mortality
   estimates using separately estimated mortality to incidence {[}MI]
   ratios), and verbal autopsy data. Cancer incidence was calculated by
   dividing mortality estimates through the modeled MI ratios. To calculate
   cancer prevalence, MI ratios were used to model survival. To calculate
   YLDs, prevalence estimates were multiplied by disability weights. The
   YLLs were estimated by multiplying age-specific cancer deaths by the
   reference life expectancy. DALYs were estimated as the sum of YLDs and
   YLLs. A sociodemographic index (SDI) was created for each location based
   on income per capita, educational attainment, and fertility. Countries
   were categorized by SDI quintiles to summarize results.
   FINDINGS In 2015, there were 17.5 million cancer cases worldwide and 8.7
   million deaths. Between 2005 and 2015, cancer cases increased by 33\%,
   with population aging contributing 16\%, population growth 13\%, and
   changes in age-specific rates contributing 4\%. For men, the most common
   cancer globallywas prostate cancer (1.6 million cases). Tracheal,
   bronchus, and lung cancerwas the leading cause of cancer deaths and
   DALYs in men (1.2 million deaths and 25.9 million DALYs). For women, the
   most common cancerwas breast cancer (2.4 million cases). Breast
   cancerwas also the leading cause of cancer deaths and DALYs forwomen
   (523000 deaths and 15.1 million DALYs). Overall, cancer caused 208.3
   million DALYs worldwide in 2015 for both sexes combined. Between 2005
   and 2015, age-standardized incidence rates for all cancers combined
   increased in 174 of 195 countries or territories. Age-standardized death
   rates (ASDRs) for all cancers combined decreased within that timeframe
   in 140 of 195 countries or territories. Countries with an increase in
   the ASDR due to all cancers were largely located on the African
   continent. Of all cancers, deaths between 2005 and 2015 decreased
   significantly for Hodgkin lymphoma (-6.1\%{[}95\% uncertainty interval
   (UI), -10.6\% to -1.3\%]). The number of deaths also decreased for
   esophageal cancer, stomach cancer, and chronic myeloid leukemia,
   although these results were not statistically significant.
   CONCLUSION AND RELEVANCE As part of the epidemiological transition,
   cancer incidence is expected to increase in the future, further
   straining limited health care resources. Appropriate allocation of
   resources for cancer prevention, early diagnosis, and curative and
   palliative care requires detailed knowledge of the local burden of
   cancer. The GBD 2015 study results demonstrate that progress is possible
   in the war against cancer. However, the major findings also highlight an
   unmet need for cancer prevention efforts, including tobacco control,
   vaccination, and the promotion of physical activity and a healthy diet.},
Publisher = {AMER MEDICAL ASSOC},
Address = {330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA},
Type = {Article},
Language = {English},
Affiliation = {Fitzmaurice, C (Corresponding Author), Univ Washington, Dept Med, Inst Hlth Metr \& Evaluat, Div Hematol, 2301 5th Ave,Ste 600, Seattle, WA 98121 USA.
   Fitzmaurice, Christina, Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA.
   Fitzmaurice, Christina; Allen, Christine; Barber, Ryan M.; Dicker, Daniel J.; Dandona, Lalit; Fleming, Tom; Forouzanfar, Mohammad H.; Hancock, Jamie; Hunter-Merrill, Rachel; Huynh, Chantal; Johnson, Catherine O.; Kutz, Michael; Lim, Stephen S.; MacIntyre, Michael F.; Marczak, Laurie; Marquez, Neal; Mokdad, Ali H.; Pinho, Christine; Sandar, Logan; Shackelford, Katya A.; Stanaway, Jeff; Steiner, Caitlyn; Vos, Theo; Wagner, Joseph A.; Wang, Haidong; Zoeckler, Leo; Murray, Christopher J. L.; Naghavi, Mohsen, Univ Washington, Inst Hlth Metr \& Evaluat, Seattle, WA 98195 USA.
   Barregard, Lars, Gothenburg Univ, Gothenburg, Sweden.
   Bhutta, Zulfiqar A., Aga Khan Univ, Karachi, Pakistan.
   Brenner, Hermann, German Canc Res Ctr, Heidelberg, Germany.
   Chimed-Orchir, Odgerel, Univ Occupat \& Environm Hlth, Fukuoka, Japan.
   Dandona, Rakhi; Kumar, G. Anil, Publ Hlth Fdn India, New Delhi, India.
   Hay, Roderick J., Int Fdn Dermatol, London, England.
   Hosgood, H. Dean, Albert Einstein Coll Med, Global Hlth Ctr, Dept Epidemiol \& Populat Hlth, New York, NY USA.
   Jonas, Jost B., Heidelberg Univ, Dept Ophthalmol, Mannheim, Germany.
   Khubchandani, Jagdish, Ball State Univ, Muncie, IN 47306 USA.
   Lan, Qing, Natl Canc Inst, Rockville, MD USA.
   Larson, Heidi J., London Sch Hyg \& Trop Med, London, England.
   Liang, Xiaofeng, Chinese Ctr Dis Control \& Prevent, Beijing, Peoples R China.
   Lopez, Alan D., Univ Melbourne, Sch Populat \& Global Hlth, Melbourne, Vic, Australia.
   Pourmalek, Farshad, Univ British Columbia, Vancouver, BC, Canada.
   Salomon, Joshua A., Harvard Univ, Dept Global Hlth \& Populat, Cambridge, MA 02138 USA.
   Sanabria, Juan Ramon, Marshall Univ, Sch Med, Huntington, WV USA.
   Sartorius, Benn, Univ KwaZulu Natal, Durban, South Africa.
   Schwartz, Stephen M., Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.
   Shibuya, Kenji; Inoue, Manami, Univ Tokyo, Tokyo, Japan.
   Sun, Jiandong, Queensland Univ Technol, Brisbane, Qld, Australia.
   Takahashi, Ken, Univ Occupat \& Environm Hlth, Kitakyushu, Fukuoka, Japan.
   Vollset, Stein Emil, Norwegian Inst Publ Hlth, Bergen, Norway.
   Westerman, Ronny, Fed Inst Populat Res, Hessen, Germany.
   Zeeb, Hajo, Leibniz Inst Prevent Res \& Epidemiol, Bremen, Germany.
   Abd-Allah, Foad, Cairo Univ, Dept Neurol, Cairo, Egypt.
   Ahmed, Muktar Beshir, Jimma Univ, Coll Hlth Sci, Dept Epidemiol, Jimma, Ethiopia.
   Alabed, Samer, Univ Sheffield, Coll Hlth Sci, Dept Univ Sheffield, Sheffield, S Yorkshire, England.
   Alam, Noore K., Queensland Hlth Herston, Brisbane, Qld, Australia.
   Aldhahri, Saleh Fahed, King Saud Univ, Dept Otolaryngol Head \& Neck Surg, Riyadh, Saudi Arabia.
   Alem, Girma; Boneya, Dube, Debre Markos Univ, Debre Markos, Ethiopia.
   Alemayohu, Mulubirhan Assefa, Mekelle Univ, Sch Publ Hlth, Mekelle, Ethiopia.
   Ali, Raghib, Univ Oxford, Canc Epidemiol Unit, Oxford, England.
   Al-Raddadi, Rajaa, Dept Prevent Med, Publ Hlth Directorate, Minist Hlth, Jeddah, Saudi Arabia.
   Amare, Azmeraw, Univ Adelaide, Sch Med, Adelaide, SA, Australia.
   Amare, Azmeraw, Bahir Dar Univ, Coll Med \& Hlth Sci, Bahir Dar, Ethiopia.
   Amoako, Yaw, Komfo Anokye Teaching Hosp Ghana, Dept Med, Kumasi, Ghana.
   Artaman, Al, Univ Manitoba, Community Hlth Sci, Winnipeg, MB, Canada.
   Asayesh, Hamid, Qom Univ Med Sci, Sch Paramed, Dept Emergency Med, Qom, Iran.
   Atnafu, Niguse, Mizan Tepi Univ, Coll Med \& Hlth Sci, Dept Nursing, Mizan Teferi, Ethiopia.
   Awasthi, Ashish, Nayati Multi Super Special Hosp, Dept Biostatist, Mathura, India.
   Saleem, Huda Ba, Aden Univ, Fac Med \& Hlth Sci, Aden Canc Registry \& Res Ctr, Dept Community Med, Aden, Yemen.
   Barac, Aleksandra, Univ Belgrade, Fac Med, Clin Ctr Serbia, Clin Infect \& Trop Dis, Belgrade, Serbia.
   Bedi, Neeraj, Dept Epidemiol, Coll Publ Hlth \& Trop Med, Trop Dis Unit, Jazan, Saudi Arabia.
   Bensenor, Isabela, Univ Sao Paul, Dept Internal Med, Sao Paulo, Brazil.
   Berhane, Adugnaw, Debre Berhan Univ, Coll Hlth Sci, Debre Berhan, Ethiopia.
   Berhane, Adugnaw; Marcenes, Wagner, Kings Coll London, Dent Inst, Div Populat \& Patient Hlth, London, England.
   Betsu, Balem, Mekelle Univ, Tigray, Ethiopia.
   Binagwaho, Agnes, Univ Global Hlth Equit, Kigali, Rwanda.
   Binagwaho, Agnes, Harvard Univ, Harvard Med Sch, Dept Global Hlth \& Social Med, Cambridge, MA 02138 USA.
   Campos-Nonato, Ismael, Natl Inst Publ Hlth, Morelos, Mexico.
   Castaneda-Orjuela, Carlos, Inst Nacl Salud Bogota, Bogota, Colombia.
   Catala-Lopez, Ferran; Tabares-Seisdedos, Rafael, Univ Valencia, INCLIVA Hlth Res Inst, Dept Med, Valencia, Spain.
   Catala-Lopez, Ferran; Tabares-Seisdedos, Rafael, CIBERSAM, Valencia, Spain.
   Catala-Lopez, Ferran, Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.
   Chiang, Peggy, Clin Governance Unit, Gold Coast Hlth, Southport, Qld, Australia.
   Chibueze, Chioma, Natl Ctr Child Hlth \& Dev, Tokyo, Japan.
   Chitheer, Abdulaal, Minist Hlth, Baghdad, Iraq.
   Choi, Jee-Young, Seoul Natl Univ Hosp, Seoul, South Korea.
   Cowie, Benjamin, Doherty Inst, WHO Collaborating Ctr Viral Hepatitis, Melbourne, Australia.
   Damtew, Solomon, Wolaita Sodo Univ, Sch Publ Hlth, Coll Hlth Sci \& Med, Wolaita Sodo, Ethiopia.
   das Neves, Jose, Univ Porto, Inst Invest Inovac Saude I3S, Oporto, Portugal.
   Dey, Suhojit, Indian Inst Publ Hlth Delhi, Publ Hlth Fdn India, Gurgaon, India.
   Dharmaratne, Samath, Univ Peradeniya, Fac Med, Dept Community Med, Peradeniya, Sri Lanka.
   Dhillon, Preet, Publ Hlth Fdn India, Ctr Chron Condit \& Injuries, Gurgaon, India.
   Ding, Eric, Harvard Univ, Dept Nutr, Boston, MA 02115 USA.
   Driscoll, Tim, Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia.
   Ekwueme, Donatus, Centers Dis Control \& Prevent CDC, Natl Ctr Chron Dis Prevent \& Hlth Promot, Div Canc Prevent \& Control, Atlanta, GA USA.
   Endries, Aman Yesuf, Arba Minch Univ, Arba Minch, Ethiopia.
   Farvid, Maryam, T H Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA.
   Farvid, Maryam, Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Harvard MGH Ctr Genom, Vulnerable Populat \& Hlth Dis, Boston, MA USA.
   Farzadfar, Farshad, Univ Tehran Med Sci, Endocrinol \& Metab Populat Sci Inst, Non Communicable Dis Res Ctr, Tehran, Iran.
   Fernandes, Joao, Cathol Univ Portugal, Fac Biotechnol, Ctr Biotechnol, Porto, Portugal.
   Fernandes, Joao, Cathol Univ Portugal, Fac Biotechnol, Fine Chem Associate Lab, Porto, Portugal.
   Fischer, Florian, Univ Bielefeld, Bielefeld, Germany.
   Ghiwot, Tsegaye Tewelde, Jimma Univ, Dept Epidemiol \& Biostatist, Jimma, Ethiopia.
   Gebru, Alemseged; Melaku, Yohannes A.; Mengiste, Desalegn Tadese; Yebyo, Henock Gebremedhin, Mekelle Univ, Mekelle, Ethiopia.
   Gopalani, Sameer, Govt Federated States Micronesia, Palikir, Pohnpei, Micronesia.
   Hailu, Alemayehu, Univ Addis Ababa, Addis Ababa, Ethiopia.
   Horino, Masako, Nevada Div Publ \& Behav Hlth, City, Carson, CA USA.
   Horita, Nobuyuki, Yokohama City Univ Grad, Sch Med, Yokohama, Kanagawa, Japan.
   Husseini, Abdullatif, Birzeit Univ, Inst Community \& Publ Hlth, Birzeit, Palestine.
   Huybrechts, Inge, Int Agcy Res Canc, Lyon, France.
   Islami, Farhad, Amer Canc Soc, Surveillance \& Hlth Serv Res, Atlanta, GA USA.
   Jakovljevic, Mihajlo, Univ Kragujevac, Kragujevac, Serbia.
   James, Spencer, Univ Colorado, Emergency Med, Denver Hlth, Denver, CO USA.
   Javanbakht, Mehdi, Newcastle Univ, Inst Hlth \& Soc, Hlth Econ Grp, Newcastle Upon Tyne, Tyne \& Wear, England.
   Jee, Sun Ha, Yonsei Univ, Seoul, South Korea.
   Kasaeian, Amir, Univ Tehran Med Sci, Hematol Oncol \& Stem Cell Transplantat Res Ctr, Tehran, Iran.
   Kedir, Muktar Sano, Mizan Tepi Univ, Dept Pharm, Coll Hlth Sci, Mizan Teferi, Ethiopia.
   Khader, Yousef S., Jordan Univ Sci \& Technol Irbid, Dept Community Med, Publ Hlth \& Family Med, Irbid, Jordan.
   Khang, Young-Ho, Seoul Natl Univ, Dept Hlth Policy \& Management, Seoul, South Korea.
   Khang, Young-Ho, Seoul Natl Univ Med Res Ctr, Inst Hlth Policy \& Management, Seoul, South Korea.
   Kim, Daniel, NE Univ, Dept Hlth Sci, Boston, MA USA.
   Leigh, James, Univ Sydney, Asbestos Dis Res Inst, Sydney, NSW, Australia.
   Linn, Shai, Univ Haifa, Sch Publ Hlth, Fac Social Welf \& Hlth, Haifa, Israel.
   Lunevicius, Raimundas, Aintree Univ, Hosp Natl Hlth Serv Fdn Trust, Liverpool, Merseyside, England.
   Abd El Razek, Hassan Magdy, Mansoura Fac Med, Dept Surg, Mansoura, Egypt.
   Malekzadeh, Reza, Shiraz Univ Med Sci, Non Communicable Dis Res Ctr, Shiraz, Iran.
   Malta, Deborah Carvalho, Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   Markos, Desalegn, Arsi Univ, Coll Hlth Sci, Assela, Ethiopia.
   Meles, Kidanu G., Mekelle Univ, Sch Publ Hlth, Dept Epidemiol, Coll Hlth Sci, Mekelle, Ethiopia.
   Mendoza, Walter, UNFPA Peru Country, Lima, Peru.
   Meretoja, Tuomo J., Helsinki Univ Hosp, Breast Surg Unit, Ctr Comprehens Canc, Helsinki, Finland.
   Miller, Ted R., Pacific Inst Res \& Evaluat, Calverton, MD USA.
   Miller, Ted R., Curtin Univ, Ctr Populat Hlth Res, Calverton, MD USA.
   Mohammad, Karzan Abdulmuhsin, Ishik Univ, Fac Educ, Erbil, Iraq.
   Mohammad, Karzan Abdulmuhsin, Univ Salahaddin, Fac Educ, Erbil, Iraq.
   Mohammadi, Alireza, Baqiyatallah Univ Med Sci, Neuroscience Res Ctr, Tehran, Iran.
   Mohammed, Shafiu, Ahmadu Bello Univ, Zaria, Nigeria.
   Moradi-Lakeh, Maziar, Iran Univ Med Sci, Dept Community Med, Prevent Med \& Publ Hlth Res Ctr, Tehran, Iran.
   Nagel, Gabriele, Univ Ulm, Ulm, Germany.
   Nand, Devina, Minist Hlth, Suva, Fiji.
   Quyen Le Nguyen, Duy Tan Univ, Da Nang, Vietnam.
   Nolte, Sandra, Charite, Berlin, Germany.
   Ogbo, Felix A., Univ Western Sydney, Ctr Hlth Res, Sydney, NSW, Australia.
   Oladimeji, Kelechi E., Univ KwaZulu Natal, Dept Publ Hlth Med, Coll Hlth Sci, Howard Coll Campus, Durban, South Africa.
   Oren, Eyal, Univ Arizona, Mel \& Enid Zuckerman Coll Publ Hlth, Dept Epidemiol \& Biostatist, Tucson, AZ USA.
   Pa, Mahesh, JSS Univ, Dept Pulm Med, JSS Med Coll, Mysore, Karnataka, India.
   Park, Eun-Kee, Kosin Univ, Busan, South Korea.
   Pereira, David M., Univ Porto, Porto, Portugal.
   Plass, Dietrich, German Environm Agcy, Dept Environm Hyg, Berlin, Germany.
   Qorbani, Mostafa, Alborz Univ Med Sci, Karaj, Iran.
   Radfar, Amir, A T Still Univ, Coll Grad Heath Study, Kirksville, MO USA.
   Rafay, Anwar, Contech Int Hlth Consultant, Epidemiol \& Biostatist, Lahore, Pakistan.
   Rahman, Mahfuzar, BRAC, Dhaka, Bangladesh.
   Rana, Saleem M., Contech Sch Publ Hlth, Lahore, Pakistan.
   Soreide, Kjetil, Stavanger Univ Hosp, Dept Gastrointestinal Surg, Stavanger, Norway.
   Soreide, Kjetil, Univ Bergen, Dept Clin Med, Bergen, Norway.
   Satpathy, Maheswar, All India Inst Med Sci, Jai Prakash Narayan Apex Trauma Ctr, New Delhi, India.
   Sawhney, Monika, Marshall Univ, Dept Publ Hlth, Coll Hlth Profess, Huntington, WV USA.
   Sepanlou, Sadaf G., Univ Tehran Med Sci, Digest Dis Res Inst, Tehran, Iran.
   Shaikh, Masood Ali, Independent consultant, Karachi, Pakistan.
   She, Jun, Fudan Univ, Shanghai, Peoples R China.
   Shiue, Ivy, Northumbria Univ, Newcastle Upon Tyne, Tyne \& Wear, England.
   Shore, Hirbo Roba, Haramaya Univ, Coll Hlth \& Med Sci, Harar, Ethiopia.
   Shrime, Mark G., Harvard Med Sch, Program Global Surg \& Social Change, Boston, MA USA.
   So, Samuel, Stanford Univ, Asian Liver Ctr, Palo Alto, CA USA.
   Soneji, Samir, Dartmouth Inst Hlth Policy \& Clin Practice, Geisel Sch Med, Lebanon, NH USA.
   Soneji, Samir, Dartmouth Med Sch, Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH USA.
   Stathopoulou, Vasiliki, Attikon Univ Hosp, Athens, Greece.
   Stroumpoulis, Konstantinos, Alexandra Gen Hosp Athens, Athens, Greece.
   Sufiyan, Muawiyyah Babale, Ahmadu Bello Univ, Dept Community Med, Fac Med, Zaria, Nigeria.
   Sykes, Bryan L., Univ Calif Irvine, Dept Criminol, Law Soc, Irvine, CA USA.
   Tadese, Fentaw, Wollo Univ, Dept Publ Hlth, Dessie, Ethiopia.
   Tedla, Bemnet Amare, Univ Gondar, Gondar, Ethiopia.
   Tessema, Gizachew Assefa, Univ Gondar, Inst Publ Hlth, Gondar, Ethiopia.
   Tessema, Gizachew Assefa, Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia.
   Thakur, J. S., Post Grad Inst Med Educ \& Res, Chandigarh, India.
   Tran, Bach Xuan, Johns Hopkins Univ Baltimore, Baltimore, MD USA.
   Ukwaja, Kingsley Nnanna, Fed Teaching Hosp, Dept Med, Abakaliki, Nigeria.
   Uzochukwu, Benjamin S. Chudi, Univ Nigeria Nsukka, Inst Publ Hlth, Coll Med, Enugu, Nigeria.
   Vlassov, Vasiliy Victorovich, Natl Res Univ, Higher Sch Econ, Ctr Hlth Policy, Moscow, Russia.
   Weiderpass, Elisabete, Canc Registry Norway, Inst PopulationBased Canc Res, Dept Res, Grp Etiol Canc Res, Oslo, Norway.
   Weiderpass, Elisabete, Karolinska Inst, Dept Med Epidemiol \& Biostatist, Stockholm, Sweden.
   Weiderpass, Elisabete, Genet Epidemiol Grp, Folkhalsan Res Ctr, Helsinki, Finland.
   Weiderpass, Elisabete, Arctic Univ Norwa, Univ Tromso, Dept Community Med, Tromso, Norway.
   Terefe, Mamo Wubshet, St Pauls Hosp Millenium Med Coll, Dept Publ Hlth, Addis Ababa, Ethiopia.
   Yimam, Hassen Hamid, Mizan Tepi Univ, Mizan Teferi, Ethiopia.
   Yonemoto, Naohiro, Kyoto Univ, Kyoto, Japan.
   Younis, Mustafa Z., Jackson State Univ, Dept Hlth Policy \& Management, Jackson, MS USA.
   Yu, Chuanhua, Wuhan Univ, Wuhan, Hubei, Peoples R China.
   Zaidi, Zoubida, Univ Hosp Setif, Dept Epidemiol, Setif, Algeria.
   Zaki, Maysaa El Sayed, Mansoura Fac Med, Dept Clin Pathol, Mansoura, Egypt.
   Zenebe, Zerihun Menlkalew, Mekelle Univ, Dept Midwidery, Coll Hlth Sci, Mekelle, Ethiopia.},
DOI = {10.1001/jamaoncol.2016.5688},
ISSN = {2374-2437},
EISSN = {2374-2445},
Keywords-Plus = {GASTRIC-CANCER; PRIMARY PREVENTION; RISK; EPIDEMIOLOGY; POPULATION;
   ESOPHAGEAL; COUNTRIES; MIDDLE; METAANALYSIS; PRIORITIES},
Research-Areas = {Oncology},
Web-of-Science-Categories  = {Oncology},
Author-Email = {cf11@uw.edu},
ResearcherID-Numbers = {Naohiro, Yonemoto/Y-3761-2019
   Neves, José das/J-8369-2013
   Brenner, Hermann/ABE-6383-2020
   Ahmed, Muktar B/G-6184-2019
   Barac, Aleksandra/W-9785-2019
   Hassen, Hamid Y./K-6445-2019
   Hassen, Hamid Y./A-1105-2019
   Awasthi, Ashish/Y-5915-2019
   Mohammadi, Alireza/R-9202-2016
   Brenner, Hermann/B-4627-2017
   Al-Raddadi, Rajaa/F-8337-2010
   Bensenor, Isabela Judith Martins/L-3306-2017
   Linn, Shai/N-3079-2019
   Basaleem, Huda/AAX-9878-2020
   Radfar, Amir/I-8057-2019
   Salomon, Joshua/S-1929-2019
   Alsharif, Ubai/C-6527-2017
   Mohammed, Shafiu/AAR-7889-2020
   Søreide, Kjetil/A-9797-2010
   f, m/AAM-2063-2021
   Roba, Hirbo Shore/AAA-3995-2021
   Zaki, Maysaa El Sayed/H-3049-2019
   Jakovljevic, Mihajlo B/B-3002-2014
   Takahashi, Ken/AAX-7705-2020
   Rana, Saleem/Y-9791-2018
   Khader, Yousef/AAE-9620-2019
   Zeeb, Hajo/I-2701-2019
   Dhimal, Meghnath/AAD-7261-2021
   Rubino, Salvatore/AAC-5848-2022
   Alabed, Samer/AAO-4969-2020
   Zaki, Maysaa El Sayed/C-1522-2013
   Satpathy, Maheswar/J-3135-2017
   Amare, Azmeraw T./B-9487-2018
   Malta, Deborah C/H-7880-2012
   wang, edwin/G-5372-2010
   Oladimeji, Kelechi Elizabeth/AAF-2155-2019
   Fernandes, Joao C/AAF-2091-2019
   Moradi-Lakeh, Maziar/ABC-9793-2021
   Ahmed, Muktar/AAY-6783-2020
   Tessema, Gizachew/J-9235-2018
   N, Bedi/H-2838-2019
   Ding, Eric L./K-1118-2019
   Catalá-López, Ferrán/N-6018-2018
   Alemayohu, Mulubirhan Assefa/ABB-1567-2020
   Oren, Eyal/AAD-5561-2019
   Khubchandani, Jagdish/D-1831-2014
   Endries, Aman Yesuf/AAN-6871-2021
   Pereira, David M./M-9286-2013
   Nagel, Gabriele/C-3635-2012
   Alabed, Samer/J-8263-2014
   Malekzadeh, Reza/U-1382-2017
   Ukwaja, Kingsley N./A-7794-2013
   Kedir, Muktar Sano/Z-2951-2019
   Salomon, Joshua A/D-3898-2009
   Bernabe, Eduardo/R-3441-2017
   Lopez, Alan/AAA-2734-2022
   Melaku, Yohannes Adama/S-2451-2019
   Hailu, Alemayehu/AAZ-5206-2020
   Kasaeian, Amir/C-8290-2017
   Pourmalek, Farshad/A-8188-2010
   Mokdad, Ali H./AAD-1232-2022
   Sepanlou, Sadaf G/H-9343-2016
   Tabares-Seisdedos, Rafael/H-6432-2013
   Lopez, Alan D/F-1487-2010
   Nolte, Sandra/B-7498-2008
   Malta, Deborah Carvalho/L-2491-2019
   Weiderpass, Elisabete/M-4029-2016
   Castañeda-Orjuela, Carlos/N-2601-2017
   Qorbani, Mostafa/M-8171-2017
   Alam, Noore/AAU-9616-2020
   Mohammed, Shafiu/P-2016-2014
   Husseini, Abdullatif/E-8377-2015
   Weiderpass, Elisabete/AAP-2747-2021
   Larson, Heidi J./N-1018-2017
   Bhutta, Zulfiqar/L-7822-2015
   },
ORCID-Numbers = {Neves, José das/0000-0002-2317-2759
   Brenner, Hermann/0000-0002-6129-1572
   Ahmed, Muktar B/0000-0002-9524-7027
   Hassen, Hamid Y./0000-0001-6485-4193
   Hassen, Hamid Y./0000-0001-6485-4193
   Awasthi, Ashish/0000-0002-9308-9782
   Mohammadi, Alireza/0000-0002-1004-5339
   Brenner, Hermann/0000-0002-6129-1572
   Al-Raddadi, Rajaa/0000-0002-8921-9628
   Linn, Shai/0000-0002-0867-2958
   Basaleem, Huda/0000-0002-7353-5140
   Radfar, Amir/0000-0001-6177-3048
   Salomon, Joshua/0000-0003-3929-5515
   Alsharif, Ubai/0000-0002-4024-3950
   Mohammed, Shafiu/0000-0001-5715-966X
   Søreide, Kjetil/0000-0001-7594-4354
   Zaki, Maysaa El Sayed/0000-0001-5431-0248
   Jakovljevic, Mihajlo B/0000-0002-9160-6846
   Takahashi, Ken/0000-0002-7310-2257
   Rana, Saleem/0000-0001-6479-9235
   Khader, Yousef/0000-0002-7830-6857
   Dhimal, Meghnath/0000-0001-7176-7821
   Alabed, Samer/0000-0002-9960-7587
   Zaki, Maysaa El Sayed/0000-0001-5431-0248
   Satpathy, Maheswar/0000-0003-3521-4781
   Amare, Azmeraw T./0000-0002-7940-0335
   Malta, Deborah C/0000-0002-8214-5734
   Oladimeji, Kelechi Elizabeth/0000-0002-0246-5595
   Fernandes, Joao C/0000-0003-1556-1698
   Moradi-Lakeh, Maziar/0000-0001-7381-5305
   Ahmed, Muktar/0000-0002-9524-7027
   Tessema, Gizachew/0000-0002-4784-8151
   Ding, Eric L./0000-0002-5881-8097
   Catalá-López, Ferrán/0000-0002-3833-9312
   Alemayohu, Mulubirhan Assefa/0000-0001-8370-019X
   Khubchandani, Jagdish/0000-0002-9058-4278
   Pereira, David M./0000-0003-0384-7592
   Nagel, Gabriele/0000-0001-6185-8535
   Alabed, Samer/0000-0002-9960-7587
   Malekzadeh, Reza/0000-0002-9820-6335
   Ukwaja, Kingsley N./0000-0002-1974-8735
   Kedir, Muktar Sano/0000-0003-2365-6523
   Salomon, Joshua A/0000-0003-3929-5515
   Bernabe, Eduardo/0000-0002-1858-3713
   Melaku, Yohannes Adama/0000-0002-3051-7313
   Hailu, Alemayehu/0000-0003-4872-8036
   Kasaeian, Amir/0000-0003-2018-9368
   Pourmalek, Farshad/0000-0002-2134-0771
   Mokdad, Ali H./0000-0002-4994-3339
   Sepanlou, Sadaf G/0000-0002-3669-5129
   Lopez, Alan D/0000-0001-5818-6512
   Nolte, Sandra/0000-0001-6185-9423
   Malta, Deborah Carvalho/0000-0002-8214-5734
   Weiderpass, Elisabete/0000-0003-2237-0128
   Castañeda-Orjuela, Carlos/0000-0002-8735-6223
   Alam, Noore/0000-0002-1150-7582
   Mohammed, Shafiu/0000-0001-5715-966X
   Husseini, Abdullatif/0000-0001-8767-5956
   Weiderpass, Elisabete/0000-0003-2237-0128
   Farvid, Maryam/0000-0003-1783-4186
   Larson, Heidi J./0000-0002-8477-7583
   Roba, Hirbo Shore/0000-0003-2454-5200
   Tabares-Seisdedos, Rafael/0000-0002-1089-2204
   Zeeb, Hajo/0000-0001-7509-242X
   Dandona, Rakhi/0000-0003-0926-788X
   Chitheer, Abdulaal/0000-0003-4899-6196
   Stanaway, Jeffrey/0000-0003-2209-8478
   Yebyo, Henock/0000-0001-5400-2448
   ZAIDI, ZOUBIDA/0000-0003-3378-4799
   Stroumpoulis, Konstantinos/0000-0003-3234-3772
   Abd-Allah, Foad/0000-0001-8308-5756
   Sufiyan, Muawiyyah Babale/0000-0003-3630-6995
   Shibuya, Kenji/0000-0003-2528-7530
   Bhutta, Zulfiqar/0000-0003-0637-599X
   Berhane, Adugnaw/0000-0003-2160-958X
   /0000-0002-4565-5364
   Marczak, Laurie/0000-0001-5979-4261
   Miller, Ted/0000-0002-0958-2639},
Funding-Acknowledgement = {Bill and Melinda Gates FoundationBill \& Melinda Gates Foundation;
   National Institutes of HealthUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USA {[}5T32HL007093-40];
   National Institute for Health ResearchNational Institute for Health
   Research (NIHR) {[}ACF-2014-04-008] Funding Source: researchfish;
   NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of
   Health \& Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung \& Blood Institute (NHLBI) {[}T32HL007093] Funding
   Source: NIH RePORTER},
Funding-Text = {The Institute for Health Metrics and Evaluation received funding from
   the Bill and Melinda Gates Foundation. Dr Fitzmaurice was supported by
   National Institutes of Health grant 5T32HL007093-40.},
Cited-References = {Action CC, 2015, M REP LOND NOV 3 4.
   Ahern RM, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-8.
   Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9.
   Anderson BO, 2011, LANCET ONCOL, V12, P387, DOI 10.1016/S1470-2045(11)70031-6.
   Anderson BO, 2015, CANC DIS CONTROL PRI, V3.
   Arbyn M, 2009, EUR J CANCER, V45, P2640, DOI 10.1016/j.ejca.2009.07.018.
   Arnold M, 2015, GUT, V64, P381, DOI 10.1136/gutjnl-2014-308124.
   Bray F, 2016, CANCER EPIDEM BIOMAR, V25, P3, DOI 10.1158/1055-9965.EPI-15-1109.
   Cao Y, 2016, JAMA ONCOL, V2, P762, DOI 10.1001/jamaoncol.2015.6396.
   Carlson JW, 2010, AM J SURG PATHOL, V34, P118, DOI 10.1097/PAS.0b013e3181c17fe6.
   Chalkidou K, 2014, LANCET ONCOL, V15, pE119, DOI 10.1016/S1470-2045(13)70547-3.
   Chan AT, 2010, GASTROENTEROLOGY, V138, P2029, DOI 10.1053/j.gastro.2010.01.057.
   Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353.
   Choi KS, 2015, BRIT J CANCER, V112, P608, DOI 10.1038/bjc.2014.608.
   Clague J, 2012, CURR ONCOL REP, V14, P550, DOI 10.1007/s11912-012-0265-5.
   Clark H, 2013, LANCET, V381, P510, DOI 10.1016/S0140-6736(13)60058-6.
   Colditz GA, 2014, CA-CANCER J CLIN, V64, P186, DOI 10.3322/caac.21225.
   Coleman MP, 2014, LANCET, V383, P564, DOI 10.1016/S0140-6736(13)62225-4.
   de Martel C, 2013, GASTROENTEROL CLIN N, V42, P219, DOI 10.1016/j.gtc.2013.01.003.
   Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735.
   Flaxman AD, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-35.
   Ford AC, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3174.
   Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1.
   Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8.
   Gandini S, 2005, EUR J CANCER, V41, P2040, DOI 10.1016/j.ejca.2005.03.034.
   Gelband H, 2016, LANCET, V387, P2133, DOI 10.1016/S0140-6736(15)00755-2.
   Grady D, 2016, NY TIMES.
   Hanahan D, 2014, LANCET, V383, P558, DOI 10.1016/S0140-6736(13)62226-6.
   Holmes RS, 2007, SEMIN RADIAT ONCOL, V17, P2, DOI 10.1016/j.semradonc.2006.09.003.
   Horton S, 2015, CANC DIS CONTROL PRI, V3.
   Ilbawi AM, 2015, ANN SURG ONCOL, V22, P719, DOI 10.1245/s10434-014-4346-6.
   International Agency for Research on Cancer, HEL PYL ER START PRE.
   Kassebaum NJ, 2016, LANCET, V388, P1603, DOI 10.1016/S0140-6736(16)31460-X.
   Lee KJ, 2006, INT J CANCER, V118, P2315, DOI 10.1002/ijc.21664.
   Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X.
   Levit L, 2013, ADDRESSING CHALLENGE.
   Lim SS, 2016, LANCET, V388, P1813, DOI 10.1016/S0140-6736(16)31467-2.
   Lin JS, 2016, JAMA-J AM MED ASSOC, V315, P2576, DOI 10.1001/jama.2016.3332.
   Lomas A, 2012, BRIT J DERMATOL, V166, P1069, DOI 10.1111/j.1365-2133.2012.10830.x.
   Loomis D, 2016, LANCET ONCOL, V17, P877, DOI 10.1016/S1470-2045(16)30239-X.
   Lowy DR, 2016, NEW ENGL J MED, V374, P1901, DOI 10.1056/NEJMp1600894.
   Mikkelsen L, 2015, LANCET, V386, P1395, DOI 10.1016/S0140-6736(15)60171-4.
   Miyamoto A, 2007, PREV MED, V44, P12, DOI 10.1016/j.ypmed.2006.07.016.
   Mizoue T, 2003, INT J CANCER, V106, P103, DOI 10.1002/ijc.11183.
   Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534.
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2.
   Pera M, 2005, J SURG ONCOL, V92, P151, DOI 10.1002/jso.20357.
   Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9.
   Petrick JL, 2016, INT J CANCER, V139, P1534, DOI 10.1002/ijc.30211.
   Plummer M, 2016, LANCET GLOB HEALTH, V4, pE609, DOI 10.1016/S2214-109X(16)30143-7.
   Qu CF, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001774.
   Ryerson AB, 2016, CANCER-AM CANCER SOC, V122, P1312, DOI 10.1002/cncr.29936.
   Siripongpreeda B, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0526-0.
   Stefan Daniela Cristina, 2015, J Glob Oncol, V1, P30, DOI 10.1200/JGO.2015.000406.
   Steffen A, 2015, INT J CANCER, V137, P646, DOI 10.1002/ijc.29432.
   Stevens GA, 2016, PLOS MED, V13, DOI {[}10.1371/journal.pmed.1002056, 10.1371/journal.pmed.1002116].
   Stringhini S, 2012, AM J EPIDEMIOL, V175, P1275, DOI 10.1093/aje/kwr461.
   Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297.
   Tsu V, 2016, NEW ENGL J MED, V374, P2509, DOI 10.1056/NEJMp1604113.
   UN, SUST DEV GOALS.
   United Nations, 2011 HIGH LEV M PREV.
   Vineis P, 2014, LANCET, V383, P549, DOI 10.1016/S0140-6736(13)62224-2.
   Vos T, 2016, LANCET, V388, P1545, DOI {[}10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1].
   Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1.
   Wolk A, 2017, J INTERN MED, V281, P106, DOI 10.1111/joim.12543.
   World Health Organization, 2016, GLOB HLTH SECT STRAT.
   World Health Organization, GLOB ACT PLAN PREV C.
   Yang P, 2009, EUR J CANCER, V45, P2867, DOI 10.1016/j.ejca.2009.04.019.
   Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370.},
Number-of-Cited-References = {69},
Times-Cited = {2391},
Usage-Count-Last-180-days = {37},
Usage-Count-Since-2013 = {404},
Journal-ISO = {JAMA Oncol.},
Doc-Delivery-Number = {ES3JL},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000399425800017},
OA = {Green Accepted, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000449559500016,
Author = {Fitzmaurice, Christina and Akinyemiju, Tomi F. and Al Lami, Faris Hasan
   and Alam, Tahiya and Alizadeh-Navaei, Reza and Allen, Christine and
   Alsharif, Ubai and Alvis-Guzman, Nelson and Amini, Erfan and Anderson,
   Benjamin O. and Aremu, Olatunde and Artaman, Al and Asgedom, Solomon
   Weldegebreal and Assadi, Reza and Atey, Tesfay Mehari and Avila-Burgos,
   Leticia and Awasthi, Ashish and Saleem, Huda Omer Ba and Barac,
   Aleksandra and Bennett, James R. and Bensenor, Isabela M. and Bhakta,
   Nickhill and Brenner, Hermann and Cahuana-Hurtado, Lucero and
   Castaneda-Orjuela, Carlos A. and Castaneda-Orjuela, Carlos A. and
   Catala-Lopez, Ferran and Choi, Jee-Young Jasmine and Christopher,
   Devasahayam Jesudas and Chung, Sheng-Chia and Curado, Maria Paula and
   Dandona, Lalit and Dandona, Rakhi and das Neves, Jose and Dey, Subhojit
   and Dharmaratne, Samath D. and Doku, David Teye and Driscoll, Timr. and
   Dubey, Manisha and Ebrahimi, Hedyeh and Edessa, Dumessa and El-Khatib,
   Ziad and Endries, Aman Yesuf and Fischer, Florian and Force, Lisa M. and
   Foreman, Kyle J. and Gebrehiwot, Solomon Weldemariam and Gopalani,
   Sameer Vali and Grosso, Giuseppe and Gupta, Rahul and Gyawali, Bishal
   and Hamadeh, Randah Ribhi and Hamidi, Samer and Harvey, James and
   Hassen, Hamid Yimam and Hay, Roderick J. and Hay, Simon I. and Heibati,
   Behzad and Hiluf, Molla Kahssay and Horita, Nobuyuki and Hosgood, H.
   Dean and Ilesanmi, Olayinka S. and Innos, Kaire and Islami, Farhad and
   Jakovljevic, Mihajlo B. and Johnson, Sarah Charlotte and Jonas, Jost B.
   and Kasaeian, Amir and Kassa, Tesfaye Dessale and Khader, Yousef Saleh
   and Khan, Ejaz Ahmad and Khan, Gulfaraz and Khang, Young-Ho and
   Khosravi, Mohammad Hossein and Khubchandani, Jagdish and Kopec, Jacek A.
   and Kumar, G. Anil and Kutz, Michael and Lad, Deepesh Pravinkumar and
   Lafranconi, Alessandra and Lan, Qing and Legesse, Yirga and Leigh, James
   and Linn, Shai and Lunevicius, Raimundas and Majeed, Azeem and
   Malekzadeh, Reza and Malta, Deborah Carvalho and Mantovani, Lorenzo G.
   and McMahon, Brian J. and Meier, Toni and Melaku, Yohannes Adama and
   Melku, Mulugeta and Memiah, Peter and Mendoza, Walter and Meretoja,
   Tuomo J. and Mezgebe, Haftay Berhane and Miller, Ted R. and Mohammed,
   Shafiu and Mokdad, Ali H. and Moosazadeh, Mahmood and Moraga, Paula and
   Mousavi, Seyyed Meysam and Nangia, Vinay and Cuong Tat Nguyen and Vuong
   Minh Nong and Ogbo, Felix Akpojene and Olagunju, Andrew Toyin and
   Mahesh, P. A. and Park, Eun-Kee and Patel, Tejas and Pereira, David M.
   and Pishgar, Farhad and Postma, Maarten J. and Pourmalek, Farshad and
   Qorbani, Mostafa and Rafay, Anwar and Rawaf, Salman and Rawaf, David
   Laith and Roshandel, Gholamreza and Safiri, Saeid and Salimzadeh,
   Hamideh and Sanabria, Juan Ramon and Milicevic, Milena M. Santric and
   Sartorius, Benn and Satpathy, Maheswar and Sepanlou, Sadaf G. and
   Shackelford, Katya Anne and Shaikh, Masood Ali and Sharif-Alhoseini,
   Mahdi and She, Jun and Shin, Min-Jeong and Shiue, Ivy and Shrime, Mark
   G. and Sinke, Abiy Hiruye and Sisay, Mekonnen and Sligar, Amber and
   Sufiyan, Muawiyyah Babale and Sykes, Bryan L. and Tabares-Seisdedos,
   Rafael and Tessema, Gizachew Assefa and Topor-Madry, Roman and Tung
   Thanh Tran and Bach Xuan Tran and Ukwaja, Kingsley Nnanna and Vlassov,
   Vasiliy Victorovich and Vollset, Stein Emil and Weiderpass, Elisabete
   and Williams, Hywel C. and Yimer, Nigus Bililign and Yonemoto, Naohiro
   and Younis, Mustafa Z. and Murray, Christopher J. L. and Naghavi, Mohsen
   and Global Burden Dis Canc Collaborat},
Title = {Global, Regional, and National Cancer Incidence, Mortality, Years of
   Life Lost, Years Lived With Disability, and Disability-Adjusted
   Life-Years for 29 Cancer Groups, 1990 to 2016 A Systematic Analysis for
   the Global Burden of Disease Study},
Journal = {JAMA ONCOLOGY},
Year = {2018},
Volume = {4},
Number = {11},
Pages = {1553-1568},
Month = {NOV},
Note = {54th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO),
   Chicago, IL, JUN 01-05, 2018},
Organization = {Amer Soc Clin Oncol},
Abstract = {IMPORTANCE The increasing burden due to cancer and other noncommunicable
   diseases poses a threat to human development, which has resulted in
   global political commitments reflected in the Sustainable Development
   Goals as well as the World Health Organization (WHO) Global Action Plan
   on Non-Communicable Diseases. To determine if these commitments have
   resulted in improved cancer control, quantitative assessments of the
   cancer burden are required.
   OBJECTIVE To assess the burden for 29 cancer groups over time to provide
   a framework for policy discussion, resource allocation, and research
   focus.
   EVIDENCE REVIEW Cancer incidence, mortality, years lived with
   disability, years of life lost, and disability-adjusted life-years
   (DALYs) were evaluated for 195 countries and territories by age and sex
   using the Global Burden of Disease study estimation methods. Levels and
   trends were analyzed over time, as well as by the Sociodemographic Index
   (SDI). Changes in incident cases were categorized by changes due to
   epidemiological vs demographic transition.
   FINDINGS In 2016, there were 17.2 million cancer cases worldwide and 8.9
   million deaths. Cancer cases increased by 28\% between 2006 and 2016.
   The smallest increase was seen in high SDI countries. Globally,
   population aging contributed 17\%; population growth, 12\%; and changes
   in age-specific rates, -1\% to this change. The most common incident
   cancer globally for men was prostate cancer (1.4 million cases). The
   leading cause of cancer deaths and DALYs was tracheal, bronchus, and
   lung cancer (1.2 million deaths and 25.4 million DALYs). For women, the
   most common incident cancer and the leading cause of cancer deaths and
   DALYs was breast cancer (1.7 million incident cases, 535 000 deaths, and
   14.9 million DALYs). In 2016, cancer caused 213.2 million DALYs globally
   for both sexes combined. Between 2006 and 2016, the average annual
   age-standardized incidence rates for all cancers combined increased in
   130 of 195 countries or territories, and the average annual
   age-standardized death rates decreased within that timeframe in 143 of
   195 countries or territories.
   CONCLUSIONS AND RELEVANCE Large disparities exist between countries in
   cancer incidence, deaths, and associated disability. Scaling up cancer
   prevention and ensuring universal access to cancer care are required for
   health equity and to fulfill the global commitments for noncommunicable
   disease and cancer control.},
Publisher = {AMER MEDICAL ASSOC},
Address = {330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA},
Type = {Article; Proceedings Paper},
Language = {English},
Affiliation = {Fitzmaurice, C (Corresponding Author), Univ Washington, Inst Hlth Metr \& Evaluat, Dept Med, Div Hematol, 2301 5th Ave,Ste 600, Seattle, WA 98121 USA.
   Fitzmaurice, Christina, Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA.
   Fitzmaurice, Christina; Alam, Tahiya; Allen, Christine; Bennett, James R.; Dandona, Lalit; Dandona, Rakhi; Foreman, Kyle J.; Harvey, James; Hay, Simon I.; Johnson, Sarah Charlotte; Kutz, Michael; Mokdad, Ali H.; Shackelford, Katya Anne; Sligar, Amber; Vollset, Stein Emil; Murray, Christopher J. L.; Naghavi, Mohsen, Univ Washington, Inst Hlth Metr \& Evaluat, Seattle, WA 98195 USA.
   Fitzmaurice, Christina, Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.
   Akinyemiju, Tomi F., Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA.
   Al Lami, Faris Hasan, Baghdad Coll Med, Baghdad, Iraq.
   Alizadeh-Navaei, Reza, Mazandaran Univ Med Sci, Gastrointestinal Canc Res Ctr, Sari, Iran.
   Alsharif, Ubai, Charite Univ Med Berlin, Berlin, Germany.
   Alvis-Guzman, Nelson, Univ Cartagena, Univ Costa, ALZAK Fdn, Cartagena De Indias, Colombia.
   Amini, Erfan; Ebrahimi, Hedyeh, Univ Tehran Med Sci, Endocrinol \& Metab Populat Sci Inst, Tehran, Iran.
   Amini, Erfan; Pishgar, Farhad, Univ Tehran Med Sci, Urooncol Res Ctr, Tehran, Iran.
   Anderson, Benjamin O., Univ Washington, Seattle, WA 98195 USA.
   Aremu, Olatunde, Birmingham City Univ, Dept Publ Hlth \& Therapies, Birmingham, W Midlands, England.
   Artaman, Al, Univ Manitoba, Winnipeg, MB, Canada.
   Asgedom, Solomon Weldegebreal; Atey, Tesfay Mehari; Kassa, Tesfaye Dessale; Legesse, Yirga; Mezgebe, Haftay Berhane, Mekelle Univ, Mekelle, Ethiopia.
   Assadi, Reza, Mashhad Univ Med Sci, Mashhad, Iran.
   Avila-Burgos, Leticia; Cahuana-Hurtado, Lucero, Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico.
   Awasthi, Ashish, Indian Inst Publ Hlth, Gandhinagar, Gujarat, India.
   Saleem, Huda Omer Ba, Aden Univ, Fac Med \& Hlth Sci, Aden, Yemen.
   Barac, Aleksandra, Univ Belgrade, Fac Med, Belgrade, Serbia.
   Bensenor, Isabela M., Univ Sao Paulo, Sao Paulo, SP, Brazil.
   Bhakta, Nickhill; Force, Lisa M., St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA.
   Brenner, Hermann, German Canc Res Ctr, Heidelberg, Germany.
   Castaneda-Orjuela, Carlos A., Colombian Natl Hlth Observ, Inst Nacl Salud, Bogota, DC, Colombia.
   Castaneda-Orjuela, Carlos A., Univ Nacl Colombia, Publ Hlth Dept, Epidemiol \& Publ Hlth Evaluat Grp, Bogota, Colombia.
   Catala-Lopez, Ferran; Tabares-Seisdedos, Rafael, Univ Valencia, INCLIVA Hlth Res Inst, Dept Med, Valencia, Spain.
   Catala-Lopez, Ferran; Tabares-Seisdedos, Rafael, CIBERSAM, Valencia, Spain.
   Catala-Lopez, Ferran, Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.
   Choi, Jee-Young Jasmine, Seoul Natl Univ Hosp, Seoul, South Korea.
   Choi, Jee-Young Jasmine, Seoul Natl Univ, Med Lib, Seoul, South Korea.
   Christopher, Devasahayam Jesudas, Christian Med Coll \& Hosp, Vellore, Tamil Nadu, India.
   Chung, Sheng-Chia, UCL, Inst Hlth Informat, Farr Inst Hlth Informat Res, London, England.
   Curado, Maria Paula, Accamargo Canc Ctr, Sao Paulo, SP, Brazil.
   Curado, Maria Paula, Int Prevent Res Inst, Ecully, France.
   Dandona, Lalit; Dandona, Rakhi; Kumar, G. Anil, Publ Hlth Fdn India, Gurugram, Natl Capital Re, India.
   das Neves, Jose, Univ Porto, Inst Engn Biomed, INEB, Porto, Portugal.
   das Neves, Jose, Univ Porto, Inst Invest Inovacao Saude, I3S, Porto, Portugal.
   Dey, Subhojit, Indian Inst Publ Hlth, Delhi, India.
   Dharmaratne, Samath D., Univ Peradeniya, Fac Med, Dept Community Med, Peradeniya, Sri Lanka.
   Doku, David Teye, Univ Cape Coast, Cape Coast, Ghana.
   Doku, David Teye, Univ Tampere, Tampere, Finland.
   Driscoll, Timr., Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia.
   Dubey, Manisha, Int Inst Populat Sci, Bombay, Maharashtra, India.
   Ebrahimi, Hedyeh, Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Inst, Liver \& Pancreaticobiliary Dis Res Ctr, Tehran, Iran.
   Edessa, Dumessa; Sisay, Mekonnen, Haramaya Univ, Harar, Ethiopia.
   El-Khatib, Ziad, Harvard Med Sch, Dept Global Hlth \& Social Med, Kigali, Rwanda.
   El-Khatib, Ziad, Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.
   Endries, Aman Yesuf, Arba Minch Univ, Arba Minch, Snnpr, Ethiopia.
   Fischer, Florian, Bielefeld Univ, Sch Publ Hlth, Bielefeld, North Rhine Wes, Germany.
   Foreman, Kyle J.; Rawaf, Salman, Imperial Coll London, London, England.
   Gebrehiwot, Solomon Weldemariam, Mekelle Univ, Coll Hlth Sci, Mekelle, Ethiopia.
   Gopalani, Sameer Vali, Govt Federated States Micronesia, Dept Hlth \& Social Affairs, Palikir, Pohnpei, Micronesia.
   Grosso, Giuseppe, Univ Hosp Policlin Vittorio Emanuele, Catania, Italy.
   Grosso, Giuseppe, NNEdPro Global Ctr Nutr \& Hlth, Cambridge, England.
   Gupta, Rahul, West Virginia Bur Publ Hlth, Charleston, WV USA.
   Gyawali, Bishal, Aarhus Univ, Aarhus, Denmark.
   Hamadeh, Randah Ribhi, Arabian Gulf Univ, Manama, Bahrain.
   Hamidi, Samer, Haan Bin Mohammed Smart Univ, Dubai, U Arab Emirates.
   Hassen, Hamid Yimam, Mizan Tepi Univ, Mizan Teferi, Ethiopia.
   Hay, Roderick J., Int Fdn Dermatol, London, England.
   Hay, Roderick J., Kings Coll London, London, England.
   Hay, Simon I., Univ Oxford, Li Ka Shing Ctr Hlth Informat \& Discovery, Oxford Big Data Inst, Oxford, England.
   Heibati, Behzad, Iran Univ Med Sci, Air Pollut Res Ctr, Tehran, Iran.
   Hiluf, Molla Kahssay, Samara Univ, Samara, Ethiopia.
   Horita, Nobuyuki, Yokohama City Univ, Grad Sch Med, Dept Pulmonol, Yokohama, Kanagawa, Japan.
   Hosgood, H. Dean, Albert Einstein Coll Med, Bronx, NY 10467 USA.
   Ilesanmi, Olayinka S., Natl Publ Hlth Inst, Monrovia, Monserrado Cty, Liberia.
   Innos, Kaire, Natl Inst Hlth Dev, Tallinn, Estonia.
   Islami, Farhad, Amer Canc Soc, Surveillance \& Hlth Serv Res, Atlanta, GA 30329 USA.
   Jakovljevic, Mihajlo B., Univ Kragujevac, Fac Med Sci, Kragujevac, Cent Serbia, Serbia.
   Jakovljevic, Mihajlo B., Univ Washington, Ctr Hlth Trends \& Forecasts, Seattle, WA 98195 USA.
   Jonas, Jost B., Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany.
   Kasaeian, Amir, Univ Tehran Med Sci, Hematol Malignancies Res Ctr, Tehran, Iran.
   Kasaeian, Amir, Univ Tehran Med Sci, Hematol Oncol \& Stem Cell Transplantat Res Ctr, Tehran, Iran.
   Khader, Yousef Saleh, Jordan Univ Sci \& Technol, Dept Community Med Publ Hlth \& Family Med, Irbid, Jordan.
   Khan, Ejaz Ahmad, Hlth Serv Acad, Islamabad, Punjab, Pakistan.
   Khan, Gulfaraz, United Arab Emirates Univ, Coll Med \& Hlth Sci, Dept Microbiol \& Immunol, Abu Dhabi, U Arab Emirates.
   Khang, Young-Ho, Seoul Natl Univ, Coll Med, Dept Hlth Policy \& Management, Seoul, South Korea.
   Khang, Young-Ho, Seoul Natl Univ, Med Ctr, Inst Hlth Policy \& Management, Seoul, South Korea.
   Khosravi, Mohammad Hossein, Baqiyatallah Univ Med Sci, Tehran, Iran.
   Khosravi, Mohammad Hossein, USERN, IORA, Tehran, Iran.
   Khubchandani, Jagdish, Ball State Univ, Dept Nutr \& Hlth Sci, Muncie, IN 47306 USA.
   Kopec, Jacek A.; Pourmalek, Farshad, Univ British Columbia, Vancouver, BC, Canada.
   Lad, Deepesh Pravinkumar, Post Grad Inst Med Educ \& Res, Chandigarh, India.
   Lafranconi, Alessandra; Mantovani, Lorenzo G., Univ Milano Bicocca, Monza, MB, Italy.
   Lan, Qing, NCI, Rockville, MD USA.
   Leigh, James, Univ Sydney, Sydney, NSW, Australia.
   Linn, Shai, Univ Haifa, Haifa, Israel.
   Lunevicius, Raimundas, Aintree Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England.
   Lunevicius, Raimundas, Univ Liverpool, Sch Med, Liverpool, Merseyside, England.
   Majeed, Azeem, Imperial Coll London, Dept Primary Care \& Publ Hlth, London, England.
   Malekzadeh, Reza; Roshandel, Gholamreza; Sepanlou, Sadaf G., Univ Tehran Med Sci, Digest Dis Res Inst, Tehran, Iran.
   Malta, Deborah Carvalho, Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   McMahon, Brian J., Alaska Native Tribal Hlth Consortium, Anchorage, AK USA.
   Meier, Toni, Martin Luther Univ Halle Wittenberg, Competence Cluster Nutr \& Cardiovasc Hlth NutriCA, Saale, Germany.
   Melaku, Yohannes Adama, Univ Adelaide, Sch Med, Adelaide, SA, Australia.
   Melaku, Yohannes Adama, Mekelle Univ, Sch Publ Hlth, Mekelle, Ethiopia.
   Melku, Mulugeta; Tessema, Gizachew Assefa, Univ Gondar, Gondar, Ethiopia.
   Memiah, Peter, Univ West Florida, Pensacola, FL 32514 USA.
   Mendoza, Walter, United Nations Populat Fund, Lima, Peru.
   Meretoja, Tuomo J., Helsinki Univ Hosp, Comprehens Canc Ctr, Breast Surg Unit, Helsinki, Finland.
   Meretoja, Tuomo J., Univ Helsinki, Helsinki, Finland.
   Miller, Ted R., Pacific Inst Res \& Evaluat, Calverton, MD USA.
   Miller, Ted R., Curtin Univ, Sch Publ Hlth, Perth, WA, Australia.
   Mohammed, Shafiu, Ahmadu Bello Univ, Hlth Syst \& Policy Res Unit, Zaria, Nigeria.
   Mohammed, Shafiu, Heidelberg Univ, Inst Publ Hlth, Heidelberg, Baden Wuettembe, Germany.
   Moosazadeh, Mahmood, Mazandaran Univ Med Sci, Addict Inst, Hlth Sci Res Ctr, Sari, Iran.
   Moraga, Paula, Univ Lancaster, Lancaster Med Sch, Lancaster, England.
   Mousavi, Seyyed Meysam, Univ Tehran Med Sci, Sch Publ Hlth, Dept Hlth Management \& Econ, Tehran, Iran.
   Nangia, Vinay, Suraj Eye Inst, Nagpur, Maharashtra, India.
   Cuong Tat Nguyen; Vuong Minh Nong; Tung Thanh Tran, Duy Tan Univ, Inst Global Hlth Innovat, De Nang, Vietnam.
   Ogbo, Felix Akpojene, Western Sydney Univ, Ctr Hlth Res, Sydney, NSW, Australia.
   Olagunju, Andrew Toyin, Univ Lagos, Coll Med, Dept Psychiat, Lagos, Lagos State, Nigeria.
   Olagunju, Andrew Toyin, Lagos Univ, Teaching Hosp, Dept Psychiat, Lagos, Nigeria.
   Olagunju, Andrew Toyin, Univ Adelaide, Discipline Psychiat, Adelaide, SA, Australia.
   Park, Eun-Kee, JSS Univ, JSS Med Coll PA, Mysore, Karnataka, India.
   Park, Eun-Kee, Kosin Univ, Coll Med, Dept Med Humanities \& Social Med, Busan, South Korea.
   Patel, Tejas, White Plains Hosp, White Plains, NY USA.
   Pereira, David M., Univ Porto, Fac Farm, Dept Quim, REQUIMTE,LAQV,Lab Farmacognosia, Porto, Portugal.
   Pishgar, Farhad, Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Tehran, Iran.
   Postma, Maarten J., Univ Med Ctr Groningen, Groningen, Netherlands.
   Postma, Maarten J., Univ Groningen, Groningen, Netherlands.
   Qorbani, Mostafa, Alborz Univ Med Sci, Noncommunicable Dis Res Ctr, Karaj, Iran.
   Rafay, Anwar, Contech Int Hlth Consultants, Lahore, Pakistan.
   Rafay, Anwar, Contech Sch Publ Hlth, Lahore, Pakistan.
   Rawaf, David Laith, North Hampshire Hosp, Basingstroke, England.
   Rawaf, David Laith, Univ Coll London Hosp, London, England.
   Rawaf, David Laith, Imperial Coll London, WHO, Collaborating Ctr, London, England.
   Roshandel, Gholamreza, Golestan Univ Med Sci, Golestan Res Ctr Gastroenterol \& Hepatol, Gorgan, Iran.
   Safiri, Saeid, Maragheh Univ Med Sci, Sch Nursing \& Midwifery, Dept Publ Hlth, Managerial Epidemiol Res Ctr, Maragheh, Iran.
   Salimzadeh, Hamideh, Univ Tehran Med Sci, Tehran, Iran.
   Sanabria, Juan Ramon, Marshall Univ, Joan C Edwards Sch Med, Huntington, WV USA.
   Sanabria, Juan Ramon, Case Western Reserve Univ, Cleveland, OH 44106 USA.
   Milicevic, Milena M. Santric, Univ Belgrade, Fac Med, Ctr Sch Publ Hlth \& Hlth Management, Belgrade, Serbia.
   Milicevic, Milena M. Santric, Univ Belgrade, Fac Med, Inst Social Med, Belgrade, Serbia.
   Sartorius, Benn, Univ KwaZulu Natal, Sch Nursing \& Publ Hlth, Publ Hlth Med, Durban, South Africa.
   Sartorius, Benn, South African Med Res Council, UKZN Gastrointestinal Canc Res Ctr, Durban, South Africa.
   Satpathy, Maheswar, Utkal Univ, Ctr Adv Study Psychol, Bhubaneswar, India.
   Sharif-Alhoseini, Mahdi, Univ Tehran Med Sci, Sina Trauma \& Surg Res Ctr, Tehran, Iran.
   She, Jun, Fudan Univ, Zhongshan Hosp She, Dept Pulm Med, Shanghai, Peoples R China.
   Shin, Min-Jeong, Korea Univ, Dept Publ Hlth Sci, Seoul, South Korea.
   Shiue, Ivy, Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland.
   Shiue, Ivy, Martin Luther Univ Halle Wittenberg, Inst Med Epidemiol Biometrie \& Informat, Saale, Germany.
   Shrime, Mark G., Harvard Med Sch, Kigali, Rwanda.
   Sinke, Abiy Hiruye, Ethiopian Med Assoc, Addis Ababa, Ethiopia.
   Sufiyan, Muawiyyah Babale, Ahmadu Bello Univ, Zaria, Nigeria.
   Sykes, Bryan L., Univ Calif Irvine, Dept Criminol, Irvine, CA USA.
   Sykes, Bryan L., Univ Calif Irvine, Dept Law \& Soc, Irvine, CA USA.
   Sykes, Bryan L., Univ Calif Irvine, Dept Sociol, Irvine, CA USA.
   Sykes, Bryan L., Univ Calif Irvine, Dept Publ Hlth, Irvine, CA USA.
   Tessema, Gizachew Assefa, Univ Adelaide, Adelaide, SA, Australia.
   Topor-Madry, Roman, Jagiellonian Univ, Med Coll, Fac Hlth Sci, Inst Publ Hlth, Krakow, Poland.
   Topor-Madry, Roman, Wroclaw Med Univ, Fac Hlth Sci, Wroclaw, Poland.
   Bach Xuan Tran, Johns Hopkins Univ, Baltimore, MD USA.
   Bach Xuan Tran, Hanoi Med Univ, Hanoi, Vietnam.
   Ukwaja, Kingsley Nnanna, Fed Teaching Hosp, Dept Internal Med, Abakaliki, Ebonyi State, Nigeria.
   Vlassov, Vasiliy Victorovich, Natl Res Univ, Higher Sch Econ, Moscow, Russia.
   Weiderpass, Elisabete, Inst Populat Based Canc Res, Canc Registry Norway, Dept Res, Oslo, Norway.
   Weiderpass, Elisabete, Arctic Univ Norway, Univ Tromso, Fac Hlth Sci, Dept Community Med, Tromso, Norway.
   Weiderpass, Elisabete, Folkhalsan Res Ctr, Genet Epidemiol Grp, Helsinki, Finland.
   Weiderpass, Elisabete, Karolinska Inst, Dept Med Epidemiol \& Biostat, Stockholm, Sweden.
   Williams, Hywel C., Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham, England.
   Yimer, Nigus Bililign, Woldia Univ, Woldia, Amhara, Ethiopia.
   Yonemoto, Naohiro, Kyoto Univ, Sch Publ Hlth, Dept Biostat, Kyoto, Japan.
   Younis, Mustafa Z., Jackson State Univ, Jackson, MS USA.},
DOI = {10.1001/jamaoncol.2018.2706},
ISSN = {2374-2437},
EISSN = {2374-2445},
Keywords-Plus = {IMPACT},
Research-Areas = {Oncology},
Web-of-Science-Categories  = {Oncology},
Author-Email = {cf11@uw.edu},
ResearcherID-Numbers = {Bhakta, Nickhill/N-8142-2018
   Malta, Deborah Carvalho/L-2491-2019
   Khan, Gulfaraz/AAC-2859-2022
   assadi, reza/AAT-6629-2020
   Naohiro, Yonemoto/Y-3761-2019
   Bensenor, Isabela Judith Martins/L-3306-2017
   Sinke, Abiy/AAP-9516-2021
   Mousavi, Seyyed Meysam/P-7797-2015
   Sisay, Mekonnen/AAD-3257-2020
   assadi, reza/AAI-1124-2021
   Hay, Simon I/F-8967-2015
   Aremu, Olatunde/AAD-1995-2019
   Milicevic, Milena/AAV-3679-2021
   Amini, Erfan/X-8366-2019
   Meier, Toni/AAB-1704-2021
   Catalá-López, Ferrán/N-6018-2018
   Christopher, DJ/R-1479-2019
   Topor-Madry, Roman/ABF-5449-2020
   Neves, José das/J-8369-2013
   Salimzadeh, Hamideh/AAL-6666-2020
   Edessa, Dumessa/K-2892-2019
   moosazadeh, mahmood/F-3730-2017
   Hassen, Hamid Y./A-1105-2019
   Roshandel, Gholamreza/AAJ-9562-2021
   Barac, Aleksandra/W-9785-2019
   Linn, Shai/N-3079-2019
   Weiderpass, Elisabete/M-4029-2016
   Khosravi, Mohammad Hossein/G-3767-2015
   Yimer, Nigus Bililign/AGD-8934-2022
   Force, Lisa M./AAP-7874-2021
   Brenner, Hermann/ABE-6383-2020
   Rubino, Salvatore/AAC-5848-2022
   T., Olagunju Andrew/B-4746-2017
   Alvis-Guzman, Nelson/D-4913-2013
   Awasthi, Ashish/P-3966-2018
   Mohammed, Shafiu/P-2016-2014
   Lad, Deepesh/AAD-4095-2019
   Grosso, Giuseppe/K-6730-2016
   Mokdad, Ali H./AAD-1232-2022
   Brenner, Hermann/B-4627-2017
   Melaku, Yohannes Adama/S-2451-2019
   Alizadeh-Navaei, Reza/Y-5124-2019
   Jakovljevic, Mihajlo B/B-3002-2014
   Tessema, Gizachew/J-9235-2018
   Endries, Aman Yesuf/AAN-6871-2021
   Mahesh, P A/R-1184-2019
   Kasaeian, Amir/C-8290-2017
   Grosso, Giuseppe/ABA-1587-2020
   Mohammed, Shafiu/AAR-7889-2020
   Pereira, David M./M-9286-2013
   Safiri, Saeid/A-1678-2017
   SOUNDRARAJAN, JOYSON/I-1779-2019
   Alsharif, Ubai/AAK-2088-2021
   Khader, Yousef/AAE-9620-2019
   Satpathy, Maheswar/J-3135-2017
   Weiderpass, Elisabete/AAP-2747-2021
   Mantovani, Lorenzo Giovanni/AAC-4263-2021
   Hassen, Hamid Y./K-6445-2019
   Ilesanmi, Olayinka/AAF-8628-2021
   Ebrahimi, Hedyeh/AAR-2899-2021
   Pourmalek, Farshad/A-8188-2010
   Basaleem, Huda/AAX-9878-2020
   Avila-Burgos, Leticia/AAR-1815-2021
   Hamadeh, Randah R./AAE-9720-2020
   Awasthi, Ashish/Y-5915-2019
   Khubchandani, Jagdish/D-1831-2014
   Ukwaja, Kingsley N./A-7794-2013
   El-Khatib, Ziad/B-5161-2017
   Lunevicius, Raimundas/B-2528-2018
   Amini, Erfan/A-2063-2009
   },
ORCID-Numbers = {Bhakta, Nickhill/0000-0001-5282-7833
   Malta, Deborah Carvalho/0000-0002-8214-5734
   Khan, Gulfaraz/0000-0001-6836-1783
   Mousavi, Seyyed Meysam/0000-0002-6795-7224
   Sisay, Mekonnen/0000-0001-6611-1174
   Hay, Simon I/0000-0002-0611-7272
   Aremu, Olatunde/0000-0002-5832-2403
   Meier, Toni/0000-0001-6056-0665
   Catalá-López, Ferrán/0000-0002-3833-9312
   Neves, José das/0000-0002-2317-2759
   Salimzadeh, Hamideh/0000-0002-0102-1722
   moosazadeh, mahmood/0000-0002-5452-514X
   Hassen, Hamid Y./0000-0001-6485-4193
   Roshandel, Gholamreza/0000-0002-5494-0722
   Linn, Shai/0000-0002-0867-2958
   Weiderpass, Elisabete/0000-0003-2237-0128
   Khosravi, Mohammad Hossein/0000-0003-0426-5092
   Force, Lisa M./0000-0003-3014-9204
   Brenner, Hermann/0000-0002-6129-1572
   T., Olagunju Andrew/0000-0003-1736-9886
   Alvis-Guzman, Nelson/0000-0001-9458-864X
   Awasthi, Ashish/0000-0002-9308-9782
   Mohammed, Shafiu/0000-0001-5715-966X
   Lad, Deepesh/0000-0003-3754-7774
   Grosso, Giuseppe/0000-0003-3930-5285
   Mokdad, Ali H./0000-0002-4994-3339
   Brenner, Hermann/0000-0002-6129-1572
   Melaku, Yohannes Adama/0000-0002-3051-7313
   Jakovljevic, Mihajlo B/0000-0002-9160-6846
   Tessema, Gizachew/0000-0002-4784-8151
   Kasaeian, Amir/0000-0003-2018-9368
   Grosso, Giuseppe/0000-0003-3930-5285
   Mohammed, Shafiu/0000-0001-5715-966X
   Pereira, David M./0000-0003-0384-7592
   Safiri, Saeid/0000-0001-7986-9072
   Alsharif, Ubai/0000-0002-4024-3950
   Khader, Yousef/0000-0002-7830-6857
   Satpathy, Maheswar/0000-0003-3521-4781
   Weiderpass, Elisabete/0000-0003-2237-0128
   Hassen, Hamid Y./0000-0001-6485-4193
   Ilesanmi, Olayinka/0000-0003-0827-6442
   Pourmalek, Farshad/0000-0002-2134-0771
   Basaleem, Huda/0000-0002-7353-5140
   Hamadeh, Randah R./0000-0002-4205-1354
   Awasthi, Ashish/0000-0002-9308-9782
   Khubchandani, Jagdish/0000-0002-9058-4278
   Hamidi, Samer/0000-0002-6766-3728
   Dandona, Rakhi/0000-0003-0926-788X
   Edessa, Dumessa/0000-0001-6558-5829
   Gyawali, Bishal/0000-0002-8315-1925
   /0000-0001-5266-0201
   Majeed, Azeem/0000-0002-2357-9858
   Barac, Aleksandra/0000-0002-0132-2277
   Meretoja, Tuomo/0000-0002-2691-0710
   Pishgar, Farhad/0000-0003-0703-8442
   Chung, Sheng-Chia/0000-0001-6025-9207
   Postma, Maarten/0000-0002-6306-3653
   Islami, Farhad/0000-0002-7357-5994
   Miller, Ted/0000-0002-0958-2639
   Rawaf, Salman/0000-0001-7191-2355
   Ebrahimi, Hedyeh/0000-0003-3647-7356
   , bennsartorius/0000-0001-6761-2325
   Ukwaja, Kingsley N./0000-0002-1974-8735
   El-Khatib, Ziad/0000-0003-0756-7280
   Lunevicius, Raimundas/0000-0003-3295-0142
   Sufiyan, Muawiyyah Babale/0000-0003-3630-6995
   Amini, Erfan/0000-0001-9647-0047
   /0000-0002-4565-5364
   Cahuana-Hurtado, Lucero/0000-0002-9438-1443
   Innos, Kaire/0000-0003-0120-2213
   Tabares-Seisdedos, Rafael/0000-0002-1089-2204},
Funding-Acknowledgement = {Bill \& Melinda Gates FoundationBill \& Melinda Gates FoundationCGIAR;
   MRCUK Research \& Innovation (UKRI)Medical Research Council UK (MRC)
   {[}MR/M015084/1] Funding Source: UKRI; Cancer Foundation Finland sr
   {[}180129, 160100] Funding Source: researchfish},
Funding-Text = {The Institute for Health Metrics and Evaluation received funding from
   the Bill \& Melinda Gates Foundation.},
Cited-References = {Akinyemiju T, 2017, JAMA ONCOL, V3, P1683, DOI 10.1001/jamaoncol.2017.3055.
   Anderson BO, 2017, J GLOB ONCOL, V3, P84, DOI 10.1200/JGO.2016.006213.
   Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688.
   Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735.
   Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1.
   Fullman N, 2017, LANCET, V390, P1423, DOI 10.1016/S0140-6736(17)32336-X.
   Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8.
   Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X.
   Horton R, 2017, LANCET, V390, P346, DOI 10.1016/S0140-6736(17)31919-0.
   Jha P, 2014, NEW ENGL J MED, V370, P60, DOI 10.1056/NEJMra1308383.
   Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9.
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2.
   Praud D, 2016, INT J CANCER, V138, P1380, DOI 10.1002/ijc.29890.
   Ryerson AB, 2016, CANCER-AM CANCER SOC, V122, P1312, DOI 10.1002/cncr.29936.
   Seventieth World Health Assembly, CANC PREV CONTR CONT.
   Tsu V, 2016, NEW ENGL J MED, V374, P2509, DOI 10.1056/NEJMp1604113.
   UN, SUST DEV GOALS.
   United Nations, 2011 HIGH LEV M PREV.
   Vaccarella S, 2016, NEW ENGL J MED, V375, P614, DOI 10.1056/NEJMp1604412.
   Vaccarella S, 2013, EUR J CANCER, V49, P3262, DOI 10.1016/j.ejca.2013.04.024.
   Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2.
   Wang HD, 2017, LANCET, V390, P1084, DOI 10.1016/S0140-6736(17)31833-0.
   World Health Organization, GLOB ACT PLAN PREV C.},
Number-of-Cited-References = {23},
Times-Cited = {793},
Usage-Count-Last-180-days = {15},
Usage-Count-Since-2013 = {169},
Journal-ISO = {JAMA Oncol.},
Doc-Delivery-Number = {GZ6OT},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)},
Unique-ID = {WOS:000449559500016},
OA = {Green Published, Green Accepted, hybrid},
DA = {2022-03-29},
}

@article{ WOS:000309250300012,
Author = {Liu, Longjian and Chen, Ming and Hankins, Shelley R. and Nunez, Ana E.
   and Watson, Robert A. and Weinstock, Perry J. and Newschaffer, Craig J.
   and Eisen, Howard J. and Drexel Cardiovasc Hlth Collaborati},
Title = {Serum 25-Hydroxyvitamin D Concentration and Mortality from Heart Failure
   and Cardiovascular Disease, and Premature Mortality from All-Cause in
   United States Adults},
Journal = {AMERICAN JOURNAL OF CARDIOLOGY},
Year = {2012},
Volume = {110},
Number = {6},
Pages = {834-839},
Month = {SEP 15},
Abstract = {We aimed to examine associations between serum 25-hydroxyvitamin D
   (25{[}OH]D) concentration and mortality from heart failure (HF) and
   cardiovascular disease (CVD) and premature death from all causes using
   data from the Third National Health and Nutrition Examination Survey,
   which included 13,131 participants (6,130 men, 7,001 women) >= 35 years
   old at baseline (1988 to 1994) and followed through December 2000.
   Premature death was defined all-cause death at <75 years of age. Results
   indicated that during an average 8-year follow-up, there were 3,266
   deaths (24.9\%) including 101 deaths from HF, 1,451 from CVD, and 1,066
   premature all-cause deaths. Among HF deaths, 37\% of decedents had serum
   25(OH)D levels <20 ng/ml, whereas only 26\% of those with non-HF deaths
   had such levels (p < 0.001). Multivariate-adjusted Cox model indicated
   that subjects with serum 25(OH)D levels <20 ng/ml had 2.06 times higher
   risk (95\% confidence interval 1.01 to 4.25) of HF death than those with
   serum 25(OH)D levels >= 30 ng/ml (p < 0.001). In addition, hazard ratios
   (95\% confidence intervals), for premature death from all causes were
   1.40 (1.17 to 1.68) in subjects with serum 25(OH)D levels <20 ng/ml and
   1.11 (0.93 to 1.33) in those with serum 25(OH)D levels of 20 to 29 ng/ml
   compared to those with serum 25(OH)D levels >= 30 ng/ml (p < 0.001, test
   for trend). In conclusion, adults with inadequate serum 25(OH)D levels
   have significantly higher risk of death from HF and all CVDs and
   all-cause premature death. (C) 2012 Elsevier Inc. All rights reserved.
   (Am J Cardiol 2012;110:834-839)},
Publisher = {EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC},
Address = {685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA},
Type = {Article},
Language = {English},
Affiliation = {Liu, LJ (Corresponding Author), Drexel Univ, Sch Publ Hlth, Dept Epidemiol \& Biostat, Philadelphia, PA 19104 USA.
   Liu, Longjian; Newschaffer, Craig J., Drexel Univ, Sch Publ Hlth, Dept Epidemiol \& Biostat, Philadelphia, PA 19104 USA.
   Chen, Ming, Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiol, Chongqing, Peoples R China.
   Hankins, Shelley R.; Eisen, Howard J., Drexel Univ, Coll Med, Div Cardiol, Philadelphia, PA 19104 USA.
   Nunez, Ana E., Drexel Univ, Coll Med, Div Internal Med, Philadelphia, PA 19104 USA.
   Watson, Robert A., Abington Mem Hosp, Div Cardiol, Abington, PA 19001 USA.
   Weinstock, Perry J., Cooper Univ Hosp, Div Cardiovasc Dis, Camden, NJ USA.},
DOI = {10.1016/j.amjcard.2012.05.013},
ISSN = {0002-9149},
EISSN = {1879-1913},
Keywords-Plus = {VITAMIN-D DEFICIENCY; 1,25-DIHYDROXYVITAMIN D-3; DOWN-REGULATION;
   ASSOCIATION; INVOLVEMENT; PREVENTION},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems},
Author-Email = {Longjian.Liu@Drexel.edu},
ResearcherID-Numbers = {Liu, Longjian/Q-4774-2018},
Cited-References = {Centers for Disease Control and Prevention National Center for Health Statistics, 1988 1994 NAT HLTH N.
   Chang CI, 2010, ARCH GERONTOL GERIAT, V50, pS17, DOI 10.1016/S0167-4943(10)70006-6.
   Chiu KC, 2004, AM J CLIN NUTR, V79, P820.
   D'Ambrosio D, 1998, J CLIN INVEST, V101, P252, DOI 10.1172/JCI1050.
   Data Linkage Team, 2010, COMP AN NHANES 3 PUB.
   DEBOLAND AR, 1994, CELL SIGNAL, V6, P717, DOI 10.1016/0898-6568(94)00042-5.
   Holick MF, 2008, AM J CLIN NUTR, V87, p1080S.
   Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001.
   Hou R, 2006, CIRCULATION, V114, P34.
   Institute of Medicine (US) Committee to Review Dietary Reference, 2011, INT VIT D CALC.
   Lee JH, 2008, J AM COLL CARDIOL, V52, P1949, DOI 10.1016/j.jacc.2008.08.050.
   Li YC, 2003, J CELL BIOCHEM, V88, P327, DOI 10.1002/jcb.10343.
   Liu LJ, 2007, CLIN EXP PHARMACOL P, V34, pS14, DOI 10.1111/j.1440-1681.2007.04762.x.
   Liu LJ, 2011, INT J CARDIOL, V149, P39, DOI 10.1016/j.ijcard.2009.11.037.
   Liu LJ, 2009, AM J CLIN NUTR, V90, P362, DOI 10.3945/ajcn.2009.27538.
   Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261.
   Mursu J, 2011, ARCH INTERN MED, V171, P1625, DOI 10.1001/archinternmed.2011.445.
   OCONNELL TD, 1994, ENDOCRINOLOGY, V134, P899, DOI 10.1210/en.134.2.899.
   Pilz S, 2008, J CLIN ENDOCR METAB, V93, P3927, DOI 10.1210/jc.2008-0784.
   Pittas AG, 2006, DIABETES CARE, V29, P650, DOI 10.2337/diacare.29.03.06.dc05-1961.
   Riachy R, 2006, APOPTOSIS, V11, P151, DOI 10.1007/s10495-006-3558-z.
   SAS Institute Inc, 2005, SAS STAT US GUID VER, P3884.
   Schleithoff SS, 2003, J BONE MINER METAB, V21, P247, DOI 10.1007/s00774-003-0417-7.
   SHRESTHA LB, 2006, LIFE EXPECTANCY US.
   Tsao Lana, 2004, Crit Pathw Cardiol, V3, P194, DOI 10.1097/01.hpc.0000146867.90558.ca.
   WEISHAAR RE, 1987, AM J PHYSIOL, V253, pE675, DOI 10.1152/ajpendo.1987.253.6.E675.
   Zittermann A, 2003, J AM COLL CARDIOL, V41, P105, DOI 10.1016/S0735-1097(02)02624-4.
   Zittermann A, 2008, CURR OPIN CLIN NUTR, V11, P752, DOI 10.1097/MCO.0b013e328312c33f.},
Number-of-Cited-References = {28},
Times-Cited = {59},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {6},
Journal-ISO = {Am. J. Cardiol.},
Doc-Delivery-Number = {012PZ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000309250300012},
DA = {2022-03-29},
}

@article{ WOS:000171000200025,
Author = {Behr, TM and Nerurkar, SS and Nelson, AH and Coatney, RW and Woods, TN
   and Sulpizio, A and Chandra, S and Brooks, DP and Kumar, S and Lee, JC
   and Ohlstein, EH and Angermann, CE and Adams, JL and Sisko, J and
   Sackner-Bernstein, JD and Willette, RN},
Title = {Hypertensive end-organ damage and premature mortality are p38
   mitogen-activated protein kinase-dependent in a rat model of cardiac
   hypertrophy and dysfunction},
Journal = {CIRCULATION},
Year = {2001},
Volume = {104},
Number = {11},
Pages = {1292-1298},
Month = {SEP 11},
Abstract = {Background-Numerous pathological mediators of cardiac hyper-trophy (eg,
   neurohormones, cytokines, and stretch) have been shown to activate p38
   MAPK. The purpose of the present study was to examine p38 MAPK
   activation and the effects of its long-term inhibition in a model of
   hypertensive cardiac hypertrophy/dysfunction and end-organ damage.
   Methods and Results-In spontaneously hypertensive stroke-prone (SP) rats
   receiving a high-salt/high-fat diet (SFD), myocardial p38 MAPK was
   activated persistently during the development of cardiac hypertrophy and
   inactivated during decompensation. Long-term oral treatment of SFD-SP
   rats with a selective p38 MAPK inhibitor (SB239063) significantly
   enhanced survival over an 18-week period compared with the untreated
   group (100\% versus 50\%). Periodic echocardiographic analysis revealed
   a significant reduction in LV hypertrophy and dysfunction in the
   SB239063-treatment groups. Little or no difference in blood pressure was
   noted in the treatment or vehicle groups. Basal and stimulated
   (lipopolysaccharide) plasma tumor necrosis factor-alpha concentrations
   were reduced in the SB239063-treatment groups. In vitro vasoreactivity
   studies demonstrated a significant preservation of endothelium-dependent
   relaxation in animals treated with the p38 MAPK inhibitor without
   effects on contraction or NO-mediated vasorelaxation. Proteinuria and
   the incidence of stroke (53\% versus 7\%) were also reduced
   significantly in the SB239063-treated groups.
   Conclusions-These results demonstrate a crucial role for p38 MAPK in
   hypertensive cardiac hypertrophy and end-organ damage. Interrupting its
   function with a specific p38 MAPK inhibitor halts clinical
   deterioration.},
Publisher = {LIPPINCOTT WILLIAMS \& WILKINS},
Address = {TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA},
Type = {Article},
Language = {English},
Affiliation = {Willette, RN (Corresponding Author), GlaxoSmithKline, Dept Cardiovasc Pharmacol, UW2510,709 Swedeland Rd,POB 1539, King Of Prussia, PA 19406 USA.
   GlaxoSmithKline, Dept Cardiovasc Pharmacol, King Of Prussia, PA 19406 USA.
   St Lukes Hosp, Dept Cardiol, New York, NY USA.},
DOI = {10.1161/hc3601.094275},
ISSN = {0009-7322},
EISSN = {1524-4539},
Keywords = {heart failure; hypertension; signal transduction; stroke; hypertrophy},
Keywords-Plus = {MYOCYTES; HEART; EXPRESSION; GROWTH; GENE; INDUCTION; MECHANISM;
   CYTOKINES; PATHWAY; SERUM},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems; Peripheral Vascular Disease},
Author-Email = {robert\_n\_willette@gsk.com},
Cited-References = {Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140.
   Barone FC, 1998, J HYPERTENS, V16, P871, DOI 10.1097/00004872-199816060-00019.
   Barone FC, 1996, J PHARMACOL EXP THER, V279, P948.
   Bhagat K, 1997, CIRCULATION, V96, P3042, DOI 10.1161/01.CIR.96.9.3042.
   Bogoyevitch MA, 1996, INT J BIOCHEM CELL B, V28, P1, DOI 10.1016/1357-2725(95)00142-5.
   Bogoyevitch MA, 2000, CARDIOVASC RES, V45, P826, DOI 10.1016/S0008-6363(99)00386-7.
   Bristow MR, 1998, LANCET, V352, P8.
   CHUNG MK, 1990, CIRC RES, V67, P753, DOI 10.1161/01.RES.67.3.753.
   Clerk A, 1999, AM J CARDIOL, V83, p64H.
   Communal C, 1999, CIRCULATION, V100, P199.
   Dorn GW, 1999, TRENDS CARDIOVAS MED, V9, P26, DOI 10.1016/S1050-1738(99)00004-3.
   Drexler H, 1999, J MOL CELL CARDIOL, V31, P51, DOI 10.1006/jmcc.1998.0843.
   FINKEL MS, 1992, SCIENCE, V257, P387, DOI 10.1126/science.1631560.
   He Q, 1999, HYPERTENSION, V33, P283, DOI 10.1161/01.HYP.33.1.283.
   Krown KA, 1996, J CLIN INVEST, V98, P2854, DOI 10.1172/JCI119114.
   LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0.
   Li CH, 1999, J BIOL CHEM, V274, P25273, DOI 10.1074/jbc.274.36.25273.
   Maeso R, 1999, AM J HYPERTENS, V12, P1105, DOI 10.1016/S0895-7061(99)00086-2.
   Mies G, 1999, J CEREBR BLOOD F MET, V19, P1238, DOI 10.1097/00004647-199911000-00008.
   OKAMOTO K, 1986, J HYPERTENS, V4, pS21.
   Pellieux C, 2000, J HYPERTENS, V18, P1307, DOI 10.1097/00004872-200018090-00017.
   Richer C, 1997, CLIN EXP HYPERTENS, V19, P925, DOI 10.3109/10641969709083196.
   SADOSHIMA J, 1993, CELL, V75, P977, DOI 10.1016/0092-8674(93)90541-W.
   SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413.
   Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358.
   SHUBEITA HE, 1990, J BIOL CHEM, V265, P20555.
   SIMPSON P, 1982, CIRC RES, V51, P787, DOI 10.1161/01.RES.51.6.787.
   Sugden PH, 1999, CIRC RES, V84, P633, DOI 10.1161/01.RES.84.6.633.
   Sugden PH, 1998, CIRC RES, V83, P345, DOI 10.1161/01.RES.83.4.345.
   THAIK CM, 1995, J CLIN INVEST, V96, P1093, DOI 10.1172/JCI118095.
   Thuerauf DJ, 1998, J BIOL CHEM, V273, P20636, DOI 10.1074/jbc.273.32.20636.
   Underwood DC, 2000, J PHARMACOL EXP THER, V293, P281.
   Willette RN, 1997, J PHARMACOL EXP THER, V280, P695.
   Yue P, 1998, AM J PHYSIOL-HEART C, V275, pH250, DOI 10.1152/ajpheart.1998.275.1.H250.
   Zechner D, 1997, J CELL BIOL, V139, P115, DOI 10.1083/jcb.139.1.115.},
Number-of-Cited-References = {35},
Times-Cited = {103},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Circulation},
Doc-Delivery-Number = {472TC},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000171000200025},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000445543500094,
Author = {Sandor, Janos and Palinkas, Anita and Vincze, Ferenc and Sipos, Valeria
   and Kovacs, Nora and Jenei, Tibor and Falusi, Zsofia and Pal, Laszlo and
   Korosi, Laszlo and Papp, Magor and Adany, Roza},
Title = {Association between the General Practitioner Workforce Crisis and
   Premature Mortality in Hungary: Cross-Sectional Evaluation of Health
   Insurance Data from 2006 to 2014},
Journal = {INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH},
Year = {2018},
Volume = {15},
Number = {7},
Month = {JUL},
Abstract = {The workforce crisis of primary care is reflected in the increasing
   number of general medical practices (GMP) with vacant general
   practitioner (GP) positions, and the GPs' ageing. Our study aimed to
   describe the association between this crisis and premature mortality.
   Age-sex-standardized mortality for 18-64 years old adults was calculated
   for all Hungarian GMPs annually in the period from 2006 to 2014. The
   relationship of premature mortality with GPs' age and vacant GP
   positions was evaluated by standardized linear regression controlled for
   list size, urbanization, geographical location, clients' education, and
   type of the GMP. The clients' education was the strongest protective
   factor (beta = -0175; p < 0.001), followed by urban residence (beta =
   -0.149; p < 0.001), and bigger list size (beta(1601-2000) = -0.054; p <
   0.001; beta(2001-X) = -0.096; p < 0.001). The geographical localization
   also significantly influenced the risk. Although GMPs with a GP aged
   older than 65 years (beta = 0; p = 0.995) did not affect the risk, GP
   vacancy was associated with higher risk (beta = 0.010; p = 0.033),
   although the corresponding number of attributable cases was 23.54 over 9
   years. The vacant GP position is associated with a significant but
   hardly detectable increased risk of premature mortality without
   considerable public health importance. Nevertheless, employment of GPs
   aged more than 65 does not impose premature mortality risk elevation.},
Publisher = {MDPI},
Address = {ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND},
Type = {Article},
Language = {English},
Affiliation = {Sandor, J (Corresponding Author), Univ Debrecen, Fac Publ Hlth, Dept Prevent Med, H-4028 Debrecen, Hungary.
   Sandor, Janos; Palinkas, Anita; Vincze, Ferenc; Sipos, Valeria; Kovacs, Nora; Jenei, Tibor; Adany, Roza, Univ Debrecen, Fac Publ Hlth, Dept Prevent Med, H-4028 Debrecen, Hungary.
   Falusi, Zsofia; Pal, Laszlo; Korosi, Laszlo, Natl Hlth Insurance Fund, Dept Financing, H-1139 Budapest, Hungary.
   Papp, Magor, Natl Inst Hlth Dev, Dioszegi St 64, H-1113 Budapest, Hungary.
   Adany, Roza, Univ Debrecen, MTA DE Publ Hlth Res Grp, H-4028 Debrecen, Hungary.
   Adany, Roza, Univ Debrecen, Fac Publ Hlth, Dept Prevent Med, WHO Collaborating Ctr Vulnerabil \& Hlth, H-4028 Debrecen, Hungary.},
DOI = {10.3390/ijerph15071388},
Article-Number = {1388},
EISSN = {1660-4601},
Keywords = {primary health care; workforce crisis; general practitioner vacancy;
   aging of general practitioners; premature mortality},
Keywords-Plus = {PRIMARY-CARE; QUALITY; IMPACT},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {sandor.janos@sph.unideb.hu
   palinkas.anita@sph.unideb.hu
   vincze.ferenc@sph.unideb.hu
   sipos.valeria@sph.unideb.hu
   kovacs.nora@sph.unideb.hu
   jenei.tibor@sph.unideb.hu
   pal.l@neak.gov.hu
   korosi.l@neak.gov.hu
   papp.magor@nefi.hu
   adany.roza@sph.unideb.hu},
ResearcherID-Numbers = {Pálinkás, Anita/AAZ-1017-2020
   },
ORCID-Numbers = {Vincze, Ferenc/0000-0003-3595-7737},
Funding-Acknowledgement = {Swiss Contribution Programme {[}SH/8/1]; Hungarian Academy of
   SciencesHungarian Academy of Sciences {[}MTA 11003, 2006TKI227];
   European UnionEuropean Commission {[}GINOP-2.3.2-15-2016-00005];
   European Regional Development FundEuropean Commission},
Funding-Text = {This study was funded by the Swiss Contribution Programme (SH/8/1), by
   the Hungarian Academy of Sciences (MTA 11003, 2006TKI227), and by the
   GINOP-2.3.2-15-2016-00005 project which was co-financed by the European
   Union and the European Regional Development Fund.},
Cited-References = {Adany Roza, 2013, Eur J Public Health, V23, P529, DOI 10.1093/eurpub/ckt095.
   Baker Richard, 2016, BMJ Open, V6, pe009981, DOI 10.1136/bmjopen-2015-009981.
   Bodenheimer T, 2010, HEALTH AFFAIR, V29, P799, DOI 10.1377/hlthaff.2010.0026.
   BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x.
   Choudhry NK, 2005, ANN INTERN MED, V142, P260, DOI 10.7326/0003-4819-142-4-200502150-00008.
   Dedeu T., 2015, BUILDING PRIMARY CAR.
   Delamaire M. L., 2010, 54 OECD.
   Dix, 2015, RECRUITMENT RETENTIO.
   European Commission, 2012, JOB RICH REC.
   Honeyford K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003391.
   Jakab Z, 2013, EUR J PUBLIC HEALTH, V23, P528, DOI 10.1093/eurpub/ckt091.
   Juhasz A, 2010, SOC SCI MED, V70, P1342, DOI 10.1016/j.socscimed.2010.01.024.
   Kontopantelis E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h904.
   Kringos D.S., 2015, BUILDING PRIMARY CAR.
   Kringos D, 2013, BRIT J GEN PRACT, V63, pE742, DOI 10.3399/bjgp13X674422.
   Krzton-Krolewiecka A, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0550-8.
   Levene LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047800.
   Morgan PA, 2008, HEALTH SERV RES, V43, P1906, DOI 10.1111/j.1475-6773.2008.00874.x.
   Murauskiene L, 2013, HEALT SYST TRANSIT, V15, P1.
   OECD, 2010, HLTH GLANC EUR 2010.
   Pavlic DR, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0386-7.
   Phillips RL, 2004, AM FAM PHYSICIAN, V70, P440.
   Rasella D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4014.
   Roland M, 2014, BRIT J GEN PRACT, V64, P63, DOI 10.3399/bjgp14X676960.
   Sandor Janos, 2013, Eur J Public Health, V23, P530, DOI 10.1093/eurpub/ckt096.
   Saunders C, 2014, BRIT J GEN PRACT, V64, P65, DOI 10.3399/bjgp14X676979.
   Scott IA, 2009, MED J AUSTRALIA, V190, P689, DOI 10.5694/j.1326-5377.2009.tb02638.x.
   Scutchfield F Douglas, 2012, Am J Public Health, V102 Suppl 3, pS312, DOI 10.2105/AJPH.2012.300724.
   Shi LY, 2001, AM J PUBLIC HEALTH, V91, P1246, DOI 10.2105/AJPH.91.8.1246.
   Shin DW, 2014, ANN FAM MED, V12, P534, DOI 10.1370/afm.1685.
   Smatana M, 2016, HEALT SYST TRANSIT, V18, P1.
   Taulbut M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004711.
   Thomas B, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3639.
   Tsugawa Y, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1797.
   WHO WHO, 2010, GLOB COD PRACT INT R.
   World Health Organization, 2016, EUR HLTH ALL DAT.},
Number-of-Cited-References = {36},
Times-Cited = {8},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {5},
Journal-ISO = {Int. J. Environ. Res. Public Health},
Doc-Delivery-Number = {GU7XC},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000445543500094},
OA = {Green Published, gold, Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000383848000022,
Author = {Gonzalez-Pier, Eduardo and Barraza-Llorens, Mariana and Beyeler, Naomi
   and Jamison, Dean and Knaul, Felicia and Lozano, Rafael and Yamey, Gavin
   and Sepulveda, Jaime},
Title = {Mexico's path towards the Sustainable Development Goal for health: an
   assessment of the feasibility of reducing premature mortality by 40\% by
   2030},
Journal = {LANCET GLOBAL HEALTH},
Year = {2016},
Volume = {4},
Number = {10},
Pages = {E714-E725},
Month = {OCT},
Abstract = {Background The United Nations Sustainable Development Goal for health
   (SDG3) poses complex challenges for signatory countries that will
   require clear roadmaps to set priorities over the next 15 years.
   Building upon the work of the Commission on Investing in Health and
   published estimates of feasible global mortality SDG3 targets, we
   analysed Mexico's mortality to assess the feasibility of reducing
   premature (0-69 years) mortality and propose a path to meet SDG3.
   Methods We developed a baseline scenario applying 2010 age-specific and
   cause-specific mortality rates from the Mexican National Institute of
   Statistics and Geography (INEGI) to the 2030 UN Population Division
   (UNPD) population projections. In a second scenario, INEGI age-specific
   and cause-specific trends in death rates from 2000 to 2014 were
   projected to 2030 and adjusted to match the UNPD 2030 mortality
   projections. A third scenario assumed a 40\% reduction in premature
   deaths across all ages and causes. By comparing these scenarios we
   quantified shortfalls in mortality reductions by age group and cause,
   and forecasted life expectancy pathways for Mexico to converge to better
   performing countries.
   Findings UNPD-projected death rates yield a 25.9\% reduction of
   premature mortality for Mexico. Accelerated reductions in adult
   mortality are necessary to reach a 40\% reduction by 2030. Mortality
   declines aggregated across all age groups mask uneven gains across
   health disorders. Injuries, particularly road traffic accidents and
   homicides, are the main health challenge for young adults (aged 20-49
   years) whereas unabated diabetes mortality is the single most important
   health concern for older adults (aged 50-69 years).
   Interpretation Urgent action is now required to control non-communicable
   diseases and reduce fatal injuries in Mexico, making a 40\% reduction in
   premature mortality by 2030 feasible and putting Mexico back on a track
   of substantial life expectancy convergence with better performing
   countries. Our study provides a roadmap for setting national health
   priorities. Further analysis of the equity implications of following the
   suggested pathway remains a subject of future research. Copyright (C)
   The Author(s). Published by Elsevier Ltd. This is an Open Access article
   under the CC BY license.},
Publisher = {ELSEVIER SCI LTD},
Address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Gonzalez-Pier, E (Corresponding Author), Mexican Hlth Fdn, Mexico City 14610, DF, Mexico.
   Gonzalez-Pier, Eduardo; Knaul, Felicia, Mexican Hlth Fdn, Mexico City 14610, DF, Mexico.
   Beyeler, Naomi; Jamison, Dean; Sepulveda, Jaime, Univ Calif San Francisco, Global Hlth Sci, San Francisco, CA 94143 USA.
   Knaul, Felicia, Univ Miami, Miami Inst Amer, Coral Gables, FL 33124 USA.
   Lozano, Rafael, Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico.
   Yamey, Gavin, Duke Univ, Duke Global Hlth Inst, Durham, NC USA.
   Sepulveda, Jaime, Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico.},
DOI = {10.1016/S2214-109X(16)30181-4},
ISSN = {2214-109X},
Keywords-Plus = {EPIDEMIOLOGIC TRANSITION; DIABETES-MELLITUS; LIFE EXPECTANCY;
   MIDDLE-INCOME; PREVALENCE; TRENDS; HOMICIDE; COVERAGE; DEATHS; BURDEN},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {egpier@gmail.com},
ResearcherID-Numbers = {Lozano, Rafael/T-5352-2018},
ORCID-Numbers = {Lozano, Rafael/0000-0002-7356-8823},
Funding-Acknowledgement = {Mexico's Ministry of Health; University of California, San
   FranciscoUniversity of California System; Bill \& Melinda Gates
   FoundationBill \& Melinda Gates FoundationCGIAR},
Funding-Text = {Funding Mexico's Ministry of Health, University of California, San
   Francisco, and Bill \& Melinda Gates Foundation.},
Cited-References = {Aburto JM, 2016, HEALTH AFFAIR, V35, P88, DOI 10.1377/hlthaff.2015.0068.
   {[}Anonymous], 2018, GLOB STAT REP ROAD S.
   Colchero MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6704.
   Barquera S, 2003, ARCH MED RES, V34, P407, DOI 10.1016/S0188-4409(03)00075-4.
   Barquera S, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-3.
   Barraza-Llorens M, 2013, CARGA EC DIABETES MI.
   Barraza-Llorens M, 2013, REV PANAM SALUD PUBL, V33, P122, DOI 10.1590/S1020-49892013000200007.
   Beyeler N, 2015, SALUD PUBLICA MEXICO, V57, P441.
   Campos-Nonato I, 2013, SALUD PUBLICA MEXICO, V55, pS144, DOI 10.21149/spm.v55s2.5110.
   Consejo Nacional para la Prevencion de Accidentes, 2013, OBS NAC LES PERF NAC.
   Dieleman JL, 2016, LANCET, V387, P2521, DOI 10.1016/S0140-6736(16)30167-2.
   Evans T, 2016, LANCET, V387, P2482, DOI 10.1016/S0140-6736(16)30238-0.
   Frenk J, 2006, LANCET, V368, P954, DOI 10.1016/S0140-6736(06)69376-8.
   Gakidou E, 2006, LANCET, V368, P1920, DOI 10.1016/S0140-6736(06)69568-8.
   Gelband H, 2016, LANCET, V387, P2133, DOI 10.1016/S0140-6736(15)00755-2.
   Gobierno de la Republica, SIST IND OBJ DES MIL.
   Gonzalez-Pier E, 2006, LANCET, V368, P1608, DOI 10.1016/S0140-6736(06)69567-6.
   Grogger J, SODA TAXES PRICES SO.
   Guajardo V, 2010, ESTIMACION GASTO TOT.
   Gutierrez J.P., 2012, ENCUESTA NACL SALUD.
   Heredia-Pi IB, CONTINUITY ANTENATAL.
   Hubert C., MATERNAL MORTALITY T.
   Institute for Health Metrics and Evaluation, 2013, GLOB BURD DIS MEX PR.
   Institute for Health Metrics and Evaluation, GLOB BURD DIS COMP.
   Instituto Mexicano del Seguro Social, GUIA PRACT CLIN RED.
   Instituto Nacional de Estadistica y Geografia, DAT PREL REV QUE 201.
   Instituto Nacional de Estadistica y Geografia, EST DEF 1990 2010.
   Instituto Nacional de Estadistica y Geografia, MORT ESP VID NAC SEG.
   International Diabetes Federation, IDF ATL REG FACT SHE.
   Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4.
   Gonzalez-Perez GJ, 2012, REV PANAM SALUD PUBL, V32, P335, DOI 10.1590/S1020-49892012001100003.
   Gonzalez-Perez GJ, 2012, CIENC SAUDE COLETIVA, V17, P3195, DOI 10.1590/S1413-81232012001200005.
   Knaul FM, 2012, INT J GYNECOL OBSTET, V119, pS85, DOI 10.1016/j.ijgo.2012.03.024.
   KONTIS V, 2014, LANCET, V384, P427, DOI DOI 10.1016/S0140-6736(14)60616-4.
   Langer A, 2015, LANCET, V386, P1165, DOI 10.1016/S0140-6736(15)60497-4.
   Lazcano-Ponce E, 2013, SALUD PUBLICA MEXICO, V55, pS214.
   Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X.
   Mexican Commission on Macroeconomics and Health, MACR HLTH INV HLTH E.
   Moore E.R., 2012, COCHRANE DB SYST REV, V5, DOI DOI 10.1002/14651858.CD003519.PUB3.
   Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127.
   Norheim OF, 2015, LANCET, V385, P239, DOI 10.1016/S0140-6736(14)61591-9.
   OECD, LIF EXP BIRTH IND.
   OECD, OECD REV HLTH CAR SY.
   OECD, 2017, OB UPD.
   OECD, CONS TAX TRENDS 2014.
   OECD, CARD DIS DIAB POL BE.
   OECD, OB EC PREV FIT NOT F.
   OECD, HLTH GLANC 2015 OECD.
   OECD ITF, ROAD SAF ANN REP 201.
   Rtveladze K, 2014, PUBLIC HEALTH NUTR, V17, P233, DOI 10.1017/S1368980013000086.
   Secretaria de Salud, MH 2015 MEJ HOSP SEC.
   Sepulveda J, 2006, LANCET, V368, P2017, DOI 10.1016/S0140-6736(06)69569-X.
   Servan-Mori E, 2000, INT J EQUITY HEALTH.
   Statistics OECD, HLTH EXP FIN.
   Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X.
   Stevens G, 2008, PLOS MED, V5, P900, DOI 10.1371/journal.pmed.0050125.
   UN, WORLD POP PROSP 2015.
   United Nations(UN), SUST DEV GOALS 17 GO.
   Verguet S, TOBACCO TAXATION CHI.
   Verguet S, 2014, LANCET GLOB HEALTH, V2, pE698, DOI 10.1016/S2214-109X(14)70316-X.
   Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7.
   Villalpando S, 2010, SALUD PUBLICA MEXICO, V52, pS19, DOI 10.1590/S0036-36342010000700005.
   Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9.
   Waters H, EC TOBACCO TOBACCO T.
   WHO, SCAL ACT NONC DIS MU.
   WHO, WHO REC INT IMPR PRE.
   WHO, 2015, GLOB ACT PLAN ANT RE.
   WHO HRP, 2015, WHO STAT CAES SECT R.},
Number-of-Cited-References = {68},
Times-Cited = {24},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {26},
Journal-ISO = {Lancet Glob. Health},
Doc-Delivery-Number = {DW7RE},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000383848000022},
OA = {Green Accepted, Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000609229400015,
Author = {Fluharty, Meg E. and Hardy, Rebecca and Ploubidis, George and
   Pongiglione, Benedetta and Bann, David},
Title = {Socioeconomic inequalities across life and premature mortality from 1971
   to 2016: findings from three British birth cohorts born in 1946, 1958
   and 1970},
Journal = {JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH},
Year = {2021},
Volume = {75},
Number = {2},
Pages = {193-196},
Month = {FEB},
Abstract = {Introduction Disadvantaged socioeconomic position (SEP) in early and
   adult life has been repeatedly associated with premature mortality.
   However, it is unclear whether these inequalities differ across time,
   nor if they are consistent across different SEP indicators. Methods
   British birth cohorts born in 1946, 1958 and 1970 were used, and
   multiple SEP indicators in early and adult life were examined. Deaths
   were identified via national statistics or notifications. Cox
   proportional hazard models were used to estimate associations between
   ridit scored SEP indicators and all-cause mortality risk-from 26 to 43
   years (n=40 784), 26 to 58 years (n=35 431) and 26 to 70 years (n=5353).
   Results More disadvantaged SEP was associated with higher mortality
   risk-magnitudes of association were similar across cohort and each SEP
   indicator. For example, HRs (95\% CI) from 26 to 43 years comparing
   lowest to highest paternal social class were 2.74 (1.02 to 7.32) in
   1946c, 1.66 (1.03 to 2.69) in 1958c, and 1.94 (1.20 to 3.15) in 1970c.
   Paternal social class, adult social class and housing tenure were each
   independently associated with mortality risk. Conclusions Socioeconomic
   circumstances in early and adult life show persisting associations with
   premature mortality from 1971 to 2016, reaffirming the need to address
   socioeconomic factors across life to reduce inequalities in survival to
   older age.},
Publisher = {BMJ PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Fluharty, ME (Corresponding Author), UCL, Ctr Longitudinal Studies, 55-59 Gordon Sq, London WC1H 0NU, England.
   Fluharty, Meg E.; Ploubidis, George; Bann, David, UCL Inst Educ, Ctr Longitudinal Studies, London, England.
   Hardy, Rebecca, UCL Inst Educ, Cohort \& Longitudinal Studies Enhancement Resourc, London, England.
   Pongiglione, Benedetta, Bocconi Univ, Ctr Res Hlth \& Social Care Management, Milan, Italy.},
DOI = {10.1136/jech-2020-214423},
ISSN = {0143-005X},
EISSN = {1470-2738},
Keywords = {Inequalities; Mortality; Socio-economic},
Keywords-Plus = {MRC NATIONAL-SURVEY; CHILDHOOD; CIRCUMSTANCES; ADULTHOOD; PROFILE;
   HEALTH},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {m.fluharty@ucl.ac.uk},
ResearcherID-Numbers = {Hardy, Rebecca/AFR-1989-2022
   },
ORCID-Numbers = {Pongiglione, Benedetta/0000-0001-8539-1554
   Bann, David/0000-0002-6454-626X
   Hardy, Rebecca/0000-0001-9949-0799},
Funding-Acknowledgement = {Economic and Social Research CouncilUK Research \& Innovation
   (UKRI)Economic \& Social Research Council (ESRC) {[}ES/M001660/1,
   ES/K000357/1]; Academy of Medical Sciences/Wellcome TrustWellcome Trust
   {[}HOP001/1025]; ESRCUK Research \& Innovation (UKRI)Economic \& Social
   Research Council (ESRC) {[}ES/K000357/1, ES/M001660/1] Funding Source:
   UKRI},
Funding-Text = {DB is supported by the Economic and Social Research Council (grant
   number ES/M001660/1) and MF and DB by The Academy of Medical
   Sciences/Wellcome Trust (`Springboard Health of the Public in 2040'
   award: HOP001/1025). RH is Director of CLOSER, which is funded by the
   Economic and Social Research Council (award reference: ES/K000357/1). GP
   is Director of Research of CLS, which is funded by the Economic and
   Social Research Council (award reference: ES/M001660/1). The funders had
   no role in study design, data collection and analysis.},
Cited-References = {{[}Anonymous], 2015, TREND LIF EXP BIRTH.
   {[}Anonymous], 2018, HUMAN MORTALITY DATA.
   Avendano M, 2005, AM J EPIDEMIOL, V161, P52, DOI 10.1093/aje/kwi011.
   Bann D, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002214.
   Galobardes B, 2006, ANN EPIDEMIOL, V16, P91, DOI 10.1016/j.annepidem.2005.06.053.
   Galobardes B, 2004, EPIDEMIOL REV, V26, P7, DOI 10.1093/epirev/mxh008.
   Kuh D, 2002, BRIT MED J, V325, P1076, DOI 10.1136/bmj.325.7372.1076.
   Kuh D, 2016, EUR J EPIDEMIOL, V31, P1135, DOI 10.1007/s10654-016-0217-8.
   Mackenbach J.P., 2019, HLTH INEQUALITIES PE.
   Marmot M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m693.
   Maughan B, 2014, PSYCHOL MED, V44, P1077, DOI 10.1017/S0033291713001402.
   McCartney D, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000737.
   McCartney G, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017590.
   Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183.
   The Marmot Review, 2010, FAIR SOC HLTH LIVES.
   UCL, 1970, BRIT COHORT STUDY 20.
   UCL, 2019, NATL CHILD DEV STUDY.
   Wadsworth M, 2006, INT J EPIDEMIOL, V35, P49, DOI 10.1093/ije/dyi201.
   Wadsworth M, 2011, ROUTL ADV SOCIOL, P1.
   Zaninotto P, 2020, J GERONTOL A-BIOL, V75, P906, DOI 10.1093/gerona/glz266.},
Number-of-Cited-References = {20},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {J. Epidemiol. Community Health},
Doc-Delivery-Number = {PU3UD},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000609229400015},
OA = {Green Published, hybrid, Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000266529400017,
Author = {Saikawa, Eri and Naik, Vaishali and Horowitz, Larry W. and Liu, Junfeng
   and Mauzerall, Denise L.},
Title = {Present and potential future contributions of sulfate, black and organic
   carbon aerosols from China to global air quality, premature mortality
   and, radiative forcing},
Journal = {ATMOSPHERIC ENVIRONMENT},
Year = {2009},
Volume = {43},
Number = {17},
Pages = {2814-2822},
Month = {JUN},
Abstract = {Aerosols are harmful to human health and have both direct and indirect
   effects on climate. China is a major contributor to global emissions of
   sulfur dioxide (SO2), a sulfate (SO42-) precursor, organic carbon (OC),
   and black carbon (BC) aerosols. Although increasingly examined, the
   effect of present and potential future levels of these emissions on
   global premature mortality and climate change has not been well
   quantified. Through both direct radiative effects and indirect effects
   on clouds, SO42- and OC exert negative radiative forcing (cooling) while
   BC exerts positive forcing (warming). We analyze the effect of China's
   emissions Of SO2, 4 OC and BC in 2000 and for three emission scenarios
   in 2030 on global surface aerosol concentrations, premature mortality,
   and radiative forcing (RF). Using global models of chemical transport
   (MOZART-2) and radiative transfer (GFDL RTM), and combining simulation
   results with gridded population data, mortality rates, and
   concentration-response relationships from the epidemiological
   literature, we estimate the contribution of Chinese aerosols to global
   annual premature mortality and to RF in 2000 and 2030. In 2000, we
   estimate these aerosols cause approximately 470 000 premature deaths in
   China and an additional 30000 deaths globally. In 2030, aggressive
   emission controls lead to a 50\% reduction in premature deaths from the
   2000 level to 240 000 in China and 10 000 elsewhere, while under a high
   emissions scenario premature deaths increase 50\% from the 2000 level to
   720 000 in China and to 40 000 elsewhere. Because the negative RF from
   SO42- and OC is larger than the positive forcing from BC, Chinese
   aerosols lead to global net direct RF of -74 mW m(-2) in 2000 and
   between -15 and -97 mW m(-2) in 2030 depending on the emissions
   scenario. Our analysis indicates that increased effort to reduce
   greenhouse gases is essential to address climate change as China's
   anticipated reduction of aerosols will result in the loss of net
   negative radiative forcing. (C) 2009 Elsevier Ltd. All rights reserved.},
Publisher = {PERGAMON-ELSEVIER SCIENCE LTD},
Address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Mauzerall, DL (Corresponding Author), Princeton Univ, Woodrow Wilson Sch Publ \& Int Affairs, Princeton, NJ 08544 USA.
   Saikawa, Eri; Naik, Vaishali; Liu, Junfeng; Mauzerall, Denise L., Princeton Univ, Woodrow Wilson Sch Publ \& Int Affairs, Princeton, NJ 08544 USA.
   Horowitz, Larry W., Geophys Fluid Dynam Lab, Princeton, NJ 08540 USA.},
DOI = {10.1016/j.atmosenv.2009.02.017},
ISSN = {1352-2310},
EISSN = {1873-2844},
Keywords = {Aerosols; China; Air pollution; Premature mortality; Health; Radiative
   forcing},
Keywords-Plus = {LONG-TERM EXPOSURE; INVENTORY; POLLUTION},
Research-Areas = {Environmental Sciences \& Ecology; Meteorology \& Atmospheric Sciences},
Web-of-Science-Categories  = {Environmental Sciences; Meteorology \& Atmospheric Sciences},
Author-Email = {mauzeral@princeton.edu},
ResearcherID-Numbers = {Saikawa, Eri/AAF-5390-2020
   Naik, Vaishali/A-4938-2013
   Mauzerall, Denise L/I-5977-2013
   Horowitz, Larry/D-8048-2014
   Naik, Vaishali/Y-5661-2019},
ORCID-Numbers = {Saikawa, Eri/0000-0003-3166-8620
   Naik, Vaishali/0000-0002-2254-1700
   Mauzerall, Denise L/0000-0003-3479-1798
   Horowitz, Larry/0000-0002-5886-3314
   },
Cited-References = {AMANN M, 1999, 7 INT I APPL SYST AN.
   Anderson JL, 2004, J CLIMATE, V17, P4641.
   Andreae MO, 2005, NATURE, V435, P1187, DOI 10.1038/nature03671.
   {[}Anonymous], 2006, CHIN STAT YB.
   Cao GL, 2006, ATMOS ENVIRON, V40, P6516, DOI 10.1016/j.atmosenv.2006.05.070.
   {*}CIESIN, 2000, GRIDD POP WORLD GPW.
   Cofala J, 2005, SCENARIOS WORLD ANTH.
   Dentener F, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002672.
   Dentener F, 2005, ATMOS CHEM PHYS, V5, P1731, DOI 10.5194/acp-5-1731-2005.
   Dentener F, 2006, ENVIRON SCI TECHNOL, V40, P3586, DOI 10.1021/es0523845.
   ECONOMY EC, 2007, FOREIGN AFFAIRS, V86.
   Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129.
   Haywood J, 2000, REV GEOPHYS, V38, P513, DOI 10.1029/1999RG000078.
   Horowitz LW, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006937.
   Horowitz LW, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002853.
   Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2.
   Koch D, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2005JD007024.
   Levy H, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009176.
   Liu J., 2008, ATMOSPHERIC CHEM PHY, V8, P5537.
   LIU J, ATMOSPHERIC EN UNPUB.
   LIU J, 2006, THESIS PRINCETON U P.
   Liu JG, 2005, NATURE, V435, P1179, DOI 10.1038/4351179a.
   Liu JF, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045029.
   Naik V, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028149.
   Nakicenovic N, 2000, SPECIAL REPORT EMISS.
   National Bureau of Statistics of China, 2007, CHIN STAT YB.
   Ohara T, 2007, ATMOS CHEM PHYS, V7, P4419, DOI 10.5194/acp-7-4419-2007.
   Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F.
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132.
   Ramanathan V, 2008, NAT GEOSCI, V1, P221, DOI 10.1038/ngeo156.
   Schwartz J, 2008, ENVIRON HEALTH PERSP, V116, P64, DOI 10.1289/ehp.9955.
   Shindell DT, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009152.
   Sinton JE, 2001, CHINA ECON REV, V12, P373, DOI 10.1016/S1043-951X(01)00067-0.
   Streets DG, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004902.
   Streets DG, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003093.
   Tie XX, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005359.
   {*}UN NAT DEP EC SOC, 2006, WORLD POP PROSP 2006.
   Wang XP, 2006, ATMOS ENVIRON, V40, P1706, DOI 10.1016/j.atmosenv.2005.10.066.
   {*}WHO, 2000, LIF DAT 2000.
   Zhang Q, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045027.},
Number-of-Cited-References = {40},
Times-Cited = {87},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {69},
Journal-ISO = {Atmos. Environ.},
Doc-Delivery-Number = {452GX},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000266529400017},
DA = {2022-03-29},
}

@article{ WOS:000753378400002,
Author = {Wijnen, Alison and Bishop, Karen and Joshy, Grace and Zhang, Yuehan and
   Banks, Emily and Paige, Ellie},
Title = {Observed and predicted premature mortality in Australia due to
   non-communicable diseases: a population-based study examining progress
   towards the WHO 25X25 goal},
Journal = {BMC MEDICINE},
Year = {2022},
Volume = {20},
Number = {1},
Month = {FEB 10},
Abstract = {Background The World Health Organization's (WHO) 25X25 goal aims for a
   25\% relative reduction in premature death due to four non-communicable
   diseases (NCD4)-cancer, cardiovascular disease, chronic respiratory
   diseases and diabetes-by 2025 compared to 2010. This study aimed to
   quantify the premature mortality in the Australian population due to
   NCD4, quantify the variation in mortality rates by age and sex, predict
   the premature mortality due to NCD4 in 2025 and evaluate the progress
   towards the WHO 25X25 goal. Methods A population-based study using
   cause-specific mortality data of all deaths which occurred in Australia
   from 2010 to 2016 and registered up to 2017, for adults aged 30-69
   years, was conducted. Age-specific and age-standardised mortality rates
   (ASMR) and probability of death for NCD4 were calculated for each year.
   ASMRs in 2016 were calculated for men and women. Deaths and the
   probability of death in 2025 were predicted using Poisson regression
   based on data from 2006 to 2016. To assess the progress against the WHO
   25X25 goal, the relative reduction in the probability of death from NCD4
   conditions in 2025 compared to 2010 was calculated. Results ASMRs for
   NCD4 decreased from 2010 to 2016, except for diabetes which increased on
   average by 2.5\% per year. Across sociodemographic factors, ASMRs were
   highest in males and increased with age. The projected probability of
   premature death in 2025 was 7.36\%, equivalent to a relative reduction
   of 25.16\% compared to 2010 levels. Conclusions Premature mortality due
   to cancer, cardiovascular disease, respiratory diseases and diabetes
   declined in Australia from 2010 to 2016. This trend is consistent across
   age groups and by sex, and higher mortality rates were observed in males
   and at older ages. Nationally, if the current trends continue, we
   estimate that Australia will achieve a 25.16\% relative reduction in
   premature deaths due to NCD4 in 2025 compared to 2010, signifying
   substantial progress towards the WHO 25X25 goal. Concerted efforts will
   need to continue to meet the 25X25 goal, especially in the context of
   the COVID-19 pandemic.},
Publisher = {BMC},
Address = {CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Paige, E (Corresponding Author), Australian Natl Univ, Nat Ctr Epidemiol \& Populat Hlth, Canberra, ACT, Australia.
   Wijnen, Alison; Bishop, Karen; Joshy, Grace; Zhang, Yuehan; Banks, Emily; Paige, Ellie, Australian Natl Univ, Nat Ctr Epidemiol \& Populat Hlth, Canberra, ACT, Australia.
   Banks, Emily, Sax Inst, Sydney, NSW, Australia.},
DOI = {10.1186/s12916-022-02253-z},
Article-Number = {57},
ISSN = {1741-7015},
Keywords = {Non-communicable diseases; Cancer; Cardiovascular disease; Chronic
   respiratory diseases; Diabetes; Premature mortality; Sociodemographic
   factors},
Keywords-Plus = {SUSTAINABLE DEVELOPMENT GOAL; TRENDS},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {ellie.paige@anu.edu.au},
Funding-Acknowledgement = {National Health and Medical Research Council of AustraliaNational Health
   and Medical Research Council of Australia {[}1163214]; NHMRCNational
   Health and Medical Research Council of Australia {[}1136128]; National
   Heart Foundation of AustraliaNational Heart Foundation of Australia
   {[}102131]},
Funding-Text = {This project was supported by a Project Grant from the National Health
   and Medical Research Council of Australia (reference 1163214). Emily
   Banks is supported by the NHMRC (reference 1136128). Ellie Paige is
   supported by a Postdoctoral Fellowship (reference: 102131) from the
   National Heart Foundation of Australia.},
Cited-References = {Australian Bureau of Statistics, 2020, AUSTR DEM STAT DEC 2.
   Australian Bureau of Statistics, 2016, CAUS DEATH AUSTR 201.
   Australian Bureau of Statistics, 2017, POPULATION PROJECTIO.
   Australian Bureau of Statistics, ERP SA2 ASGS 2016 AG.
   Australian Bureau of Statistics, 2019, CAUS DEATH AUSTR 201.
   Australian Institute of Health and Welfare, 2017, TRENDS CARDIOVASCULA.
   Australian Institute of Health and Welfare, 2017, BURD CHRON RESP COND.
   Australian Institute of Health and Welfare, 2019, CANC AUSTR 2019.
   Australian Institute of Health and Welfare, 2019, AUSTR BURD DIS STUD.
   Bennett JE, 2020, LANCET, V396, P918, DOI 10.1016/S0140-6736(20)31761-X.
   Bennett JE, 2018, LANCET, V392, P1072, DOI 10.1016/S0140-6736(18)31992-5.
   Cancer Australia, 2020, REV IMP COVID 19 MED.
   Cobiac LJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012805.
   Dasgupta P, 2019, CANCER EPIDEMIOL, V62, DOI 10.1016/j.canep.2019.101568.
   Harriss LR, 2011, AUST NZ J PUBL HEAL, V35, P466, DOI 10.1111/j.1753-6405.2011.00739.x.
   Li YC, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0894-5.
   Moreno-Betancur M, 2017, EPIDEMIOLOGY, V28, P12, DOI 10.1097/EDE.0000000000000531.
   Murphy K., 2020, AUSTR GOVT MOVES CLO.
   Norheim OF, 2015, LANCET, V385, P239, DOI 10.1016/S0140-6736(14)61591-9.
   Santosa A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0313-8.
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1.
   World Health Organisation, 2020, NONC DIS PROGR MON 2.
   World Health Organisation, 2013, GLOB ACT PLAN PREV C.
   World Health Organisation, 2017, NONC DIS PROGR MON.
   World Health Organization, 2014, NONC DIS GLOB MON FR.
   World Health Organization, 2019, INT STAT CLASS DIS R, V11th.},
Number-of-Cited-References = {26},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {BMC Med.},
Doc-Delivery-Number = {YW4IP},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000753378400002},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000454512300002,
Author = {Zhou, Zheng-Yi and Tang, Wenxi and Villa, Kathleen F.},
Title = {Indirect costs associated with premature mortality among those with
   veno-occlusive disease/sinusoidal obstruction syndrome with multiorgan
   dysfunction post-hematopoietic stem-cell-transplant},
Journal = {CLINICOECONOMICS AND OUTCOMES RESEARCH},
Year = {2019},
Volume = {11},
Pages = {13-22},
Abstract = {Purpose: The study objective was to develop an economic model to assess
   projected costs of lost productivity associated with premature deaths
   due to veno-occlusive disease (VOD)/sinusoidal obstruction syndrome
   (SOS) with multiorgan dysfunction (MOD) among patients in the US who
   underwent hematopoietic stem-cell transplant (HSCT) in 2013.
   Methods: Data sources included the US Census Bureau and Department of
   Health, epidemiologic research organizations, and medical research
   literature. The model considered only lost productivity associated with
   premature death, with lifetime salary assumed to reflect productivity.
   Average annual salary was assumed to be the same for HSCT survivors and
   the general population, with a working age range between 18 and 65
   years. Key data inputs included number of HSCTs by graft type
   (allogeneic and autologous) performed in the US in 2013, HSCT-related
   mortality, mortality associated with VOD/SOS with MOD, and
   life-expectancy reduction for HSCT survivors vs the general population.
   Excess mortality equaled total deaths among patients with VOD/SOS and
   MOD minus deaths in these patients due to causes other than VOD/SOS with
   MOD.
   Results: Among 18,284 patients who underwent HSCT in the US in 2013, the
   model estimated that 361 excess deaths due to VOD/SOS with MOD occurred
   (158 following allogeneic and 203 after autologous transplants). These
   deaths accounted for total lost work productivity of 5,990 years and
   \$124,212,173 in lost wages, averaging 17 years and \$343,791 per
   patient. A sensitivity analysis incorporating adjustment factors for
   epidemiologic and economic inputs calculated total financial loss of
   \$84 million to \$194 million.
   Limitation: Estimates of post-HSCT VOD/SOS with MOD incidence and
   mortality were approximated, due to changing HSCT practices.
   Conclusion: Premature death due to VOD/SOS with MOD imposes a
   substantial economic burden in this population in terms of lost
   productivity. Additional studies of this economic burden are warranted.},
Publisher = {DOVE MEDICAL PRESS LTD},
Address = {PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND},
Type = {Article},
Language = {English},
Affiliation = {Villa, KF (Corresponding Author), Jazz Pharmaceut, 3170 Porter Dr, Palo Alto, CA 94304 USA.
   Zhou, Zheng-Yi; Tang, Wenxi, Anal Grp, New York, NY USA.
   Villa, Kathleen F., Jazz Pharmaceut, Hlth Econ \& Outcomes Res, Palo Alto, CA USA.},
DOI = {10.2147/CEOR.S184883},
ISSN = {1178-6981},
Keywords = {veno-occlusive disease/sinusoidal obstruction syndrome; stem-cell
   transplantation; mortality; lost productivity/income; indirect costs;
   economic burden},
Keywords-Plus = {LONG-TERM SURVIVAL; OCCLUSIVE DISEASE; MARROW-TRANSPLANTATION;
   EUROPEAN-SOCIETY; RISK-FACTORS; SEVERITY CRITERIA; 2-YEAR SURVIVORS;
   ADULT SURVIVORS; OPEN-LABEL; BLOOD},
Research-Areas = {Health Care Sciences \& Services},
Web-of-Science-Categories  = {Health Care Sciences \& Services},
Author-Email = {kathleen.villa@jazzpharma.com},
Funding-Acknowledgement = {Jazz Pharmaceuticals IncJazz Pharmaceuticals; Jazz - PharmaceuticalsJazz
   Pharmaceuticals; Good Publication Practice (GPP3)},
Funding-Text = {This research was funded by Jazz Pharmaceuticals Inc, the manufacturer
   of defibrotide. The authors thank Larry Deblinger and The Curry
   Rockefeller Group, LLC of Tarrytown, NY for providing medical writing
   support and editorial assistance in formatting, proofreading, and copy
   editing, and fact-checking, which was funded by Jazz - Pharmaceuticals
   in accordance with Good Publication Practice (GPP3) guidelines
   (http://www.ismpp.org/gpp3). Jazz Pharmaceuticals also reviewed and
   edited the publication for scientific accuracy.},
Cited-References = {Baker KS, 2010, BIOL BLOOD MARROW TR, V16, pS90, DOI 10.1016/j.bbmt.2009.09.017.
   BEARMAN SI, 1995, BLOOD, V85, P3005, DOI 10.1182/blood.V85.11.3005.bloodjournal85113005.
   BEARMAN SI, 1993, J CLIN ONCOL, V11, P1729, DOI 10.1200/JCO.1993.11.9.1729.
   Bhatia S, 2007, BLOOD, V110, P3784, DOI 10.1182/blood-2007-03-082933.
   Broder MS, 2017, AM HEALTH DRUG BENEF, V10, P366.
   Cao Z, 2017, J MED ECON, V20, P871, DOI 10.1080/13696998.2017.1336623.
   Carreras E, 1998, BLOOD, V92, P3599.
   Carreras E, 2007, BIOL BLOOD MARROW TR, V13, P1448, DOI 10.1016/j.bbmt.2007.08.002.
   Carreras E, 2011, BIOL BLOOD MARROW TR, V17, P1713, DOI 10.1016/j.bbmt.2011.06.006.
   Cesaro S, 2005, HAEMATOLOGICA, V90, P1396.
   Coppell JA, 2010, BIOL BLOOD MARROW TR, V16, P157, DOI 10.1016/j.bbmt.2009.08.024.
   Corbacioglu S, 2018, BONE MARROW TRANSPL, V53, P138, DOI 10.1038/bmt.2017.161.
   Corbacioglu S, 2012, LANCET, V379, P1301, DOI 10.1016/S0140-6736(11)61938-7.
   D'Souza A, 2017, BIOL BLOOD MARROW TR, V23, P1417, DOI 10.1016/j.bbmt.2017.05.035.
   Dignan FL, 2013, BRIT J HAEMATOL, V163, P444, DOI 10.1111/bjh.12558.
   Dvorak CC, 2015, 57 AM SOC HEM ANN M.
   Freycon F, 2014, PEDIATR HEMAT ONCOL, V31, P225, DOI 10.3109/08880018.2013.829541.
   Goldman JM, 2010, J CLIN ONCOL, V28, P1888, DOI 10.1200/JCO.2009.26.7757.
   Gooley TA, 2010, NEW ENGL J MED, V363, P2091, DOI 10.1056/NEJMoa1004383.
   Health Resources and Services Administration, US PAT SURV REP.
   JONES RJ, 1987, TRANSPLANTATION, V44, P778, DOI 10.1097/00007890-198712000-00011.
   Kantarjian HM, 2017, LANCET HAEMATOL, V4, pE387, DOI 10.1016/S2352-3026(17)30103-5.
   Khera N, 2014, BIOL BLOOD MARROW TR, V20, P1375, DOI 10.1016/j.bbmt.2014.05.011.
   Kirchhoff AC, 2010, J CANCER SURVIV, V4, P33, DOI 10.1007/s11764-009-0105-2.
   Lee SJ, 2001, J CLIN ONCOL, V19, P242, DOI 10.1200/JCO.2001.19.1.242.
   Majhail NS, 2013, BONE MARROW TRANSPL, V48, P1145, DOI 10.1038/bmt.2012.258.
   Majhail NS, 2013, BONE MARROW TRANSPL, V48, P294, DOI 10.1038/bmt.2012.133.
   Majhail NS, 2011, BONE MARROW TRANSPL, V46, P385, DOI 10.1038/bmt.2010.115.
   Majhail NS, 2015, BIOL BLOOD MARROW TR, V21, P1863, DOI 10.1016/j.bbmt.2015.07.032.
   Majhail NS, 2013, BIOL BLOOD MARROW TR, V19, P1498, DOI 10.1016/j.bbmt.2013.07.020.
   Majhail NS, 2009, BRIT J HAEMATOL, V147, P129, DOI 10.1111/j.1365-2141.2009.07798.x.
   Martin PJ, 2010, J CLIN ONCOL, V28, P1011, DOI 10.1200/JCO.2009.25.6693.
   MCDONALD GB, 1993, ANN INTERN MED, V118, P255, DOI 10.7326/0003-4819-118-4-199302150-00003.
   Mohty M, 2016, BONE MARROW TRANSPL, V51, P906, DOI 10.1038/bmt.2016.130.
   Mohty M, 2015, BONE MARROW TRANSPL, V50, P781, DOI 10.1038/bmt.2015.52.
   Nivison-Smith I, 2009, BIOL BLOOD MARROW TR, V15, P1323, DOI 10.1016/j.bbmt.2009.06.014.
   Organisation for Economic Co-operation and Development, LAB FORC STAT SEX AG.
   Pasquini MC, 2016, CURRENT USES OUTCOME.
   Pasquini MC, 2013, CIBMTR SUMMARY SLIDE.
   Strouse C, 2016, BIOL BLOOD MARROW TR, V22, P1306, DOI 10.1016/j.bbmt.2016.04.011.
   Syrjala KL, 2005, J CLIN ONCOL, V23, P6596, DOI 10.1200/JCO.2005.12.674.
   Tichelli A, 2017, BONE MARROW TRANSPL, V52, P1436, DOI 10.1038/bmt.2017.115.
   Tsirigotis PD, 2014, BONE MARROW TRANSPL, V49, P1389, DOI 10.1038/bmt.2014.168.
   United States Census Bureau, 2013, HIST INC TABL PEOPL.
   VanderWalde AM, 2013, LEUKEMIA, V27, P1139, DOI 10.1038/leu.2012.311.
   Wingard JR, 2011, J CLIN ONCOL, V29, P2230, DOI 10.1200/JCO.2010.33.7212.
   Xu Jiaquan, 2016, Natl Vital Stat Rep, V64, P1.
   Yakushijin K, 2016, BONE MARROW TRANSPL, V51, P403, DOI 10.1038/bmt.2015.283.},
Number-of-Cited-References = {48},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {CLINICOECONOMICS OUTCOMES RES.},
Doc-Delivery-Number = {HF8SK},
Web-of-Science-Index = {Emerging Sources Citation Index (ESCI)},
Unique-ID = {WOS:000454512300002},
OA = {Green Submitted, Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000482549900026,
Author = {Wu, Zhiyong and Zhang, Yuqiang and Zhang, Leiming and Huang, Minjuan and
   Zhong, Liuju and Chen, Duohong and Wang, Xuemei},
Title = {Trends of outdoor air pollution and the impact on premature mortality in
   the Pearl River Delta region of southern China during 2006-2015},
Journal = {SCIENCE OF THE TOTAL ENVIRONMENT},
Year = {2019},
Volume = {690},
Pages = {248-260},
Month = {NOV 10},
Abstract = {Severe air pollution in the Pearl River Delta (PRD) region of southern
   China has increased attention of both the scientific community and
   policy makers. Air quality data collected at the PRD Regional Air
   Quality Monitoring Network during 2006-2015 were analyzed for assessing
   the effectiveness of pollution control measures and for estimating the
   trends of premature mortality attributable to ambient PM2.5 and O-3.
   Statistically significant decreasing trends were detected for PM2.5
   (-1.74 to -1.83 mu g m(-3)yr(-1)), PM10 (-2.70 to -2.78 mu g
   m(-3)yr(-1)), NO (-0.61 to -0.74 mu g m(-3)yr(-1)), NO2 (-1.20 to -1.22
   mu g m(-3)yr(-1)), and SO2 (-3.46 to -4.01 mu g m(-3)yr(-1)), while an
   increasing trend was found for O-3 (0.70-0.86 mu g m(-3) yr(-1)) during
   the study period. The findings demonstrate the effectiveness of control
   measures implemented in the last decade for primary pollutants and also
   indicate the challenges for controlling secondary pollutants. The
   PM2.5-related premature deaths varied little, e.g., from 40.6 thousand
   deaths in 2006 to 40.4 thousand deaths in 2015, due to the two
   contrasting factors, i.e., the decreased PM2.5 concentration and
   increased population. The increases in both O-3 concentration and
   exposed population resulted in a significant rising trend for the O-3
   -related premature deaths, which increased from 2.7 thousand deaths in
   2006 to 4.5 thousand deaths in 2015, at a rate of 165 deaths yr(-1).
   Consistent with the spatial distribution of air pollution and population
   density, high levels of premature deaths from PM2.5 and O-3 were located
   in the central PRD including Guangzhou, Foshan, Dongguan, and Shenzhen.
   Decreasing PM2.5 concentration is the most effective way in reducing the
   regional mortality burden from air pollution in the near future. Besides
   controlling primary emissions of PM2.5, reducing VOCs emissions is also
   important for limiting atmospheric oxidizing capacity and associated
   secondary PM2.5 formation. (C) 2019 Elsevier B.V. All rights reserved.},
Publisher = {ELSEVIER},
Address = {RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS},
Type = {Article},
Language = {English},
Affiliation = {Wang, XM (Corresponding Author), Jinan Univ, Inst Environm \& Climate Res, Guangzhou 510632, Guangdong, Peoples R China.
   Wu, Zhiyong, Sun Yat Sen Univ, Sch Environm Sci \& Engn, Guangzhou 510275, Guangdong, Peoples R China.
   Wu, Zhiyong; Zhang, Leiming, Environm \& Climate Change Canada, Air Qual Res Div, Sci \& Technol Branch, Toronto, ON M3H 5T4, Canada.
   Zhang, Yuqiang, Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.
   Huang, Minjuan, Sun Yat Sen Univ, Sch Atmospher Sci, Guangzhou 510275, Guangdong, Peoples R China.
   Huang, Minjuan, Sun Yat Sen Univ, Guangdong Prov Key Lab Climate Change \& Nat Disas, Guangzhou 510275, Guangdong, Peoples R China.
   Zhong, Liuju, Guangdong Polytechn Environm Protect Engn, Foshan 528216, Peoples R China.
   Chen, Duohong, Guangdong Prov Environm Monitoring Ctr, Guangzhou 510308, Guangdong, Peoples R China.
   Wang, Xuemei, Jinan Univ, Inst Environm \& Climate Res, Guangzhou 510632, Guangdong, Peoples R China.},
DOI = {10.1016/j.scitotenv.2019.06.401},
ISSN = {0048-9697},
EISSN = {1879-1026},
Keywords = {Long-term trend; Ozone; Particulate matter; Air pollution; Health
   burden; Pearl River Delta (PRD)},
Keywords-Plus = {LONG-TERM TREND; COMPARATIVE RISK-ASSESSMENT; FINE PARTICULATE MATTER;
   OZONE POLLUTION; GLOBAL BURDEN; CHEMICAL-COMPOSITION; SYSTEMATIC
   ANALYSIS; HEALTH IMPACTS; SURFACE OZONE; PM2.5},
Research-Areas = {Environmental Sciences \& Ecology},
Web-of-Science-Categories  = {Environmental Sciences},
Author-Email = {eciwxm@jnu.edu.cn},
ResearcherID-Numbers = {Wu, Zhiyong/H-5421-2011
   Zhang, Yuqiang Alan/C-5027-2015
   Zhang, Leiming/L-3118-2018},
ORCID-Numbers = {Wu, Zhiyong/0000-0002-8376-2232
   Zhang, Yuqiang Alan/0000-0002-9161-7086
   Zhang, Leiming/0000-0001-5437-5412},
Funding-Acknowledgement = {Chinese National Key Research and Development Plan {[}2017YFC0210100];
   National Natural Science Foundation of China for Distinguished Young
   ScholarsNational Natural Science Foundation of China (NSFC)National
   Science Fund for Distinguished Young Scholars {[}41425020]; Guangdong
   Special Funds for Science and Technology Development {[}2017B020216007]},
Funding-Text = {X.M. Wang is supported by Chinese National Key Research and Development
   Plan (2017YFC0210100) and National Natural Science Foundation of China
   for Distinguished Young Scholars (41425020). D.H. Chen is supported by
   Guangdong Special Funds for Science and Technology Development
   (2017B020216007). We thank Yu Wang and Buqing Zhong for data collection.},
Cited-References = {Anenberg SC, 2018, ENVIRON HEALTH PERSP, V126, DOI {[}10.1289/EHP3766, 10.1289/ehp3766].
   Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049.
   CARDELINO CA, 1995, J AIR WASTE MANAGE, V45, P161, DOI 10.1080/10473289.1995.10467356.
   Cheng NL, 2018, ENVIRON POLLUT, V237, P262, DOI 10.1016/j.envpol.2018.02.051.
   China MEP, 2007, NAT 11 5 YEAR PLAN E.
   China MEP, 2011, NAT 12 5 YEAR PLAN E.
   China MEP, 2016, NAT 13 5 YEAR PLAN E.
   Cohen AJ, 2017, LANCET, V389, P1907, DOI {[}10.1016/S0140-6736(17)30505-6, 10.1016/s0140-6736(17)30505-6].
   de Foy B, 2016, SCI REP-UK, V6, DOI 10.1038/srep35912.
   Fang D., 2019, ENVIRON SCI POLLUT R, P1.
   Feng LW, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111321.
   Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2.
   Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8.
   GDEMC and HKEPD, 2006, PEARL RIV DELT REG A.
   Gilbert R. O., 1987, STATISTICAL METHODS.
   Health Effects Institute, 2019, STAT GLOB AIR 2019, P24.
   HKSAR Department of Health, 2013, ANN REP TABL HLTH ST.
   HKSAR EPD, 2007, PEARL RIV DELT REG A.
   HKSAR Government, 2013, CLEAN AIR PLAN HONG.
   Hu JL, 2017, ENVIRON SCI TECHNOL, V51, P9950, DOI 10.1021/acs.est.7b03193.
   Huang DS, 2012, ENVIRON SCI POLICY, V15, P38, DOI 10.1016/j.envsci.2011.09.007.
   Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894.
   Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371.
   Lelieveld J, 2013, ATMOS CHEM PHYS, V13, P7023, DOI 10.5194/acp-13-7023-2013.
   Li J, 2018, ENVIRON POLLUT, V243, P1710, DOI 10.1016/j.envpol.2018.09.089.
   Li Y, 2015, ENVIRON SCI TECHNOL, V49, P11670, DOI 10.1021/acs.est.5b02776.
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8.
   Lin HL, 2016, ENVIRON INT, V96, P91, DOI 10.1016/j.envint.2016.09.007.
   Lin YY, 2018, ATMOS ENVIRON, V194, P41, DOI 10.1016/j.atmosenv.2018.09.024.
   Liu H, 2013, ATMOS CHEM PHYS, V13, P12013, DOI 10.5194/acp-13-12013-2013.
   Liu H, 2018, ATMOS ENVIRON, V173, P223, DOI 10.1016/j.atmosenv.2017.11.014.
   Liu J, 2016, SCI TOTAL ENVIRON, V568, P1253, DOI 10.1016/j.scitotenv.2016.05.165.
   Liu MM, 2017, ENVIRON INT, V98, P75, DOI 10.1016/j.envint.2016.10.003.
   Lu KD, 2010, SCI CHINA CHEM, V53, P651, DOI 10.1007/s11426-010-0055-6.
   Lu XC, 2019, SCI TOTAL ENVIRON, V652, P683, DOI 10.1016/j.scitotenv.2018.10.140.
   Lu XC, 2017, ENVIRON INT, V98, P160, DOI 10.1016/j.envint.2016.11.002.
   Maji KJ, 2019, ENVIRON POLLUT, V247, P792, DOI 10.1016/j.envpol.2019.01.049.
   Maji KJ, 2018, ENVIRON INT, V121, P392, DOI 10.1016/j.envint.2018.09.024.
   Motulsky H., 1995, INTUITIVE BIOSTATIST.
   Qi HX, 2012, SCI CHINA CHEM, V55, P1451, DOI 10.1007/s11426-012-4524-y.
   Seinfeld J. H., 2006, Atmospheric chemistry and physics: from air pollution to climate change.
   Sillman S, 1999, ATMOS ENVIRON, V33, P1821, DOI 10.1016/S1352-2310(98)00345-8.
   Silva RA, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034005.
   Song CB, 2017, ENVIRON POLLUT, V223, P575, DOI 10.1016/j.envpol.2017.01.060.
   Strosnider HM, 2019, AM J RESP CRIT CARE, V199, P882, DOI 10.1164/rccm.201806-1147OC.
   Sun W, 2018, EARTHS FUTURE, V6, P1112, DOI 10.1029/2018EF000822.
   Tao J, 2017, ATMOS CHEM PHYS, V17, P9485, DOI 10.5194/acp-17-9485-2017.
   The State Council of China, 2013, AIR POLL PREV CONTR.
   US EPA, 2012, EPA600R12056F.
   Wang T, 2009, ATMOS CHEM PHYS, V9, P6217, DOI 10.5194/acp-9-6217-2009.
   Wang T, 2017, SCI TOTAL ENVIRON, V575, P1582, DOI 10.1016/j.scitotenv.2016.10.081.
   Wang T, 2018, ATMOS CHEM PHYS, V18, P18063, DOI 10.5194/acp-18-18063-2018.
   Wang XM, 2009, ADV ATMOS SCI, V26, P471, DOI 10.1007/s00376-009-0471-8.
   Wang XM, 2005, ATMOS ENVIRON, V39, P5227, DOI 10.1016/j.atmosenv.2005.04.035.
   Wang XM, 2016, FRONT ENV SCI ENG, V10, P53, DOI 10.1007/s11783-014-0728-z.
   Wang ZF, 2016, FRONT ENV SCI ENG, V10, DOI 10.1007/s11783-016-0853-y.
   World Health Organization, 2016, AMBIENT AIR POLLUTIO.
   Wu RS, 2018, SCI TOTAL ENVIRON, V645, P491, DOI 10.1016/j.scitotenv.2018.07.091.
   Xie R, 2016, ENVIRON INT, V97, P180, DOI 10.1016/j.envint.2016.09.003.
   Xu X, 2008, ATMOS CHEM PHYS, V8, P2595, DOI 10.5194/acp-8-2595-2008.
   Ye LM, 2016, FRONT ENV SCI ENG, V10, DOI 10.1007/s11783-016-0887-1.
   Yin P, 2017, ENVIRON HEALTH PERSP, V125, DOI {[}10.1289/EHP1673, 10.1289/ehp1673].
   Zhang Q, 2017, NATURE, V543, P705, DOI 10.1038/nature21712.
   Zhang YH, 2008, ATMOS ENVIRON, V42, P6203, DOI 10.1016/j.atmosenv.2008.05.002.
   Zheng YX, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa8a32.
   Zhong LJ, 2013, AEROSOL AIR QUAL RES, V13, P1582, DOI 10.4209/aaqr.2012.10.0276.
   Zhong LJ, 2013, ATMOS ENVIRON, V76, P3, DOI 10.1016/j.atmosenv.2013.03.012.},
Number-of-Cited-References = {67},
Times-Cited = {27},
Usage-Count-Last-180-days = {11},
Usage-Count-Since-2013 = {162},
Journal-ISO = {Sci. Total Environ.},
Doc-Delivery-Number = {IT0QC},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000482549900026},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000686033500028,
Author = {Warrilow, Adele and Der, Geoff and Cooper, Sally-Ann and Minnis, Helen
   and Pell, Jill P.},
Title = {Childhood neurodevelopmental markers and risk of premature mortality:
   Follow-up to age 60-65 years in the Aberdeen Children of the 1950s study},
Journal = {PLOS ONE},
Year = {2021},
Volume = {16},
Number = {8},
Abstract = {Background Individual neurodevelopmental disorders are associated with
   premature mortality. Little is known about the association between
   multiple neurodevelopmental markers and premature mortality at a
   population level. The ESSENCE (Early Symptomatic Syndromes Eliciting
   Neurodevelopmental Clinical Examinations) approach considers multiple
   neurodevelopmental parameters, assessing several markers in parallel
   that cluster, rather than considering individual diagnostic categories
   in isolation. Objectives To determine whether childhood
   neurodevelopmental markers, including reduced intellectual functioning,
   are associated with all-cause premature mortality. Methods and
   procedures In a general population cohort study (n = 12,150) with
   longitudinal follow up from childhood to middle age, Cox proportional
   hazard models were used to study the associations between childhood
   neurodevelopmental markers (Rutter B scale and IQ) and premature
   all-cause mortality. Outcomes and results The cognitive measures and 21
   of the 26 Rutter B items were significantly associated with premature
   mortality in bivariate analyses with hazard ratios from 1.24 (95\% CI
   1.05-1.47) to 2.25 (95\% CI 1.78-2.90). In the final adjusted model,
   neurodevelopmental markers suggestive of several domains including
   hyperactivity, conduct problems and intellectual impairment were
   positively associated with premature mortality and improved prediction
   of premature mortality. Conclusions A wide range of neurodevelopmental
   markers, including childhood IQ, were found to predict premature
   mortality in a large general population cohort with longitudinal follow
   up to 60-65 years of age. Implications These findings highlight the
   importance of a holistic assessment of children with neurodevelopmental
   markers that addresses a range of neurodevelopmental conditions. Our
   findings could open the door to a shift in child public mental health
   focus, where multiple and/or cumulative markers of neurodevelopmental
   conditions alert clinicians to the need for early intervention. This
   could lead to a reduction in the risk of broad health outcomes at a
   population level.},
Publisher = {PUBLIC LIBRARY SCIENCE},
Address = {1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA},
Type = {Article},
Language = {English},
Affiliation = {Minnis, H (Corresponding Author), Univ Glasgow, Inst Hlth \& Wellbeing, Glasgow, Lanark, Scotland.
   Warrilow, Adele; Der, Geoff; Cooper, Sally-Ann; Minnis, Helen; Pell, Jill P., Univ Glasgow, Inst Hlth \& Wellbeing, Glasgow, Lanark, Scotland.
   Der, Geoff, Univ Glasgow, MRC CSO Social \& Publ Hlth Sci Unit, Glasgow, Lanark, Scotland.},
DOI = {10.1371/journal.pone.0255649},
Article-Number = {e0255649},
ISSN = {1932-6203},
Keywords-Plus = {INTELLECTUAL DISABILITIES; COHORT PROFILE; HEALTH-STATUS; AUTISM;
   DISORDERS; TEACHERS; PEOPLE},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {Helen.minnis@glasgow.ac.uk},
ORCID-Numbers = {Minnis, Helen/0000-0002-2377-8945},
Funding-Acknowledgement = {PsySTAR fellowship (Medical Research Foundation); Medical Research
   CouncilUK Research \& Innovation (UKRI)Medical Research Council UK
   (MRC)European Commission {[}MR/J000914/1]},
Funding-Text = {PsySTAR fellowship (Medical Research Foundation and the Medical Research
   Council Grant Ref: MR/J000914/1) to Dr Adele Warrilow.},
Cited-References = {Agnew-Blais JC, 2018, BRIT J PSYCHIAT, V213, P526, DOI 10.1192/bjp.2018.97.
   Anckarsater H, 2011, TWIN RES HUM GENET, V14, P495, DOI 10.1375/twin.14.6.495.
   Batty GD, 2004, PAEDIATR PERINAT EP, V18, P221, DOI 10.1111/j.1365-3016.2004.00552.x.
   Bishop-Fitzpatrick L, 2018, AUTISM RES, V11, P1120, DOI 10.1002/aur.1960.
   Brander G, 2019, JAMA NEUROL, V76, P454, DOI 10.1001/jamaneurol.2018.4279.
   Brook JS, 2013, PEDIATRICS, V131, P5, DOI 10.1542/peds.2012-1725.
   Copeland WE, 2015, JAMA PSYCHIAT, V72, P892, DOI 10.1001/jamapsychiatry.2015.0730.
   Croen LA, 2015, AUTISM, V19, P814, DOI 10.1177/1362361315577517.
   Dalsgaard S, 2015, LANCET, V385, P2190, DOI 10.1016/S0140-6736(14)61684-6.
   Elander J, 1996, INT J METHOD PSYCH, V6, P63, DOI 10.1002/(SICI)1234-988X(199607)6:2<63::AID-MPR151>3.3.CO;2-M.
   Ghanizadeh Ahmad, 2011, BMC Res Notes, V4, P116, DOI 10.1186/1756-0500-4-116.
   Gillberg C, 2010, RES DEV DISABIL, V31, P1543, DOI 10.1016/j.ridd.2010.06.002.
   Gordon-Lipkin E, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-1377.
   Gotby VO, 2018, J CHILD PSYCHOL PSYC, V59, P957, DOI 10.1111/jcpp.12884.
   Hippisley-Cox J, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2099.
   Hirvikoski T, 2016, BRIT J PSYCHIAT, V208, P232, DOI 10.1192/bjp.bp.114.160192.
   Hughes-McCormack LA, 2018, J EPIDEMIOL COMMUN H, V72, P78, DOI 10.1136/jech-2017-209748.
   Jacobs DR, 1999, ARCH INTERN MED, V159, P733, DOI 10.1001/archinte.159.7.733.
   Kerekes N, 2014, PEERJ, V2, DOI 10.7717/peerj.359.
   Leon DA, 2006, INT J EPIDEMIOL, V35, P549, DOI 10.1093/ije/dyi319.
   Li KB, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002438.
   Lundstrom S, 2015, J CHILD PSYCHOL PSYC, V56, P702, DOI 10.1111/jcpp.12329.
   Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170.
   Maughan B, 2014, PSYCHOL MED, V44, P1077, DOI 10.1017/S0033291713001402.
   Miller-Johnson S, 2002, J ABNORM CHILD PSYCH, V30, P217.
   O'Leary L, 2018, J APPL RES INTELLECT, V31, P325, DOI 10.1111/jar.12417.
   Ostrolenk A, 2017, NEUROSCI BIOBEHAV R, V79, P134, DOI 10.1016/j.neubiorev.2017.04.029.
   Pettersson E, 2013, J CHILD PSYCHOL PSYC, V54, P1356, DOI 10.1111/jcpp.12113.
   RUTTER M, 1967, J CHILD PSYCHOL PSYC, V8, P1, DOI 10.1111/j.1469-7610.1967.tb02175.x.
   Rydzewska E, 2019, AUTISM, V23, P1201, DOI 10.1177/1362361318791279.
   Rydzewska E, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023945.
   Schendel DE, 2016, JAMA PEDIATR, V170, P243, DOI 10.1001/jamapediatrics.2015.3935.
   Scott JG, 2017, PSYCHIAT RES, V251, P255, DOI 10.1016/j.psychres.2017.02.029.
   Stickley A, 2017, EUR PSYCHIAT, V45, P227, DOI 10.1016/j.eurpsy.2017.07.010.
   Thapar A, 2017, LANCET PSYCHIAT, V4, P339, DOI 10.1016/S2215-0366(16)30376-5.
   Uchida M, 2018, J ATTEN DISORD, V22, P523, DOI 10.1177/1087054715604360.},
Number-of-Cited-References = {36},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {PLoS One},
Doc-Delivery-Number = {UB7PL},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000686033500028},
OA = {Green Published, gold, Green Accepted},
DA = {2022-03-29},
}

@article{ WOS:000654684600008,
Author = {Doring, Nora and Lundberg, Michael and Dalman, Christina and
   Hemmingsson, Tomas and Rasmussen, Finn and Wallin, Alma Sorberg and
   Wicks, Susanne and Magnusson, Cecilia and Lager, Anton},
Title = {Labour market position of young people and premature mortality in adult
   life: A 26-year follow-up of 569 528 Swedish 18 year-olds},
Journal = {LANCET REGIONAL HEALTH-EUROPE},
Year = {2021},
Volume = {3},
Month = {APR},
Abstract = {Background: Throughout the industrialized world, demand for low skilled
   labour is falling. The length of schooling is increasing in response,
   but so is the proportion of individuals not finishing upper secondary
   school. The objective of this study was to evaluate the associations
   between labour market positions at age 18 and all-cause and suicide- and
   accident-specific mortality in later adulthood.
   Methods: Labour market positions at age 18 were categorized for all
   Swedes born 1972-77 (n=630 959) into four main groups: employed,
   successful students, students not about to qualify (SNAQs), and
   individuals not in employment, education or training (NEETs). Cox
   proportional hazard models were fitted to assess allcause, suicide and
   accident mortality up to 2016 (ages 39-44), adjusting for high school
   grades, parental and own prior psychiatric diagnoses, and childhood
   socioeconomic status.
   Findings: SNAQs had substantially increased all-cause (men: HR=2.10;
   95\% CI 1.92-2.28, women: HR=1.64; 95\% CI: 1.44-1.86), suicide (men:
   HR=2.16; CI: 1.86-2.51, women: HR=2.10; 95\% CI 1.64-2.69), and accident
   specific (men: HR=2.08; 95\% CI 1.77-2.44, women: 1.87; 95\% CI
   1.33;2.62) mortality risks compared to successful students. The risks
   were similar for NEETs. There was no increased risk among full-time
   employed compared to successful students.
   Interpretation: Expanding the educational system may be a natural
   response to falling demand for low skilled labour but not by far one
   that corrects the major societal challenge of it. Unless educational
   systems adequately respond to this challenge, only more inequality is to
   be expected ahead. (C) 2021 The Author(s). Published by Elsevier Ltd.},
Publisher = {ELSEVIER},
Address = {RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS},
Type = {Article},
Language = {English},
Affiliation = {Doring, N (Corresponding Author), Karolinska Inst, Dept Med Epidemiol \& Biostat, Solna, Sweden.
   Doring, Nora, Karolinska Inst, Dept Med Epidemiol \& Biostat, Solna, Sweden.
   Lundberg, Michael; Magnusson, Cecilia; Lager, Anton, Karolinska Inst, Dept Global Publ Hlth, Prevent Intervent \& Mech Publ Hlth PRIME Hlth, Solna, Sweden.
   Dalman, Christina; Wallin, Alma Sorberg; Wicks, Susanne, Karolinska Inst, Dept Global Publ Hlth, Epidemiol Psychiat Condit Subst Use \& Social Envi, Solna, Sweden.
   Dalman, Christina; Wicks, Susanne; Magnusson, Cecilia; Lager, Anton, Ctr Epidemiol \& Community Med, Stockholm, Sweden.
   Hemmingsson, Tomas, Karolinska Inst, Inst Environm Med, Stockholm, Sweden.
   Hemmingsson, Tomas, Stockholm Univ, Dept Publ Hlth Sci, Stockholm, Sweden.
   Hemmingsson, Tomas, Karolinska Inst, Dept Global Publ Hlth, Solna, Sweden.},
DOI = {10.1016/j.lanepe.2021.100048},
EarlyAccessDate = {FEB 2021},
Article-Number = {100048},
ISSN = {2666-7762},
Keywords = {Education; unemployment; school dropout; mortality; mental health; NEET},
Keywords-Plus = {UNEMPLOYMENT; EDUCATION; SWEDEN; COHORT; HEALTH},
Research-Areas = {Health Care Sciences \& Services; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Public, Environmental \& Occupational
   Health},
Author-Email = {nora.doering@ki.se},
ORCID-Numbers = {Sorberg Wallin, Alma/0000-0002-8804-095X
   Lager, Anton/0000-0001-5263-8063},
Funding-Acknowledgement = {Swedish National Board and Welfare},
Funding-Text = {The data that support the findings of this study is available from the
   Swedish National Board and Welfare but restrictions apply to the
   availability of these data, which were used under license for the
   current study, and so are not publicly available. Questions or requests
   concerning this data is directed to the principal investigator Cecilia
   Magnusson.},
Cited-References = {ALLEBECK P, 1991, SCAND J SOC MED, V19, P242, DOI 10.1177/140349489101900405.
   Avendano M, 2017, DOES MORE ED ALWAYS.
   Bergmark A, 2003, INT J SOC WELF, V12, P108, DOI 10.1111/1468-2397.00249.
   Canivet C, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3358-5.
   Esch P, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0237-4.
   Hallsten M, 2017, EUR SOCIOL REV, V33, P169, DOI 10.1093/esr/jcw053.
   Krueger PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131809.
   Lager ACJ, 2012, P NATL ACAD SCI USA, V109, P8461, DOI 10.1073/pnas.1105839109.
   Lundahl L, 2014, INT J ADOLESC YOUTH, V19, P19, DOI 10.1080/02673843.2013.852593.
   Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8.
   McKee-Ryan FM, 2005, J APPL PSYCHOL, V90, P53, DOI 10.1037/0021-9010.90.1.53.
   OECD, 2012, ED GLANC 2012.
   OECD, 2018, YOUTH NOT EMPL ED TR.
   Olausson PO, 1991, J OFF STAT, V7, P93.
   Postlethwaite TN., WHAT DO INT ASSESSME.
   Reneflot A, 2014, INT J SOC WELF, V23, P3, DOI 10.1111/ijsw.12000.
   Statistics Sweden, 2017, YOUNG PEOPLE LEFT BE.
   Susanne Wicks CD, VASENTLIGT FLER KVIN, P2.
   Sweden S, 1982, SOCIOEKONOMISK INDEL.
   Viner RM, 2015, LIFE COURSE EPIDEMIO.
   Voss M, 2004, AM J PUBLIC HEALTH, V94, P2155, DOI 10.2105/AJPH.94.12.2155.},
Number-of-Cited-References = {21},
Times-Cited = {2},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Lancet Reg. Health-Eur.},
Doc-Delivery-Number = {SI2VO},
Web-of-Science-Index = {Emerging Sources Citation Index (ESCI)},
Unique-ID = {WOS:000654684600008},
OA = {gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000231209100018,
Author = {Weitoft, GR and Rosen, M},
Title = {Is perceived nervousness and anxiety a predictor of premature mortality
   and severe morbidity? A longitudinal follow up of the Swedish survey of
   living conditions},
Journal = {JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH},
Year = {2005},
Volume = {59},
Number = {9},
Pages = {794-798},
Month = {SEP},
Abstract = {Study objective: To find out if people perceiving nervousness,
   uneasiness, and anxiety have excess risks of premature death and severe
   morbidity.
   Design, setting, participants: Random samples of the Swedish population
   aged 16 - 74 years in 1980 - 81, 1988 - 89, and 1995 - 96 were followed
   up for 5 and 10 years with regard to deaths and hospital admissions for
   different causes. Relative risks were estimated by Poisson regression,
   comparing those who reported perceived nervousness, uneasiness, and
   anxiety with those who did not and adjustments were made for baseline
   characteristics as age, education, smoking, and longstanding illness.
   Main results: Perceived nervousness, uneasiness, and anxiety was
   strongly related to subsequent risks of suicide attempt and psychiatric
   disease. Those perceiving severe complaints of anxiety had a relative
   risk ( fully adjusted) for suicide attempt of 9.2 (95\% CI 3.0 to 28.8)
   for men and 3.1 (1.4 to 7.1) for women. Even for less severe complaints,
   there was a significant, but less pronounced excess risk. These negative
   feelings were also associated with later risks for all cause mortality,
   hospital care, and ischaemic heart disease, although to a lesser extent
   and more strongly among men. Unchanged relative risks over time shows no
   trend in response attitude and perceived anxiety seems to be a better
   predictor of a negative health outcome than self reported longstanding
   illness.
   Conclusions: Positive responses to self report survey questions about
   anxiety/nervousness are associated with adverse health outcomes,
   particularly hospital admission for deliberate self harm. This is an
   alarming signal bearing in mind the rapid increase in prevalence of
   perceived anxiety in the Swedish society.},
Publisher = {BMJ PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Weitoft, GR (Corresponding Author), Swedish Natl Board Hlth \& Welf, Ctr Epidemiol, S-10630 Stockholm, Sweden.
   Swedish Natl Board Hlth \& Welf, Ctr Epidemiol, S-10630 Stockholm, Sweden.
   Karolinska Inst, Dept Publ Hlth \& Clin Med, Stockholm, Sweden.},
DOI = {10.1136/jech.2005.033076},
ISSN = {0143-005X},
EISSN = {1470-2738},
Keywords-Plus = {SELF-RATED HEALTH; CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; RISK;
   DEPRESSION; SUICIDE; HOPELESSNESS; DISORDER; LIFE; MEN},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {gunilla.ringback@socialstyrelsen.se},
Cited-References = {Benjamins MR, 2004, SOC SCI MED, V59, P1297, DOI 10.1016/j.socscimed.2003.01.001.
   Burstrom B, 2001, J EPIDEMIOL COMMUN H, V55, P836, DOI 10.1136/jech.55.11.836.
   Everson SA, 1996, PSYCHOSOM MED, V58, P113, DOI 10.1097/00006842-199603000-00003.
   Glassman AH, 1998, AM J PSYCHIAT, V155, P4, DOI 10.1176/ajp.155.1.4.
   Gunnell D, 2002, SOC PSYCH PSYCH EPID, V37, P457, DOI 10.1007/s00127-002-0579-y.
   HAINES AP, 1987, BRIT MED J, V295, P297, DOI 10.1136/bmj.295.6593.297.
   HAYWARD C, 1995, EPIDEMIOL REV, V17, P129, DOI 10.1093/oxfordjournals.epirev.a036169.
   Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359.
   Jylha M, 1998, J GERONTOL B-PSYCHOL, V53, pS144, DOI 10.1093/geronb/53B.3.S144.
   KAWACHI I, 1994, CIRCULATION, V90, P2225, DOI 10.1161/01.CIR.90.5.2225.
   Kiecolt-Glaser JK, 2002, ANNU REV PSYCHOL, V53, P83, DOI 10.1146/annurev.psych.53.100901.135217.
   Koivumaa-Honkanen H, 2003, SOC PSYCH PSYCH EPID, V38, P244, DOI 10.1007/s00127-003-0625-4.
   Koivumaa-Honkanen H, 2001, AM J PSYCHIAT, V158, P433, DOI 10.1176/appi.ajp.158.3.433.
   Kubzansky LD, 1998, ANN BEHAV MED, V20, P47, DOI 10.1007/BF02884448.
   Kubzansky LD, 2000, J PSYCHOSOM RES, V48, P323, DOI 10.1016/S0022-3999(99)00091-4.
   Kubzansky LD, 1997, CIRCULATION, V95, P818.
   Kuo WH, 2004, SOC PSYCH PSYCH EPID, V39, P497, DOI 10.1007/s00127-004-0775-z.
   Larsson D, 2002, SCAND J PUBLIC HEALT, V30, P259, DOI 10.1080/14034940210133997.
   Macintyre S, 1999, SOC SCI MED, V48, P89, DOI 10.1016/S0277-9536(98)00292-5.
   MOSSEY JM, 1982, AM J PUBLIC HEALTH, V72, P800, DOI 10.2105/AJPH.72.8.800.
   Pratt LA, 1996, CIRCULATION, V94, P3123, DOI 10.1161/01.CIR.94.12.3123.
   {*}STAT SWED, 1995, SUPPL APP 15 TECHN R.
   Van Hout HPJ, 2004, BRIT J PSYCHIAT, V185, P399, DOI 10.1192/bjp.185.5.399.
   VERBRUGGE LM, 1989, J HEALTH SOC BEHAV, V30, P282, DOI 10.2307/2136961.},
Number-of-Cited-References = {24},
Times-Cited = {56},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {J. Epidemiol. Community Health},
Doc-Delivery-Number = {955EV},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000231209100018},
OA = {Green Published, Bronze},
DA = {2022-03-29},
}

@article{ WOS:000649614500005,
Author = {Fong, Kelvin C. and Bell, Michelle L.},
Title = {Do fine particulate air pollution (PM2.5) exposure and its attributable
   premature mortality differ for immigrants compared to those born in the
   United States?},
Journal = {ENVIRONMENTAL RESEARCH},
Year = {2021},
Volume = {196},
Month = {MAY},
Abstract = {In the United States (US), immigrants constitute a considerable and
   growing proportion of the general population. Compared to the US-born,
   immigrants have differential health risks, and it is unclear if
   environmental exposures contribute. In this work, we estimated
   disparities between immigrants and the US-born in fine particulate
   matter (PM2.5) exposure and attributable premature mortality, including
   by region of origin and time since immigration. With PM2.5 estimates
   from a validated model at similar to 1 km(2) spatial resolution and
   residential Census tract population data, we calculated the annual
   area-weighted average PM2.5 exposure for immigrants overall, the
   US-born, and immigrants separately by geographic region of origin and
   time since immigration. We then calculated the premature mortality
   attributed to PM2.5 for each population group, assessing disparities by
   immigrant status in PM2.5 exposure and attributable premature mortality
   in the US as a whole and in each US county to evevaluate spatial
   heterogeneity. Overall, immigrants were exposed to slightly higher PM2.5
   (0.36 mu g/m(3), 3.8\%) than the US-born. This exposure difference
   translates to 2.11 more premature deaths attributable to PM2.5 per
   100,000 in population for immigrants compared to the US-born in 2010.
   Immigrant - US-born disparities in PM2.5 and attributable premature
   mortality were more severe among immigrants originating from Asia,
   Africa, and Latin America than those from Europe, Oceania, and North
   America. Disparities between immigrant groups by time since immigration
   were comparatively small. Sensitivity analyses using 2000 data and a
   non-linear set of PM2.5 attributable mortality coefficients identified
   similar patterns. Our findings suggest that environmental exposure
   disparities, such as in PM2.5, may contribute to immigrant health
   disparities in the US.},
Publisher = {ACADEMIC PRESS INC ELSEVIER SCIENCE},
Address = {525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA},
Type = {Article},
Language = {English},
Affiliation = {Fong, KC (Corresponding Author), ScD, 301 Prospect St, New Haven, CT 06511 USA.
   Fong, Kelvin C.; Bell, Michelle L., Yale Univ, Yale Sch Environm, New Haven, CT USA.},
DOI = {10.1016/j.envres.2020.110387},
EarlyAccessDate = {MAY 2021},
Article-Number = {110387},
ISSN = {0013-9351},
EISSN = {1096-0953},
Keywords = {Air pollution; Health disparity; Immigrant health; PM2.5; Environmental
   justice},
Keywords-Plus = {LIFE EXPECTANCY; OLDER-ADULTS; FOLLOW-UP; HEALTH; MATTER; DISEASE;
   DISPARITIES; IMPACTS; TRENDS; RACE},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {kelvin.fong@yale.edu},
ResearcherID-Numbers = {Bell, Michelle/Y-4608-2018
   },
ORCID-Numbers = {Bell, Michelle/0000-0002-3965-1359
   Fong, Kelvin/0000-0002-8659-6794},
Funding-Acknowledgement = {U.S. Environmental Protection AgencyUnited States Environmental
   Protection Agency {[}RD835871]; National Institute On Minority Health
   And Health Disparities of the National Institutes of Health
   {[}R01MD012769]},
Funding-Text = {This publication was developed under Assistance Agreement No. RD835871
   awarded by the U.S. Environmental Protection Agency to Yale University.
   It has not been formally reviewed by EPA. The views expressed in this
   document are solely those of the authors and do not necessarily reflect
   those of the Agency. EPA does not endorse any products or commercial
   services mentioned in this publication. Research reported in this
   publication was also supported by the National Institute On Minority
   Health And Health Disparities of the National Institutes of Health under
   Award Number R01MD012769. The content is solely the responsibility of
   the authors and does not necessarily represent the official views of the
   National Institutes of Health.},
Cited-References = {Arandia Gabriela, 2012, Journal of Nutrition in Gerontology and Geriatrics, V31, P16, DOI 10.1080/21551197.2012.647553.
   Baird J, 2008, SOCIOL INQ, V78, P310, DOI 10.1111/j.1475-682X.2008.00242.x.
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1.
   Brugge D, 2000, J Immigr Health, V2, P97, DOI 10.1023/A:1009538002661.
   Centers for Disease Control and Prevention, 2020, WID RANG ONL DAT EP.
   Cohen AJ, 2017, LANCET, V389, P1907, DOI {[}10.1016/S0140-6736(17)30505-6, 10.1016/s0140-6736(17)30505-6].
   Cunningham SA, 2008, HEALTH PLACE, V14, P623, DOI 10.1016/j.healthplace.2007.12.002.
   Dupre ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037177.
   Eamranond PP, 2008, ENVIRON HEALTH INSIG, V1, P45.
   Enstrom JE, 2017, NEW ENGL J MED, V377, P1498, DOI 10.1056/NEJMc1709849.
   Erickson AC, 2020, HEALTH REP, V31, P14, DOI 10.25318/82-003-x202000300002-eng.
   Fann N, 2018, ENVIRON RES, V167, P506, DOI 10.1016/j.envres.2018.08.018.
   Fann N, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP507.
   Franklin BA, 2015, CURR PROB CARDIOLOGY, V40, P207, DOI 10.1016/j.cpcardiol.2015.01.003.
   Gany F, 2017, J EXPO SCI ENV EPID, V27, P221, DOI 10.1038/jes.2016.23.
   Hajat Anjum, 2015, Curr Environ Health Rep, V2, P440, DOI 10.1007/s40572-015-0069-5.
   Hayes RB, 2020, INT J EPIDEMIOL, V49, P25, DOI 10.1093/ije/dyz114.
   Hempstead K, 2007, INT MIGR REV, V41, P466, DOI 10.1111/j.1747-7379.2007.00075.x.
   Horlyck-Romanovsky M.F., 2019, J IMMIGR MINORITY HL, V21, P47.
   HubeII B., 2009, AIR QUAL ATMOS HLTH, P99.
   Johnson BB, 2011, RISK ANAL, V31, P984, DOI 10.1111/j.1539-6924.2010.01557.x.
   Krewski Daniel, 2009, Res Rep Health Eff Inst, P5.
   Lepeule J, 2012, ENVIRON HEALTH PERSP, V120, P965, DOI 10.1289/ehp.1104660.
   Lievanos RS, 2015, SOC SCI RES, V54, P50, DOI 10.1016/j.ssresearch.2015.06.014.
   Mehta NK, 2016, DEMOGRAPHY, V53, P1109, DOI 10.1007/s13524-016-0488-4.
   Moyce S.C., 2017, CURR ENV HLTH REP, V4, P349.
   Nasari MM, 2016, AIR QUAL ATMOS HLTH, V9, P961, DOI 10.1007/s11869-016-0398-z.
   National Academies of Sciences E. and Medicine, 2015, INT IMM AM SOC.
   Pappalardo AA, 2018, CURR ALLERGY ASTHM R, V18, DOI 10.1007/s11882-018-0779-5.
   Parker JD, 2018, CIRCULATION, V137, P1688, DOI 10.1161/CIRCULATIONAHA.117.029376.
   Parks SE, 2014, MMWR SURVEILL SUMM, V63, P1.
   Passel J., 2008, US POPULATION PROJEC.
   Pinault L, 2017, HEALTH REP, V28, P9.
   Pope CA, 2019, ENVIRON HEALTH PERSP, V127, DOI 10.1289/EHP4438.
   Pun VC, 2017, AM J EPIDEMIOL, V186, P961, DOI 10.1093/aje/kwx166.
   R Core Team, 2019, LANG ENV STAT COMP R, DOI DOI 11/44679/INDEX.HTM.
   Ritz B, 2019, DTSCH ARZTEBL INT, V116, P881, DOI 10.3238/arztebl.2019.0881.
   Singh GK, 2001, AM J PUBLIC HEALTH, V91, P392, DOI 10.2105/AJPH.91.3.392.
   Singh GK, 2004, CAN J PUBLIC HEALTH, V95, pI14, DOI 10.1007/BF03403660.
   Singh GK, 2002, HUM BIOL, V74, P83, DOI 10.1353/hub.2002.0011.
   Singh GK, 2006, INT J EPIDEMIOL, V35, P903, DOI 10.1093/ije/dyl089.
   Singh GK, 2013, SCI WORLD J, DOI 10.1155/2013/512313.
   Thind MPS, 2019, ENVIRON SCI TECHNOL, V53, P14010, DOI 10.1021/acs.est.9b02527.
   U.S. Census Bureau, 2019, AM FACTFINDER.
   U.S. Census Bureau, 2018, DIFF ACS DEC CENS UN.
   van Donkelaar A, 2019, ENVIRON SCI TECHNOL, V53, P2595, DOI 10.1021/acs.est.8b06392.
   Vespa J., 2018, CURRENT POPULATION R, P2018.
   Woo B, 2019, RACE SOC PROBL, V11, P60, DOI 10.1007/s12552-018-9254-0.
   Yang M, 2020, ENVIRON SCI POLLUT R, V27, P798, DOI 10.1007/s11356-019-06824-1.
   Zhang HH, 2020, SCI TOTAL ENVIRON, V719, DOI 10.1016/j.scitotenv.2020.137349.},
Number-of-Cited-References = {50},
Times-Cited = {1},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {4},
Journal-ISO = {Environ. Res.},
Doc-Delivery-Number = {SA9HS},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000649614500005},
DA = {2022-03-29},
}

@article{ WOS:000393682700002,
Author = {Levira, Francis and Thurman, David J. and Sander, Josemir W. and Hauser,
   W. Allen and Hesdorffer, Dale C. and Masanja, Honorati and Odermatt,
   Peter and Logroscino, Giancarlo and Newton, Charles R. and Epidemiology
   Commission Int Leag},
Title = {Premature mortality of epilepsy in low- and middle-income countries: A
   systematic review from the Mortality Task Force of the International
   League Against Epilepsy},
Journal = {EPILEPSIA},
Year = {2017},
Volume = {58},
Number = {1},
Pages = {6-16},
Month = {JAN},
Abstract = {To determine the magnitude of risk factors and causes of premature
   mortality associated with epilepsy in low- and middle-income countries
   (LMICs). We conducted a systematic search of the literature reporting
   mortality and epilepsy in the World Bank-defined LMICs. We assessed the
   quality of the studies based on representativeness; ascertainment of
   cases, diagnosis, and mortality; and extracted data on standardized
   mortality ratios (SMRs) and mortality rates in people with epilepsy. We
   examined risk factors and causes of death. The annual mortality rate was
   estimated at 19.8 (range 9.7-45.1) deaths per 1,000 people with epilepsy
   with a weighted median SMR of 2.6 (range 1.3-7.2) among higher-quality
   population-based studies. Clinical cohort studies yielded 7.1 (range
   1.6-25.1) deaths per 1,000 people. The weighted median SMRs were 5.0 in
   male and 4.5 in female patients; relatively higher SMRs within studies
   were measured in children and adolescents, those with symptomatic
   epilepsies, and those reporting less adherence to treatment. The main
   causes of death in people with epilepsy living in LMICs include those
   directly attributable to epilepsy, which yield a mean proportional
   mortality ratio (PMR) of 27.3\% (range 5-75.5\%) derived from
   population-based studies. These direct causes comprise status
   epilepticus, with reported PMRs ranging from 5 to 56.6\%, and sudden
   unexpected death in epilepsy (SUDEP), with reported PMRs ranging from 1
   to 18.9\%. Important causes of mortality indirectly related to epilepsy
   include drowning, head injury, and burns. Epilepsy in LMICs has a
   significantly greater premature mortality, as in high-income countries,
   but in LMICs the excess mortality is more likely to be associated with
   causes attributable to lack of access to medical facilities such as
   status epilepticus, and preventable causes such as drowning, head
   injuries, and burns. This excess premature mortality could be
   substantially reduced with education about the risk of death and
   improved access to treatments, including AEDs.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Review},
Language = {English},
Affiliation = {Newton, CR (Corresponding Author), POB 230, Kilifi, Kenya.
   Levira, Francis; Masanja, Honorati, Ifakara Hlth Inst, Dar Es Salaam, Tanzania.
   Levira, Francis; Odermatt, Peter, Swiss Trop \& Publ Hlth Inst, Basel, Switzerland.
   Levira, Francis; Odermatt, Peter, Univ Basel, Basel, Switzerland.
   Thurman, David J., Emory Univ, Dept Neurol, Atlanta, GA 30322 USA.
   Sander, Josemir W., UCL Inst Neurol, NIHR Univ Coll London Hosp, Biomed Res Ctr, London, England.
   Sander, Josemir W., Epilepsy Inst Netherlands SEIN, Heemstede, Netherlands.
   Hauser, W. Allen; Hesdorffer, Dale C., Columbia Univ, Med Ctr, Sergievsky Ctr, New York, NY USA.
   Logroscino, Giancarlo, Univ Bari Aldo Moro, Bari, Italy.
   Newton, Charles R., UCL, Dept Neurosci, Inst Child Hlth, London, England.
   Newton, Charles R., Muhimbili Univ Hlth \& Allied Sci, Dept Pediat, Dar Es Salaam, Tanzania.
   Newton, Charles R., Univ Oxford, Dept Psychiat, Oxford, England.},
DOI = {10.1111/epi.13603},
ISSN = {0013-9580},
EISSN = {1528-1167},
Keywords = {Seizures; Convulsions; Death; Case fatality; Developing countries;
   Resource-poor countries; Premature mortality},
Keywords-Plus = {SUDDEN UNEXPECTED DEATH; SUB-SAHARAN AFRICA; FOLLOW-UP; CONVULSIVE
   EPILEPSY; VERBAL AUTOPSY; TREATMENT GAP; RURAL CHINA; METAANALYSIS;
   EPIDEMIOLOGY; PEOPLE},
Research-Areas = {Neurosciences \& Neurology},
Web-of-Science-Categories  = {Clinical Neurology},
Author-Email = {cnewton@kemri-wellcome.org},
ResearcherID-Numbers = {Sander, Ley/C-1576-2008
   Odermatt, Peter/AAF-4996-2020
   Newton, Charles RJC/B-7578-2014
   Hauser, W Allen/AAB-5277-2020
   },
ORCID-Numbers = {Sander, Ley/0000-0001-6041-9661
   Newton, Charles RJC/0000-0002-6999-5507
   Thurman, David/0000-0002-0533-7062},
Funding-Acknowledgement = {Wellcome Trust, United KingdomWellcome Trust; UCB Inc.UCB Pharma SA;
   UpsherSmith; Cyberonics; Department of Rehabilitation; Mount Sinai
   Medical Center; NYU Epilepsy Center; National Institutes of HealthUnited
   States Department of Health \& Human ServicesNational Institutes of
   Health (NIH) - USA; Centers for Disease Control and PreventionUnited
   States Department of Health \& Human ServicesCenters for Disease Control
   \& Prevention - USA; Epilepsy Study Consortium; Epilepsia; Department of
   Health's NIHR Biomedical Research Centres'National Institute for Health
   Research (NIHR); Marvin Weil Epilepsy Research Fund;
   GlaxoSmithKlineGlaxoSmithKline; EisaiEisai Co Ltd; UCBUCB Pharma SA;
   European UnionEuropean Commission; Dutch Epilepsy Funds; World Health
   OrganizationWorld Health Organization; United Kingdom Epilepsy Society},
Funding-Text = {CN is funded by the Wellcome Trust, United Kingdom. DJT is funded by UCB
   Inc. DCH receives personal fees from UpsherSmith, Cyberonics, the
   Department of Rehabilitation, Mount Sinai Medical Center, and the NYU
   Epilepsy Center, as well as grants from the National Institutes of
   Health, the Centers for Disease Control and Prevention, The Epilepsy
   Study Consortium, and Epilepsia. JWS is based at the University College
   London Hospitals Bio-Medical Research Centre, which received a
   proportion of funding from the Department of Health's NIHR Biomedical
   Research Centres' funding scheme. His current position is endowed by
   United Kingdom Epilepsy Society, and he received research support from
   the Marvin Weil Epilepsy Research Fund. His department has received
   research grants from GlaxoSmithKline, Eisai, UCB, European Union, Dutch
   Epilepsy Funds, World Health Organization, and United Kingdom Epilepsy
   Society. He has received honoraria from UCB, Eisai, GSK, Lundbeck and
   Teva. GL has no conflict of interest. We confirm that we have read the
   Journal's position on issues involved in ethical publication and affirm
   that this report is consistent with those guidelines.},
Cited-References = {{[}Anonymous], 1993, EPILEPSIA, V34, P592.
   Aspray TJ, 2005, EPILEPSIA, V46, P15, DOI 10.1111/j.1528-1167.2005.00402.x.
   Baiden F, 2007, B WORLD HEALTH ORGAN, V85, P570, DOI 10.2471/BLT.07.043745.
   Banerjee TK, 2010, EPILEPSIA, V51, P2384, DOI 10.1111/j.1528-1167.2010.02740.x.
   Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x.
   Birbeck G, 2007, LANCET NEUROL, V6, P39, DOI 10.1016/S1474-4422(06)70629-9.
   Carpio A, 2005, EPILEPSIA, V46, P28, DOI 10.1111/j.1528-1167.2005.00404.x.
   de Almeida AG, 2010, ARQ NEURO-PSIQUIAT, V68, P898, DOI 10.1590/S0004-282X2010000600013.
   de Boer HM, 2008, EPILEPSY BEHAV, V12, P540, DOI 10.1016/j.yebeh.2007.12.019.
   Devilat-Barros M, 2004, REV NEUROLOGIA, V38, P607, DOI 10.33588/rn.3807.2003416.
   Ding D, 2006, LANCET NEUROL, V5, P823, DOI 10.1016/S1474-4422(06)70528-2.
   Ding D, 2013, EPILEPSIA, V54, P512, DOI 10.1111/epi.12048.
   Diop AG, 2005, EPILEPSIA, V46, P33, DOI 10.1111/j.1528-1167.2005.00405.x.
   Escalaya AL, 2015, SEIZURE-EUR J EPILEP, V25, P99, DOI 10.1016/j.seizure.2014.09.012.
   Forsgren L, 2005, EPILEPSIA, V46, P18, DOI 10.1111/j.1528-1167.2005.00403.x.
   Higgins JPT, 2008, INT J EPIDEMIOL, V37, P1158, DOI 10.1093/ije/dyn204.
   Houinato D, 2013, EPILEPSIA, V54, P757, DOI 10.1111/epi.12082.
   Hoyert Donna L, 2011, NCHS Data Brief, P1.
   JILEKAALL L, 1992, EPILEPSIA, V33, P645, DOI 10.1111/j.1528-1157.1992.tb02341.x.
   Kaiser C, 2007, T ROY SOC TROP MED H, V101, P48, DOI 10.1016/j.trstmh.2006.06.003.
   Kamgno J, 2003, EPILEPSIA, V44, P956, DOI 10.1046/j.1528-1157.2003.59302.x.
   Kochen S, 2005, ACTA NEUROL SCAND, V112, P370, DOI 10.1111/j.1600-0404.2005.00519.x.
   Mateen FJ, 2012, AM J TROP MED HYG, V86, P237, DOI 10.4269/ajtmh.2012.11-0535.
   Mbuba CK, 2008, EPILEPSIA, V49, P1491, DOI 10.1111/j.1528-1167.2008.01693.x.
   Meinardi H, 2001, EPILEPSIA, V42, P136, DOI 10.1046/j.1528-1157.2001.32800.x.
   Meyer AC, 2010, B WORLD HEALTH ORGAN, V88, P260, DOI 10.2471/BLT.09.064147.
   Mu J, 2011, NEUROLOGY, V77, P132, DOI 10.1212/WNL.0b013e318223c784.
   Mushi D, 2011, EPILEPSY BEHAV, V20, P338, DOI 10.1016/j.yebeh.2010.11.016.
   Nashef L, 1997, EPILEPSIA, V38, pS6, DOI 10.1111/j.1528-1157.1997.tb06130.x.
   Nashef L, 2012, EPILEPSIA, V53, P227, DOI 10.1111/j.1528-1167.2011.03358.x.
   Nevalainen O, 2014, NEUROLOGY, V83, P1968, DOI 10.1212/WNL.0000000000001005.
   Newton CR, 2013, EPILEPSIA, V54, P50, DOI 10.1111/epi.12277.
   Newton CR, 2012, LANCET, V380, P1193, DOI 10.1016/S0140-6736(12)61381-6.
   Ngugi AK, 2011, NEUROLOGY, V77, P1005, DOI 10.1212/WNL.0b013e31822cfc90.
   Ngugi AK, 2014, NEUROLOGY, V82, P582, DOI 10.1212/WNL.0000000000000123.
   Ngugi AK, 2010, EPILEPSIA, V51, P883, DOI 10.1111/j.1528-1167.2009.02481.x.
   Nicoletti A, 2009, EPILEPSIA, V50, P2199, DOI 10.1111/j.1528-1167.2009.02174.x.
   Preux PM, 2005, LANCET NEUROL, V4, P21, DOI 10.1016/S1474-4422(04)00963-9.
   Rothman K, 2008, MODERN EPIDEMIOLOGY.
   Schraeder PL, 2006, EPILEPSY RES, V68, P137, DOI 10.1016/j.eplepsyres.2005.10.004.
   Shorvon S, 2011, LANCET, V378, P2028, DOI 10.1016/S0140-6736(11)60176-1.
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008.
   Terra VC, 2011, ARQ NEURO-PSIQUIAT, V69, P766, DOI 10.1590/S0004-282X2011000600008.
   Terra VC, 2010, CHILD NERV SYST, V26, P1075, DOI 10.1007/s00381-010-1108-z.
   Terra VC, 2009, ARQ NEURO-PSIQUIAT, V67, P1001, DOI 10.1590/S0004-282X2009000600007.
   Thomas SV, 2001, SEIZURE-EUR J EPILEP, V10, P370, DOI 10.1053/seiz.2000.0514.
   Thurman DJ, 2017, EPILEPSIA, V58, P17, DOI 10.1111/epi.13604.
   Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x.
   WHO, 2015, WORLD HLTH STAT 2015.
   World Bank, 2015, DAT COUNTR LEND GROU.},
Number-of-Cited-References = {50},
Times-Cited = {69},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {14},
Journal-ISO = {Epilepsia},
Doc-Delivery-Number = {EK1JX},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000393682700002},
OA = {hybrid, Green Published, Green Accepted, Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000488653800014,
Author = {Truong-Minh Pham and Shack, Lorraine and Cheung, Winson Y.},
Title = {Introduction of a novel measure of premature mortality caused by chronic
   conditions: real-world examples from prostate and testis cancers in
   Canada, 1980-2015},
Journal = {ANNALS OF EPIDEMIOLOGY},
Year = {2019},
Volume = {37},
Pages = {81-83},
Month = {SEP},
Publisher = {ELSEVIER SCIENCE INC},
Address = {STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA},
Type = {Article},
Language = {English},
Affiliation = {Pham, TM (Corresponding Author), Alberta Hlth Serv, Canc Control Alberta, Canc Res \& Analyt, Surveillance \& Reporting, Suite 1400,Sun Life Bldg,10123-99 St, Edmonton, AB T5J 3H1, Canada.
   Truong-Minh Pham; Shack, Lorraine, Alberta Hlth Serv, Canc Control Alberta, Canc Res \& Analyt, Surveillance \& Reporting, Suite 1400,Sun Life Bldg,10123-99 St, Edmonton, AB T5J 3H1, Canada.
   Truong-Minh Pham; Shack, Lorraine, Alberta Hlth Serv, Canc Control Alberta, Canc Res \& Analyt, Surveillance \& Reporting, Calgary, AB, Canada.
   Cheung, Winson Y., Univ Calgary, Cumming Sch Med, Dept Oncol, Calgary, AB, Canada.},
DOI = {10.1016/j.annepidem.2019.07.011},
ISSN = {1047-2797},
EISSN = {1873-2585},
Keywords = {Premature mortality; Years of life lost; Average life span shortened;
   Prostate cancer; Testis cancer},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {TruongMinh.Pham@ahs.ca},
Cited-References = {Atchison MM, 2019, LARYNGOSCOPE.
   Boswell-Purdy Jane, 2007, Chronic Dis Can, V28, P42.
   Canada's International Health System, PERF 50 YEARS EX POT.
   Goverment of Alberta, HLTH IND POT YEARS L.
   Manitoba Health, SEN ACT LIV ANN STAT.
   Pham TM, 2018, J EPIDEMIOL.
   Public Health Ontario, POT YEARS LIF LOST S.
   Statistics Canada, TABL 13 10 0742 01 M.
   Pham TM, 2018, NEUROEPIDEMIOLOGY, V50, P195, DOI 10.1159/000488145.
   Pham TM, 2018, EUR J PUBLIC HEALTH, V28, P348, DOI 10.1093/eurpub/ckx195.},
Number-of-Cited-References = {10},
Times-Cited = {5},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Ann. Epidemiol.},
Doc-Delivery-Number = {JB6DC},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000488653800014},
DA = {2022-03-29},
}

@article{ WOS:000723965100001,
Author = {Welsh, Brandon C. and Zane, Steven N. and Reeves, Jillian},
Title = {Impact of Interventions for At-Risk and Criminally Involved Youths and
   Adults on Premature Mortality over the Life-Course: a Systematic Review
   and Meta-analysis},
Journal = {JOURNAL OF DEVELOPMENTAL AND LIFE-COURSE CRIMINOLOGY},
Abstract = {Premature mortality represents an important outcome for crime and
   violence prevention and related social interventions, but little is
   known about premature mortality in relation to these interventions. This
   article assesses the impact of interventions for at-risk and criminally
   involved youths and adults on premature mortality over the life-course.
   Systematic review methods are used, including comprehensive search
   strategies to identify, screen, and code eligible studies. Meta-analytic
   techniques are used to assess the impact of interventions on premature
   mortality, the influence of key moderators, and cause of mortality
   (natural vs. unnatural). A total of 11 studies met the inclusion
   criteria. Studies originated in five countries and were reported in the
   last two decades. Sample size can be considered large (>500
   participants) for all but two of the studies. Analysis of pooled effects
   showed a non-significant impact of interventions on premature mortality
   (OR= 0.89; 95\% CI: 0.46, 1.74). Life-course stage, intervention type,
   and evaluation design did not moderate the mean effect. Of the nine
   studies that reported cause of mortality, interventions were associated
   with an increased likelihood of death by unnatural causes (OR = 1.78;
   95\% CI: 1.05, 2.39; p= .03). We conclude that greater attention needs
   to be paid to evaluating and understanding premature mortality over the
   life-course as part of the study of the effectiveness of crime and
   violence prevention interventions, and research opportunities exist to
   make an immediate contribution to this body of knowledge.},
Publisher = {SPRINGER INT PUBL AG},
Address = {GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND},
Type = {Review; Early Access},
Language = {English},
Affiliation = {Welsh, BC (Corresponding Author), Northeastern Univ, Sch Criminol \& Criminal Justice, Boston, MA 02115 USA.
   Welsh, Brandon C.; Reeves, Jillian, Northeastern Univ, Sch Criminol \& Criminal Justice, Boston, MA 02115 USA.
   Zane, Steven N., Florida State Univ, Tallahassee, FL 32306 USA.},
DOI = {10.1007/s40865-021-00185-5},
EarlyAccessDate = {DEC 2021},
ISSN = {2199-4641},
EISSN = {2199-465X},
Keywords = {Crime and violence prevention; Premature mortality; Public health;
   Systematic review},
Keywords-Plus = {FOLLOW-UP; PREVENTION; DEATH; DELINQUENCY; VIOLENCE; HEALTH; PRISON;
   CARE; CHILDREN; THERAPY},
Research-Areas = {Criminology \& Penology},
Web-of-Science-Categories  = {Criminology \& Penology},
Author-Email = {b.welsh@northeastern.edu},
Cited-References = {Border R, 2018, ADDICTION, V113, P2107, DOI 10.1111/add.14366.
   Bullock R, 2012, CHILD YOUTH SERV REV, V34, P1947, DOI 10.1016/j.childyouth.2012.06.003.
   Campbell Collaboration, 2019, CAMPB SYST REV POL G, V1, DOI {[}10.4073/cpg.2016.1, DOI 10.4073/CPG.2016.1].
   Campbell FA, 2012, DEV PSYCHOL, V48, P1033, DOI 10.1037/a0026644.
   Catalano RF, 2012, LANCET, V379, P1653, DOI 10.1016/S0140-6736(12)60238-4.
   Chassin L, 2013, J ADOLESCENT HEALTH, V52, P689, DOI 10.1016/j.jadohealth.2012.11.018.
   Coffey C, 2003, BRIT MED J, V326, P1064, DOI 10.1136/bmj.326.7398.1064.
   Daigle MS, 2012, CAN J CRIMINOL CRIM, V54, P511, DOI 10.3138/cjccj.2011.E.54.
   Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529.
   Eckenrode J, 2010, ARCH PEDIAT ADOL MED, V164, P9, DOI 10.1001/archpediatrics.2009.240.
   Elliott D., 2017, PREVENTION CRIME.
   Elliott DS, 2020, CRIMINOL PUBLIC POL, V19, P1305, DOI 10.1111/1745-9133.12520.
   Elonheimo H, 2017, CRIM BEHAV MENT HEAL, V27, P15, DOI 10.1002/cbm.1973.
   Farrington DP, 2017, AGGRESS VIOLENT BEH, V33, P91, DOI 10.1016/j.avb.2016.11.003.
   Farrington DP, 2013, J EXP CRIMINOL, V9, P385, DOI 10.1007/s11292-013-9195-y.
   Ferriter M, 2016, CRIM BEHAV MENT HEAL, V26, P403, DOI 10.1002/cbm.1970.
   Gisev N, 2015, ADDICTION, V110, P1975, DOI 10.1111/add.13073.
   Glueck E. T., 1950, UNRAVELING JUVENILE.
   Heckman JJ, 2019, 25888 NAT BUR EC RES.
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557.
   Kinner SA, 2013, ADDICTION, V108, P38, DOI 10.1111/add.12010.
   Kosterman R, 2019, PREV SCI, V20, P986, DOI 10.1007/s11121-019-01023-3.
   Lattimore PK, 1997, J RES CRIME DELINQ, V34, P187, DOI 10.1177/0022427897034002002.
   Laub JH, 2000, AM J PSYCHIAT, V157, P96, DOI 10.1176/ajp.157.1.96.
   Lindqvist Per, 2007, Crim Behav Ment Health, V17, P107, DOI 10.1002/cbm.643.
   Lipsey M.W., 2001, PRACTICAL META ANAL.
   Manninen M, 2015, CHILD ADOL PSYCH MEN, V9, DOI 10.1186/s13034-015-0078-z.
   MCCORD J, 1978, AM PSYCHOL, V33, P284.
   McCord J., 1984, HDB LONGITUDINAL RES, P522.
   McCord J., 1981, NEW DIRECTIONS REHAB, P394.
   Merrall ELC, 2010, ADDICTION, V105, P1545, DOI 10.1111/j.1360-0443.2010.02990.x.
   Mikton CR, 2016, AM J PREV MED, V50, P652, DOI 10.1016/j.amepre.2015.10.007.
   Olds DL, 2014, JAMA PEDIATR, V168, P800, DOI 10.1001/jamapediatrics.2014.472.
   Patterson EJ, 2013, AM J PUBLIC HEALTH, V103, P523, DOI 10.2105/AJPH.2012.301148.
   Piquero AR, 2014, JUSTICE Q, V31, P445, DOI 10.1080/07418825.2011.641027.
   Reynolds AJ, 2018, JAMA PEDIATR, V172, P247, DOI 10.1001/jamapediatrics.2017.4673.
   Sawyer AM, 2011, J CONSULT CLIN PSYCH, V79, P643, DOI 10.1037/a0024862.
   Shepherd JP, 2009, J PUBLIC HEALTH-UK, V31, P506, DOI 10.1093/pubmed/fdp054.
   Sherman LW, 2013, J EXP CRIMINOL, V9, P491, DOI 10.1007/s11292-013-9193-0.
   SHERMAN LW, 1991, CRIMINOLOGY, V29, P821, DOI 10.1111/j.1745-9125.1991.tb01089.x.
   Skinner GCM, 2020, AGGRESS VIOLENT BEH, V53, DOI 10.1016/j.avb.2020.101431.
   Spaulding AC, 2011, AM J EPIDEMIOL, V173, P479, DOI 10.1093/aje/kwq422.
   Teplin LA, 2005, PEDIATRICS, V115, P1586, DOI 10.1542/peds.2004-1459.
   Tonry M., 1995, BUILDING SAFER SOC S, P1.
   van de Weijer S, 2016, ADV LIFE COURSE RES, V28, P91, DOI 10.1016/j.alcr.2015.11.004.
   Vinnerljung B, 2001, INT J SOC WELF, V10, P164, DOI 10.1111/1468-2397.00169.
   Vitaro F, 2013, J EXP CRIMINOL, V9, P411, DOI 10.1007/s11292-013-9188-x.
   Weisburd D, 2016, WHAT WORKS CRIME PRE.
   Welsh, 2007, SAVING CHILDREN LIFE.
   Welsh BC, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.0782.
   Wilson DB, 2009, J EXP CRIMINOL, V5, P429, DOI 10.1007/s11292-009-9085-5.
   Wilson DB, 2010, HANDBOOK OF QUANTITATIVE CRIMINOLOGY, P181, DOI 10.1007/978-0-387-77650-7\_10.
   YOSHIKAWA H, 1994, PSYCHOL BULL, V115, P28, DOI 10.1037/0033-2909.115.1.28.
   Zane SN, 2019, J QUANT CRIMINOL, V35, P691, DOI 10.1007/s10940-018-9399-4.},
Number-of-Cited-References = {55},
Times-Cited = {0},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {2},
Journal-ISO = {J. Dev. Life-Course Criminol.},
Doc-Delivery-Number = {XF3HL},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000723965100001},
DA = {2022-03-29},
}

@article{ WOS:000449071000084,
Author = {Shi, Yusheng and Zhao, Aimei and Matsunaga, Tsuneo and Yamaguchi,
   Yasushi and Zang, Shuying and Li, Zhengqiang and Yu, Tao and Gu, Xingfa},
Title = {Underlying causes of PM2.5-induced premature mortality and potential
   health benefits of air pollution control in South and Southeast Asia
   from 1999 to 2014},
Journal = {ENVIRONMENT INTERNATIONAL},
Year = {2018},
Volume = {121},
Number = {1},
Pages = {814-823},
Month = {DEC},
Abstract = {Quantification of spatial and temporal variations in premature mortality
   attributable to PM2.5 has important implications for air quality control
   in South and Southeast Asia (SSEA). The number of PM25-induced premature
   deaths during 1999-2014 in SSEA was estimated using an integrated
   exposure-response model based on 0.01 degrees x 0.01 degrees
   satellite-retrieved PM2.5 data, population density, and spatially and
   temporally variable baseline mortality data. The results showed
   extremely high premature death rates in North India and Bangladesh.
   PM2.5-induced premature deaths in SSEA increased with small interannual
   variations from 1999 to 2014 owing to the interannual variations in
   PM2.5 concentrations. Moreover, four scenarios on the effects of
   premature deaths by PM2.5 mitigation efforts based on World Health
   Organization (WHO) air quality guidelines (AQG) and interim targets
   (ITs) were investigated for each disease and each country during
   1999-2014. Four scenarios based on WHO AQG (10 mu g/m(3)), IT-3 (15 mu
   g/m(3)), IT-2 (25 mu g/m(3)), and IT-1 (35 mu g/m(3)) resulted in
   69.3\%, 49.1\%, 25.4\%, and 12.8\% reductions compared to the total
   reference premature deaths (1256,300), which was calculated using the
   original PM2.5 datasets. Overall, stroke was the most serious disease
   associated with air pollution, causing 40\% of total premature deaths.
   Ischemic heart disease was the largest contributor (58\%) to the deaths
   in relatively cleaner air (Scenario 1). The annual rate of change in
   premature deaths in South Asian countries (India, Bangladesh, and
   Pakistan) was higher than that in Southeast Asian countries under all
   scenarios. The results for different scenarios provide insight into the
   largest health benefits of PM2.5 reduction efforts.},
Publisher = {PERGAMON-ELSEVIER SCIENCE LTD},
Address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Shi, YS (Corresponding Author), Chinese Acad Sci, Inst Remote Sensing \& Digital Earth, 20A Datun Rd, Beijing 100101, Peoples R China.
   Shi, Yusheng; Zhao, Aimei; Li, Zhengqiang; Yu, Tao; Gu, Xingfa, Chinese Acad Sci, Inst Remote Sensing \& Digital Earth, State Environm Protect Key Lab Satellite Remote S, Beijing 100101, Peoples R China.
   Shi, Yusheng; Matsunaga, Tsuneo, Natl Inst Environm Studies, Ctr Global Environm Res, Tsukuba, Ibaraki 3058506, Japan.
   Shi, Yusheng; Matsunaga, Tsuneo, Natl Inst Environm Studies, Satellite Observat Ctr, Tsukuba, Ibaraki 3058506, Japan.
   Yamaguchi, Yasushi, Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan.
   Zang, Shuying, Harbin Normal Univ, Sch Geog Sci, Harbin 150025, Heilongjiang, Peoples R China.},
DOI = {10.1016/j.envint.2018.10.019},
ISSN = {0160-4120},
EISSN = {1873-6750},
Keywords = {PM2.5 concentration; Premature mortality; Scenario analysis; Interannual
   variations; Annual rate of change; South and Southeast Asia},
Keywords-Plus = {FINE PARTICULATE MATTER; LONG-TERM TRENDS; GLOBAL BURDEN;
   HIGH-RESOLUTION; PM2.5 CONCENTRATIONS; SPATIAL-PATTERNS; EMISSIONS;
   DISEASE; EXPOSURE; CHINA},
Research-Areas = {Environmental Sciences \& Ecology},
Web-of-Science-Categories  = {Environmental Sciences},
Author-Email = {shiys@radi.ac.cn},
ResearcherID-Numbers = {li, zhengqiang/C-5678-2013
   Matsunaga, Tsuneo/H-3040-2018
   Shi, Yusheng/U-7320-2017},
ORCID-Numbers = {li, zhengqiang/0000-0002-7795-3630
   Matsunaga, Tsuneo/0000-0002-3380-5230
   Yamaguchi, Yasushi/0000-0002-2554-1060
   Shi, Yusheng/0000-0001-7256-3628},
Funding-Acknowledgement = {CAS Pioneer Hundred Talents Program, China {[}Y8YR2200QM, Y7S00100CX,
   Y7S0010030]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China (NSFC) {[}41701498]; NIES GOSAT-2
   Project, Japan},
Funding-Text = {This research was supported by the CAS Pioneer Hundred Talents Program,
   China (Y8YR2200QM, Y7S00100CX, Y7S0010030), National Natural Science
   Foundation of China (41701498) and NIES GOSAT-2 Project, Japan. The
   authors thank Dr. Aaron van Donkelaar of the Atmospheric Physics
   Institute at Dalhousie University in Canada who offered the
   PM<INF>2.5</INF> data used in this research. The gridded demographic
   data were derived from Center for International Earth Science
   Information Network -CIESIN -Columbia University SEDAC website.},
Cited-References = {Amegah AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113920.
   Apte JS, 2015, ENVIRON SCI TECHNOL, V49, P8057, DOI 10.1021/acs.est.5b01236.
   Bonjour S, 2013, ENVIRON HEALTH PERSP, V121, P784, DOI 10.1289/ehp.1205987.
   Brauer M, 2016, ENVIRON SCI TECHNOL, V50, P79, DOI 10.1021/acs.est.5b03709.
   Brauer M, 2012, ENVIRON SCI TECHNOL, V46, P652, DOI 10.1021/es2025752.
   Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049.
   Chowdhury S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02755-y.
   Chowdhury S, 2016, ENVIRON INT, V91, P283, DOI 10.1016/j.envint.2016.03.004.
   Cohen AJ, 2017, LANCET, V389, P1907, DOI {[}10.1016/S0140-6736(17)30505-6, 10.1016/s0140-6736(17)30505-6].
   Dey S, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013395.
   Fang D, 2016, SCI TOTAL ENVIRON, V569, P1545, DOI 10.1016/j.scitotenv.2016.06.248.
   Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2.
   Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8.
   Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8.
   Ghude SD, 2016, GEOPHYS RES LETT, V43, P4650, DOI 10.1002/2016GL068949.
   Guttikunda SK, 2014, ATMOS ENVIRON, V92, P449, DOI 10.1016/j.atmosenv.2014.04.057.
   Health Effects Institute, 2017, STAT GLOB AIR 2017.
   Health Effects Institute, 2018, SPECIAL REPORT.
   Hu JL, 2017, ENVIRON SCI TECHNOL, V51, P9950, DOI 10.1021/acs.est.7b03193.
   Huang Y, 2014, ENVIRON SCI TECHNOL, V48, P13834, DOI 10.1021/es503696k.
   Kahn RA, 2009, IEEE T GEOSCI REMOTE, V47, P4095, DOI 10.1109/TGRS.2009.2023115.
   Koplitz SN, 2017, ENVIRON SCI TECHNOL, V51, P1467, DOI 10.1021/acs.est.6b03731.
   Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371.
   Liu J, 2016, SCI TOTAL ENVIRON, V568, P1253, DOI 10.1016/j.scitotenv.2016.05.165.
   Liu MM, 2017, ENVIRON INT, V98, P75, DOI 10.1016/j.envint.2016.10.003.
   Maji KJ, 2018, SCI TOTAL ENVIRON, V612, P683, DOI 10.1016/j.scitotenv.2017.08.254.
   Meng WJ, 2017, ENVIRON SCI TECHNOL, V51, P2821, DOI 10.1021/acs.est.6b03694.
   Roman HA, 2008, ENVIRON SCI TECHNOL, V42, P2268, DOI 10.1021/es0713882.
   Shi YS, 2018, SCI TOTAL ENVIRON, V631-632, P1504, DOI 10.1016/j.scitotenv.2018.03.146.
   Shi YS, 2018, SCI TOTAL ENVIRON, V615, P177, DOI 10.1016/j.scitotenv.2017.09.241.
   Shi YS, 2015, ENVIRON SCI TECHNOL, V49, P10806, DOI 10.1021/acs.est.5b01598.
   Shi YS, 2014, ATMOS ENVIRON, V98, P8, DOI 10.1016/j.atmosenv.2014.08.050.
   Shi YS, 2014, ECOL MODEL, V272, P98, DOI 10.1016/j.ecolmodel.2013.09.021.
   Shi YS, 2012, INT J REMOTE SENS, V33, P4482, DOI 10.1080/01431161.2011.649863.
   van Donkelaar A, 2016, ENVIRON SCI TECHNOL, V50, P3762, DOI 10.1021/acs.est.5b05833.
   World Bank, 2016, COST AIR POLLUTION S.
   World Health Organisation, 2006, GLOB UPD 2005 SUMM R.
   Xie R, 2016, ENVIRON INT, V97, P180, DOI 10.1016/j.envint.2016.09.003.
   Zhang Q, 2017, NATURE, V543, P705, DOI 10.1038/nature21712.
   Zhang YQ, 2017, ENVIRON POLLUT, V230, P1073, DOI 10.1016/j.envpol.2017.07.053.},
Number-of-Cited-References = {40},
Times-Cited = {11},
Usage-Count-Last-180-days = {6},
Usage-Count-Since-2013 = {43},
Journal-ISO = {Environ. Int.},
Doc-Delivery-Number = {GZ0RA},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000449071000084},
OA = {hybrid},
DA = {2022-03-29},
}

@article{ WOS:000736039200005,
Author = {Barnard, Sharmani and Fryers, Paul and Fitzpatrick, Justine and Fox,
   Sebastian and Waller, Zachary and Baker, Allan and Burton, Paul and
   Newton, John and Doyle, Yvonne and Goldblatt, Peter},
Title = {Inequalities in excess premature mortality in England during the
   COVID-19 pandemic: a cross-sectional analysis of cumulative excess
   mortality by area deprivation and ethnicity},
Journal = {BMJ OPEN},
Year = {2021},
Volume = {11},
Number = {12},
Month = {DEC},
Abstract = {Objectives To examine magnitude of the impact of the COVID-19 pandemic
   on inequalities in premature mortality in England by deprivation and
   ethnicity. Design A statistical model to estimate increased mortality in
   population subgroups during the COVID-19 pandemic by comparing observed
   with expected mortality in each group based on trends over the previous
   5 years. Setting Information on deaths registered in England since 2015
   was used, including age, sex, area of residence and cause of death.
   Ethnicity was obtained from Hospital Episode Statistics records linked
   to death data. Participants Population study of England, including all
   569 824 deaths from all causes registered between 21 March 2020 and 26
   February 2021. Main outcome measures Excess mortality in each subgroup
   over and above the number expected based on trends in mortality in that
   group over the previous 5 years. Results The gradient in excess
   mortality by area deprivation was greater in the under 75s (the most
   deprived areas had 1.25 times as many deaths as expected, least deprived
   1.14) than in all ages (most deprived had 1.24 times as many deaths as
   expected, least deprived 1.20). Among the black and Asian groups, all
   area deprivation quintiles had significantly larger excesses than white
   groups in the most deprived quintiles and there were no clear gradients
   across quintiles. Among the white group, only those in the most deprived
   quintile had more excess deaths than deaths directly involving COVID-19.
   Conclusion The COVID-19 pandemic has widened inequalities in premature
   mortality by area deprivation. Among those under 75, the direct and
   indirect effects of the pandemic on deaths have disproportionately
   impacted ethnic minority groups irrespective of area deprivation, and
   the white group the most deprived areas. Statistics limited to deaths
   directly involving COVID-19 understate the pandemic's impact on
   inequalities by area deprivation and ethnic group at younger ages.},
Publisher = {BMJ PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Fryers, P (Corresponding Author), Publ Hlth England, Hlth Intelligence, London, England.
   Barnard, Sharmani; Fryers, Paul; Fitzpatrick, Justine; Fox, Sebastian; Waller, Zachary; Baker, Allan; Burton, Paul; Newton, John; Doyle, Yvonne; Goldblatt, Peter, Publ Hlth England, Hlth Intelligence, London, England.
   Barnard, Sharmani, Telethon Kids Inst, ARC Ctr Excellence Children \& Families Life Cours, Life Course Ctr, Nedlands, WA, Australia.
   Burton, Paul, Newcastle Univ, Populat Hlth Sci Inst, Newcastle Upon Tyne, Tyne \& Wear, England.
   Goldblatt, Peter, UCL, UCL Inst Hlth Equ, London, England.},
DOI = {10.1136/bmjopen-2021-052646},
Article-Number = {e052646},
ISSN = {2044-6055},
Keywords = {COVID-19; epidemiology; public health; public health},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {paul.fryers@phe.gov.uk},
ORCID-Numbers = {Newton, John/0000-0002-5641-6457
   Goldblatt, Peter/0000-0003-0491-2077
   Barnard, Sharmani/0000-0001-7582-5558},
Funding-Acknowledgement = {ARC Centre of Excellence for Children and Families over the Life Course
   (Life Course Centre)},
Funding-Text = {SB acknowledges funding received from the ARC Centre of Excellence for
   Children and Families over the Life Course (Life Course Centre).},
Cited-References = {Ahmed F, 2020, LANCET PUBLIC HEALTH, V5, pE240, DOI 10.1016/S2468-2667(20)30085-2.
   {[}Anonymous], 2020, BBC NEWS.
   Bambra C, 2021, ENVIRON PLANN A, V53, P607, DOI 10.1177/0308518X20969420.
   Bambra C, 2020, J EPIDEMIOL COMMUN H, V74, P964, DOI 10.1136/jech-2020-214401.
   Iacobucci G, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1810.
   Lewer D, 2020, LANCET PUBLIC HEALTH, V5, pE33, DOI 10.1016/S2468-2667(19)30219-1.
   Ministry of Housing Communities Local Government, 2019, ENGLISH INDICES DEPR.
   NHS Digital, 2019, HLTH SURVEY ENGLAND.
   Office for National Statistics, 2020, AN DEATH REG NOT INV.
   Office for National Statistics, 2020, DEATHS INV COVID 19.
   Office for National Statistics, 2020, UPD ETHN CONTR DEATH.
   Office for National Statistics, 2020, CHANG TRENDS MORT NA.
   Office for National Statistics, 2020, IMP COR CAR HOM ENGL.
   Office of National Statistics, 2021, DEATHS REG WEEKL ENG.
   Office of National Statistics,, 2020, COR COVID 19 REL DEA.
   Public Health England, 2021, WID IMP COVID 19 HLT.
   Public Health England, 2020, AN REL PREEX HLTH CO.
   Public Health England, 2018, REV REC TRENDS MORT.
   Public Health England, 2020, DISP RISK OUTC COVID.
   Public Health England, 2021, EXC MORT ENGL WEEK E.
   Public Health England, 2020, EXC MORT ENGL METH W.
   R Core Team, 2020, R LANGUAGE ENV STAT.
   Raleigh V., 2021, HLTH PEOPLE ETHNIC M.
   Sinnathamby MA, 2020, EUROSURVEILLANCE, V25, P13, DOI 10.2807/1560-7917.ES.2020.25.28.2001239.
   Vestergaard LS, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.26.2001214.
   Watkinson RE, 2021, LANCET PUBLIC HEALTH, V6, pE145, DOI 10.1016/S2468-2667(20)30287-5.},
Number-of-Cited-References = {26},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {BMJ Open},
Doc-Delivery-Number = {XX1AZ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000736039200005},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000440723800013,
Author = {Ostergren, Olof},
Title = {Educational inequalities in mortality are larger at low levels of
   income: A register-based study on premature mortality among 2.3 million
   Swedes, 2006-2009},
Journal = {SSM-POPULATION HEALTH},
Year = {2018},
Volume = {5},
Pages = {122-128},
Month = {AUG},
Abstract = {Education develops skills that help individuals use available material
   resources more efficiently. When material resources are scarce, each
   decision becomes comparatively more important. Education may also
   protect from health-related income decline, since the highly educated
   tend to work in occupations with lower physical demands. Educational
   inequalities in health may, therefore, be more pronounced at lower
   levels of income. The aim of this study is to assess whether the shape
   of the income gradient in premature mortality depends on the level of
   education.
   Total population data on education, income and mortality was obtained by
   linking several Swedish registers. Income was defined as five-year
   average disposable household income for ages 35-64 and mortality
   follow-up covered the period 2006-2009. The final population comprised
   2.3 million individuals, 6.2 million person-years and 14,362 deaths.
   Income was modeled using splines in order to allow variation in the
   functional form of the association across educational categories.
   Poisson regression with robust standard errors was used.
   The curvilinear shape of the association between income and mortality
   was more pronounced among those with a low education. Both absolute and
   relative educational inequalities in premature mortality tended to be
   larger at low levels of income. The greatest income differences in
   mortality were observed for those with a low education and the smallest
   for the highly educated.
   Education and income interact as predictors of mortality. Education is a
   more important factor for health when access to material resources is
   limited.},
Publisher = {ELSEVIER SCI LTD},
Address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Ostergren, O (Corresponding Author), Stockholm Univ, Dept Publ Hlth Sci, Sveavagen 160, SE-10691 Stockholm, Sweden.
   Ostergren, Olof, Stockholm Univ, Dept Publ Hlth Sci, Sveavagen 160, SE-10691 Stockholm, Sweden.},
DOI = {10.1016/j.ssmph.2018.05.008},
ISSN = {2352-8273},
Keywords = {Education; Income; Mortality; Register data; Health inequalities; Sweden},
Keywords-Plus = {HEALTH INEQUALITIES; UNITED-STATES; DIFFERENTIALS; MOBILITY; GRADIENT;
   SHAPE},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {olof.ostergren@su.se},
ORCID-Numbers = {Ostergren, Olof/0000-0002-7156-3260},
Funding-Acknowledgement = {Faculty of Social Sciences, Stockholm University; Marianne and Marcus
   Wallenberg Foundation {[}MMW.0016]},
Funding-Text = {This work was supported by the Faculty of Social Sciences, Stockholm
   University and the Marianne and Marcus Wallenberg Foundation (grant no
   MMW.0016).},
Cited-References = {Backlund E, 1996, ANN EPIDEMIOL, V6, P12, DOI 10.1016/1047-2797(95)00090-9.
   Bambra C, 2011, J EPIDEMIOL COMMUN H, V65, P740, DOI 10.1136/jech.2011.136333.
   Benzeval M, 2001, SOC SCI MED, V52, P1371, DOI 10.1016/S0277-9536(00)00244-6.
   Blane D, 1999, J ROY STAT SOC A STA, V162, P59, DOI 10.1111/1467-985X.00121.
   Bonaccio M, 2016, INT J PUBLIC HEALTH, V61, P765, DOI 10.1007/s00038-016-0822-z.
   Boyle PJ, 2009, SOC SCI MED, V68, P1835, DOI 10.1016/j.socscimed.2009.02.051.
   Case A, 2005, J HEALTH ECON, V24, P365, DOI 10.1016/j.jhealeco.2004.09.008.
   Elo IT, 1996, SOC SCI MED, V42, P47, DOI 10.1016/0277-9536(95)00062-3.
   Elstad J. I., 2014, SOKELYS ARBEIDSLIVET, V31, P267.
   Elstad JI, 2001, EUR J PUBLIC HEALTH, V11, P135, DOI 10.1093/eurpub/11.2.135.
   Falk J, 2014, INT J HEALTH SERV, V44, P155, DOI 10.2190/HS.44.1.i.
   Gerdtham UG, 2004, J HUM RESOUR, V39, P228, DOI 10.2307/3559011.
   Geyer S, 2006, J EPIDEMIOL COMMUN H, V60, P804, DOI 10.1136/jech.2005.041319.
   Geyer S, 2011, J EPIDEMIOL COMMUN H, V65, P491, DOI 10.1136/jech.2009.103390.
   Gravelle H, 1998, BMJ-BRIT MED J, V316, P382, DOI 10.1136/bmj.316.7128.382.
   Hallerod B, 2011, SOC SCI MED, V72, P116, DOI 10.1016/j.socscimed.2010.09.036.
   Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519.
   Mackenbach JP, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1732.
   Mackenbach JP, 2012, SOC SCI MED, V75, P761, DOI 10.1016/j.socscimed.2012.02.031.
   McDonough P, 1997, AM J PUBLIC HEALTH, V87, P1476, DOI 10.2105/AJPH.87.9.1476.
   Miething A, 2014, OTHERS INCOME ONES O.
   Mirowsky J., 2003, ED SOCIAL STATUS HLT, V1st ed..
   Mirowsky J, 2005, LOND REV EDUC, V3, P205, DOI 10.1080/14748460500372366.
   Molander P., 2016, ANATOMY INEQUALITY I.
   Mortensen LH, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010974.
   OECD, 1982, OECD LIST SOC IND.
   Ostergren O., 2015, SCANDINAVIAN J PUBLI.
   PRESTON SH, 1975, POP STUD-J DEMOG, V29, P231, DOI 10.2307/2173509.
   Rehnberg J, 2016, SSM-POPUL HLTH, V2, P750, DOI 10.1016/j.ssmph.2016.10.005.
   Schnittker J, 2004, J HEALTH SOC BEHAV, V45, P286, DOI 10.1177/002214650404500304.
   Shkolnikov VM, 2012, J EPIDEMIOL COMMUN H, V66, P372, DOI 10.1136/jech.2009.104786.
   Statistics Sweden, 2006, EV UTB.
   Stronks K, 1997, INT J EPIDEMIOL, V26, P592, DOI 10.1093/ije/26.3.592.
   Sundquist J, 1997, SOC SCI MED, V45, P1757, DOI 10.1016/S0277-9536(97)00107-X.
   Torssander J, 2010, EUR SOCIOL REV, V26, P465, DOI 10.1093/esr/jcp034.
   vanDoorslaer E, 1997, J HEALTH ECON, V16, P93, DOI 10.1016/S0167-6296(96)00532-2.},
Number-of-Cited-References = {36},
Times-Cited = {1},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {SSM-Popul. Health},
Doc-Delivery-Number = {GP3EF},
Web-of-Science-Index = {Emerging Sources Citation Index (ESCI)},
Unique-ID = {WOS:000440723800013},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000393682700005,
Author = {Thurman, David J. and Logroscino, Giancarlo and Beghi, Ettore and
   Hauser, W. Allen and Hesdorffer, Dale C. and Newton, Charles R. and
   Scorza, Fulvio Alexandre and Sander, Josemir W. and Tomson, Torbjorn and
   Epidemiology Commission Int Lea},
Title = {The burden of premature mortality of epilepsy in high-income countries:
   A systematic review from the Mortality Task Force of the International
   League Against Epilepsy},
Journal = {EPILEPSIA},
Year = {2017},
Volume = {58},
Number = {1},
Pages = {17-26},
Month = {JAN},
Abstract = {Since previous reviews of epidemiologic studies of premature mortality
   among people with epilepsy were completed several years ago, a large
   body of new evidence about this subject has been published. We aim to
   update prior reviews of mortality in epilepsy and to reevaluate and
   quantify the risks, potential risk factors, and causes of these deaths.
   We systematically searched the Medline and Embase databases to identify
   published reports describing mortality risks in cohorts and populations
   of people with epilepsy. We reviewed relevant reports and applied
   criteria to identify those studies likely to accurately quantify these
   risks in representative populations. From these we extracted and
   summarized the reported data. All population-based studies reported an
   increased risk of premature mortality among people with epilepsy
   compared to general populations. Standard mortality ratios are
   especially high among people with epilepsy aged <50 years, among those
   whose epilepsy is categorized as structural/metabolic, those whose
   seizures do not fully remit under treatment, and those with convulsive
   seizures. Among deaths directly attributable to epilepsy or seizures,
   important immediate causes include sudden unexpected death in epilepsy
   (SUDEP), status epilepticus, unintentional injuries, and suicide.
   Epilepsy-associated premature mortality imposes a significant public
   health burden, and many of the specific causes of death are potentially
   preventable. These require increased attention from healthcare
   providers, researchers, and public health professionals.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Review},
Language = {English},
Affiliation = {Thurman, DJ (Corresponding Author), 468 Pensdale Rd, Decatur, GA USA.
   Thurman, David J., Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA.
   Logroscino, Giancarlo, Univ Bari Aldo Moro, Pia Fdn Cardinale G Panico, Dept Clin Res Neurol, Lecce, Italy.
   Logroscino, Giancarlo, Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci \& Sense Organs, Bari, Italy.
   Beghi, Ettore, Mario Negri Inst Pharmacol Res, Milan, Italy.
   Hauser, W. Allen; Hesdorffer, Dale C., Columbia Univ, Sergievsky Ctr, New York, NY USA.
   Hauser, W. Allen; Hesdorffer, Dale C., Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA.
   Newton, Charles R., UCL, Inst Child Hlth, Dept Neurosci, London, England.
   Newton, Charles R., Muhimbili Univ Hlth \& Allied Sci, Dept Paediat, Dar Es Salaam, Tanzania.
   Newton, Charles R., Univ Oxford, Dept Psychiat, Oxford, England.
   Scorza, Fulvio Alexandre, Univ Fed Sao Paulo, Dept Neurol \& Neurosurg, Sao Paulo, Brazil.
   Sander, Josemir W., UCL Inst Neurol, NIHR Univ Coll London Hosp, Biomed Res Ctr, London, England.
   Sander, Josemir W., Epilepsy Inst Netherlands Fdn SEIN, Heemstede, England.
   Tomson, Torbjorn, Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.},
DOI = {10.1111/epi.13604},
ISSN = {0013-9580},
EISSN = {1528-1167},
Keywords = {Seizures; Convulsions; Death; Developed countries; Resource-rich
   countries; Premature mortality},
Keywords-Plus = {SUDDEN UNEXPECTED DEATH; UNEXPLAINED DEATH; LONG-TERM; UNPROVOKED
   SEIZURES; ANTIEPILEPTIC DRUGS; GENERAL-PRACTICE; RISK-FACTORS; COHORT;
   CHILDREN; ADULTS},
Research-Areas = {Neurosciences \& Neurology},
Web-of-Science-Categories  = {Clinical Neurology},
Author-Email = {david.j.thurman@emory.edu},
ResearcherID-Numbers = {Scorza, Carla Alessandra/C-4199-2013
   Newton, Charles RJC/B-7578-2014
   Hauser, W Allen/AAB-5277-2020
   Scorza, Fulvio/C-7048-2013
   Sander, Ley/C-1576-2008
   Beghi, Ettore/AAA-7426-2020
   },
ORCID-Numbers = {Scorza, Carla Alessandra/0000-0001-7810-4748
   Newton, Charles RJC/0000-0002-6999-5507
   Scorza, Fulvio/0000-0002-0694-8674
   Sander, Ley/0000-0001-6041-9661
   Beghi, Ettore/0000-0003-2542-0469
   Thurman, David/0000-0002-0533-7062},
Funding-Acknowledgement = {UpsherSmith; Cyberonics; Department of Rehabilitation; Mount Sinai
   Medical Center; New York University Langone Comprehensive Epilepsy
   Center; National Institutes of HealthUnited States Department of Health
   \& Human ServicesNational Institutes of Health (NIH) - USA; Centers for
   Disease Control and PreventionUnited States Department of Health \&
   Human ServicesCenters for Disease Control \& Prevention - USA; Epilepsy
   Study Consortium; Epilepsia; Wellcome Trust, United KingdomWellcome
   Trust; Department of Health's NIHR Biomedical Research CentresNational
   Institute for Health Research (NIHR); Marvin Weil Epilepsy Research
   Fund; GlaxoSmithKline (GSK)GlaxoSmithKline; EisaiEisai Co Ltd; UCBUCB
   Pharma SA; European UnionEuropean Commission; Dutch Epilepsy Funds;
   World Health Organization (WHO)World Health Organization; United Kingdom
   Epilepsy Society; GlaxoSmithKlineGlaxoSmithKline; NovartisNovartis;
   BialBial Group; Citizens United for Research in Epilepsy (CURE);
   Stockholm County CouncilStockholm County Council},
Funding-Text = {DJT receives consultant fees under contract with UCB, Inc. GL has no
   conflict of interest. DCH receives personal fees from UpsherSmith,
   Cyberonics, the Department of Rehabilitation, Mount Sinai Medical
   Center, and the New York University Langone Comprehensive Epilepsy
   Center, as well as grants from the National Institutes of Health, the
   Centers for Disease Control and Prevention, The Epilepsy Study
   Consortium, and Epilepsia. CN is funded by the Wellcome Trust, United
   Kingdom. JWS is based at the University College London Hospitals
   Bio-Medical Research Centre, which received a proportion of funding from
   the Department of Health's NIHR Biomedical Research Centres funding
   scheme; his current position is endowed by United Kingdom Epilepsy
   Society and he has received research support from the Marvin Weil
   Epilepsy Research Fund. His department has received research grants from
   GlaxoSmithKline (GSK), Eisai, UCB, European Union, Dutch Epilepsy Funds,
   World Health Organization (WHO), and United Kingdom Epilepsy Society. He
   has received honoraria from UCB, Eisai, GSK, Lundbeck, and Teva. TT has
   received research grants and/or speakers honoraria to his institution
   from: Eisai, GlaxoSmithKline, Novartis, Bial, and UCB. He has also
   received grants from Citizens United for Research in Epilepsy (CURE),
   Stockholm County Council, and European Union. We confirm that we have
   read the Journal's position on issues involved in ethical publication
   and affirm that this report is consistent with those guidelines.},
Cited-References = {Ackers R, 2011, DRUG SAFETY, V34, P403, DOI 10.2165/11588480-000000000-00000.
   Annegers JF, 2000, EPILEPSIA, V41, P549, DOI 10.1111/j.1528-1157.2000.tb00208.x.
   Benn EKT, 2008, EPILEPSIA, V49, P1431, DOI 10.1111/j.1528-1167.2008.01564.x.
   Berg AT, 2013, PEDIATRICS, V132, P124, DOI 10.1542/peds.2012-3998.
   Berg AT, 2004, ARCH PEDIAT ADOL MED, V158, P1147, DOI 10.1001/archpedi.158.12.1147.
   Callenbach PMC, 2001, PEDIATRICS, V107, P1259, DOI 10.1542/peds.107.6.1259.
   Camfield CS, 2002, LANCET, V359, P1891, DOI 10.1016/S0140-6736(02)08779-2.
   Cockerell OC, 1997, EPILEPSIA, V38, P31, DOI 10.1111/j.1528-1157.1997.tb01075.x.
   Derby LE, 1996, EPILEPSIA, V37, P931, DOI 10.1111/j.1528-1157.1996.tb00529.x.
   DIEKEMA DS, 1993, PEDIATRICS, V91, P612.
   Donner EJ, 2001, NEUROLOGY, V57, P430, DOI 10.1212/WNL.57.3.430.
   Fazel S, 2013, LANCET, V382, P1646, DOI 10.1016/S0140-6736(13)60899-5.
   Ficker DM, 1998, NEUROLOGY, V51, P1270, DOI 10.1212/WNL.51.5.1270.
   Forsgren L, 1996, EPILEPSIA, V37, P224, DOI 10.1111/j.1528-1157.1996.tb00017.x.
   Forsgren L, 2005, EPILEPSIA, V46, P18, DOI 10.1111/j.1528-1167.2005.00403.x.
   Gaitatzis A, 2004, BRAIN, V127, P2427, DOI 10.1093/brain/awh267.
   Granbichler CA, 2015, J NEUROL, V262, P126, DOI 10.1007/s00415-014-7536-z.
   HAUSER WA, 1980, EPILEPSIA, V21, P399, DOI 10.1111/j.1528-1157.1980.tb04088.x.
   Holst AG, 2013, EPILEPSIA, V54, P1613, DOI 10.1111/epi.12328.
   Keezer MR, 2016, NEUROLOGY, V86, P704, DOI 10.1212/WNL.0000000000002390.
   Lhatoo SD, 2005, EPILEPSIA, V46, P36, DOI 10.1111/j.1528-1167.2005.00406.x.
   Lhatoo SD, 2001, ANN NEUROL, V49, P336.
   Lindsten H, 2000, EPILEPSIA, V41, P1469, DOI 10.1111/j.1528-1157.2000.tb00124.x.
   LIP GYH, 1992, J ROY SOC MED, V85, P609.
   Loiseau P, 2005, EPILEPSIA, V46, P11, DOI 10.1111/j.1528-1167.2005.00401.x.
   Mohanraj R, 2006, LANCET NEUROL, V5, P481, DOI 10.1016/S1474-4422(06)70448-3.
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI {[}10.1016/j.ijsu.2010.02.007, 10.1136/bmj.g7647, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086].
   Morgan CL, 2002, EPILEPSIA, V43, P1251, DOI 10.1046/j.1528-1157.2002.38701.x.
   Moseley BD, 2013, EPILEPSY RES, V105, P410, DOI 10.1016/j.eplepsyres.2013.03.002.
   NASHEF L, 1995, J NEUROL NEUROSUR PS, V58, P462, DOI 10.1136/jnnp.58.4.462.
   NASHEF L, 1995, EPILEPSIA, V36, P1187, DOI 10.1111/j.1528-1157.1995.tb01061.x.
   Neligan A, 2011, BRAIN, V134, P388, DOI 10.1093/brain/awq378.
   Nickels KC, 2012, EPILEPSIA, V53, P2164, DOI 10.1111/j.1528-1167.2012.03661.x.
   Nikolas H, 2007, EPILEPSY BEHAV, V10, P363, DOI 10.1016/j.yebeh.2007.01.005.
   Nilsson L, 1997, EPILEPSIA, V38, P1062, DOI 10.1111/j.1528-1157.1997.tb01194.x.
   Nilsson L, 2003, EPILEPSIA, V44, P575, DOI 10.1046/j.1528-1157.2003.03302.x.
   Olafsson E, 1998, EPILEPSIA, V39, P89, DOI 10.1111/j.1528-1157.1998.tb01279.x.
   Opeskin K, 2003, SEIZURE-EUR J EPILEP, V12, P456, DOI 10.1016/S1059-1311(02)00352-7.
   Rafnsson V, 2001, NEUROEPIDEMIOLOGY, V20, P232, DOI 10.1159/000054795.
   Rakitin A, 2011, EUR J NEUROL, V18, P465, DOI 10.1111/j.1468-1331.2010.03195.x.
   Ridsdale L, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X572463.
   Rothman KJ, 2008, MODERN EPIDEMIOLOGY, V3rd.
   Sillanpaa M, 1998, NEW ENGL J MED, V338, P1715, DOI 10.1056/NEJM199806113382402.
   Sillanpaa M, 2010, NEW ENGL J MED, V363, P2522, DOI 10.1056/NEJMoa0911610.
   Sperling MR, 2005, EPILEPSIA, V46, P49, DOI 10.1111/j.1528-1167.2005.00410.x.
   Tellez-Zenteno JF, 2005, EPILEPSY RES, V65, P101, DOI 10.1016/j.eplepsyres.2005.05.004.
   TENNIS P, 1995, EPILEPSIA, V36, P29, DOI 10.1111/j.1528-1157.1995.tb01661.x.
   Thurman DJ, 2014, EPILEPSIA, V55, P1479, DOI 10.1111/epi.12666.
   Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x.
   Timmings PL, 1998, SEIZURE-EUR J EPILEP, V7, P289, DOI 10.1016/S1059-1311(98)80020-4.
   Tomson T, 2004, EPILEPSY RES, V60, P1, DOI 10.1016/j.eplepsyres.2004.05.004.
   Tomson T, 2000, J NEUROL, V247, P15, DOI 10.1007/s004150050004.
   Tomson T, 2008, LANCET NEUROL, V7, P1021, DOI 10.1016/S1474-4422(08)70202-3.
   Trinka E, 2013, EPILEPSIA, V54, P495, DOI 10.1111/epi.12014.
   Vickrey BG, 1997, EPILEPSIA, V38, pS67, DOI 10.1111/j.1528-1157.1997.tb06133.x.
   Walczak TS, 2001, NEUROLOGY, V56, P519, DOI 10.1212/WNL.56.4.519.
   Weber P, 2005, ACTA PAEDIATR, V94, P564, DOI 10.1080/08035250410023872.},
Number-of-Cited-References = {57},
Times-Cited = {133},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {11},
Journal-ISO = {Epilepsia},
Doc-Delivery-Number = {EK1JX},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000393682700005},
OA = {Bronze, Green Submitted, Green Accepted},
DA = {2022-03-29},
}

@article{ WOS:000760941700007,
Author = {He, Qingqing and Gu, Yefu and Yim, Steve Hung Lam},
Title = {What drives long-term PM2.5-attributable premature mortality change? A
   case study in central China using high-resolution satellite data from
   2003 to 2018},
Journal = {ENVIRONMENT INTERNATIONAL},
Year = {2022},
Volume = {161},
Month = {MAR},
Abstract = {Ambient PM2.5 was reported to be related to numerous negative health
   outcomes, leading to adverse public health impacts in many countries
   such as China. Despite the apparent reduction in PM2.5 levels over China
   due to its emission control policies in recent years, the health burdens
   were not reduced as much as expected. This calls for a comprehensive
   analysis to explain the reasons behind to provide a useful reference for
   formulating effective emission control strategies. Taking central China
   as an example due to its large population and high levels of PM2.5, this
   study quantified the spatiotemporal dynamics of premature mortality
   associated with PM2.5 pollution in central China for each year during
   2003-2018 and applied a decomposition analysis to dissect the
   contribution of various driving factors including ambient PM2.5 level,
   demographic distribution and baseline incidence rate of four diseases
   related to air pollution. Results show significant spatiotemporal
   variations in PM2.5-attributed health impact in central China, including
   Henan, Hubei, and Hunan provinces. Five Henan cities had the largest
   PM2.5-attributable premature mortality (similar to 8-12 K premature
   mortalities), while three Hubei cities and one Hebei city had the least
   chronic PM2.5-related all-cause mortality numbers (<1 K mortalities).
   Throughout the study period, the PM2.5-caused premature mortality
   decreased by 54 K, in which changes in PM2.5 levels and baseline
   incidence rates of stroke and chronic obstructive pulmonary disease
   contributed to the positive effect, whereas demographic changes and
   baseline incidence rate change of ischemic heart disease and lung cancer
   brought a countervailing effect. Our findings suggest more dynamic and
   comprehensive policies and measures that take into account
   spatiotemporal variations of health burden for effective alleviation of
   the health impact of PM2.5 pollution in the country.},
Publisher = {PERGAMON-ELSEVIER SCIENCE LTD},
Address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Yim, SHL (Corresponding Author), Nanyang Technol Univ, Asian Sch Environm, Singapore, Singapore.
   He, Qingqing, Wuhan Univ Technol, Sch Resource \& Environm Engn, Wuhan 430070, Peoples R China.
   He, Qingqing, Chinese Univ Hong Kong, Inst Environm Energy \& Sustainabil, Hong Kong, Peoples R China.
   Gu, Yefu, Chinese Univ Hong Kong, Dept Geog \& Resource Management, Shatin, Hong Kong, Peoples R China.
   Yim, Steve Hung Lam, Nanyang Technol Univ, Asian Sch Environm, Singapore, Singapore.
   Yim, Steve Hung Lam, Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   Yim, Steve Hung Lam, Nanyang Technol Univ, Earth Observ Singapore, Singapore, Singapore.},
DOI = {10.1016/j.envint.2022.107110},
Article-Number = {107110},
ISSN = {0160-4120},
EISSN = {1873-6750},
Keywords = {PM2.5; Satellite remote sensing; Health burden; Spatiotemporal
   variation; Decomposition analysis},
Keywords-Plus = {PEARL RIVER DELTA; TRANSBOUNDARY AIR-POLLUTION; PM2.5 CONCENTRATIONS;
   PARTICULATE MATTER; GLOBAL BURDEN; SPATIOTEMPORAL TRENDS; LOCAL
   EMISSIONS; CLIMATE-CHANGE; AMBIENT PM2.5; HONG-KONG},
Research-Areas = {Environmental Sciences \& Ecology},
Web-of-Science-Categories  = {Environmental Sciences},
Author-Email = {yimsteve@gmail.com},
Funding-Acknowledgement = {Vice-Chancellor's Discretionary Fund of The Chinese University of Hong
   Kong {[}4930744]; Dr. Stanley Ho Medicine Development Foundation
   {[}8305509]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China (NSFC) {[}41901324]},
Funding-Text = {This research was funded by the Vice-Chancellor's Discretionary Fund of
   The Chinese University of Hong Kong (Grant No. 4930744) , Dr. Stanley Ho
   Medicine Development Foundation (Grant No. 8305509) , and the National
   Natural Science Foundation of China (Grant No. 41901324) .},
Cited-References = {Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1.
   Burnett R, 2018, P NATL ACAD SCI USA, V115, P9592, DOI 10.1073/pnas.1803222115.
   Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049.
   Chudnovsky AA, 2013, ENVIRON POLLUT, V172, P131, DOI 10.1016/j.envpol.2012.08.016.
   Cohen AJ, 2017, LANCET, V389, P1907, DOI {[}10.1016/S0140-6736(17)30505-6, 10.1016/s0140-6736(17)30505-6].
   Critchley J, 2004, CIRCULATION, V110, P1236, DOI 10.1161/01.CIR.0000140668.91896.AE.
   Fang D, 2016, SCI TOTAL ENVIRON, V569, P1545, DOI 10.1016/j.scitotenv.2016.06.248.
   Gao SG, 2020, J THORAC ONCOL, V15, P1567, DOI 10.1016/j.jtho.2020.04.028.
   Gu Y, 2016, ENVIRON INT, V97, P117, DOI 10.1016/j.envint.2016.08.004.
   Gu YF, 2020, RESOUR CONSERV RECY, V159, DOI 10.1016/j.resconrec.2020.104812.
   Hata J, 2013, CIRC J, V77, P1923, DOI 10.1253/circj.CJ-13-0786.
   He QQ, 2021, J CLEAN PROD, V286, DOI 10.1016/j.jclepro.2020.124965.
   He QQ, 2020, ENVIRON INT, V137, DOI 10.1016/j.envint.2020.105536.
   Hoesly RM, 2018, GEOSCI MODEL DEV, V11, P369, DOI 10.5194/gmd-11-369-2018.
   Hou X, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/aaf493.
   IHME, 2018, I HLTH METR EV.
   Kloog I, 2014, ATMOS ENVIRON, V95, P581, DOI 10.1016/j.atmosenv.2014.07.014.
   Li ZY, 2020, J CLEAN PROD, V268, DOI 10.1016/j.jclepro.2020.121975.
   Liang FC, 2020, P NATL ACAD SCI USA, V117, P25601, DOI 10.1073/pnas.1919641117.
   Liang FC, 2018, SCI TOTAL ENVIRON, V616, P1589, DOI 10.1016/j.scitotenv.2017.10.155.
   Lin CQ, 2018, ATMOS ENVIRON, V180, P110, DOI 10.1016/j.atmosenv.2018.02.045.
   Lin CQ, 2016, REMOTE SENS ENVIRON, V179, P13, DOI 10.1016/j.rse.2016.03.023.
   Liu J, 2016, SCI TOTAL ENVIRON, V568, P1253, DOI 10.1016/j.scitotenv.2016.05.165.
   Liu MM, 2017, ENVIRON INT, V98, P75, DOI 10.1016/j.envint.2016.10.003.
   Liu N, 2019, ATMOS CHEM PHYS, V19, P8243, DOI 10.5194/acp-19-8243-2019.
   Liu Z, 2018, GEOPHYS RES LETT, V45, P4410, DOI 10.1029/2018GL077517.
   Lu XC, 2019, SCI TOTAL ENVIRON, V652, P683, DOI 10.1016/j.scitotenv.2018.10.140.
   Lu XC, 2017, ENVIRON INT, V98, P160, DOI 10.1016/j.envint.2016.11.002.
   Lu Z, 2010, ATMOS CHEM PHYS, V10, P6311, DOI 10.5194/acp-10-6311-2010.
   Luo M, 2018, SCI TOTAL ENVIRON, V618, P132, DOI 10.1016/j.scitotenv.2017.11.001.
   Ma ZW, 2019, ATMOS CHEM PHYS, V19, P6861, DOI 10.5194/acp-19-6861-2019.
   Ma ZW, 2016, ATMOS ENVIRON, V133, P156, DOI 10.1016/j.atmosenv.2016.03.040.
   Ma ZW, 2016, ENVIRON HEALTH PERSP, V124, P184, DOI 10.1289/ehp.1409481.
   Maji KJ, 2018, ENVIRON INT, V121, P392, DOI 10.1016/j.envint.2018.09.024.
   Ning GC, 2020, ATMOS ENVIRON, V240, DOI 10.1016/j.atmosenv.2020.117808.
   Peng J, 2016, REMOTE SENS ENVIRON, V174, P109, DOI 10.1016/j.rse.2015.12.008.
   Pope C. Arden III, 2000, Environmental Health Perspectives, V108, P713, DOI 10.2307/3454408.
   Shen JF, 2016, HABITAT INT, V57, P1, DOI 10.1016/j.habitatint.2016.06.007.
   Shen JF, 2015, REG STUD, V49, P1176, DOI 10.1080/00343404.2013.812783.
   Shi CN, 2020, ATMOS ENVIRON, V223, DOI 10.1016/j.atmosenv.2019.117239.
   Song CB, 2017, ENVIRON POLLUT, V223, P575, DOI 10.1016/j.envpol.2017.01.060.
   Song YM, 2019, ENVIRON POLLUT, V253, P288, DOI 10.1016/j.envpol.2019.06.057.
   Stanaway JD, 2018, LANCET, V392, P1923, DOI 10.1016/s0140-6736(18)32225-6.
   Tong CHM, 2018, ATMOS ENVIRON, V193, P79, DOI 10.1016/j.atmosenv.2018.08.053.
   van Donkelaar A, 2016, ENVIRON SCI TECHNOL, V50, P3762, DOI 10.1021/acs.est.5b05833.
   Wan X, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4558-3.
   Wang MY, 2020, ATMOS ENVIRON, V222, DOI 10.1016/j.atmosenv.2019.117026.
   Wang Q, 2018, ENVIRON INT, V110, P105, DOI 10.1016/j.envint.2017.10.015.
   Wang YL, 2019, INT J CLIMATOL, V39, P2984, DOI 10.1002/joc.5996.
   Wei J, 2021, REMOTE SENS ENVIRON, V252, DOI 10.1016/j.rse.2020.112136.
   Xiao QY, 2017, REMOTE SENS ENVIRON, V199, P437, DOI 10.1016/j.rse.2017.07.023.
   Xue T, 2019, SCI CHINA EARTH SCI, V62, P1847, DOI 10.1007/s11430-018-9348-2.
   Xue T, 2019, ENVIRON INT, V123, P345, DOI 10.1016/j.envint.2018.11.075.
   Yang YJ, 2019, J GEOPHYS RES-ATMOS, V124, P9609, DOI 10.1029/2019JD031140.
   Yim SHL, 2019, ATMOS RES, V218, P50, DOI 10.1016/j.atmosres.2018.10.021.
   Yim S.H.L., 2022, ATMOS ENV, V269, DOI {[}10.1016/j.atmosenv.2021.118835, DOI 10.1016/J.ATMOSENV.2021.118835].
   Yim SHL, 2010, ATMOS ENVIRON, V44, P4850, DOI 10.1016/j.atmosenv.2010.08.037.
   Yim SHL, 2019, J GEOPHYS RES-ATMOS, V124, P11568, DOI 10.1029/2019JD030562.
   Yim SHL, 2019, ATMOS CHEM PHYS, V19, P13309, DOI 10.5194/acp-19-13309-2019.
   Zhang Q, 2019, P NATL ACAD SCI USA, V116, P24463, DOI 10.1073/pnas.1907956116.
   Zhou MG, 2016, LANCET, V387, P251, DOI 10.1016/S0140-6736(15)00551-6.
   Zou B, 2019, ENVIRON INT, V125, P529, DOI 10.1016/j.envint.2018.10.045.},
Number-of-Cited-References = {62},
Times-Cited = {0},
Usage-Count-Last-180-days = {7},
Usage-Count-Since-2013 = {7},
Journal-ISO = {Environ. Int.},
Doc-Delivery-Number = {ZH4WQ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000760941700007},
OA = {gold},
DA = {2022-03-29},
}

@article{ WOS:000351929700033,
Author = {Geels, Camilla and Andersson, Camilla and Hanninen, Otto and Lanso, Anne
   Sofie and Schwarze, Per E. and Skjoth, Carsten Ambelas and Brandt,
   Jorgen},
Title = {Future Premature Mortality Due to O-3, Secondary Inorganic Aerosols and
   Primary PM in Europe - Sensitivity to Changes in Climate, Anthropogenic
   Emissions, Population and Building Stock},
Journal = {INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH},
Year = {2015},
Volume = {12},
Number = {3},
Pages = {2837-2869},
Month = {MAR},
Abstract = {Air pollution is an important environmental factor associated with
   health impacts in Europe and considerable resources are used to reduce
   exposure to air pollution through emission reductions. These reductions
   will have non-linear effects on exposure due, e.g., to interactions
   between climate and atmospheric chemistry. By using an integrated
   assessment model, we quantify the effect of changes in climate,
   emissions and population demography on exposure and health impacts in
   Europe. The sensitivity to the changes is assessed by investigating the
   differences between the decades 2000-2009, 2050-2059 and 2080-2089. We
   focus on the number of premature deaths related to atmospheric ozone,
   Secondary Inorganic Aerosols and primary PM. For the Nordic region we
   furthermore include a projection on how population exposure might
   develop due to changes in building stock with increased energy
   efficiency. Reductions in emissions cause a large significant decrease
   in mortality, while climate effects on chemistry and emissions only
   affects premature mortality by a few percent. Changes in population
   demography lead to a larger relative increase in chronic mortality than
   the relative increase in population. Finally, the projected changes in
   building stock and infiltration rates in the Nordic indicate that this
   factor may be very important for assessments of population exposure in
   the future.},
Publisher = {MDPI},
Address = {ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND},
Type = {Article},
Language = {English},
Affiliation = {Geels, C (Corresponding Author), Aarhus Univ, Dept Environm Sci, Frederiksborgvej 399,POB 358, DK-4000 Roskilde, Denmark.
   Geels, Camilla; Lanso, Anne Sofie; Brandt, Jorgen, Aarhus Univ, Dept Environm Sci, DK-4000 Roskilde, Denmark.
   Andersson, Camilla, Swedish Meteorol \& Hydrol Inst, SE-60176 Norrkoping, Sweden.
   Hanninen, Otto, Natl Inst Hlth \& Welf THL, Dept Hlth Protect, Kuopio 70701, Finland.
   Schwarze, Per E., Norwegian Inst Publ Hlth, Dept Air Pollut \& Noise, N-4404 Nydalen, Norway.
   Skjoth, Carsten Ambelas, Univ Worcester, Inst Sci \& Environm, Natl Pollen \& Aerobiol Res Unit, Worcester WR2 6AJ, England.},
DOI = {10.3390/ijerph120302837},
EISSN = {1660-4601},
Keywords-Plus = {HEALTH-COST EXTERNALITIES; AIR-POLLUTION LEVELS; SURFACE OZONE; NITROGEN
   DEPOSITION; AMBIENT PM2.5; MODEL; IMPACTS; INFILTRATION; QUALITY;
   EXPOSURE},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {cag@envs.au.dk
   camilla.andersson@smhi.se
   otto.hanninen@thl.fi
   asla@envs.au.dk
   per.schwarze@fhi.no
   c.skjoth@worc.ac.uk
   jbr@envs.au.dk},
ResearcherID-Numbers = {Hänninen, Otto/C-7951-2012
   Brandt, Jørgen/B-3733-2011
   Skjøth, Carsten/AAM-1002-2021
   Geels, Camilla/G-4757-2013
   Schwarze, Per/I-2080-2016
   Andersson, Camilla/B-7580-2014},
ORCID-Numbers = {Hänninen, Otto/0000-0002-4868-4822
   Brandt, Jørgen/0000-0002-7580-9547
   Skjøth, Carsten/0000-0001-5992-9568
   Geels, Camilla/0000-0003-2549-1750
   Andersson, Camilla/0000-0001-7853-932X},
Funding-Acknowledgement = {Nordic Council of Ministers through FAN project {[}KOL-1204]; EU project
   ECLAIRE {[}282910]; Danish Strategic Research Council project ECOCLIM;
   Academy of FinlandAcademy of Finland {[}133792]; Swedish EPA through the
   ERA-ENVHEALTH network; EUEuropean Commission {[}FP7-ENV-2009-1-243406,
   ENV4-CT95-0205]},
Funding-Text = {This study was mainly supported by the Nordic Council of Ministers
   through the FAN project (KOL-1204). The development of an ammonia
   scenario has been funded through the EU project ECLAIRE (project No.:
   282910) and the Danish Strategic Research Council project ECOCLIM.
   Additional support through: Academy of Finland Contract 133792 (PM
   Sizex), the Swedish EPA through the ERA-ENVHEALTH network (the ACCEPTED
   project), EU Contracts FP7-ENV-2009-1-243406 (TRANSPHORM), and
   ENV4-CT95-0205 (ULTRA), and intramural funding by the participating
   institutes.},
Cited-References = {Amann M., 2012, TSAP 2012 BASELINE H, P49.
   Amann M, 2011, ENVIRON MODELL SOFTW, V26, P1489, DOI 10.1016/j.envsoft.2011.07.012.
   Andersson C, 2007, TELLUS B, V59, P77, DOI 10.1111/j.1600-0889.2006.00231.x.
   Andersson C, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2008JD011690.
   Andersson C, 2009, ATMOS ENVIRON, V43, P3614, DOI 10.1016/j.atmosenv.2009.03.040.
   {[}Anonymous], MULT ROADM LONG TERM.
   Brandt J, 2013, ATMOS CHEM PHYS, V13, P7725, DOI 10.5194/acp-13-7725-2013.
   Brandt J, 2013, ATMOS CHEM PHYS, V13, P7747, DOI 10.5194/acp-13-7747-2013.
   Brandt J, 2012, ATMOS ENVIRON, V53, P156, DOI 10.1016/j.atmosenv.2012.01.011.
   Carter WPL, 1996, ATMOS ENVIRON, V30, P4275, DOI 10.1016/1352-2310(96)00088-X.
   Christensen JH, 1997, ATMOS ENVIRON, V31, P4169, DOI 10.1016/S1352-2310(97)00264-1.
   Colette A, 2013, ATMOS CHEM PHYS, V13, P7451, DOI 10.5194/acp-13-7451-2013.
   Cuvelier C., 12013 EMEP.
   Davidson L, 1986, OCEANIC WHITECAPS TH, P167, DOI DOI 10.1007/978-94-009-4668-2\_16.
   Delfino RJ, 2009, ENVIRON HEALTH PERSP, V117, P1232, DOI {[}10.1289/ehp.0800194, 10.1289/journla.ehp.0800194].
   Engardt M, 2013, TELLUS B, V65, DOI 10.3402/tellusb.v65i0.20348.
   Engardt M, 2009, AMBIO, V38, P452, DOI 10.1579/0044-7447-38.8.452.
   Erhorn-Kluttig H., AIRTIGHTNESS REQUIRE.
   Fiore AM, 2012, CHEM SOC REV, V41, P6663, DOI 10.1039/c2cs35095e.
   Foltescu VL, 2005, ATMOS ENVIRON, V39, P2123, DOI 10.1016/j.atmosenv.2004.12.030.
   Frohn LM, 2002, J COMPUT PHYS, V179, P68, DOI 10.1006/jcph.2002.7036.
   Geels C, 2012, BIOGEOSCIENCES, V9, P2625, DOI 10.5194/bg-9-2625-2012.
   Gens A, 2014, ATMOS ENVIRON, V84, P213, DOI 10.1016/j.atmosenv.2013.11.054.
   Gerba CP, 1996, INT J FOOD MICROBIOL, V30, P113, DOI 10.1016/0168-1605(96)00996-8.
   Grell GA, 1994, TN398IA NCAR, P1.
   GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950.
   Hanninen O., 2013, EFFICIENT REDUCTION.
   Hanninen OO, 2005, INDOOR AIR, V15, P246, DOI 10.1111/j.1600-0668.2005.00365.x.
   Hanninen OO, 2004, ATMOS ENVIRON, V38, P6411, DOI 10.1016/j.atmosenv.2004.07.015.
   Hanninen O, 2014, ENVIRON HEALTH PERSP, V122, P439, DOI 10.1289/ehp.1206154.
   Hanninen O, 2013, J AEROSOL SCI, V66, P111, DOI 10.1016/j.jaerosci.2013.08.004.
   Hanninen O, 2011, AIR QUAL ATMOS HLTH, V4, P221, DOI 10.1007/s11869-010-0076-5.
   {[}Health Risks of Air Pollution in Europe-HRAPIE Project WHO], 2013, HLTH RISKS AIR POLL, P60.
   Hedegaard GB, 2008, ATMOS CHEM PHYS, V8, P3337, DOI 10.5194/acp-8-3337-2008.
   Hedegaard GB, 2013, ATMOS CHEM PHYS, V13, P3569, DOI 10.5194/acp-13-3569-2013.
   Hedegaard G. B., 2012, Atmospheric and Climate Sciences, V2, P546, DOI 10.4236/acs.2012.24050.
   Hedegaard G.B., 2011, ATMOS CHEM PHYS DISC, V11, P6805, DOI DOI 10.5194/ACPD-11-6805-2011.
   Hoek G, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-43.
   Hole L, 2008, AMBIO, V37, P9, DOI 10.1579/0044-7447(2008)37{[}9:CCIOAN]2.0.CO;2.
   Hole LR, 2009, ATMOS ENVIRON, V43, P928, DOI 10.1016/j.atmosenv.2008.10.043.
   Iehias, IEH INT ENV HLTH IMP.
   Jacob DJ, 2009, ATMOS ENVIRON, V43, P51, DOI 10.1016/j.atmosenv.2008.09.051.
   Janssen NAH, 2011, ENVIRON HEALTH PERSP, V119, P1691, DOI 10.1289/ehp.1003369.
   Jimenez JL, 2009, SCIENCE, V326, P1525, DOI 10.1126/science.1180353.
   Kearney J, 2014, ATMOS ENVIRON, V94, P793, DOI 10.1016/j.atmosenv.2014.05.020.
   Kjellstrom E, 2011, TELLUS A, V63, P24, DOI 10.1111/j.1600-0870.2010.00475.x.
   Langner J, 2005, ATMOS ENVIRON, V39, P1129, DOI 10.1016/j.atmosenv.2004.09.082.
   Langner J, 2012, ATMOS CHEM PHYS, V12, P10423, DOI 10.5194/acp-12-10423-2012.
   Langner J, 2012, ATMOS CHEM PHYS, V12, P10097, DOI 10.5194/acp-12-10097-2012.
   Langner J., 1998, EUROPEAN SCALE MODEL.
   Langner J, 2009, BOREAL ENVIRON RES, V14, P226.
   Manders AMM, 2012, ATMOS CHEM PHYS, V12, P9441, DOI 10.5194/acp-12-9441-2012.
   Martensson EM, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002263.
   Nakicenovic N, 2000, SPECIAL REPORT EMISS.
   OECD, 2012, OECD ENV OUTL 2050 C.
   Orru H, 2013, EUR RESPIR J, V41, P285, DOI 10.1183/09031936.00210411.
   Oxley T, 2013, ENVIRON INT, V61, P17, DOI 10.1016/j.envint.2013.09.009.
   Pacifico F, 2009, ATMOS ENVIRON, V43, P6121, DOI 10.1016/j.atmosenv.2009.09.002.
   Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485.
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132.
   Post ES, 2012, ENVIRON HEALTH PERSP, V120, P1559, DOI 10.1289/ehp.1104271.
   Punger EM, 2013, AIR QUAL ATMOS HLTH, V6, P563, DOI 10.1007/s11869-013-0197-8.
   Robertson L, 1999, J APPL METEOROL, V38, P190, DOI 10.1175/1520-0450(1999)038<0190:AELAAT>2.0.CO;2.
   Roeckner E., 2006, IPCC AR4 MPI ECHAM5, DOI {[}10.1594/wdcc/eh5-t63131\_omgrl.5140\_ctl\_6h, DOI 10.1594/WDCC/EH5-T63L31].
   Rogelj J, 2014, NAT CLIM CHANGE, V4, P446, DOI {[}10.1038/NCLIMATE2178, 10.1038/nclimate2178].
   Samuelsson P, 2011, TELLUS A, V63, P4, DOI 10.1111/j.1600-0870.2010.00478.x.
   Silva RA, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034005.
   Simpson D, 2014, ATMOS CHEM PHYS, V14, P6995, DOI 10.5194/acp-14-6995-2014.
   Simpson D, 2012, ATMOS CHEM PHYS, V12, P7825, DOI 10.5194/acp-12-7825-2012.
   Skjoth CA, 2013, ATMOS CHEM PHYS, V13, P117, DOI 10.5194/acp-13-117-2013.
   Stocker T.F., 2013, PHYS SCI BASIS CONTR, P1535, DOI {[}10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324].
   Sutton MA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0166.
   Tai APK, 2013, GEOPHYS RES LETT, V40, P3479, DOI 10.1002/grl.50650.
   Thomson AM, 2011, CLIMATIC CHANGE, V109, P77, DOI 10.1007/s10584-011-0151-4.
   Watkiss P, 2005, CAFE CBA BASELINE AN.
   West JJ, 2007, CR GEOSCI, V339, P775, DOI 10.1016/j.crte.2007.08.005.
   World Health Organization, 2014, 7 MILL PREM DEATHS A.
   WORLD HEALTH ORGANIZATION, 2013, REV EV HLTH ASP AIR.
   Zare A, 2014, ATMOS CHEM PHYS, V14, P2735, DOI 10.5194/acp-14-2735-2014.
   Zare A, 2012, ATMOS CHEM PHYS, V12, P7399, DOI 10.5194/acp-12-7399-2012.
   Zou Y., 2010, THESIS BUILDING PHYS.
   {[}No title captured].},
Number-of-Cited-References = {82},
Times-Cited = {29},
Usage-Count-Last-180-days = {5},
Usage-Count-Since-2013 = {36},
Journal-ISO = {Int. J. Environ. Res. Public Health},
Doc-Delivery-Number = {CE6EP},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000351929700033},
OA = {Green Published, Green Submitted, gold, Green Accepted},
DA = {2022-03-29},
}

@article{ WOS:000752737400022,
Author = {Cousin, Ewerton and Schmidt, Maria Ines and Stein, Caroline and de
   Aquino, Erika Carvalho and Dutra Pozzetti Gouvea, Ellen de Cassia and
   Malta, Deborah Carvalho and Naghavi, Mohsen and Duncan, Bruce B.},
Title = {Premature mortality due to four main non-communicable diseases and
   suicide in Brazil and its states from 1990 to 2019: A Global Burden of
   Disease Study},
Journal = {ENGENHARIA AGRICOLA},
Year = {2022},
Volume = {55},
Number = {1},
Abstract = {Introduction: The goal of reducing the burden of non-communicable
   diseases (NCDs) requires close monitoring. Our objective is to
   characterize the decline of premature NCD mortality in Brazil based on
   Global Burden of Diseases (GBD) Study 2019 estimates. Methods: We used
   GBD 2019 data to estimate death rates of the four main NCDs -
   cardiovascular diseases, neoplasms, diabetes, and chronic respiratory
   diseases. We estimated the unconditional probability of death between
   ages 30 to 69, as recommended by the World Health Organization, as well
   as premature crude- and age-standardized death rates and
   disability-adjusted life years (DALYs) lost for these conditions. We
   also estimated trends in suicide (self-harm) death rates. Results: From
   2010 to 2019, the age-standardized unconditional probability of
   premature death declined -1.4\%/year (UI: -1.7\%;-1.0\%).
   Age-standardized death rates declined -1.5\%/year (UI: -1.9\%; -1.2\%),
   and crude death rates -0.6\%/year (UI: (-1.0\%; -0.2\%). Level of
   development correlated strongly with the rate of decline, with greatest
   declines occurring in the Southeast, Center West and South regions.
   Age-standardized mortality from self-harm declined, most notably in the
   elderly. Conclusions: Premature mortality due to the main NCDs has
   declined from 1990 in Brazil, although at a diminishing rate over time.
   The unconditional probability of death and the age-standardized
   mortality rate produced similar estimates of decline for the four main
   NCDs, and mirror well decline in mortality from all NCDs. Declines,
   especially more recent ones, fall short of the international goals.
   Strategic public health actions are needed. The challenge to implement
   them will be great, considering the political and economic instability
   currently faced by Brazil.},
Publisher = {SOC BRASIL ENGENHARIA AGRICOLA},
Address = {FCAV-UNESP, DEPT ENGENHARIA RURAL, VIA DE ACESSO PROF PAULO DONATO
   CASTELLANE, KM 5, JABOTICABAL, 14884 900, SPAIN},
Type = {Article},
Language = {English},
Affiliation = {Duncan, BB (Corresponding Author), Univ Fed Rio Grande do Sul, Programa Posgrad Epidemiol, Porto Alegre, RS, Brazil.
   Duncan, BB (Corresponding Author), Univ Fed Rio Grande do Sul, Fac Med, Dept Med Social, Porto Alegre, RS, Brazil.
   Cousin, Ewerton; Naghavi, Mohsen, Univ Washington, Inst Hlth Metr \& Evaluat, Seattle, WA 98195 USA.
   Cousin, Ewerton; Schmidt, Maria Ines; Stein, Caroline; Duncan, Bruce B., Univ Fed Rio Grande do Sul, Programa Posgrad Epidemiol, Porto Alegre, RS, Brazil.
   Schmidt, Maria Ines; Duncan, Bruce B., Univ Fed Rio Grande do Sul, Fac Med, Dept Med Social, Porto Alegre, RS, Brazil.
   de Aquino, Erika Carvalho; Dutra Pozzetti Gouvea, Ellen de Cassia, Minist Saude, Coordenacao Geral Vigilancia Doencas \& Agravos Na, Dept Anal Saude \& Vigilancia Doencas Nao Transmis, Brasilia, DF, Brazil.
   Malta, Deborah Carvalho, Univ Fed Minas Gerais, Dept Enfermagem Materno Infantil \& Saude Publ, Escola Enfermagem, Belo Horizonte, MG, Brazil.},
DOI = {10.1590/0037-8682-0328-2021},
Article-Number = {e0328-2021},
ISSN = {0100-6916},
Keywords = {Mortality; Noncommunicable Diseases; Global Burden of Disease; Brazil},
Research-Areas = {Agriculture},
Web-of-Science-Categories  = {Agricultural Engineering},
Author-Email = {bbduncan@ufrgs.br},
ResearcherID-Numbers = {Duncan, Bruce/L-4140-2016
   Carvalho Malta, Deborah/H-7880-2012},
ORCID-Numbers = {Carvalho de Aquino, Erika/0000-0002-5659-0308
   Dutra Pozzetti Gouvea, Ellen de Cassia/0000-0003-0611-3738
   Stein, Caroline/0000-0003-4777-1630
   Duncan, Bruce/0000-0002-7491-2630
   Carvalho Malta, Deborah/0000-0002-8214-5734},
Funding-Acknowledgement = {Brazilian Ministry of Health {[}TED 95/2019]; Bill \& Melinda Gates
   FoundationBill \& Melinda Gates FoundationCGIAR; Instituto de Avaliacao
   de Tecnologias em Saude (IATS, Brazil) {[}465518/2014-1]},
Funding-Text = {Brazilian Ministry of Health (TED 95/2019). This study used data from
   IHME, funded by the Bill \& Melinda Gates Foundation. BBD and MIS
   receive grants from the Instituto de Avaliacao de Tecnologias em Saude
   (IATS, Brazil; 465518/2014-1).},
Cited-References = {Abbafati C, 2020, LANCET, V396, P1204, DOI 10.1016/S0140-6736(20)30925-9.
   Brasil, 2011, PLAN AC ESTR ENFR DO.
   Capewell S, 2018, J PUBLIC HEALTH-UK, V40, P350, DOI 10.1093/pubmed/fdx055.
   Institute for Health Metrics and Evaluation, 2020, GBD COMPARE.
   Instituto Brasileiro de Geografia e Estatistica, 2014, COORD TRAB PESQ NAC.
   Instituto Brasileiro de Geografia e Estatistica, 2019, COORD TRAB PESQ NAC.
   Instituto Brasileiro de Geografia e Estatistica, 2021, COORD TRAB PESQ NAC.
   Jeong NJ, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020612.
   Malta DC, 2011, EPIDEMIOL SERV SAUDE, V20, P425, DOI 10.5123/S1679-49742011000400002.
   Malta DC, 2020, POPUL HEALTH METR, V18, DOI 10.1186/s12963-020-00216-1.
   Malta Deborah Carvalho, 2019, Rev. bras. epidemiol., V22, pe190030, DOI 10.1590/1980-549720190030.
   Martinez R, 2020, J CLIN HYPERTENS, V22, P1296, DOI 10.1111/jch.13922.
   Meleiro A., 2020, WOMENS MENTAL HLTH, P221.
   Ministerio da Saude (BR) Secretaria de Vigilancia em Saude, 2020, PLAN AC ESTR ENFR DO.
   Murray CJL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000262.
   NCD Countdown 2030, SDG TARGET 3 4 RANKI.
   NCD Countdown 2030, 2020, LANCET.
   O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188.
   Rasella D, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002570.
   Schramm JM, 2018, FUTUROS BRASIL TEXTO, P1.
   Stein C, 2021, J BRAZILIAN SOC TROP.
   Too LS, 2019, J AFFECT DISORDERS, V259, P302, DOI 10.1016/j.jad.2019.08.054.
   United Nations, 2015, TRANSF OUR WORLD 203.
   Wang HD, 2020, LANCET, V396, P1160, DOI 10.1016/S0140-6736(20)30977-6.
   World Health Organization, 2013, GLOB ACT PLAN PREV.
   World Health Organization, 2017, TACKL NCDS BEST BUYS.
   World Health Organization, 2019, 13 GEN PROGR WORK 20.
   World Health Organization, SUIC FACT SHEETS.
   World Health Organization, 2014, NONC DIS GLOB FRAM I.},
Number-of-Cited-References = {29},
Times-Cited = {0},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Eng. Agric.},
Doc-Delivery-Number = {YV4ZG},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000752737400022},
OA = {gold},
DA = {2022-03-29},
}

@article{ WOS:000616714000002,
Author = {Sommar, Johan Nilsson and Schantz, Peter and Stromgren, Magnus and
   Forsberg, Bertil},
Title = {Potential for reduced premature mortality by current and increased
   bicycle commuting: a health impact assessment using registry data on
   home and work addresses in Stockholm, Sweden},
Journal = {BMJ OPEN SPORT \& EXERCISE MEDICINE},
Year = {2021},
Volume = {7},
Number = {1},
Abstract = {Objectives The study aims to make use of individual data to estimate the
   impact on premature mortality due to both existing commuter bicycling
   and the potential impact due to increased physical activity through
   shifting transport mode from car commuting to bicycling.
   Methods Using registry data on home and work addresses for the
   population of Stockholm County the shortest bicycling route on a network
   of bicycle paths and roads was retrieved. Travel survey data were used
   to establish current modes of commuting. The relation between duration
   of bicycling and distance bicycled within the general population in 2015
   was established as a basis for identifying individuals that currently
   drive a car to work but were estimated to have the physical capacity to
   bicycle to work within 30 min. Within this mode-shift scenario from
   car-to-bike the duration of bicycling per week was estimated, both among
   current and potential bicycle commuters. The health impact assessment
   (HIA) on mortality due to bicycle commuting physical activity was
   estimated using the same relative risk as within the WHO Health Economic
   Assessment Tool.
   Results The current number of bicycle commuters were 53 000, and the
   scenario estimated an additional 111 000. Their mean bicycle distances
   were 4.5 and 3.4 km, respectively. On average these respective amounts
   of physical activity reduced the yearly mortality by 16\% and 12\%,
   resulting in 11.3 and 16.2 fewer preterm deaths per year.
   Conclusion The HIA of transferring commuting by car to bicycle estimated
   large health benefits due to increased physical activity.},
Publisher = {BMJ PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Sommar, JN (Corresponding Author), Umea Univ, Dept Publ Hlth \& Clin Med, Sect Sustainable Hlth, Umea, Sweden.
   Sommar, Johan Nilsson; Forsberg, Bertil, Umea Univ, Dept Publ Hlth \& Clin Med, Sect Sustainable Hlth, Umea, Sweden.
   Schantz, Peter, GIH, Res Unit Movement Hlth \& Environm, Swedish Sch Sport \& Hlth Sci, Stockholm, Sweden.
   Stromgren, Magnus, Umea Univ, Dept Geog, Umea, Sweden.},
DOI = {10.1136/bmjsem-2020-000980},
Article-Number = {e000980},
ISSN = {2398-9459},
EISSN = {2055-7647},
Keywords = {cycling; physical activity; death},
Keywords-Plus = {ALL-CAUSE MORTALITY; PHYSICAL-ACTIVITY; PUBLIC TRANSPORT; CAR TRIPS;
   BENEFITS; TRAVEL; METAANALYSIS; BARCELONA; DISTANCE; SHIFT},
Research-Areas = {Sport Sciences},
Web-of-Science-Categories  = {Sport Sciences},
Author-Email = {johan.sommar@umu.se},
ORCID-Numbers = {Sommar, Johan/0000-0002-8854-498X},
Funding-Acknowledgement = {Swedish Research Council for Health, Working Life and WelfareSwedish
   Research CouncilSwedish Research Council for Health Working Life \&
   Welfare (Forte) {[}2012-1296]},
Funding-Text = {This work was funded by the Swedish Research Council for Health, Working
   Life and Welfare (grant number 2012-1296). The paper reflects only the
   authors views, and the funder had no role in the design or conduct of
   the study.},
Cited-References = {Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12.
   {[}Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1.
   de Hartog JJ, 2010, ENVIRON HEALTH PERSP, V118, P1109, DOI 10.1289/ehp.0901747.
   Dhondt S, 2013, ENVIRON INT, V51, P45, DOI 10.1016/j.envint.2012.10.005.
   Donaire-Gonzalez D, 2015, AM J PREV MED, V49, P842, DOI 10.1016/j.amepre.2015.03.036.
   Gotschi Thomas, 2017, Curr Environ Health Rep, V4, P286, DOI 10.1007/s40572-017-0149-9.
   Grabow ML, 2012, ENVIRON HEALTH PERSP, V120, P68, DOI 10.1289/ehp.1103440.
   Holm AL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001135.
   Johansson C, 2017, SCI TOTAL ENVIRON, V584, P55, DOI 10.1016/j.scitotenv.2017.01.145.
   Kelly P, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0132-x.
   Maizlish N, 2013, AM J PUBLIC HEALTH, V103, P703, DOI 10.2105/AJPH.2012.300939.
   Mueller N, 2015, PREV MED, V76, P103, DOI 10.1016/j.ypmed.2015.04.010.
   NBHW, 2013, SE10630 NBHW.
   Rabl A, 2012, TRANSPORT POLICY, V19, P121, DOI 10.1016/j.tranpol.2011.09.008.
   Rojas-Rueda D, 2013, PREV MED, V57, P573, DOI 10.1016/j.ypmed.2013.07.021.
   Rojas-Rueda D, 2012, ENVIRON INT, V49, P100, DOI 10.1016/j.envint.2012.08.009.
   Rojas-Rueda D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149990.
   Rojas-Rueda D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4521.
   Sahlqvist S, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-28.
   Saunders LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069912.
   Schantz P, 2020, FRONT SPORTS ACT LIV, V2, DOI 10.3389/fspor.2020.00065.
   Schantz P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218866.
   Schantz P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218221.
   Schantz P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207573.
   Schantz P, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101166.
   Schantz P, 2009, MED SCI SPORT EXER, V41, P472, DOI 10.1249/MSS.0b013e3181877aaf.
   Stjernstrom O., 2011, GEOGRAFISKA NOTISER, V69, P79.
   Stromgren M, 2020, J TRANSP GEOGR, V86, DOI 10.1016/j.jtrangeo.2020.102740.
   Woodcock J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g425.
   Woodcock J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051462.
   Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104.
   Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1.
   World Health Organization, 2008, The global burden of disease: 2004 update.},
Number-of-Cited-References = {33},
Times-Cited = {1},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {BMJ Open Sport Exerc. Med.},
Doc-Delivery-Number = {QF2FE},
Web-of-Science-Index = {Emerging Sources Citation Index (ESCI)},
Unique-ID = {WOS:000616714000002},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000449748200023,
Author = {Cao, Bochen and Bray, Freddie and Ilbawi, Andre and Soerjomataram,
   Isabelle},
Title = {Effect on longevity of one-third reduction in premature mortality from
   non-communicable diseases by 2030: a global analysis of the Sustainable
   Development Goal health target},
Journal = {LANCET GLOBAL HEALTH},
Year = {2018},
Volume = {6},
Number = {12},
Pages = {E1288-E1296},
Month = {DEC},
Abstract = {Background To curb the rising global burden of non-communicable diseases
   (NCDs), the UN Sustainable Development Goals (SDGs) include a target to
   reduce premature mortality from NCDs by a third by 2030. A quantitative
   assessment of the effect on longevity of meeting this target is one of
   the many important measures needed to advocate and inform national
   disease control policies. We did a global analysis to estimate
   improvements in average expected years lived between 30 and 70 years of
   age that would result from meeting the SDG target.
   Methods We estimated age-specific mortality in 183 countries in 2015,
   for the four major NCDs (cardiovascular diseases, cancers, chronic
   respiratory diseases, and diabetes) and all NCDs combined, using data
   from WHO Global Health Estimates. We then estimated the potential gains
   in average expected years lived between 30 and 70 years of age
   (LE{[}30-70)) by eliminating all or a third of premature mortality from
   specific causes of death in countries grouped by World Bank income
   groups. The feasibility of reducing mortality to the targeted level over
   15 years was also assessed on the basis of historical mortality trends
   from 2000 to 2015.
   Findings Reducing a third of premature mortality from NCDs over 15 years
   is feasible in high-income and uppermiddle-income countries, but remains
   challenging in countries with lower income levels. National longevity
   will improve if this target is met, corresponding to an average gain in
   LE{[}30-70) of 0.64 years worldwide from reduced premature mortality for
   the four major NCDs and 0.80 years for all NCDs. According to major NCD
   type, the largest gains attributable to cardiovascular diseases would be
   in lower-middle-income countries (a gain of 0.45 years), whereas gains
   attributable to cancer would be in low-income countries (0.33 years).
   Interpretation A one-third reduction in premature mortality from the
   major NCDs in 2015-30 would have substantial effects on longevity.
   High-level political commitments to effective and equitable national
   surveillance and prioritised prevention, early detection, and treatment
   programmes tailored to the major NCD types are needed urgently in
   lowerresourced settings if this SDG target is to be met by 2030.
   Copyright (C) 2018 The Authorts. Published by Elsevier Ltd.},
Publisher = {ELSEVIER SCI LTD},
Address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Cao, B (Corresponding Author), Int Agcy Res Canc, Sect Canc Surveillance, F-69372 Lyon, France.
   Cao, Bochen; Bray, Freddie; Soerjomataram, Isabelle, Int Agcy Res Canc, Sect Canc Surveillance, F-69372 Lyon, France.
   Ilbawi, Andre, WHO, Geneva, Switzerland.},
DOI = {10.1016/S2214-109X(18)30411-X},
ISSN = {2214-109X},
Keywords-Plus = {LIFE EXPECTANCY; EPIDEMIOLOGIC TRANSITION; SYSTEMATIC ANALYSIS;
   PHYSICAL-ACTIVITY; CANCER; BURDEN; POPULATION; MIDDLE; DEATH},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {caob@fellows.iarc.fr},
ORCID-Numbers = {Ilbawi, Andre/0000-0002-4751-6595
   Bray, Freddie/0000-0002-3248-7787},
Funding-Acknowledgement = {World Health OrganizationWorld Health Organization {[}001] Funding
   Source: Medline},
Cited-References = {Acemoglu D, 2007, J POLIT ECON, V115, P925, DOI 10.1086/529000.
   {[}Anonymous], 2015, ASS NAT CAP PREV CON.
   Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1.
   Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492.
   Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5.
   CALDWELL JC, 1976, POPUL DEV REV, V2, P321, DOI 10.2307/1971615.
   Cao BC, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2765.
   Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3.
   de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7.
   Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0.
   Ezzati M, 2012, SCIENCE, V337, P1482, DOI 10.1126/science.1227001.
   Ezzati Majid, 2002, Lancet (North American Edition), V360, P1347, DOI 10.1016/S0140-6736(02)11403-6.
   Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935.
   Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8.
   Gelband H, 2015, DIS CONTROL PRIORITI, V3.
   Gelband H, 2016, LANCET, V387, P2133, DOI 10.1016/S0140-6736(15)00755-2.
   Guthold R, 2011, AM J PREV MED, V41, P52, DOI 10.1016/j.amepre.2011.03.008.
   Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616.
   Initiative, 2001, WOMEN TOBACCO EPIDEM.
   International Agency for Research on Cancer, 2017, GLOBOCAN 2012 EST CA.
   Jemal A, 2017, J NATL CANC I, V109.
   OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375.
   Pearce A, 2018, CANCER EPIDEMIOL, V53, P27, DOI 10.1016/j.canep.2017.12.013.
   Pratt M, 2012, LANCET, V380, P282, DOI 10.1016/S0140-6736(12)60736-3.
   Preston S., 2000, DEMOGRAPHY MEASURING, V1.
   Preston SH, MORTALITY PATTERNS N.
   Salomon J. A., 2001, METHODS LIFE EXPECTA.
   Salomon JA, 2002, POPUL DEV REV, V28, P205, DOI 10.1111/j.1728-4457.2002.00205.x.
   Santosa A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0313-8.
   Singh T, 2016, MMWR-MORBID MORTAL W, V65, P361, DOI 10.15585/mmwr.mm6514a1.
   Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262.
   Townsend N, 2016, EUR HEART J, V37, P3232, DOI 10.1093/eurheartj/ehw334.
   UN General Assembly, 2015, TRANSF OUR WORLD 203.
   United Nations, 2015, WORLD POP PROSP 2015.
   Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1.
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1.
   WHO, 2016, GLOB HLTH EST 2015 D.
   WHO WHO, 2016, GLOB STAT REP ALC HL.
   World Bank, WORLD BANK COUNTR LE.
   World Health Organization, 2017, WHO METHODS DATA SOU.
   World Health Organization, 2019, WHO REPORT GLOBAL TO.
   World Health Organization, GLOB ACT PLAN PREV C.
   World Health Organization (WHO), 2017, BEST BUYS OTH REC IN.
   {[}No title captured].},
Number-of-Cited-References = {44},
Times-Cited = {40},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {17},
Journal-ISO = {Lancet Glob. Health},
Doc-Delivery-Number = {GZ8NE},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000449748200023},
OA = {gold},
DA = {2022-03-29},
}

@article{ WOS:000182132700003,
Author = {Morgan, MG and Scully, PJ and Youssef, HA and Kinsella, A and Owens, JM
   and Waddington, JL},
Title = {Prospective analysis of premature mortality in schizophrenia in relation
   to health service engagement: a 7.5-year study within an
   epidemiologically complete, homogeneous population in rural Ireland},
Journal = {PSYCHIATRY RESEARCH},
Year = {2003},
Volume = {117},
Number = {2},
Pages = {127-135},
Month = {FEB 15},
Abstract = {While premature death in schizophrenia is well recognised, mortality
   risk has received little longitudinal study in relation to population
   representativeness and patient engagement with health services. Within a
   rural Irish catchment area of socioeconomic, ethnic and geographical
   homogeneity and low residential mobility, an epidemiologically complete
   population of 72 patients with schizophrenia was followed up over 7.5
   years in order to quantify mortality. prospectively. Information was
   obtained in relation to 99\% of the cohort, with 94\% of those surviving
   retained in engagement with psychiatric care. There were 25 deaths (35\%
   of cohort). A relative risk of 2.06 (95\% CI, 1.40-2.80; P<0.001) among
   this epidemiologically complete population may constitute an estimate of
   risk for mortality inherent to schizophrenia when disengagement from
   health services, residential mobility and socioeconomic, ethnic and
   geographical diversity are minimised. On long-term prospective
   evaluation, risk for death in schizophrenia was doubled on a background
   of enduring engagement in psychiatric care with increasing provision of
   community-based services and introduction of second-generation
   antipsychotics. (C) 2003 Elsevier Science Ireland Ltd. All rights
   reserved.},
Publisher = {ELSEVIER SCI IRELAND LTD},
Address = {CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND},
Type = {Article},
Language = {English},
Affiliation = {Waddington, JL (Corresponding Author), St Davnets Hosp, Stanley Res Unit, Monaghan, Ireland.
   St Davnets Hosp, Stanley Res Unit, Monaghan, Ireland.
   Royal Coll Surgeons Ireland, Dept Clin Pharmacol, Dublin 2, Ireland.
   Dublin Inst Technol, Sch Math, Dublin 8, Ireland.},
DOI = {10.1016/S0165-1781(03)00002-7},
ISSN = {0165-1781},
Keywords = {survival; health service provision; longitudinal study; psychosis;
   antipsychotic polypharmacy},
Keywords-Plus = {GRONINGEN CASE-REGISTER; EXCESS MORTALITY; BIPOLAR DISORDER;
   CATCHMENT-AREA; LIFE-SPAN; FOLLOW-UP; BRAIN; CARE; METAANALYSIS;
   PREVALENCE},
Research-Areas = {Psychiatry},
Web-of-Science-Categories  = {Psychiatry},
ORCID-Numbers = {Scully, Paul/0000-0003-0789-2606},
Cited-References = {ALLMAN J, 1993, P NATL ACAD SCI USA, V90, P118, DOI 10.1073/pnas.90.1.118.
   ALLMAN JM, 1993, P NATL ACAD SCI USA, V90, P3559, DOI 10.1073/pnas.90.8.3559.
   American Psychiatric Association, 1987, DIAGN STAT MAN MENT.
   Brown S, 1997, BRIT J PSYCHIAT, V171, P502, DOI 10.1192/bjp.171.6.502.
   CALDWELL CB, 1990, SCHIZOPHRENIA BULL, V16, P571, DOI 10.1093/schbul/16.4.571.
   {*}CENTR STAT OFF, 1997, CENC 1996.
   {*}CENTR STAT OFF, 1994, LOC POP REP, V4.
   {*}CENTR STAT OFF, 1993, LOC POP REP, V29.
   Druss BG, 2001, ARCH GEN PSYCHIAT, V58, P565, DOI 10.1001/archpsyc.58.6.565.
   Fenton WS, 1997, AM J PSYCHIAT, V154, P199.
   Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11.
   Harvey CA, 1996, BRIT J PSYCHIAT, V168, P418, DOI 10.1192/bjp.168.4.418.
   Jablensky A., 1995, P206.
   Jeste DV, 1996, SCHIZOPHRENIA BULL, V22, P413, DOI 10.1093/schbul/22.3.413.
   Killaspy H, 2000, BRIT J PSYCHIAT, V176, P160, DOI 10.1192/bjp.176.2.160.
   KULLER LH, 1995, AM J PUBLIC HEALTH, V85, P1198, DOI 10.2105/AJPH.85.9.1198.
   LANG FH, 1999, SCHIZOPHRENIA CONCEP, P161.
   Moller HJ, 1995, SCHIZOPHRENIA, P106.
   Reilly JG, 2002, BRIT J PSYCHIAT, V180, P515, DOI 10.1192/bjp.180.6.515.
   Salokangas RKR, 1997, ACTA PSYCHIAT SCAND, V96, P459, DOI 10.1111/j.1600-0447.1997.tb09948.x.
   Salokangas RKR, 2002, SCHIZOPHR RES, V54, P265, DOI 10.1016/S0920-9964(01)00281-X.
   Scully PJ, 2000, ACTA NEUROPSYCHIATR, V12, P73, DOI 10.1017/S0924270800035444.
   Scully PJ, 2002, BRIT J PSYCHIAT, V181, pS3, DOI 10.1192/bjp.181.43.s3.
   Simmonds S, 2001, BRIT J PSYCHIAT, V178, P497, DOI 10.1192/bjp.178.6.497.
   Simpson JC, 1996, SCHIZOPHRENIA BULL, V22, P485, DOI 10.1093/schbul/22.3.485.
   SIMS ACP, 1973, LANCET, V2, P433.
   Sytema S, 1999, ACTA PSYCHIAT SCAND, V100, P212, DOI 10.1111/j.1600-0447.1999.tb10848.x.
   Sytema S, 1997, PSYCHOL MED, V27, P1355, DOI 10.1017/S0033291797005539.
   TSUANG MT, 1985, ARCH GEN PSYCHIAT, V42, P98.
   Waddington JL, 1998, BRIT J PSYCHIAT, V173, P325, DOI 10.1192/bjp.173.4.325.
   Waddington JL, 1997, SCHIZOPHR RES, V28, P207, DOI 10.1016/S0920-9964(97)00115-1.
   Waddington JL, 1999, BIOL PSYCHIAT, V46, P31, DOI 10.1016/S0006-3223(99)00055-4.
   WADDINGTON JL, 2002, IN PRESS SCHIZOPHREN.
   Ward KE, 1996, SCHIZOPHR RES, V22, P197, DOI 10.1016/S0920-9964(96)00076-X.
   Youssef HA, 1999, SCHIZOPHR RES, V37, P233, DOI 10.1016/S0920-9964(98)00171-6.
   YOUSSEF HA, 1991, ARCH GEN PSYCHIAT, V48, P254.},
Number-of-Cited-References = {36},
Times-Cited = {25},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Psychiatry Res.},
Doc-Delivery-Number = {665QT},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000182132700003},
DA = {2022-03-29},
}

@article{ WOS:000759057000001,
Author = {McHugh, Catherine and Song, Yun Ju Christine and Zmicerevska, Natalia
   and Crouse, Jacob and Nichles, Alissa and Wilson, Chloe and Ho, Nicholas
   and Iorfino, Frank and Skinner, Adam and Scott, Elizabeth M. and Hickie,
   Ian B.},
Title = {Premature mortality in early-intervention mental health services: a data
   linkage study protocol to examine mortality and morbidity outcomes in a
   cohort of help-seeking young people},
Journal = {BMJ OPEN},
Year = {2022},
Volume = {12},
Number = {2},
Month = {FEB},
Abstract = {Introduction Understanding the risk of premature death from suicide,
   accident and injury and other physical health conditions in people
   seeking healthcare for mental disorders is essential for delivering
   targeted clinical interventions and secondary prevention strategies. It
   is not clear whether morbidity and mortality outcomes in hospital-based
   adult cohorts are applicable to young people presenting to
   early-intervention services. Methods and analysis The current data
   linkage project will establish the Brain and Mind Patient Research
   Register-Mortality and Morbidity (BPRR-M\&M) database. The existing
   Brain and Mind Research Institute Patient Research Register (BPRR) is a
   cohort of 6743 young people who have accessed primary care-based
   early-intervention services; subsets of the BPRR contain rich
   longitudinal clinical, neurobiological, social and functional data. The
   BPRR will be linked with the routinely collected health data from
   emergency department (ED), hospital admission and mortality databases in
   New South Wales from January 2010 to November 2020. Mortality will be
   the primary outcome of interest, while hospital presentations will be a
   secondary outcome. The established BPRR-M\&M database will be used to
   establish mortality rates and rates of ED presentations and hospital
   admissions. Survival analysis will determine how time to death or
   hospital presentation varies by identified social, demographic and
   clinical variables. Bayesian modelling will be used to identify
   predictors of these morbidity and mortality outcomes. Ethics and
   dissemination The study has been reviewed and approved by the human
   research ethics committee of the Sydney Local Health District
   (2019/ETH00469). All data will be non-identifiable, and research
   findings will be disseminated through peer-reviewed journals and
   scientific conference presentations.},
Publisher = {BMJ PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {McHugh, C (Corresponding Author), Univ Sydney, Brain \& Mind Ctr, Sydney, NSW, Australia.
   McHugh, Catherine; Song, Yun Ju Christine; Zmicerevska, Natalia; Crouse, Jacob; Nichles, Alissa; Wilson, Chloe; Ho, Nicholas; Iorfino, Frank; Scott, Elizabeth M.; Hickie, Ian B., Univ Sydney, Brain \& Mind Ctr, Sydney, NSW, Australia.
   Skinner, Adam, Sax Inst, Sydney, NSW, Australia.},
DOI = {10.1136/bmjopen-2021-054264},
Article-Number = {e054264},
ISSN = {2044-6055},
Keywords = {suicide \& self-harm; child \& adolescent psychiatry; adult psychiatry;
   mental health; public health},
Keywords-Plus = {SELF-HARM; SUICIDAL-BEHAVIOR},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {catherine.mchugh@sydney.edu.au},
ORCID-Numbers = {Iorfino, Frank/0000-0003-1109-0972
   , Chloe/0000-0001-6539-423X
   Zmicerevska, Natalia/0000-0001-7649-4711},
Funding-Acknowledgement = {NHMRC Research fellowshipNational Health and Medical Research Council of
   Australia {[}1046899]; 2020 HETI NSW Research Fellowship; RANZCP New
   Investigator Grant},
Funding-Text = {IBH was supported by the NHMRC Research fellowship (number 1046899). The
   funding source provided grant funds for the project but was not involved
   in data analysis, interpretation or manuscript preparation. CM was
   supported by a 2020 HETI NSW Research Fellowship and also received a
   RANZCP New Investigator Grant.},
Cited-References = {ABS, 2020, REG POP AG SEX.
   ABS, 2020, CAUS DEATH.
   AIHW, 2020, DEATHS AUSTR.
   Atkinson JA, 2019, AUST NZ J PSYCHIAT, V53, P642, DOI 10.1177/0004867418817381.
   Bjorkenstam E, 2015, BRIT J PSYCHIAT, V207, P339, DOI 10.1192/bjp.bp.114.149583.
   Carpenter JS, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-030985.
   CHeReL, 2020, REC LINK WORKS CTR H.
   Crouse JJ, 2020, BJPSYCH OPEN, V6, DOI 10.1192/bjo.2020.12.
   Firth J, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0910-2.
   Goldberg A., 2004, CHOICEMAKER 2 RECORD.
   GOLDMAN HH, 1992, AM J PSYCHIAT, V149, P1148.
   Hawton K, 2003, BRIT J PSYCHIAT, V182, P537, DOI 10.1192/bjp.182.6.537.
   Herbert A, 2017, LANCET, V390, P577, DOI {[}10.1016/S0140-6736(17)31045-0, 10.1016/s0140-6736(17)31045-0].
   Hickie IB, 2020, WORLD PSYCHIATRY, V19, P38, DOI 10.1002/wps.20697.
   Iorfino F., 2020, USING MACHINE LEARNI.
   Iorfino F, 2019, JAMA PSYCHIAT, V76, P1167, DOI 10.1001/jamapsychiatry.2019.2360.
   Iorfino F, 2018, J AFFECT DISORDERS, V238, P563, DOI 10.1016/j.jad.2018.06.032.
   Iorfino F, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020678.
   Iorfino F, 2017, J MED INTERNET RES, V19, DOI {[}10.2196/jmir.7897, 10.2196/jmir.8804].
   Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015.
   Large MM, 2018, DIALOGUES CLIN NEURO, V20, P197.
   Lee RSC, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.50.
   Lee RSC, 2014, J PSYCHIATR RES, V57, P1, DOI 10.1016/j.jpsychires.2014.06.019.
   McGorry PD, 2011, CURR OPIN PSYCHIATR, V24, P301, DOI 10.1097/YCO.0b013e3283477a09.
   McHugh CM, 2021, J AFFECT DISORDERS, V281, P289, DOI 10.1016/j.jad.2020.11.077.
   McHugh CM, 2020, CURR OPIN PSYCHIATR, V33, P369, DOI 10.1097/YCO.0000000000000609.
   McHugh CM, 2019, J PSYCHIATR RES, V116, P51, DOI 10.1016/j.jpsychires.2019.05.012.
   Moran P, 2012, LANCET, V379, P236, DOI 10.1016/S0140-6736(11)61141-0.
   Nuechterlein KH, 2008, AM J PSYCHIAT, V165, P203, DOI 10.1176/appi.ajp.2007.07010042.
   Robinson J, 2018, ECLINICALMEDICINE, V4-5, P52, DOI 10.1016/j.eclinm.2018.10.004.
   SAHAKIAN BJ, 1992, J ROY SOC MED, V85, P399.
   Sawyer SM, 2018, MED J AUSTRALIA, V208, P339, DOI 10.5694/mja18.00213.
   Simon GE, 2018, JAMA PSYCHIAT, V75, P254, DOI 10.1001/jamapsychiatry.2017.4437.
   SNOMED, 2008, INT HLTH TERM STAND.
   Strauss E., 2006, COMPENDIUM NEUROPSYC, V3th.
   Turecki G, 2016, LANCET, V387, P1227, DOI 10.1016/S0140-6736(15)00234-2.
   Walter F, 2017, JAMA PSYCHIAT, V74, P485, DOI 10.1001/jamapsychiatry.2017.0071.
   Weschler D., 2001, WECHSLER TEST ADULT.
   Westman J, 2018, EPIDEMIOL PSYCH SCI, V27, P519, DOI 10.1017/S2045796017000166.
   Wilkinson GS., 2006, WIDE RANGE ACHIEVEME.},
Number-of-Cited-References = {40},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {BMJ Open},
Doc-Delivery-Number = {ZE7KM},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000759057000001},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000397143700035,
Author = {Stringhini, Silvia and Carmeli, Cristian and Jokela, Markus and
   Avendano, Mauricio and Muennig, Peter and Guida, Florence and Ricceri,
   Fulvio and d'Errico, Angelo and Barros, Henrique and Bochud, Murielle
   and Chadeau-Hyam, Marc and Clavel-Chapelon, Francoise and Costa,
   Giuseppe and Delpierre, Cyrille and Fraga, Silvia and Goldberg, Marcel
   and Giles, Graham G. and Krogh, Vittorio and Kelly-Irving, Michelle and
   Layte, Richard and Lasserre, Aurelie M. and Marmot, Michael G. and
   Preisig, Martin and Shipley, Martin J. and Vollenweider, Peter and Zins,
   Marie and Kawachi, Ichiro and Steptoe, Andrew and Mackenbach, Johan P.
   and Vineis, Paolo and Kivimaki, Mika and LIFEPATH Consortium},
Title = {Socioeconomic status and the 25 x 25 risk factors as determinants of
   premature mortality: a multicohort study and meta-analysis of 1.7
   million men and women},
Journal = {LANCET},
Year = {2017},
Volume = {389},
Number = {10075},
Pages = {1229-1237},
Month = {MAR 25},
Abstract = {Background In 2011, WHO member states signed up to the 25 x 25
   initiative, a plan to cut mortality due to noncommunicable diseases by
   25\% by 2025. However, socioeconomic factors influencing
   non-communicable diseases have not been included in the plan. In this
   study, we aimed to compare the contribution of socioeconomic status to
   mortality and years-of-life-lost with that of the 25 x 25 conventional
   risk factors.
   Methods We did a multicohort study and meta-analysis with
   individual-level data from 48 independent prospective cohort studies
   with information about socioeconomic status, indexed by occupational
   position, 25 x 25 risk factors (high alcohol intake, physical
   inactivity, current smoking, hypertension, diabetes, and obesity), and
   mortality, for a total population of 1 751 479 (54\% women) from seven
   high-income WHO member countries. We estimated the association of
   socioeconomic status and the 25 x 25 risk factors with all-cause
   mortality and cause-specific mortality by calculating minimally adjusted
   and mutually adjusted hazard ratios {[}HR] and 95\% CIs. We also
   estimated the population attributable fraction and the years of life
   lost due to suboptimal risk factors.
   Findings During 26.6 million person-years at risk (mean follow-up 13.3
   years {[}SD 6.4 years]), 310 277 participants died. HR for the 25 x 25
   risk factors and mortality varied between 1.04 (95\% CI 0.98-1.11) for
   obesity in men and 2.17 (2.06-2.29) for current smoking in men.
   Participants with low socioeconomic status had greater mortality
   compared with those with high socioeconomic status (HR 1.42, 95\% CI
   1.38-1.45 for men; 1.34, 1.28-1.39 for women); this association remained
   significant in mutually adjusted models that included the 25 x 25
   factors (HR 1.26, 1.21-1.32, men and women combined). The population
   attributable fraction was highest for smoking, followed by physical
   inactivity then socioeconomic status. Low socioeconomic status was
   associated with a 2.1-year reduction in life expectancy between ages 40
   and 85 years, the corresponding years-of-life-lost were 0.5 years for
   high alcohol intake, 0.7 years for obesity, 3.9 years for diabetes, 1.6
   years for hypertension, 2.4 years for physical inactivity, and 4.8 years
   for current smoking.
   Interpretation Socioeconomic circumstances, in addition to the 25 x 25
   factors, should be targeted by local and global health strategies and
   health risk surveillance to reduce mortality.},
Publisher = {ELSEVIER SCIENCE INC},
Address = {STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA},
Type = {Article},
Language = {English},
Affiliation = {Stringhini, S (Corresponding Author), Univ Lausanne Hosp, Inst Social \& Prevent Med IUMSP, 10 Route Corniche, CH-1010 Lausanne, Switzerland.
   Stringhini, Silvia; Carmeli, Cristian; Bochud, Murielle; Lasserre, Aurelie M.; Preisig, Martin; Vollenweider, Peter, Univ Lausanne Hosp, Inst Social \& Prevent Med, Lausanne, Switzerland.
   Stringhini, Silvia; Carmeli, Cristian; Bochud, Murielle; Lasserre, Aurelie M.; Preisig, Martin; Vollenweider, Peter, Univ Lausanne Hosp, Dept Psychiat, Lausanne, Switzerland.
   Stringhini, Silvia; Carmeli, Cristian; Bochud, Murielle; Lasserre, Aurelie M.; Preisig, Martin; Vollenweider, Peter, Univ Lausanne Hosp, Dept Internal Med, Lausanne, Switzerland.
   Jokela, Markus, Univ Helsinki, Inst Behav Sci, Helsinki, Finland.
   Avendano, Mauricio, Kings Coll London, Dept Global Hlth \& Social Med, London, England.
   Avendano, Mauricio; Kawachi, Ichiro, Harvard TH Chan Sch Publ Hlth, Boston, MA USA.
   Muennig, Peter, Columbia Univ, Global Res Analyt Populat Hlth, Hlth Policy \& Management, New York, NY USA.
   Guida, Florence; Chadeau-Hyam, Marc; Vineis, Paolo, Imperial Coll London, MRC PHE Ctr Environm \& Hlth, Sch Publ Hlth, Dept Epidemiol \& Biostat, London, England.
   Ricceri, Fulvio; d'Errico, Angelo, ASL TO3 Piedmont Reg, Epidemiol Unit, Grugliasco, Italy.
   Bochud, Murielle; Fraga, Silvia, Univ Porto, EPIUnit, Inst Publ Hlth, Oporto, Portugal.
   Barros, Henrique, Univ Porto, Sch Med, Dept Clin Epidemiol Predict Med \& Publ Hlth, Oporto, Portugal.
   Clavel-Chapelon, Francoise, INSERM, U1018, Ctr Res Epidemiol \& Populat Hlth, Villejuif, France.
   Costa, Giuseppe, Univ Turin, Dept Biol \& Clin Sci, Turin, Italy.
   Delpierre, Cyrille; Kelly-Irving, Michelle, INSERM, UMR1027, Toulouse, France.
   Delpierre, Cyrille; Kelly-Irving, Michelle, Univ Toulouse III Paul Sabatier, UMR1027, Toulouse, France.
   Goldberg, Marcel; Zins, Marie, INSERM, UMS 11, Populat Based Epidemiol Cohorts Unit, Villejuif, France.
   Goldberg, Marcel; Zins, Marie, Paris Descartes Univ, Paris, France.
   Giles, Graham G., Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia.
   Krogh, Vittorio, Fdn IRCCS Ist Nazl Tumori, Epidemiol \& Prevent Unit, Milan, Italy.
   Layte, Richard, Trinity Coll Dublin, Dept Sociol, Dublin, Ireland.
   Marmot, Michael G.; Shipley, Martin J.; Steptoe, Andrew; Kivimaki, Mika, UCL, Dept Epidemiol \& Publ Hlth, London, England.
   Mackenbach, Johan P., Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands.
   Kivimaki, Mika, Univ Helsinki, Clinicum, Fac Med, Helsinki, Finland.},
DOI = {10.1016/S0140-6736(16)32380-7},
ISSN = {0140-6736},
EISSN = {1474-547X},
Keywords-Plus = {NONCOMMUNICABLE DISEASES; LIFE EXPECTANCY; UNITED-STATES; HEALTH;
   INCOME; INEQUALITIES; BURDEN; ASSOCIATION; COUNTRIES},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {silvia.stringhini@chuv.ch},
ResearcherID-Numbers = {Marmot, M G/Y-3920-2019
   Zins, Marie/AAX-6551-2021
   Lasserre, Aurélie M/AEA-0456-2022
   Steptoe, Andrew/Y-2440-2019
   Goldberg, Marcel/I-7834-2012
   Jokela, Markus/A-4669-2009
   Ribeiro, Ana Isabel/AAH-8373-2019
   Guida, Florence/AAD-1839-2019
   d'Errico, Angelo/K-5547-2018
   Ricceri, Fulvio/I-9910-2018
   Krogh, Vittorio/K-2628-2016
   Barros, Henrique/A-5488-2008
   Greco, Dario/T-7113-2019
   Colaus, PsyColaus/K-6607-2013
   Lang, Thierry/C-1686-2009
   Kelly-Irving, Michelle/G-3151-2010
   Kelly Irving, Michelle/AAA-5052-2022
   Barros, Henrique/Q-8609-2019
   LANG, THIERRY/ABC-4576-2021
   costa, giuseppe/K-2526-2016
   Chadeau, Marc/AAN-7586-2021
   d'Errico, Angelo/AAB-8993-2019
   Krogh, Vittorio/AAA-9171-2019
   LEPAGE, Benoit/C-1228-2011
   Avendano, Mauricio/C-9658-2018
   },
ORCID-Numbers = {Marmot, M G/0000-0002-2431-6419
   Lasserre, Aurélie M/0000-0003-3925-6663
   Goldberg, Marcel/0000-0002-6161-5880
   Jokela, Markus/0000-0003-0117-0012
   Ribeiro, Ana Isabel/0000-0001-8880-6962
   Guida, Florence/0000-0002-9652-2430
   Ricceri, Fulvio/0000-0001-8749-9737
   Krogh, Vittorio/0000-0003-0122-8624
   Greco, Dario/0000-0001-9195-9003
   Kelly-Irving, Michelle/0000-0001-5749-4791
   Kelly Irving, Michelle/0000-0001-5749-4791
   Barros, Henrique/0000-0003-4699-6571
   LANG, THIERRY/0000-0003-3406-8970
   Chadeau, Marc/0000-0001-8341-5436
   Krogh, Vittorio/0000-0003-0122-8624
   Kivimaki, Mika/0000-0002-4699-5627
   delpierre, cyrille/0000-0002-0831-080X
   Fraga, Silvia/0000-0002-5268-7751
   Hodge, Allison/0000-0001-5464-2197
   Preisig, Martin/0000-0001-5689-4259
   Carmeli, Cristian/0000-0002-1463-4587
   tumino, rosario/0000-0003-2666-414X
   LEPAGE, Benoit/0000-0002-1586-2055
   Avendano, Mauricio/0000-0002-7295-2911
   Courtin, Emilie/0000-0001-5073-7279
   d'Errico, Angelo/0000-0003-3171-413X
   COSTA, Giuseppe/0000-0003-3187-4889
   Alenius, Harri/0000-0003-0106-8923
   Muennig, Peter/0000-0002-4234-0498
   Elliott, Paul/0000-0002-7511-5684},
Funding-Acknowledgement = {European CommissionEuropean CommissionEuropean Commission Joint Research
   Centre; Swiss State Secretariat for Education; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF)European Commission;
   Medical Research CouncilUK Research \& Innovation (UKRI)Medical Research
   Council UK (MRC)European Commission; NordForsk; Portuguese Foundation
   for Science and TechnologyPortuguese Foundation for Science and
   Technology; European CommissionEuropean CommissionEuropean Commission
   Joint Research Centre; Swiss State Secretariat for Education; Swiss
   National Science FoundationSwiss National Science Foundation
   (SNSF)European Commission; Medical Research CouncilUK Research \&
   Innovation (UKRI)Medical Research Council UK (MRC)European Commission;
   NordForsk; Portuguese Foundation for Science and TechnologyPortuguese
   Foundation for Science and Technology; Economic and Social Research
   CouncilUK Research \& Innovation (UKRI)Economic \& Social Research
   Council (ESRC) {[}ES/M001660/1, ES/J023299/1] Funding Source:
   researchfish; Medical Research CouncilUK Research \& Innovation
   (UKRI)Medical Research Council UK (MRC)European Commission
   {[}MR/M501669/1, MR/K013351/1, MR/L01341X/1] Funding Source:
   researchfish; ESRCUK Research \& Innovation (UKRI)Economic \& Social
   Research Council (ESRC) {[}ES/J023299/1, ES/M001660/1] Funding Source:
   UKRI; MRCUK Research \& Innovation (UKRI)Medical Research Council UK
   (MRC) {[}MR/L01341X/1, MR/K013351/1, MR/M501669/1] Funding Source: UKRI},
Funding-Text = {European Commission, Swiss State Secretariat for Education, Swiss
   National Science Foundation, the Medical Research Council, NordForsk,
   Portuguese Foundation for Science and Technology.},
Cited-References = {{[}Anonymous], 2010, FAIR SOC HLTH LIVES, DOI DOI 10.7748/NS2010.10.25.6.30.P4603.
   Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226.
   de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367.
   Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437.
   Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0.
   ELESH D, 1977, J HEALTH SOC BEHAV, V18, P391, DOI 10.2307/2955347.
   Gellert C, 2012, ARCH INTERN MED, V172, P837, DOI 10.1001/archinternmed.2012.1397.
   Heckman JJ, 2006, SCIENCE, V312, P1900, DOI 10.1126/science.1128898.
   HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001.
   Hosseinpoor AR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-474.
   IntHout J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010247.
   IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25.
   Levin H, COSTS BENEFITS EXCEL.
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8.
   Lleras-Muney A, 2005, REV ECON STUD, V72, P189, DOI 10.1111/0034-6527.00329.
   Lopez- Arana S, 2016, PUBLIC HEALTH NUTR, V19, P1.
   Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519.
   Mackenbach JP, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1732.
   Maki NE, 2014, J EPIDEMIOL COMMUN H, V68, P635, DOI 10.1136/jech-2013-203501.
   MARMOT MG, 1984, LANCET, V1, P1003.
   Mayhew L., 2016, INVESTIGATION INEQUA.
   Muennig P, 2005, SOC SCI MED, V61, P2018, DOI 10.1016/j.socscimed.2005.04.005.
   Muennig P, 2010, AM J PUBLIC HEALTH, V100, P1758, DOI 10.2105/AJPH.2009.165019.
   Muennig PA, 2016, AM J PREV MED, V51, P874, DOI 10.1016/j.amepre.2016.07.001.
   Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09.
   Rasella D, 2013, LANCET, V382, P57, DOI 10.1016/S0140-6736(13)60715-1.
   Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203.
   Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862.
   Stringhini S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102858.
   Stringhini S, 2013, INT J CARDIOL, V168, P1201, DOI 10.1016/j.ijcard.2012.11.064.
   Stringhini S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000419.
   Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297.
   Townsend P, 1982, INEQUALITIES HLTH BL.
   Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4.
   WHO, 2008, CLOS GAP GEN HLTH EQ.
   WHO, 2011, RIO POL DECL SOC DET.
   WHO, 2015, GLOB ACT PLAN ANT RE.
   WHO, 2016, METR POP ATTR FRACT.},
Number-of-Cited-References = {38},
Times-Cited = {459},
Usage-Count-Last-180-days = {13},
Usage-Count-Since-2013 = {113},
Journal-ISO = {Lancet},
Doc-Delivery-Number = {EP1KL},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000397143700035},
OA = {Green Published, hybrid},
DA = {2022-03-29},
}

@article{ WOS:000235108300011,
Author = {Bridges, FS and Kunselman, JC},
Title = {Premature mortality due to suicide, homicide, and motor vehicle
   accidents in health service delivery areas: Comparison of status Indians
   in British Columbia, Canada, with all other residents},
Journal = {PSYCHOLOGICAL REPORTS},
Year = {2005},
Volume = {97},
Number = {3},
Pages = {739-749},
Month = {DEC},
Abstract = {From each of 15 health regions, potential years of life lost (PYLL)
   before age 75 for Status Indians is compared for select causes of death
   with all other residents. Mortality data from 1991 to 2001 for rates of
   PYLL (standardized to the 1991 population) are from tables of the
   British Columbia Vital Statistics Agency and First Nations and Inuit
   Health Branch in 2002. PYLL rate differences and rate ratios were
   compared for two groups with significance of the former indicated by the
   95\% confidence interval. Overall, the rates of PYLL for suicide,
   homicide, and deaths due to motor vehicle accidents were about 224\%,
   340\%, and 248\% higher among Status Indians than all other residents.
   Rates of PYLL for homicide and deaths from motor vehicle accidents among
   Status Indian women exceeded those of other residents who were men. For
   suicide, Status Indian men ranked first and all other male residents of
   British Columbia ranked second.},
Publisher = {SAGE PUBLICATIONS INC},
Address = {2455 TELLER RD, THOUSAND OAKS, CA 91320 USA},
Type = {Article},
Language = {English},
Affiliation = {Bridges, FS (Corresponding Author), Univ W Florida, Div Hlth Leisure \& Exercise Sci, 11000 Univ Pkwy, Pensacola, FL 32514 USA.
   Univ W Florida, Div Hlth Leisure \& Exercise Sci, Pensacola, FL 32514 USA.},
DOI = {10.2466/PR0.97.7.739-749},
ISSN = {0033-2941},
EISSN = {1558-691X},
Keywords-Plus = {RATES},
Research-Areas = {Psychology},
Web-of-Science-Categories  = {Psychology, Multidisciplinary},
Author-Email = {fbridges@uwf.edu},
Cited-References = {Allard Yvon E, 2004, Health Rep, V15, P51.
   {[}Anonymous], 1986, MMWR-MORBID MORTAL W, V35, p1S.
   {*}BRIT COL VIT STAT, 2002, REG AN HLTH STAT STA.
   {*}CDCP, 1986, MORBIDITY MORTALITY, V35, P353.
   {*}CDCP, 1993, MMWR-MORBID MORTAL W, V42, P251.
   {*}CDCP, 1989, MMWR-MORBID MORTAL W, V38, P37.
   COOPER M, 1992, CANADAS MENTAL HLTH, V40, P19.
   Durkheim ?., 1897, SUICIDE STUDY SOCIOL.
   Kirmayer L. J., 1994, TRANSCULT PSYCHIATRY, V31, P3, DOI DOI 10.1177/136346159403100101.
   Lester D, 1995, PERCEPT MOTOR SKILL, V81, P1282, DOI 10.2466/pms.1995.81.3f.1282.
   LESTER D, 1987, J SOC PSYCHOL, V127, P339, DOI 10.1080/00224545.1987.9713700.
   Lester D., 1989, SUICIDE SOCIOLOGICAL.
   Lester D., 1997, SUICIDE AM INDIANS.
   LESTER D, 1991, J RURAL COMMUNITY PS, V12, P15.
   LESTER D, 2001, SUICIDE AM INDIANS.
   ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143.
   Schenker N, 2001, AM STAT, V55, P182, DOI 10.1198/000313001317097960.
   WARD JA, 1978, P 9 INT C INT ASS SU, P389.
   WECHSLER H, 1967, AM J SOCIOL, V73, P331, DOI 10.1086/224480.},
Number-of-Cited-References = {19},
Times-Cited = {15},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Psychol. Rep.},
Doc-Delivery-Number = {009JP},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000235108300011},
DA = {2022-03-29},
}

@article{ WOS:000512774800380,
Author = {Sara, Grant and Arumuganathan, Myu and Chen, Wendy and Wu, Fred and
   Currow, David and Large, Matthew and Mulder, Cornelis and Ramanuj,
   Parashar Pravin and Burgess, Philip M.},
Title = {Cohort profile: Mental Health Living Longer: a population-wide data
   linkage to understand and reduce premature mortality in mental health
   service users in New South Wales, Australia},
Journal = {BMJ OPEN},
Year = {2019},
Volume = {9},
Number = {11},
Month = {NOV},
Abstract = {Purpose Health systems must move from recognition to action if we are to
   address premature mortality in people with mental illness. Population
   data registers are an essential tool for planning and monitoring
   improvement efforts. The Mental Health Living Longer (MHLL) programme
   establishes a population-wide data linkage to support research
   translation and service reform in New South Wales (NSW), Australia.
   Participants A total of 8.6 million people who have had contact with NSW
   public and private health services between July 2001 and June 2018 are
   currently included in the study. Data include more than 120 million
   linked records from NSW data collections covering public and private
   hospital care, emergency departments, ambulance, community mental health
   services, cancer notifications and care, and death registrations.
   Linkage is occurring with population-wide breast and cervical cancer
   screening programmes. Data will be updated 6 monthly.
   Findings to date The cohort includes 970 145 people who have received
   mental healthcare: 79\% have received community mental healthcare, 35\%
   a general hospital admission with a primary mental health diagnosis and
   25\% have received specialist mental health inpatient care. The most
   frequent pattern of care is receipt of community mental healthcare only
   (50\%). The median age of the mental health cohort is 34 years, and
   three-quarters are younger than 53 years. Eleven per cent of the mental
   health cohort had died during the observation period. Their median age
   at death was 69 years, which was younger than the median age at death
   for people accessing other health services.
   Future plans The MHLL programme will examine (i) all-cause mortality,
   (ii) suicide, (iii) cancer mortality and (iv) medical mortality. Within
   each theme, the programme will quantify the problem in mental health
   service users compared with the NSW population, describe the people most
   affected, describe the care received, identify predictors of premature
   mortality, and identify variation and opportunities for change.},
Publisher = {BMJ PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Sara, G (Corresponding Author), NSW Minist Hlth, Syst Informat \& Analyt Branch, InforMH, N Ryde, NSW, Australia.
   Sara, G (Corresponding Author), Univ Sydney, Northern Clin Sch, Sydney Med Sch, Fac Med \& Hlth, Sydney, NSW, Australia.
   Sara, Grant; Arumuganathan, Myu; Chen, Wendy; Wu, Fred, NSW Minist Hlth, Syst Informat \& Analyt Branch, InforMH, N Ryde, NSW, Australia.
   Sara, Grant, Univ Sydney, Northern Clin Sch, Sydney Med Sch, Fac Med \& Hlth, Sydney, NSW, Australia.
   Currow, David, Canc Inst NSW, Eveleigh, NSW, Australia.
   Large, Matthew, Univ New South Wales, Sch Psychiat, Sydney, NSW, Australia.
   Mulder, Cornelis, Erasmus Univ, Erasmus Med Ctr, Epidemiol \& Social Psychiat Res Inst, Rotterdam, Netherlands.
   Mulder, Cornelis, Mental Hlth Grp Europoort, Parnassia Psychiat Inst, Barendrecht, Netherlands.
   Ramanuj, Parashar Pravin, Royal Natl Orthopaed Hosp NHS Trust, London Spinal Cord Injury Ctr, Stanmore, Middx, England.
   Burgess, Philip M., Univ Queensland, Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia.},
DOI = {10.1136/bmjopen-2019-033588},
Article-Number = {e033588},
ISSN = {2044-6055},
Keywords-Plus = {CANCER-MORTALITY; SCHIZOPHRENIA; DISORDERS; RISKS},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {Grant.Sara@health.nsw.gov.au},
ResearcherID-Numbers = {Burgess, Philip/ABD-3040-2020
   Ramanuj, Parashar/AAP-4189-2020
   },
ORCID-Numbers = {Burgess, Philip/0000-0001-7184-0363
   Ramanuj, Parashar/0000-0002-0488-7070
   Currow, David/0000-0003-1988-1250},
Funding-Acknowledgement = {NSW Mental Health Reform funding},
Funding-Text = {The MHLL programme is carried out by the InforMH unit, System
   Information and Analytics Branch, NSW Ministry of Health, within the
   standard operating budget of that unit. The Mental Health Branch, NSW
   Ministry of Health, has provided supplementary funds for 2018-2019 and
   2019-2020 from NSW Mental Health Reform funding.},
Cited-References = {Ajetunmobi O, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002768.
   Australian Bureau of Statistics, 2019, MIGR AUSTR 3412 0.
   Australian Bureau of Statistics, 2019, 2016 CENS QUICKSTATS.
   Australian Insitute of Health and Welfare, 2018, BREASTSCREEN AUSTR M.
   Australian Institute of Health and Welfare, 2019, CERV SCREEN AUSTR 20.
   Cahoon EK, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-37.
   Cancer Institute NSW, 2015, CERV CANC SCREEN NEW.
   Chang CK, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004295.
   CHeReL, 2019, QUALITY ASSURANCE.
   CHeReL, 2019, DAT DICT.
   Chesney E, 2014, WORLD PSYCHIATRY, V13, P153, DOI 10.1002/wps.20128.
   Chou FHC, 2016, PSYCHIAT CLIN NEUROS, V70, P473, DOI 10.1111/pcn.12420.
   Department of Health, 2017, 5 NAT MENT HLTH SUIC.
   Firth J, 2019, LANCET PSYCHIAT, V6, P675, DOI 10.1016/S2215-0366(19)30132-4.
   Goldberg A., 2004, CHOICEMAKER 2 RECORD.
   HealthStats NSW, 2019, POP AG.
   Hennekens CH, 2005, AM HEART J, V150, P1115, DOI 10.1016/j.ahj.2005.02.007.
   Hoang U, 2011, BMJ-BRIT MED J, P343.
   Irwin KE, 2017, ONCOLOGIST, V22, P1374, DOI 10.1634/theoncologist.2016-0489.
   Kisely S, 2013, JAMA PSYCHIAT, V70, P209, DOI 10.1001/jamapsychiatry.2013.278.
   Kisely S, 2008, CAN J PSYCHIAT, V53, P753, DOI 10.1177/070674370805301107.
   Kisely S, 2016, AUST NZ J PSYCHIAT, V50, P254, DOI 10.1177/0004867415577979.
   Liu NH, 2017, WORLD PSYCHIATRY, V16, P30, DOI 10.1002/wps.20384.
   Mai Q, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-163.
   Mitchell AJ, 2014, BRIT J PSYCHIAT, V205, P428, DOI 10.1192/bjp.bp.114.147629.
   National Centre for Classification in Health Australia, 2010, INT STAT CLASS DIS R.
   National Mental Health Commission, 2016, EQ WELL CONS STAT IM.
   NSW Register of Births Deaths and Marriages, NSW REG BIRTHS DEATH.
   Olfson M, 2015, JAMA PSYCHIAT, V72, P1172, DOI 10.1001/jamapsychiatry.2015.1737.
   Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123.
   Sara G., 2016, IDENTIFYING SUICIDE.
   SNOMED International, 2019, SNOMED CT.
   Suetani S, 2015, JAMA PSYCHIAT, V72, P1166, DOI 10.1001/jamapsychiatry.2015.1981.
   The Productivity Commission, 2019, REP GOV SERV MENT HL.
   Wahlbeck K, 2011, BRIT J PSYCHIAT, V199, P453, DOI 10.1192/bjp.bp.110.085100.},
Number-of-Cited-References = {35},
Times-Cited = {2},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {BMJ Open},
Doc-Delivery-Number = {KK5IG},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000512774800380},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000433129800168,
Author = {Chandola, Tarani and Mikkilineni, Sitamma and Chandran, Anil and
   Bandyopadhyay, Souvik Kumar and Zhang, Nan and Bassanesi, Sergio Luiz},
Title = {Is socioeconomic segregation of the poor associated with higher
   premature mortality under the age of 60? A cross-sectional analysis of
   survey data in major Indian cities},
Journal = {BMJ OPEN},
Year = {2018},
Volume = {8},
Number = {2},
Month = {MAY},
Abstract = {Objectives Although urbanisation is generally associated with poverty
   reduction in low-income and middle-income countries, it also results in
   increased socioeconomic segregation of the poor. Cities with higher
   levels of socioeconomic segregation tend to have higher mortality rates,
   although the evidence is based on ecological associations. The paper
   examines whether socioeconomic segregation of the poor is associated
   with higher under-60 years ('premature') mortality risk in Indian cities
   and whether this association is confounded by contextual and
   compositional sociodemographic and socioeconomic factors.
   Setting and participants A population representative sample of over one
   million from 39 427 households living in 1876 urban wards within 59
   Indian districts (cities) from the third (2008) District Level Household
   Survey (DLHS-3).
   Primary outcome and other measures The outcome was any death under the
   age of 60 reported by households in the preceding 4years of the DLHS-3.
   Socioeconomic segregation, estimated at the district (city) level, was
   measured using an isolation index of the poor and the index of
   dissimilarity.
   Results Poor households living in cities where the poor were more
   isolated had higher probabilities of premature mortality than poor
   households living in cities where the poor were less isolated. In
   contrast, it did not matter whether rich households lived in more or
   less socioeconomically segregated cities. A 1 SD increase in the
   isolation index was associated with an absolute increase of 1.1\% in the
   probability of premature mortality for the poorest households.
   Conclusion Increasing segregation of the poor may result in higher
   premature mortality. As low-income and middle-income countries become
   increasingly urbanised, there is a risk that this may lead to increased
   segregation of the poor as well as increased premature mortality.},
Publisher = {BMJ PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Chandola, T (Corresponding Author), Univ Manchester, Dept Social Stat, Cathie Marsh Inst, Manchester, Lancs, England.
   Chandola, Tarani; Zhang, Nan, Univ Manchester, Dept Social Stat, Cathie Marsh Inst, Manchester, Lancs, England.
   Mikkilineni, Sitamma, IFHE Univ, IBS Business Sch, Hyderabad, Telangana, India.
   Chandran, Anil, Univ Kerala, Dept Demog \& Populat Studies, Thiruvananthapuram, Kerala, India.
   Bandyopadhyay, Souvik Kumar, Publ Hlth Fdn India, Indian Inst Publ Hlth, Hyderabad, Telangana, India.
   Bassanesi, Sergio Luiz, Univ Fed Rio Grande do Sul, Dept Med Social, Porto Alegre, RS, Brazil.},
DOI = {10.1136/bmjopen-2017-018885},
Article-Number = {e018885},
ISSN = {2044-6055},
Keywords-Plus = {ECONOMIC SEGREGATION; DEVELOPING-COUNTRIES; HEALTH; DIMENSIONS;
   INEQUALITY; OUTCOMES; POVERTY; INCOME},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {tarani.chandola@manchester.ac.uk},
ResearcherID-Numbers = {chandola, tarani/I-3192-2013
   },
ORCID-Numbers = {chandola, tarani/0000-0002-1864-3413
   ZHANG, NAN/0000-0002-8032-275X},
Funding-Acknowledgement = {Economic and Social Research Council (ESRC)UK Research \& Innovation
   (UKRI)Economic \& Social Research Council (ESRC) {[}RES-238-25-0015,
   ES/J019119/1]; ESRCUK Research \& Innovation (UKRI)Economic \& Social
   Research Council (ESRC) {[}ES/P009824/1, ES/H024972/1, ES/J019119/1]
   Funding Source: UKRI},
Funding-Text = {This work was supported by the Economic and Social Research Council
   (ESRC): RES-238-25-0015 and ES/J019119/1.},
Cited-References = {Alirol E, 2011, LANCET INFECT DIS, V11, P131, DOI 10.1016/S1473-3099(10)70223-1.
   ANDERTON DL, 1994, EVALUATION REV, V18, P123, DOI 10.1177/0193841X9401800201.
   Ash M, 2004, SOC SCI QUART, V85, P441, DOI 10.1111/j.0038-4941.2004.08502011.x.
   Cohen DA, 2003, AM J PUBLIC HEALTH, V93, P467, DOI 10.2105/AJPH.93.3.467.
   Ellen IG, 2001, J URBAN AFF, V23, P391, DOI 10.1111/0735-2166.00096.
   Galobardes B, 2004, EPIDEMIOL REV, V26, P7, DOI 10.1093/epirev/mxh008.
   Harpham T, 2009, HEALTH PLACE, V15, P107, DOI 10.1016/j.healthplace.2008.03.004.
   Hassing C, 2009, EUR J CARDIOV PREV R, V16, P10, DOI 10.1097/HJR.0b013e32831de25d.
   Immink MDC, 1994, URBAN POOR HOUSEHOLD.
   International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S.
   JAMES DR, 1985, SOCIOL METHODOL, P1.
   Jargowsky PA, 1996, AM SOCIOL REV, V61, P984, DOI 10.2307/2096304.
   Kawachi I, 2003, NEIGHBORHOODS HLTH.
   Lobmayer P, 2002, J EPIDEMIOL COMMUN H, V56, P183, DOI 10.1136/jech.56.3.183.
   Massey DS, 1996, DEMOGRAPHY, V33, P395, DOI 10.2307/2061773.
   MASSEY DS, 1988, SOC FORCES, V67, P281, DOI 10.2307/2579183.
   Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111.
   Poverty DRE, 2010, SOC PROBL, V57, P114.
   Ross N. A., 2001, GeoJournal, V53, P117, DOI 10.1023/A:1015720518936.
   Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205.
   STEARNS LB, 1986, URBAN AFF REV, V22, P124, DOI 10.1177/004208168602200107.
   Szwarcwald CL, 2002, SOC SCI MED, V55, P2083, DOI 10.1016/S0277-9536(01)00353-7.
   UN-Habitat, 2010, STAT WORLDS CIT 2010.
   van Ham M., 2012, UNDERSTANDING NEIGHB.
   Waitzman NJ, 1998, MILBANK Q, V76, P341, DOI 10.1111/1468-0009.00095.
   Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2.
   Yadav S, 2014, GLOBAL HEALTH ACTION, V7, P84, DOI 10.3402/gha.v7.23248.},
Number-of-Cited-References = {27},
Times-Cited = {2},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {BMJ Open},
Doc-Delivery-Number = {GH0ZB},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000433129800168},
OA = {gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:A1984TD45600010,
Author = {PETERSSON, B and TRELL, E and KRANTZ, P and HOOD, B},
Title = {MAJOR DETERMINANTS OF PREMATURE MORTALITY IN MIDDLE-AGED URBAN MALES -
   ALCOHOL-RELATED DEATHS AND DEGREE OF PARTICIPATION IN A PREVENTIVE
   POPULATION PROGRAM AGAINST ALCOHOL AND ITS COMPLICATIONS},
Journal = {AMERICAN JOURNAL OF EPIDEMIOLOGY},
Year = {1984},
Volume = {120},
Number = {2},
Pages = {265-272},
Publisher = {JOHNS HOPKINS UNIV SCHOOL HYGIENE PUB HEALTH},
Address = {111 MARKET PLACE, STE 840, BALTIMORE, MD 21202-6709},
Type = {Article},
Language = {English},
Affiliation = {PETERSSON, B (Corresponding Author), MALMO GEN HOSP,DEPT INTERNAL MED,PREVENT MED SECT,S-21401 MALMO,SWEDEN.
   UNIV LUND,MALMO GEN HOSP,DEPT FORENS MED,S-21401 MALMO,SWEDEN.},
DOI = {10.1093/oxfordjournals.aje.a113889},
ISSN = {0002-9262},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Cited-References = {BOLANDER AM, 1981, SKANDIA INT S MEDICA, P236.
   BOTTIGER LE, 1982, ACTA MED SCAND, V211, P437.
   HACKL H, 1980, DEUT MED WOCHENSCHR, V105, P1743, DOI 10.1055/s-2008-1070948.
   HEDSTRAND H, 1975, THESIS UPPSALA.
   KRISTENSON H, 1980, PREV MED, V9, P108, DOI 10.1016/0091-7435(80)90062-6.
   KRISTENSON H, 1983, ALCOHOL CLIN EXP RES, V7, P203, DOI 10.1111/j.1530-0277.1983.tb05441.x.
   KRISTENSON H, 1982, BRIT J ADDICT, V77, P297.
   KRISTENSON H, 1981, AM J EPIDEMIOL, V114, P862, DOI 10.1093/oxfordjournals.aje.a113256.
   KRISTENSON H, 1982, PREV MED, V11, P403, DOI 10.1016/0091-7435(82)90044-5.
   KRISTENSON H, 1982, DRUG ALCOHOL DEPEN, V9, P325, DOI 10.1016/0376-8716(82)90070-9.
   KRISTENSON H, 1982, THESIS U LUND MALMO.
   LANNERSTAD O, 1978, THESIS U LUND MALMO.
   LEISS J, 1982, DEUT MED WOCHENSCHR, V107, P1069.
   LIEBER CS, 1978, AM J MED, V65, P722, DOI 10.1016/0002-9343(78)90788-X.
   NASHOLD RD, 1981, AM J PUBLIC HEALTH, V71, P1237, DOI 10.2105/AJPH.71.11.1237.
   PETERSON B, 1980, BMJ-BRIT MED J, V280, P1403, DOI 10.1136/bmj.280.6229.1403.
   PETERSSON B, 1982, LANCET, V2, P1088.
   POIKOLAINEN K, 1975, ALCOHOL POISONING MO.
   TIBBLIN G, 1982, SCAND J SOC MED, V10, P27, DOI 10.1177/140349488201000106.
   TIBBLIN G, 1965, ACTA MED SCAND, V178, P453.
   TRELL E, 1983, PREV MED, V12, P397, DOI 10.1016/0091-7435(83)90248-7.
   WILHELMSEN L, 1976, J CHRON DIS, V29, P331, DOI 10.1016/0021-9681(76)90093-X.},
Number-of-Cited-References = {22},
Times-Cited = {19},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Am. J. Epidemiol.},
Doc-Delivery-Number = {TD456},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:A1984TD45600010},
DA = {2022-03-29},
}

@article{ WOS:000359342300087,
Author = {Zhao, Dan and Azimi, Parham and Stephens, Brent},
Title = {Evaluating the Long-Term Health and Economic Impacts of Central
   Residential Air Filtration for Reducing Premature Mortality Associated
   with Indoor Fine Particulate Matter (PM2.5) of Outdoor Origin},
Journal = {INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH},
Year = {2015},
Volume = {12},
Number = {7},
Pages = {8448-8479},
Month = {JUL},
Note = {11th International Symposium on Recent Advances in Environmental Health
   Research, Jackson, MS, SEP 14-18, 2014},
Organization = {Jackson State Univ},
Abstract = {Much of human exposure to fine particulate matter (PM2.5) of outdoor
   origin occurs in residences. High-efficiency particle air filtration in
   central heating, ventilating, and air-conditioning (HVAC) systems is
   increasingly being used to reduce concentrations of particulate matter
   inside homes. However, questions remain about the effectiveness of
   filtration for reducing exposures to PM2.5 of outdoor origin and adverse
   health outcomes. Here we integrate epidemiology functions and mass
   balance modeling to estimate the long-term health and economic impacts
   of HVAC filtration for reducing premature mortality associated with
   indoor PM2.5 of outdoor origin in residences. We evaluate 11
   classifications of filters (MERV 5 through HEPA) using six case studies
   of single-family home vintages and ventilation system combinations
   located in 22 U.S. cities. We estimate that widespread use of higher
   efficiency filters would reduce premature mortality by 0.002-2.5\% and
   increase life expectancy by 0.02-1.6 months, yielding annual monetary
   benefits ranging from \$1 to \$1348 per person in the homes and
   locations modeled herein. Large differences in the magnitude of health
   and economic impacts are driven largely by differences in rated filter
   efficiency and building and ventilation system characteristics that
   govern particle infiltration and persistence, with smaller influences
   attributable to geographic location.},
Publisher = {MDPI},
Address = {ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND},
Type = {Article; Proceedings Paper},
Language = {English},
Affiliation = {Stephens, B (Corresponding Author), IIT, Dept Civil Architectural \& Environm Engn, Chicago, IL 60616 USA.
   Zhao, Dan; Azimi, Parham; Stephens, Brent, IIT, Dept Civil Architectural \& Environm Engn, Chicago, IL 60616 USA.},
DOI = {10.3390/ijerph120708448},
EISSN = {1660-4601},
Keywords = {indoor air; HVAC filter; DALYs; premature mortality; exposure;
   infiltration},
Keywords-Plus = {ULTRAFINE PARTICLES; INFILTRATION FACTOR; LIFE EXPECTANCY; HVAC
   FILTRATION; EXPOSURE; POLLUTION; AMBIENT; RISK; BENEFITS; DISEASE},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {dzhao14@hawk.iit.edu
   pazimi@hawk.iit.edu
   brent@iit.edu},
ORCID-Numbers = {ZHAO, DAN/0000-0002-1497-6499},
Funding-Acknowledgement = {ASHRAE {[}RP-1691]; U.S. Environmental Protection AgencyUnited States
   Environmental Protection Agency {[}83575001]},
Funding-Text = {This work was supported in part by ASHRAE RP-1691, an ASHRAE Graduate
   Student Grant-in-Aid Award to Parham Azimi, and by the U.S.
   Environmental Protection Agency under Assistance Agreement No.
   \#83575001 awarded to Illinois Institute of Technology. It has not been
   formally reviewed by the EPA. The views expressed in this document are
   solely those of the authors and do not necessarily reflect those of the
   Agency. EPA does not endorse any products or commercial services
   mentioned in this publication.},
Cited-References = {Aldred J. R., 2015, INDOOR AIR, DOI {[}10.1111/ina.1222025952610, DOI 10.1111/INA.1222025952610].
   Allen R, 2004, J AIR WASTE MANAGE, V54, P1197, DOI 10.1080/10473289.2004.10470988.
   Allen RW, 2012, ENVIRON HEALTH PERSP, V120, P824, DOI 10.1289/ehp.1104447.
   {[}Anonymous], 2013, 622 ASHRAE.
   Azimi P., 2015, 1691RP ASHRAE.
   Azimi P, 2014, ATMOS ENVIRON, V98, P337, DOI 10.1016/j.atmosenv.2014.09.007.
   Azimi P, 2013, BUILD ENVIRON, V70, P150, DOI 10.1016/j.buildenv.2013.08.025.
   Baxter LK, 2007, ATMOS ENVIRON, V41, P6561, DOI 10.1016/j.atmosenv.2007.04.027.
   Baxter LK, 2013, J EXPO SCI ENV EPID, V23, P241, DOI 10.1038/jes.2012.118.
   Baxter LK, 2013, AIR QUAL ATMOS HLTH, V6, P195, DOI 10.1007/s11869-011-0160-5.
   Beko G, 2008, BUILD ENVIRON, V43, P1647, DOI 10.1016/j.buildenv.2007.10.006.
   Brauner EV, 2008, AM J RESP CRIT CARE, V177, P419, DOI 10.1164/rccm.200704-632OC.
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1.
   Brown KW, 2014, J ASTHMA, V51, P585, DOI 10.3109/02770903.2014.895011.
   Burroughs HEB, 1998, ASHRAE J, V40, P47.
   Chan W. R., 2015, INDOOR AIR, DOI {[}10.1111/ina.1218925639183, DOI 10.1111/INA.1218925639183].
   Chen C, 2012, EPIDEMIOLOGY, V23, P870, DOI 10.1097/EDE.0b013e31826b800e.
   Chen C, 2012, ENVIRON HEALTH PERSP, V120, P235, DOI 10.1289/ehp.1103970.
   Chen C, 2011, ATMOS ENVIRON, V45, P275, DOI 10.1016/j.atmosenv.2010.09.048.
   Clark NA, 2010, INT J ENV RES PUB HE, V7, P3211, DOI 10.3390/ijerph7083211.
   Correia AW, 2013, EPIDEMIOLOGY, V24, P23, DOI 10.1097/EDE.0b013e3182770237.
   DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401.
   Eftim SE, 2008, EPIDEMIOLOGY, V19, P209, DOI 10.1097/EDE.0b013e3181632c09.
   El Orch Z, 2014, BUILD ENVIRON, V74, P106, DOI 10.1016/j.buildenv.2014.01.006.
   Fisk WJ, 2013, INDOOR AIR, V23, P357, DOI 10.1111/ina.12036.
   Fugler D., 2000, ASHRAE T, V106, P317.
   Gao TT, 2015, SCI TOTAL ENVIRON, V511, P268, DOI 10.1016/j.scitotenv.2014.11.048.
   Hodas N, 2013, J EXPO SCI ENV EPID, V23, P573, DOI 10.1038/jes.2013.24.
   Hodas N, 2012, J EXPO SCI ENV EPID, V22, P448, DOI 10.1038/jes.2012.34.
   Huijbregts MAJ, 2005, INTEGR ENVIRON ASSES, V1, P181, DOI 10.1897/2004-007R.1.
   Ji WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124238.
   Kearney J, 2014, ATMOS ENVIRON, V94, P793, DOI 10.1016/j.atmosenv.2014.05.020.
   Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165.
   Lachenmyer C, 2000, AEROSOL SCI TECH, V32, P34, DOI 10.1080/027868200303911.
   Laden F, 2006, AM J RESP CRIT CARE, V173, P667, DOI 10.1164/rccm.200503-443OC.
   Lin LY, 2011, ATMOS ENVIRON, V45, P5540, DOI 10.1016/j.atmosenv.2011.05.014.
   Logue JM, 2012, ENVIRON HEALTH PERSP, V120, P216, DOI 10.1289/ehp.1104035.
   Lvovsky K., 2000, ENV DEP PAPERS, V78.
   MacIntosh DL, 2010, J EXPO SCI ENV EPID, V20, P213, DOI 10.1038/jes.2009.16.
   MacNeill M, 2014, INDOOR AIR, V24, P362, DOI 10.1111/ina.12084.
   MacNeill M, 2012, ATMOS ENVIRON, V61, P518, DOI 10.1016/j.atmosenv.2012.07.005.
   Meng QY, 2009, ATMOS ENVIRON, V43, P5750, DOI 10.1016/j.atmosenv.2009.07.066.
   Meng QY, 2005, J EXPO ANAL ENV EPID, V15, P17, DOI 10.1038/sj.jea.7500378.
   Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409.
   Montgomery JF, 2015, BUILD ENVIRON, V85, P17, DOI 10.1016/j.buildenv.2014.11.005.
   Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2.
   Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485.
   Pope CA, 2009, NEW ENGL J MED, V360, P376, DOI 10.1056/NEJMsa0805646.
   POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3\_Pt\_1.669.
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132.
   Puett RC, 2008, AM J EPIDEMIOL, V168, P1161, DOI 10.1093/aje/kwn232.
   Riley WJ, 2002, ENVIRON SCI TECHNOL, V36, P200, DOI 10.1021/es010723y.
   Robinson LA, 2007, REV ENV ECON POLICY, V1, P283, DOI 10.1093/reep/rem018.
   Roman HA, 2008, ENVIRON SCI TECHNOL, V42, P2268, DOI 10.1021/es0713882.
   ROSNER B, 1989, STAT MED, V8, P1051, DOI 10.1002/sim.4780080905.
   Standard A., 2007, 5222007 AM SOC HEAT.
   Stephens B, 2013, INDOOR AIR, V23, P488, DOI 10.1111/ina.12045.
   Stephens B, 2012, INDOOR AIR, V22, P501, DOI 10.1111/j.1600-0668.2012.00779.x.
   Stephens B., 2010, ENERGY IMPLICATIONS.
   Stephens B, 2015, SCI TECHNOL BUILT EN, V21, P3, DOI 10.1080/10789669.2014.961849.
   Stephens B, 2010, ASHRAE TRAN, V116, P346.
   Stephens B, 2010, HVAC\&R RES, V16, P273, DOI 10.1080/10789669.2010.10390905.
   Stieb D. M., 2015, RISK ANAL, DOI {[}10.1111/risa.1235525808859, DOI 10.1111/RISA.1235525808859].
   Walker I. S., 2012, ENERGY IMPLICATIONS.
   Walker IS, 2013, BUILD ENVIRON, V59, P456, DOI 10.1016/j.buildenv.2012.09.013.
   Wallace L, 2005, ENVIRON SCI TECHNOL, V39, P1707, DOI 10.1021/es049547u.
   Wallace L, 2013, ENVIRON SCI TECHNOL, V47, P12929, DOI 10.1021/es402580t.
   Williams R, 2003, ATMOS ENVIRON, V37, P5365, DOI 10.1016/j.atmosenv.2003.09.010.
   Zeger SL, 2008, ENVIRON HEALTH PERSP, V116, P1614, DOI 10.1289/ehp.11449.
   Zuraimi MS, 2015, BUILD ENVIRON, V89, P336, DOI 10.1016/j.buildenv.2015.03.010.},
Number-of-Cited-References = {70},
Times-Cited = {32},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {59},
Journal-ISO = {Int. J. Environ. Res. Public Health},
Doc-Delivery-Number = {CO7MB},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)},
Unique-ID = {WOS:000359342300087},
OA = {Green Published, gold, Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000458039700015,
Author = {Shiels, Meredith S. and de Gonzalez, Amy Berrington and Best, Ana F. and
   Chen, Yingxi and Chemyayskiy, Pavel and Hartge, Patricia and Khan, Sahar
   Q. and Perez-Stable, Eliseo J. and Rodriquez, Eril C. J. and Spillane,
   Susan and Thomas, David A. and Withrow, Diana and Freedman, Neal D.},
Title = {Premature mortality from all causes and drug poisonings in the USA
   according to socioeconomic status and rurality: an analysis of death
   certificate data by county from 2000-15},
Journal = {LANCET PUBLIC HEALTH},
Year = {2019},
Volume = {4},
Number = {2},
Pages = {E97-E106},
Month = {FEB},
Abstract = {Background Increasing premature mortality among some groups of Americans
   has been largely driven by increases in drug poisoning deaths. However,
   to our knowledge, a formal descriptive study by race and ethnicity,
   socioeconomic status, rurality, and geography has not been done. In this
   study, we examined US trends in premature all-cause and drug poisoning
   mortality between 2000 and 2015 at the county level among white, black,
   and Latino people.
   Methods We used US mortality data for the period Jan 1, 2000, to Dec 31,
   2015, including underlying cause of death and demographic data,
   collected from death certificates by the Centers for Disease Control and
   Prevention National Center for Health Statistics, and ascertained county
   attributes from the 2011-15 Census American Community Survey. We
   categorised counties into quintiles on the basis of the percentage of
   people unemployed, the percentage of people with a bachelor's degree,
   median income, and rurality. We estimated premature (ie, deaths in those
   aged 25-64 years) age-standardised mortality for all causes (by race and
   ethnicity) and drug poisoning, by county, for the periods of 2000-03 and
   2012-15. We estimated annual percentage changes in mortality (2000-15)
   by county-level characteristics.
   Findings Premature mortality declined from 2000-03 to 2012-15 among
   black and Latino people, but increased among white people in many US
   counties. Drug poisoning mortality increased in counties throughout the
   country. Significant increases between 2000 and 2015 occurred across low
   and high socioeconomic status and urban and rural counties among white
   people aged 25-64 years (annual percentage change range 4.56\% per year
   {[}95\% CI 3.56-5.57] to 11.51\% per year {[}9.41-13.65]), black people
   aged 50-64 years (2.27\% per year {[}0.42-4.16] to 9.46\% per year
   {[}7.02-11.96]), Latino women aged 25-49 years (2.43\% per year
   {[}1.18-3.71] to 5.01\% per year {[}3.80-6.23]), and Latino men aged
   50-64 years (2.42\% per year {[}0.53-4.34] to 5.96\% per year
   {[}3.86-8.11]). Although drug poisoning mortality increased rapidly in
   counties with the lowest socioeconomic status and in rural counties,
   most deaths during 2012-15 occurred in the largest metropolitan counties
   (121 395 {[}76\%] in metropolitan counties with >= 250 000 people vs
   2175 {[}1\%] in the most rural counties), reflecting population size.
   Interpretation Premature mortality has declined among black and Latino
   people in the USA, and increased among white people, particularly in
   less affluent and rural counties. Increasing drug poisoning mortality
   was not limited to poor white people in rural areas. Rapid increases
   have occurred in communities throughout the USA regardless of race and
   ethnicity, socioeconomic status, or rurality. Widespread public health
   interventions are needed to addess this public health emergency.
   Funding National Institutes of Health. Copyright (c) 2019 The Author(s).
   Published by Elsevier Ltd. This is an Open Access article under the CC
   BY 4.0 license.},
Publisher = {ELSEVIER SCI LTD},
Address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Shiels, MS (Corresponding Author), NCI, NIH, Bethesda, MD 20892 USA.
   Shiels, Meredith S.; de Gonzalez, Amy Berrington; Best, Ana F.; Chen, Yingxi; Chemyayskiy, Pavel; Hartge, Patricia; Khan, Sahar Q.; Spillane, Susan; Withrow, Diana; Freedman, Neal D., NCI, Div Canc Epidemiol \& Genet, Rockville, MD USA.
   Chemyayskiy, Pavel, Univ Wyoming, Dept Math \& Stat, Laramie, WY 82071 USA.
   Perez-Stable, Eliseo J., Natl Inst Minor Hlth \& Hlth Dispar, Bethesda, MD USA.
   Rodriquez, Eril C. J., NHLBI, Div Intramural Res, Bldg 10, Bethesda, MD 20892 USA.
   Thomas, David A., NIDA, Div Epidemiol Serv \& Prevent Res, Bethesda, MD 20892 USA.},
DOI = {10.1016/S2468-2667(18)30208-1},
ISSN = {2468-2667},
Keywords-Plus = {UNITED-STATES; LIFE EXPECTANCY; OVERDOSE DEATHS; TRENDS; PATTERNS;
   RATES; ASSOCIATION; INEQUALITY; ADULTS; HEALTH},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {shielsms@mail.nih.gov},
ResearcherID-Numbers = {Chen, Yingxi/ABF-2593-2020
   Freedman, Neal David/AAA-5929-2022
   Freedman, Neal D/B-9741-2015
   },
ORCID-Numbers = {Chen, Yingxi/0000-0002-3565-1052
   Freedman, Neal David/0000-0003-0074-1098
   Freedman, Neal D/0000-0003-0074-1098
   Best, Ana/0000-0002-4467-1725},
Funding-Acknowledgement = {National Cancer InstituteUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI); National Health, Lung, and Blood InstituteUnited States
   Department of Health \& Human ServicesNational Institutes of Health
   (NIH) - USANIH National Heart Lung \& Blood Institute (NHLBI); National
   Institute on Minority Health and Health DisparitiesUnited States
   Department of Health \& Human ServicesNational Institutes of Health
   (NIH) - USANIH National Institute on Minority Health \& Health
   Disparities (NIMHD); NATIONAL CANCER INSTITUTEUnited States Department
   of Health \& Human ServicesNational Institutes of Health (NIH) - USANIH
   National Cancer Institute (NCI) {[}ZIACP010150] Funding Source: NIH
   RePORTER},
Funding-Text = {This work was funded by the intramural research programmes of the
   National Cancer Institute, National Health, Lung, and Blood Institute,
   and the National Institute on Minority Health and Health Disparities.
   MSS, ABdG, AFB, YC, PC, SQK, EJP-S, EJR, SS, DAT, DW, and NDF were
   employed by the National Institutes of Health while this work was done.
   The authors acknowledge Michael Curry and Jeremy Lyman (Information
   Management Services) for statistical support.},
Cited-References = {Arias E., 2016, VALIDITY RACE HISPAN.
   Bor J, 2017, LANCET, V389, P1475, DOI 10.1016/S0140-6736(17)30571-8.
   Buchanich JM, 2016, PREV MED, V89, P317, DOI 10.1016/j.ypmed.2016.04.007.
   Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112.
   CDC, 2017, US OP PRESCR RAT MAP.
   CDC, 2016, REP LAW ENF ENC TEST.
   Centers for Disease Control and Prevention, 2016, DRUG OV MORT STAT.
   Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226.
   Compton WM, 2016, NEW ENGL J MED, V374, P154, DOI 10.1056/NEJMra1508490.
   Currie J, 2016, SCIENCE, V352, P708, DOI 10.1126/science.aaf1437.
   Dwyer-Lindgren L, 2018, JAMA-J AM MED ASSOC, V319, P1013, DOI 10.1001/jama.2018.0900.
   Dwyer-Lindgren L, 2017, JAMA INTERN MED, V177, P1003, DOI 10.1001/jamainternmed.2017.0918.
   Dwyer-Lindgren L, 2016, JAMA-J AM MED ASSOC, V316, P2385, DOI 10.1001/jama.2016.13645.
   Egen O, 2017, AM J PUBLIC HEALTH, V107, P130, DOI 10.2105/AJPH.2016.303515.
   Fretz A, 2016, AM J EPIDEMIOL, V183, P452, DOI 10.1093/aje/kwv253.
   Hedegaard H, 2017, NCHS DATA BRIEF, V273, p1 .
   Hedegaard Holly, 2017, NCHS Data Brief, P1.
   Jalal H, 2018, SCIENCE, V361, P1218, DOI 10.1126/science.aau1184.
   Karb RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153516.
   Khan SQ, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.3317.
   Kochanek Kenneth D, 2017, NCHS Data Brief, P1.
   Mack Karin A, 2017, MMWR Surveill Summ, V66, P1, DOI 10.15585/mmwr.ss6619a1.
   Mars SG, 2018, J PSYCHOACTIVE DRUGS, V50, P167, DOI 10.1080/02791072.2017.1394508.
   Monnat SM, 2018, AM J PREV MED, V54, P611, DOI 10.1016/j.amepre.2018.01.040.
   Murphy Sherry L, 2017, Natl Vital Stat Rep, V66, P1.
   Seth P, 2018, MMWR-MORBID MORTAL W, V67, P349, DOI 10.15585/mmwr.mm6712a1.
   Sharfstein JM, 2018, JAMA-J AM MED ASSOC, V319, P537, DOI 10.1001/jama.2018.0058.
   Shiels MS, 2018, ANN INTERN MED, V168, P453, DOI 10.7326/M17-1812.
   Shiels MS, 2017, LANCET, V389, P1043, DOI {[}10.1016/S0140-6736(17)30187-3, 10.1016/s0140-6736(17)30187-3].
   Simard EP, 2012, ARCH INTERN MED, V172, P1591, DOI 10.1001/archinternmed.2012.4508.
   Singh GK, 2017, J ENVIRON PUBLIC HEA, V2017, P1, DOI 10.1155/2017/2819372.
   U.S. Census Bureau, 2016, ACS SUMM FIL TECHN D.
   Vivolo-Kantor AM, 2018, MMWR-MORBID MORTAL W, V67, P279, DOI 10.15585/mmwr.mm6709e1.
   Warner M., 2013, ACAD FORENSIC PATHOL, V3, P231, DOI {[}DOI 10.23907/2013.029, 10.23907/2013.029].},
Number-of-Cited-References = {34},
Times-Cited = {27},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Lancet Public Health},
Doc-Delivery-Number = {HK5WO},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000458039700015},
OA = {Green Accepted, gold},
DA = {2022-03-29},
}

@article{ WOS:000763326500001,
Author = {Luo, Zheng and Zou, Yongbin and Xie, Jiaxin and Cao, Hui and Chen,
   Yichen and Ding, Yibo and Li, Xiaopan and Deng, Yang and Wu, Lile},
Title = {Influence of Demographic Factors on Long-Term Trends of Premature
   Mortality and Burden Due to Liver Cancer: Findings From a
   Population-Based Study in Shanghai, China, 1973-2019},
Journal = {FRONTIERS IN PUBLIC HEALTH},
Year = {2022},
Volume = {10},
Month = {FEB 15},
Abstract = {ObjectiveLiver cancer is one of the most common causes of cancer-related
   death. Understanding how demographic factors influence mortality due to
   liver cancer is crucial for optimizing disease-control strategies. We
   aimed to characterize the long-term trends in the mortality and years of
   life lost (YLL) of liver cancer in Shanghai, China, 1973-2019, and
   quantitatively analyze the contributions of demographic and
   non-demographic factors on the mortality of liver cancer. MethodsUsing
   mortality data from the Mortality Registration System of Pudong New
   Area, the largest district of Shanghai with a population of permanent
   resident of 5.68 million, during 1973-2019, we analyzed the temporal
   trends for the mortality rates and YLL by Joinpoint Regression Program.
   The difference decomposition method was employed to estimate the
   increasing mortality rates related to demographic and non-demographic
   factors. ResultsA total of 21,530 deaths from liver cancer occurred from
   1973 to 2019. The crude mortality rates (CMR) and age-standardized
   mortality rate by Segi's world standard population (ASMRW) of liver
   cancer were 26.73/10(5) person-years and 15.72/10(5) person-years,
   respectively. The CMR, ASMRW, and YLL rates of liver cancer showed
   significantly decreasing trends in males, females and the total
   population from 1973 to 2019, whereas the upward trends in the YLL were
   seen in males, females and the total population (all P < 0.05). A
   significant upward trend was observed in the increased CMR caused by
   demographic factors, but the changing rate caused by non-demographic
   factors decreased. ConclusionsThe CMR and ASMRW of liver cancer
   continually decreased although YLL increased during 1973-2019 in Pudong
   New Area, Shanghai. The demographic factors, especially aging, might be
   responsible for the increase in the mortality of liver cancer. More
   effective prevention strategies tailored to liver cancer are needed to
   further reduce its disease burden in the elderly population.},
Publisher = {FRONTIERS MEDIA SA},
Address = {AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND},
Type = {Article},
Language = {English},
Affiliation = {Li, XP (Corresponding Author), Fudan Univ, Ctr Dis Control \& Prevent Pudong New Area, Pudong Inst Prevent Med, Shanghai, Peoples R China.
   Deng, Y (Corresponding Author), Shandong First Med Univ \& Shandong Acad Med Sci, Sch Publ Hlth, Tai An, Shandong, Peoples R China.
   Wu, LL (Corresponding Author), Southwest Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp, Luzhou, Peoples R China.
   Luo, Zheng, Shanghai Univ Med \& Hlth Sci, Dept Neurol, Affiliated Zhoupu Hosp, Shanghai, Peoples R China.
   Zou, Yongbin; Cao, Hui, Chenzhou First Peoples Hosp, Dept Oncol, Chenzhou, Peoples R China.
   Xie, Jiaxin, Army Med Univ, Dept High Altitude Operat Med, Chongqing, Peoples R China.
   Chen, Yichen; Li, Xiaopan, Fudan Univ, Ctr Dis Control \& Prevent Pudong New Area, Pudong Inst Prevent Med, Shanghai, Peoples R China.
   Ding, Yibo, Second Mil Med Univ, Dept Epidemiol, Shanghai, Peoples R China.
   Deng, Yang, Shandong First Med Univ \& Shandong Acad Med Sci, Sch Publ Hlth, Tai An, Shandong, Peoples R China.
   Wu, Lile, Southwest Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp, Luzhou, Peoples R China.},
DOI = {10.3389/fpubh.2022.808917},
Article-Number = {808917},
EISSN = {2296-2565},
Keywords = {liver cancer; mortality; years of life lost; difference decomposition
   method; demographic factors},
Keywords-Plus = {HEPATOCELLULAR-CARCINOMA; STATISTICS; LIFE},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {xiaopanli0224@126.com
   dengyang3417@126.com
   wbm\_bigcat@hotmail.com},
Cited-References = {Are C, 2017, J SURG ONCOL, V115, P591, DOI 10.1002/jso.24518.
   Brustugun OT, 2014, BRIT J CANCER, V111, P1014, DOI 10.1038/bjc.2014.364.
   Cen XZ, 2020, CANCER MED-US, V9, P1562, DOI 10.1002/cam4.2765.
   Chen HY, 2018, BMC PUBLIC HEALTH, V18, DOI {[}10.1186/s12889-018-5112-7, 10.1186/s12889-018-5146-x].
   Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338.
   Cheng XJ, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003138.
   Cucchetti A, 2016, ALIMENT PHARM THER, V43, P814, DOI 10.1111/apt.13554.
   Deng Y, 2020, J VIRAL HEPATITIS, V27, P1150, DOI 10.1111/jvh.13353.
   Fujiwara N, 2014, EUR J GASTROEN HEPAT, V26, P1039, DOI 10.1097/MEG.0000000000000161.
   Lee CL, 2003, CANCER EPIDEM BIOMAR, V12, P57.
   Li M, 2017, ONCOTARGET, V8, P92470, DOI 10.18632/oncotarget.21419.
   Li XP, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00579.
   Li XP, 2019, PREV MED, V118, P243, DOI 10.1016/j.ypmed.2018.11.002.
   Liu ZQ, 2019, CANCER MED-US, V8, P5787, DOI 10.1002/cam4.2477.
   Luo Z, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.625042.
   Luo Z, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09593-6.
   McGlynn KA, 2021, HEPATOLOGY, V73, P4, DOI 10.1002/hep.31288.
   Nakajima T, 2011, PATHOL INT, V61, P572, DOI 10.1111/j.1440-1827.2011.02743.x.
   Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7.
   Shi JF, 2021, INT J CANCER, V148, P1051, DOI 10.1002/ijc.33313.
   Sun YY, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020490.
   Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660.
   Tang X, 2018, J VIRAL HEPATITIS, V25, P1008, DOI 10.1111/jvh.12901.
   Wang F, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16162878.
   Wang S, 2018, CAN MED ASSOC J, V190, pE1153, DOI 10.1503/cmaj.180272.
   Yin JH, 2015, CANCER PREV RES, V8, P978, DOI 10.1158/1940-6207.CAPR-15-0160.
   Zhang LJ, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09390-1.
   Zhou MG, 2019, LANCET, V394, P1145, DOI 10.1016/S0140-6736(19)30427-1.},
Number-of-Cited-References = {28},
Times-Cited = {0},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Front. Public Health},
Doc-Delivery-Number = {ZK9UH},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000763326500001},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000692409400001,
Author = {Liu, Li and Li, Yanxia and Song, Junmin and Chen, Qian and Li, Shuang
   and Mu, Huijuan and Na, Jun and Zhang, Rui and Yu, Liya and Sun, Wei and
   Pan, Guowei},
Title = {Current status of premature mortality from four non-communicable
   diseases and progress towards the Sustainable Development Goal target
   3.4: a population-based study in northeast China, 2004-2017},
Journal = {BMC PUBLIC HEALTH},
Year = {2021},
Volume = {21},
Number = {1},
Month = {SEP 2},
Abstract = {Background and aim According to the United Nations' Sustainable
   Development Goal (SDG) target 3.4, premature mortality from four
   non-communicable diseases (cardiovascular diseases, cancer, chronic
   respiratory diseases, and diabetes mellitus, collectively referred to as
   NCD4) should achieve a minimum decline of 33\% in 2030 relative to 2015.
   This remains a challenge for China. This study aimed to evaluate the
   current status and progress towards this target in Liaoning Province,
   one of the three provinces in northeast China. Methods We calculated the
   premature mortality rates (PMRs) per year and average annual percentage
   changes (AAPCs) from NCD4 using mortality data between 2004 and 2017.
   The trend was analyzed in the whole population, as well as in
   subpopulations of gender (male/female) and inhabiting area
   (urban/rural). PMRs from NCD4 for 2030 were projected by fitting a
   linear regression based on the current trend, which was identified by a
   Joinpoint model. Findings In the whole population, only chronic
   respiratory diseases showed a significant decline (AAPC: - 6.5\%, p <
   0.05), while only cancer showed a significant increase (AAPC: + 1.3\%, p
   < 0.05); taken together, NCD4 showed a significant increase (AAPC: +
   0.6\%, p < 0.05). In the subpopulations, while males showed a
   significant increase in NCD4 (AAPC: + 1.5\%, p < 0.05), cardiovascular
   diseases (AAPC: + 1.7\%, p < 0.05), cancer (AAPC: + 1.8\%, p < 0.05),
   and diabetes mellitus (AAPC: + 4.2\%, p < 0.05), females showed a
   significant decline in NCD4 (AAPC: - 1.2\%, p < 0.05), cardiovascular
   diseases (AAPC: - 1.8\%, p < 0.05), diabetes mellitus (AAPC: - 2.1\%, p
   < 0.05), but showed a mild increase in cancer (AAPC: + 0.5\%, p > 0.05).
   A comparative analysis of the projected PMRs for 2030 with the 2015
   levels revealed that only chronic respiratory diseases are expected to
   achieve the SDG target 3.4, apart from in the urban male subpopulation.
   Conclusion Except for chronic respiratory diseases, NCD4 cannot be
   expected to achieve the SDG target 3.4 in the whole population of
   Liaoning Province. Under these circumstances, special attention should
   be paid to reducing the risks of cancer and providing preventative
   interventions for men.},
Publisher = {BMC},
Address = {CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Pan, GW (Corresponding Author), China Med Univ, Inst Prevent Med, Shenyang 110122, Peoples R China.
   Pan, GW (Corresponding Author), China Med Univ, Res Ctr Universal Hlth, Sch Publ Hlth, 77 Puhe Rd, Shenyang 110122, Peoples R China.
   Liu, Li; Li, Yanxia; Song, Junmin; Chen, Qian; Li, Shuang; Mu, Huijuan; Na, Jun; Zhang, Rui; Yu, Liya; Sun, Wei; Pan, Guowei, China Med Univ, Inst Prevent Med, Shenyang 110122, Peoples R China.
   Liu, Li; Li, Yanxia; Li, Shuang; Mu, Huijuan; Na, Jun; Zhang, Rui; Yu, Liya, Liaoning Prov Ctr Dis Control \& Prevent, Inst Chron Dis, Shenyang, Peoples R China.
   Song, Junmin, China Med Univ, Dept Gastroenterol, Shengjing Hosp, Shenyang 110004, Peoples R China.
   Chen, Qian; Sun, Wei; Pan, Guowei, China Med Univ, Res Ctr Universal Hlth, Sch Publ Hlth, 77 Puhe Rd, Shenyang 110122, Peoples R China.},
DOI = {10.1186/s12889-021-11611-0},
Article-Number = {1608},
EISSN = {1471-2458},
Keywords = {Average annual percentage change; China; Chronic disease; Liaoning;
   Mortality; Non-communicable disease; Premature; Sustainable Development
   Goal},
Keywords-Plus = {CARDIOVASCULAR-DISEASE; MIDLIFE TRANSITION; RURAL-POPULATION;
   PREVALENCE; POLLUTION; QUALITY; RISK},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {gwpan@cmu.edu.cn},
Funding-Acknowledgement = {Natural Science Foundation of Liaoning ProvinceNatural Science
   Foundation of Liaoning Province {[}2020-MS-160]; Liaoning Revitalization
   Talents Program {[}XLYC1802131]},
Funding-Text = {This research was supported by the Natural Science Foundation of
   Liaoning Province (grand number: 2020-MS-160) and Liaoning
   Revitalization Talents Program (grand number: XLYC1802131). The sponsor
   had no role in design of the study, collection, analysis, or
   interpretation of the data, and writing of the manuscript.},
Cited-References = {An RP, 2019, ENVIRON RES, V176, DOI 10.1016/j.envres.2019.108545.
   Anand S, 2008, LANCET, V372, P1774, DOI 10.1016/S0140-6736(08)61363-X.
   Bao MY, 2020, ANN PALLIAT MED, V9, P2485, DOI 10.21037/apm-19-377.
   Bennett JE, 2020, LANCET, V396, P918, DOI 10.1016/S0140-6736(20)31761-X.
   Bennett JE, 2018, LANCET, V392, P1072, DOI 10.1016/S0140-6736(18)31992-5.
   Cao YY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051803.
   Ding CC, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17010158.
   Dong EH, 2021, ARCH PUBLIC HEALTH, V79, DOI 10.1186/s13690-021-00597-1.
   Du XF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226756.
   Duan Rui-Rui, 2020, Chronic Dis Transl Med, V6, P260, DOI 10.1016/j.cdtm.2020.05.004.
   Frieden TR, 2020, GLOB HEART, V15, DOI 10.5334/gh.531.
   Guo B, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000018625.
   Hou JL, 2019, ADV MED EDUC PRACT, V10, P1021, DOI 10.2147/AMEP.S227028.
   Hu D, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-016-0505-7.
   Hu YD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121477.
   Hua JJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114048.
   Kase NG, 2020, AM J OBSTET GYNECOL, V223, P820, DOI 10.1016/j.ajog.2020.05.051.
   Kase NG, 2020, AM J OBSTET GYNECOL, V223, P834, DOI 10.1016/j.ajog.2020.06.008.
   Keetile M, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7405-x.
   Kontis V, 2014, LANCET, V384, P427, DOI 10.1016/S0140-6736(14)60616-4.
   Li G, 2016, Zhonghua Liu Xing Bing Xue Za Zhi, V37, P1268, DOI 10.3760/cma.j.issn.0254-6450.2016.09.017.
   Li JJ, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-2905-4.
   Li Y R, 2018, Zhonghua Liu Xing Bing Xue Za Zhi, V39, P898, DOI 10.3760/cma.j.issn.0254-6450.2018.07.007.
   Li YX, 2017, CANCER RES TREAT, V49, P1106, DOI 10.4143/crt.2016.613.
   Li YC, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0894-5.
   Liu XX, 2020, CANCER COMMUN, V40, P611, DOI 10.1002/cac2.12099.
   Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692.
   Mills KT, 2020, NAT REV NEPHROL, V16, P223, DOI 10.1038/s41581-019-0244-2.
   Pang Y J, 2021, Zhonghua Liu Xing Bing Xue Za Zhi, V42, P369, DOI 10.3760/cma.j.cn112338-20210111-00024.
   Ren QQ, 2020, IRAN J PUBLIC HEALTH, V49, P1476, DOI 10.18502/ijph.v49i8.3891.
   Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7.
   Rust P, 2017, ADV EXP MED BIOL, V956, P61, DOI 10.1007/5584\_2016\_147.
   Santosa A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0313-8.
   Shi T, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155441.
   Shin S, 2021, AM J RESP CRIT CARE, V203, P1138, DOI 10.1164/rccm.201909-1744OC.
   Shou MH, 2020, ENVIRON SCI POLLUT R, V27, P34357, DOI 10.1007/s11356-020-09435-3.
   Tian Y, 2016, LANCET DIABETES ENDO, V4, P487, DOI 10.1016/S2213-8587(16)00081-4.
   Tokuc B, 2016, BALK MED J, V33, P662, DOI 10.5152/balkanmedj.2016.151277.
   Wang D Z, 2017, Zhonghua Liu Xing Bing Xue Za Zhi, V38, P1672, DOI 10.3760/cma.j.issn.0254-6450.2017.12.018.
   Wang T, 2015, LANCET, V386, P1441, DOI 10.1016/S0140-6736(15)00402-X.
   Wang Y, 2021, BRIT J NUTR, V126, P110, DOI 10.1017/S0007114520003955.
   Wang ZQ, 2021, J HUM NUTR DIET, V34, P233, DOI 10.1111/jhn.12836.
   Xia X, 2020, SCI CHINA LIFE SCI, V63, P1317, DOI 10.1007/s11427-020-1656-8.
   Xing LY, 2021, J EPIDEMIOL COMMUN H, V75, P800, DOI 10.1136/jech-2020-213755.
   Xing LY, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/1456720.
   Xu QH, 2020, PEERJ, V8, DOI 10.7717/peerj.10298.
   Xu X H, 2019, Zhonghua Liu Xing Bing Xue Za Zhi, V40, P1084, DOI 10.3760/cma.j.issn.0254-6450.2019.09.012.
   Yang T, 2017, ENVIRON POLLUT, V230, P692, DOI 10.1016/j.envpol.2017.06.007.
   Yang ZM, 2021, DRUG ALCOHOL DEPEN, V218, DOI 10.1016/j.drugalcdep.2020.108431.
   Yin XL, 2021, INT J HEALTH PLAN M, V36, P100, DOI 10.1002/hpm.3070.
   Yu Lian-zheng, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P399.
   Zeng X Y, 2017, Zhonghua Yu Fang Yi Xue Za Zhi, V51, P209, DOI 10.3760/cma.j.issn.0253-9624.2017.03.004.
   Zhang JY, 2021, J EXPO SCI ENV EPID, V31, P266, DOI 10.1038/s41370-020-00273-6.
   Zhang J, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.554778.
   Zhang Jiyu, 2019, Zhonghua Yufang Yixue Zazhi, V53, P316, DOI 10.3760/cma.j.issn.0253-9624.2019.03.015.
   Zhou B, 2016, INT J CARDIOL, V215, P377, DOI 10.1016/j.ijcard.2016.04.073.
   Zhou MG, 2019, LANCET, V394, P1145, DOI 10.1016/S0140-6736(19)30427-1.
   Zhou X, 2015, DIABETIC MED, V32, P332, DOI 10.1111/dme.12599.},
Number-of-Cited-References = {58},
Times-Cited = {0},
Usage-Count-Last-180-days = {5},
Usage-Count-Since-2013 = {6},
Journal-ISO = {BMC Public Health},
Doc-Delivery-Number = {UL1HE},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000692409400001},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000345450100032,
Author = {Williams, Roger and Aspinall, Richard and Bellis, Mark and Camps-Walsh,
   Ginette and Cramp, Matthew and Dhawan, Anil and Ferguson, James and
   Forton, Dan and Foster, Graham and Gilmore, Ian and Hickman, Matthew and
   Hudson, Mark and Kelly, Deirdre and Langford, Andrew and Lombard, Martin
   and Longworth, Louise and Martin, Natasha and Moriarty, Kieran and
   Newsome, Philip and O'Grady, John and Pryke, Rachel and Rutter, Harry
   and Ryder, Stephen and Sheron, Nick and Smith, Tom},
Title = {Addressing liver disease in the UK: a blueprint for attaining excellence
   in health care and reducing premature mortality from lifestyle issues of
   excess consumption of alcohol, obesity, and viral hepatitis},
Journal = {LANCET},
Year = {2014},
Volume = {384},
Number = {9958},
Pages = {1953-1997},
Month = {NOV 29},
Publisher = {ELSEVIER SCIENCE INC},
Address = {STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA},
Type = {Review},
Language = {English},
Affiliation = {Williams, R (Corresponding Author), Fdn Liver Res, London WC1E 6HX, England.
   Williams, Roger, Fdn Liver Res, London WC1E 6HX, England.
   Aspinall, Richard, Queen Alexandra Hosp, Portsmouth, Hants, England.
   Bellis, Mark, Bangor Univ, Coll Hlth \& Behav Sci, Bangor, Gwynedd, Wales.
   Camps-Walsh, Ginette, Med Mkt Consultants, Oxford, England.
   Cramp, Matthew, Plymouth Hosp NHS Trust, Plymouth, Devon, England.
   Cramp, Matthew, Plymouth Univ Peninsula, Sch Med, Plymouth, Devon, England.
   Cramp, Matthew, Plymouth Univ Peninsula, Sch Dent, Plymouth, Devon, England.
   Dhawan, Anil; O'Grady, John, Kings Coll Hosp London, London, England.
   Ferguson, James, Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England.
   Forton, Dan, St George Hosp, London, England.
   Foster, Graham, Queen Marys Univ, London, England.
   Gilmore, Ian, Univ Liverpool, Liverpool L69 3BX, Merseyside, England.
   Hickman, Matthew; Martin, Natasha, Univ Bristol, Bristol, Avon, England.
   Hudson, Mark, Freeman Rd Hosp, Newcastle Upon Tyne, Tyne \& Wear, England.
   Kelly, Deirdre, Birmingham Childrens Hosp, Birmingham, W Midlands, England.
   Langford, Andrew, British Liver Trust, Ringwood, England.
   Lombard, Martin, Royal Liverpool \& Broadgreen Univ Hosp NHS Trust, Liverpool, Merseyside, England.
   Longworth, Louise, Brunel Univ, Uxbridge UB8 3PH, Middx, England.
   Moriarty, Kieran, Royal Bolton Hosp, Bolton, England.
   Newsome, Philip, Univ Birmingham, Natl Inst Hlth Res NIHR Ctr Liver Res, Birmingham, W Midlands, England.
   Newsome, Philip, Univ Birmingham, Biomed Res Unit, Birmingham, W Midlands, England.
   Pryke, Rachel, Winyates Hlth Ctr, Redditch, Worcs, England.
   Rutter, Harry, London Sch Hyg \& Trop Med, London WC1, England.
   Ryder, Stephen, Nottingham Univ Hosp NHS Trust, Nottingham, England.
   Sheron, Nick, Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England.
   Smith, Tom, British Soc Gastroenterol, London, England.},
DOI = {10.1016/S0140-6736(14)61838-9},
ISSN = {0140-6736},
EISSN = {1474-547X},
Keywords-Plus = {ADVERSE CHILDHOOD EXPERIENCES; OPIATE SUBSTITUTION THERAPY; C
   VIRUS-INFECTION; B SURFACE-ANTIGEN; 15-YEAR FOLLOW-UP;
   COST-EFFECTIVENESS; ADVANCED FIBROSIS; SYRINGE PROGRAMS; BILIARY
   ATRESIA; NATURAL-HISTORY},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {r.williams@researchinliver.org.uk},
ResearcherID-Numbers = {Forton, Daniel/AAN-6669-2020
   Newsome, Philip N/D-4495-2018
   Hickman, Matthew/Y-2400-2019
   },
ORCID-Numbers = {Newsome, Philip N/0000-0001-6085-3652
   Hickman, Matthew/0000-0001-9864-459X
   Foster, Graham/0000-0002-3704-386X
   Ryder, Stephen David/0000-0001-9649-4444
   Rutter, Harry/0000-0002-9322-0656
   Martin, Natasha/0000-0001-8344-1810
   Forton, Daniel/0000-0002-0903-9169
   Dhawan, Anil/0000-0002-4942-0845
   Sheron, Nick/0000-0002-6156-8367
   Sheron, Nick/0000-0001-5232-8292
   Aspinall, Richard/0000-0002-5208-8185},
Funding-Acknowledgement = {MRCUK Research \& Innovation (UKRI)Medical Research Council UK (MRC)
   {[}MR/K023233/1] Funding Source: UKRI; Medical Research CouncilUK
   Research \& Innovation (UKRI)Medical Research Council UK (MRC)European
   Commission {[}MR/K023195/1, MR/J006742/1, MR/K023233/1, MR/K023195/1B]
   Funding Source: researchfish; National Institute for Health
   ResearchNational Institute for Health Research (NIHR)
   {[}PDF-2011-04-049, RP-DG-0610-10055] Funding Source: researchfish},
Cited-References = {Abdel-Hady M, 2011, J VIRAL HEPATITIS, V18, pE535, DOI 10.1111/j.1365-2893.2011.01456.x.
   Academy of Medical Royal Colleges, 2013, MEAS MED PROF PRESCR.
   Academy of Medical Sciences, 2004, CALL TIM NAT DRINK M.
   Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454.
   All- Party Parliamentary Hepatology Group (APPHG), 2014, INQ IMPR OUTC LIV DI.
   Annunziato RA, 2007, PEDIATR TRANSPLANT, V11, P608, DOI 10.1111/j.1399-3046.2007.00689.x.
   {[}Anonymous], 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16040.
   {[}Anonymous], 2012, AC UPP GASTR BLEED M.
   Armstrong MJ, 2014, QJM-INT J MED, V107, P33, DOI 10.1093/qjmed/hct198.
   Armstrong MJ, 2012, J HEPATOL, V56, P234, DOI 10.1016/j.jhep.2011.03.020.
   Aspinall EJ, 2013, CLIN INFECT DIS, V57, pS80, DOI 10.1093/cid/cit306.
   Babor T., 2003, ALCOHOL NO ORDINARY.
   Balogun MA, 2013, EPIDEMIOL INFECT, V141, P916, DOI 10.1017/S0950268812001513.
   Barrett B, 2006, DRUG ALCOHOL DEPEN, V81, P47, DOI 10.1016/j.drugalcdep.2005.05.015.
   Barshop NJ, 2008, ALIMENT PHARM THER, V28, P13, DOI 10.1111/j.1365-2036.2008.03703.x.
   Baumberg B., 2006, ALCOHOL EUROPE PUBLI.
   Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0.
   Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004.
   Bellis MA, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-72.
   Bellis MA, 2014, J PUBLIC HEALTH-UK, V36, P81, DOI 10.1093/pubmed/fdt038.
   Bernal W, 2013, J HEPATOL, V59, P74, DOI 10.1016/j.jhep.2013.02.010.
   Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8.
   Boxall EH, 2004, ARCH DIS CHILD-FETAL, V89, pF456, DOI 10.1136/adc.2002.009837.
   British Society of Paediatric Gastreonterology Hepatology and Nutrition, 2012, INV NEON CONJ HYP.
   Bruce CK, 2010, HUM MUTAT, V31, P858, DOI 10.1002/humu.21261.
   Cartledge P, 2012, ARCH DIS CHILD, V97, P166, DOI 10.1136/adc.2009.179812.
   Castelnuovo E, 2006, HEALTH TECHNOL ASSES, V10, P1.
   Centre for Workforce Intelligence, 2011, REC MED SPEC TRAIN G.
   Chen SM, 2006, PEDIATRICS, V117, P1147, DOI 10.1542/peds.2005-1267.
   Chief Medical Officer Department of Health, 2014, GETT AH CURV STRAT C.
   Chief Medical Officer for England, 2008, ANN REPORT.
   Chien YC, 2006, EPIDEMIOL REV, V28, P126, DOI 10.1093/epirev/mxj010.
   Coates T, 2001, CLIN THER, V23, P392, DOI 10.1016/S0149-2918(01)80044-8.
   Crawford M, 2004, LANCET, V364, P1334, DOI 10.1016/S0140-6736(04)17190-0.
   Crossan C, HLTH TECHNO IN PRESS.
   Davenport M, 2011, J PEDIATR SURG, V46, P1689, DOI 10.1016/j.jpedsurg.2011.04.013.
   Day CP, 2000, J ROY COLL PHYS LOND, V34, P557.
   De Angelis D, 2009, STAT METHODS MED RES, V18, P361, DOI 10.1177/0962280208094691.
   de Franchis R, 2005, J HEPATOL, V43, P167, DOI 10.1016/j.jhep.2005.05.009.
   Department of Health, 2007, PROGR BUDG GUID MAN.
   Department of Health, PUBL HLTH RESP DEAL.
   Department of Health, 2013, LIV WELL LONG CALL A.
   Department of Health, 2008, TRANS MOV WELL GOOD.
   Department of Health, 2011, CONS STRAT IMPR LIV.
   Department of Health (UK), 2008, SAF SENS SOC GOV ALC.
   Dong M, 2003, ARCH INTERN MED, V163, P1949, DOI 10.1001/archinte.163.16.1949.
   Donnan PT, 2009, HEALTH TECHNOL ASSES, V13, pIX, DOI 10.3310/hta13250.
   Dube S. R., 2006, Journal of Adolescent Health, V38, DOI 10.1016/j.jadohealth.2005.06.006.
   Dwyer MJ, 1996, EPIDEMIOL INFECT, V117, P121, DOI 10.1017/S0950268800001217.
   Dyson J, 2014, J HEPATOL, V60, P110, DOI 10.1016/j.jhep.2013.08.011.
   Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327.
   Feldstein AE, 2009, GUT, V58, P1538, DOI 10.1136/gut.2008.171280.
   Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8.
   Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338.
   Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034.
   General Medical Council, 2010, SPEC TRAIN CURR GAST.
   Giraudon I, 2009, VACCINE, V27, P2016, DOI 10.1016/j.vaccine.2008.12.016.
   Godbole G, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-222.
   Goldberger JJ, 2013, JAMA-J AM MED ASSOC, V309, P2559, DOI 10.1001/jama.2013.6629.
   Gordon SC, 2012, HEPATOLOGY, V56, P1651, DOI 10.1002/hep.25842.
   Gornall J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3190.
   Gornall J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7646.
   Government Office for Science, 2014, TRACKL OB FUT CHOIC.
   Gregorio GV, 2002, AUTOIMMUNITY, V35, P515, DOI 10.1080/0891693021000056721.
   Hahne S, 2004, J CLIN VIROL, V29, P211, DOI 10.1016/j.jcv.2003.09.016.
   Harman DJ, 2013, HEPATOLOGY, V58, p328A.
   Harris RJ, 2014, J HEPATOL, V61, P530, DOI 10.1016/j.jhep.2014.05.008.
   Hastings G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1227.
   Hastings G, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1767.
   Hatton J, 2009, ADDICTION, V104, P587, DOI 10.1111/j.1360-0443.2008.02493.x.
   HCV Action, 2011, CENS MED WORKF INFR.
   Health and Social Care Information Centre (HSCIC), HOSP EP STAT.
   Health and Social Care Information Centre (HSCIC) Public Health England, 2013, PUBL HLTH ENGL NAT C.
   HM Government, 2012, GOV ALC STRAT.
   Holmes J, 2014, LANCET, V383, P1655, DOI 10.1016/S0140-6736(13)62417-4.
   HRUBEC Z, 1981, ALCOHOL CLIN EXP RES, V5, P207, DOI 10.1111/j.1530-0277.1981.tb04890.x.
   HSCIC, 2014, STAT OB PHYS ACT DIE.
   Hughes NR, 2013, FRONTLINE GASTROENTE, V4, P130, DOI 10.1136/flgastro-2012-100260.
   Hutchinson SJ, 2006, SCOT MED J, V51, P8.
   Jackson R., 2009, SCREENING BRIEF INTE.
   Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854.
   Jairath V, 2014, DIGEST LIVER DIS, V46, P419, DOI 10.1016/j.dld.2013.12.010.
   Jewell J, 2010, CLIN MED, V10, P259, DOI 10.7861/clinmedicine.10-3-259.
   Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub3.
   Kaner EFS, 2009, DRUG ALCOHOL REV, V28, P301, DOI 10.1111/j.1465-3362.2009.00071.x.
   Kim D, 2013, HEPATOLOGY, V57, P1357, DOI 10.1002/hep.26156.
   Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355.
   Kozlitina J, 2014, NAT GENET, V46, P352, DOI 10.1038/ng.2901.
   Kwon JA, 2012, AIDS, V26, P2201, DOI 10.1097/QAD.0b013e3283578b5d.
   Lawitz EJ, 2014, J GASTROEN HEPATOL, V29, P1574, DOI 10.1111/jgh.12632.
   Lawson A, 2010, J VIRAL HEPATITIS, V17, P51, DOI 10.1111/j.1365-2893.2009.01148.x.
   Lee CF, 2006, BMJ-BRIT MED J, V332, P328, DOI 10.1136/bmj.38719.435833.7C.
   Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3.
   Liang WB, 2011, DRUG ALCOHOL REV, V30, P524, DOI 10.1111/j.1465-3362.2010.00281.x.
   Lilford RJ, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17280.
   Lister G, 2007, P NATL SOCIAL MARKET.
   Marcos A, 2000, TRANSPLANTATION, V69, P2410, DOI 10.1097/00007890-200006150-00034.
   Martin NK, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003153.
   Martin NK, 2013, HEPATOLOGY, V58, P1598, DOI 10.1002/hep.26431.
   Martin NK, 2013, CLIN INFECT DIS, V57, pS39, DOI 10.1093/cid/cit296.
   Martin NK, 2012, HEPATOLOGY, V55, P49, DOI 10.1002/hep.24656.
   Martin NK, 2014, J VIRAL HEPATITUS, DOI {[}10.1111/jvh.1233, DOI 10.1111/JVH.1233].
   Martinez SM, 2011, HEPATOLOGY, V53, P325, DOI 10.1002/hep.24013.
   McDonagh JE, 2003, PEDIATR CLIN N AM, V50, P1561, DOI 10.1016/S0031-3955(03)00131-7.
   McKiernan PJ, 2000, LANCET, V355, P25, DOI 10.1016/S0140-6736(99)03492-3.
   McLernon DJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004837.
   McPherson S, 2010, GUT, V59, P1265, DOI 10.1136/gut.2010.216077.
   McVernon J, 2003, LANCET, V361, P1521, DOI 10.1016/S0140-6736(03)13171-6.
   Mieli-Vergani G, 2008, DIS LIVER BILIARY SY, P191.
   Miller WR, 2002, ADDICTION, V97, P265, DOI 10.1046/j.1360-0443.2002.00019.x.
   Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3.
   Morando F, 2013, J HEPATOL, V59, P257, DOI 10.1016/j.jhep.2013.03.010.
   Moriarty JK, 2014, ALCOHOL RELATED DIS.
   Moriarty K, 2014, QUALITY PRODUCTIVITY.
   Moriarty KJ, 2007, CLIN MED, V7, P125, DOI 10.7861/clinmedicine.7-2-125.
   Moriarty KJ, 2011, FRONTLINE GASTROENTE, V2, P77, DOI 10.1136/fg.2010.002105.
   Morling JR, 2014, LIVER INT, V34, P1267, DOI 10.1111/liv.12385.
   Morling JR, 2014, J HEPATOL, V60, P384, DOI 10.1016/j.jhep.2013.10.017.
   Mushtaq I, 1999, BRIT MED J, V319, P471, DOI 10.1136/bmj.319.7208.471.
   Nakamura R, 2014, ADDICTION, V109, P558, DOI 10.1111/add.12419.
   NatCen Social Research University College London Department of Epidemiology and Public Health, 2014, HLTH SURV ENGL.
   National Confidential Enquiry into Patient Outcome and Death (NCEPOD), 2013, ALC REL LIV DIS MEAS.
   National Health Service Blood and Transplant, 2014, TAK ORG TRANSPL 2020.
   National Health Service Right Care, 2013, LIV DIS NHS ATL VAR.
   National Institute for Health and Care Excellence, ALC DEP NALM.
   National Institute for Health and Clinical Excellence, 2010, ALC US DIS PREV DEV.
   National Offender Management Service, 2013, NAT PARTN AGR.
   NHS Commissioning Board, 2013, CLIN COMM POL COMPL.
   NHS Information Centre, 2014, IND QUAL IMPR.
   NHS National Institute of Health Research, 2014, LOCATE STUD.
   NICE, 2010, NEON JAUND.
   NICE, 2012, HEP B C WAYS PROM OF.
   Nobili V, 2010, GUT, V59, P561, DOI 10.1136/gut.2009.187039.
   O'Brien AJ, 2012, INTENS CARE MED, V38, P991, DOI 10.1007/s00134-012-2523-2.
   O'Grady JG, 2013, FRONTLINE GASTROENTE, V4, P187, DOI 10.1136/flgastro-2012-100267.
   Office for National Statistics, 2013, MORT STAT DEATHS REG.
   Office for National Statistics, 2010, MORT STAT DEATHS REG.
   Office for National Statistics, 2014, CANC SURV RAT.
   Olds D, 1998, JAMA-J AM MED ASSOC, V280, P1238, DOI 10.1001/jama.280.14.1238.
   Olds DL, 1997, JAMA-J AM MED ASSOC, V278, P637, DOI 10.1001/jama.278.8.637.
   Organization WH, 2014, GUID SCREEN CAR TREA.
   Pagadala MR, 2012, AM J GASTROENTEROL, V107, P1859, DOI 10.1038/ajg.2012.320.
   Patanwala I, 2012, FRONTLINE GASTROENTE, V3, P52, DOI 10.1136/flgastro-2011-100028.
   PETERSON B, 1983, DRUG ALCOHOL DEPEN, V11, P279, DOI 10.1016/0376-8716(83)90019-4.
   PETERSSON B, 1985, CIBA F SYMP, V110, P143.
   Petta S, 2015, LIVER INT, V35, P1566, DOI 10.1111/liv.12584.
   Powell JE, 2003, J MED SCREEN, V10, P112, DOI 10.1258/096914103769010996.
   Poynard T, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-40.
   Poynard Thierry, 2011, Gastroenterol Hepatol (N Y), V7, P445.
   Poynard T, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-40.
   Prime Ministers Strategy Unit, 2003, STRAT UN ALC HARM RE.
   Public Health England, LOC ALC PROF ENGL LA.
   Public Health England, 2012, DEATHS LIV DIS IMPL.
   Public Health England, HLTH PROF ENGL IND D.
   Public Health England National Liver Disease Information Service, 2014, LOC AUTH LIV DIS PRO.
   Puoti C, 2012, J VIRAL HEPATITIS, V19, P229, DOI 10.1111/j.1365-2893.2011.01485.x.
   Purshouse RC, 2010, LANCET, V375, P1355, DOI 10.1016/S0140-6736(10)60058-X.
   Rand Europe, 2012, ASS YOUNG PEOPL EXP.
   Ratib S, 2014, J HEPATOL, V60, P282, DOI 10.1016/j.jhep.2013.09.027.
   Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257.
   Roulot D, 2011, GUT, V60, P977, DOI 10.1136/gut.2010.221382.
   Royal College of Nursing Competences, 2013, CAR PEOPL LIV DIS CO.
   Ryder SD, 2010, CLIN MED, V10, P435, DOI 10.7861/clinmedicine.10-5-435.
   Sarri G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3893.
   SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x.
   Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033.
   Science Group of the European Alcohol and Health Forum, 2009, DOES MARK COMM IMP V.
   Sheen D, 2013, STAT HDB 2013.
   Sheron N, 2013, BRIT J GEN PRACT, V63, pE698, DOI 10.3399/bjgp13X673711.
   Sheron N, 2011, BMJ-BRIT MED J, V341, P1105.
   Sheron N, 2014, CLIN MED, V14, P396, DOI 10.7861/clinmedicine.14-4-396.
   Sheron N, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X654588.
   Shield KD, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-53.
   Siddiqui MR, 2011, VACCINE, V29, P466, DOI 10.1016/j.vaccine.2010.10.075.
   Siegler Veronique, 2011, Health Stat Q, P4, DOI 10.1057/hsq.2011.7.
   Simon TG, 2015, J HEPATOL, V62, P18, DOI 10.1016/j.jhep.2014.08.013.
   Smith GB, 2013, RESUSCITATION, V84, P465, DOI 10.1016/j.resuscitation.2012.12.016.
   Stockwell T, 2011, ADDICTION, V106, P768, DOI 10.1111/j.1360-0443.2010.03331.x.
   The Royal College of Psychiatrists The Royal College of General Practitioners, 2014, ALC BRAIN DAM AD REF.
   Turner KME, 2011, ADDICTION, V106, P1978, DOI 10.1111/j.1360-0443.2011.03515.x.
   University of Stirling, 2013, HLTH 1 EV BAS ALC ST.
   Vergniol J, 2014, HEPATOLOGY, V60, P65, DOI 10.1002/hep.27069.
   Verma S, 2013, LIVER INT, V33, P1398, DOI 10.1111/liv.12226.
   Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x.
   Verrill C, 2009, ADDICTION, V104, P768, DOI 10.1111/j.1360-0443.2009.02521.x.
   Vickerman P, 2012, ADDICTION, V107, P1984, DOI 10.1111/j.1360-0443.2012.03932.x.
   Volk ML, 2010, GASTROENTEROLOGY, V139, P14, DOI 10.1053/j.gastro.2010.05.017.
   Wallis DE, 1999, BRIT MED J, V318, P1112, DOI 10.1136/bmj.318.7191.1112.
   WANLESS IR, 1990, HEPATOLOGY, V12, P1106, DOI 10.1002/hep.1840120505.
   Wedemeyer H, 2014, J VIRAL HEPATITIS, V21, P60, DOI 10.1111/jvh.12249.
   WHO Regional Office for Europe, 2013, EUR REP PREV CHILD M.
   Williams R, 2013, LANCET, V381, P2164, DOI 10.1016/S0140-6736(13)61438-5.
   Wong VWS, 2012, GUT, V61, P409, DOI 10.1136/gutjnl-2011-300342.
   World Health Organization regional office for Europe, 2014, EUR HLTH ALL DAT HFA.
   Wright M, 2006, HEALTH TECHNOL ASSES, V10, P1.
   Yeomans J, 2014, GROCER          0319.
   Zhao JH, 2013, ADDICTION, V108, P1059, DOI 10.1111/add.12139.},
Number-of-Cited-References = {197},
Times-Cited = {321},
Usage-Count-Last-180-days = {3},
Usage-Count-Since-2013 = {51},
Journal-ISO = {Lancet},
Doc-Delivery-Number = {AU2LP},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000345450100032},
OA = {Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000208638000030,
Author = {Sokka, Tuulikki and Pincus, Theodore},
Title = {Poor physical function, pain and limited exercise: risk factors for
   premature mortality in the range of smoking or hypertension, identified
   on a simple patient self-report questionnaire for usual care},
Journal = {BMJ OPEN},
Year = {2011},
Volume = {1},
Number = {1},
Abstract = {Objective: To analyse poor physical function, pain, limited exercise and
   smoking, assessed in a patient-friendly self-report questionnaire format
   that has been completed by every patient at every visit over 20-30 years
   in the authors' and other usual care settings, to predict 5-year
   mortality in a general older population.
   Methods: An extended version of a Multidimensional Health Assessment
   Questionnaire was mailed to 2000 subjects in Finland, identified as a
   randomly selected control cohort for a rheumatoid arthritis cohort. The
   questionnaire included queries concerning baseline physical function,
   pain, exercise and smoking status, identical to the clinic version, as
   well as age and 25 medical conditions. Five-year survival was analysed
   according to descriptive statistics, Kaplan-Meier curves and Cox
   regressions.
   Results: The questionnaire was returned by 1523 subjects (76\%).
   Five-year survival was 94\% in all subjects, 98\% in subjects with no
   disease or no acutely life-threatening disease, and 17\% in subjects
   with an acutely life-threatening disease. Hazard ratios (HRs) for 5-year
   mortality were 3.5 for poor physical function, 2.2 for pain, 5.2 for
   limited exercise and 4.6 for smoking (p<0.01); 5-year survivals were
   93\%, 97\%, 93\% and 95\%, respectively, compared with 91\% for
   hypertension. Each of the four patient history variables predicted
   mortality at higher levels in subjects who reported no versus one or
   more acutely life-threatening conditions.
   Conclusions: Poor physical function, pain, limited exercise and smoking
   can be assessed systematically on a simple standard Multidimensional
   Health Assessment Questionnaire, to identify potentially modifiable risk
   factors for premature mortality in the infrastructure of usual medical
   care and health maintenance.},
Publisher = {BMJ PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Pincus, T (Corresponding Author), NYU, Sch Med, New York, NY USA.
   Sokka, Tuulikki, Jyvaskyla Cent Hosp, Jyvaskyla, Finland.
   Sokka, Tuulikki, Medcare Oy, Aanekoski, Finland.
   Pincus, Theodore, NYU, Sch Med, New York, NY USA.
   Pincus, Theodore, NYU Hosp Joint Dis, New York, NY USA.},
DOI = {10.1136/bmjopen-2011-000070},
Article-Number = {e000070},
ISSN = {2044-6055},
Keywords-Plus = {HEALTH-ASSESSMENT QUESTIONNAIRE; RHEUMATOID-ARTHRITIS; VITAL SIGNS;
   MDHAQ; INFRASTRUCTURE; POPULATION; DISABILITY; DISEASE; SMOKERS; SCORES},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {tedpincus@gmail.com},
Cited-References = {Andersson HI, 2004, EUR J PAIN, V8, P47, DOI 10.1016/S1090-3801(03)00064-8.
   {[}Anonymous], 2000, PAIN ASS MAN ORG APP.
   Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205.
   Covinsky KE, 1997, J GEN INTERN MED, V12, P203, DOI 10.1046/j.1525-1497.1997.012004203.x.
   Davis MP, 2004, CLEV CLIN J MED, V71, P625, DOI 10.3949/ccjm.71.8.625.
   Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3.
   Fiore MC, 2004, AM J PUBLIC HEALTH, V94, P205, DOI 10.2105/AJPH.94.2.205.
   FIORE MC, 1995, MAYO CLIN PROC, V70, P209, DOI 10.4065/70.3.209.
   FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202.
   Gawande A, 2009, CHECKLIST MANIFESTO.
   GORDON T, 1977, JAMA-J AM MED ASSOC, V238, P497, DOI 10.1001/jama.238.6.497.
   Hakim AA, 1998, NEW ENGL J MED, V338, P94, DOI 10.1056/NEJM199801083380204.
   Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119.
   Helgason AR, 2002, SCAND J PUBLIC HEALT, V30, P141, DOI 10.1080/14034940210133799.
   HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8.
   Justice AC, 1996, J CLIN EPIDEMIOL, V49, P193, DOI 10.1016/0895-4356(95)00546-3.
   KAPLAN GA, 1987, AM J PUBLIC HEALTH, V77, P307, DOI 10.2105/AJPH.77.3.307.
   Kareholt I, 1998, PAIN, V77, P271, DOI 10.1016/S0304-3959(98)00103-1.
   Kauppi M, 2005, J RHEUMATOL, V32, P807.
   Konstam V, 1996, AM J CARDIOL, V78, P890, DOI 10.1016/S0002-9149(96)00463-8.
   Kvien TK, 1996, J RHEUMATOL, V23, P1866.
   McBeth J, 2009, RHEUMATOLOGY, V48, P74, DOI 10.1093/rheumatology/ken424.
   Pincus T, 1999, ARTHRITIS RHEUM-US, V42, P2220, DOI 10.1002/1529-0131(199910)42:10<2220::AID-ANR26>3.0.CO;2-5.
   Pincus T, 2000, J RHEUMATOL, V27, P2727.
   PINCUS T, 1984, ARTHRITIS RHEUM-US, V27, P864, DOI 10.1002/art.1780270805.
   Pincus T, 2005, J RHEUMATOL, V32, P1432.
   Pincus T, 2005, ARTHRITIS RHEUM-US, V52, P1009, DOI 10.1002/art.20941.
   Pincus T, 2008, BULL HOSP JT DIS, V66, P155.
   Pincus T, 2010, BULL HOSP JT DIS, V68, P223.
   Pincus T, 2009, RHEUM DIS CLIN N AM, V35, P799, DOI 10.1016/j.rdc.2009.10.012.
   Pincus T, 2009, RHEUM DIS CLIN N AM, V35, P787, DOI 10.1016/j.rdc.2009.10.011.
   Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644.
   Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS14.
   Sokka T, 2008, RHEUMATOLOGY, V47, P1543, DOI 10.1093/rheumatology/ken316.
   Sokka T, 2004, ANN RHEUM DIS, V63, P494, DOI 10.1136/ard.2003.009530.
   Sokka T, 2003, ARTHRITIS RHEUM, V48, P59, DOI 10.1002/art.10731.
   Thorndike AN, 1998, JAMA-J AM MED ASSOC, V279, P604, DOI 10.1001/jama.279.8.604.
   WOLFE F, 1994, ARTHRITIS RHEUM-US, V37, P481, DOI 10.1002/art.1780370408.},
Number-of-Cited-References = {38},
Times-Cited = {20},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {BMJ Open},
Doc-Delivery-Number = {V27UL},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000208638000030},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000562920900002,
Author = {Martinez, Ramon and Soliz, Patricia and Mujica, Oscar J. and Reveiz,
   Ludovic and Campbell, Norm R. C. and Ordunez, Pedro},
Title = {The slowdown in the reduction rate of premature mortality from
   cardiovascular diseases puts the Americas at risk of achieving SDG 3.4:
   A population trend analysis of 37 countries from 1990 to 2017},
Journal = {JOURNAL OF CLINICAL HYPERTENSION},
Year = {2020},
Volume = {22},
Number = {8},
Pages = {1296-1309},
Month = {AUG},
Abstract = {Cardiovascular diseases (CVD) are leading causes of mortality and
   morbidity in the Americas, resulting in substantial negative economic
   and social impacts. This study describes the trends and inequalities of
   CVD burden in the Americas to guide programmatic interventions and
   health system responses. We examined the CVD burden trends by age, sex,
   and countries between 1990 and 2017 and quantified social inequalities
   in CVD burden across countries. In 2017, CVD accounted for 2 million
   deaths in the Americas, 29\% of total deaths. Age-standardized DALY
   rates caused by CVD declined by -1.9\% (95\% uncertainty interval, -2.0
   to -1.7) annually from 1990 to 2017. This trend varied with a striking
   decreasing trend over the interval 1994-2003 (annual percent change
   (APC) -2.4\% {[}-2.5 to 2.2]) and 2003-2007 (APC -2.8\% {[}-3.4 to
   -2.2]). This was followed by a slowdown in the rate of decline over
   2007-2013 (APC -1.83\% {[}-2.1 to -1.6]) and a stagnation during the
   most recent period 2013-2017 (APC -0.1\% {[}-0.5 to 0.3]). The social
   inequality in CVD burden along the socio-demographic gradient across
   countries decreased 2.75-fold. The CVD burden and related social
   inequality have both substantially decreased in the Americas since 1990,
   driven by the reduction in premature mortality. This trend occurred in
   parallel with the improvement in the socioeconomic development and
   health care of the region. The deceleration and stagnation in the rate
   of improvement of CVD burden and persistent social inequality pose major
   challenges to reduce the CVD burden and the achievement of the United
   Nations' Sustainable Development Goals Target 3.4.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Martinez, R (Corresponding Author), Pan Amer Hlth Org, 525 23rd St NW, Washington, DC 20037 USA.
   Martinez, Ramon; Soliz, Patricia; Mujica, Oscar J.; Reveiz, Ludovic; Ordunez, Pedro, Pan Amer Hlth Org, 525 23rd St NW, Washington, DC 20037 USA.
   Campbell, Norm R. C., Univ Calgary, Dept Med, Calgary, AB, Canada.
   Campbell, Norm R. C., Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada.},
DOI = {10.1111/jch.13922},
ISSN = {1524-6175},
EISSN = {1751-7176},
Keywords = {cardiovascular diseases; epidemiology; global burden of disease; health
   inequalities; trend analysis},
Keywords-Plus = {SEX-SPECIFIC MORTALITY; GLOBAL BURDEN; SYSTEMATIC ANALYSIS; TERRITORIES},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Peripheral Vascular Disease},
Author-Email = {martiner@paho.org},
ORCID-Numbers = {Mujica, Oscar/0000-0002-2893-4206
   Martinez-Piedra, Ramon/0000-0003-0641-0206},
Cited-References = {Atun R, 2015, LANCET, V385, P1230, DOI 10.1016/S0140-6736(14)61646-9.
   Bernabe-Ortiz A, 2020, NAT MED, V26, P374, DOI 10.1038/s41591-020-0754-2.
   Bilano V, 2015, LANCET, V385, P966, DOI 10.1016/S0140-6736(15)60264-1.
   Dicker D, 2018, LANCET, V392, P1684, DOI 10.1016/s0140-6736(18)31891-9.
   Economic Commission for Latin America and the Caribbean , 2019, LCPUB20193P ECLAC.
   Frieden TR, 2018, LANCET, V391, P709, DOI 10.1016/S0140-6736(17)32443-1.
   {[}Global Burden of Disease Collaborative Network Seattle USIfHMaEI], 2017, GLOB BURD DIS STUD 2.
   Hachinski V, 2016, LANCET NEUROL, V15, P892, DOI 10.1016/S1474-4422(16)30120-X.
   Hone T, 2019, LANCET GLOB HEALTH, V7, pE1575, DOI 10.1016/S2214-109X(19)30409-7.
   James SL, 2018, LANCET, V392, P1789, DOI 10.1016/s0140-6736(18)32279-7.
   Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.3.CO;2-Q.
   Kontis V, 2019, CIRCULATION, V140, P715, DOI 10.1161/CIRCULATIONAHA.118.038160.
   Kyu HH, 2018, LANCET, V392, P1859, DOI {[}10.1016/S0140-6736(18)32335-3, 10.1016/s0140-6736(18)32335-3].
   Lee ES, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157036.
   Lloyd-Sherlock P, 2019, LANCET GLOB HEALTH, V7, pE604, DOI 10.1016/S2214-109X(19)30069-5.
   Lopez AD, 2019, INT J EPIDEMIOL, V48, P1815, DOI 10.1093/ije/dyz143.
   Malta DC, 2018, CIENC SAUDE COLETIVA, V23, P3115, DOI 10.1590/1413-812320182310.25222018.
   Margerison-Zilko Claire, 2016, Curr Epidemiol Rep, V3, P81.
   Martinez R, 2020, LANCET GLOB HEALTH, V8, pE511, DOI 10.1016/S2214-109X(20)30035-8.
   Martinez R, 2019, INT J EPIDEMIOL, V48, P1367, DOI 10.1093/ije/dyy254.
   Minujin A, 2003, J HUM DEV, V4, P397, DOI DOI 10.1080/1464988032000125764.
   Mujica J, 2019, PAN AM J PUBLIC HLTH, V43, P1.
   National Cancer Institute, JOINP REGR PROGR.
   Nichols E, 2019, LANCET NEUROL, V18, P88, DOI 10.1016/S1474-4422(18)30403-4.
   PAHO/WHO, HEARTS AM.
   Pan American Health Organization/, 2017, HLTH AM 2017 ED SUMM.
   Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7.
   Roth GA, 2018, JAMA CARDIOL, V3, P375, DOI 10.1001/jamacardio.2018.0385.
   Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052.
   Roth GA, 2015, NEUROEPIDEMIOLOGY, V45, P146, DOI 10.1159/000441083.
   Stevens GA, 2016, PLOS MED, V13, DOI {[}10.1371/journal.pmed.1002056, 10.1371/journal.pmed.1002116].
   The WHO Alliance for Maternal and Newborn Health Improvement late pregnancy dating study group, 2020, LANCET GLOB HEALTH, V8, pe545.
   U.S Centers for Disease Prevention and Control, 2019, HLTH US SPOTL RAC ET, P2.
   Gonzalez YV, 2020, J CLIN HYPERTENS, V22, P142, DOI 10.1111/jch.13814.
   World Health Organization, WHO GLOB HEARTS IN W.
   World Health Organization, GLOB ACT PLAN PREV C.
   Yusuf S, 2020, LANCET, V395, P795, DOI 10.1016/S0140-6736(19)32008-2.
   Zhou B, 2018, INT J EPIDEMIOL, V47, P872, DOI 10.1093/ije/dyy016.
   2013, HDB HLTH IN MON, P1.},
Number-of-Cited-References = {39},
Times-Cited = {8},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {J. Clin. Hypertens.},
Doc-Delivery-Number = {NE9JY},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000562920900002},
OA = {Green Published},
DA = {2022-03-29},
}

@article{ WOS:000748131900002,
Author = {Sariaslan, Amir and Sharpe, Michael and Larsson, Henrik and Wolf, Achim
   and Lichtenstein, Paul and Fazel, Seena},
Title = {Psychiatric comorbidity and risk of premature mortality and suicide
   among those with chronic respiratory diseases, cardiovascular diseases,
   and diabetes in Sweden: A nationwide matched cohort study of over 1
   million patients and their unaffected siblings},
Journal = {PLOS MEDICINE},
Year = {2022},
Volume = {19},
Number = {1},
Month = {JAN},
Abstract = {Author summary Why was this study done? Noncommunicable diseases are a
   global public health challenge accounting for an excess of 40 million
   deaths annually.Comorbid psychiatric disorders have been identified as
   potential risk markers for premature mortality in patients with
   noncommunicable diseases.There is uncertainty about the extent and the
   nature of the association between psychiatric comorbidities and
   premature mortality.As most of the research has focused on comorbid
   depression as a risk marker and all-cause mortality as outcome, less is
   known about other psychiatric comorbidities and cause-specific
   mortality, including death by suicide. What did the researchers do and
   find? We used national registers in Sweden to investigate over 1 million
   patients born between 1932 and 1995 and diagnosed with chronic
   respiratory diseases, cardiovascular diseases, and diabetes.More than
   7\% of the patients died of any cause within 5 years, and 0.3\% died
   from suicide. These risks were more than doubled in patients with
   psychiatric comorbidities compared to those without such
   comorbidities.Most of the psychiatric comorbidities were identified and
   diagnosed before the noncommunicable diseases.By comparing each of the
   patients with their unaffected siblings, we accounted for familial risk
   factors that were shared between the siblings (e.g., genetic and
   childhood environmental risk factors).We found that psychiatric
   comorbidity was consistently associated with elevated rates of premature
   mortality and suicide in the sibling comparison analyses and persisted
   following additional adjustments for sociodemographic factors and body
   mass index (BMI). What do these findings mean? Identification and
   treatment of co-occurring substance use disorders and depression in
   people admitted to general hospitals for chronic health conditions may
   improve mortality and morbidity in these patients.Public health
   initiatives can consider how to improve detection and management of
   comorbid psychiatric conditions in primary care.New models for the
   delivery of more integrated services for physical health, psychiatry,
   and substance use disorders need investigation as part of wider measures
   to reduce mortality in noncommunicable diseases.
   BackgroundPersons with noncommunicable diseases have elevated rates of
   premature mortality. The contribution of psychiatric comorbidity to this
   is uncertain. We aimed to determine the risks of premature mortality and
   suicide in people with common noncommunicable diseases, with and without
   psychiatric disorder comorbidity. Methods and findingsWe used nationwide
   registries to study all individuals born in Sweden between 1932 and 1995
   with inpatient and outpatient diagnoses of chronic respiratory diseases
   (n = 249,825), cardiovascular diseases (n = 568,818), and diabetes (n =
   255,579) for risks of premature mortality (<= age 65 years) and suicide
   until 31 December 2013. Patients diagnosed with either chronic
   respiratory diseases, cardiovascular diseases, or diabetes were compared
   with age and sex-matched population controls (n = 10,345,758) and
   unaffected biological full siblings (n = 1,119,543). Comorbidity with
   any psychiatric disorder, and by major psychiatric categories, was
   examined using diagnoses from patient registers. Associations were
   quantified using stratified Cox regression models that accounted for
   time at risk, measured sociodemographic factors, and unmeasured familial
   confounders via sibling comparisons. Within 5 years of diagnosis, at
   least 7\% (range 7.4\% to 10.8\%; P < 0.001) of patients with
   respiratory diseases, cardiovascular diseases, or diabetes (median age
   at diagnosis: 48 to 54 years) had died from any cause, and 0.3\% (0.3\%
   to 0.3\%; P < 0.001) had died from suicide, 25\% to 32\% of people with
   these medical conditions had co-occurring lifetime diagnoses of any
   psychiatric disorder, most of which antedated the medical diagnosis.
   Comorbid psychiatric disorders were associated with higher all-cause
   mortality (15.4\% to 21.1\%) when compared to those without such
   conditions (5.5\% to 9.1\%). Suicide mortality was also elevated (1.2\%
   to 1.6\% in comorbid patients versus 0.1\% to 0.1\% without
   comorbidity). When we compared relative risks with siblings without
   noncommunicable diseases and psychiatric disorders, the comorbidity with
   any psychiatric disorder was associated with substantially increased
   mortality rates (adjusted HR range: aHR(CR) = 7.2 {[}95\% CI: 6.8 to
   7.7; P < 0.001] to aHR(CV) = 8.9 {[}95\% CI: 8.5 to 9.4; P < 0.001]).
   Notably, comorbid substance use disorders were associated with a higher
   mortality rate (aHR range: aHR(CR) = 8.3 {[}95\% CI: 7.6 to 9.1; P <
   0.001] to aHR(CV) = 9.9 {[}95\% CI: 9.3 to 10.6; P < 0.001]) than
   depression (aHR range: aHR(CR) = 5.3 {[}95\% CI: 4.7 to 5.9; P < 0.001]
   to aHR(CV) = 7.4 {[}95\% CI: 7.0 to 7.9; P < 0.001]), but risks of
   suicide were similar for these 2 psychiatric comorbidities.One
   limitation is that we relied on secondary care data to assess
   psychiatric comorbidities, which may have led to missing some patients
   with less severe comorbidities. Residual genetic confounding is another
   limitation, given that biological full siblings share an average of half
   of their cosegregating genes. However, the reported associations
   remained large even after adjustment for shared and unmeasured familial
   confounders. ConclusionsIn this longitudinal study of over 1 million
   patients with chronic health diseases, we observed increased risks of
   all-cause and suicide mortality in individuals with psychiatric
   comorbidities. Improving assessment, treatment, and follow-up of people
   with comorbid psychiatric disorders may reduce the risk of mortality in
   people with chronic noncommunicable diseases.},
Publisher = {PUBLIC LIBRARY SCIENCE},
Address = {1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA},
Type = {Article},
Language = {English},
Affiliation = {Fazel, S (Corresponding Author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England.
   Sariaslan, Amir; Sharpe, Michael; Wolf, Achim; Fazel, Seena, Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England.
   Larsson, Henrik; Lichtenstein, Paul, Karolinska Inst, Dept Med Epidemiol \& Biostat, Stockholm, Sweden.
   Larsson, Henrik, Orebro Univ, Sch Med Sci, Orebro, Sweden.},
DOI = {10.1371/journal.pmed.1003864},
Article-Number = {e1003864},
ISSN = {1549-1277},
EISSN = {1549-1676},
Keywords-Plus = {CORONARY-HEART-DISEASE; COLLABORATIVE CARE; MAJOR DEPRESSION; EXCESS
   MORTALITY; TOTAL POPULATION; DISORDERS; PREVALENCE; HEALTH;
   METAANALYSIS; ASSOCIATION},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {seena.fazel@psych.ox.ac.uk},
Funding-Acknowledgement = {Wellcome TrustWellcome TrustEuropean Commission {[}202836/Z/16/Z];
   Swedish Research Council for Health, Working Life and WelfareSwedish
   Research CouncilSwedish Research Council for Health Working Life \&
   Welfare (Forte) {[}2012-1678]; Swedish Research CouncilSwedish Research
   CouncilEuropean Commission {[}2016-01989]; National Institute for Health
   Research (NIHR) Collaboration for Leadership in Applied Health Research
   and Care Oxford at Oxford Health NHS Foundation Trust},
Funding-Text = {This research was funded by the Wellcome Trust, project: \#202836/Z/16/Z
   (https://wellcome.org/), to SF; the Swedish Research Council for Health,
   Working Life and Welfare, 2012-1678 (https://forte.se/en/), to PL; the
   Swedish Research Council, project: 2016-01989 (https://www.vr.se/), to
   PL, and the National Institute for Health Research (NIHR) Collaboration
   for Leadership in Applied Health Research and Care Oxford at Oxford
   Health NHS Foundation Trust (https://www.clahrc-oxford.nihr.ac.uk/) to
   MS. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.},
Cited-References = {Abbafati C, 2020, LANCET, V396, P1204, DOI 10.1016/S0140-6736(20)30925-9.
   Abdoli S, 2020, J DIABETES COMPLICAT, V34, DOI 10.1016/j.jdiacomp.2020.107608.
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069.
   {[}Anonymous], 2015, DIABETES CARE, V38, pS20, DOI 10.2337/dc15-S007.
   Chamberlain SR, 2019, BRIT J PSYCHIAT, V214, P11, DOI 10.1192/bjp.2018.66.
   Cuijpers P, 2014, AM J PSYCHIAT, V171, P453, DOI 10.1176/appi.ajp.2013.13030325.
   D'Onofrio BM, 2020, ANNU REV CLIN PSYCHO, V16, P25, DOI 10.1146/annurev-clinpsy-032816-045030.
   Deelen J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11558-2.
   Egede LE, 2007, GEN HOSP PSYCHIAT, V29, P409, DOI 10.1016/j.genhosppsych.2007.06.002.
   Erlangsen A, 2020, JAMA-J AM MED ASSOC, V323, P444, DOI 10.1001/jama.2019.21834.
   Eurostat, 2009, HLTH STAT ATL MORT E.
   Falcone GJ, 2014, LANCET NEUROL, V13, P405, DOI 10.1016/S1474-4422(14)70029-8.
   Fazel S, 2015, LANCET PSYCHIAT, V2, P224, DOI 10.1016/S2215-0366(14)00128-X.
   Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935.
   Fazel S, 2013, LANCET, V382, P1646, DOI 10.1016/S0140-6736(13)60899-5.
   Fazel S, 2009, JAMA-J AM MED ASSOC, V301, P2016, DOI 10.1001/jama.2009.675.
   Fortney JC, 2013, GEN HOSP PSYCHIAT, V35, P455, DOI 10.1016/j.genhosppsych.2013.04.010.
   Gagne JJ, 2011, J CLIN EPIDEMIOL, V64, P749, DOI 10.1016/j.jclinepi.2010.10.004.
   Ganna A, 2015, LANCET, V386, P533, DOI 10.1016/S0140-6736(15)60175-1.
   Gavin JR, 1999, DIABETES CARE, V22, pS5.
   Gold SM, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-020-0200-2.
   GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515.
   Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002.
   Halfdanarson O, 2017, EUR NEUROPSYCHOPHARM, V27, P1064, DOI 10.1016/j.euroneuro.2017.07.001.
   Hall M, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002501.
   Harding JL, 2014, DIABETES CARE, V37, P2579, DOI 10.2337/dc14-0096.
   Hippisley-Cox J, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2099.
   Hurst JR, 2018, LANCET GLOB HEALTH, V6, pE1270, DOI 10.1016/S2214-109X(18)30391-7.
   Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7.
   Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955.
   Khera AV, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2016.160.
   Klein-Geltink JE, 2007, J CLIN EPIDEMIOL, V60, P766, DOI 10.1016/j.jclinepi.2006.11.008.
   Lankester J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0255801.
   Lawson CA, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002540.
   Leuzzi G, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0070-2016.
   Levesque LE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5087.
   Licher S, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002741.
   Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769.
   Lichtman JH, 2014, CIRCULATION, V129, P1350, DOI 10.1161/CIR.0000000000000019.
   Liu NH, 2017, WORLD PSYCHIATRY, V16, P30, DOI 10.1002/wps.20384.
   Livingstone SJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001321.
   Ludvigsson JF, 2016, EUR J EPIDEMIOL, V31, P125, DOI 10.1007/s10654-016-0117-y.
   Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450.
   Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y.
   Machado MO, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1101-z.
   Marrie RA, 2018, GEN HOSP PSYCHIAT, V53, P65, DOI 10.1016/j.genhosppsych.2018.06.001.
   Mitchell AJ, 2009, BRIT J PSYCHIAT, V194, P491, DOI 10.1192/bjp.bp.107.045732.
   Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9.
   Neeleman J, 1997, PSYCHOL MED, V27, P467, DOI 10.1017/S0033291796004631.
   Nilsson A C, 1994, Lakartidningen, V91, P603.
   Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4.
   Northam EA, 2005, DIABETIC MED, V22, P152, DOI 10.1111/j.1464-5491.2004.01370.x.
   Ntritsos G, 2018, INT J CHRONIC OBSTR, V13, P1507, DOI 10.2147/COPD.S146390.
   Ortqvist AK, 2013, PHARMACOEPIDEM DR S, V22, P850, DOI 10.1002/pds.3465.
   Osimo EF, 2020, BRAIN BEHAV IMMUN, V87, P901, DOI 10.1016/j.bbi.2020.02.010.
   Papaioannou AI, 2013, EUR RESPIR J, V41, P815, DOI 10.1183/09031936.00013112.
   Park M, 2013, GEN HOSP PSYCHIAT, V35, P217, DOI 10.1016/j.genhosppsych.2013.01.006.
   Peng MM, 2019, ADDICTION, V114, P436, DOI 10.1111/add.14475.
   Pettersson E, 2019, PSYCHOL MED, V49, P1166, DOI 10.1017/S0033291718002039.
   Plana-Ripoll O, 2019, LANCET, V394, P1827, DOI 10.1016/S0140-6736(19)32316-5.
   Poole L, 2011, J PSYCHOSOM RES, V71, P61, DOI 10.1016/j.jpsychores.2010.12.009.
   Postma DS, 2015, LANCET, V385, P899, DOI 10.1016/S0140-6736(14)60446-3.
   Runeson B, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3222.
   Sariaslan A, 2020, JAMA PSYCHIAT, V77, P359, DOI 10.1001/jamapsychiatry.2019.4275.
   Sharpe M, 2016, LANCET PSYCHIAT, V3, P312, DOI 10.1016/S2215-0366(16)00062-6.
   Sharpe M, 2014, LANCET, V384, P1099, DOI 10.1016/S0140-6736(14)61231-9.
   Silverman EK, 2020, ANNU REV PHYSIOL, V82, P413, DOI 10.1146/annurev-physiol-021317-121224.
   Stensrud MJ, 2020, JAMA-J AM MED ASSOC, V323, P1401, DOI 10.1001/jama.2020.1267.
   The National Board of Health and Welfare, 2010, CAUS DEATH STAT HIST.
   Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP.
   Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2987, DOI 10.1001/jama.285.23.2987.
   Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6.
   WHO, 2018, WORLD HLTH STAT 2018.},
Number-of-Cited-References = {73},
Times-Cited = {0},
Usage-Count-Last-180-days = {3},
Usage-Count-Since-2013 = {3},
Journal-ISO = {PLos Med.},
Doc-Delivery-Number = {YO7QU},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000748131900002},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000251248200015,
Author = {Sokka, T. and Haugeberg, G. and Pincus, T.},
Title = {Assessment of quality of rheumatoid arthritis care requires joint count
   and/or patient questionnaire data not found in a usual medical record:
   examples from studies of premature mortality, changes in clinical status
   between 1985 and 2000, and a QUEST-RA global perspective},
Journal = {CLINICAL AND EXPERIMENTAL RHEUMATOLOGY},
Year = {2007},
Volume = {25},
Number = {6, 47},
Pages = {S86-S97},
Month = {NOV-DEC},
Abstract = {Quality of care of many diseases, such as diabetes, hypertension,
   hyperlipidemia, and osteoporosis, can be assessed effectively from
   information in usual medical records concerning blood tests, blood
   pressure, bone density, etc. However quality of care of rheumatoid
   arthritis (RA), as well as most rheumatic diseases, cannot be assessed
   from usual medical records. The primary basis for this problem. involves
   limitations of laboratory tests and the absence of a single `' gold
   standard `' measure in RA Therefore, indices which include laboratory
   tests, joint counts, and patient questionnaires have been developed.
   These indices are collected in all RA clinical trials and other clinical
   research, but not in usual clinical care, a phenomenon which may limit
   severely possible assessment and improvement of quality and patient.
   outcomes. Patient questionnaires and joint counts, rather than
   laboratory tests or radiographs in a Medical record, are the best
   measures to assess and monitor RA patient status. Patient questionnaires
   are the most significant clinical prognostic markers for severe
   long-term RA out-comes, such as work disability, costs and premature
   mortality, and are More cost-effective and easily-collected than formal
   quantitative joint counts in busy clinical settings. The value of
   patient questionnaires and joint counts in RA is reviewed in three
   examples from the authors research concerning premature mortality in RA,
   changes in patient clinical status between 1985 and 20001, and a
   QUEST-RA global perspective, to better evaluate the structure,
   processes, and outcomes of RA care.},
Publisher = {CLINICAL \& EXPER RHEUMATOLOGY},
Address = {VIA SANTA MARIA 31, 56126 PISA, ITALY},
Type = {Review},
Language = {English},
Affiliation = {Sokka, T (Corresponding Author), Jyvaskyla Cent Hosp, Jyvaskyla 40620, Finland.
   Jyvaskyla Cent Hosp, Jyvaskyla 40620, Finland.
   Medcare Oy, Aanekoski, Finland.
   Norwegian Univ Sci \& Technol, N-7034 Trondheim, Norway.
   Sorlandet Hosp, Kristiansand, Norway.
   NYU, Hosp Joint Dis, New York, NY USA.},
ISSN = {0392-856X},
EISSN = {1593-098X},
Keywords = {rheumatoid arthritis; quality care; QUEST-RA},
Keywords-Plus = {HEALTH-ASSESSMENT QUESTIONNAIRE; LONG-TERM OUTCOMES; MODIFYING
   ANTIRHEUMATIC DRUGS; SELF-REPORT QUESTIONNAIRES; GROSS DOMESTIC PRODUCT;
   ACTIVITY SCORE DAS; DATA SET MEASURES; 2ND LINE THERAPY;
   DISEASE-ACTIVITY; WORK DISABILITY},
Research-Areas = {Rheumatology},
Web-of-Science-Categories  = {Rheumatology},
Author-Email = {tuulikki.sokka@ksshp.fi},
Cited-References = {Aletaha D, 2005, CLIN EXP RHEUMATOL, V23, pS100.
   ALLEBECK P, 1981, SCAND J RHEUMATOL, V10, P301, DOI 10.3109/03009748109095320.
   ANDESON LG, 2007, CLIN EXP RHEUMAT S47, V47, pS6.
   Bergstrom U, 1999, SCAND J RHEUMATOL, V28, P160.
   Callahan LF, 1997, ARTHRIT CARE RES, V10, P381, DOI 10.1002/art.1790100606.
   Callahan LF, 1996, ARTHRIT CARE RES, V9, P463, DOI 10.1002/art.1790090608.
   CALLAHAN LF, 1992, J CLIN EPIDEMIOL, V45, P127.
   CHALMERS TC, 1983, NEW ENGL J MED, V309, P1358, DOI 10.1056/NEJM198312013092204.
   Choi HK, 2002, LANCET, V359, P1173, DOI 10.1016/S0140-6736(02)08213-2.
   COBB S, 1953, NEW ENGL J MED, V249, P553, DOI 10.1056/NEJM195310012491402.
   Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507.
   DIAMOND GA, 1983, ANN INTERN MED, V98, P385, DOI 10.7326/0003-4819-98-3-385.
   DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969.
   EGSMOSE C, 1995, J RHEUMATOL, V22, P2208.
   EMERY P, 1995, ANN RHEUM DIS, V54, P944, DOI 10.1136/ard.54.12.944.
   Feinstein AR, 1997, AM J MED, V103, P529, DOI 10.1016/S0002-9343(97)00244-1.
   FEINSTEIN AR, 1983, ANN INTERN MED, V99, P544, DOI 10.7326/0003-4819-99-4-544.
   FELSON DT, 1993, ARTHRITIS RHEUM-US, V36, P729, DOI 10.1002/art.1780360601.
   FELSON DT, 1990, ARTHRITIS RHEUM, V33, P140, DOI 10.1002/art.1780330119.
   Fex E, 1996, BRIT J RHEUMATOL, V35, P1106.
   FRIEREICH EJ, 1983, CONTROVERSY SURG, P5.
   FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202.
   FRIES JF, 1984, J MED PHILOS, V9, P161, DOI 10.1093/jmp/9.2.161.
   Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI {[}10.1002/art.21405, 10.1002/art.23364].
   Gogus F, 2005, CLIN EXP RHEUMATOL, V23, P681.
   GOLDSMITH CH, 1993, J RHEUMATOL, V20, P575.
   GORDON DA, 1973, AM J MED, V54, P445, DOI 10.1016/0002-9343(73)90040-5.
   Gordon P, 2001, J RHEUMATOL, V28, P2409.
   GOTZSCHE PC, 1989, CONTROL CLIN TRIALS, V10, P31, DOI 10.1016/0197-2456(89)90017-2.
   Graudal N, 2000, J RHEUMATOL, V27, P47.
   Grigor C, 2004, LANCET, V364, P263, DOI 10.1016/S0140-6736(04)16676-2.
   Hawley D J, 1992, Arthritis Care Res, V5, P130, DOI 10.1002/art.1790050304.
   HAWLEY DJ, 1991, J RHEUMATOL, V18, P1008.
   Horwitz RI, 1998, J CLIN EPIDEMIOL, V51, P305, DOI 10.1016/S0895-4356(98)00006-7.
   Isomaki HA, 1994, RHEUMATOID ARTHRITIS, P235.
   Janssen F, 2006, SOC SCI MED, V63, P239, DOI 10.1016/j.socscimed.2005.11.040.
   Jantti J, 2001, CLIN EXP RHEUMATOL, V19, P573.
   KAPLAN HS, 1972, HODGKINS DISEASE, P360.
   Korpela M, 2004, ARTHRITIS RHEUM, V50, P2072, DOI 10.1002/art.20351.
   Krause D, 2000, ARTHRITIS RHEUM-US, V43, P14, DOI 10.1002/1529-0131(200001)43:1<14::AID-ANR3>3.0.CO;2-7.
   Krishnan E, 2003, AM J MED, V115, P371, DOI 10.1016/S0002-9343(03)00397-8.
   Kvien TK, 2003, CLIN EXP RHEUMATOL, V21, pS118.
   Kvien TK, 2003, J RHEUMATOL, V30, P1135.
   LEIGH JP, 1991, J RHEUMATOL, V18, P1307.
   LUBECK DP, 1986, ARTHRITIS RHEUM, V29, P488, DOI 10.1002/art.1780290405.
   MacLean CH, 2004, ARTHRIT RHEUM-ARTHR, V51, P193, DOI 10.1002/art.20248.
   Micheli A, 2003, ANN ONCOL, V14, pV41, DOI 10.1093/annonc/mdg753.
   Minaur NJ, 2004, J RHEUMATOL, V31, P3.
   MITCHELL DM, 1986, ARTHRITIS RHEUM-US, V29, P706, DOI 10.1002/art.1780290602.
   Mottonen T, 1999, LANCET, V353, P1568, DOI 10.1016/S0140-6736(98)08513-4.
   Mulherin D, 1996, BRIT J RHEUMATOL, V35, P1263.
   NEATON JD, 1992, ARCH INTERN MED, V152, P56, DOI 10.1001/archinte.152.1.56.
   OLSEN NJ, 1988, AM J MED, V84, P257, DOI 10.1016/0002-9343(88)90422-6.
   Pincus T, 2000, J RHEUMATOL, V27, P2727.
   PINCUS T, 1984, ARTHRITIS RHEUM-US, V27, P864, DOI 10.1002/art.1780270805.
   PINCUS T, 1992, J AUTOIMMUN, V5, P209, DOI 10.1016/0896-8411(92)90036-P.
   PINCUS T, 1990, J RHEUMATOL, V17, P1582.
   Pincus T, 2005, CLIN EXP RHEUMATOL, V23, pS1.
   Pincus T, 2006, ANN RHEUM DIS, V65, P820, DOI 10.1136/ard.2005.044230.
   Pincus T, 1997, CLIN EXP RHEUMATOL, V15, P591.
   Pincus T, 2005, CLIN EXP RHEUMATOL, V23, pS19.
   Pincus T, 2005, J RHEUMATOL, V32, P1432.
   Pincus T, 2005, ARTHRITIS RHEUM-US, V52, P1009, DOI 10.1002/art.20941.
   Pincus T, 2005, ARTHRITIS RHEUM, V52, P1031, DOI 10.1002/art.20995.
   Pincus T, 2005, J RHEUMATOL, V32, P575.
   Pincus T, 2004, RHEUM DIS CLIN N AM, V30, P725, DOI 10.1016/j.rdc.2004.08.001.
   Pincus T, 2004, CLIN EXP RHEUMATOL, V22, pS26.
   Pincus T, 1997, CLIN EXP RHEUMATOL, V15, pS27.
   Pincus T, 1996, Arthritis Care Res, V9, P339, DOI 10.1002/1529-0131(199610)9:5<339::AID-ANR1790090502>3.0.CO;2-M.
   PINCUS T, 1988, J CLIN EPIDEMIOL, V41, P1037, DOI 10.1016/0895-4356(88)90072-8.
   Pincus T, 2004, J RHEUMATOL, V31, P229.
   PINCUS T, 1986, J RHEUMATOL, V13, P841.
   PINCUS T, 1994, ANN INTERN MED, V120, P26, DOI 10.7326/0003-4819-120-1-199401010-00005.
   Pincus T, 2003, CLIN EXP RHEUMATOL, V21, pS179.
   Pincus T, 2003, BEST PRACT RES CL RH, V17, P753, DOI 10.1016/S1521-6942(03)00077-9.
   Pincus T, 2003, ARTHRITIS RHEUM, V48, P625, DOI 10.1002/art.10824.
   Pincus T, 1999, ANN INTERN MED, V131, P768, DOI 10.7326/0003-4819-131-10-199911160-00009.
   Pincus T, 2002, CLIN EXP RHEUMATOL, V20, pS42.
   PINCUS T, 1993, PRIMARY CARE, V20, P795.
   PINCUS T, 1993, SEMIN ARTHRITIS RHEU, V23, P2, DOI 10.1016/S0049-0172(10)80002-2.
   PINCUS T, 1994, SCAND J RHEUMATOL, P21.
   Pincus T, 1999, J RHEUMATOL, V26, P473.
   Pincus T, 1989, Scand J Rheumatol Suppl, V79, P67.
   PINCUS T, 1997, RHEUMATOLOGY.
   Pincus T, 2006, RHEUM DIS CLIN UPDAT, V1, P1.
   Pincus T, 2007, BEST PRACT RES CL RH, V21, P601, DOI 10.1016/j.berh.2007.02.007.
   Pincus T, 2006, BULL HOSP JT DIS, V64, P32.
   Pincus T, 2006, J RHEUMATOL, V33, P2146.
   PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107.
   PROUDFIT WL, 1978, PROG CARDIOVASC DIS, V21, P53, DOI 10.1016/S0033-0620(78)80004-8.
   Rau R, 1997, J RHEUMATOL, V24, P1881.
   SACKETT DL, 1979, NEW ENGL J MED, V301, P1410, DOI 10.1056/NEJM197912273012602.
   Salaffi E, 2005, CLIN EXP RHEUMATOL, V23, pS31.
   SCOTT DL, 1984, ANN RHEUM DIS, V43, P8, DOI 10.1136/ard.43.1.8.
   SHARP JT, 1991, ARTHRITIS RHEUM, V34, P660, DOI 10.1002/art.1780340606.
   Soderlin MK, 1998, J RHEUMATOL, V25, P1895.
   Sokka T, 2003, ARTHRITIS RHEUM-US, V48, P313, DOI 10.1002/art.10817.
   Sokka T, 2007, ANN RHEUM DIS, V66, P274.
   Sokka T, 2004, J RHEUMATOL, V31, P1073.
   Sokka T, 2005, CLIN EXP RHEUMATOL, V23, pS58.
   Sokka T, 2004, ANN RHEUM DIS, V63, P494, DOI 10.1136/ard.2003.009530.
   Sokka T, 2003, J RHEUMATOL, V30, P1138.
   Sokka T, 1999, J RHEUMATOL, V26, P1681.
   SOKKA T, 2007, ANN RHEUM DIS.
   Sokka TM, 1999, CLIN EXP RHEUMATOL, V17, P527.
   Sokka T, 2007, ANN RHEUM DIS, V66, P341, DOI 10.1136/ard.2006.057067.
   Stein CM, 1999, LANCET, V353, P400, DOI 10.1016/S0140-6736(98)01373-7.
   STUCKI G, 1995, ARTHRITIS RHEUM, V38, P795, DOI 10.1002/art.1780380612.
   TRESSERRAS R, 1992, AM J PUBLIC HEALTH, V82, P435, DOI 10.2105/AJPH.82.3.435.
   VANDERHEIJDE DMFM, 1993, J RHEUMATOL, V20, P579.
   WAALER H, 1984, WORLD HEALTH FORUM, V5, P276.
   WEINBLATT ME, 1985, NEW ENGL J MED, V312, P818, DOI 10.1056/NEJM198503283121303.
   Weinblatt ME, 1996, ANN INTERN MED, V124, P773, DOI 10.7326/0003-4819-124-8-199604150-00012.
   Welsing PMJ, 2001, ARTHRITIS RHEUM, V44, P2009, DOI 10.1002/1529-0131(200109)44:9<2009::AID-ART349>3.0.CO;2-L.
   WEYL S, 1975, COMPUT BIOMED RES, V8, P279, DOI 10.1016/0010-4809(75)90045-2.
   WILSKE KR, 1989, J RHEUMATOL, V16, P565.
   Wolfe F, 1998, J RHEUMATOL, V25, P2108.
   Wolfe F, 1999, ARTHRITIS RHEUM, V42, P1797, DOI 10.1002/1529-0131(199909)42:9<1797::AID-ANR2>3.0.CO;2-Q.
   WOLFE F, 1991, J RHEUMATOL, V18, P1298.
   WOLFE F, 1985, J RHEUMATOL, V12, P245.
   WOLFE F, 1988, J RHEUMATOL, V15, P1480.
   Wolfe F, 2004, ARTHRITIS RHEUM-US, V50, P3296, DOI 10.1002/art.20549.
   Wolfe F, 2003, ARTHRITIS RHEUM, V48, P1530, DOI 10.1002/art.11024.
   Wolfe F, 2003, ARTHRIT RHEUM-ARTHR, V49, P59, DOI 10.1002/art.10904.
   Wolfe F, 1998, ARTHRITIS RHEUM, V41, P1072, DOI 10.1002/1529-0131(199806)41:6<1072::AID-ART14>3.0.CO;2-G.
   WOLFE F, 1994, J RHEUMATOL, V21, P1227.
   WOLFE F, 1994, ARTHRITIS RHEUM-US, V37, P481, DOI 10.1002/art.1780370408.
   YELIN E, 1980, ANN INTERN MED, V93, P551, DOI 10.7326/0003-4819-93-4-551.},
Number-of-Cited-References = {128},
Times-Cited = {22},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Clin. Exp. Rheumatol.},
Doc-Delivery-Number = {235QA},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000251248200015},
DA = {2022-03-29},
}
